Gene,Inheritance
A2M,"AR (Anterior segment dysgenesis 8); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); AR (Hemochromatosis, type 2B); AD ({Otitis media, susceptibility to}); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); {Myocardial infarction, susceptibility to}",
A2ML1,"AD ({Otitis media, susceptibility to})",
A4GALT,"[Blood group, P1Pk system, p phenotype]; [Blood group, P1Pk system, P(2) phenotype]; NOR polyagglutination syndrome; [Blood group, globoside system]; [Blood group, P1PK system, P(k) phenotype]",
AAAS,"AR (Achalasia-addisonianism-alacrimia syndrome); AD (Aortic aneurysm, familial abdominal 1); {Transcription of plasminogen activator inhibitor, modulator of}; AR (Plasminogen activator inhibitor-1 deficiency); AR (Alacrima, achalasia, and impaired intellectual development syndrome)",
AAGAB,"AD (Keratoderma, palmoplantar, punctate type IA)",
AARS1,"AD (?Leukoencephalopathy, hereditary diffuse, with spheroids 2); AD (Charcot-Marie-Tooth disease, axonal, type 2N); AR (Developmental and epileptic encephalopathy 29); AR (Trichothiodystrophy 8, nonphotosensitive); AR (?Trichothiodystrophy 9, nonphotosensitive); AD (Charcot-Marie-Tooth disease, axonal, type 2U); AR (Interstitial lung and liver disease); AR (Spastic paraplegia 70, autosomal recessive)",
AARS2,"AR (Combined oxidative phosphorylation deficiency 8); AR (Leukoencephalopathy, progressive, with ovarian failure)",
AARSD1,"AD (?Leukoencephalopathy, hereditary diffuse, with spheroids 2); AD (Charcot-Marie-Tooth disease, axonal, type 2N); AR (Developmental and epileptic encephalopathy 29); AR (Trichothiodystrophy 8, nonphotosensitive)",
AASS,"AR (Hyperlysinemia); AR (2,4-dienoyl-CoA reductase deficiency)",
AATK,Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1,
ABAT,"AR (GABA-transaminase deficiency); AD ({Autism, susceptibility to, 14B}); AD (Chromosome 16p11.2 duplication syndrome); AD ({Autism susceptibility 14A}); AD (Chromosome 16p11.2 deletion syndrome, 593kb)",
ABCA1,"AD (HDL deficiency, familial, 1); AR (Tangier disease); AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AR (Sitosterolemia 2); {Gallbladder disease 4}; AR (Sitosterolemia 1)",
ABCA10,"AR (Hypertrichosis terminalis, generalized, with or without gingival hyperplasia)",
ABCA12,"AR (Ichthyosis, congenital, autosomal recessive 4A); AR (Ichthyosis, congenital, autosomal recessive 4B (harlequin))",
ABCA13,AD ({Major affective disorder 1}),
ABCA2,"AR (Intellectual developmental disorder with poor growth and with or without seizures or ataxia); AR (?Hypertrichosis, congenital generalized, with gingival hyperplasia); AD (HDL deficiency, familial, 1); AR (Tangier disease)",
ABCA3,"AR (Surfactant metabolism dysfunction, pulmonary, 3); AR (Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome); AD (Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension); Chromosome 17q23.1-q23.2 deletion syndrome; AR (Ichthyosis, congenital, autosomal recessive 4A); AR (Ichthyosis, congenital, autosomal recessive 4B (harlequin))",
ABCA4,"AD ({Macular degeneration, age-related, 2}); AR (Cone-rod dystrophy 3); AR (Fundus flavimaculatus); AR (Retinal dystrophy, early-onset severe); AR (Retinitis pigmentosa 19); AR (Stargardt disease 1); AR (Cone-rod dystrophy 12); AD (Macular dystrophy, retinal, 2); AR (Retinitis pigmentosa 41); AD (Stargardt disease 4); AD (Orofacial cleft-1)",
ABCA5,"AR (?Hypertrichosis, congenital generalized, with gingival hyperplasia); AR (Hypertrichosis terminalis, generalized, with or without gingival hyperplasia); AR (Intellectual developmental disorder with poor growth and with or without seizures or ataxia); AD (?Hypertrichosis universalis congenita, Ambras type)",
ABCA6,"AR (Hypertrichosis terminalis, generalized, with or without gingival hyperplasia)",
ABCA7,"AD ({Alzheimer disease 9, susceptibility to}); AR (Intellectual developmental disorder with poor growth and with or without seizures or ataxia); AR (Ichthyosis, congenital, autosomal recessive 4A); AR (Ichthyosis, congenital, autosomal recessive 4B (harlequin))",
ABCA8,"AR (Hypertrichosis terminalis, generalized, with or without gingival hyperplasia)",
ABCA9,"AR (Hypertrichosis terminalis, generalized, with or without gingival hyperplasia)",
ABCB1,"{Colchicine resistance}; {Inflammatory bowel disease 13}; AR (Encephalopathy, acute transient); AR (Clopidogrel, impaired responsiveness to); AR (Mephenytoin poor metabolizer); AR (Omeprazole poor metabolizer); AR (Proguanil poor metabolizer); {Opioid dependence, susceptibility to, 1}; AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AR (Myoectodermal gonadal dysgenesis syndrome); AD (Spermatogenic failure 36); [Junior blood group system]; AD ([Uric acid concentration, serum, QTL1])",
ABCB11,"AR (Cholestasis, benign recurrent intrahepatic, 2); AR (Cholestasis, progressive familial intrahepatic 2); AR (Cholestasis, progressive familial intrahepatic, 5); [Fasting plasma glucose level QTL 1]; AR (?Cholestasis, progressive familial intrahepatic, 11); [Blood group, John-Milton-Hagen system]; AR (Cholestasis, progressive familial intrahepatic, 8)",
ABCB4,"AR (Cholestasis, intrahepatic, of pregnancy, 3); AR (Cholestasis, progressive familial intrahepatic 3); AR (Gallbladder disease 1); AR (Cholestasis, progressive familial intrahepatic, 10); AR (Diarrhea 2, with microvillus atrophy, with or without cholestasis)",
ABCB5,"AD ({Melanoma, cutaneous malignant, 1})",
ABCB6,"[Blood group, Langereis system]; AD (Dyschromatosis universalis hereditaria 3); AD (Microphthalmia/coloboma 7); AD (Pseudohyperkalemia, familial, 2, due to red cell leak); Microphthalmia with coloboma 1; Dyschromatosis universalis hereditaria 2",
ABCB7,"Anemia, sideroblastic, with ataxia; AR (Neurodevelopmental disorder with cerebellar atrophy and with or without seizures); AR (Rigidity and multifocal seizure syndrome, lethal neonatal); [Blood group, Langereis system]; AD (Dyschromatosis universalis hereditaria 3); AD (Microphthalmia/coloboma 7); AD (Pseudohyperkalemia, familial, 2, due to red cell leak)",
ABCB9,AR (Kaya-Barakat-Masson syndrome),
ABCC1,"AD (?Deafness, autosomal dominant 77); AR (Arterial calcification, generalized, of infancy, 2); AR (Pseudoxanthoma elasticum); AD (Pseudoxanthoma elasticum, forme fruste); Adrenoleukodystrophy; Adrenomyeloneuropathy, adult",
ABCC11,"AD ([Axillary odor, variation in]); AD ([Colostrum secretion, variation in]); AD ([Earwax, wet/dry])",
ABCC12,"AD ([Axillary odor, variation in]); AD ([Colostrum secretion, variation in]); AD ([Earwax, wet/dry])",
ABCC2,"AR (Dubin-Johnson syndrome); AR (Deafness, autosomal recessive 24); AR (?Cholestasis, progressive familial intrahepatic, 11); [Blood group, John-Milton-Hagen system]; AD (?Deafness, autosomal dominant 77); AR (Cholestasis, progressive familial intrahepatic, 8)",
ABCC3,"Hyperbilirubinemia, Rotor type, digenic; Hyperbilirubinemia, Rotor type, digenic; AD (?Deafness, autosomal dominant 77); AR (?Cholestasis, progressive familial intrahepatic, 6); AD ([Axillary odor, variation in]); AD ([Colostrum secretion, variation in]); AD ([Earwax, wet/dry])",
ABCC4,"AR (Cholestasis, progressive familial intrahepatic, 5); AD ([Axillary odor, variation in]); AD ([Colostrum secretion, variation in]); AD ([Earwax, wet/dry])",
ABCC5,"AD (?Deafness, autosomal dominant 77); AD ([Axillary odor, variation in]); AD ([Colostrum secretion, variation in]); AD ([Earwax, wet/dry])",
ABCC6,"AR (Arterial calcification, generalized, of infancy, 2); AR (Pseudoxanthoma elasticum); AD (Pseudoxanthoma elasticum, forme fruste); Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency; AR (Vitamin K-dependent clotting factors, combined deficiency of, 1); AR (Spastic paraplegia 56, autosomal recessive); AD ({Diabetes mellitus, non-insulin-dependent, susceptibility to}); AR ({Obesity, susceptibility to}); AR (Arterial calcification, generalized, of infancy, 1); AD (Cole disease); AR (Hypophosphatemic rickets, autosomal recessive, 2); {Microvascular complications of diabetes 1}",
ABCC8,"AD (Diabetes mellitus, noninsulin-dependent); AR (Diabetes mellitus, permanent neonatal 3); AD (Diabetes mellitus, transient neonatal 2); AR (Hyperinsulinemic hypoglycemia, familial, 1); AD (Hypoglycemia of infancy, leucine-sensitive); AD (Maturity-onset diabetes of the young, type 12); AD (Diabetes mellitus, transient neonatal 3); AD (Diabetes, permanent neonatal 2, with or without neurologic features); AR (Hyperinsulinemic hypoglycemia, familial, 2); AD (Maturity-onset diabetes of the young, type 13); AR ({Diabetes mellitus, transient neonatal 1})",
ABCC9,"AD (?Atrial fibrillation, familial, 12); AD (Cardiomyopathy, dilated, 1O); AD (Hypertrichotic osteochondrodysplasia (Cantu syndrome)); AR (Intellectual disability and myopathy syndrome); AD (Diabetes mellitus, transient neonatal 3); AD (Diabetes, permanent neonatal 2, with or without neurologic features); AR (Hyperinsulinemic hypoglycemia, familial, 2); AD (Maturity-onset diabetes of the young, type 13); AD (Atrial fibrillation, familial, 1)",
ABCD1,"Adrenoleukodystrophy; Adrenomyeloneuropathy, adult; AR (Methylmalonic aciduria and homocystinuria, cblJ type); AR (Retinal dystrophy with leukodystrophy); AD (?Neuropathy, inflammatory demyelinating); AD (Charcot-Marie-Tooth disease, type 1A); AD (Charcot-Marie-Tooth disease, type 1E); AR (Dejerine-Sottas disease); AD (Neuropathy, recurrent, with pressure palsies); AD (Roussy-Levy syndrome)",
ABCD2,"Adrenoleukodystrophy; Adrenomyeloneuropathy, adult; AR (Methylmalonic aciduria and homocystinuria, cblJ type)",
ABCD3,"AR (?Bile acid synthesis defect, congenital, 5); Adrenoleukodystrophy; Adrenomyeloneuropathy, adult; AR (Methylmalonic aciduria and homocystinuria, cblJ type)",
ABCD4,"AR (Methylmalonic aciduria and homocystinuria, cblJ type); AR (Methylmalonic aciduria and homocystinuria, cblF type); Adrenoleukodystrophy; Adrenomyeloneuropathy, adult",
ABCG1,"AD (HDL deficiency, familial, 1); AR (Tangier disease); Down syndrome; AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AR (Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy); AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease)",
ABCG2,"[Junior blood group system]; AD ([Uric acid concentration, serum, QTL1]); {Colchicine resistance}; {Inflammatory bowel disease 13}; AR (Encephalopathy, acute transient); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Polycystic kidney disease 2)",
ABCG5,"AR (Sitosterolemia 2); {Gallbladder disease 4}; AR (Sitosterolemia 1); Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); Rhabdomyosarcoma, alveolar; AD (Abdominal obesity-metabolic syndrome 1)",
ABCG8,"{Gallbladder disease 4}; AR (Sitosterolemia 1); AR (Sitosterolemia 2); Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); Rhabdomyosarcoma, alveolar",
ABHD12,"AR (Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract); AR (Spastic paraplegia 86, autosomal recessive)",
ABHD16A,"AR (Spastic paraplegia 86, autosomal recessive)",
ABHD17A,"?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic; Colorectal cancer, somatic; Epidermal nevus, somatic; Melanocytic nevus syndrome, congenital, somatic; Neurocutaneous melanosis, somatic; AD (Noonan syndrome 6); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Thyroid carcinoma, follicular, somatic",
ABHD2,AR (Spermatogenic failure 7),
ABHD5,"AR (Chanarin-Dorfman syndrome); AD (Lipodystrophy, familial partial, type 4); AR (Neutral lipid storage disease with myopathy)",
ABHD6,"AR (Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract)",
ABHD8,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome)",
ABI1,"AD (Wiedemann-Steiner syndrome); AR (?Deafness, autosomal recessive 102); AD (Intellectual developmental disorder, autosomal dominant 48)",
ABI2,"AD (Intellectual developmental disorder, autosomal dominant 26); AD (Intellectual developmental disorder, autosomal dominant 48); AD (Neurodevelopmental disorder with absent language and variable seizures)",
ABL1,"AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib; AR ({Encephalopathy, acute, infection-induced, susceptibility to, 9}); Leukemia, acute myeloid, somatic; Leukemia, T-cell acute lymphoblastic, somatic; Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic; Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic; AD (Immunodeficiency, common variable, 13); {Leukemia, acute lymphocytic, susceptibility to, 1}; {Leukemia, acute lymphoblastic, susceptibility to, 2}",
ABL2,"Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); AR (Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects); AR (Fetal akinesia deformation sequence 1); AR (Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency); AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib",
ABO,"[Blood group, ABO system]; AR (Anemia, congenital, nonspherocytic hemolytic, 3, adenylate kinase deficient); [Bilirubin, serum level of, QTL1]; AR ([Gilbert syndrome]); AR (Crigler-Najjar syndrome, type I); AR (Crigler-Najjar syndrome, type II); AR (Hyperbilirubinemia, familial transient neonatal); AR ({Lead poisoning, susceptibility to}); AR (Porphyria, acute hepatic)",
ABR,"AR (Spastic paraplegia, optic atrophy, and neuropathy)",
ABRA,"AD (Corneal dystrophy, punctiform and polychromatic pre-Descemet); AR (Spinocerebellar ataxia, autosomal recessive 32); AR (Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay); AD (Focal segmental glomerulosclerosis 10); AD (Nail-patella syndrome)",
ABT1,"AR (Charcot-Marie-Tooth disease, axonal, type 2S); AR (Neuronopathy, distal hereditary motor, autosomal recessive 1)",
ACAA1,AR (?Leukoencephalopathy with dystonia and motor neuropathy); AD (Mitchell syndrome); AR (Peroxisomal acyl-CoA oxidase deficiency),
ACACA,"AR (Acetyl-CoA carboxylase deficiency); AR (Obesity, morbid, due to leptin deficiency); AD (?Juvenile myelomonocytic leukemia); AD (Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia); AD (HDL deficiency, familial, 1); AR (Tangier disease)",
ACACB,AR (Acetyl-CoA carboxylase deficiency),
ACAD8,AR (Isobutyryl-CoA dehydrogenase deficiency); AR (2-methylbutyrylglycinuria),
ACAD9,"AR (Mitochondrial complex I deficiency, nuclear type 20); AR (Mitochondrial complex I deficiency, nuclear type 29)",
ACADL,AR (Isobutyryl-CoA dehydrogenase deficiency); AR (VLCAD deficiency),
ACADM,"AR (Acyl-CoA dehydrogenase, medium chain, deficiency of); AR (Congenital disorder of glycosylation, type It); AR (Glutaric acidemia IIB); AR (Isobutyryl-CoA dehydrogenase deficiency); AR (VLCAD deficiency)",
ACADS,"AR (Acyl-CoA dehydrogenase, short-chain, deficiency of); AR (Isobutyryl-CoA dehydrogenase deficiency); AR (Mitochondrial complex I deficiency, nuclear type 20); AR (2-methylbutyrylglycinuria); AR (Glutaric acidemia IIA); AR (VLCAD deficiency)",
ACADSB,AR (2-methylbutyrylglycinuria); AR (Isobutyryl-CoA dehydrogenase deficiency),
ACADVL,"AR (VLCAD deficiency); AR (Mitochondrial complex I deficiency, nuclear type 20); AD (Muscular dystrophy, limb-girdle, autosomal dominant 4); AR (Muscular dystrophy, limb-girdle, autosomal recessive 1); AR (Isobutyryl-CoA dehydrogenase deficiency)",
ACAN,"AD (?Spondyloepiphyseal dysplasia, Kimberley type); AD (Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans); AR (Spondyloepimetaphyseal dysplasia, aggrecan type); {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AD (Deafness, autosomal dominant 56)",
ACAT1,"AR (Alpha-methylacetoacetic aciduria); AR (Diarrhea 7, protein-losing enteropathy type); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; ?ACAT2 deficiency; AR ({Alzhieimer disease 17, susceptibility to}); AR (Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2)",
ACAT2,"?ACAT2 deficiency; AD (Intellectual developmental disorder with polymicrogyria and seizures); AD (Drug metabolism, altered, CES1-related); AR (Alpha-methylacetoacetic aciduria)",
ACBD3,"AD (Deafness, autosomal dominant 87); Diaphragmatic hernia 1",
ACBD4,"AD (Amyotrophic lateral sclerosis 8); AD (Spinal muscular atrophy, late-onset, Finkel type)",
ACBD5,AR (Retinal dystrophy with leukodystrophy); AD (Thrombocytopenia 2),
ACBD6,AR (Neurodevelopmental disorder with progressive movement abnormalities),
ACD,"AR (?Dyskeratosis congenita, autosomal dominant 6); AR (?Dyskeratosis congenita, autosomal recessive 7); AR (?Cerebroretinal microangiopathy with calcifications and cysts 3); AD (?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8); AD (Tumor predisposition syndrome 3); AR (?Mungan syndrome); AD (Cornelia de Lange syndrome 4); AR (Hemochromatosis, type 1)",
ACE,"[Angiotensin I-converting enzyme, benign serum increase]; {Microvascular complications of diabetes 3}; {Myocardial infarction, susceptibility to}; {SARS, progression of}; {Stroke, hemorrhagic}; AR (Renal tubular dysgenesis); AD ({IgA nephropathy, susceptibility to, 1}); AR (Renal tubular dysgenesis); AD (?Immune dysregulation, autoimmunity, and autoinflammation); AD (Autoinflammation, antibody deficiency, and immune dysregulation syndrome); AD (Familial cold autoinflammatory syndrome 3)",
ACE2,"AR (Hartnup disorder); {Hypertension, essential}; AR (Renal tubular dysgenesis)",
ACER2,"AR (?Leukodystrophy, progressive, early childhood-onset)",
ACER3,"AR (?Leukodystrophy, progressive, early childhood-onset)",
ACHE,"[Blood group, Yt system]; AR (Myasthenic syndrome, congenital, 5); AR ({Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}); AR (Butyrylcholinesterase deficiency); AR (Dyssegmental dysplasia, Silverman-Handmaker type); AR (Schwartz-Jampel syndrome, type 1); {Autism susceptibility, X-linked 1}",
ACKR1,"AR ([Blood group, Duffy system]); AR ([White blood cell count QTL]); {Malaria, vivax, protection against}",
ACKR3,AR (?Oculomotor-abducens synkinesis),
ACLY,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE); AD (Charcot-Marie-Tooth disease, axonal, type 2Z); AD (Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy); AD (HDL deficiency, familial, 1); AR (Tangier disease)",
ACO1,"AR (Infantile cerebellar-retinal degeneration); AR (Optic atrophy 9); AR (Myopathy with lactic acidosis, hereditary); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR ({Lead poisoning, susceptibility to}); AR (Porphyria, acute hepatic)",
ACO2,"AR (Infantile cerebellar-retinal degeneration); AR (Optic atrophy 9); AR (Kanzaki disease); AR (Schindler disease, type I); AR (Schindler disease, type III); AR (Anemia, sideroblastic, 3, pyridoxine-refractory); AR (Spasticity, childhood-onset, with hyperglycinemia); AR (Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy); AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3); AR (Metachromatic leukodystrophy)",
ACOD1,"AD ({Parkinson disease 26, autosomal dominant, susceptibility to})",
ACOT7,"AD (Epilepsy, familial temporal lobe, 2)",
ACOX1,"AD (Mitchell syndrome); AR (Peroxisomal acyl-CoA oxidase deficiency); AR (Retinal dystrophy with leukodystrophy); AR (Bile acid synthesis defect, congenital, 6); AD (Adiponectin deficiency)",
ACOX2,"AR (Bile acid synthesis defect, congenital, 6); AD (Mitchell syndrome); AR (Peroxisomal acyl-CoA oxidase deficiency)",
ACOX3,AD (Mitchell syndrome); AR (Peroxisomal acyl-CoA oxidase deficiency),
ACP1,"AD (?Keratoderma, palmoplantar, punctate type 3); AR (?Developmental and epileptic encephalopathy 88); AR (?Lysosomal acid phosphatase deficiency); AR ({Obesity, early-onset, susceptibility to}); AR (Obesity, adrenal insufficiency, and red hair due to POMC deficiency)",
ACP2,"AR (?Lysosomal acid phosphatase deficiency); AR (Spondyloenchondrodysplasia with immune dysregulation); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AR (Cortical dysplasia, complex, with other brain malformations 10); AR (Intellectual developmental disorder, autosomal recessive 74); Supranuclear palsy, progressive, 3; AR (Amelogenesis imperfecta, type IJ)",
ACP4,"AR (Amelogenesis imperfecta, type IJ); AD (Amelogenesis imperfecta, type IB); AR (Amelogenesis imperfecta, type IC)",
ACP5,AR (Spondyloenchondrodysplasia with immune dysregulation),
ACR,"AR (?Spermatogenic failure 87); Chromosome 22q13 duplication syndrome; AD (Autoinflammatory disease, systemic, with vasculitis); AD ({Malignant hyperthermia susceptibility 1}); AD (Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia); AR (Congenital myopathy 1B, autosomal recessive); AD (King-Denborough syndrome)",
ACRV1,"AD (Brachydactyly, type B2); AD (Multiple synostoses syndrome 1); AD (Stapes ankylosis with broad thumbs and toes); AD (Symphalangism, proximal, 1A); AD (Tarsal-carpal coalition syndrome); AR (Spermatogenic failure 78)",
ACSBG1,"AR (Methylmalonic aciduria and homocystinuria, cblJ type); Adrenoleukodystrophy; Adrenomyeloneuropathy, adult",
ACSF3,"AR (Combined malonic and methylmalonic aciduria); AR (Intellectual developmental disorder, autosomal recessive 69)",
ACSL4,"Intellectual developmental disorder, X-linked 63; AR (Neurodevelopmental disorder with hypotonia and seizures); AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development); Meningioma, NF2-related, somatic; Schwannomatosis, somatic; AD (Schwannomatosis, vestibular)",
ACSL5,AR (?Diarrhea 13),
ACSM1,"{?Hypertension, essential}",
ACSM3,"{?Hypertension, essential}",
ACTA1,"AD (?Myopathy, scapulohumeroperoneal); AD (Congenital myopathy 2A, typical, autosomal dominant); AR (Congenital myopathy 2B, severe infantile, autosomal recessive); AD (Congenital myopathy 2C, severe infantile, autosomal dominant); AD (Cardiomyopathy, dilated, 1C, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 24); AD (Left ventricular noncompaction 3); AD (Myopathy, myofibrillar, 4); AD ({Epilepsy, idiopathic generalized, susceptibility to, 19}); AD (Arthrogryposis, distal, type 2A (Freeman-Sheldon)); AD (Arthrogryposis, distal, type 2B3 (Sheldon-Hall)); AD (Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A); AR (Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B); AD (Arthrogryposis, distal, type 1A); AD (Arthrogryposis, distal, type 2B4); AD (Congenital myopathy 23)",
ACTA2,"AD (Aortic aneurysm, familial thoracic 6); Moyamoya disease 5; AD (Smooth muscle dysfunction syndrome); AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay); AD (Corneal dystrophy, Fuchs endothelial, 6); AD (Corneal dystrophy, posterior polymorphous, 3); AD (Megacystis-microcolon-intestinal hypoperistalsis syndrome 5); AD (Visceral myopathy 1); AD (Baraitser-Winter syndrome 2); AD (Deafness, autosomal dominant 20/26)",
ACTB,"AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay); AD (Baraitser-Winter syndrome 2); AD (Deafness, autosomal dominant 20/26); AR (Spermatogenic failure 78); AD (?Myopathy, scapulohumeroperoneal); AD (Congenital myopathy 2A, typical, autosomal dominant); AR (Congenital myopathy 2B, severe infantile, autosomal recessive); AD (Congenital myopathy 2C, severe infantile, autosomal dominant)",
ACTBL2,AR (Spermatogenic failure 78),
ACTC1,"AD (Atrial septal defect 5); AD (Cardiomyopathy, dilated, 1R); AD (Cardiomyopathy, hypertrophic, 11); AD (Left ventricular noncompaction 4); AD (?Myopathy, scapulohumeroperoneal); AD (Congenital myopathy 2A, typical, autosomal dominant); AR (Congenital myopathy 2B, severe infantile, autosomal recessive); AD (Congenital myopathy 2C, severe infantile, autosomal dominant); AD (Aortic valve disease 3); AD (Aortic aneurysm, familial thoracic 6); Moyamoya disease 5; AD (Smooth muscle dysfunction syndrome)",
ACTG1,"AD (Baraitser-Winter syndrome 2); AD (Deafness, autosomal dominant 20/26); AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay); AR (Ceroid lipofuscinosis, neuronal, 5); AD (?Myopathy, scapulohumeroperoneal); AD (Congenital myopathy 2A, typical, autosomal dominant); AR (Congenital myopathy 2B, severe infantile, autosomal recessive); AD (Congenital myopathy 2C, severe infantile, autosomal dominant); AD (Aortic aneurysm, familial thoracic 6); Moyamoya disease 5; AD (Smooth muscle dysfunction syndrome)",
ACTG2,"AD (Megacystis-microcolon-intestinal hypoperistalsis syndrome 5); AD (Visceral myopathy 1); AD (Aortic aneurysm, familial thoracic 6); Moyamoya disease 5; AD (Smooth muscle dysfunction syndrome)",
ACTL6A,"AR (Developmental and epileptic encephalopathy 76); AD (Intellectual developmental disorder with severe speech and ambulation defects); AD (Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities); AD ({Rhabdoid tumor predisposition syndrome 1}); AD ({Schwannomatosis-1, susceptibility to}); AD (Coffin-Siris syndrome 3); Rhabdoid tumors, somatic; AD ({Hydrocephalus, congenital, 5, susceptibility to}); AD (Coffin-Siris syndrome 2); AD (?Otosclerosis 12); AD ({Rhabdoid tumor predisposition syndrome 2}); AD (Coffin-Siris syndrome 4); AD (Coffin-Siris syndrome 12)",
ACTL6B,"AR (Developmental and epileptic encephalopathy 76); AD (Intellectual developmental disorder with severe speech and ambulation defects); AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5)",
ACTL7A,"AR (Spermatogenic failure 86); AR (Spermatogenic failure 53); {Spermatogenic failure, X-linked, 8, susceptibility to}; AR (Spermatogenic failure 78); AR (?Spermatogenic failure 87); AR (?Spermatogenic failure 85)",
ACTL7B,AR (Spermatogenic failure 86); Hypertensive nephropathy,
ACTL9,AR (Spermatogenic failure 53); AR (Spermatogenic failure 86),
ACTN1,"AD (Bleeding disorder, platelet-type, 15); AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay); AD (Cardiomyopathy, dilated, 1C, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 24); AD (Left ventricular noncompaction 3); AD (Myopathy, myofibrillar, 4); AD (Cardiomyopathy, dilated, 1AA, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 23, with or without LVNC); AD (Congenital myopathy 8); AD (Myopathy, distal, 6, adult onset); AR ([Alpha-actinin-3 deficiency]); AR ([Sprinting performance]); AD (?Myopathy, scapulohumeroperoneal); AD (Congenital myopathy 2A, typical, autosomal dominant); AR (Congenital myopathy 2B, severe infantile, autosomal recessive); AD (Congenital myopathy 2C, severe infantile, autosomal dominant); AR (?Congenital myopathy 9A with respiratory insufficiency and bone fractures); AR (Congenital myopathy 9B, proximal, with minicore lesions)",
ACTN2,"AD (Cardiomyopathy, dilated, 1AA, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 23, with or without LVNC); AD (Congenital myopathy 8); AD (Myopathy, distal, 6, adult onset); AR ([Alpha-actinin-3 deficiency]); AR ([Sprinting performance]); AD (Cardiomyopathy, dilated, 1C, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 24); AD (Left ventricular noncompaction 3); AD (Myopathy, myofibrillar, 4); AD (Cardiomyopathy, dilated, 1KK); AD (Cardiomyopathy, familial restrictive, 4); AD (Cardiomyopathy, hypertrophic, 22); AR (Congenital myopathy 24)",
ACTN3,"AR ([Alpha-actinin-3 deficiency]); AR ([Sprinting performance]); AD (Cardiomyopathy, dilated, 1AA, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 23, with or without LVNC); AD (Congenital myopathy 8); AD (Myopathy, distal, 6, adult onset); AR (McArdle disease); AR (Pyruvate carboxylase deficiency)",
ACTN4,"AD (Glomerulosclerosis, focal segmental, 1); AR (?Nephrotic syndrome, type 19)",
ACTR1A,"AR ({Amyotrophic lateral sclerosis, susceptibility to}); AD (Neuronopathy, distal hereditary motor, autosomal dominant 14); AD (Perry syndrome)",
ACTR2,"AD (Developmental delay, language impairment, and ocular abnormalities); AR (Immunodeficiency 113 with autoimmunity and autoinflammation); AR (Cortical dysplasia, complex, with other brain malformations 9); AD (Gastrointestinal stromal tumor, familial); Germ cell tumors, somatic; Leukemia, acute myeloid, somatic; AD (Mastocytosis, cutaneous); Mastocytosis, systemic, somatic; AD (Piebaldism)",
ACTR3,"AD (Amyloidosis, Finnish type); AR (Nephrotic syndrome, type 21); AR (Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia); AD (Developmental delay, language impairment, and ocular abnormalities); AR (Immunodeficiency 113 with autoimmunity and autoinflammation)",
ACTRT1,"Bazex-Dupre-Christol syndrome; {Spermatogenic failure, X-linked, 8, susceptibility to}",
ACTRT2,"{Spermatogenic failure, X-linked, 8, susceptibility to}",
ACVR1,"AD (Fibrodysplasia ossificans progressiva); {Atrioventricular septal defect, susceptibility to, 1}; AD (Brachydactyly, type B2); AD (Multiple synostoses syndrome 1); AD (Stapes ankylosis with broad thumbs and toes); AD (Symphalangism, proximal, 1A); AD (Tarsal-carpal coalition syndrome); Polyposis syndrome, hereditary mixed, 2; AD (Polyposis, juvenile intestinal); AR (Acromesomelic dysplasia 3); AD (Brachydactyly, type A1, D); AD (Brachydactyly, type A2)",
ACVR1B,"Pancreatic cancer, somatic; AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor); AD (Telangiectasia, hereditary hemorrhagic, type 2)",
ACVR1C,"Klippel-Feil syndrome 3, autosomal dominant; AD (Microphthalmia, isolated 7); AD (Microphthalmia, isolated, with coloboma 6)",
ACVR2A,"AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Telangiectasia, hereditary hemorrhagic, type 5)",
ACVR2B,"Heterotaxy, visceral, 4, autosomal; AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea); AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III)",
ACVRL1,"AD (Telangiectasia, hereditary hemorrhagic, type 2); AD (Telangiectasia, hereditary hemorrhagic, type 1); AD (Fibrodysplasia ossificans progressiva); AD (Telangiectasia, hereditary hemorrhagic, type 5); AD (Pulmonary hypertension, familial primary, 1, with or without HHT); AD (Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated); AD (Pulmonary venoocclusive disease 1)",
ACY1,"AR (Aminoacylase 1 deficiency); AR (GM1-gangliosidosis, type I); AR (GM1-gangliosidosis, type II); AR (GM1-gangliosidosis, type III); AR (Mucopolysaccharidosis type IVB (Morquio)); AR (Atransferrinemia); AR (Canavan disease)",
ADA,"AR (Adenosine deaminase deficiency, partial); AR (Severe combined immunodeficiency due to ADA deficiency); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
ADA2,"AR (Sneddon syndrome); AR (Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome); AR (Adenosine deaminase deficiency, partial); AR (Severe combined immunodeficiency due to ADA deficiency); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
ADAD1,"{Autoimmune disease, susceptibility to, 5}; {Celiac disease, susceptibility to, 6}",
ADAM10,"{Alzheimer disease 18, susceptibility to}; AD (Reticulate acropigmentation of Kitamura); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AR (?Inflammatory skin and bowel disease, neonatal, 1); AD ({Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection}); AD (Autoinflammation, panniculitis, and dermatosis syndrome, autosomal dominant); AR (Autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive)",
ADAM12,"Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy",
ADAM15,"AR (Frank-ter Haar syndrome); AR (Cone-rod dystrophy 9); AD (Tylosis with esophageal cancer); AR (?Fanconi anemia, complementation group V)",
ADAM17,"AR (?Inflammatory skin and bowel disease, neonatal, 1); AD (Tylosis with esophageal cancer); {Alzheimer disease 18, susceptibility to}; AD (Reticulate acropigmentation of Kitamura); AR (?Tumoral calcinosis, hyperphosphatemic, familial, 3); AR (Cone-rod dystrophy 9); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}",
ADAM19,"AR (Cone-rod dystrophy 9); AR (?Inflammatory skin and bowel disease, neonatal, 1); AR (?Fanconi anemia, complementation group V)",
ADAM22,"AR (Developmental and epileptic encephalopathy 61); AD (Epilepsy, familial temporal lobe, 1); AR (Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects); AR (Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect)",
ADAM23,"AR (Developmental and epileptic encephalopathy 61); AD (Epilepsy, familial temporal lobe, 1); AR (Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects)",
ADAM9,"AR (Cone-rod dystrophy 9); AR (Epidermolysis bullosa, junctional 4, intermediate); AD (Epithelial recurrent erosion dystrophy); AR (?Inflammatory skin and bowel disease, neonatal, 1); AR (?Fanconi anemia, complementation group V); {Alzheimer disease 18, susceptibility to}; AD (Reticulate acropigmentation of Kitamura)",
ADAMTS1,"AR (?Progesterone resistance); AR (Arthrogryposis, distal, type 12)",
ADAMTS10,"AR (Weill-Marchesani syndrome 1, recessive); AR (Geleophysic dysplasia 1); AR (Weill-Marchesani 4 syndrome, recessive)",
ADAMTS12,"AD (Brachydactyly, type E2)",
ADAMTS13,"AR (Thrombotic thrombocytopenic purpura, hereditary); AD (von Willebrand disease, type 1); AR (von Willebrand disease, type 3); AR (von Willebrand disease, types 2A, 2B, 2M, and 2N)",
ADAMTS15,"AR (Arthrogryposis, distal, type 12)",
ADAMTS16,"{Hypertension, essential, susceptibility to, 6}; AR (Microcornea, myopic chorioretinal atrophy, and telecanthus); AD (Macular dystrophy, retinal, 3)",
ADAMTS17,"AR (Weill-Marchesani 4 syndrome, recessive); AR (Ichthyosis, congenital, autosomal recessive 9); AR (Cardiac valvular dysplasia 2); AR (Weill-Marchesani syndrome 1, recessive)",
ADAMTS18,"AR (Microcornea, myopic chorioretinal atrophy, and telecanthus); [Bone mineral density QTL 13]; [Bone mineral density QTL 14]",
ADAMTS19,"AR (Cardiac valvular dysplasia 2); AR (Weill-Marchesani 4 syndrome, recessive)",
ADAMTS2,"AR (Ehlers-Danlos syndrome, dermatosparaxis type); AD ({Bone mineral density variation QTL, osteoporosis}); AD (Caffey disease); AD (Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1); AD (Ehlers-Danlos syndrome, arthrochalasia type, 1); AD (Osteogenesis imperfecta, type I); AD (Osteogenesis imperfecta, type II); AD (Osteogenesis imperfecta, type III); AD (Osteogenesis imperfecta, type IV); AR (Geleophysic dysplasia 1); AR (Thrombotic thrombocytopenic purpura, hereditary)",
ADAMTS3,AR (Hennekam lymphangiectasia-lymphedema syndrome 3); AD (Chopra-Amiel-Gordon syndrome); {Stature QTL 1},
ADAMTS4,"AD (?Spondyloepiphyseal dysplasia, Kimberley type); AD (Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans); AR (Spondyloepimetaphyseal dysplasia, aggrecan type); AR (?Deafness, autosomal recessive 110); AD (Deafness, autosomal dominant 9); AD (Erythrocytosis, familial, 4); AR (Hennekam lymphangiectasia-lymphedema syndrome 3)",
ADAMTS5,"AD (?Spondyloepiphyseal dysplasia, Kimberley type); AD (Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans); AR (Spondyloepimetaphyseal dysplasia, aggrecan type); AR (Acrocapitofemoral dysplasia); AD (Brachydactyly, type A1); AR (?Deafness, autosomal recessive 110); AD (Deafness, autosomal dominant 9); AR (Ehlers-Danlos syndrome, dermatosparaxis type); AR (Hennekam lymphangiectasia-lymphedema syndrome 3)",
ADAMTS6,"AR (Ehlers-Danlos syndrome, dermatosparaxis type); AR (Hennekam lymphangiectasia-lymphedema syndrome 3); AR (Weill-Marchesani syndrome 1, recessive)",
ADAMTS7,"AD (Carpal tunnel syndrome 2); AD (Epiphyseal dysplasia, multiple, 1); AD (Pseudoachondroplasia); AD (Brachydactyly, type E2); AR (Ehlers-Danlos syndrome, dermatosparaxis type)",
ADAMTS8,"AR (Arthrogryposis, distal, type 12)",
ADAMTSL2,"AR (Geleophysic dysplasia 1); {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2)",
ADAMTSL3,AD (Chromosome 15q25 deletion syndrome),
ADAMTSL4,"AR (Ectopia lentis et pupillae); AR (Ectopia lentis, isolated, autosomal recessive); AD (Acromicric dysplasia); AD (Ectopia lentis, familial); AD (Geleophysic dysplasia 2); AD (Marfan lipodystrophy syndrome); AD (Marfan syndrome); AD (MASS syndrome); AD (Stiff skin syndrome); AD (Weill-Marchesani syndrome 2, dominant)",
ADAP2,"AD (Chromosome 17q11.2 deletion syndrome, 1.4Mb)",
ADAR,"AR (Aicardi-Goutieres syndrome 6); AD (Dyschromatosis symmetrica hereditaria); AR (Neurodevelopmental disorder with hypotonia, microcephaly, and seizures); AD (Intellectual developmental disorder, autosomal dominant 75); AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); AD (Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia)",
ADARB1,"AR (Neurodevelopmental disorder with hypotonia, microcephaly, and seizures)",
ADARB2,"AR (Neurodevelopmental disorder with hypotonia, microcephaly, and seizures)",
ADAT1,"AD (?Leukoencephalopathy, hereditary diffuse, with spheroids 2); AD (Charcot-Marie-Tooth disease, axonal, type 2N); AR (Developmental and epileptic encephalopathy 29); AR (Trichothiodystrophy 8, nonphotosensitive); AR (?Charcot-Marie-Tooth disease, recessive intermediate, B); AR (Deafness, autosomal recessive 89); AR (Deafness, congenital, and adult-onset progressive leukoencephalopathy); AR (Leukoencephalopathy, progressive, infantile-onset, with or without deafness); AR (Neurodevelopmental disorder with hypotonia, microcephaly, and seizures)",
ADAT2,"AR (Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies)",
ADAT3,"AR (Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies); AD (Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster)",
ADCK5,AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal),
ADCY1,"AR (?Deafness, autosomal recessive 44)",
ADCY10,"AD ({Hypercalciuria, absorptive, susceptibility to})",
ADCY3,"AR ({Obesity, susceptibility to, BMIQ19}); AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20)); AR (Joubert syndrome 21); AR (?Meckel syndrome 9); AR (Joubert syndrome 27); [Body mass index QTL1]",
ADCY5,"AD (Dyskinesia with orofacial involvement, autosomal dominant); AR (Dyskinesia with orofacial involvement, autosomal recessive); AR (Neurodevelopmental disorder with hyperkinetic movements and dyskinesia); [Birth weight QTL 3]; [Fasting plasma glucose level QTL 6]; [Birth weight QTL 1]; [Fasting plasma glucose level QTL 2]; AD (Dystonia 25)",
ADCY6,"AR (Lethal congenital contracture syndrome 8); AD (Deafness, autosomal dominant 50); AR (Hypomyelinating neuropathy, congenital, 3); AR (Lethal congenital contracture syndrome 7); AR (Arthrogryposis multiplex congenita 3, myogenic type); AD (Emery-Dreifuss muscular dystrophy 4, autosomal dominant); AR (Spinocerebellar ataxia, autosomal recessive 8)",
ADCY8,"AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; AR (?Deafness, autosomal recessive 44); AR (?Bleeding disorder, platelet-type, 19); Pituitary tumor, invasive; AD (Developmental and epileptic encephalopathy 27); AD (Intellectual developmental disorder, autosomal dominant 6, with or without seizures); AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development); AD (Intellectual developmental disorder, autosomal dominant 59)",
ADCY9,"AD ({Melanoma, cutaneous malignant, 1})",
ADD1,"{Hypertension, essential, salt-sensitive}; AR (Cerebral palsy, spastic quadriplegic, 3); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome)",
ADD2,"{Hypertension, essential, salt-sensitive}; AR (Cerebral palsy, spastic quadriplegic, 3)",
ADD3,"AR (Cerebral palsy, spastic quadriplegic, 3); {Hypertension, essential, salt-sensitive}",
ADGRE1,"AR ({Hemolytic uremic syndrome, atypical, susceptibility to, 1}); AD ({Macular degeneration, age-related, 4}); AD (Basal laminar drusen); AR (Complement factor H deficiency)",
ADGRE2,AD (Vibratory urticaria),
ADGRG1,"AR (Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal)); Cortical dysplasia, complex, with other brain malformations 14B, (bilateral perisylvian); AD (Ehlers-Danlos syndrome, vascular type); AR (Polymicrogyria with or without vascular-type EDS)",
ADGRG2,"Congenital bilateral absence of vas deferens, X-linked",
ADGRG6,"AR (Lethal congenital contracture syndrome 9); {Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features)",
ADGRL1,"AD (Developmental delay, behavioral abnormalities, and neuropsychiatric disorders); AR (?Microphthalmia/coloboma 9); AR (Microphthalmia, syndromic 15); AD (Essential tremor, hereditary, 5)",
ADGRL2,"AD (Developmental delay, behavioral abnormalities, and neuropsychiatric disorders); AR (?Microphthalmia/coloboma 9); AR (Microphthalmia, syndromic 15); AD (Essential tremor, hereditary, 5)",
ADGRL3,"AD (Developmental delay, behavioral abnormalities, and neuropsychiatric disorders); AD (Hypogonadotropic hypogonadism 21 with anosmia); AR (?Microphthalmia/coloboma 9); AR (Microphthalmia, syndromic 15); AD (Essential tremor, hereditary, 5)",
ADGRV1,"AD (?Febrile seizures, familial, 4); AR (Usher syndrome, type 2C); AR (Usher syndrome, type 2C, GPR98/PDZD7 digenic); AR ({Retinal disease in Usher syndrome type IIA, modifier of}); AR (Deafness, autosomal recessive 57); AR (Usher syndrome, type IIC, GPR98/PDZD7 digenic); AD (Febrile seizures, familial, 1); AR (Dysostosis multiplex, Ain-Naz type)",
ADH1A,"{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; AMED syndrome, digenic; {Esophageal cancer, alcohol-related, susceptibility to}; AD ({Hangover, susceptibility to}); {Sublingual nitroglycerin, susceptibility to poor response to}; AD (Alcohol sensitivity, acute); {Alcohol dependence, protection against}; AD ({Parkinson disease, susceptibility to})",
ADH1B,"{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; {Esophageal cancer, alcohol-related, susceptibility to}; AD ({Hangover, susceptibility to}); {Sublingual nitroglycerin, susceptibility to poor response to}; AD (Alcohol sensitivity, acute); {Alcohol dependence, protection against}; AD ({Parkinson disease, susceptibility to})",
ADH1C,"{Alcohol dependence, protection against}; AD ({Parkinson disease, susceptibility to}); {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; {Esophageal cancer, alcohol-related, susceptibility to}; AD ({Hangover, susceptibility to}); {Sublingual nitroglycerin, susceptibility to poor response to}; AD (Alcohol sensitivity, acute); AD (Orofacial cleft-1)",
ADH4,"{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; AMED syndrome, digenic",
ADH5,"AMED syndrome, digenic; {Esophageal cancer, alcohol-related, susceptibility to}; AD ({Hangover, susceptibility to}); {Sublingual nitroglycerin, susceptibility to poor response to}; AD (Alcohol sensitivity, acute); {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}",
ADH6,"{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}",
ADH7,"{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; {Esophageal cancer, alcohol-related, susceptibility to}; AD ({Hangover, susceptibility to}); {Sublingual nitroglycerin, susceptibility to poor response to}; AD (Alcohol sensitivity, acute)",
ADIPOQ,AD (Adiponectin deficiency),
ADIPOR1,AD (Adiponectin deficiency),
ADK,AR (Hypermethioninemia due to adenosine kinase deficiency); AR (Spermatogenic failure 43),
ADM,"AR (?Lymphatic malformation 8); AR (Auriculocondylar syndrome 3); AD (Question mark ears, isolated); AR (Erythrocytosis, familial, 2); Hemangioblastoma, cerebellar, somatic; AD (Pheochromocytoma); Renal cell carcinoma, somatic; AD (von Hippel-Lindau syndrome)",
ADNP,AD (Helsmoortel-van der Aa syndrome); AD (Sifrim-Hitz-Weiss syndrome),
ADNP2,AD (Helsmoortel-van der Aa syndrome),
ADO,{Anxiety-related personality traits}; AD ({Obsessive-compulsive disorder}); {Autism susceptibility 1},
ADORA1,"AR (Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities); {Parkinson disease 16}; AR (Spastic paraplegia 64, autosomal recessive)",
ADORA2A,"AD (Dystonia 25); AD (?[Short sleep, familial natural, 2]); [Resting heart rate]",
ADORA2B,AD (Mirror movements 4),
ADPRS,"AR (Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures)",
ADRA1B,"Beta-2-adrenoreceptor agonist, reduced response to; AD (?[Short sleep, familial natural, 2]); [Resting heart rate]",
ADRA2A,"AD (?Lipodystrophy, familial partial, type 8); AD (?[Short sleep, familial natural, 2]); [Resting heart rate]; AD (Leukemia, acute myeloid)",
ADRA2B,"AD (?Lipodystrophy, familial partial, type 8); AD (Epilepsy, familial adult myoclonic, 2)",
ADRA2C,"AD (?Lipodystrophy, familial partial, type 8); AD (?[Short sleep, familial natural, 2]); [Resting heart rate]",
ADRB1,"AD (?[Short sleep, familial natural, 2]); [Resting heart rate]; Beta-2-adrenoreceptor agonist, reduced response to; AD (Intellectual developmental disorder, autosomal dominant 59); AR ({Obesity, susceptibility to})",
ADRB2,"Beta-2-adrenoreceptor agonist, reduced response to; AD (?[Short sleep, familial natural, 2]); [Resting heart rate]; AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AR ({Obesity, susceptibility to}); ACTH-independent macronodular adrenal hyperplasia 1, somatic; McCune-Albright syndrome, somatic mosaic; AD (Osseous heteroplasia, progressive); Pituitary adenoma 3, multiple types, somatic; AD (Pseudohypoparathyroidism Ia); AD (Pseudohypoparathyroidism Ib); AD (Pseudohypoparathyroidism Ic); AD (Pseudopseudohypoparathyroidism)",
ADRB3,"AR ({Obesity, susceptibility to}); AD (?[Short sleep, familial natural, 2]); [Resting heart rate]; Beta-2-adrenoreceptor agonist, reduced response to; {AIDS, resistance to}",
ADSL,"AR (Adenylosuccinase deficiency); AR (AICA-ribosiduria due to ATIC deficiency); AD (PCWH syndrome); AD (Waardenburg syndrome, type 2E, with or without neurologic involvement); AD (Waardenburg syndrome, type 4C)",
ADSS1,"AR (Myopathy, distal, 5)",
AEBP1,"AR (Ehlers-Danlos syndrome, classic-like, 2)",
AEBP2,AD (Developmental delay with variable intellectual disability and dysmorphic facies); AD (Imagawa-Matsumoto syndrome),
AFDN,AR (Cleft lip/palate-ectodermal dysplasia syndrome); AR (Orofacial cleft 7); AR (Ectodermal dysplasia-syndactyly syndrome 1),
AFF2,"Intellectual developmental disorder, X-linked 109; AD (KINSSHIP syndrome); {Autism susceptibility 1}; Chromosome Xq27.3-q28 duplication syndrome",
AFF3,AD (KINSSHIP syndrome),
AFF4,AD (CHOPS syndrome),
AFG2A,"AR (Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities)",
AFG2B,"AR (Deafness, autosomal recessive 119); AR (Neurodevelopmental disorder with hearing loss and spasticity)",
AFG3L2,"AD (Optic atrophy 12); AR (Spastic ataxia 5, autosomal recessive); AD (Spinocerebellar ataxia 28); AR (Spastic paraplegia 7, autosomal recessive)",
AFM,AD ([Hereditary persistence of alpha-fetoprotein]); AR (Alpha-fetoprotein deficiency); AD (Chopra-Amiel-Gordon syndrome),
AFP,AD ([Hereditary persistence of alpha-fetoprotein]); AR (Alpha-fetoprotein deficiency); AD (Primrose syndrome); Down syndrome,
AGA,"AR (Aspartylglucosaminuria); AD (Alopecia, androgenetic, 1); AR (Hypogonadotropic hypogonadism 24 without anosmia); Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect; AR ({Obesity, susceptibility to}); AR ({Obesity, susceptibility to})",
AGBL1,"AD (Corneal dystrophy, Fuchs endothelial, 8); Corneal dystrophy, Fuchs endothelial, 5; AR (Neurodegeneration, childhood-onset, with cerebellar atrophy)",
AGBL2,"AR (Immunodeficiency 104, severe combined)",
AGBL4,"AD (Corneal dystrophy, Fuchs endothelial, 8); AR (Neurodegeneration, childhood-onset, with cerebellar atrophy)",
AGBL5,AR (Retinitis pigmentosa 75),
AGER,"[Aquaporin-1 deficiency]; [Blood group, Colton]; AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting); AR (Rh-null disease, amorph type); AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-; {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AD (Elliptocytosis-2); AR (Pyropoikilocytosis); AR (Spherocytosis, type 3); AD (Palmoplantar keratoderma, Bothnian type)",
AGGF1,Klippel-Trenaunay-Weber syndrome,
AGK,"AR (Cataract 38, autosomal recessive); AR (Sengers syndrome); AR (?Combined oxidative phosphorylation deficiency 43); AR (Intellectual developmental disorder, autosomal recessive 69)",
AGL,AR (Glycogen storage disease IIIa); AR (Glycogen storage disease IIIb); AR (Myoclonic epilepsy of Lafora 2),
AGO1,"AD (Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures); AD (Lessel-Kreienkamp syndrome); AD (?Epilepsy, familial adult myoclonic, 6); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome); AD (EDICT syndrome); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1",
AGO2,"AD (Lessel-Kreienkamp syndrome); GLOW syndrome, somatic mosaic; AD (Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors); AD (Pleuropulmonary blastoma); Rhabdomyosarcoma, embryonal, 2; AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); AD (Cole-Carpenter syndrome 1); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome)",
AGO3,AD (Lessel-Kreienkamp syndrome); AD (Cole-Carpenter syndrome 1),
AGO4,AD (Cole-Carpenter syndrome 1); AD (Lessel-Kreienkamp syndrome),
AGPAT2,"AR (Lipodystrophy, congenital generalized, type 1); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3); AR (Encephalopathy, progressive, with or without lipodystrophy); AR (Lipodystrophy, congenital generalized, type 2); AD (Neuronopathy, distal hereditary motor, autosomal dominant 13); AD (Silver spastic paraplegia syndrome)",
AGPS,"AR (Rhizomelic chondrodysplasia punctata, type 3); AR (Rhizomelic chondrodysplasia punctata, type 2)",
AGR2,"AR (Respiratory infections, recurrent, and failure to thrive with or without diarrhea)",
AGRN,"AR (Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects); AR (?Myasthenic syndrome, congenital, 17); AR (Cenani-Lenz syndactyly syndrome); AR (Sclerosteosis 2); AD (Alternating hemiplegia of childhood 2); AD (CAPOS syndrome); AD (Developmental and epileptic encephalopathy 99); AD (Dystonia-12); AD (?Myopathy, isolated mitochondrial, autosomal dominant); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 2); AD (Spinal muscular atrophy, Jokela type); AR (Fetal akinesia deformation sequence 1); AR (Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency)",
AGRP,"AR ({Leanness, inherited}); AR ({Obesity, late-onset}); Rhabdomyosarcoma, alveolar; AR (Obesity, morbid, due to leptin deficiency); AR ({Obesity, susceptibility to}); AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20)); AR ({Obesity, early-onset, susceptibility to}); AR (Obesity, adrenal insufficiency, and red hair due to POMC deficiency); AD (Acromicric dysplasia); AD (Ectopia lentis, familial); AD (Geleophysic dysplasia 2); AD (Marfan lipodystrophy syndrome); AD (Marfan syndrome); AD (MASS syndrome); AD (Stiff skin syndrome); AD (Weill-Marchesani syndrome 2, dominant)",
AGT,"AR (Renal tubular dysgenesis); AR (Hyperoxaluria, primary, type 1); AD ({IgA nephropathy, susceptibility to, 1}); [Angiotensin I-converting enzyme, benign serum increase]; {Microvascular complications of diabetes 3}; {Myocardial infarction, susceptibility to}; {SARS, progression of}; {Stroke, hemorrhagic}; AR (Renal tubular dysgenesis); Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect; AD ({Bronchiectasis with or without elevated sweat chloride 1, modifier of}); {Hypertrypsinemia, neonatal}; AD ({Pancreatitis, hereditary}); AR (Congenital bilateral absence of vas deferens); AR (Cystic fibrosis); Sweat chloride elevation without CF",
AGTPBP1,"AR (Neurodegeneration, childhood-onset, with cerebellar atrophy); AD (Corneal dystrophy, Fuchs endothelial, 8)",
AGTR1,"{Hypertension, essential}; AR (Renal tubular dysgenesis); AD ({Attention deficit-hyperactivity disorder, susceptibility to}); AD ({Blepharospasm, primary benign}); AD (Acromicric dysplasia); AD (Ectopia lentis, familial); AD (Geleophysic dysplasia 2); AD (Marfan lipodystrophy syndrome); AD (Marfan syndrome); AD (MASS syndrome); AD (Stiff skin syndrome); AD (Weill-Marchesani syndrome 2, dominant); AR (Renal tubular dysgenesis); AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AD (Preeclampsia/eclampsia 1)",
AGTR2,"Intellectual developmental disorder, X-linked 88; AR (Renal tubular dysgenesis); {Hypertension, essential}; AR (Renal tubular dysgenesis); AD (Preeclampsia/eclampsia 1)",
AGTRAP,"AR (?Congenital disorder of glycosylation, type IIz)",
AGXT,"AR (Hyperoxaluria, primary, type 1); AR (Hyperoxaluria, primary, type III); AR ([Beta-aminoisobutyric acid, urinary excretion of])",
AGXT2,"AR ([Beta-aminoisobutyric acid, urinary excretion of])",
AHCTF1,"AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18)",
AHCY,"AR (Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase); [Skin/hair/eye pigmentation 9, brown/nonbrown eyes]; [Skin/hair/eye pigmentation 9, dark/light hair]; AD (Obesity and hypopigmentation); AR (Glycine N-methyltransferase deficiency)",
AHCYL1,AR (Proximal renal tubular acidosis-ocular anomaly syndrome),
AHDC1,AD (Xia-Gibbs syndrome),
AHI1,AR (Joubert syndrome 3); AR (COACH syndrome 2); AR (Joubert syndrome 9); AR (Meckel syndrome 6); AR (Retinitis pigmentosa 93); AR (?Meckel syndrome 9); AR (Joubert syndrome 27),
AHNAK,"AD (Muscular dystrophy, limb-girdle, autosomal dominant 4); AR (Muscular dystrophy, limb-girdle, autosomal recessive 1); AR (?Mitochondrial complex IV deficiency, nuclear type 15); AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9)",
AHR,"AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3); AD (Pituitary adenoma 1, multiple types); AD (Pituitary adenoma predisposition); AR (Anterior segment dysgenesis 6, multiple subtypes); AR (Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset); Intellectual developmental disorder, X-linked syndromic, Cabezas type",
AHSA1,"AR (Osteootohepatoenteric syndrome); AD ({Bronchiectasis with or without elevated sweat chloride 1, modifier of}); {Hypertrypsinemia, neonatal}; AD ({Pancreatitis, hereditary}); AR (Congenital bilateral absence of vas deferens); AR (Cystic fibrosis); Sweat chloride elevation without CF",
AHSG,"AR (?Alopecia-intellectual disability syndrome 1); AR (Atransferrinemia); AR ([High molecular weight kininogen deficiency]); AR ([Kininogen deficiency]); AD (Angioedema, hereditary, 6)",
AHSP,"AD ({Alzheimer disease, late-onset, susceptibility to}); {Coronary artery spasm 1, susceptibility to}; AD ({Hypertension, pregnancy-induced}); {Hypertension, susceptibility to}; {Ischemic stroke, susceptibility to}; {Placental abruption}; AD ([Hereditary persistence of fetal hemoglobin]); AR (Anemia, congenital dyserythropoietic, type IVb); AD (Anemia, dyserythropoietic congenital, type IVa); AD (Blood group--Lutheran inhibitor)",
AICDA,"AR (Immunodeficiency with hyper-IgM, type 2); AR (?Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias); AR (Immunodeficiency, common variable, 3); AR (Ataxia-telangiectasia-like disorder 1)",
AIDA,"AD ({?Epilepsy idiopathic generalized, susceptibility to, 8}); AR (Hyperparathyroidism, neonatal); AD (Hypocalcemia, autosomal dominant); AD (Hypocalcemia, autosomal dominant, with Bartter syndrome); AD (Hypocalciuric hypercalcemia, type I); AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-; AD ({Lung cancer, resistance to}); {Nicotine addiction, protection from}; AD (Coumarin resistance); AR (GABA-transaminase deficiency)",
AIF1,"{Malaria, mild, susceptibility to}; AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AR ({Alzhieimer disease 17, susceptibility to}); AR (Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2)",
AIFM1,"Combined oxidative phosphorylation deficiency 6; Cowchock syndrome; Deafness, X-linked 5; Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy; AD (Night blindness, congenital stationary, autosomal dominant 2); AR (Retinitis pigmentosa-40)",
AIFM2,AR (?Autoimmune disease with susceptibility to mycobacterium tuberculosis),
AIM2,"{Gastric cancer risk after H. pylori infection}; AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AR (Dystonia 33); AD (Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome); AR (Autoimmune lymphoproliferative syndrome, type III)",
AIMP1,"AR (Leukodystrophy, hypomyelinating, 3)",
AIMP2,"AR (Leukodystrophy, hypomyelinating, 17); AR (?Charcot-Marie-Tooth disease, recessive intermediate, B); AR (Deafness, autosomal recessive 89); AR (Deafness, congenital, and adult-onset progressive leukoencephalopathy); AR (Leukoencephalopathy, progressive, infantile-onset, with or without deafness); AR (Aicardi-Goutieres syndrome 6); AD (Dyschromatosis symmetrica hereditaria); Lynch syndrome 4; AR (Mismatch repair cancer syndrome 4); AR (Neurodevelopmental disorder with hypotonia, microcephaly, and seizures); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AR (Parkinson disease 6, early onset)",
AIP,"AD (Pituitary adenoma 1, multiple types); AD (Pituitary adenoma predisposition); AR (Encephalopathy, porphyria-related); AR (Leukoencephalopathy, porphyria-related); AD (Porphyria, acute intermittent); AD (Porphyria, acute intermittent, nonerythroid variant); AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic; AD (Acrodysostosis 1, with or without hormone resistance); Adrenocortical tumor, somatic; AD (Carney complex, type 1); AD (Myxoma, intracardiac); AD (Pigmented nodular adrenocortical disease, primary, 1)",
AIPL1,"AR (Cone-rod dystrophy); AR (Leber congenital amaurosis 4); AR (Retinitis pigmentosa, juvenile)",
AIRE,"AR (Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia); Down syndrome; {Leprosy, susceptibility to, 4}; {Myocardial infarction, susceptibility to}; {Psoriatic arthritis, susceptibility to}; AD (Immunodeficiency, common variable, 10)",
AJAP1,"[Blood group, OK]",
AJUBA,"AD ({Colon cancer, susceptibility to}); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); {Alzheimer disease 18, susceptibility to}; AD (Reticulate acropigmentation of Kitamura)",
AK1,"AR (Anemia, congenital, nonspherocytic hemolytic, 3, adenylate kinase deficient); [Blood group, ABO system]; AR ({Lead poisoning, susceptibility to}); AR (Porphyria, acute hepatic); AD ({Major affective disorder 1}); AR (Transcobalamin II deficiency)",
AK2,"AR (Reticular dysgenesis); AD (Autoimmune lymphoproliferative syndrome, type II); Gastric cancer, somatic; Lymphoma, non-Hodgkin, somatic; AR (Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction); AR (Anemia, congenital, nonspherocytic hemolytic, 3, adenylate kinase deficient); AR (Congenital disorder of glycosylation, type It); AR (Fucosidosis)",
AK3,"AD (Leukemia, juvenile myelomonocytic); AD (Neurofibromatosis-Noonan syndrome); AD (Neurofibromatosis, familial spinal); AD (Neurofibromatosis, type 1); AD (Watson syndrome); AR (Basal ganglia calcification, idiopathic, 10, autosomal recessive); AR (Galactosemia)",
AK7,"AR (?Spermatogenic failure 27); AD ({Myeloproliferative neoplasms, familial, susceptibility to})",
AK8,AR (?Spermatogenic failure 27),
AK9,AR (Spermatogenic failure 89),
AKAP1,AR (Spermatogenic failure 51),
AKAP10,[Longevity 1],
AKAP11,[Bone mineral density QTL 9]; Kyphoscoliosis 1,
AKAP3,"AR (Spermatogenic failure 82); AR (Spermatogenic failure 35); AR (?Spermatogenic failure 93); AR (Mitochondrial complex I deficiency, nuclear type 18)",
AKAP4,AR (Spermatogenic failure 82); AR (?Spermatogenic failure 27); AR (Spermatogenic failure 34); AR (Spermatogenic failure 83); AR (?Spermatogenic failure 93),
AKAP5,"AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91)",
AKAP6,"AD (Acrodysostosis 2, with or without hormone resistance); AD (Acrodysostosis 1, with or without hormone resistance); Adrenocortical tumor, somatic; AD (Carney complex, type 1); AD (Myxoma, intracardiac); AD (Pigmented nodular adrenocortical disease, primary, 1); AD (Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome); AD (Ventricular tachycardia, catecholaminergic polymorphic, 1)",
AKAP8L,AD (Sessile serrated polyposis cancer syndrome),
AKAP9,"AD (?Long QT syndrome 11); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AR (Jervell and Lange-Nielsen syndrome 2); AD (Long QT syndrome 5); AR (Cardiomyopathy, dilated, 2K)",
AKR1B1,"{?Membranous nephropathy, susceptibility to}; AR (Transaldolase deficiency)",
AKR1B10,"AD (Immunodeficiency, developmental delay, and hypohomocysteinemia)",
AKR1C1,"AR (46XY sex reversal 8); AR ({46XY sex reversal 8, modifier of}); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia)",
AKR1C2,"AR (46XY sex reversal 8); AR ({46XY sex reversal 8, modifier of}); AR (Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities)",
AKR1C3,"AR ({46XY sex reversal 8, modifier of}); AR (46XY sex reversal 8)",
AKR1C4,"AR ({46XY sex reversal 8, modifier of}); AR (46XY sex reversal 8)",
AKR1D1,"AR (Bile acid synthesis defect, congenital, 2); AD (Hypospadias 3, autosomal)",
AKT1,"Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AR (PEHO syndrome-like); Houge-Janssens syndrome 4; AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AD (Immunodeficiency, common variable, 12); AD (Diabetes mellitus, type II); AD (Hypoinsulinemic hypoglycemia with hemihypertrophy); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic",
AKT2,"AD (Diabetes mellitus, type II); AD (Hypoinsulinemic hypoglycemia with hemihypertrophy); AD ({Maturity-onset diabetes of the young, type 14}); Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2)",
AKT3,"AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2); AD (Buratti-Harel syndrome); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1)",
AKTIP,"AR (Spastic paraplegia 50, autosomal recessive)",
ALAD,"AR ({Lead poisoning, susceptibility to}); AR (Porphyria, acute hepatic); AR (Coproporphyria); AR (Harderoporphyria); AR (Porphyria cutanea tarda); AR (Porphyria, hepatoerythropoietic)",
ALAS1,"AD (?Protoporphyria, erythropoietic, 2); Anemia, sideroblastic, 1; Protoporphyria, erythropoietic, X-linked; AR (Encephalopathy, porphyria-related); AR (Leukoencephalopathy, porphyria-related); AD (Porphyria, acute intermittent); AD (Porphyria, acute intermittent, nonerythroid variant); AD (?Advanced sleep phase syndrome, familial, 1)",
ALAS2,"Anemia, sideroblastic, 1; Protoporphyria, erythropoietic, X-linked; AR (Anemia, sideroblastic, 3, pyridoxine-refractory); AR (Spasticity, childhood-onset, with hyperglycinemia); AD (?Protoporphyria, erythropoietic, 2); AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4)",
ALB,AR (?[Dysalbuminemic hypertriiodothyroninemia]); AR ([Dysalbuminemic hyperthyroxinemia]); AR (Analbuminemia); AD ([Hereditary persistence of alpha-fetoprotein]); AR (Alpha-fetoprotein deficiency),
ALDH16A1,"AR (Mast syndrome); [Uric acid concentration, serum, QTL5]; [Uric acid concentration, serum, QTL6]",
ALDH18A1,"AD (Cutis laxa, autosomal dominant 3); AR (Cutis laxa, autosomal recessive, type IIIA); AD (Spastic paraplegia 9A, autosomal dominant); AR (Spastic paraplegia 9B, autosomal recessive)",
ALDH1A1,"{Esophageal cancer, alcohol-related, susceptibility to}; AD ({Hangover, susceptibility to}); {Sublingual nitroglycerin, susceptibility to poor response to}; AD (Alcohol sensitivity, acute); AR (Charcot-Marie-Tooth disease, axonal, type 2S); AR (Neuronopathy, distal hereditary motor, autosomal recessive 1); AR (Arterial tortuosity syndrome)",
ALDH1A2,"AR (Diaphragmatic hernia 4, with cardiovascular defects); Diaphragmatic hernia 1; AD ({Colorectal cancer, susceptibility to}); AD ({Leprosy, susceptibility to}); {Mycobacterium tuberculosis, susceptibility to}; ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); {Aspergillosis, susceptibility to}; AR (Candidiasis, familial, 4, autosomal recessive)",
ALDH1A3,"AR (Microphthalmia, isolated 8); AR (Microphthalmia, isolated 1)",
ALDH2,"{Esophageal cancer, alcohol-related, susceptibility to}; AD ({Hangover, susceptibility to}); {Sublingual nitroglycerin, susceptibility to poor response to}; AD (Alcohol sensitivity, acute); AD (Silver-Russell syndrome 5); {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; AMED syndrome, digenic; AR (Fanconi anemia, complementation group D2); {Alcohol dependence, protection against}; AD ({Parkinson disease, susceptibility to})",
ALDH3A2,AR (Sjogren-Larsson syndrome),
ALDH4A1,"AR (Hyperprolinemia, type II)",
ALDH5A1,AR (Succinic semialdehyde dehydrogenase deficiency),
ALDH6A1,AR (Methylmalonate semialdehyde dehydrogenase deficiency),
ALDH7A1,"AR (Epilepsy, early-onset, 4, vitamin B6-dependent); AD (Leukodystrophy, demyelinating, adult-onset, autosomal dominant, atypical); AD (Microcephaly 26, primary, autosomal dominant); AD (Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typical)",
ALDOA,"AR (Glycogen storage disease XII); AR (Fructose intolerance, hereditary)",
ALDOB,"AR (Fructose intolerance, hereditary); AR (Glycogen storage disease XII); AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I); AR (Xeroderma pigmentosum, group A); AR (Hypercholanemia, familial 3)",
ALDOC,"AR (Glycogen storage disease XII); AR (Fructose intolerance, hereditary)",
ALG1,"AR (Congenital disorder of glycosylation, type Ik); AD (Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures)",
ALG10,"AD ({Long QT syndrome, acquired, reduced susceptibility to})",
ALG10B,"AD ({Long QT syndrome, acquired, reduced susceptibility to})",
ALG11,"AR (Congenital disorder of glycosylation, type Ip); AR (Congenital disorder of glycosylation, type In)",
ALG12,"AR (Congenital disorder of glycosylation, type Ig)",
ALG13,"Developmental and epileptic encephalopathy 36; AR (?Myasthenic syndrome, congenital, 15, without tubular aggregates); AR (Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies); AR (Myopathy, epilepsy, and progressive cerebral atrophy)",
ALG14,"AR (?Myasthenic syndrome, congenital, 15, without tubular aggregates); AR (Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies); AR (Myopathy, epilepsy, and progressive cerebral atrophy); Developmental and epileptic encephalopathy 36; AD (Pituitary adenoma 1, multiple types); AD (Pituitary adenoma predisposition); AR (Congenital disorder of glycosylation, type Ii); AR (Myasthenic syndrome, congenital, 14, with tubular aggregates)",
ALG2,"AR (Congenital disorder of glycosylation, type Ii); AR (Myasthenic syndrome, congenital, 14, with tubular aggregates); AR (?Microcephaly 29, primary, autosomal recessive); AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V)",
ALG3,"AR (Congenital disorder of glycosylation, type Id); AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V)",
ALG5,AD (Polycystic kidney disease 7),
ALG6,"AR (Congenital disorder of glycosylation, type Ic); AD (Bosch-Boonstra-Schaaf optic atrophy syndrome); AR (Congenital disorder of glycosylation, type Ia); AR (?Congenital disorder of glycosylation, type 1bb); AD (Developmental delay and seizures with or without movement abnormalities); AR (Retinitis pigmentosa 59); Omphalocele due to duplication of 1p31.3; AD (Polycystic kidney disease 7)",
ALG8,"AR (Congenital disorder of glycosylation, type Ih); AD (Polycystic liver disease 3 with or without kidney cysts); AR (Congenital disorder of glycosylation, type Ic)",
ALG9,"AR (Congenital disorder of glycosylation, type Il); AR (Gillessen-Kaesbach-Nishimura syndrome)",
ALK,"{Neuroblastoma, susceptibility to, 3}; AR ({Moyamoya disease 2, susceptibility to}); AD (Intellectual developmental disorder, autosomal dominant 56); Leukemia, acute myeloid, somatic; AR (Microcephaly, developmental delay, and brittle hair syndrome)",
ALKBH1,"AR (Intellectual developmental disorder, autosomal recessive 71); AR (Combined oxidative phosphorylation deficiency 48)",
ALKBH5,AR (Oxoglutarate dehydrogenase deficiency),
ALKBH8,"AR (Intellectual developmental disorder, autosomal recessive 71)",
ALMS1,"AR (Alstrom syndrome); AR (Seckel syndrome 11); AD (Brugada syndrome 3); AD (Long QT syndrome 8); AD (Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures); AD (Timothy syndrome); AR (Achromatopsia 2); AD (Deafness, autosomal dominant 11); AR (Deafness, autosomal recessive 2); AR (Usher syndrome, type 1B)",
ALOX12,"AR (Ichthyosis, congenital, autosomal recessive 2)",
ALOX12B,"AR (Ichthyosis, congenital, autosomal recessive 2); AR (Ichthyosis, congenital, autosomal recessive 3); AR (Ichthyosis, congenital, autosomal recessive 9); AR (Ichthyosis, congenital, autosomal recessive 1)",
ALOX15,"{Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AR (Obesity, morbid, due to leptin deficiency)",
ALOX15B,"AR (Ichthyosis, congenital, autosomal recessive 3); AR (Ichthyosis, congenital, autosomal recessive 2)",
ALOX5,"AD ({Asthma, diminished response to antileukotriene treatment in}); {Atherosclerosis, susceptibility to}; AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); GLOW syndrome, somatic mosaic; AD (Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors); AD (Pleuropulmonary blastoma); Rhabdomyosarcoma, embryonal, 2; {Myocardial infarction, susceptibility to, 2}",
ALOX5AP,"{Stroke, susceptibility to}; {Myocardial infarction, susceptibility to, 2}; AD ({Asthma, diminished response to antileukotriene treatment in}); {Atherosclerosis, susceptibility to}",
ALOXE3,"AR (Ichthyosis, congenital, autosomal recessive 3); AR (Ichthyosis, congenital, autosomal recessive 2); AR (Ichthyosis, congenital, autosomal recessive 9); AR (Ichthyosis, congenital, autosomal recessive 1); AR (Spondylocostal dysostosis 4, autosomal recessive)",
ALPI,"AR (Hypophosphatasia, adult); AR (Hypophosphatasia, childhood); AR (Hypophosphatasia, infantile); AR (Odontohypophosphatasia); AD ({Alkaline phosphatase, plasma level of, QTL1}); AR (Immunodeficiency due to defect in MAPBP-interacting protein); Trichothiodystrophy 5, nonphotosensitive",
ALPK1,"AD (ROSAH syndrome); AR (Cardiomyopathy, familial hypertrophic 27)",
ALPK2,"AR (Cardiomyopathy, familial hypertrophic 27); AD (ROSAH syndrome)",
ALPK3,"AR (Cardiomyopathy, familial hypertrophic 27); AD (ROSAH syndrome); AD (Cardiomyopathy, hypertrophic, 10); AR (Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy)",
ALPL,"AR (Hypophosphatasia, adult); AR (Hypophosphatasia, childhood); AR (Hypophosphatasia, infantile); AR (Odontohypophosphatasia); {Alkaline phosphatase, plasma level of, QTL 2}; {Vitamin B6 plasma level QTL 1}; AD ({Epilepsy, idiopathic generalized, susceptibility to, 12}); AD (Dystonia 9); AR (GLUT1 deficiency syndrome 1, infantile onset, severe); AD (GLUT1 deficiency syndrome 2, childhood onset); AD (Stomatin-deficient cryohydrocytosis with neurologic defects); AR (Lichtenstein-Knorr syndrome); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91)",
ALPP,"AD ({Alkaline phosphatase, plasma level of, QTL1}); AR (Hypophosphatasia, adult); AR (Hypophosphatasia, childhood); AR (Hypophosphatasia, infantile); AR (Odontohypophosphatasia); AR (Nephrotic syndrome, type 21); AD (Craniofacial-deafness-hand syndrome); Rhabdomyosarcoma 2, alveolar; AD (Waardenburg syndrome, type 1); AR (Waardenburg syndrome, type 3)",
ALS2,"AR (Amyotrophic lateral sclerosis 2, juvenile); AR (Primary lateral sclerosis, juvenile); AR (Spastic paralysis, infantile onset ascending); AR (Joubert syndrome 14)",
ALX1,AR (Frontonasal dysplasia 3),
ALX3,"AR (Frontonasal dysplasia 1); AR (Intellectual developmental disorder, autosomal recessive 4)",
ALX4,"AD ({Craniosynostosis 5, susceptibility to}); AR (Frontonasal dysplasia 2); AD (Parietal foramina 2); AD (Potocki-Shaffer syndrome); AD (Craniosynostosis 2); AD (Parietal foramina 1); AD (Parietal foramina with cleidocranial dysplasia); AR (Frontonasal dysplasia 1)",
ALYREF,"?Intellectual developmental disorder, X-linked syndromic, Gustavson type; ?Intellectual developmental disorder, X-linked syndromic, Shashi type",
AMACR,"AR (Alpha-methylacyl-CoA racemase deficiency); AR (Bile acid synthesis defect, congenital, 4)",
AMBN,"AR (Amelogenesis imperfecta, type IF); Amelogenesis imperfecta, type 1E; AD (Amelogenesis imperfecta, type IK); AD (?Amelogenesis imperfecta, type IIIB); AD (Amelogenesis imperfecta, type IB); AR (Amelogenesis imperfecta, type IC)",
AMBP,"AR (Fructose intolerance, hereditary); AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea)",
AMD1,"AR (Acromesomelic dysplasia 1, Maroteaux type); AD (Epiphyseal chondrodysplasia, Miura type); AD (Short stature with nonspecific skeletal abnormalities); AD (Faundes-Banka syndrome); AR (?Spastic paraplegia 63, autosomal recessive); AR (Pontocerebellar hypoplasia, type 9)",
AMDHD1,"{Leukemia, acute lymphocytic, susceptibility to, 1}",
AMELX,"Amelogenesis imperfecta, type 1E; AR (Amelogenesis imperfecta, type IIA3); AD (?Amelogenesis imperfecta, type IIIB); AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea)",
AMER1,"Osteopathia striata with cranial sclerosis; AD ({Uveal melanoma, susceptibility to, 1}); AR (Tumor predisposition syndrome 2)",
AMER2,Osteopathia striata with cranial sclerosis,
AMFR,"AR (Spastic paraplegia 89, autosomal recessive); AR (Emphysema due to AAT deficiency); AR (Emphysema-cirrhosis, due to AAT deficiency); AR (Hemorrhagic diathesis due to antithrombin Pittsburgh); AR (Anemia, congenital, nonspherocytic hemolytic, 4, glucose phosphate isomerase deficient); AD (Charcot-Marie-Tooth disease, type 2Y); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 6); AD (Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1); AR (Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum)",
AMH,"AR (Persistent Mullerian duct syndrome, type I); AR (Persistent Mullerian duct syndrome, type II); AD (46XY sex reversal 9); Diaphragmatic hernia 3; AD (Tetralogy of Fallot); AD (46XX sex reversal 4); AD (46XY sex reversal 3); AD (Adrenocortical insufficiency); AD (Premature ovarian failure 7); AD (Spermatogenic failure 8); AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AR (Hypogonadotropic hypogonadism 24 without anosmia)",
AMHR2,"AR (Persistent Mullerian duct syndrome, type II); AR (Persistent Mullerian duct syndrome, type I); Polyposis syndrome, hereditary mixed, 2; AD (Polyposis, juvenile intestinal)",
AMIGO3,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14)",
AMMECR1,"Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis; AMME complex; Intellectual developmental disorder, X-linked 63",
AMN,"AR (Imerslund-Grasbeck syndrome 2); Adrenoleukodystrophy; Adrenomyeloneuropathy, adult; AR ([Proteinuria, chronic benign]); AR (Imerslund-Grasbeck syndrome 1); AR (Methylmalonic aciduria and homocystinuria, cblJ type); AR (Intrinsic factor deficiency)",
AMOT,AD (Takenouchi-Kosaki syndrome); AD (Craniofaciocardiohepatic syndrome),
AMOTL1,AD (Craniofaciocardiohepatic syndrome),
AMOTL2,AD (Craniofaciocardiohepatic syndrome),
AMPD1,"AR (Myopathy due to myoadenylate deaminase deficiency); AR (?Spastic paraplegia 63, autosomal recessive); AR (Pontocerebellar hypoplasia, type 9); AR ([AMP deaminase deficiency, erythrocytic]); AR (Glycogen storage disease VII)",
AMPD2,"AR (?Spastic paraplegia 63, autosomal recessive); AR (Pontocerebellar hypoplasia, type 9); AR (Myopathy due to myoadenylate deaminase deficiency); AR ([AMP deaminase deficiency, erythrocytic]); AD (Auriculocondylar syndrome 1)",
AMPD3,"AR ([AMP deaminase deficiency, erythrocytic]); AR (?Spastic paraplegia 63, autosomal recessive); AR (Pontocerebellar hypoplasia, type 9); AR (Myopathy due to myoadenylate deaminase deficiency)",
AMPH,"AR (Centronuclear myopathy 2); AR (Developmental and epileptic encephalopathy 53); AR (Parkinson disease 20, early-onset)",
AMT,"AR (Glycine encephalopathy 2); AR (Glycine encephalopathy1); AR (Anemia, hemolytic, Rh-null, regulator type); AD (Overhydrated hereditary stomatocytosis); AR (D-glyceric aciduria)",
AMTN,"AD (?Amelogenesis imperfecta, type IIIB)",
AMY2B,"AR (Neuropathy, hereditary sensory and autonomic, type V); ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic; Colorectal cancer, somatic; Epidermal nevus, somatic; Melanocytic nevus syndrome, congenital, somatic; Neurocutaneous melanosis, somatic; AD (Noonan syndrome 6); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Thyroid carcinoma, follicular, somatic; AR (Hypothyroidism, congenital, nongoitrous 4)",
ANAPC1,"AR (Rothmund-Thomson syndrome, type 1); AD (Developmental and epileptic encephalopathy 72); AR (Rothmund-Thomson syndrome, type 3); AR (Microcephaly 14, primary, autosomal recessive)",
ANAPC10,AR (Oocyte/zygote/embryo maturation arrest 12); AR (Spermatogenic failure 64),
ANAPC2,AD (Developmental and epileptic encephalopathy 109); AR (Oocyte/zygote/embryo maturation arrest 12); AR (Spermatogenic failure 64),
ANAPC7,AR (Ferguson-Bonni neurodevelopmental syndrome),
ANG,"Amyotrophic lateral sclerosis 9; AR (Erythrocytosis, familial, 2); Hemangioblastoma, cerebellar, somatic; AD (Pheochromocytoma); Renal cell carcinoma, somatic; AD (von Hippel-Lindau syndrome); AR (Renal tubular dysgenesis); AR (Leukodystrophy, hypomyelinating, 4); AD (Spastic paraplegia 13, autosomal dominant); Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia; AD (Essential tremor, hereditary, 4)",
ANGPT1,"AD (?Angioedema, hereditary, 5); AD (Lymphatic malformation 10); {Microvascular complications of diabetes 1}; AD (Lymphatic malformation 11); AD (?Bleeding disorder, vascular-type)",
ANGPT2,"AD (Lymphatic malformation 10); AD (?Angioedema, hereditary, 5); {Microvascular complications of diabetes 1}; AD (?Bleeding disorder, vascular-type); AR (Microcephaly 1, primary, autosomal recessive)",
ANGPT4,"AD (?Angioedema, hereditary, 5); AD (Lymphatic malformation 10); AR (Hypobetalipoproteinemia, familial, 2)",
ANGPTL2,"AR (Hypobetalipoproteinemia, familial, 2)",
ANGPTL3,"AR (Hypobetalipoproteinemia, familial, 2); AD (Plasma triglyceride level QTL, low); AR (Congenital disorder of glycosylation, type IIt)",
ANGPTL4,"AD (Plasma triglyceride level QTL, low)",
ANGPTL5,"AD (Plasma triglyceride level QTL, low); AR (Hypobetalipoproteinemia, familial, 2)",
ANGPTL6,"AD (Plasma triglyceride level QTL, low); AR (Hypobetalipoproteinemia, familial, 2)",
ANGPTL7,"AD (Plasma triglyceride level QTL, low)",
ANGPTL8,"AR (Hypobetalipoproteinemia, familial, 2)",
ANK1,"AR (Spherocytosis, type 1); AD (Spinocerebellar ataxia 5); AR (Spinocerebellar ataxia, autosomal recessive 14); AR (Intellectual developmental disorder, autosomal recessive 37); AD (?Episodic pain syndrome, familial, 1)",
ANK2,"AD (Cardiac arrhythmia, ankyrin-B-related); AD (Long QT syndrome 4); AR (Intellectual developmental disorder, autosomal recessive 37); AD (Developmental delay, impaired speech, and behavioral abnormalities); AR (Neurodevelopmental disorder with neuromuscular and skeletal abnormalities); AD (?Avascular necrosis of femoral head, primary, 2); [Sodium serum level QTL 1]; AD (Brachyolmia type 3); AD (Digital arthropathy-brachydactyly, familial); AD (Hereditary motor and sensory neuropathy, type IIc); AD (Metatropic dysplasia); AD (Neuronopathy, distal hereditary motor, autosomal dominant 8); AD (Parastremmatic dwarfism); AD (Scapuloperoneal spinal muscular atrophy); AD (SED, Maroteaux type); AD (Spondylometaphyseal dysplasia, Kozlowski type)",
ANK3,"AR (Intellectual developmental disorder, autosomal recessive 37); AR (Congenital disorder of glycosylation, type Il); AR (Gillessen-Kaesbach-Nishimura syndrome); AR (Neurodevelopmental disorder with hypotonia, neuropathy, and deafness); AD ({Major affective disorder 1}); {Major affective disorder-8, susceptibility to}; AD (Cardiac arrhythmia, ankyrin-B-related); AD (Long QT syndrome 4)",
ANKFY1,AR (?Autoimmune disease with susceptibility to mycobacterium tuberculosis),
ANKH,AD (Chondrocalcinosis 2); AD (Craniometaphyseal dysplasia),
ANKLE2,"AR (Microcephaly 16, primary, autosomal recessive); AR (Nestor-Guillermo progeria syndrome); AR (Microcephaly 10, primary, autosomal recessive)",
ANKRD1,"AD (Cardiomyopathy, dilated, 1KK); AD (Cardiomyopathy, familial restrictive, 4); AD (Cardiomyopathy, hypertrophic, 22); AR (Congenital myopathy 24)",
ANKRD11,"AD (KBG syndrome); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD (Williams-Beuren syndrome); AD (Erythermalgia, primary); AR (Insensitivity to pain, congenital); AR (Neuropathy, hereditary sensory and autonomic, type IID); AD (Paroxysmal extreme pain disorder); AD (Small fiber neuropathy); AD (Chromosome 7q11.23 duplication syndrome)",
ANKRD16,"AD (?Leukoencephalopathy, hereditary diffuse, with spheroids 2); AD (Charcot-Marie-Tooth disease, axonal, type 2N); AR (Developmental and epileptic encephalopathy 29); AR (Trichothiodystrophy 8, nonphotosensitive)",
ANKRD17,AD (Chopra-Amiel-Gordon syndrome),
ANKRD2,"AR (Intellectual developmental disorder with autism and dysmorphic facies); AR (Arthrogryposis multiplex congenita 6); AR (Nemaline myopathy 2, autosomal recessive)",
ANKRD26,AD (Thrombocytopenia 2); AR (Retinal dystrophy with leukodystrophy),
ANKRD30B,AD (Williams-Beuren syndrome); AD (Chromosome 7q11.23 duplication syndrome),
ANKRD31,AR (Oocyte/zygote/embryo maturation arrest 10),
ANKRD34A,"AR (Short stature, oligodontia, dysmorphic facies, and motor delay)",
ANKRD52,AD (Lessel-Kreienkamp syndrome),
ANKS3,AR (Nephronophthisis 16),
ANKS6,"AR (Nephronophthisis 16); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2); AR (Nephronophthisis 2, infantile); AR (Meckel syndrome 7); AR (Nephronophthisis 3); AR (Renal-hepatic-pancreatic dysplasia 1)",
ANKZF1,"AD (Charcot-Marie-Tooth disease, type 2Y); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 6); AD (Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1)",
ANLN,"AD (Focal segmental glomerulosclerosis 8); AR (Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive)",
ANO1,"AR (?Intestinal dysmotility syndrome); AR (Moyamoya disease 7); AD (Gnathodiaphyseal dysplasia); AR (Miyoshi muscular dystrophy 3); AR (Muscular dystrophy, limb-girdle, autosomal recessive 12); AD (Otodental dysplasia chromosome deletion syndrome); AR (Moyamoya disease); AD (Dystonia 24)",
ANO10,"AR (Spinocerebellar ataxia, autosomal recessive 10)",
ANO3,AD (Dystonia 24),
ANO5,"AD (Gnathodiaphyseal dysplasia); AR (Miyoshi muscular dystrophy 3); AR (Muscular dystrophy, limb-girdle, autosomal recessive 12)",
ANO6,"AR (Scott syndrome); AD (Gnathodiaphyseal dysplasia); AR (Miyoshi muscular dystrophy 3); AR (Muscular dystrophy, limb-girdle, autosomal recessive 12)",
ANOS1,Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1),
ANP32D,"{Chronic mountain sickness, susceptibility to}",
ANP32E,"AD (Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities)",
ANPEP,"AD (?Spinocerebellar ataxia 43); AR (Charcot-Marie-Tooth disease, axonal, type 2T)",
ANTXR1,"AD ({?Hemangioma, capillary infantile, susceptibility to}); AR (GAPO syndrome); AR (Hyaline fibromatosis syndrome); AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic; AD ({Coronary artery disease, autosomal dominant, 2}); AD (Tooth agenesis, selective, 7)",
ANTXR2,"AR (Hyaline fibromatosis syndrome); AD ({?Hemangioma, capillary infantile, susceptibility to}); AR (GAPO syndrome); AD ({Coronary artery disease, autosomal dominant, 2}); AD (Tooth agenesis, selective, 7)",
ANXA11,"AD (Amyotrophic lateral sclerosis 23); AD (Inclusion body myopathy and brain white matter abnormalities); {Sarcoidosis, susceptibility to, 3}",
ANXA13,"AD (Trichorhinophalangeal syndrome, type II)",
ANXA2,"AR (Miyoshi muscular dystrophy 1); AR (Muscular dystrophy, limb-girdle, autosomal recessive 2); AR (Myopathy, distal, with anterior tibial onset); Opitz GBBB syndrome",
ANXA5,"AD ({Pregnancy loss, recurrent, susceptibility to, 3}); AD (Baraitser-Winter syndrome 2); AD (Deafness, autosomal dominant 20/26); AR ({Hemolytic uremic syndrome, atypical, susceptibility to, 1}); AD ({Macular degeneration, age-related, 4}); AD (Basal laminar drusen); AR (Complement factor H deficiency)",
ANXA8,"AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); ?Rolandic epilepsy, impaired intellectual development, and speech dyspraxia",
AOC2,AD (Retinitis pigmentosa 17),
AOPEP,AR (Dystonia 31),
AOX1,"AR (Xanthinuria, type II); AR (Molybdenum cofactor deficiency B)",
AP1B1,"AR (Keratitis-ichthyosis-deafness syndrome, autosomal recessive); AR (Spastic paraplegia 47, autosomal recessive); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); AD ({Renal dysplasia, cystic, susceptibility to}); AR (Hermansky-Pudlak syndrome 2)",
AP1G1,"AD (Usmani-Riazuddin syndrome, autosomal dominant); AR (Usmani-Riazuddin syndrome, autosomal recessive); AR (Bardet-Biedl syndrome 4); AR (Bardet-Biedl syndrome 1); AD (Keratoderma, palmoplantar, punctate type IA); AR (Spastic paraplegia 51, autosomal recessive); AD (Stuttering, familial persistent, 1)",
AP1G2,"AD (Okur-Chung neurodevelopmental syndrome); AD (Poirier-Bienvenu neurodevelopmental syndrome); AR (Keratitis-ichthyosis-deafness syndrome, autosomal recessive)",
AP1M1,"AR (Myasthenic syndrome, congenital, 22)",
AP1S1,"AR (MEDNIK syndrome); AR (Arthrogryposis, renal dysfunction, and cholestasis 1); AR (Cholestasis, progressive familial intrahepatic, 12); AR (Keratoderma-ichthyosis-deafness syndrome, autosomal recessive)",
AP1S2,Pettigrew syndrome,
AP1S3,"AD ({Psoriasis 15, pustular, susceptibility to}); AR (Psoriasis 14, pustular)",
AP2A1,"AD (Intellectual developmental disorder, autosomal dominant 56); AR (Developmental and epileptic encephalopathy 21); AR (Congenital myopathy 10A, severe variant); AR (Congenital myopathy 10B, mild variant)",
AP2B1,"AR (Spastic paraplegia 47, autosomal recessive); AR (Dystonia 2, torsion, autosomal recessive); AR (Congenital myopathy 10A, severe variant); AR (Congenital myopathy 10B, mild variant); AR (Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum); AR (Hermansky-Pudlak syndrome 2); AR (Hypercholesterolemia, familial, 4)",
AP2M1,"AD (Intellectual developmental disorder 60 with seizures); AR (Lethal congenital contractural syndrome 3); AR (Congenital myopathy 10A, severe variant); AR (Congenital myopathy 10B, mild variant)",
AP2S1,"AD (Hypocalciuric hypercalcemia, type III); AD (Hypocalcemia, autosomal dominant 2); AD (Hypocalciuric hypercalcemia, type II)",
AP3B1,"AR (Hermansky-Pudlak syndrome 2); AR (Spastic paraplegia 47, autosomal recessive); AD (Neutropenia, cyclic); AD (Neutropenia, severe congenital 1, autosomal dominant); AR (Epilepsy, progressive myoclonic 4, with or without renal failure); AD (Deafness, autosomal dominant 87); AR (Hermansky-Pudlak syndrome 4)",
AP3B2,"AR (Developmental and epileptic encephalopathy 48); AR (Spastic paraplegia 47, autosomal recessive)",
AP3D1,"AR (?Hermansky-Pudlak syndrome 10); AR (Hermansky-Pudlak syndrome 2); AR (Spastic paraplegia 51, autosomal recessive); AD (Stuttering, familial persistent, 1); AR (Spinocerebellar ataxia, autosomal recessive 29)",
AP3M1,"AR (Ceroid lipofuscinosis, neuronal, 3); AR (?Hermansky-Pudlak syndrome 10)",
AP3S1,AR (?Hermansky-Pudlak syndrome 10),
AP3S2,AR (?Hermansky-Pudlak syndrome 10),
AP4B1,"AR (Spastic paraplegia 47, autosomal recessive); AR (Spastic paraplegia 51, autosomal recessive); AD (Stuttering, familial persistent, 1); AR (Spastic paraplegia 50, autosomal recessive); AR (Spastic paraplegia 52, autosomal recessive)",
AP4E1,"AR (Spastic paraplegia 51, autosomal recessive); AD (Stuttering, familial persistent, 1); AR (Spastic paraplegia 52, autosomal recessive); AR (Spastic paraplegia 47, autosomal recessive); AR (Immunodeficiency 86, mycobacteriosis); AR (Spastic paraplegia 50, autosomal recessive)",
AP4M1,"AR (Spastic paraplegia 50, autosomal recessive); AR (Spastic paraplegia 51, autosomal recessive); AD (Stuttering, familial persistent, 1); AR (Spastic paraplegia 47, autosomal recessive); AR (Spastic paraplegia 52, autosomal recessive)",
AP4S1,"AR (Spastic paraplegia 52, autosomal recessive); AR (Spastic paraplegia 51, autosomal recessive); AD (Stuttering, familial persistent, 1); AR (Spastic paraplegia 47, autosomal recessive); AR (Spastic paraplegia 50, autosomal recessive)",
AP5M1,"AR (Spastic paraplegia 48, autosomal recessive)",
AP5S1,"AR (Spastic paraplegia 48, autosomal recessive); AR (Spastic paraplegia 15, autosomal recessive); AR (Amyotrophic lateral sclerosis 5, juvenile); AR (Charcot-Marie-Tooth disease, axonal, type 2X); AR (Spastic paraplegia 11, autosomal recessive)",
AP5Z1,"AR (Spastic paraplegia 48, autosomal recessive)",
APAF1,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AR (Oocyte/zygote/embryo maturation arrest 18); AD (Familial cold autoinflammatory syndrome 2); AR (Hydatidiform mole, recurrent, 1)",
APBA1,"FG syndrome 4; Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia; Intellectual developmental disorder, with or without nystagmus; AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes)",
APBA2,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); {Schizophrenia, susceptibility to, 17}; AR (Pitt-Hopkins-like syndrome 2); {Autism susceptibility 1}",
APBB1,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); AD (Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties)",
APC,"Adenoma, periampullary, somatic; AD (Adenomatous polyposis coli); AD (Brain tumor-polyposis syndrome 2); Colorectal cancer, somatic; AD (Desmoid disease, hereditary); AD (Gardner syndrome); AD (Gastric adenocarcinoma and proximal polyposis of the stomach); Gastric cancer, somatic; Hepatoblastoma, somatic; AR (Cortical dysplasia, complex, with other brain malformations 10); AR (Intellectual developmental disorder, autosomal recessive 74); AR ({Budd-Chiari syndrome}); AD ({Pregnancy loss, recurrent, susceptibility to, 1}); {Stroke, ischemic, susceptibility to}; AD ({Thrombophilia, susceptibility to, due to factor V Leiden}); AR (Factor V deficiency); AD (Thrombophilia 2 due to activated protein C resistance); AD (Hypotrichosis 1)",
APC2,"AR (Cortical dysplasia, complex, with other brain malformations 10); AR (Intellectual developmental disorder, autosomal recessive 74); AR (Nephronophthisis 2, infantile); AD (Developmental and epileptic encephalopathy 109); Adenoma, periampullary, somatic; AD (Adenomatous polyposis coli); AD (Brain tumor-polyposis syndrome 2); Colorectal cancer, somatic; AD (Desmoid disease, hereditary); AD (Gardner syndrome); AD (Gastric adenocarcinoma and proximal polyposis of the stomach); Gastric cancer, somatic; Hepatoblastoma, somatic",
APCDD1,AD (Hypotrichosis 1),
APCS,"AR (Pulmonary venoocclusive disease 2); {Celiac disease, susceptibility to, 3}; {Diabetes mellitus, insulin-dependent, 12}; AD ({Hashimoto thyroiditis}); AD ({Systemic lupus erythematosus, susceptibility to}); AD (Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation); AD ([Dystransthyretinemic hyperthyroxinemia]); AD (Amyloidosis, hereditary, transthyretin-related); AD (Carpal tunnel syndrome, familial); AR (?Immunodeficiency 16); {Multiple sclerosis, susceptibility to, 5}; AD (Periodic fever, familial)",
APEX1,"AR (Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia); AR (Baller-Gerold syndrome); AR (RAPADILINO syndrome); AR (Rothmund-Thomson syndrome, type 2); AR (?De Sanctis-Cacchione syndrome); AD ({Lung cancer, susceptibility to}); {Macular degeneration, age-related, susceptibility to, 5}; AR (Cerebrooculofacioskeletal syndrome 1); AR (Cockayne syndrome, type B); AD (Premature ovarian failure 11); AR (UV-sensitive syndrome 1)",
APH1A,"AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (Acne inversa, familial, 1); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V); AD (Acne inversa, familial, 2, with or without Dowling-Degos disease)",
APH1B,"AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V); AD (Acne inversa, familial, 1)",
APLP1,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (?Spinocerebellar ataxia 43); AR (Charcot-Marie-Tooth disease, axonal, type 2T); {Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AR (Nephrotic syndrome, type 1); AD (Intellectual developmental disorder, autosomal dominant 21)",
APLP2,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AR ({Pseudoxanthoma elasticum, modifier of severity of}); AR (Desbuquois dysplasia 2); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); AD (?Spinocerebellar ataxia 43); AR (Charcot-Marie-Tooth disease, axonal, type 2T)",
APOA1,"Amyloidosis, hereditary systemic 3; AR (Hypoalphalipoproteinemia, primary, 2); AD (Hypoalphalipoproteinemia, primary, 2, intermediate); Apolipoprotein C-III deficiency; AR (Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy); AD (HDL deficiency, familial, 1); AR (Tangier disease); AD (Tubulointerstitial kidney disease, autosomal dominant 6); AR ([Proteinuria, chronic benign]); AR (Imerslund-Grasbeck syndrome 1)",
APOA2,"AR ({Hypercholesterolemia, familial, modifier of}); Apolipoprotein A-II deficiency; Amyloidosis, hereditary systemic 3; AR (Hypoalphalipoproteinemia, primary, 2); AD (Hypoalphalipoproteinemia, primary, 2, intermediate); AR (Hypercholesterolemia, familial, 1); AR (LDL cholesterol level QTL2); AD ({Atherosclerosis, susceptibility to}); AD ({Lupus nephritis, susceptibility to}); {Malaria, severe, susceptibility to}; AR ({Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}); AD (Charcot-Marie-Tooth disease, dominant intermediate D); AD (Charcot-Marie-Tooth disease, type 1B); AD (Charcot-Marie-Tooth disease, type 2I); AD (Charcot-Marie-Tooth disease, type 2J); AR (Dejerine-Sottas disease); AD (Hypomyelinating neuropathy, congenital, 2); AD (Roussy-Levy syndrome)",
APOA4,"AD (Tubulointerstitial kidney disease, autosomal dominant 6); Amyloidosis, hereditary systemic 3; AR (Hypoalphalipoproteinemia, primary, 2); AD (Hypoalphalipoproteinemia, primary, 2, intermediate); AD ({Hypertriglyceridemia, susceptibility to}); AD (Hyperchylomicronemia, late-onset); Apolipoprotein C-III deficiency; AD (Familial apolipoprotein gene cluster deletion syndrome); AR ({Hypercholesterolemia, familial, modifier of}); Apolipoprotein A-II deficiency; AD ({Atherosclerosis, susceptibility to})",
APOA5,"AD ({Hypertriglyceridemia, susceptibility to}); AD (Hyperchylomicronemia, late-onset); AR (Hypercholesterolemia, familial, 1); AR (LDL cholesterol level QTL2); Apolipoprotein C-III deficiency; AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AR (Hyperlipoproteinemia, type 1D)",
APOB,"AD (Hypercholesterolemia, familial, 2); AR (Hypobetalipoproteinemia); AD ([LPA deficiency, congenital]); AD ({Coronary artery disease, susceptibility to})",
APOBEC1,"AD (Polycystic kidney disease 6 with or without polycystic liver disease); AD (Leukemia, juvenile myelomonocytic); AD (Neurofibromatosis-Noonan syndrome); AD (Neurofibromatosis, familial spinal); AD (Neurofibromatosis, type 1); AD (Watson syndrome)",
APOBEC2,"AR (Immunodeficiency with hyper-IgM, type 2)",
APOBEC3A,AD (Cleidocranial dysplasia 2),
APOBEC3B,"AD ({Systemic lupus erythematosus, susceptibility to}); AR (Aicardi-Goutieres syndrome 1, dominant and recessive); AD (Chilblain lupus); AD (Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations)",
APOBEC3G,"AD (Cleidocranial dysplasia 2); {HIV1 infection, resistance to}; AR ({Immunodeficiency 83, susceptibility to viral infections})",
APOC1,"AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AD ([High density lipoprotein cholesterol level QTL 10]); AD (Hyperalphalipoproteinemia); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 5}); {Macular degeneration, age-related, 9}; AR (C3 deficiency); AR (Prolidase deficiency); AR (Hyperlipoproteinemia, type Ib)",
APOC2,"AR (Hyperlipoproteinemia, type Ib); AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AD (Orofacial cleft 3); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 5}); {Macular degeneration, age-related, 9}; AR (C3 deficiency); AR (Prolidase deficiency); AR (Hyperlipoproteinemia, type 1D); [Kallikrein, decreased urinary activity of]",
APOC3,"Apolipoprotein C-III deficiency; Amyloidosis, hereditary systemic 3; AR (Hypoalphalipoproteinemia, primary, 2); AD (Hypoalphalipoproteinemia, primary, 2, intermediate); AD ({Hypertriglyceridemia, susceptibility to}); AD (Hyperchylomicronemia, late-onset); AR (Congenital disorder of glycosylation, type IIt); AD (Tubulointerstitial kidney disease, autosomal dominant 6); Rhabdomyosarcoma, alveolar",
APOD,"AD (Developmental and epileptic encephalopathy 47); AD (ADULT syndrome); AD (Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3); AD (Hay-Wells syndrome); AD (Limb-mammary syndrome); Orofacial cleft 8; AD (Premature ovarian failure 21); AD (Rapp-Hodgkin syndrome); AD (Split-hand/foot malformation 4)",
APOE,"AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
APOH,"AD (?Antiphospholipid syndrome, familial)",
APOL1,"AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to}); AD ({Schizophrenia}); AD ({Schizophrenia})",
APOL2,"AD ({Schizophrenia}); AD ({Schizophrenia}); AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to})",
APOL3,"AD ({Schizophrenia}); AD ({Schizophrenia}); AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to}); {Prostate cancer, susceptibility to}",
APOL4,"AD ({Schizophrenia}); AD ({Schizophrenia}); AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to})",
APOL5,"AD ({Schizophrenia}); AD ({Schizophrenia}); AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to})",
APOL6,"AD ({Schizophrenia}); AD ({Schizophrenia}); AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to})",
APOLD1,"AD (?Bleeding disorder, vascular-type); AD (Multiple endocrine neoplasia, type IV)",
APOM,"AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Homocystinuria-megaloblastic anemia, cbl E type)",
APOO,AR (Combined oxidative phosphorylation deficiency 37),
APOOL,AR (Combined oxidative phosphorylation deficiency 37),
APP,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (Keratolytic winter erythema); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); {Alzheimer disease 18, susceptibility to}; AD (Reticulate acropigmentation of Kitamura)",
APPBP2,"Breast cancer, somatic; AD (Jansen-de Vries syndrome)",
APPL1,"AD ({Maturity-onset diabetes of the young, type 14}); Dent disease 2; Lowe syndrome",
APPL2,"AD ({Maturity-onset diabetes of the young, type 14})",
APRT,"AR (Adenine phosphoribosyltransferase deficiency); [Anhaptoglobinemia]; [Hypohaptoglobinemia]; Hyperuricemia, HRPT-related; Lesch-Nyhan syndrome; AD (?Myopathy, scapulohumeroperoneal); AD (Congenital myopathy 2A, typical, autosomal dominant); AR (Congenital myopathy 2B, severe infantile, autosomal recessive); AD (Congenital myopathy 2C, severe infantile, autosomal dominant); AR (Developmental and epileptic encephalopathy 82); AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-; AD (Intellectual developmental disorder, autosomal dominant 3)",
APTX,"AR (Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia); AD (Spinocerebellar ataxia 14); AR (?Spinocerebellar ataxia, autosomal recessive 26)",
AQP1,"[Aquaporin-1 deficiency]; [Blood group, Colton]; AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting); AD (Palmoplantar keratoderma, Bothnian type); [Blood group GIL]; AR (Diabetes insipidus, nephrogenic, 2); AD ([Hereditary persistence of fetal hemoglobin]); AR (Anemia, congenital dyserythropoietic, type IVb); AD (Anemia, dyserythropoietic congenital, type IVa); AD (Blood group--Lutheran inhibitor)",
AQP2,"AR (Diabetes insipidus, nephrogenic, 2); AD (Cataract 15, multiple types); [Aquaporin-1 deficiency]; [Blood group, Colton]; AR (?Deafness, autosomal recessive 123); [Blood group GIL]; AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting)",
AQP3,"[Blood group GIL]; [Aquaporin-1 deficiency]; [Blood group, Colton]; AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting); AR ([Glycerol quantitative trait locus]); AR (Diabetes insipidus, nephrogenic, 2)",
AQP4,"AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting); [Aquaporin-1 deficiency]; [Blood group, Colton]; [Blood group GIL]; [Blood pressure regulation QTL]; AR (Megalencephalic leukoencephalopathy with subcortical cysts 2A); AD (Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development); AD (Long QT syndrome 12); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3)",
AQP5,"AD (Palmoplantar keratoderma, Bothnian type); AD (Hyperhidrosis palmaris et plantaris); [Aquaporin-1 deficiency]; [Blood group, Colton]; AD (?Avascular necrosis of femoral head, primary, 2); [Sodium serum level QTL 1]; AD (Brachyolmia type 3); AD (Digital arthropathy-brachydactyly, familial); AD (Hereditary motor and sensory neuropathy, type IIc); AD (Metatropic dysplasia); AD (Neuronopathy, distal hereditary motor, autosomal dominant 8); AD (Parastremmatic dwarfism); AD (Scapuloperoneal spinal muscular atrophy); AD (SED, Maroteaux type); AD (Spondylometaphyseal dysplasia, Kozlowski type); AD (Cataract 15, multiple types); [Blood group GIL]; AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting)",
AQP6,"AD (Cataract 15, multiple types); [Aquaporin-1 deficiency]; [Blood group, Colton]; AR ([Glycerol quantitative trait locus])",
AQP7,AR ([Glycerol quantitative trait locus]); AR (Trichohepatoenteric syndrome 1); [Body mass index QTL1],
AQP9,"AR ([Glycerol quantitative trait locus]); [Aquaporin-1 deficiency]; [Blood group, Colton]",
AR,"{Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; Beta-2-adrenoreceptor agonist, reduced response to; AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features)",
ARAF,"Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders; Intellectual developmental disorder, X-linked 50; Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); AD (Retinitis pigmentosa 60); Properdin deficiency, X-linked",
ARC,"AR (Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia); AD (?Myoclonus, familial, 1); AD (Developmental delay, language impairment, and ocular abnormalities); AR (Immunodeficiency 113 with autoimmunity and autoinflammation); AR (Arthrogryposis, renal dysfunction, and cholestasis 1); AR (Cholestasis, progressive familial intrahepatic, 12); AR (Keratoderma-ichthyosis-deafness syndrome, autosomal recessive); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
ARCN1,AD (Short stature-micrognathia syndrome),
AREG,"{Diphtheria, susceptibility to}; AD (Tylosis with esophageal cancer); AR (?Inflammatory skin and bowel disease, neonatal, 1)",
ARF1,"AD (Periventricular nodular heterotopia 8); AD ({Autoinflammation and autoimmunity, systemic, with immune dysregulation})",
ARF3,"AD (Periventricular nodular heterotopia 8); AD (Takenouchi-Kosaki syndrome); AD (Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures)",
ARF4,AD (Periventricular nodular heterotopia 8),
ARF6,"AD (Deafness, autosomal dominant 65); AR (Deafness, autosomal recessive 86); AR (Developmental and epileptic encephalopathy 16); AR (DOORS syndrome); AR (Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp); AR (Myoclonic epilepsy, infantile, familial); AR (Intellectual developmental disorder with short stature and behavioral abnormalities)",
ARFGAP1,"AR (?Immunodeficiency 128); AD (Periventricular nodular heterotopia 8); AD ({Autoinflammation and autoimmunity, systemic, with immune dysregulation}); AR (Achondrogenesis, type IA); AR (Odontochondrodysplasia 1)",
ARFGEF1,"AD (Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures)",
ARFGEF2,"AR (Periventricular heterotopia with microcephaly); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic",
ARG1,"AR (Argininemia); AR (Spinocerebellar ataxia, autosomal recessive 31); {Leprosy, protection against}; {Leprosy, susceptibility to, 5}; AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AR (Cone-rod dystrophy and hearing loss 2); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; {Microvascular complications of diabetes 1}",
ARG2,"AR (Argininemia); AD (Dystonia 4, torsion, autosomal dominant); AD (Leukodystrophy, hypomyelinating, 6); Dystonia-Parkinsonism, X-linked; Intellectual developmental disorder, X-linked syndromic 33; AR (Immunodeficiency 46); AR (Oocyte/zygote/embryo maturation arrest 2); AD ({Kaposi sarcoma, susceptibility to}); AD (Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies)",
ARHGAP1,"AD (Takenouchi-Kosaki syndrome); Colorectal cancer, somatic",
ARHGAP10,"AD (Periventricular nodular heterotopia 8); Hypertrichosis, congenital generalized; AD (?Knobloch syndrome 2); Leukemia, juvenile myelomonocytic, somatic",
ARHGAP17,AD (Takenouchi-Kosaki syndrome),
ARHGAP18,"Immunodeficiency 50; AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development)",
ARHGAP20,"Intellectual developmental disorder, X-linked 93",
ARHGAP24,"AD (?Microcephaly 18, primary, autosomal dominant)",
ARHGAP26,"Leukemia, juvenile myelomonocytic, somatic",
ARHGAP29,"AD (?Facial clefting, oblique, 1); AD (Teebi hypertelorism syndrome 1)",
ARHGAP31,AD (Adams-Oliver syndrome 1),
ARHGAP36,Bazex-Dupre-Christol syndrome,
ARHGAP39,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 3; Intellectual developmental disorder, X-linked syndromic, Houge type",
ARHGAP5,AD (Blepharocheilodontic syndrome 2); Chromosome 14q11-q22 deletion syndrome,
ARHGAP6,"Amelogenesis imperfecta, type 1E; Linear skin defects with multiple congenital anomalies 1; AD (Potocki-Shaffer syndrome)",
ARHGDIA,"AR (Nephrotic syndrome, type 8); AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair); Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy; AD (Pseudohypoaldosteronism type I, autosomal dominant); AD (Intellectual developmental disorder, autosomal dominant 48); AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24)",
ARHGDIB,"AR (Nephrotic syndrome, type 8)",
ARHGEF1,"AR (?Immunodeficiency 62); Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic",
ARHGEF10,"AD (?Slowed nerve conduction velocity, AD)",
ARHGEF12,"AD (Hypocalcemia, autosomal dominant 2); AD (Hypocalciuric hypercalcemia, type II); Capillary malformations, congenital, 1, somatic, mosaic; Sturge-Weber syndrome, somatic, mosaic",
ARHGEF15,"AR (?Bleeding disorder, platelet-type, 22); {Prostate cancer/brain cancer susceptibility, somatic}; AD (Angelman syndrome)",
ARHGEF16,"AD (Cataract 6, multiple types); AR (Vascular malformation, primary intraosseous)",
ARHGEF18,"AR (Retinitis pigmentosa 78); Melanoma, malignant, somatic; Pancreatic cancer, somatic; AD (Peutz-Jeghers syndrome); Testicular tumor, somatic",
ARHGEF2,AR (?Neurodevelopmental disorder with midbrain and hindbrain malformations),
ARHGEF25,"AR (Muscular dystrophy, limb-girdle, autosomal recessive 25)",
ARHGEF26,"AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in)",
ARHGEF3,[Mean platelet volume QTL2],
ARHGEF39,AD (Noonan syndrome 13),
ARHGEF6,"Intellectual developmental disorder, X-linked 46; Chromosome Xq26.3 duplication syndrome; Intellectual developmental disorder, X-linked syndromic, Houge type",
ARHGEF7,"Intellectual developmental disorder, X-linked syndromic, Houge type; Intellectual developmental disorder, X-linked 104; AD (Chromosome 13q33-q34 deletion syndrome)",
ARHGEF9,Developmental and epileptic encephalopathy 8,
ARID1A,"AD (Coffin-Siris syndrome 2); AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development); AD (Houge-Janssens syndrome 2); AD (Helsmoortel-van der Aa syndrome); AD ({Rhabdoid tumor predisposition syndrome 1}); AD ({Schwannomatosis-1, susceptibility to}); AD (Coffin-Siris syndrome 3); Rhabdoid tumors, somatic",
ARID1B,"AD (Coffin-Siris syndrome 1); Intellectual developmental disorder, X-linked 99; Intellectual developmental disorder, X-linked 99, syndromic, female-restricted; AD (Coffin-Siris syndrome 2); AD (Wiedemann-Steiner syndrome); AD (Helsmoortel-van der Aa syndrome)",
ARID2,"AD (Coffin-Siris syndrome 6); ?Renal cell carcinoma, clear cell; AD (Congenital contractures of the limbs and face, hypotonia, and developmental delay); AR (Hypotonia, infantile, with psychomotor retardation and characteristic facies 1); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic",
ARID4B,AD (Witteveen-Kolk syndrome),
ARID5B,"AR ({Obesity, susceptibility to, BMIQ14}); AR (Growth retardation, developmental delay, facial dysmorphism); {Leukemia, acute lymphocytic, susceptibility to, 1}; AR (Hamamy syndrome)",
ARL1,"AD (Epilepsy, familial temporal lobe, 2); AR (Pontocerebellar hypoplasia, type 11)",
ARL11,"AD ({Leukemia, chronic lymphocytic, susceptibility to, 2})",
ARL13A,AR (Joubert syndrome 8),
ARL13B,"AR (Joubert syndrome 8); AR (Joubert syndrome 35); AD (Retinitis pigmentosa 83); AR (Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome); AR (Joubert syndrome 1); AR (Joubert syndrome 22); AR (Joubert syndrome 21); AR (Nephronophthisis 15)",
ARL2,"AR (Retinitis pigmentosa 82 with or without situs inversus); AD (?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1); AR (Joubert syndrome 8); AR (Joubert syndrome 35); AD (Retinitis pigmentosa 83); AR (Joubert syndrome 22); AD (?Deafness, autosomal dominant 81); AR (?Deafness, autosomal recessive 88); AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24); AR (Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum)",
ARL2BP,"AR (Retinitis pigmentosa 82 with or without situs inversus); AR (Ciliary dyskinesia, primary, 5); AD (?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1)",
ARL3,"AR (Joubert syndrome 35); AD (Retinitis pigmentosa 83); Retinitis pigmentosa 2; AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24); AD (?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1); AR (Joubert syndrome 22)",
ARL6,"AR ({Bardet-Biedl syndrome 1, modifier of}); AR (Bardet-Biedl syndrome 3); AR (Retinitis pigmentosa 55); AR (Bardet-Biedl syndrome 4); AR (Bardet-Biedl syndrome 1); AR (Bardet-Biedl syndrome 7); AR (Bardet-Biedl syndrome 2); AR (Retinitis pigmentosa 74); AR (Bardet-Biedl syndrome 5); AR (?Retinitis pigmentosa 51); AR (Bardet-Biedl syndrome 8)",
ARL6IP1,"AR (Spastic paraplegia 61, autosomal recessive)",
ARL8B,"AR (Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities)",
ARMC12,AR (Spermatogenic failure 90),
ARMC2,AR (Spermatogenic failure 38); AR (Spermatogenic failure 40),
ARMC5,AD ({ACTH-independent macronodular adrenal hyperplasia 2}),
ARMC9,AR (Joubert syndrome 30); AR (Joubert syndrome 37),
ARMH3,"AD (STING-associated vasculopathy, infantile-onset); AD (Deafness, autosomal dominant 87)",
ARMS2,"{Macular degeneration, age-related, 8}; {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2); AR ({Hemolytic uremic syndrome, atypical, susceptibility to, 1}); AD ({Macular degeneration, age-related, 4}); AD (Basal laminar drusen); AR (Complement factor H deficiency)",
ARNT,"Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); AR (?Webb-Dattani syndrome); AD (Erythrocytosis, familial, 4); AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3)",
ARNT2,AR (?Webb-Dattani syndrome),
ARPC1A,AR (Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia),
ARPC1B,"AR (Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia); AD (Developmental delay, language impairment, and ocular abnormalities); AR (Immunodeficiency 113 with autoimmunity and autoinflammation)",
ARPC2,"AD (Developmental delay, language impairment, and ocular abnormalities); AR (Immunodeficiency 113 with autoimmunity and autoinflammation); {Inflammatory bowel disease 23}; AD (Neurodevelopmental disorder with absent language and variable seizures)",
ARPC3,"AD (Developmental delay, language impairment, and ocular abnormalities); AR (Immunodeficiency 113 with autoimmunity and autoinflammation); AD (Neurodevelopmental disorder with absent language and variable seizures); AR (Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia)",
ARPC4,"AD (Developmental delay, language impairment, and ocular abnormalities); AR (Immunodeficiency 113 with autoimmunity and autoinflammation); AR (Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia)",
ARPC5,"AR (Immunodeficiency 113 with autoimmunity and autoinflammation); AD (Developmental delay, language impairment, and ocular abnormalities); AR (Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia)",
ARPIN,"Meningioma, NF2-related, somatic; Schwannomatosis, somatic; AD (Schwannomatosis, vestibular)",
ARPP19,AD (Houge-Janssens syndrome 3),
ARR3,"Myopia 26, X-linked, female-limited; AR (Joubert syndrome 14); AD (?[Short sleep, familial natural, 2]); [Resting heart rate]; AD (Myopia 2); AR (?Retinitis pigmentosa 58)",
ARRB1,"AD (?[Short sleep, familial natural, 2]); [Resting heart rate]; Beta-2-adrenoreceptor agonist, reduced response to; AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
ARRB2,"Basal cell carcinoma, somatic; Curry-Jones syndrome, somatic mosaic; AR (Pallister-Hall-like syndrome); Basal cell carcinoma, somatic; AD (Basal cell nevus syndrome 1); AD (Holoprosencephaly 7); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); Beta-2-adrenoreceptor agonist, reduced response to; AD (Myelokathexis, isolated); AD (WHIM syndrome 1)",
ARRDC1,"AR (Autoimmune disease, multisystem, with facial dysmorphism); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
ARSA,"AR (Metachromatic leukodystrophy); AR (?Cardiomyopathy, dilated, 2H); AR (Methemoglobinemia, type I); AR (Methemoglobinemia, type II); AR (Infantile cerebellar-retinal degeneration); AR (Optic atrophy 9); AR (Kanzaki disease); AR (Schindler disease, type I); AR (Schindler disease, type III); AD ({Parkinson disease 24, autosomal dominant, susceptibility to}); AR (Combined SAP deficiency); Gaucher disease, atypical; AR (Krabbe disease, atypical); AR (Metachromatic leukodystrophy due to SAP-b deficiency); AR (Epilepsy, early-onset, 5, with or without developmental delay); AR (Mucopolysaccharidosis type VI (Maroteaux-Lamy))",
ARSB,"AR (Mucopolysaccharidosis type VI (Maroteaux-Lamy)); AR (Sandhoff disease, infantile, juvenile, and adult forms); Chondrodysplasia punctata, X-linked recessive",
ARSD,"Chondrodysplasia punctata, X-linked recessive",
ARSF,"Chondrodysplasia punctata, X-linked recessive",
ARSG,"AR (Usher syndrome, type IV)",
ARSK,"AR (Mucopolysaccharidosis, type X)",
ARSL,"Chondrodysplasia punctata, X-linked recessive",
ART1,"[Blood group, Dombrock]; AR (Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures)",
ART3,"[Blood group, Dombrock]",
ART4,"[Blood group, Dombrock]",
ART5,"AD (?Neuropathy, inflammatory demyelinating); AD (Charcot-Marie-Tooth disease, type 1A); AD (Charcot-Marie-Tooth disease, type 1E); AR (Dejerine-Sottas disease); AD (Neuropathy, recurrent, with pressure palsies); AD (Roussy-Levy syndrome)",
ARTN,"AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma)",
ARV1,AR (Developmental and epileptic encephalopathy 38),
ARVCF,"AD ({Panic disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to}); {Anorexia nervosa, susceptibility to, 1}; AR (Cutis laxa, autosomal recessive, type IIC); AR (?Glucocorticoid deficiency 5); AD (Chromosome 22q11.2 microduplication syndrome)",
ARX,"Developmental and epileptic encephalopathy 1; Hydranencephaly with abnormal genitalia; Intellectual developmental disorder, X-linked 29; Lissencephaly, X-linked 2; Partington syndrome; Proud syndrome; Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type; AR ({Diabetes mellitus, ketosis-prone, susceptibility to}); AD (Diabetes mellitus, type 2); Maturity-onset diabetes of the young, type IX; AD (Hypotonia, ataxia, and delayed development syndrome)",
ASAH1,"AR (Farber lipogranulomatosis); AR (Spinal muscular atrophy with progressive myoclonic epilepsy); AR (?Lymphatic malformation 8); AD ({Parkinson disease 24, autosomal dominant, susceptibility to}); AR (Combined SAP deficiency); Gaucher disease, atypical; AR (Krabbe disease, atypical); AR (Metachromatic leukodystrophy due to SAP-b deficiency); AR (Krabbe disease); AR (Chediak-Higashi syndrome)",
ASAH2,"AR (?Leukodystrophy, progressive, early childhood-onset)",
ASAP1,"?Intellectual developmental disorder, X-linked syndromic, Gustavson type; ?Intellectual developmental disorder, X-linked syndromic, Shashi type; AR (Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies)",
ASB1,"AD (Glaucoma 1, open angle, F)",
ASB10,"AD (Glaucoma 1, open angle, F)",
ASB4,"Hypothyroidism, congenital, nongoitrous, 9",
ASCC1,"Barrett esophagus/esophageal adenocarcinoma; AR (Spinal muscular atrophy with congenital bone fractures 2); AR (?Muscular dystrophy, congenital, Davignon-Chauveau type); AR (Spinal muscular atrophy with congenital bone fractures 1); Barrett esophagus/esophageal adenocarcinoma; AR (Intellectual developmental disorder, autosomal recessive 81)",
ASCC2,"Barrett esophagus/esophageal adenocarcinoma; AR (Spinal muscular atrophy with congenital bone fractures 2); AR (?Muscular dystrophy, congenital, Davignon-Chauveau type); AR (Spinal muscular atrophy with congenital bone fractures 1); AR (Intellectual developmental disorder, autosomal recessive 81); Trichothiodystrophy 5, nonphotosensitive",
ASCC3,"AR (Intellectual developmental disorder, autosomal recessive 81); Barrett esophagus/esophageal adenocarcinoma; AR (Spinal muscular atrophy with congenital bone fractures 2); AR (?Muscular dystrophy, congenital, Davignon-Chauveau type); AR (Spinal muscular atrophy with congenital bone fractures 1); Trichothiodystrophy 5, nonphotosensitive",
ASCL1,"AD (Corneal dystrophy, Fuchs endothelial, 3); AD (Pitt-Hopkins syndrome); AD (Intellectual developmental disorder, autosomal dominant 39); AR (Diencephalic-mesencephalic junction dysplasia syndrome 2)",
ASCL2,"AR (Tayoun-Maawali syndrome); Breast cancer, somatic; Lung cancer, somatic; Rhabdomyosarcoma, somatic; AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AD (Beckwith-Wiedemann syndrome)",
ASF1A,"AD (Menke-Hennekam syndrome 1); AD (Rubinstein-Taybi syndrome 1); Colorectal cancer, somatic; AD (Menke-Hennekam syndrome 2); AD (Rubinstein-Taybi syndrome 2)",
ASF1B,"AR (Spondyloepimetaphyseal dysplasia, sponastrime type)",
ASGR1,"[Bilirubin, serum level of, QTL1]; AR ([Gilbert syndrome]); AR (Crigler-Najjar syndrome, type I); AR (Crigler-Najjar syndrome, type II); AR (Hyperbilirubinemia, familial transient neonatal)",
ASH1L,"AD (Intellectual developmental disorder, autosomal dominant 52); AR (Xeroderma pigmentosum, group C); AR (Xeroderma pigmentosum, group E, DDB-negative subtype); AR (Grange syndrome)",
ASH2L,"AD (Dystonia 28, childhood-onset); AD (Intellectual developmental disorder, autosomal dominant 68); AD (Wiedemann-Steiner syndrome); AR (El Hayek-Chahrour neurodevelopmental syndrome); AD (Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome); AD (Kabuki syndrome 1); AD (Kleefstra syndrome 2); AR (Intellectual developmental disorder, autosomal recessive 65)",
ASIC3,"AD (Congenital contractures of the limbs and face, hypotonia, and developmental delay); AR (Hypotonia, infantile, with psychomotor retardation and characteristic facies 1); AD (?Episodic pain syndrome, familial, 1)",
ASIP,"[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]; [Skin/hair/eye pigmentation 9, dark/light hair]; AD (Obesity and hypopigmentation); {Melanoma, cutaneous malignant, 7}; [Analgesia from kappa-opioid receptor agonist, female-specific]; AR ([Skin/hair/eye pigmentation 2, blond hair/fair skin]); AR ([Skin/hair/eye pigmentation 2, red hair/fair skin]); AR ({Albinism, oculocutaneous, type II, modifier of}); {Melanoma, cutaneous malignant, 5}; AR ({UV-induced skin damage}); AD ([Skin/hair/eye pigmentation 3, blue/green eyes]); AD ([Skin/hair/eye pigmentation 3, light/dark/freckling skin]); AD ({Melanoma, cutaneous malignant, susceptibility to, 8}); AR (Albinism, oculocutaneous, type IA); AR (Albinism, oculocutaneous, type IB); {Basal cell carcinoma, susceptibility to, 1}; AD ({Melanoma, cutaneous malignant, 1})",
ASL,"AR (Argininosuccinic aciduria); AD ({Bronchiectasis with or without elevated sweat chloride 1, modifier of}); {Hypertrypsinemia, neonatal}; AD ({Pancreatitis, hereditary}); AR (Congenital bilateral absence of vas deferens); AR (Cystic fibrosis); Sweat chloride elevation without CF; Amyloidosis, hereditary systemic 3; AR (Hypoalphalipoproteinemia, primary, 2); AD (Hypoalphalipoproteinemia, primary, 2, intermediate); AR (Microcephaly 9, primary, autosomal recessive); AR (Seckel syndrome 5); AR (Microcephaly and chorioretinopathy, autosomal recessive, 2); AR (Afibrinogenemia, congenital); AD (Amyloidosis, hereditary systemic 2); AD (Dysfibrinogenemia, congenital); AD (Hypodysfibrinogenemia, congenital); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections)",
ASMT,Raynaud-Claes syndrome,
ASNS,"AR (Asparagine synthetase deficiency); AR (Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive); AD (Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant); AR (Cutis laxa, autosomal recessive, type IIB); AR (Cutis laxa, autosomal recessive, type IIIB)",
ASPA,"AR (Canavan disease); AR (Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate)",
ASPG,{Asperger syndrome susceptibility 2},
ASPH,"AR (Traboulsi syndrome); AR (Cardiac arrhythmia syndrome, with or without skeletal muscle weakness)",
ASPM,"AR (Microcephaly 5, primary, autosomal recessive); AR (Microcephaly 1, primary, autosomal recessive); AR (Microcephaly 7, primary, autosomal recessive); AR (Microcephaly 2, primary, autosomal recessive, with or without cortical malformations)",
ASPN,{Lumbar disc degeneration}; AD ({Osteoarthritis susceptibility 3}),
ASPRV1,"AD (Ichthyosis, lamellar, autosomal dominant)",
ASPSCR1,"Alveolar soft-part sarcoma; Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies; Renal cell carcinoma, papillary, 1; AD (Charcot-Marie-Tooth disease, type 2Y); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 6); AD (Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1); AD ({Epilepsy, idiopathic generalized, susceptibility to, 19})",
ASS1,AR (Citrullinemia),
ASTE1,AD (Hailey-Hailey disease),
ASTL,AR (?Oocyte/zygote/embryo maturation arrest 11),
ASTN2,"AR (?Bardet-Biedl syndrome 11); AR (Muscular dystrophy, limb-girdle, autosomal recessive 8); {Autism susceptibility 1}",
ASXL1,"AD (Bohring-Opitz syndrome); Myelodysplastic syndrome, somatic; AD (Shashi-Pena syndrome); AD (Bainbridge-Ropers syndrome); AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1)",
ASXL2,"AD (Shashi-Pena syndrome); AD (Bohring-Opitz syndrome); Myelodysplastic syndrome, somatic; AD (Bainbridge-Ropers syndrome); AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1)",
ASXL3,AD (Bainbridge-Ropers syndrome),
ATAD1,AR (Hyperekplexia 4),
ATAD3A,"AR (Harel-Yoon syndrome); AR (Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal); AD (Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes)",
ATAD3B,"AR (Harel-Yoon syndrome); AR (Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal); AD (Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster)",
ATAD3C,"AR (Harel-Yoon syndrome); AR (Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal); AD (Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster)",
ATAT1,AD (Branchiooculofacial syndrome),
ATCAY,"AR (Ataxia, cerebellar, Cayman type)",
ATE1,"AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay); AR (Johanson-Blizzard syndrome)",
ATF1,"Ewing sarcoma; Neuroepithelioma; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia; AD (Essential tremor, hereditary, 4); Histiocytoma, angiomatoid fibrous, somatic; AR (Achromatopsia 7)",
ATF2,"Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic; AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; AR (Immunodeficiency 29, mycobacteriosis); AD ({Type 2 diabetes mellitus, susceptibility to})",
ATF3,"{Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); AR (Burn-McKeown syndrome)",
ATF4,"Coffin-Lowry syndrome; Intellectual developmental disorder, X-linked 19; AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6); {Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); {Schizophrenia 9, susceptibility to}",
ATF5,"{Schizophrenia 9, susceptibility to}; AD (?Myopathy, isolated mitochondrial, autosomal dominant); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 2); AD (Spinal muscular atrophy, Jokela type)",
ATF6,"AR (Achromatopsia 7); ?Olmsted syndrome, X-linked; IFAP syndrome with or without BRESHECK syndrome; Keratosis follicularis spinulosa decalvans, X-linked; Osteogenesis imperfecta, type XIX; AR (?Spondyloepiphyseal dysplasia, Kondo-Fu type); {Major affective disorder-7, susceptibility to}; AD (Spinocerebellar ataxia 50)",
ATF6B,"{Major affective disorder-7, susceptibility to}; AR (Achromatopsia 7)",
ATF7IP,"Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); AD (Charcot-Marie-Tooth disease, axonal, type 2Z); AD (Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy); {Leukemia, acute lymphocytic, susceptibility to, 1}",
ATG10,AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1),
ATG101,AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1),
ATG12,"AR (?Spinocerebellar ataxia, autosomal recessive 25); {Inflammatory bowel disease (Crohn disease) 10}",
ATG13,AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1),
ATG14,"AR (?Spinocerebellar ataxia, autosomal recessive 25); AR (Spinocerebellar ataxia, autosomal recessive 15)",
ATG16L1,"{Inflammatory bowel disease (Crohn disease) 10}; {Inflammatory bowel disease 1, Crohn disease}; {Yao syndrome}; AD (Blau syndrome); AR (?Spinocerebellar ataxia, autosomal recessive 25)",
ATG2B,"AD ({Myeloproliferative neoplasms, familial, susceptibility to}); AR (?Spinocerebellar ataxia, autosomal recessive 25)",
ATG3,"AR (?Spinocerebellar ataxia, autosomal recessive 25); AR (Spinocerebellar ataxia, autosomal recessive 31); ?Retinitis pigmentosa 23; Joubert syndrome 10; Orofaciodigital syndrome I; Simpson-Golabi-Behmel syndrome, type 2",
ATG4B,"AR (?Spinocerebellar ataxia, autosomal recessive 25)",
ATG5,"AR (?Spinocerebellar ataxia, autosomal recessive 25); AR (Spinocerebellar ataxia, autosomal recessive 31); {Inflammatory bowel disease (Crohn disease) 10}; AD (?Microcephaly 18, primary, autosomal dominant)",
ATG7,"AR (Spinocerebellar ataxia, autosomal recessive 31); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AR (?Spinocerebellar ataxia, autosomal recessive 25); AR (Argininemia); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 3); AD (Myopathy, distal, with rimmed vacuoles); AR (Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset); AD (Paget disease of bone 3); AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic",
ATG9A,"AR (Spastic paraplegia 50, autosomal recessive); AR (Spastic paraplegia 51, autosomal recessive); AD (Stuttering, familial persistent, 1)",
ATG9B,"AR (?Spinocerebellar ataxia, autosomal recessive 25)",
ATIC,AR (AICA-ribosiduria due to ATIC deficiency); AR (Adenylosuccinase deficiency),
ATL1,"AD (Neuropathy, hereditary sensory, type ID); AD (Spastic paraplegia 3A, autosomal dominant); AD (Spastic paraplegia 4, autosomal dominant); Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); AR (Neuronopathy, distal hereditary motor, autosomal recessive 11, with spasticity); AD (Spastic paraplegia 12, autosomal dominant)",
ATL3,"AD (Neuropathy, hereditary sensory, type IF)",
ATM,"AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; AR (Neurodevelopmental disorder with cerebellar atrophy and with or without seizures); AR (Rigidity and multifocal seizure syndrome, lethal neonatal); Aplastic anemia; Leukemia, acute lymphoblastic; AR (Nijmegen breakage syndrome); AD (?Cutaneous telangiectasia and cancer syndrome, familial); AR (Seckel syndrome 1); Osteosarcoma, somatic; Prostate cancer, somatic; Tumor predisposition syndrome 4, breast/prostate/colorectal; AR (Ataxia-telangiectasia-like disorder 1)",
ATN1,"AD (Congenital hypotonia, epilepsy, developmental delay, and digital anomalies); AD (Dentatorubral-pallidoluysian atrophy); AD (Spinocerebellar ataxia 1)",
ATOH1,"AD (?Deafness, autosomal dominant 89); AR (Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay); AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4); AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3); AD (Spinocerebellar ataxia 27A); AD (Spinocerebellar ataxia 27B, late-onset); AD (Corneal dystrophy, Fuchs endothelial, 3); AD (Pitt-Hopkins syndrome)",
ATOH7,"AR (Persistent hyperplastic primary vitreous, autosomal recessive); AD (Optic atrophy 13 with retinal and foveal abnormalities); AD (?Vertebral hypersegmentation and orofacial anomalies)",
ATOH8,"AD ({Iron overload, susceptibility to}); AR (Hemochromatosis, type 2B)",
ATP1A1,"AD (Charcot-Marie-Tooth disease, axonal, type 2DD); AD (Hypomagnesemia, seizures, and impaired intellectual development 2); AD (Alternating hemiplegia of childhood 1); AD (Developmental and epileptic encephalopathy 98); AR (Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies); AD (Migraine, familial basilar); AD (Migraine, familial hemiplegic, 2); ?Spinocerebellar ataxia, X-linked 1; AD (Primary aldosteronism, seizures, and neurologic abnormalities); AR (Sinoatrial node dysfunction and deafness); AD (Alternating hemiplegia of childhood 2); AD (CAPOS syndrome); AD (Developmental and epileptic encephalopathy 99); AD (Dystonia-12); AR (Neuropathy, hereditary sensory and autonomic, type V)",
ATP1A2,"AD (Alternating hemiplegia of childhood 1); AD (Developmental and epileptic encephalopathy 98); AR (Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies); AD (Migraine, familial basilar); AD (Migraine, familial hemiplegic, 2); AD (Charcot-Marie-Tooth disease, axonal, type 2DD); AD (Hypomagnesemia, seizures, and impaired intellectual development 2); AD (Alternating hemiplegia of childhood 2); AD (CAPOS syndrome); AD (Developmental and epileptic encephalopathy 99); AD (Dystonia-12)",
ATP1A3,"AD (Alternating hemiplegia of childhood 2); AD (CAPOS syndrome); AD (Developmental and epileptic encephalopathy 99); AD (Dystonia-12); AR (Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects); AD (Alternating hemiplegia of childhood 1); AD (Developmental and epileptic encephalopathy 98); AR (Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies); AD (Migraine, familial basilar); AD (Migraine, familial hemiplegic, 2)",
ATP1A4,"AD (Charcot-Marie-Tooth disease, axonal, type 2DD); AD (Hypomagnesemia, seizures, and impaired intellectual development 2); AD (Alternating hemiplegia of childhood 1); AD (Developmental and epileptic encephalopathy 98); AR (Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies); AD (Migraine, familial basilar); AD (Migraine, familial hemiplegic, 2)",
ATP1B1,"[Blood pressure regulation QTL]; AD (Alternating hemiplegia of childhood 1); AD (Developmental and epileptic encephalopathy 98); AR (Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies); AD (Migraine, familial basilar); AD (Migraine, familial hemiplegic, 2); AD (?Cataract 41); AD ({Diabetes mellitus, noninsulin-dependent, association with}); AD (Deafness, autosomal dominant 6/14/38); AR (Wolfram syndrome 1); AD (Wolfram-like syndrome, autosomal dominant); AR (Megalencephalic leukoencephalopathy with subcortical cysts 1)",
ATP1B2,"AD (Alternating hemiplegia of childhood 2); AD (CAPOS syndrome); AD (Developmental and epileptic encephalopathy 99); AD (Dystonia-12); AR (Deafness, autosomal recessive 42)",
ATP1B3,"AD (Deafness, autosomal dominant 50)",
ATP2A1,"AR (Brody myopathy); AD (Cardiac arrhythmia, ankyrin-B-related); AD (Long QT syndrome 4); AR (Immunodeficiency, common variable, 3); AD (Acrokeratosis verruciformis); AD (Darier disease); AD (Alternating hemiplegia of childhood 1); AD (Developmental and epileptic encephalopathy 98); AR (Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies); AD (Migraine, familial basilar); AD (Migraine, familial hemiplegic, 2)",
ATP2A2,"AD (Acrokeratosis verruciformis); AD (Darier disease); AD (Holt-Oram syndrome); AD (Hailey-Hailey disease); AR (Brody myopathy); AD (Alternating hemiplegia of childhood 1); AD (Developmental and epileptic encephalopathy 98); AR (Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies); AD (Migraine, familial basilar); AD (Migraine, familial hemiplegic, 2); AD (Alternating hemiplegia of childhood 2); AD (CAPOS syndrome); AD (Developmental and epileptic encephalopathy 99); AD (Dystonia-12)",
ATP2A3,AD (Acrokeratosis verruciformis); AD (Darier disease),
ATP2B1,"AD (Intellectual developmental disorder, autosomal dominant 66); AR ({Deafness, autosomal recessive 12, modifier of}); AD (Deafness, autosomal dominant 82); AD (Acrokeratosis verruciformis); AD (Darier disease); AR (Hyperparathyroidism, transient neonatal); AR (Immunodeficiency 10); AD (Myopathy, tubular aggregate, 1); AD (Stormorken syndrome); ?Spinocerebellar ataxia, X-linked 1",
ATP2B2,"AR ({Deafness, autosomal recessive 12, modifier of}); AD (Deafness, autosomal dominant 82); AD ({Pituitary adenoma 5, multiple types}); AR (Deafness, autosomal recessive 12); AR (Usher syndrome, type 1D); AR (Usher syndrome, type 1D/F digenic); ?Spinocerebellar ataxia, X-linked 1; AD (Intellectual developmental disorder, autosomal dominant 66); AD (3p- syndrome)",
ATP2B3,"?Spinocerebellar ataxia, X-linked 1; AD (Charcot-Marie-Tooth disease, axonal, type 2DD); AD (Hypomagnesemia, seizures, and impaired intellectual development 2); AR ({Deafness, autosomal recessive 12, modifier of}); AD (Deafness, autosomal dominant 82); AD (Intellectual developmental disorder, autosomal dominant 66)",
ATP2B4,"AD (Intellectual developmental disorder, autosomal dominant 66); AR ({Deafness, autosomal recessive 12, modifier of}); AD (Deafness, autosomal dominant 82); AD (Long QT syndrome 12); ?Spinocerebellar ataxia, X-linked 1",
ATP2C1,AD (Hailey-Hailey disease),
ATP2C2,"Specific language impairment QTL, 1; AR (Immunodeficiency 9); AD (Myopathy, tubular aggregate, 2)",
ATP4A,"AR (Trichohepatoenteric syndrome 1); AD (Intellectual developmental disorder, autosomal dominant 21)",
ATP4B,AR (Wilson disease),
ATP5F1A,"AR (?Combined oxidative phosphorylation deficiency 22); AR (?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4B, encephalopathic type); AD (Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A); AR (Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3); AD (?Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2); AR (Mitochondrial complex V (ATP synthase) deficiency); {Leber hereditary optic neuropathy, modifier of}",
FADD,"AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic; AR (Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction); AD (Autoimmune lymphoproliferative syndrome, type II); Gastric cancer, somatic; Lymphoma, non-Hodgkin, somatic; AD (Autoinflammation with episodic fever and lymphadenopathy); AR (Immunodeficiency 57 with autoinflammation); AR (Reticular dysgenesis); AD ({Autoimmune lymphoproliferative syndrome}); AD (Autoimmune lymphoproliferative syndrome, type IA); Squamous cell carcinoma, burn scar-related, somatic; AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic",
FADS1,"[Polyunsaturated fatty acids plasma level QTL1]; AR (Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency); AR (Fetal akinesia deformation sequence 1); AR (Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency)",
FADS2,"AR (Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency); [Polyunsaturated fatty acids plasma level QTL1]; AR (Fetal akinesia deformation sequence 2); AR (Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency); AR (CPT deficiency, hepatic, type IA)",
FADS3,"AR (Fetal akinesia deformation sequence 3); AR (Myasthenic syndrome, congenital, 10); [Polyunsaturated fatty acids plasma level QTL1]",
FAF1,"Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AD (Orofacial cleft 13); AR (Pierre Robin syndrome)",
FAF2,"AD (Cole-Carpenter syndrome 1); AD (Leukemia, juvenile myelomonocytic); AD (Neurofibromatosis-Noonan syndrome); AD (Neurofibromatosis, familial spinal); AD (Neurofibromatosis, type 1); AD (Watson syndrome); AD (Charcot-Marie-Tooth disease, type 2Y); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 6); AD (Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1); AR (?Neurodevelopmental disorder with poor growth, absent speech, progressive ataxia, and dysmorphic facies); AR (Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia)",
FAH,"AR (Tyrosinemia, type I); AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; AD ({Melanoma and neural system tumor syndrome}); AD ({Melanoma-pancreatic cancer syndrome}); AD ({Melanoma, cutaneous malignant, 2}); AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AR (Glycogen storage disease Ia)",
FAM107B,"AD ({Amyotrophic lateral sclerosis, susceptibility to, 13}); AD ({Parkinson disease, late-onset, susceptibility to}); AD (Spinocerebellar ataxia 2)",
FAM111A,"AD (Gracile bone dysplasia); AD (Kenny-Caffey syndrome, type 2); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91)",
FAM111B,"AD (Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis)",
FAM120B,AD (Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures),
FAM13A,"Pulmonary disease, chronic obstructive, severe early-onset",
FAM149B1,AR (Joubert syndrome 36),
FAM161A,AR (Retinitis pigmentosa 28); AR (Cone-rod dystrophy 20),
FAM167A,"{Systemic lupus erythematosus, susceptibility to, 12}",
FAM177A1,AR (Neurodevelopmental disorder with white matter abnormalities and gait disturbance); AR (Cohen syndrome),
FAM20A,"AR (Amelogenesis imperfecta, type IG (enamel-renal syndrome)); AR (Raine syndrome)",
FAM20B,"AR (Raine syndrome); AR (Amelogenesis imperfecta, type IG (enamel-renal syndrome))",
FAM20C,"AR (Raine syndrome); AD (Deafness, autosomal dominant 39, with dentinogenesis); AD (Dentin dysplasia, type II); AD (Dentinogenesis imperfecta, Shields type II); AD (Dentinogenesis imperfecta, Shields type III); AR (Amelogenesis imperfecta, type IG (enamel-renal syndrome)); AR (Hypophosphatemic rickets, AR)",
FAM50A,"Intellectual developmental disorder, X-linked syndromic, Armfield type",
FAM50B,"AR (Basal ganglia calcification, idiopathic, 9, autosomal recessive)",
FAM83D,"AD (Spondyloepimetaphyseal dysplasia with joint laxity, type 2)",
FAM83H,"AD (Amelogenesis imperfecta, type IIIA)",
FAM9B,[Social cognition],
FAN1,"AR (Interstitial nephritis, karyomegalic); AR (Fanconi anemia, complementation group D2); AR (Fanconi anemia, complementation group I); Chromosome 15q13.3 microdeletion syndrome; AR (Neurodevelopmental disorder with hypotonia and seizures)",
FANCA,"AR (Fanconi anemia, complementation group A); AR (Fanconi anemia, complementation group G); AR (Fanconi anemia, complementation group C); AR (Premature ovarian failure 15); AR (Spermatogenic failure 28); AR (Fanconi anemia, complementation group F); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); Fanconi anemia, complementation group B",
FANCB,"Fanconi anemia, complementation group B; AR (Fanconi anemia, complementation group L)",
FANCC,"AR (Fanconi anemia, complementation group C); AR (Fanconi anemia, complementation group A); AR (Fanconi anemia, complementation group G); AR (Dystonia 33); AD (Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Fanconi anemia, complementation group E); AR (Fanconi anemia, complementation group D2)",
FANCD2,"AR (Fanconi anemia, complementation group D2); AR (Interstitial nephritis, karyomegalic); AR (Fanconi anemia, complementation group I); AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor); AR (Premature ovarian failure 15); AR (Spermatogenic failure 28); AR (Fanconi anemia, complementation group G); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Cerebrooculofacioskeletal syndrome 4)",
FANCE,"AR (Fanconi anemia, complementation group E); AR (Fanconi anemia, complementation group C); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor); AR (Fanconi anemia, complementation group F); AR (Fanconi anemia, complementation group G); AR (Bloom syndrome); AR (Fanconi anemia, complementation group A)",
FANCF,"AR (Fanconi anemia, complementation group F); AR (Fanconi anemia, complementation group G); AR (Fanconi anemia, complementation group A); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Fanconi anemia, complementation group C); AR (Fanconi anemia, complementation group E); AR (Fanconi anemia, complementation group D2)",
FANCG,"AR (Fanconi anemia, complementation group G); AR (Fanconi anemia, complementation group A); AR (Fanconi anemia, complementation group C); AR (Fanconi anemia, complementation group D2); AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor); AR (Fanconi anemia, complementation group F); AD ({Breast cancer, susceptibility to}); {Melanoma, cutaneous malignant, 6}; AR (Dystonia 33); AD (Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome)",
FANCI,"AR (Fanconi anemia, complementation group I); AR (Interstitial nephritis, karyomegalic); AR (Fanconi anemia, complementation group D2); AD ({Breast cancer, susceptibility to}); AD (Fanconi anemia, complementation group R); AD (Mirror movements 2); AD (?Intellectual developmental disorder with hypertelorism and distinctive facies); AR (Fanconi anemia, complementation group C)",
FANCL,"AR (Fanconi anemia, complementation group L); Fanconi anemia, complementation group B; AR (Fanconi anemia, complementation group T); AR (Fanconi anemia, complementation group D2); AR (Fanconi anemia, complementation group F)",
FANCM,"AR (Premature ovarian failure 15); AR (Spermatogenic failure 28); AR (You-Hoover-Fong syndrome); AD (?Deafness, autosomal dominant 70); AR (Immunodeficiency 54)",
FAP,"AD (Maturity-onset diabetes of the young, type VIII); Adenoma, periampullary, somatic; AD (Adenomatous polyposis coli); AD (Brain tumor-polyposis syndrome 2); Colorectal cancer, somatic; AD (Desmoid disease, hereditary); AD (Gardner syndrome); AD (Gastric adenocarcinoma and proximal polyposis of the stomach); Gastric cancer, somatic; Hepatoblastoma, somatic; AD ([Dystransthyretinemic hyperthyroxinemia]); AD (Amyloidosis, hereditary, transthyretin-related); AD (Carpal tunnel syndrome, familial); AD ({?Colorectal cancer, susceptibility to}); AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma)",
FAR1,"AD (Cataracts, spastic paraparesis, and speech delay); AR (Peroxisomal fatty acyl-CoA reductase 1 disorder)",
FAR2,"AD (Cataracts, spastic paraparesis, and speech delay); AR (Peroxisomal fatty acyl-CoA reductase 1 disorder)",
FARP1,"Nystagmus 1, congenital, X-linked; Nystagmus, infantile periodic alternating, X-linked",
FARP2,"Nystagmus 1, congenital, X-linked; Nystagmus, infantile periodic alternating, X-linked",
FARS2,"AR (Combined oxidative phosphorylation deficiency 14); AR (Spastic paraplegia 77, autosomal recessive)",
FARSA,"AR (?Rajab interstitial lung disease with brain calcifications 2); AR (Rajab interstitial lung disease with brain calcifications 1); AR (Combined oxidative phosphorylation deficiency 14); AR (Spastic paraplegia 77, autosomal recessive)",
FARSB,AR (Rajab interstitial lung disease with brain calcifications 1); AR (?Rajab interstitial lung disease with brain calcifications 2),
FAS,"AD ({Autoimmune lymphoproliferative syndrome}); AD (Autoimmune lymphoproliferative syndrome, type IA); Squamous cell carcinoma, burn scar-related, somatic; AR (Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction); AD ({Lung cancer, susceptibility to}); AD (Autoimmune lymphoproliferative syndrome, type IB)",
FASLG,"AD ({Lung cancer, susceptibility to}); AD (Autoimmune lymphoproliferative syndrome, type IB); AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; {Malaria, resistance to}",
FASN,"AR (?Visceral neuropathy, familial, 2, autosomal recessive); Adenocarcinoma of lung, somatic; Gastric cancer, somatic; Glioblastoma, somatic; Ovarian cancer, somatic; {Hyperlipidemia, familial combined, susceptibility to}; AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance); AD (HDL deficiency, familial, 1); AR (Tangier disease)",
FASTKD2,AR (Combined oxidative phosphorylation deficiency 44); AR (CODAS syndrome),
FAT1,AR (Hennekam lymphangiectasia-lymphedema syndrome 2); AR (Van Maldergem syndrome 2); AD (Facioscapulohumeral muscular dystrophy 1); AD (Spinocerebellar ataxia 45),
FAT2,AD (Spinocerebellar ataxia 45); AR (Hennekam lymphangiectasia-lymphedema syndrome 2); AR (Van Maldergem syndrome 2); {Restless legs syndrome 8},
FAT3,AR (Hennekam lymphangiectasia-lymphedema syndrome 2); AR (Van Maldergem syndrome 2); AD (Spinocerebellar ataxia 45),
FAT4,AR (Hennekam lymphangiectasia-lymphedema syndrome 2); AR (Van Maldergem syndrome 2); AD (Mitral valve prolapse 2); AR (Van Maldergem syndrome 1); AD (Neural tube defects); AR ([ER blood group system]); AD (Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema); AR (Lymphatic malformation 6),
FAU,"AR (Combined oxidative phosphorylation deficiency 60); AR (Spastic paraplegia 76, autosomal recessive); AR (?Mitochondrial complex IV deficiency, nuclear type 15)",
FBF1,AR (Orofaciodigital syndrome XIV),
FBH1,"AD (Epilepsy, early-onset, 2, with or without developmental delay); AD (Neurodevelopmental disorder with speech impairment and dysmorphic facies)",
FBL,"AR (Neurodegeneration with brain iron accumulation 1); Leukemia, acute myeloid, somatic",
FBLN1,"AD (Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses); AD (?Spondyloepiphyseal dysplasia, Kimberley type); AD (Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans); AR (Spondyloepimetaphyseal dysplasia, aggrecan type); AR (Cutis laxa, autosomal recessive, type ID); AD (Doyne honeycomb degeneration of retina); AD (Glaucoma 1, open angle, H); AD (?Cutis laxa, autosomal dominant 2); AD (Charcot-Marie-Tooth disease, demyelinating, type 1H); AR (Cutis laxa, autosomal recessive, type IA); AD (Macular degeneration, age-related, 3)",
FBLN2,"AD (Bethlem myopathy 1A); AR (Ullrich congenital muscular dystrophy 1A); AR (?Myosclerosis, congenital); AR (Bethlem myopathy 1B); AR (Ullrich congenital muscular dystrophy 1B); AD (?Spondyloepiphyseal dysplasia, Kimberley type); AD (Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans); AR (Spondyloepimetaphyseal dysplasia, aggrecan type); AD (Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses); Down syndrome; {Osteoarthritis susceptibility 1}; {Atrioventricular septal defect, susceptibility to, 1}",
FBLN5,"AD (?Cutis laxa, autosomal dominant 2); AD (Charcot-Marie-Tooth disease, demyelinating, type 1H); AR (Cutis laxa, autosomal recessive, type IA); AD (Macular degeneration, age-related, 3); AR (Cutis laxa, autosomal recessive, type IB)",
FBN1,"AD (Acromicric dysplasia); AD (Ectopia lentis, familial); AD (Geleophysic dysplasia 2); AD (Marfan lipodystrophy syndrome); AD (Marfan syndrome); AD (MASS syndrome); AD (Stiff skin syndrome); AD (Weill-Marchesani syndrome 2, dominant); AD (Contractural arachnodactyly, congenital); AD (Macular degeneration, early-onset); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy)",
FBN2,"AD (Contractural arachnodactyly, congenital); AD (Macular degeneration, early-onset); AD (Aneurysm, intracranial berry, 1); AD (Ehlers-Danlos syndrome, classic type, 1); AD (Fibromuscular dysplasia, multifocal)",
FBN3,AD (Polycystic ovary syndrome 1),
FBP1,"AR (Fructose-1,6-bisphosphatase deficiency); AD (?Leukodystrophy, childhood-onset, remitting)",
FBP2,"AD (?Leukodystrophy, childhood-onset, remitting); AR (Fructose-1,6-bisphosphatase deficiency)",
FBXL15,"AD (?Advance sleep phase syndrome, familial, 4)",
FBXL2,"AR ({Diabetes, type 1, susceptibility to}); AD (Charcot-Marie-Tooth disease, demyelinating, type 1J); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic",
FBXL3,"AR (Intellectual developmental disorder with short stature, facial anomalies, and speech defects)",
FBXL4,AR (Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)),
FBXL5,"AR (Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia)",
FBXL7,"AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor)",
FBXO11,"AD (Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
FBXO22,AR (Tayoun-Maawali syndrome),
FBXO28,AD (Developmental and epileptic encephalopathy 100); Chromosome 1q41-q42 deletion syndrome,
FBXO30,"AD (Developmental delay, hypotonia, and impaired language); AR (?Acromesomelic dysplasia 2C, Hunter-Thompson type); {Osteoarthritis-5}; AR (Acromesomelic dysplasia 2A); AR (Acromesomelic dysplasia 2B); AR (Brachydactyly, type A1, C); AD (Brachydactyly, type A2); AD (Brachydactyly, type C); AD (Multiple synostoses syndrome 2); AD (Symphalangism, proximal, 1B); AD (Pulmonary hypertension, primary, 2); AD (Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome); AD (Myhre syndrome); Pancreatic cancer, somatic; AD (Polyposis, juvenile intestinal)",
FBXO31,"AR (?Intellectual developmental disorder, autosomal recessive 45); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); AD ({Colorectal cancer, susceptibility to}); {Multiple myeloma, susceptibility to}; AD ({von Hippel-Lindau syndrome, modifier of})",
FBXO32,"AR (Insulin-like growth factor I deficiency); ?Cardiomyopathy, dilated, 1M; AD (Cardiomyopathy, hypertrophic, 12); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis)",
FBXO38,"AD (Neuronopathy, distal hereditary motor, autosomal dominant 6); AR (?Autoimmune disease with susceptibility to mycobacterium tuberculosis); AD (Neuronopathy, distal hereditary motor, autosomal dominant 1)",
FBXO40,{Autism susceptibility 1},
FBXO43,AR (Oocyte/zygote/embryo maturation arrest 12); AR (Spermatogenic failure 64),
FBXO45,Chromosome 3q29 microdeletion syndrome,
FBXO7,"AR (Parkinson disease 15, autosomal recessive); AR (Kufor-Rakeb syndrome); AR (Spastic paraplegia 78, autosomal recessive)",
FBXW11,"AD (Neurodevelopmental, jaw, eye, and digital syndrome); Osteopathia striata with cranial sclerosis; AR (3-M syndrome 1)",
FBXW4,"AR (Cortical dysplasia, complex, with other brain malformations 12); AD (Split-hand/foot malformation 3, gene duplication syndrome); AD (Hypogonadotropic hypogonadism 6 with or without anosmia); AD (Hypoplastic femurs and pelvis)",
FBXW5,"?Focal cortical dysplasia, type II, somatic; Lymphangioleiomyomatosis, somatic; AD (Tuberous sclerosis-2)",
FBXW7,"AD (Developmental delay, hypotonia, and impaired language); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AD ({Colorectal cancer, susceptibility to, 10}); AR (Immunodeficiency 120); AD (Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2)",
FBXW8,AD (Glomuvenous malformations); AR (3-M syndrome 1),
FCAR,"AD ({IgA nephropathy, susceptibility to, 1}); AR (Bleeding disorder, platelet-type, 11)",
FCER1A,"{Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); AR (Intellectual developmental disorder, autosomal recessive 66); AR (Thrombocytopenia 3); AR (Smith-Lemli-Opitz syndrome)",
FCER1G,"AR (Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1); [IgG receptor I, phagocytic, familial deficiency of]; AR (Immunodeficiency 20); AD (Autoinflammatory disease, systemic, with vasculitis)",
FCER2,"AR (?Immunodeficiency, common variable, 7); {Systemic lupus erythematosus, susceptibility to, 9}; IgG2 deficiency, selective; {Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); {Alzheimer disease 18, susceptibility to}; AD (Reticulate acropigmentation of Kitamura)",
FCGR1A,"[IgG receptor I, phagocytic, familial deficiency of]; AD ({Lupus nephritis, susceptibility to}); {Malaria, severe, susceptibility to}; AR ({Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}); {H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD); AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}",
FCGR2A,"AD ({Lupus nephritis, susceptibility to}); {Malaria, severe, susceptibility to}; AR ({Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}); [IgG receptor I, phagocytic, familial deficiency of]; AD (Charcot-Marie-Tooth disease, dominant intermediate D); AD (Charcot-Marie-Tooth disease, type 1B); AD (Charcot-Marie-Tooth disease, type 2I); AD (Charcot-Marie-Tooth disease, type 2J); AR (Dejerine-Sottas disease); AD (Hypomyelinating neuropathy, congenital, 2); AD (Roussy-Levy syndrome)",
FCGR2B,"{Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); AR (?Autoimmune disease with susceptibility to mycobacterium tuberculosis); IgG2 deficiency, selective",
FCGR2C,"{Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to})",
FCGR3A,"AR (Immunodeficiency 20); {Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); [IgG receptor I, phagocytic, familial deficiency of]; AD ({Lupus nephritis, susceptibility to}); {Malaria, severe, susceptibility to}; AR ({Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}); AR (Immunodeficiency 104, severe combined)",
FCGR3B,"AR (Immunodeficiency 20); {Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); AD ({Lupus nephritis, susceptibility to}); {Malaria, severe, susceptibility to}; AR ({Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis})",
FCGRT,"AD (Myotonic dystrophy 1); Amyloidosis, hereditary systemic 6; AR (Immunodeficiency 43)",
FCHO1,AR (Immunodeficiency 76),
FCHO2,AR (Immunodeficiency 76),
FCHSD2,AR (Alkuraya-Kucinskas syndrome),
FCN1,"AR (Immunodeficiency due to ficolin 3 deficiency); Hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature; Tn polyagglutination syndrome, somatic",
FCN2,AR (Immunodeficiency due to ficolin 3 deficiency); AR (MASP2 deficiency),
FCN3,AR (Immunodeficiency due to ficolin 3 deficiency),
FCSK,AR (Congenital disorder of glycosylation with defective fucosylation 2),
FDFT1,AR (Squalene synthase deficiency); AD (Keratolytic winter erythema); AR (Alopecia-intellectual disability syndrome 4); AR (Cataract 44); AR (Hypotrichosis 14),
FDPS,"AD (Porokeratosis 9, multiple types)",
FDX1,"AR (Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy)",
FDX2,"AR (Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy); AR (Auditory neuropathy and optic atrophy); AR (Multiple mitochondrial dysfunctions syndrome 9B)",
FDXR,"AR (Auditory neuropathy and optic atrophy); AR (Multiple mitochondrial dysfunctions syndrome 9B); AR (Spastic paraplegia, optic atrophy, and neuropathy); AR (Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy)",
FECH,"AR (Protoporphyria, erythropoietic, 1); AR (Anemia, sideroblastic, 3, pyridoxine-refractory); AR (Spasticity, childhood-onset, with hyperglycinemia); Anemia, sideroblastic, 1; Protoporphyria, erythropoietic, X-linked; AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4)",
FEN1,"Colorectal cancer, somatic; AD (Menke-Hennekam syndrome 2); AD (Rubinstein-Taybi syndrome 2); AR (Werner syndrome); AR (Bloom syndrome); AR (Baller-Gerold syndrome); AR (RAPADILINO syndrome); AR (Rothmund-Thomson syndrome, type 2); AR (?Ataxia-telangiectasia-like disorder 2); Endometrial carcinoma, somatic; AR (Familial adenomatous polyposis 4)",
FER,"AR (?Attention deficit-hyperactivity disorder 8); AD (Agenesis of corpus callosum, cardiac, ocular, and genital syndrome); AD (Arrhythmogenic right ventricular dysplasia 14); AR (Miyoshi muscular dystrophy 1); AR (Muscular dystrophy, limb-girdle, autosomal recessive 2); AR (Myopathy, distal, with anterior tibial onset); AR (Auditory neuropathy, autosomal recessive, 1); AR (Deafness, autosomal recessive 9); AR (Immunodeficiency 76); Adenoma, periampullary, somatic; AD (Adenomatous polyposis coli); AD (Brain tumor-polyposis syndrome 2); Colorectal cancer, somatic; AD (Desmoid disease, hereditary); AD (Gardner syndrome); AD (Gastric adenocarcinoma and proximal polyposis of the stomach); Gastric cancer, somatic; Hepatoblastoma, somatic",
FERMT1,"AR (Kindler syndrome); AR (Leukocyte adhesion deficiency, type III)",
FERMT2,"AR (Leukocyte adhesion deficiency, type III)",
FERMT3,"AR (Leukocyte adhesion deficiency, type III)",
FERRY3,"AR (Intellectual developmental disorder, autosomal recessive 66)",
FES,"AR (Mitochondrial complex I deficiency, nuclear type 5); AR (Mitochondrial complex I deficiency, nuclear type 3); AR (Mitochondrial complex I deficiency, nuclear type 2); AR (Mitochondrial complex I deficiency, nuclear type 1); AR (?Leber-like hereditary optic neuropathy, autosomal recessive 2); AR (Mitochondrial complex I deficiency, nuclear type 6); AR (Mitochondrial complex I deficiency, nuclear type 8)",
FETUB,AR (?Alopecia-intellectual disability syndrome 1),
FEV,Ewing sarcoma; Neuroepithelioma; AR (Aromatic L-amino acid decarboxylase deficiency); AD (Focal segmental glomerulosclerosis 10); AD (Nail-patella syndrome),
FEZ1,"Esophageal squamous cell carcinoma, somatic; AD (Schaaf-Yang syndrome); AR (?Orofaciodigital syndrome II); AD ({Amyotrophic lateral sclerosis, susceptibility to, 24}); AR (Short-rib thoracic dysplasia 6 with or without polydactyly)",
FEZ2,"AD (Macrophthalmia, colobomatous, with microcornea); Esophageal squamous cell carcinoma, somatic",
FEZF1,"AR (Hypogonadotropic hypogonadism 22, with or without anosmia)",
FEZF2,"AD (Immunodeficiency 49, severe combined); AD (Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities); AD (Coffin-Siris syndrome 10); AD (Lamb-Shaffer syndrome); AD (Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism); AD ({Epilepsy, familial temporal lobe, 7}); AR (Lissencephaly 2 (Norman-Roberts type)); AR (Hypogonadotropic hypogonadism 22, with or without anosmia); AD (Chromosome 19q13.11 deletion syndrome, proximal); AR (Dworschak-Punetha neurodevelopmental syndrome)",
FFAR4,"{Obesity, susceptibility to}; [Body mass index QTL1]",
FGA,"AR (Afibrinogenemia, congenital); AD (Amyloidosis, hereditary systemic 2); AD (Dysfibrinogenemia, congenital); AD (Hypodysfibrinogenemia, congenital); AR (Afibrinogenemia, congenital); AD (Dysfibrinogenemia, congenital); AR (Hypofibrinogenemia, congenital); AR (Afibrinogenemia, congenital); AD (Dysfibrinogenemia, congenital); AD (Hypodysfibrinogenemia); AR (Hypofibrinogenemia, congenital); AD ({?Thyroid cancer, nonmedullary, 5}); AD ({Venous thromboembolism, susceptibility to})",
FGB,"AR (Afibrinogenemia, congenital); AD (Dysfibrinogenemia, congenital); AR (Hypofibrinogenemia, congenital); AR (Afibrinogenemia, congenital); AD (Amyloidosis, hereditary systemic 2); AD (Dysfibrinogenemia, congenital); AD (Hypodysfibrinogenemia, congenital); AR (Afibrinogenemia, congenital); AD (Dysfibrinogenemia, congenital); AD (Hypodysfibrinogenemia); AR (Hypofibrinogenemia, congenital)",
FGD1,"Aarskog-Scott syndrome; AR (Charcot-Marie-Tooth disease, type 4H); AD (Takenouchi-Kosaki syndrome); Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type",
FGD2,AR (Glucocorticoid deficiency 3),
FGD3,AR (Glucocorticoid deficiency 3); Prieto syndrome,
FGD4,"AR (Charcot-Marie-Tooth disease, type 4H)",
FGF1,"AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); AD (Hypogonadotropic hypogonadism 20 with or without anosmia); AD (Aneurysm, intracranial berry, 1)",
FGF10,"AD (Aplasia of lacrimal and salivary glands); AD (LADD syndrome 3); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; AD (Hypogonadotropic hypogonadism 6 with or without anosmia); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AR (Deafness, congenital with inner ear agenesis, microtia, and microdontia)",
FGF12,"AD (Developmental and epileptic encephalopathy 47); AD (Spinocerebellar ataxia 27A); AD (Spinocerebellar ataxia 27B, late-onset); Developmental and epileptic encephalopathy 90; Intellectual developmental disorder, X-linked 110",
FGF13,"Developmental and epileptic encephalopathy 90; Intellectual developmental disorder, X-linked 110; Hypertrichosis, congenital generalized; Spinocerebellar ataxia, X-linked 5",
FGF14,"AD (Spinocerebellar ataxia 27A); AD (Spinocerebellar ataxia 27B, late-onset); AD (Neurodevelopmental disorder with motor abnormalities, and facial dysmorphism)",
FGF16,Metacarpal 4-5 fusion; AR (?Renal hypodysplasia/aplasia 2),
FGF17,"AD (Hypogonadotropic hypogonadism 20 with or without anosmia); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Hypogonadotropic hypogonadism 21 with anosmia); AD ({Hypogonadotropic hypogonadism 15 with or without anosmia})",
FGF18,"{Cancer progression/metastasis}; AR (Spinocerebellar ataxia, autosomal recessive 31); AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant)",
FGF19,"AD (Hypogonadotropic hypogonadism 20 with or without anosmia); {Melanoma, cutaneous malignant, susceptibility to, 8}; AR (COMMAD syndrome); AD (Tietz albinism-deafness syndrome); AD (Waardenburg syndrome, type 2A); AR (Deafness, congenital with inner ear agenesis, microtia, and microdontia); AR (?Cholestasis, progressive familial intrahepatic, 6)",
FGF2,"AR (Mosaic variegated aneuploidy syndrome 2); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related); AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); Leukemia, acute myeloid, somatic",
FGF20,AR (?Renal hypodysplasia/aplasia 2); AD (Multiple synostoses syndrome 3),
FGF21,"AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AD (Charcot-Marie-Tooth disease, axonal, type 2A2A); AR (Charcot-Marie-Tooth disease, axonal, type 2A2B); AD (Hereditary motor and sensory neuropathy VIA); AR (Lipomatosis, multiple symmetric, with or without peripheral neuropathy); AR (Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)); AR (Perrault syndrome 5); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3); [Fasting plasma glucose level QTL 5]; AD (Hypertriglyceridemia 2)",
FGF22,AD (Aplasia of lacrimal and salivary glands); AD (LADD syndrome 3),
FGF23,"AD (Hypophosphatemic rickets, autosomal dominant); AR (Tumoral calcinosis, hyperphosphatemic, familial, 2); AR (Tumoral calcinosis, hyperphosphatemic, familial, 1); AR (?Tumoral calcinosis, hyperphosphatemic, familial, 3); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1)",
FGF3,"AR (Deafness, congenital with inner ear agenesis, microtia, and microdontia); AD (Otodental dysplasia chromosome deletion syndrome); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); AR (Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction); AD (Aplasia of lacrimal and salivary glands); AD (LADD syndrome 3)",
FGF4,"AD (Hypogonadotropic hypogonadism 6 with or without anosmia); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AR (Deafness, congenital with inner ear agenesis, microtia, and microdontia); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; AR (Diarrhea 4, malabsorptive, congenital)",
FGF5,AR (Trichomegaly); AR (?Humerofemoral hypoplasia with radiotibial ray deficiency); AR (Tetraamelia syndrome 2); AD (Developmental and epileptic encephalopathy 47); AD (?Hypotrichosis 13),
FGF6,"?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; AD (Developmental and epileptic encephalopathy 47); AD (Hypophosphatemic rickets, autosomal dominant); AR (Tumoral calcinosis, hyperphosphatemic, familial, 2)",
FGF7,"AD (Aplasia of lacrimal and salivary glands); AD (LADD syndrome 3); AR (Dyssegmental dysplasia, Silverman-Handmaker type); AR (Schwartz-Jampel syndrome, type 1); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1)",
FGF8,"AD (Hypogonadotropic hypogonadism 6 with or without anosmia); AD (Hypoplastic femurs and pelvis); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Hypogonadotropic hypogonadism 20 with or without anosmia); AD (Aplasia of lacrimal and salivary glands); AD (LADD syndrome 3); AR (Hypogonadotropic hypogonadism 18 with or without anosmia)",
FGF9,"AD (Multiple synostoses syndrome 3); AR (?Renal hypodysplasia/aplasia 2); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1)",
FGFBP1,"AR (Dyssegmental dysplasia, Silverman-Handmaker type); AR (Schwartz-Jampel syndrome, type 1)",
FGFR1,"Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); Myeloproliferative disorder; Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic; Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic; AD (Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities); Chromosome 8p11 myeloproliferative syndrome",
FGFR1OP2,"Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); Chromosome 8p11 myeloproliferative syndrome",
FGFR2,"?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Craniosynostosis 1); AD (Robinow-Sorauf syndrome); AD (Saethre-Chotzen syndrome with or without eyelid anomalies); AD (Sweeney-Cox syndrome); AR (?Deafness, autosomal recessive 109)",
FGFR3,"AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly",
FGFR4,"{Cancer progression/metastasis}; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Spinocerebellar ataxia, autosomal recessive 31); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly; AD (Hypogonadotropic hypogonadism 6 with or without anosmia); AD (Developmental and epileptic encephalopathy 47)",
FGG,"AR (Afibrinogenemia, congenital); AD (Dysfibrinogenemia, congenital); AD (Hypodysfibrinogenemia); AR (Hypofibrinogenemia, congenital); AR (Afibrinogenemia, congenital); AD (Amyloidosis, hereditary systemic 2); AD (Dysfibrinogenemia, congenital); AD (Hypodysfibrinogenemia, congenital); AR (Afibrinogenemia, congenital); AD (Dysfibrinogenemia, congenital); AR (Hypofibrinogenemia, congenital); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 3}); AD ({Macular degeneration, age-related, 13, susceptibility to}); AR (Complement factor I deficiency); AR (?Neurodevelopmental disorder with poor growth, absent speech, progressive ataxia, and dysmorphic facies); AR (Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia)",
FGGY,AR ([Sedoheptulokinase deficiency]),
FGR,"{Myocardial infarction, susceptibility to}; AR (Immunodeficiency 22); AR (Autoimmune disease, multisystem, infantile-onset, 3)",
FH,"AR (Fumarase deficiency); AD (Leiomyomatosis and renal cell cancer); AR (Hypercholesterolemia, familial, 1); AR (LDL cholesterol level QTL2); AR (Sitosterolemia 2); {Gallbladder disease 4}; AR (Sitosterolemia 1)",
FHIP1B,"AR (Spastic paraplegia 50, autosomal recessive)",
FHIT,"Renal cell carcinoma; Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AR (Neuromyotonia and axonal neuropathy, autosomal recessive)",
FHL1,"?Uruguay faciocardiomusculoskeletal syndrome; Emery-Dreifuss muscular dystrophy 6, X-linked; Myopathy, X-linked, with postural muscle atrophy; Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset; Reducing body myopathy, X-linked 1b, with late childhood or adult onset; Scapuloperoneal myopathy, X-linked dominant; AR ({Hemolytic uremic syndrome, atypical, susceptibility to, 1}); AD ({Macular degeneration, age-related, 4}); AD (Basal laminar drusen); AR (Complement factor H deficiency); AR (Hemophagocytic lymphohistiocytosis, familial, 1)",
FHL2,"Aplastic anemia; AR (Hemophagocytic lymphohistiocytosis, familial, 2); Lymphoma, non-Hodgkin; AR (Hemophagocytic lymphohistiocytosis, familial, 1); AD (Cardiomyopathy, dilated, 1G); AD (Cardiomyopathy, familial hypertrophic, 9); AR (Congenital myopathy 5 with cardiomyopathy); AR (Muscular dystrophy, limb-girdle, autosomal recessive 10); AD (Myopathy, myofibrillar, 9, with early respiratory failure); AD (Tibial muscular dystrophy, tardive); AR ([Uridine-cytidineuria])",
FHL3,"AR (Hemophagocytic lymphohistiocytosis, familial, 3); AR (Hemophagocytic lymphohistiocytosis, familial, 1); AR (Mitchell-Riley syndrome); ?Uruguay faciocardiomusculoskeletal syndrome; Emery-Dreifuss muscular dystrophy 6, X-linked; Myopathy, X-linked, with postural muscle atrophy; Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset; Reducing body myopathy, X-linked 1b, with late childhood or adult onset; Scapuloperoneal myopathy, X-linked dominant",
FHL5,"AR (Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease); AR (Hemophagocytic lymphohistiocytosis, familial, 1)",
FHOD1,"AR (Osteogenesis imperfecta, type IX); AD (Cardiomyopathy, familial hypertrophic, 28)",
FHOD3,"AD (Cardiomyopathy, familial hypertrophic, 28)",
FIBP,AR (Thauvin-Robinet-Faivre syndrome),
FICD,"AR (Spastic paraplegia 92, autosomal recessive)",
FIG4,"AR (?Polymicrogyria, bilateral temporooccipital); AD (Amyotrophic lateral sclerosis 11); AR (Charcot-Marie-Tooth disease, type 4J); AR (Yunis-Varon syndrome); AR (Striatonigral degeneration, childhood-onset); AD (Corneal fleck dystrophy)",
FIGLA,AR (Premature ovarian failure 6); AR (Ovarian dysgenesis 5); AD (Spermatogenic failure 32),
FIGNL1,AR (Ovarian dysgenesis 9),
FILIP1,"AR (Neuromuscular disorder, congenital, with dysmorphic facies)",
FIP1L1,"Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial; Hypereosinophilic syndrome, idiopathic, resistant to imatinib; AD (Gastrointestinal stromal tumor, familial); Germ cell tumors, somatic; Leukemia, acute myeloid, somatic; AD (Mastocytosis, cutaneous); Mastocytosis, systemic, somatic; AD (Piebaldism); AR (Immunodeficiency 75); Myelodysplastic syndrome, somatic",
FIS1,"AD (Optic atrophy 14); AR (Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1); AD (Optic atrophy 5); AR (?Combined oxidative phosphorylation deficiency 49); AD (Charcot-Marie-Tooth disease, type 2B); AR (3-methylglutaconic aciduria, type III); AD (Optic atrophy 3 with cataract)",
FITM2,AR (Siddiqi syndrome),
FIZ1,"Leukemia, acute lymphoblastic, somatic; Leukemia, acute myeloid, reduced survival in, somatic; Leukemia, acute myeloid, somatic; Retinal degeneration, autosomal recessive, clumped pigment type; AD (Retinitis pigmentosa 27)",
FJX1,AR (Hennekam lymphangiectasia-lymphedema syndrome 2); AR (Van Maldergem syndrome 2); AD (?Aniridia 3),
FKBP10,"AR (Bruck syndrome 1); AR (Osteogenesis imperfecta, type XI); {Preterm premature rupture of the membranes, susceptibility to}; AR (Osteogenesis imperfecta, type X); AR (Osteogenesis imperfecta, type IX); AR (Bruck syndrome 2); AR (Osteogenesis imperfecta, type XXI)",
FKBP14,"AR (Ehlers-Danlos syndrome, kyphoscoliotic type, 2)",
FKBP1A,"{Major depressive disorder and accelerated response to antidepressant drug treatment}; AD (Pituitary adenoma 1, multiple types); AD (Pituitary adenoma predisposition); AD (Fibrodysplasia ossificans progressiva); AD (Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome); AD (Ventricular tachycardia, catecholaminergic polymorphic, 1)",
FKBP1B,"AD (Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome); AD (Ventricular tachycardia, catecholaminergic polymorphic, 1); AR (Ventricular tachycardia, catecholaminergic polymorphic, 2)",
FKBP2,"AR (?Mitochondrial complex IV deficiency, nuclear type 15); AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9); AR (Spondylometaphyseal dysplasia with corneal dystrophy)",
FKBP4,"AD (Pituitary adenoma 1, multiple types); AD (Pituitary adenoma predisposition); AR (Osteootohepatoenteric syndrome); AD (Glomuvenous malformations)",
FKBP5,"{Major depressive disorder and accelerated response to antidepressant drug treatment}; AR (Developmental and epileptic encephalopathy 101); AD (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant); AR (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive); AR (?Bleeding disorder, platelet-type, 22); {Prostate cancer/brain cancer susceptibility, somatic}; {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; Leukemia, acute promyelocytic, PL2F/RARA type",
FKBP6,AR (Spermatogenic failure 77); AD (Williams-Beuren syndrome); AD (Chromosome 7q11.23 duplication syndrome),
FKBP8,AR (Hepatorenocardiac degenerative fibrosis),
FKBPL,"[Blood group, Indian system]; AD (Glucocorticoid resistance); AR (Polyglucosan body myopathy 1 with or without immunodeficiency)",
FKRP,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5); AR (Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9); AR (Muscular dystrophy, congenital, merosin deficient or partially deficient); AR (Muscular dystrophy, limb-girdle, autosomal recessive 23); AR (?Bardet-Biedl syndrome 11); AR (Muscular dystrophy, limb-girdle, autosomal recessive 8)",
FKTN,"AR (Cardiomyopathy, dilated, 1X); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4); AR (Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9)",
FLAD1,"AR (Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency); AD (Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities); AD (Floating-Harbor syndrome)",
FLCN,"AD (Birt-Hogg-Dube syndrome); Colorectal cancer, somatic; AD (Pneumothorax, primary spontaneous); Renal carcinoma, chromophobe, somatic; AR (Immunodeficiency 93 and hypertrophic cardiomyopathy); AD (?Birt-Hogg-Dube syndrome 2); AD (Amyotrophic lateral sclerosis 10, with or without FTD); AD (Frontotemporal lobar degeneration, TARDBP-related)",
FLG,"AD ({Dermatitis, atopic, susceptibility to, 2}); AR (Ichthyosis vulgaris); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AR (Peeling skin syndrome 6); {Psoriasis susceptibility 4}; AD (Vohwinkel syndrome with ichthyosis); {Cancer progression/metastasis}",
FLG2,"AR (Peeling skin syndrome 6); AD ({Dermatitis, atopic, susceptibility to, 2}); AR (Ichthyosis vulgaris)",
FLI1,"AR (Bleeding disorder, platelet-type, 21); Ewing sarcoma; Neuroepithelioma; ?Thrombocytopenia, Paris-Trousseau type; AD (Lymphatic malformation 14); Jacobsen syndrome; Leukemia, acute T-cell",
FLII,"AR (Cardiomyopathy, dilated, 2J)",
FLNA,"?FG syndrome 2; Cardiac valvular dysplasia, X-linked; Congenital short bowel syndrome; Frontometaphyseal dysplasia 1; Heterotopia, periventricular, 1; Intestinal pseudoobstruction, neuronal; Melnick-Needles syndrome; Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Terminal osseous dysplasia; AD (Atelosteogenesis, type I); AD (Atelosteogenesis, type III); AD (Boomerang dysplasia); AD (Larsen syndrome); AR (Spondylocarpotarsal synostosis syndrome); AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay)",
FLNB,"AD (Atelosteogenesis, type I); AD (Atelosteogenesis, type III); AD (Boomerang dysplasia); AD (Larsen syndrome); AR (Spondylocarpotarsal synostosis syndrome); ?FG syndrome 2; Cardiac valvular dysplasia, X-linked; Congenital short bowel syndrome; Frontometaphyseal dysplasia 1; Heterotopia, periventricular, 1; Intestinal pseudoobstruction, neuronal; Melnick-Needles syndrome; Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Terminal osseous dysplasia; AD (Arrhythmogenic right ventricular dysplasia, familial); AD (Cardiomyopathy, familial hypertrophic, 26); AD (Cardiomyopathy, familial restrictive 5); AD (Myopathy, distal, 4); AD (Myopathy, myofibrillar, 5)",
FLNC,"AD (Arrhythmogenic right ventricular dysplasia, familial); AD (Cardiomyopathy, familial hypertrophic, 26); AD (Cardiomyopathy, familial restrictive 5); AD (Myopathy, distal, 4); AD (Myopathy, myofibrillar, 5); ?FG syndrome 2; Cardiac valvular dysplasia, X-linked; Congenital short bowel syndrome; Frontometaphyseal dysplasia 1; Heterotopia, periventricular, 1; Intestinal pseudoobstruction, neuronal; Melnick-Needles syndrome; Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Terminal osseous dysplasia; AD ({Epilepsy, idiopathic generalized, susceptibility to, 19}); AR (Neuromuscular disorder, congenital, with dysmorphic facies); AD (?Myopathy, scapulohumeroperoneal); AD (Congenital myopathy 2A, typical, autosomal dominant); AR (Congenital myopathy 2B, severe infantile, autosomal recessive); AD (Congenital myopathy 2C, severe infantile, autosomal dominant)",
FLOT1,"[Ezetimibe, nonresponse to]; [Low density lipoprotein cholesterol level QTL 7]; AD (Glaucoma 1A, primary open angle); AR (Rhizomelic chondrodysplasia punctata, type 2)",
FLOT2,"[Ezetimibe, nonresponse to]; [Low density lipoprotein cholesterol level QTL 7]",
FLRT1,"AD (Hypogonadotropic hypogonadism 21 with anosmia); AR (Spastic paraplegia, optic atrophy, and neuropathy)",
FLRT2,AD (Hypogonadotropic hypogonadism 21 with anosmia),
FLRT3,"AD (Hypogonadotropic hypogonadism 21 with anosmia); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Hypogonadotropic hypogonadism 20 with or without anosmia); AD ({Hypogonadotropic hypogonadism 15 with or without anosmia})",
FLT1,"AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic; {Microvascular complications of diabetes 1}; Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy; AD (Robinow syndrome, autosomal dominant 1); AR (Zaki syndrome); AD (Preeclampsia/eclampsia 1); Leukemia, acute lymphoblastic, somatic; Leukemia, acute myeloid, reduced survival in, somatic; Leukemia, acute myeloid, somatic",
FLT3,"Leukemia, acute lymphoblastic, somatic; Leukemia, acute myeloid, reduced survival in, somatic; Leukemia, acute myeloid, somatic; AR (?Immunodeficiency 125); Leukemia, acute myeloid, somatic; AR (Bone marrow failure syndrome 4); {Leukemia, acute lymphocytic, susceptibility to, 1}; AD (Congenital heart defects, multiple types, 7); Hemangioma, capillary infantile, somatic; AD (Lymphatic malformation 1); {Leukemia, acute lymphoblastic, susceptibility to, 3}",
FLT3LG,"AR (?Immunodeficiency 125); AD (?Juvenile myelomonocytic leukemia); AD (Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia); Leukemia, acute lymphoblastic, somatic; Leukemia, acute myeloid, reduced survival in, somatic; Leukemia, acute myeloid, somatic; Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AR (?Immunodeficiency, common variable, 11)",
FLT4,"AD (Congenital heart defects, multiple types, 7); Hemangioma, capillary infantile, somatic; AD (Lymphatic malformation 1); AD (Lymphatic malformation 4); AD (Lymphedema-distichiasis syndrome); AD (Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus); AD (Adams-Oliver syndrome 3); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
FLVCR1,"AR (Neurodevelopmental disorder with microcephaly, absent speech, and hypotonia); AR (Retinopathy-sensory neuropathy syndrome); AR (Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome)",
FLVCR2,"AR (Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome); AR (Neurodevelopmental disorder with microcephaly, absent speech, and hypotonia); AR (Retinopathy-sensory neuropathy syndrome)",
FMN1,"AD (Atelosteogenesis, type I); AD (Atelosteogenesis, type III); AD (Boomerang dysplasia); AD (Larsen syndrome); AR (Spondylocarpotarsal synostosis syndrome); ?FG syndrome 2; Cardiac valvular dysplasia, X-linked; Congenital short bowel syndrome; Frontometaphyseal dysplasia 1; Heterotopia, periventricular, 1; Intestinal pseudoobstruction, neuronal; Melnick-Needles syndrome; Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Terminal osseous dysplasia; AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor)",
FMN2,"AR (Intellectual developmental disorder, autosomal recessive 47)",
FMNL3,"AR (Nephrotic syndrome, type 24)",
FMO1,AR (Trimethylaminuria),
FMO3,AR (Trimethylaminuria),
FMO4,AR (Trimethylaminuria),
FMO5,AR (?Progesterone resistance),
FMOD,"AR ({Hemolytic uremic syndrome, atypical, susceptibility to, 1}); AD ({Macular degeneration, age-related, 4}); AD (Basal laminar drusen); AR (Complement factor H deficiency)",
FMR1,"Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; AR (?Congenital myopathy 9A with respiratory insufficiency and bone fractures); AR (Congenital myopathy 9B, proximal, with minicore lesions); AD (Branchiooculofacial syndrome); AR (Intellectual developmental disorder with paroxysmal dyskinesia or seizures)",
FN1,"AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); AD (Glomerulopathy with fibronectin deposits 1); AD (Holoprosencephaly 11); AR (Multicentric osteolysis, nodulosis, and arthropathy); {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2)",
FNDC3A,AD (Neurodevelopmental disorder with speech or visual impairment and brain hypomyelination),
FNIP1,"AR (Immunodeficiency 93 and hypertrophic cardiomyopathy); AD (Birt-Hogg-Dube syndrome); Colorectal cancer, somatic; AD (Pneumothorax, primary spontaneous); Renal carcinoma, chromophobe, somatic",
FNIP2,AR (Immunodeficiency 93 and hypertrophic cardiomyopathy),
FNTA,"AR (Myasthenia, congenital, 12, with tubular aggregates)",
FOCAD,"AR (Liver disease, severe congenital)",
FOLR1,AR (Neurodegeneration due to cerebral folate transport deficiency),
FOLR2,AR (Neurodegeneration due to cerebral folate transport deficiency),
FOS,"AD (Aplasia cutis-enamel dysplasia syndrome); AR (Congenital disorder of deglycosylation 2); AR (Pituitary hormone deficiency, combined or isolated, 1); {Coronary heart disease, susceptibility to, 6}",
FOSB,AR (?Lissencephaly 7 with cerebellar hypoplasia); AR (Cerebrooculofacioskeletal syndrome 4); AD (Aplasia cutis-enamel dysplasia syndrome),
FOSL1,"AD (Immunodeficiency, common variable, 12); AR (?Mitochondrial complex IV deficiency, nuclear type 15); AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9)",
FOSL2,AD (Aplasia cutis-enamel dysplasia syndrome),
FOXA1,"AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance); AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1); ?Scaphocephaly, maxillary retrusion, and impaired intellectual development; AD (Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis); AD (Apert syndrome); AD (Beare-Stevenson cutis gyrata syndrome); AD (Bent bone dysplasia syndrome); AD (Craniofacial-skeletal-dermatologic dysplasia); Craniosynostosis, nonspecific; AD (Crouzon syndrome); Gastric cancer, somatic; AD (Jackson-Weiss syndrome); AD (LADD syndrome 1); AD (Pfeiffer syndrome); AD (Saethre-Chotzen syndrome); Scaphocephaly and Axenfeld-Rieger anomaly",
FOXA2,"AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1); AD (?Narcolepsy 1); AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); AD (Diabetes mellitus, type II); AD (Hypoinsulinemic hypoglycemia with hemihypertrophy)",
FOXA3,"AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; AD ({Melanoma and neural system tumor syndrome}); AD ({Melanoma-pancreatic cancer syndrome}); AD ({Melanoma, cutaneous malignant, 2}); AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I); AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1)",
FOXC1,"AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3); Chromosome 6pter-p24 deletion syndrome; AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea); AD (Lymphedema-distichiasis syndrome); AD (Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus); {AIDS, resistance to}; Rhabdomyosarcoma, alveolar",
FOXC2,"AD (Lymphedema-distichiasis syndrome); AD (Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus); AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3); AD (Congenital heart defects, multiple types, 7); Hemangioma, capillary infantile, somatic; AD (Lymphatic malformation 1); AD (Alveolar capillary dysplasia with misalignment of pulmonary veins)",
FOXD3,"AD ({Autoimmune disease, susceptibility to, 1}); Omphalocele due to duplication of 1p31.3; AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal); AD (Bryant-Li-Bhoj neurodevelopmental syndrome 1); AR (Frontonasal dysplasia 3)",
FOXE1,"AD ({Thyroid cancer, nonmedullary, 4}); AR (Bamforth-Lazarus syndrome); AD (Orofacial cleft-1); AD ({Thyroid cancer, nonmedullary, 1}); AD (Chorea, hereditary benign); AD (Choreoathetosis, hypothyroidism, and neonatal respiratory distress); AD (Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia); AD (Ectodermal dysplasia 3, Witkop type); AD (Orofacial cleft 5); AD (Tooth agenesis, selective, 1, with or without orofacial cleft); AD (Arrhythmogenic right ventricular dysplasia 1); AD (Loeys-Dietz syndrome 5)",
FOXE3,"AD ({Aortic aneurysm, familial thoracic 11, susceptibility to}); AR (Anterior segment dysgenesis 2, multiple subtypes); AR (Cataract 34, multiple types); AR ({Medulloblastoma predisposition syndrome}); AR (Cerebellar, ocular, craniofacial, and genital syndrome); AR (Anterior segment dysgenesis 7, with sclerocornea); Aortic aneurysm, familial thoracic 1",
FOXF1,AD (Alveolar capillary dysplasia with misalignment of pulmonary veins); AD (Otosclerosis 11); AD (Lymphedema-distichiasis syndrome); AD (Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus),
FOXF2,"Chromosome 6pter-p24 deletion syndrome; AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3)",
FOXG1,"AD (Rett syndrome, congenital variant)",
FOXH1,"AD (Chromosome 5q14.3 deletion syndrome); AD (Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language); AD (Heterotaxy, visceral, 5)",
FOXI1,"AR (Enlarged vestibular aqueduct); AR (Deafness, autosomal recessive 4, with enlarged vestibular aqueduct); AR (Pendred syndrome); AD ({Bronchiectasis with or without elevated sweat chloride 1, modifier of}); {Hypertrypsinemia, neonatal}; AD ({Pancreatitis, hereditary}); AR (Congenital bilateral absence of vas deferens); AR (Cystic fibrosis); Sweat chloride elevation without CF; AR (Gitelman syndrome); Ectodermal dysplasia 1, hypohidrotic, X-linked; Tooth agenesis, selective, X-linked 1",
FOXI3,AR (Craniofacial microsomia 2),
FOXJ1,"AD (Ciliary dyskinesia, primary, 43); AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea); AR (Nephronophthisis 2, infantile); AR (Ciliary dyskinesia, primary, 42); AR (Ciliary dyskinesia, primary, 47, and lissencephaly); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Hypogonadotropic hypogonadism 6 with or without anosmia)",
FOXJ3,AR (?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)),
FOXL1,AD (Otosclerosis 11); AD (Alveolar capillary dysplasia with misalignment of pulmonary veins); AD (Lymphedema-distichiasis syndrome); AD (Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus); AD (Otosclerosis 1),
FOXL2,"AR (Blepharophimosis, epicanthus inversus, and ptosis, type 1); AR (Blepharophimosis, epicanthus inversus, and ptosis, type 2); AD (Premature ovarian failure 3); AR (Combined oxidative phosphorylation deficiency 5); AR (Ovarian dysgenesis 7); AD (46XX sex reversal 5); AD (Congenital heart defects, multiple types, 4); AD (46XX sex reversal 4); AD (46XY sex reversal 3); AD (Adrenocortical insufficiency); AD (Premature ovarian failure 7); AD (Spermatogenic failure 8)",
FOXM1,"AR (Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly); AD (?Cutaneous telangiectasia and cancer syndrome, familial); AR (Seckel syndrome 1)",
FOXN1,"AR (T-cell immunodeficiency, congenital alopecia, and nail dystrophy); AD (T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant); AR (Otofaciocervical syndrome 2 with T-cell deficiency)",
FOXO1,"Rhabdomyosarcoma, alveolar; Apolipoprotein C-III deficiency; AR (BDV syndrome); AR (Diarrhea 4, malabsorptive, congenital)",
FOXO3,"Pulmonary disease, chronic obstructive, severe early-onset; AR (?Immunodeficiency 39); {Melanoma, cutaneous malignant, susceptibility to, 8}; AR (COMMAD syndrome); AD (Tietz albinism-deafness syndrome); AD (Waardenburg syndrome, type 2A); Rhabdomyosarcoma, alveolar; AR (T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations); AD (Silver-Russell syndrome 3)",
FOXO4,"AD ({Parkinson disease, late-onset, susceptibility to}); AD (Machado-Joseph disease); Rhabdomyosarcoma, alveolar; AD (Megabladder, congenital)",
FOXP1,"AD (Intellectual developmental disorder with language impairment with or without autistic features); Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked; {Inflammatory bowel disease 11}; AD (Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities)",
FOXP2,"AD (Speech-language disorder-1); AD (Intellectual developmental disorder with autism and speech delay); {Specific language impairment 4}; AD (Intellectual developmental disorder with language impairment with or without autistic features); ?Rolandic epilepsy, impaired intellectual development, and speech dyspraxia; {Autism, susceptibility to, 9}; {Autism susceptibility 15}; AR (Pitt-Hopkins like syndrome 1)",
FOXP3,"Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked; AR (Immunodeficiency 42); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity)",
FOXQ1,"Chromosome 6pter-p24 deletion syndrome; AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3)",
FOXRED1,"AR (Mitochondrial complex I deficiency, nuclear type 19); AR (Mitochondrial complex I deficiency, nuclear type 10); AR (Mitochondrial complex I deficiency, nuclear type 21)",
FPGS,"AR (Charcot-Marie-Tooth disease, axonal, type 2EE); AR (Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Focal segmental glomerulosclerosis 10); AD (Nail-patella syndrome)",
FPR1,"AR ({Alzhieimer disease 17, susceptibility to}); AR (Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2); AR (?WHIM syndrome 2)",
FRA10AC1,"AR (Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities)",
FRAS1,"AR (Fraser syndrome 1); AR (Bifid nose with or without anorectal and renal anomalies); AR (Manitoba oculotrichoanal syndrome); AD (Trigonocephaly 2); AR (Cryptophthalmos, unilateral or bilateral, isolated); AR (Fraser syndrome 2); AR (Fraser syndrome 3)",
FRAT1,AD (46XY sex reversal 6),
FREM1,"AR (Bifid nose with or without anorectal and renal anomalies); AR (Manitoba oculotrichoanal syndrome); AD (Trigonocephaly 2); AR (Cryptophthalmos, unilateral or bilateral, isolated); AR (Fraser syndrome 2); AD (Chromosome 9p deletion syndrome); AR (Fraser syndrome 1)",
FREM2,"AR (Cryptophthalmos, unilateral or bilateral, isolated); AR (Fraser syndrome 2); AR (Bifid nose with or without anorectal and renal anomalies); AR (Manitoba oculotrichoanal syndrome); AD (Trigonocephaly 2); AR (Fraser syndrome 1); Diaphragmatic hernia 1; AR (Fraser syndrome 3)",
FRG1,"AD (Facioscapulohumeral muscular dystrophy 1); AD (Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD); AR (Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2)",
FRG2,"AD (Facioscapulohumeral muscular dystrophy 1); AD (Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD); AR (Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2)",
FRMD1,AR (Chudley-McCullough syndrome),
FRMD4A,"AR (?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia)",
FRMD4B,"AR (?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia)",
FRMD5,AD (Neurodevelopmental disorder with eye movement abnormalities and ataxia),
FRMD7,"Nystagmus 1, congenital, X-linked; Nystagmus, infantile periodic alternating, X-linked; Nystagmus 5, congenital, X-linked; AD (Nystagmus 3, congenital, autosomal dominant); AD (Nystagmus 7, congenital, autosomal dominant); AD (Nystagmus 2, congenital, autosomal dominant)",
FRMD8,"AD (Tylosis with esophageal cancer); AR (?Inflammatory skin and bowel disease, neonatal, 1)",
FRMPD1,AR (Chudley-McCullough syndrome),
FRMPD4,"Intellectual developmental disorder, X-linked 104",
FRRS1L,AR (Developmental and epileptic encephalopathy 37),
FRS2,"Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma); AD ({?IgA nephropathy, susceptibility to, 3})",
FRY,"AD (Pan-Chung-Bellen syndrome); Developmental and epileptic encephalopathy 90; Intellectual developmental disorder, X-linked 110; AR (?Retinitis pigmentosa 67); AD (Turnpenny-Fry syndrome); AR (Cone-rod dystrophy and hearing loss 2); [Blood group, ABO system]",
FRYL,"AD (Pan-Chung-Bellen syndrome); AD (Wiedemann-Steiner syndrome); AR (?Neurodevelopmental disorder with poor growth, absent speech, progressive ataxia, and dysmorphic facies); AR (Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia)",
FRZB,"{Osteoarthritis susceptibility 1}; AD (Bethlem myopathy 1A); AR (Ullrich congenital muscular dystrophy 1A); AR (?Myosclerosis, congenital); AR (Bethlem myopathy 1B); AR (Ullrich congenital muscular dystrophy 1B); {Atrioventricular septal defect, susceptibility to, 1}; AD (Dias-Logan syndrome); AR (Pyle disease)",
FSCN1,"Retinitis pigmentosa 30; AD (Plasma triglyceride level QTL, low); AR (Developmental and epileptic encephalopathy 76); AD (Intellectual developmental disorder with severe speech and ambulation defects)",
FSCN2,Retinitis pigmentosa 30,
FSHB,"AR (Hypogonadotropic hypogonadism 24 without anosmia); AR (Ovarian dysgenesis 1); AD (Ovarian hyperstimulation syndrome); AR (Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum); AR (Hypogonadotropic hypogonadism 23 with or without anosmia); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia)",
FSHR,AR (Ovarian dysgenesis 1); AD (Ovarian hyperstimulation syndrome); AR (Hypogonadotropic hypogonadism 24 without anosmia),
FSIP1,AR (Spermatogenic failure 34),
FSIP2,AR (Spermatogenic failure 34),
FST,"Amyotrophic lateral sclerosis 9; {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6)",
FSTL3,"AD ({Colorectal cancer, susceptibility to}); {Multiple myeloma, susceptibility to}; AD ({von Hippel-Lindau syndrome, modifier of})",
FTCD,"AR (Glutamate formiminotransferase deficiency); AR ([Histidinemia]); {Leukemia, acute lymphocytic, susceptibility to, 1}; AR (Glycine N-methyltransferase deficiency)",
FTH1,"AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9); AR (?Mitochondrial complex IV deficiency, nuclear type 15); AD (Hyperferritinemia-cataract syndrome); AR (L-ferritin deficiency, dominant and recessive); AD (Neurodegeneration with brain iron accumulation 3); AD (Hemochromatosis, type 4); AD (?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2); Bestrophinopathy, autosomal recessive; AD (Macular dystrophy, vitelliform, 2); Retinitis pigmentosa-50; Retinitis pigmentosa, concentric; AD (Vitreoretinochoroidopathy)",
FTL,"AD (Hyperferritinemia-cataract syndrome); AR (L-ferritin deficiency, dominant and recessive); AD (Neurodegeneration with brain iron accumulation 3); AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9); AD (Hemochromatosis, type 4)",
FTMT,AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes),
FTO,"AR ({Obesity, susceptibility to, BMIQ14}); AR (Growth retardation, developmental delay, facial dysmorphism); AR (Hamamy syndrome); AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20)); [Body mass index QTL1]",
FTSJ1,"Intellectual developmental disorder, X-linked 9",
FUBP1,"AD (Intellectual developmental disorder, autosomal dominant 45); AD (Verheij syndrome)",
FUBP3,"AR (Neuropathy, hereditary sensory and autonomic, type VIII)",
FUCA1,"AR (Fucosidosis); AR (Rh-null disease, amorph type); AR (Hypophosphatasia, adult); AR (Hypophosphatasia, childhood); AR (Hypophosphatasia, infantile); AR (Odontohypophosphatasia); AR (Congenital disorder of glycosylation, type It)",
FUCA2,"AD (Angioedema, hereditary, 4); AR (Dysplasminogenemia); AR (Plasminogen deficiency, type I); AR (Fucosidosis)",
FUNDC1,Kabuki syndrome 2,
FURIN,"Ectodermal dysplasia 1, hypohidrotic, X-linked; Tooth agenesis, selective, X-linked 1; AD (Schuurs-Hoeijmakers syndrome); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); Immunodeficiency 47; AD ({Low density lipoprotein cholesterol level QTL 1}); AD (Hypercholesterolemia, familial, 3); AR (?Humerofemoral hypoplasia with radiotibial ray deficiency); AR (Tetraamelia syndrome 2); AR (Hypoparathyroidism, familial isolated 1)",
FUS,"Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia; AD (Essential tremor, hereditary, 4); AD (Lymphatic malformation 14); AD ({Amyotrophic lateral sclerosis, susceptibility to, 13}); AD ({Parkinson disease, late-onset, susceptibility to}); AD (Spinocerebellar ataxia 2); Ewing sarcoma; Neuroepithelioma",
FUT1,"AR ([Bombay phenotype]); AR ([Bombay phenotype, digenic]); {Norwalk virus infection, resistance to}; {Vitamin B12 plasma level QTL1}; [Blood group, ABO system]; [Blood group, Lewis]",
FUT2,"AR ([Bombay phenotype, digenic]); {Norwalk virus infection, resistance to}; {Vitamin B12 plasma level QTL1}; AR ([Bombay phenotype]); [Blood group, Lewis]; [Blood group, Auberger system]; AR ([Blood group, Lutheran null]); [Blood group, Lutheran system]",
FUT3,"[Blood group, Lewis]; [Fucosyltransferase 6 deficiency]; AR ([Bombay phenotype, digenic]); {Norwalk virus infection, resistance to}; {Vitamin B12 plasma level QTL1}",
FUT5,"[Fucosyltransferase 6 deficiency]; [Blood group, Lewis]; AR ([Bombay phenotype, digenic]); {Norwalk virus infection, resistance to}; {Vitamin B12 plasma level QTL1}; AR ([Bombay phenotype])",
FUT6,"[Fucosyltransferase 6 deficiency]; [Blood group, Lewis]; AR ([Bombay phenotype, digenic]); {Norwalk virus infection, resistance to}; {Vitamin B12 plasma level QTL1}; AR (Combined low LDL and fibrinogen); AR (Congenital disorder of glycosylation, type IId); AR ([Bombay phenotype])",
FUT7,"AD (Hypoparathyroidism, sensorineural deafness, and renal dysplasia); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps)",
FUT8,AR (Congenital disorder of glycosylation with defective fucosylation 1),
FUT9,"AD ({Migraine with or without aura, susceptibility to, 1})",
FUZ,"AD ({Neural tube defects, susceptibility to}); AR (?Orofaciodigital syndrome XVII); AR (?Short-rib thoracic dysplasia 20 with polydactyly); AR (Bardet-Biedl syndrome 15); AR (Congenital heart defects, hamartomas of tongue, and polysyndactyly)",
FXN,"AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR (?Combined oxidative phosphorylation deficiency 19); AR (Friedreich ataxia 2); AR (Dihydrolipoamide dehydrogenase deficiency); AR (Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome); AR (Spinocerebellar ataxia, autosomal recessive 2); AD (Anemia, sideroblastic, 4); AR (Even-plus syndrome); AR (Combined oxidative phosphorylation deficiency 31)",
FXR1,"AR (?Congenital myopathy 9A with respiratory insufficiency and bone fractures); AR (Congenital myopathy 9B, proximal, with minicore lesions); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1",
FXR2,"Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; AR (?Congenital myopathy 9A with respiratory insufficiency and bone fractures); AR (Congenital myopathy 9B, proximal, with minicore lesions); AD (Chromosome 17p13.1 deletion syndrome)",
FXYD1,"{Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant",
FXYD2,"AD (Hypomagnesemia 2, renal); AR (Hyperphenylalaninemia, BH4-deficient, D); [Blood pressure regulation QTL]",
FXYD4,"AR (Deafness, autosomal recessive 33)",
FXYD5,"AD (Intellectual developmental disorder, autosomal dominant 21)",
FXYD6,AD ({?Schizophrenia}),
FYB1,AR (Thrombocytopenia 3),
FYCO1,"AR (Cataract 18, autosomal recessive)",
FYN,"AR (Thrombocytopenia 3); Lymphoproliferative syndrome, X-linked, 1; AD (Autoinflammatory disease, systemic, with vasculitis); Colorectal cancer, somatic; Esophageal carcinoma, somatic; AR (Gaze palsy, familial horizontal, with progressive scoliosis, 2); AD (Mirror movements 1 and/or agenesis of the corpus callosum)",
FZD1,"AD (Omodysplasia 2); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); AR (Microphthalmia, isolated 5); AR (Nanophthalmos 2); AD (Robinow syndrome, autosomal dominant 1); {Osteoarthritis susceptibility 1}; AD (Exudative vitreoretinopathy 1); AD (Retinopathy of prematurity); AD ([Bone mineral density variability 1, high bone mass]); AD (Endosteal hyperostosis); AR (Exudative vitreoretinopathy 4); AD (Osteopetrosis, autosomal dominant 1); AR (Osteoporosis-pseudoglioma syndrome); AD (Polycystic liver disease 4 with or without kidney cysts)",
FZD2,AD (Omodysplasia 2); AR (Pyle disease); {Osteoarthritis susceptibility 1}; AD (Exudative vitreoretinopathy 1); AD (Retinopathy of prematurity),
FZD3,"AD (Neural tube defects); AD (Robinow syndrome, autosomal dominant 2); AR (Microphthalmia, isolated 5); AR (Nanophthalmos 2); Barrett esophagus/esophageal adenocarcinoma; AD (Williams-Beuren syndrome)",
FZD4,"AD (Exudative vitreoretinopathy 1); AD (Retinopathy of prematurity); AD ([Bone mineral density variability 1, high bone mass]); AD (Endosteal hyperostosis); AR (Exudative vitreoretinopathy 4); AD (Osteopetrosis, autosomal dominant 1); AR (Osteoporosis-pseudoglioma syndrome); AD (Polycystic liver disease 4 with or without kidney cysts); Exudative vitreoretinopathy 2, X-linked; Norrie disease; AD (Exudative vitreoretinopathy 5); AD (Neural tube defects)",
FZD5,AD (Microphthalmia/coloboma 11); {Osteoarthritis susceptibility 4}; Microphthalmia with coloboma 1; AD (Omodysplasia 2),
FZD6,"AR (Nail disorder, nonsyndromic congenital, 1); AD (Neural tube defects); AD (Lymphatic malformation 9)",
FZD7,"AD (Omodysplasia 2); AD (Exudative vitreoretinopathy 1); AD (Retinopathy of prematurity); AR (T-cell immunodeficiency, congenital alopecia, and nail dystrophy); AD (T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant); AD (Neural tube defects)",
FZD8,"AR (T-cell immunodeficiency, congenital alopecia, and nail dystrophy); AD (T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant); {Osteoarthritis susceptibility 1}",
FZD9,AD (Williams-Beuren syndrome); AD (Chromosome 7q11.23 duplication syndrome); AD (Exudative vitreoretinopathy 1); AD (Retinopathy of prematurity),
FZR1,"AD (Developmental and epileptic encephalopathy 109); AD (Neurodevelopmental disorder with hypotonia, seizures, and absent language); AD ({Melanoma, cutaneous malignant, 3}); AD ({Colorectal cancer, susceptibility to}); {Multiple myeloma, susceptibility to}; AD ({von Hippel-Lindau syndrome, modifier of}); AD (Nabais Sa-de Vries syndrome, type 1); AD (Nabais Sa-de Vries syndrome, type 2); AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
G3BP1,"AD (Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies)",
G6PC1,"AR (Glycogen storage disease Ia); AR (Dursun syndrome); AR (Neutropenia, severe congenital 4, autosomal recessive)",
G6PC2,"[Fasting plasma glucose level QTL 1]; AR (Dursun syndrome); AR (Neutropenia, severe congenital 4, autosomal recessive)",
G6PC3,"AR (Dursun syndrome); AR (Neutropenia, severe congenital 4, autosomal recessive); AD (Congenital disorder of glycosylation, type IIw); AR (Glycogen storage disease Ib); AR (Glycogen storage disease Ic)",
G6PD,"{Resistance to malaria due to G6PD deficiency}; Anemia, congenital, nonspherocytic hemolytic, 1, G6PD deficient; AR (Cortisone reductase deficiency 1); Hyperuricemia, HRPT-related; Lesch-Nyhan syndrome; Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect; Phosphoglycerate kinase 1 deficiency",
GAA,"AR (Glycogen storage disease II); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AD (Spinocerebellar ataxia 27A); AD (Spinocerebellar ataxia 27B, late-onset); AR (?[Dysalbuminemic hypertriiodothyroninemia]); AR ([Dysalbuminemic hyperthyroxinemia]); AR (Analbuminemia); Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect",
GAB1,"AR (?Deafness, autosomal recessive 26); AD ({?Deafness, autosomal recessive 26, modifier of}); AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); AD (Myelokathexis, isolated); AD (WHIM syndrome 1)",
GAB2,"AD (Autoinflammatory disease, systemic, with vasculitis); AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); AD (?Agammaglobulinemia 5); AD (Autoinflammation, antibody deficiency, and immune dysregulation syndrome); AD (Familial cold autoinflammatory syndrome 3)",
GABARAP,"AR (Spinocerebellar ataxia, autosomal recessive 31)",
GABBR1,"AD (Neurodevelopmental disorder with language delay and variable cognitive abnormalities); {Nicotine dependence, protection against}; {Nicotine dependence, susceptibility to}; AD (Developmental and epileptic encephalopathy 59); AD (Neurodevelopmental disorder with poor language and loss of hand skills); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AR (Deafness, autosomal recessive 121); {Nasopharyngeal carcinoma, susceptibility to, 2}; AD (Deafness, autosomal dominant 31)",
GABBR2,"{Nicotine dependence, protection against}; {Nicotine dependence, susceptibility to}; AD (Developmental and epileptic encephalopathy 59); AD (Neurodevelopmental disorder with poor language and loss of hand skills); AD (Neurodevelopmental disorder with language delay and variable cognitive abnormalities); AR (Deafness, autosomal recessive 121)",
GABPA,"AR (Intellectual developmental disorder, autosomal recessive 44); AR (Charcot-Marie-Tooth disease, recessive intermediate D); AD ({Type 2 diabetes mellitus, susceptibility to})",
GABRA1,"{Epilepsy, childhood absence, susceptibility to, 4}; {Epilepsy, juvenile myoclonic, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 19); AD ({Schizophrenia}); AD (Developmental and epileptic encephalopathy 74); AD (Febrile seizures, familial, 8); AD (Generalized epilepsy with febrile seizures plus, type 3); AD (Developmental and epileptic encephalopathy 92)",
GABRA2,"{Alcohol dependence, susceptibility to}; AD (Developmental and epileptic encephalopathy 78); Intellectual developmental disorder, X-linked syndromic 34; {Epilepsy, childhood absence, susceptibility to, 4}; {Epilepsy, juvenile myoclonic, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 19); AD (Developmental and epileptic encephalopathy 45); Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features",
GABRA3,"Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features; {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; Myopathy, centronuclear, X-linked; Mucopolysaccharidosis II; Meester-Loeys syndrome; Spondyloepimetaphyseal dysplasia, X-linked; {Alcohol dependence, susceptibility to}; AD (Developmental and epileptic encephalopathy 78)",
GABRA4,"{Alcohol dependence, susceptibility to}; AD (Developmental and epileptic encephalopathy 78); AD ({?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}); {Autism susceptibility 1}",
GABRA5,"AD (Developmental and epileptic encephalopathy 79); {Epilepsy, childhood absence, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 43); AD (Chromosome 15q11-q13 duplication syndrome); {Alcohol dependence, susceptibility to}; AD (Developmental and epileptic encephalopathy 78); {Epilepsy, childhood absence, susceptibility to, 4}; {Epilepsy, juvenile myoclonic, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 19); AD ({?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to})",
GABRA6,"AD ({Schizophrenia}); {Epilepsy, childhood absence, susceptibility to, 4}; {Epilepsy, juvenile myoclonic, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 19); AD ({?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to})",
GABRB1,"AD (Developmental and epileptic encephalopathy 45); {Alcohol dependence, susceptibility to}; AD (Developmental and epileptic encephalopathy 78); {Epilepsy, childhood absence, susceptibility to, 4}; {Epilepsy, juvenile myoclonic, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 19); AD (Developmental and epileptic encephalopathy 92)",
GABRB2,"AD (Developmental and epileptic encephalopathy 92); {Epilepsy, childhood absence, susceptibility to, 4}; {Epilepsy, juvenile myoclonic, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 19); AR (Succinic semialdehyde dehydrogenase deficiency); AD (Developmental and epileptic encephalopathy 79); AD ({?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}); {Epilepsy, childhood absence, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 43)",
GABRB3,"{Epilepsy, childhood absence, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 43); AD (Orofacial cleft-1); {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; AD (Developmental and epileptic encephalopathy 79); AD (Angelman syndrome); AD (Chromosome 15q11-q13 duplication syndrome); AR (Developmental and epileptic encephalopathy 89)",
GABRD,"AD ({?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}); Chromosome 1p36 deletion syndrome, distal; AD (Developmental and epileptic encephalopathy 79); AD (Myoclonic-atonic epilepsy); AD (Epilepsy, childhood absence, 1); AD ({Epilepsy, idiopathic generalized, susceptibility to, 1})",
GABRE,"Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features",
GABRG1,"{Alcohol dependence, susceptibility to}; AD (Developmental and epileptic encephalopathy 78); AD (Developmental and epileptic encephalopathy 74); AD (Febrile seizures, familial, 8); AD (Generalized epilepsy with febrile seizures plus, type 3); AD (Developmental and epileptic encephalopathy 92)",
GABRG2,"AD (Developmental and epileptic encephalopathy 74); AD (Febrile seizures, familial, 8); AD (Generalized epilepsy with febrile seizures plus, type 3); AD (Developmental and epileptic encephalopathy 6B, non-Dravet); AD (Dravet syndrome); AD (Febrile seizures, familial, 3A); AD (Generalized epilepsy with febrile seizures plus, type 2); AD (Migraine, familial hemiplegic, 3)",
GABRG3,"{Epilepsy, childhood absence, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 43); AD (Developmental and epileptic encephalopathy 79); AD (Chromosome 15q11-q13 duplication syndrome)",
GABRP,AD ({Schizophrenia}),
GAD1,"AR (Developmental and epileptic encephalopathy 89); Wieacker-Wolff syndrome; Wieacker-Wolff syndrome, female-restricted; AR (Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities); AR (Spastic paraplegia 83, autosomal recessive); AR (?Split-hand/foot malformation 1 with sensorineural hearing loss); AD (Split-hand/foot malformation 1)",
GAD2,"AR (Developmental and epileptic encephalopathy 89); {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Alexander disease)",
GADD45A,"AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S)",
GADD45B,"Intellectual developmental disorder, X-linked syndromic 14",
GADD45G,"{Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1",
GADD45GIP1,"AD (Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination)",
GADL1,AD ({Major affective disorder 1}),
GAK,"AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Parkinson disease 19a, juvenile-onset); AR (Parkinson disease 19b, early-onset); Exudative vitreoretinopathy 2, X-linked; Norrie disease; AR (Vitamin K-dependent clotting factors, combined deficiency of, 2); AD (Warfarin resistance); AD (Rett syndrome, congenital variant)",
GAL,"AR (Al-Gazali syndrome); AR (Ehlers-Danlos syndrome, spondylodysplastic type, 2); AR (Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures); AD (?Epilepsy, familial temporal lobe, 8); AR (Peters-plus syndrome); AR (GM1-gangliosidosis, type I); AR (GM1-gangliosidosis, type II); AR (GM1-gangliosidosis, type III); AR (Mucopolysaccharidosis type IVB (Morquio)); AR (Galactosemia IV); AR (Combined low LDL and fibrinogen); AR (Congenital disorder of glycosylation, type IId)",
GAL3ST2,"AD (Tubulointerstitial kidney disease, autosomal dominant, 1)",
GALC,"AR (Krabbe disease); AD ({Parkinson disease 24, autosomal dominant, susceptibility to}); AR (Combined SAP deficiency); Gaucher disease, atypical; AR (Krabbe disease, atypical); AR (Metachromatic leukodystrophy due to SAP-b deficiency); AR (GM1-gangliosidosis, type I); AR (GM1-gangliosidosis, type II); AR (GM1-gangliosidosis, type III); AR (Mucopolysaccharidosis type IVB (Morquio)); AD ({Lewy body dementia, susceptibility to}); AD ({Parkinson disease, late-onset, susceptibility to}); AR (Gaucher disease, perinatal lethal); AR (Gaucher disease, type I); AR (Gaucher disease, type II); AR (Gaucher disease, type III); AR (Gaucher disease, type IIIC); AR (Farber lipogranulomatosis); AR (Spinal muscular atrophy with progressive myoclonic epilepsy); AD (Myelokathexis, isolated); AD (WHIM syndrome 1); AR (Immunodeficiency 79); OKT4 epitope deficiency; {Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}",
GALE,"AR (Galactose epimerase deficiency); AR (Thrombocytopenia 13, syndromic); AD (Adams-Oliver syndrome 6); AD (Nephropathy due to CFHR5 deficiency); AD (Lymphatic malformation 10); Leukemia, acute lymphoblastic, somatic; Leukemia, acute myeloid, reduced survival in, somatic; Leukemia, acute myeloid, somatic",
GALK1,AR (Galactokinase deficiency with cataracts); AR (Galactosemia IV); AD (Cole-Carpenter syndrome 1),
GALK2,AR (Galactokinase deficiency with cataracts),
GALM,AR (Galactosemia IV),
GALNS,"AR (Mucopolysaccharidosis IVA); AR (Adenine phosphoribosyltransferase deficiency); AD (HDL deficiency, familial, 1); AR (Tangier disease); AR (Fanconi anemia, complementation group A)",
GALNT1,"AR (Tumoral calcinosis, hyperphosphatemic, familial, 1); AR (Congenital disorder of glycosylation, type IIt)",
GALNT11,"AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AR (Sandestig-Stefanova syndrome); Colorectal cancer, hereditary nonpolyposis, type 6; Esophageal cancer, somatic; AD (Loeys-Dietz syndrome 2); AR (?Retinitis pigmentosa 67)",
GALNT12,"{Colorectal cancer, susceptibility to, 1}",
GALNT15,"AR (Congenital disorder of glycosylation, type IIt)",
GALNT2,"AR (Congenital disorder of glycosylation, type IIt); AR (Tumoral calcinosis, hyperphosphatemic, familial, 1); {Colorectal cancer, susceptibility to, 1}",
GALNT3,"AR (Tumoral calcinosis, hyperphosphatemic, familial, 1); AD (Hypophosphatemic rickets, autosomal dominant); AR (Tumoral calcinosis, hyperphosphatemic, familial, 2); AD (MIRAGE syndrome); AD (Monosomy 7 myelodysplasia and leukemia syndrome 2); AR (Tumoral calcinosis, familial, normophosphatemic); AR (Congenital disorder of glycosylation, type IIt)",
GALNT4,"{Colorectal cancer, susceptibility to, 1}",
GALNT5,"AD (Exostoses, multiple, type 2); AR (Seizures, scoliosis, and macrocephaly syndrome)",
GALR1,"AD (?Epilepsy, familial temporal lobe, 8)",
GALR2,"AD (?Epilepsy, familial temporal lobe, 8)",
GALT,"AR (Galactosemia); AR (Craniosynostosis and dental anomalies); AR (Congenital disorder of glycosylation, type IIi); AR (Al-Gazali syndrome); AR (Ehlers-Danlos syndrome, spondylodysplastic type, 2); AR (Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures); AR (Combined low LDL and fibrinogen); AR (Congenital disorder of glycosylation, type IId); AD (?Myoclonus, familial, 2); AD (Cognitive impairment with or without cerebellar ataxia); AD (Developmental and epileptic encephalopathy 13); AD (Seizures, benign familial infantile, 5)",
GAMT,"AR (Cerebral creatine deficiency syndrome 2); Cerebral creatine deficiency syndrome 1; {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant",
GAN,"AR (Giant axonal neuropathy-1); AR (Spastic paraplegia 76, autosomal recessive); Breast cancer, somatic; AD ({Lewy body dementia, susceptibility to}); AD ({Parkinson disease, late-onset, susceptibility to}); AR (Gaucher disease, perinatal lethal); AR (Gaucher disease, type I); AR (Gaucher disease, type II); AR (Gaucher disease, type III); AR (Gaucher disease, type IIIC); AD ({Dermatitis, atopic, susceptibility to, 2}); AR (Ichthyosis vulgaris)",
GANAB,AD (Polycystic kidney disease 3),
GANC,AD (Polycystic kidney disease 3),
GAP43,"AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III); AD (Chromosome 3q13.31 deletion syndrome)",
GAPDH,"AD (Oculopharyngodistal myopathy 4); AD (Buratti-Harel syndrome); AR (Leukodystrophy, hypomyelinating, 15); AR (Apparent mineralocorticoid excess); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); Arteriovenous malformation of the brain, somatic; Bladder cancer, somatic; Breast cancer, somatic; AD (Cardiofaciocutaneous syndrome 2); Gastric cancer, somatic; Leukemia, acute myeloid, somatic; Lung cancer, somatic; AD (Noonan syndrome 3); Oculoectodermal syndrome, somatic; Pancreatic carcinoma, somatic; AD (RAS-associated autoimmune leukoproliferative disorder); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic",
GAPDHS,AD (?Premature ovarian failure 16),
GAR1,"AR (Retinitis pigmentosa 45); ?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1; Dyskeratosis congenita, X-linked; AR (Dyskeratosis congenita, autosomal recessive 2)",
GARS1,"AD (Charcot-Marie-Tooth disease, type 2D); AD (Neuronopathy, distal hereditary motor, autosomal dominant 5); AD (Spinal muscular atrophy, infantile, James type)",
GART,"AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia); AR (Microcephaly-micromelia syndrome); AR (Microcephaly, short stature, and limb abnormalities); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR (?Hypogonadotropic hypogonadism 12 with or without anosmia); AD (ZTTK syndrome); AR (Adenylosuccinase deficiency)",
GAS1,"AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Holoprosencephaly 11); AD (Holoprosencephaly 1); Burkitt lymphoma, somatic",
GAS2,"AR (?Ciliary dyskinesia, primary, 41); AR (?Deafness, autosomal recessive 125); AR (Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency); AR (Neuropathy, hereditary sensory and autonomic, type VI)",
GAS2L1,"AD (Lissencephaly 9 with complex brainstem malformation); AR (?Ciliary dyskinesia, primary, 41)",
GAS2L2,"AR (?Ciliary dyskinesia, primary, 41)",
GAS6,"AR (Retinitis pigmentosa 38); AD (Thrombophilia 5 due to protein S deficiency, autosomal dominant); AR (Thrombophilia 5 due to protein S deficiency, autosomal recessive)",
GAST,"Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome); AD ([Eculizumab, poor response to]); AR (C5 deficiency); AR (Diarrhea 3, secretory sodium, congenital, syndromic); {Leukemia, acute lymphocytic, susceptibility to, 1}; {Leukemia, acute lymphoblastic, susceptibility to, 2}",
GATA1,"Anemia, congenital, nonspherocytic hemolytic, 9; Anemia, X-linked, with/without neutropenia and/or platelet abnormalities; Leukemia, megakaryoblastic, with or without Down syndrome, somatic; Thrombocytopenia with beta-thalassemia, X-linked; Thrombocytopenia, X-linked, with or without dyserythropoietic anemia; Down syndrome; [XG blood group system, Xg(a-) phenotype]",
GATA2,"AD ({Leukemia, acute myeloid, susceptibility to}); {Myelodysplastic syndrome, susceptibility to}; AD (Emberger syndrome); AD (Immunodeficiency 21); AD (46XY sex reversal 9); Diaphragmatic hernia 3; AD (Tetralogy of Fallot); AD (Hypoparathyroidism, sensorineural deafness, and renal dysplasia); AR (Lymphatic malformation 12); AR (Pituitary hormone deficiency, combined or isolated, 1)",
GATA3,"AD (Hypoparathyroidism, sensorineural deafness, and renal dysplasia); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AD ({Leukemia, acute myeloid, susceptibility to}); {Myelodysplastic syndrome, susceptibility to}; AD (Emberger syndrome); AD (Immunodeficiency 21); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AD (den Hoed-de Boer-Voisin syndrome); AD (Developmental delay with dysmorphic facies and dental anomalies)",
GATA4,AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AD (46XY sex reversal 9); Diaphragmatic hernia 3; AD (Tetralogy of Fallot); AD (Atrial septal defect 9); AD (Atrioventricular septal defect 5); AD (Pancreatic agenesis and congenital heart defects); Persistent truncus arteriosus; AD (Tetralogy of Fallot); AD (Holt-Oram syndrome),
GATA5,"AR (Congenital heart defects, multiple types, 5); AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; Atrial septal defect 4; AR (Lactase deficiency, congenital); AD (Bethlem myopathy 1A); AR (Ullrich congenital muscular dystrophy 1A); AR (?Myosclerosis, congenital); AR (Bethlem myopathy 1B); AR (Ullrich congenital muscular dystrophy 1B); {Atrioventricular septal defect, susceptibility to, 1}; {Osteoarthritis susceptibility 1}",
GATA6,AD (Atrial septal defect 9); AD (Atrioventricular septal defect 5); AD (Pancreatic agenesis and congenital heart defects); Persistent truncus arteriosus; AD (Tetralogy of Fallot); AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1),
GATAD1,"AR (?Cardiomyopathy, dilated, 2B)",
GATAD2A,AD (GAND syndrome),
GATAD2B,AD (GAND syndrome),
GATB,AR (?Combined oxidative phosphorylation deficiency 41); AR (Combined oxidative phosphorylation deficiency 42); AR (Combined oxidative phosphorylation deficiency 40); AR (Combined oxidative phosphorylation deficiency 12),
GATC,AR (Combined oxidative phosphorylation deficiency 42); AR (Combined oxidative phosphorylation deficiency 40); AR (?Combined oxidative phosphorylation deficiency 41); AR (Combined oxidative phosphorylation deficiency 12),
GATM,AR (Cerebral creatine deficiency syndrome 3); AD (Fanconi renotubular syndrome 1),
GBA1,"AD ({Lewy body dementia, susceptibility to}); AD ({Parkinson disease, late-onset, susceptibility to}); AR (Gaucher disease, perinatal lethal); AR (Gaucher disease, type I); AR (Gaucher disease, type II); AR (Gaucher disease, type III); AR (Gaucher disease, type IIIC)",
GBA2,"AR (Spastic paraplegia 46, autosomal recessive)",
GBE1,"AR (Glycogen storage disease IV); AR (Polyglucosan body disease, adult form); AD (Abdominal obesity-metabolic syndrome 1)",
GBF1,"AD (Charcot-Marie-Tooth disease, axonal, type 2GG); AD (Deafness, autosomal dominant 87)",
GBP1,"AD (Neuropathy, hereditary sensory, type ID); AD (Spastic paraplegia 3A, autosomal dominant)",
GBP5,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome)",
GBX2,"AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); Nystagmus 6, congenital, X-linked; Ocular albinism, type I, Nettleship-Falls type; AD ({Osteoporosis, early-onset, susceptibility to, autosomal dominant}); AR (Osteogenesis imperfecta, type XV); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor)",
GC,"AD ({Lewy body dementia, susceptibility to}); AD ({Parkinson disease, late-onset, susceptibility to}); AR (Gaucher disease, perinatal lethal); AR (Gaucher disease, type I); AR (Gaucher disease, type II); AR (Gaucher disease, type III); AR (Gaucher disease, type IIIC); AR (Epilepsy, progressive myoclonic 4, with or without renal failure); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus})",
GCA,"AD (CASGID syndrome); AR (Developmental and epileptic encephalopathy 71); AR (Global developmental delay, progressive ataxia, and elevated glutamine); AD (Oculopharyngeal muscular dystrophy); AR (Thrombophilia 7 due to antithrombin III deficiency); AR (Boudin-Mortier syndrome); Chronic granulomatous disease, X-linked; Immunodeficiency 34, mycobacteriosis, X-linked; Neurofibrosarcoma, somatic; Prostate cancer, somatic",
GCDH,"AR (Glutaricaciduria, type I); AD (?Charcot-Marie-Tooth disease, axonal, type 2Q); AR (Alpha-aminoadipic and alpha-ketoadipic aciduria); AR (Isobutyryl-CoA dehydrogenase deficiency); AR (Glutaric acidemia IIB)",
GCG,"AD (Oculopharyngeal muscular dystrophy); Developmental and epileptic encephalopathy 1; Hydranencephaly with abnormal genitalia; Intellectual developmental disorder, X-linked 29; Lissencephaly, X-linked 2; Partington syndrome; Proud syndrome; AD (Spastic paraplegia 6, autosomal dominant); Chronic granulomatous disease, X-linked; Immunodeficiency 34, mycobacteriosis, X-linked; Fabry disease; Fabry disease, cardiac variant; AR (Hemolytic anemia due to glutathione peroxidase deficiency)",
GCGR,AR (Mahvash disease),
GCH1,"AR (Dystonia, DOPA-responsive); AR (Hyperphenylalaninemia, BH4-deficient, B); AR (Segawa syndrome, recessive)",
GCK,"AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II); [Fasting plasma glucose level QTL 5]; [Birth weight QTL 1]; [Fasting plasma glucose level QTL 2]; AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I); AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma",
GCKR,"[Fasting plasma glucose level QTL 5]; AR (?[Fructosuria, essential]); [Fasting plasma glucose level QTL 1]; AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; [Leptin serum levels QTL1]",
GCLC,"{Myocardial infarction, susceptibility to}; AR (Anemia, congenital, nonspherocytic hemolytic, 7); AD ({Schizophrenia}); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); {Myocardial infarction, susceptibility to}",
GCLM,"{Myocardial infarction, susceptibility to}; AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); {Myocardial infarction, susceptibility to}; AR (Anemia, congenital, nonspherocytic hemolytic, 7)",
GCM1,"AD (Hyperparathyroidism 4); AR (Hypoparathyroidism, familial isolated 2)",
GCM2,"AD (Hyperparathyroidism 4); AR (Hypoparathyroidism, familial isolated 2); AD ({?Epilepsy idiopathic generalized, susceptibility to, 8}); AR (Hyperparathyroidism, neonatal); AD (Hypocalcemia, autosomal dominant); AD (Hypocalcemia, autosomal dominant, with Bartter syndrome); AD (Hypocalciuric hypercalcemia, type I); Aromatase deficiency",
GCNA,"Spermatogenic failure, X-linked, 4",
GCNT1,"AD ([Blood group, Ii]); AD (Adult i phenotype without cataract); AR (Cataract 13 with adult i phenotype)",
GCNT2,"AD ([Blood group, Ii]); AD (Adult i phenotype without cataract); AR (Cataract 13 with adult i phenotype)",
GCSH,"AR (Multiple mitochondrial dysfunctions syndrome 7); AR (Glycine encephalopathy1); AR (Lipoyltransferase 1 deficiency); AR (Glycine encephalopathy 2); AR (Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities)",
GDA,"AR (Epidermolysis bullosa dystrophica inversa); AD (Epidermolysis bullosa dystrophica, autosomal dominant); AR (Epidermolysis bullosa dystrophica, autosomal recessive); AD (Epidermolysis bullosa dystrophica, Bart type); AR (Epidermolysis bullosa dystrophica, localisata variant); AR (Epidermolysis bullosa pruriginosa); AR (Epidermolysis bullosa, pretibial); AD (Nail disorder, nonsyndromic congenital, 8); AR (Transient bullous of the newborn)",
GDAP1,"AR (Charcot-Marie-Tooth disease, axonal, type 2K); AR (Charcot-Marie-Tooth disease, axonal, with vocal cord paresis); AR (Charcot-Marie-Tooth disease, recessive intermediate, A); AR (Charcot-Marie-Tooth disease, type 4A); AR ({?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}); AR (Congenital myopathy 25); AR (Charcot-Marie-Tooth disease, axonal, type 2H); AD (?Charcot-Marie-Tooth disease, axonal, type 2V); AR (Mucopolysaccharidosis type IIIB (Sanfilippo B))",
GDAP2,"AR (Spinocerebellar ataxia, autosomal recessive 27)",
GDF1,"AD (Congenital heart defects, multiple types, 6); AR (Right atrial isomerism (Ivemark)); AR (Epilepsy, progressive myoclonic, 8); Klippel-Feil syndrome 3, autosomal dominant; AD (Microphthalmia, isolated 7); AD (Microphthalmia, isolated, with coloboma 6)",
GDF11,AD (?Vertebral hypersegmentation and orofacial anomalies); AR (Fraser syndrome 1),
GDF15,"AD ({Hyperemesis gravidarum, susceptibility to}); AR (Hemochromatosis, type 2B); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AR (Ciliary dyskinesia, primary, 47, and lissencephaly)",
GDF2,"AD (Telangiectasia, hereditary hemorrhagic, type 5); AD (Microphthalmia, syndromic 6); AD (Orofacial cleft 11); AD (?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type); AR (Kyphomelic dysplasia); Klippel-Feil syndrome 3, autosomal dominant; AD (Microphthalmia, isolated 7); AD (Microphthalmia, isolated, with coloboma 6); AD (Pulmonary hypertension, familial primary, 1, with or without HHT); AD (Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated); AD (Pulmonary venoocclusive disease 1)",
GDF3,"Klippel-Feil syndrome 3, autosomal dominant; AD (Microphthalmia, isolated 7); AD (Microphthalmia, isolated, with coloboma 6); AD (Klippel-Feil syndrome 1, autosomal dominant); AR (Leber congenital amaurosis 17); AD (Microphthalmia with coloboma 6, digenic); Microphthalmia, isolated 4; AD (Multiple synostoses syndrome 4); AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome)",
GDF5,"AR (?Acromesomelic dysplasia 2C, Hunter-Thompson type); {Osteoarthritis-5}; AR (Acromesomelic dysplasia 2A); AR (Acromesomelic dysplasia 2B); AR (Brachydactyly, type A1, C); AD (Brachydactyly, type A2); AD (Brachydactyly, type C); AD (Multiple synostoses syndrome 2); AD (Symphalangism, proximal, 1B); AR (Acromesomelic dysplasia 3); AD (Brachydactyly, type A1, D); AD (Brachydactyly, type A2); AD (Brachydactyly, type B2); AD (Multiple synostoses syndrome 1); AD (Stapes ankylosis with broad thumbs and toes); AD (Symphalangism, proximal, 1A); AD (Tarsal-carpal coalition syndrome); {Stature QTL 14}; AD (Klippel-Feil syndrome 1, autosomal dominant); AR (Leber congenital amaurosis 17); AD (Microphthalmia with coloboma 6, digenic); Microphthalmia, isolated 4; AD (Multiple synostoses syndrome 4)",
GDF6,"AD (Klippel-Feil syndrome 1, autosomal dominant); AR (Leber congenital amaurosis 17); AD (Microphthalmia with coloboma 6, digenic); Microphthalmia, isolated 4; AD (Multiple synostoses syndrome 4); AR (?Acromesomelic dysplasia 2C, Hunter-Thompson type); {Osteoarthritis-5}; AR (Acromesomelic dysplasia 2A); AR (Acromesomelic dysplasia 2B); AR (Brachydactyly, type A1, C); AD (Brachydactyly, type A2); AD (Brachydactyly, type C); AD (Multiple synostoses syndrome 2); AD (Symphalangism, proximal, 1B); AR (Deafness, autosomal recessive 118, with cochlear aplasia); AD (Leri pleonosteosis chromosome duplication syndrome)",
GDF7,"AR (?Acromesomelic dysplasia 2C, Hunter-Thompson type); {Osteoarthritis-5}; AR (Acromesomelic dysplasia 2A); AR (Acromesomelic dysplasia 2B); AR (Brachydactyly, type A1, C); AD (Brachydactyly, type A2); AD (Brachydactyly, type C); AD (Multiple synostoses syndrome 2); AD (Symphalangism, proximal, 1B); AD (Klippel-Feil syndrome 1, autosomal dominant); AR (Leber congenital amaurosis 17); AD (Microphthalmia with coloboma 6, digenic); Microphthalmia, isolated 4; AD (Multiple synostoses syndrome 4)",
GDF9,"AR (Premature ovarian failure 14); Ovarian dysgenesis 2; Premature ovarian failure 4; AD (Premature ovarian failure 5); AD (Tooth agenesis, selective, 9)",
GDI1,"Intellectual developmental disorder, X-linked 41; Chromosome Xq28 duplication syndrome; {Autism susceptibility 1}",
GDI2,"Intellectual developmental disorder, X-linked 41",
GDNF,"AD ({Hirschsprung disease, susceptibility to, 3}); AR (Joint laxity, short stature, and myopia); AR (Renal hypodysplasia/aplasia 4); AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma)",
GDPD1,AD (Retinitis pigmentosa 17),
GDPD5,"AR (Methylmalonic aciduria and homocystinuria, cblC type, digenic)",
GEM,"AR (Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities); AR (Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction); AD (Meier-Gorlin syndrome 6)",
GEMIN2,"AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); AR (Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities); AR (Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction); AD (Lessel-Kreienkamp syndrome)",
GEMIN4,"AR (Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); AD (Lessel-Kreienkamp syndrome)",
GEMIN5,"AR (Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction); AD (Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline); AD (Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder); AD (Lessel-Kreienkamp syndrome); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4)",
GEMIN6,AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); AD (Lessel-Kreienkamp syndrome),
GEMIN7,AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4),
GEN1,"AR (Bloom syndrome); AR (Fanconi anemia, complementation group P)",
GET1,"AR (?Congenital disorder of glycosylation, type IIy); AR (?Congenital disorder of glycosylation, type IIz)",
GET3,"AR (?Cardiomyopathy, dilated, 2H); AR (?Congenital disorder of glycosylation, type IIy); AR (?Congenital disorder of glycosylation, type IIz)",
GET4,"AR (?Congenital disorder of glycosylation, type IIy); AR (?Cardiomyopathy, dilated, 2H); AR (?Congenital disorder of glycosylation, type IIz)",
GFAP,"AD (Alexander disease); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (Cardiomyopathy, dilated, 1II); AR (Cataract 16, multiple types); AD (Myopathy, myofibrillar, 2A, adult-onset); AR (Myopathy, myofibrillar, 2B, infantile-onset); AR (Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure); AR (Osteopetrosis, autosomal recessive 2)",
GFER,"AR (Myopathy, mitochondrial progressive, with congenital cataract and developmental delay)",
GFI1,"AD (?Neutropenia, nonimmune chronic idiopathic, of adults); AD (Neutropenia, severe congenital 2, autosomal dominant); AR (Bleeding disorder, platelet-type, 17); AD (Deafness, autosomal dominant 15/52); AR (Brittle cornea syndrome 2); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD (Neutropenia, cyclic); AD (Neutropenia, severe congenital 1, autosomal dominant)",
GFI1B,"AR (Bleeding disorder, platelet-type, 17); AD (?Neutropenia, nonimmune chronic idiopathic, of adults); AD (Neutropenia, severe congenital 2, autosomal dominant); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); Burkitt lymphoma, somatic; AR (Carpenter syndrome 2)",
GFM1,"AR (Combined oxidative phosphorylation deficiency 1); AR (Combined oxidative phosphorylation deficiency 39); AR (Combined oxidative phosphorylation deficiency 7); AR (Spastic paraplegia 55, autosomal recessive)",
GFM2,AR (Combined oxidative phosphorylation deficiency 39),
GFPT1,"AR (Myasthenia, congenital, 12, with tubular aggregates); AR (Multiple mitochondrial dysfunctions syndrome 1); AR (Spastic paraplegia 93, autosomal recessive)",
GFPT2,"AR (Myasthenia, congenital, 12, with tubular aggregates)",
GFRA1,"AR (Renal hypodysplasia/aplasia 4); AD ({Hirschsprung disease, susceptibility to, 3}); AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma); AR (Ovarian dysgenesis 5); AD (Spermatogenic failure 32); [Respiratory rhythmicity in sleep]",
GFRA2,AR (Renal hypodysplasia/aplasia 4),
GFRA3,"AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma); AD (?Marsili syndrome)",
GFRAL,"AD ({Hyperemesis gravidarum, susceptibility to})",
GGA1,"AD (Okur-Chung neurodevelopmental syndrome); AD (Poirier-Bienvenu neurodevelopmental syndrome); AR (Keratitis-ichthyosis-deafness syndrome, autosomal recessive); AR (MEDNIK syndrome); AD (Usmani-Riazuddin syndrome, autosomal dominant); AR (Usmani-Riazuddin syndrome, autosomal recessive)",
GGA2,"Hepatocellular carcinoma, somatic; AR (Ceroid lipofuscinosis, neuronal, 10)",
GGA3,"AD (Okur-Chung neurodevelopmental syndrome); AD (Poirier-Bienvenu neurodevelopmental syndrome); AR (Keratitis-ichthyosis-deafness syndrome, autosomal recessive); AR (MEDNIK syndrome)",
GGCX,"Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency; AR (Vitamin K-dependent clotting factors, combined deficiency of, 1); AR (Arterial calcification, generalized, of infancy, 2); AR (Pseudoxanthoma elasticum); AD (Pseudoxanthoma elasticum, forme fruste); AR (Vitamin K-dependent clotting factors, combined deficiency of, 2); AD (Warfarin resistance); AR (Keutel syndrome)",
GGH,"AR ({Thiopurines, poor metabolism of, 1})",
GGN,"AR (Spermatogenic failure 69); {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; Alopecia, androgenetic, 2; AR (Spermatogenic failure 9); AD (Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties)",
GGNBP2,AR (Spermatogenic failure 69),
GGPS1,"AR (Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome)",
GGT1,AR (?Glutathioninuria),
GGT5,AR (?Glutathioninuria),
GGT6,AR (?Glutathioninuria),
GGT7,AR (?Glutathioninuria),
GGTLC1,AR (?Glutathioninuria),
GGTLC2,AR (?Glutathioninuria),
GGTLC3,AR (?Glutathioninuria),
GH1,"AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); Pituitary tumor, invasive; AR ({Hypercholesterolemia, familial, modifier of}); AD (Growth hormone insensitivity, partial); AD (Increased responsiveness to growth hormone); AR (Laron dwarfism); AR (Deafness, autosomal recessive 15)",
GH2,"AR (Deafness, autosomal recessive 15); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); AD (Erythrocytosis, familial, 7); AD (Heinz body anemia); Hemoglobin H disease, deletional and nondeletional; Thalassemia, alpha-; Fabry disease; Fabry disease, cardiac variant; AR (Nephrotic syndrome, type 21); AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-",
GHR,"AR ({Hypercholesterolemia, familial, modifier of}); AD (Growth hormone insensitivity, partial); AD (Increased responsiveness to growth hormone); AR (Laron dwarfism); AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); {Budd-Chiari syndrome, somatic}; Erythrocytosis, somatic; Leukemia, acute myeloid, somatic; Myelofibrosis, somatic; Polycythemia vera, somatic; AD (Thrombocythemia 3); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant)",
GHRH,"?Isolated growth hormone deficiency due to defect in GHRF; Gigantism due to GHRF hypersecretion; AR (Growth hormone deficiency, isolated, type IV); Chromosome Xq26.3 duplication syndrome; AR ({Obesity, susceptibility to}); [Placental lactogen deficiency]",
GHRHR,"AR (Growth hormone deficiency, isolated, type IV); AR (Pituitary hormone deficiency, combined, 2); AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); ?Isolated growth hormone deficiency due to defect in GHRF; Gigantism due to GHRF hypersecretion",
GHRL,"AR ({Obesity, susceptibility to}); AR (Growth hormone deficiency, isolated partial); AD ({Diabetes mellitus, type 2, susceptibility to})",
GHSR,"AR (Growth hormone deficiency, isolated partial); AR ({Obesity, susceptibility to})",
GIGYF1,"AR (Insulin-like growth factor I, resistance to); {Parkinson disease 11}",
GIGYF2,{Parkinson disease 11},
GIMAP5,"AR (Portal hypertension, noncirrhotic, 2); AR (Wolfram syndrome 2)",
GINS1,"AR (Immunodeficiency 55); AR (Immunodeficiency 124, severe combined); AR (Microphthalmia/coloboma 13); AD (?Deafness, autosomal dominant 70); AR (Meier-Gorlin syndrome 7)",
GINS2,AR (Immunodeficiency 55),
GINS3,AR (Immunodeficiency 55),
GINS4,AR (Immunodeficiency 55),
GIP,"AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD ({Diabetes mellitus, type 2, susceptibility to}); Pituitary adenoma, ACTH-secreting, somatic; AD (Ventricular tachycardia, idiopathic)",
GIPC1,"AD (Oculopharyngodistal myopathy 2); AR (Deafness, autosomal recessive 15); AD (Telangiectasia, hereditary hemorrhagic, type 1); AR (Donnai-Barrow syndrome); AD (Deafness, autosomal dominant 22); AD (Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy); AR (Deafness, autosomal recessive 37)",
GIPC2,"AR (Deafness, autosomal recessive 15)",
GIPC3,"AR (Deafness, autosomal recessive 15); AR (Perrault syndrome 3)",
GIPR,"AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); [Birth weight QTL 3]; [Fasting plasma glucose level QTL 6]; AD ({Diabetes mellitus, type 2, susceptibility to}); [Body mass index QTL1]",
GIT1,"{Attention deficit-hyperactivity disorder, susceptibility to, 2}; Intellectual developmental disorder, X-linked syndromic, Houge type",
GIT2,"Intellectual developmental disorder, X-linked syndromic, Houge type",
GJA1,"AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III); AR (CATIFA syndrome); AD (Atrial fibrillation, familial, 11); AD (Atrial standstill, digenic (GJA5/SCN5A)); AD (Arrhythmogenic right ventricular dysplasia 8); AR (Cardiomyopathy, dilated, with woolly hair and keratoderma); AD (Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis); AR (Epidermolysis bullosa, lethal acantholytic); AD (Keratosis palmoplantaris striata II)",
GJA3,"AD (Cataract 14, multiple types); AD (Bart-Pumphrey syndrome); AD (Deafness, autosomal dominant 3A); AR (Deafness, autosomal recessive 1A); AD (Hystrix-like ichthyosis with deafness); AD (Keratitis-ichthyosis-deafness syndrome); AD (Keratoderma, palmoplantar, with deafness); AD (Vohwinkel syndrome); AD (Cataract 1, multiple types)",
GJA4,"AD (Atrial fibrillation, familial, 11); AD (Atrial standstill, digenic (GJA5/SCN5A)); AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III); {Transcription of plasminogen activator inhibitor, modulator of}; AR (Plasminogen activator inhibitor-1 deficiency); AD (Deafness, autosomal dominant 2B, with or without peripheral neuropathy); AR (Deafness, digenic, GJB2/GJB3); AR (Erythrokeratodermia variabilis et progressiva 1)",
GJA5,"AD (Atrial fibrillation, familial, 11); AD (Atrial standstill, digenic (GJA5/SCN5A)); AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III); AD (Myotonic dystrophy 1); AD (Atrial fibrillation, familial, 1)",
GJA8,"AD (Cataract 1, multiple types); AD (Cataract 14, multiple types); AR (Cataract 9, multiple types); AD (Cataract 10, multiple types); AD (Cataract 3, multiple types); AD (Chromosome 1q21.1 deletion syndrome); AD (Cataract 4, multiple types)",
GJB1,"Charcot-Marie-Tooth neuropathy, X-linked dominant, 1; AR (?Spastic paraplegia 44, autosomal recessive); AR (Leukodystrophy, hypomyelinating, 2); AD (Lymphatic malformation 3); AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III); AD (Deafness, autosomal dominant 2B, with or without peripheral neuropathy); AR (Deafness, digenic, GJB2/GJB3); AR (Erythrokeratodermia variabilis et progressiva 1); AD (Charcot-Marie-Tooth disease, type 1D); AR (Dejerine-Sottas disease); AR (Hypomyelinating neuropathy, congenital, 1); AD (?Neuropathy, inflammatory demyelinating); AD (Charcot-Marie-Tooth disease, type 1A); AD (Charcot-Marie-Tooth disease, type 1E); AR (Dejerine-Sottas disease); AD (Neuropathy, recurrent, with pressure palsies); AD (Roussy-Levy syndrome)",
GJB2,"AD (Bart-Pumphrey syndrome); AD (Deafness, autosomal dominant 3A); AR (Deafness, autosomal recessive 1A); AD (Hystrix-like ichthyosis with deafness); AD (Keratitis-ichthyosis-deafness syndrome); AD (Keratoderma, palmoplantar, with deafness); AD (Vohwinkel syndrome); AD (Deafness, autosomal dominant 3B); AR (Deafness, autosomal recessive 1B); AR (Deafness, digenic GJB2/GJB6); AD (Ectodermal dysplasia 2, Clouston type); AD (Deafness, autosomal dominant 2B, with or without peripheral neuropathy); AR (Deafness, digenic, GJB2/GJB3); AR (Erythrokeratodermia variabilis et progressiva 1)",
GJB3,"AD (Deafness, autosomal dominant 2B, with or without peripheral neuropathy); AR (Deafness, digenic, GJB2/GJB3); AR (Erythrokeratodermia variabilis et progressiva 1); AD (Erythrokeratodermia variabilis et progressiva 2); AD (Bart-Pumphrey syndrome); AD (Deafness, autosomal dominant 3A); AR (Deafness, autosomal recessive 1A); AD (Hystrix-like ichthyosis with deafness); AD (Keratitis-ichthyosis-deafness syndrome); AD (Keratoderma, palmoplantar, with deafness); AD (Vohwinkel syndrome)",
GJB4,"AD (Erythrokeratodermia variabilis et progressiva 2); AD (Deafness, autosomal dominant 2B, with or without peripheral neuropathy); AR (Deafness, digenic, GJB2/GJB3); AR (Erythrokeratodermia variabilis et progressiva 1); ?Olmsted syndrome, X-linked; IFAP syndrome with or without BRESHECK syndrome; Keratosis follicularis spinulosa decalvans, X-linked; Osteogenesis imperfecta, type XIX",
GJB5,"AD (Erythrokeratodermia variabilis et progressiva 2); AD (Deafness, autosomal dominant 2B, with or without peripheral neuropathy); AR (Deafness, digenic, GJB2/GJB3); AR (Erythrokeratodermia variabilis et progressiva 1)",
GJB6,"AD (Deafness, autosomal dominant 3B); AR (Deafness, autosomal recessive 1B); AR (Deafness, digenic GJB2/GJB6); AD (Ectodermal dysplasia 2, Clouston type); AD (Bart-Pumphrey syndrome); AD (Deafness, autosomal dominant 3A); AR (Deafness, autosomal recessive 1A); AD (Hystrix-like ichthyosis with deafness); AD (Keratitis-ichthyosis-deafness syndrome); AD (Keratoderma, palmoplantar, with deafness); AD (Vohwinkel syndrome); AR (Deafness, autosomal recessive 16); {Lumbar disc herniation, susceptibility to}; AD (Deafness, autosomal dominant 37); AR (Fibrochondrogenesis 1); AD (Marshall syndrome); AD (Stickler syndrome, type II); AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III); ?Premature ovarian failure 2A",
GJC2,"AR (?Spastic paraplegia 44, autosomal recessive); AR (Leukodystrophy, hypomyelinating, 2); AD (Lymphatic malformation 3); AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III)",
GJD2,"AD (Bart-Pumphrey syndrome); AD (Deafness, autosomal dominant 3A); AR (Deafness, autosomal recessive 1A); AD (Hystrix-like ichthyosis with deafness); AD (Keratitis-ichthyosis-deafness syndrome); AD (Keratoderma, palmoplantar, with deafness); AD (Vohwinkel syndrome); AD (Myopia 2)",
GK,"Glycerol kinase deficiency; AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II); Chromosome Xp21 deletion syndrome; AD ({Type 2 diabetes mellitus, susceptibility to}); AR (Nephrotic syndrome, type 15)",
GKAP1,"AD (Aortic aneurysm, familial thoracic 8)",
GLA,"Fabry disease; Fabry disease, cardiac variant; AR (Keutel syndrome); AR (Factor X deficiency); Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency; AR (Vitamin K-dependent clotting factors, combined deficiency of, 1)",
GLB1,"AR (GM1-gangliosidosis, type I); AR (GM1-gangliosidosis, type II); AR (GM1-gangliosidosis, type III); AR (Mucopolysaccharidosis type IVB (Morquio)); AR (Aminoacylase 1 deficiency); AR (Atransferrinemia); AR (Sialidosis, type I); AR (Sialidosis, type II); AR (Liberfarb syndrome); AR (Galactosialidosis)",
GLCCI1,"{Glucocorticoid therapy, response to}",
GLCE,"Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; AD ({Diabetes mellitus, type 2, susceptibility to})",
GLDC,"AR (Glycine encephalopathy1); AR (Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities); AR (Glycine encephalopathy 2); AR (Multiple mitochondrial dysfunctions syndrome 7)",
GLDN,AR (Lethal congenital contracture syndrome 11),
GLE1,"AR (Congenital arthrogryposis with anterior horn cell disease); AR (Lethal congenital contracture syndrome 1); AR (Developmental delay with hypotonia, myopathy, and brain abnormalities)",
GLI1,"AR (Polydactyly, postaxial, type A8); AR (Polydactyly, preaxial I); AR ({Medulloblastoma}); AD ({Meningioma, familial, susceptibility to}); Basal cell nevus syndrome 2; AR (Joubert syndrome 32); Basal cell carcinoma, somatic; Curry-Jones syndrome, somatic mosaic; AR (Pallister-Hall-like syndrome); AR (?Ciliary dyskinesia, primary, 46); AD (Holoprosencephaly 11); Basal cell carcinoma, somatic; AD (Basal cell nevus syndrome 1); AD (Holoprosencephaly 7); AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal)",
GLI2,"AD (Culler-Jones syndrome); AD (Holoprosencephaly 9); Basal cell carcinoma, somatic; Curry-Jones syndrome, somatic mosaic; AR (Pallister-Hall-like syndrome); AD (Pachyonychia congenita 2); AD (Steatocystoma multiplex); AR (Polydactyly, postaxial, type A8); AR (Polydactyly, preaxial I); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AR (?Ciliary dyskinesia, primary, 46); Basal cell carcinoma, somatic; AD (Basal cell nevus syndrome 1); AD (Holoprosencephaly 7)",
GLI3,"AD (Greig cephalopolysyndactyly syndrome); AD (Pallister-Hall syndrome); AD (Polydactyly, postaxial, types A1 and B); AD (Polydactyly, preaxial, type IV); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AR (Polydactyly, postaxial, type A8); AR (Polydactyly, preaxial I); AD (Gastrointestinal stromal tumor, familial); Germ cell tumors, somatic; Leukemia, acute myeloid, somatic; AD (Mastocytosis, cutaneous); Mastocytosis, systemic, somatic; AD (Piebaldism)",
GLIS1,"AR (Diabetes mellitus, neonatal, with congenital hypothyroidism)",
GLIS2,"AR (Nephronophthisis 7); AR (Diabetes mellitus, neonatal, with congenital hypothyroidism)",
GLIS3,"AR (Diabetes mellitus, neonatal, with congenital hypothyroidism)",
GLMN,AD (Glomuvenous malformations); AR (3-M syndrome 1),
GLO1,"{Myocardial infarction, protection against}; AD ({Venous thrombosis, protection against}); AR (Factor XIIIA deficiency); AD (Intellectual developmental disorder with polymicrogyria and seizures); AR (Acyl-CoA dehydrogenase, short-chain, deficiency of); AR (Methylmalonic aciduria, mut(0) type); AR (Transcobalamin II deficiency); AR (?Complement factor B deficiency); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 4}); {Macular degeneration, age-related, 14, reduced risk of}",
GLP1R,"AD ({Diabetes mellitus, type 2, susceptibility to})",
GLRA1,"AR (Hyperekplexia 1); AR (Hyperekplexia 2); Intellectual developmental disorder, X-linked syndromic, Pilorge type; AD (46XY sex reversal 11); AR (Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies); AR (Hyperekplexia 3)",
GLRA2,"Intellectual developmental disorder, X-linked syndromic, Pilorge type; AR (Hyperekplexia 1); ?Retinitis pigmentosa 23; Joubert syndrome 10; Orofaciodigital syndrome I; Simpson-Golabi-Behmel syndrome, type 2; AD (46XY sex reversal 11); AR (Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies); AR (Hyperekplexia 2)",
GLRA3,AD (46XY sex reversal 11); AR (Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies),
GLRB,AR (Hyperekplexia 2); AR (Molybdenum cofactor deficiency C); AR (Hyperekplexia 1),
GLRX,"AD (Helsmoortel-van der Aa syndrome); AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive)",
GLRX2,"AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive)",
GLRX5,"AR (Anemia, sideroblastic, 3, pyridoxine-refractory); AR (Spasticity, childhood-onset, with hyperglycinemia); AR (Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia); AR (Hyperglycinemia, lactic acidosis, and seizures)",
GLS,"AD (CASGID syndrome); AR (Developmental and epileptic encephalopathy 71); AR (Global developmental delay, progressive ataxia, and elevated glutamine); AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic); AR (Ataxia, cerebellar, Cayman type)",
GLS2,"AR (Methylmalonic aciduria, mut(0) type)",
GLT8D1,AD (Poirier-Bienvenu neurodevelopmental syndrome),
GLUD1,"AD (Hyperinsulinism-hyperammonemia syndrome); {Esophageal cancer, alcohol-related, susceptibility to}; AD ({Hangover, susceptibility to}); {Sublingual nitroglycerin, susceptibility to poor response to}; AD (Alcohol sensitivity, acute); {Pulmonary hypertension, neonatal, susceptibility to}; AR (Carbamoylphosphate synthetase I deficiency); AR (Methylmalonic aciduria, mut(0) type); Aspartate aminotransferase, serum level of, QTL1; AD (Developmental and epileptic encephalopathy 116); AR (Glutamine deficiency, congenital)",
GLUD2,AD (Hyperinsulinism-hyperammonemia syndrome),
GLUL,"AD (Developmental and epileptic encephalopathy 116); AR (Glutamine deficiency, congenital); {Pulmonary hypertension, neonatal, susceptibility to}; AR (Carbamoylphosphate synthetase I deficiency)",
GLYCTK,AR (D-glyceric aciduria); AR (Glycine encephalopathy 2),
GM2A,"AR (GM2-gangliosidosis, AB variant); AR (Sandhoff disease, infantile, juvenile, and adult forms); AR ([Hex A pseudodeficiency]); AR (GM2-gangliosidosis, several forms); AR (Tay-Sachs disease)",
GMDS,"Chromosome 6pter-p24 deletion syndrome; AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3)",
GMNC,"AR (Ciliary dyskinesia, primary, 42); AD (Meier-Gorlin syndrome 6); AR (Ciliary dyskinesia, primary, 29)",
GMNN,"AD (Meier-Gorlin syndrome 6); AR (Ciliary dyskinesia, primary, 42)",
GMPPA,"AR (Alacrima, achalasia, and impaired intellectual development syndrome); Intellectual developmental disorder, X-linked syndromic 17",
GMPPB,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14); AR (Alacrima, achalasia, and impaired intellectual development syndrome)",
GMPS,"AD (Wiedemann-Steiner syndrome); AR (?Spinocerebellar ataxia, autosomal recessive 24); AR (Developmental and epileptic encephalopathy 44)",
GNA11,"AD (Hypocalcemia, autosomal dominant 2); AD (Hypocalciuric hypercalcemia, type II); Capillary malformations, congenital, 1, somatic, mosaic; Sturge-Weber syndrome, somatic, mosaic",
GNA12,"AR (Nephrotic syndrome, type 3); AD (Hypocalcemia, autosomal dominant 2); AD (Hypocalciuric hypercalcemia, type II); Capillary malformations, congenital, 1, somatic, mosaic; Sturge-Weber syndrome, somatic, mosaic",
GNA13,"AR (Neutropenia, severe congenital 3, autosomal recessive); AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development)",
GNA14,"AR (Choreoacanthocytosis); AD (Erythrocytosis, familial, 4)",
GNA15,"AD (Hypocalcemia, autosomal dominant 2); AD (Hypocalciuric hypercalcemia, type II)",
GNAI1,"AD (Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities); AR (Leukodystrophy and acquired microcephaly with or without dystonia)",
GNAI2,"Pituitary adenoma, ACTH-secreting, somatic; AD (Ventricular tachycardia, idiopathic); AD (Auriculocondylar syndrome 1); AR (Chudley-McCullough syndrome)",
GNAI3,AD (Auriculocondylar syndrome 1); AD (Auriculocondylar syndrome 2A); AR (Auriculocondylar syndrome 2B); AR (PEHO syndrome-like),
GNAL,AD (Dystonia 25); AD ({Schizophrenia}); AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6),
GNAO1,"AD (Developmental and epileptic encephalopathy 17); AD (Neurodevelopmental disorder with involuntary movements); AD (Charcot-Marie-Tooth disease, dominant intermediate F); AD (Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities)",
GNAQ,"Capillary malformations, congenital, 1, somatic, mosaic; Sturge-Weber syndrome, somatic, mosaic; AD (Hypocalcemia, autosomal dominant 2); AD (Hypocalciuric hypercalcemia, type II)",
GNAS,"ACTH-independent macronodular adrenal hyperplasia 1, somatic; McCune-Albright syndrome, somatic mosaic; AD (Osseous heteroplasia, progressive); Pituitary adenoma 3, multiple types, somatic; AD (Pseudohypoparathyroidism Ia); AD (Pseudohypoparathyroidism Ib); AD (Pseudohypoparathyroidism Ic); AD (Pseudopseudohypoparathyroidism); AD (Pseudohypoparathyroidism Ib); AD (Pseudohypoparathyroidism Ib)",
GNAT1,"AD (Night blindness, congenital stationary, autosomal dominant 3); AR (Night blindness, congenital stationary, type 1G); AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24); AR (Leber congenital amaurosis 2); AR (Retinitis pigmentosa 20); AD (Retinitis pigmentosa 87 with choroidal involvement); AR (Leber congenital amaurosis 14); AR (Retinal dystrophy, early-onset severe); AR (Retinitis pigmentosa, juvenile); Achromatopsia 4; AD (Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities)",
GNAT2,"Achromatopsia 4; AR (Achromatopsia 3); AR (Achromatopsia 2); AR (Cone-rod dystrophy 8); AD (Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities); AD (Night blindness, congenital stationary, autosomal dominant 3); AR (Night blindness, congenital stationary, type 1G); AD (Omodysplasia 2)",
GNB1,"AD (Intellectual developmental disorder, autosomal dominant 42); Leukemia, acute lymphoblastic, somatic; Myelodysplastic syndrome, somatic; AD (?Sick sinus syndrome 4); AD (Neurodevelopmental disorder with hypotonia and dysmorphic facies); AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (Charcot-Marie-Tooth disease, dominant intermediate F); AR (Leukodystrophy and acquired microcephaly with or without dystonia)",
GNB1L,Conotruncal anomaly face syndrome; AD (DiGeorge syndrome); AD (Tetralogy of Fallot); AD (Velocardiofacial syndrome),
GNB2,"AD (?Sick sinus syndrome 4); AD (Neurodevelopmental disorder with hypotonia and dysmorphic facies); {Hypertension, essential, susceptibility to}; AR (Night blindness, congenital stationary, type 1H); AD (Intellectual developmental disorder, autosomal dominant 42); Leukemia, acute lymphoblastic, somatic; Myelodysplastic syndrome, somatic",
GNB3,"{Hypertension, essential, susceptibility to}; AR (Night blindness, congenital stationary, type 1H); AD (Charcot-Marie-Tooth disease, dominant intermediate F); AD (Myopia 2); AD (Retinitis pigmentosa 70)",
GNB4,"AD (Charcot-Marie-Tooth disease, dominant intermediate F); {Hypertension, essential, susceptibility to}; AR (Night blindness, congenital stationary, type 1H)",
GNB5,"AR (Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia); AR (Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia); AR (Griscelli syndrome, type 1); AR (Prolonged electroretinal response suppression 1); AR (Night blindness, congenital stationary (complete), 1F, autosomal recessive); AR (Prolonged electroretinal response suppression 2)",
GNE,"AR (Nonaka myopathy); AD (Sialuria); AR (Thrombocytopenia 12 with or without myopathy); AR (?Bleeding disorder, platelet-type, 19); AD (Hao-Fountain syndrome)",
GNG10,"AD (Intellectual developmental disorder, autosomal dominant 42); Leukemia, acute lymphoblastic, somatic; Myelodysplastic syndrome, somatic",
GNG12,"AD (Intellectual developmental disorder, autosomal dominant 42); Leukemia, acute lymphoblastic, somatic; Myelodysplastic syndrome, somatic",
GNG13,"AD (Intellectual developmental disorder, autosomal dominant 62); AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6); AD (Charcot-Marie-Tooth disease, dominant intermediate F); {Hypertension, essential, susceptibility to}; AR (Night blindness, congenital stationary, type 1H); AD (Intellectual developmental disorder, autosomal dominant 42); Leukemia, acute lymphoblastic, somatic; Myelodysplastic syndrome, somatic",
GNG2,"AD (?Sick sinus syndrome 4); AD (Neurodevelopmental disorder with hypotonia and dysmorphic facies); AD (Charcot-Marie-Tooth disease, dominant intermediate F); AR (Leukodystrophy and acquired microcephaly with or without dystonia); AD (Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant); AR (Ataxia-oculomotor apraxia 3)",
GNG3,"AD (Intellectual developmental disorder, autosomal dominant 42); Leukemia, acute lymphoblastic, somatic; Myelodysplastic syndrome, somatic",
GNG4,"AD (Charcot-Marie-Tooth disease, dominant intermediate F)",
GNGT1,"AD (Charcot-Marie-Tooth disease, dominant intermediate F)",
GNGT2,"AD (Retinitis pigmentosa 17); AD (Charcot-Marie-Tooth disease, dominant intermediate F)",
GNL2,"AD (Epilepsy, early-onset, 3, with or without developmental delay)",
GNL3,"AR (Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies)",
GNMT,AR (Glycine N-methyltransferase deficiency),
GNPAT,"AR (Rhizomelic chondrodysplasia punctata, type 2); AR (Rhizomelic chondrodysplasia punctata, type 3)",
GNPNAT1,"AR (?Rhizomelic dysplasia, Ain-Naz type)",
GNPTAB,"AR (Mucolipidosis II alpha/beta); AR (Mucolipidosis III alpha/beta); AR (Dysostosis multiplex, Ain-Naz type); Stuttering, familial persistent, 2; AR (Mucolipidosis III gamma); AR (?Spondyloepiphyseal dysplasia, Kondo-Fu type)",
GNPTG,"AR (Mucolipidosis III gamma); AR (Mucolipidosis II alpha/beta); AR (Mucolipidosis III alpha/beta); Stuttering, familial persistent, 2",
GNRH1,"AR (?Hypogonadotropic hypogonadism 12 with or without anosmia); AD (Asplenia, isolated congenital); AD (Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures)",
GNRH2,"AD (Asplenia, isolated congenital); AR (?Hypogonadotropic hypogonadism 12 with or without anosmia)",
GNRHR,"AR (Hypogonadotropic hypogonadism 7 without anosmia); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AR (?Hypogonadotropic hypogonadism 12 with or without anosmia); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; AR (Thrombocytopenia-absent radius syndrome); Hypothyroidism, central, and testicular enlargement",
GNS,"AR (Mucopolysaccharidosis type IIID); AD (Glaucoma 1, open angle, P)",
GOLGA1,"AR (Developmental delay with hypotonia, myopathy, and brain abnormalities); AR (Achondrogenesis, type IA); AR (Odontochondrodysplasia 1)",
GOLGA2,"AR (Developmental delay with hypotonia, myopathy, and brain abnormalities); AR (Polyhydramnios, megalencephaly, and symptomatic epilepsy); AR (Intellectual developmental disorder, autosomal recessive 14)",
GOLGA3,"AR (Developmental delay with hypotonia, myopathy, and brain abnormalities)",
GOLGA4,"AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AR (Developmental delay with hypotonia, myopathy, and brain abnormalities); AR (Achondrogenesis, type IA); AR (Odontochondrodysplasia 1)",
GOLGA5,"AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma); AR (Developmental delay with hypotonia, myopathy, and brain abnormalities); AR (Achondrogenesis, type IA); AR (Odontochondrodysplasia 1)",
GOLGA7,"Intellectual developmental disorder, X-linked syndromic, Raymond type",
GOLGA8B,AD (Myopia 2),
GOLGA8S,Chromosome 15q13.3 microdeletion syndrome,
GOLIM4,AD (Hailey-Hailey disease),
GOLM1,AR (Dyggve-Melchior-Clausen disease); AR (Smith-McCort dysplasia),
GOLPH3,"Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AD (Myopia 19)",
GON4L,AR (Grange syndrome); AR (Perrault syndrome 7),
GON7,"AR (Galloway-Mowat syndrome 9); Galloway-Mowat syndrome 2, X-linked; AR (Galloway-Mowat syndrome 4); AR (Galloway-Mowat syndrome 5); AR (Galloway-Mowat syndrome 10); AR (Galloway-Mowat syndrome 3)",
GOPC,"AR (?Spermatogenic failure 67); AD ({Bronchiectasis with or without elevated sweat chloride 1, modifier of}); {Hypertrypsinemia, neonatal}; AD ({Pancreatitis, hereditary}); AR (Congenital bilateral absence of vas deferens); AR (Cystic fibrosis); Sweat chloride elevation without CF",
GORAB,"AR (Geroderma osteodysplasticum); AR (Cutis laxa, autosomal recessive, type IIA); AR (Wrinkly skin syndrome); AD (Cutis laxa, autosomal dominant 3); AR (Cutis laxa, autosomal recessive, type IIIA); AD (Spastic paraplegia 9A, autosomal dominant); AR (Spastic paraplegia 9B, autosomal recessive); AR (Spinocerebellar ataxia, autosomal recessive 21)",
GOSR1,"AR (Epilepsy, progressive myoclonic 6); AR (Muscular dystrophy, congenital, with or without seizures)",
GOSR2,"AR (Epilepsy, progressive myoclonic 6); AR (Muscular dystrophy, congenital, with or without seizures); AR (Muscular dystrophy, congenital, with rapid progression); AR (Congenital disorder of glycosylation, type IIbb)",
GOT1,"Aspartate aminotransferase, serum level of, QTL1; AD (Hyperinsulinism-hyperammonemia syndrome); AR (17-alpha-hydroxylase/17,20-lyase deficiency); AR (17,20-lyase deficiency, isolated); AR (Cholesteryl ester storage disease); AR (Wolman disease)",
GOT2,"AR (Developmental and epileptic encephalopathy 82); AR (Tyrosinemia, type II)",
GP1BA,"AR ({Nonarteritic anterior ischemic optic neuropathy, susceptibility to}); AR (Bernard-Soulier syndrome, type A1 (recessive)); AD (Bernard-Soulier syndrome, type A2 (dominant)); AD (von Willebrand disease, platelet-type); AD (von Willebrand disease, type 1); AR (von Willebrand disease, type 3); AR (von Willebrand disease, types 2A, 2B, 2M, and 2N); AD ({Pregnancy loss, recurrent, susceptibility to, 2}); {Stroke, ischemic, susceptibility to}; AR (Dysprothrombinemia); AR (Hypoprothrombinemia); AD (Thrombophilia 1 due to thrombin defect); AR (Bernard-Soulier syndrome, type B); AR (Giant platelet disorder, isolated); AR (Bleeding disorder, platelet-type, 17)",
GP1BB,"AR (Bernard-Soulier syndrome, type B); AR (Giant platelet disorder, isolated); AR (Cutis laxa, autosomal recessive, type IIC); Conotruncal anomaly face syndrome; AD (DiGeorge syndrome); AD (Tetralogy of Fallot); AD (Velocardiofacial syndrome); AD (von Willebrand disease, type 1); AR (von Willebrand disease, type 3); AR (von Willebrand disease, types 2A, 2B, 2M, and 2N)",
GP2,"AR (Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)); AR (Perrault syndrome 5); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3); AR (Niemann-Pick disease, type C1); AR (Niemann-Pick disease, type D)",
GP5,"AR (Bernard-Soulier syndrome, type B); AR (Giant platelet disorder, isolated); AR (Bernard-Soulier syndrome, type C); AR ({Nonarteritic anterior ischemic optic neuropathy, susceptibility to}); AR (Bernard-Soulier syndrome, type A1 (recessive)); AD (Bernard-Soulier syndrome, type A2 (dominant)); AD (von Willebrand disease, platelet-type); AD (von Willebrand disease, type 1); AR (von Willebrand disease, type 3); AR (von Willebrand disease, types 2A, 2B, 2M, and 2N)",
GP6,"AR (Bleeding disorder, platelet-type, 11); AR (Bleeding disorder, platelet-type, 21); Colon cancer, somatic; AR (Thrombocytopenia 10); AD (Ehlers-Danlos syndrome, vascular type); AR (Polymicrogyria with or without vascular-type EDS)",
GP9,"AR (Bernard-Soulier syndrome, type C); AR (Bernard-Soulier syndrome, type B); AR (Giant platelet disorder, isolated); AR (Bleeding disorder, platelet-type, 21); AR ({Nonarteritic anterior ischemic optic neuropathy, susceptibility to}); AR (Bernard-Soulier syndrome, type A1 (recessive)); AD (Bernard-Soulier syndrome, type A2 (dominant)); AD (von Willebrand disease, platelet-type); AD (von Willebrand disease, type 1); AR (von Willebrand disease, type 3); AR (von Willebrand disease, types 2A, 2B, 2M, and 2N)",
GPAA1,"AR (Glycosylphosphatidylinositol biosynthesis defect 15); AR (Developmental and epileptic encephalopathy 95); AD (?Paroxysmal nocturnal hemoglobinuria 2); AR (Multiple congenital anomalies-hypotonia-seizures syndrome 3); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic; AR (Lowry-Wood syndrome); AR (Microcephalic osteodysplastic primordial dwarfism, type I); AR (Roifman syndrome)",
GPANK1,"AR (Spastic paraplegia 86, autosomal recessive)",
GPC1,"Keipert syndrome; Simpson-Golabi-Behmel syndrome, type 1; Wilms tumor, somatic; AR (Myasthenia, congenital, 12, with tubular aggregates)",
GPC3,"Simpson-Golabi-Behmel syndrome, type 1; Wilms tumor, somatic; Keipert syndrome; AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Beckwith-Wiedemann syndrome); AD (IMAGE syndrome); AD (Silver-Russell syndrome 3)",
GPC4,"Keipert syndrome; AR (Omodysplasia 1); AR (?Intellectual developmental disorder, autosomal recessive 76); AD (Intellectual developmental disorder, autosomal dominant 67); Simpson-Golabi-Behmel syndrome, type 1; Wilms tumor, somatic",
GPC5,AD (Feingold syndrome 2); AR (Omodysplasia 1); Kyphoscoliosis 1,
GPC6,"AR (Omodysplasia 1); Keipert syndrome; AR (?Intellectual developmental disorder, autosomal recessive 76); AD (Intellectual developmental disorder, autosomal dominant 67)",
GPD1,"AR (Hypertriglyceridemia, transient infantile); AD (Brugada syndrome 2); AD ({Type 2 diabetes mellitus, susceptibility to}); AD (Cataract 6, multiple types)",
GPD1L,AD (Brugada syndrome 2),
GPD2,"AD ({Type 2 diabetes mellitus, susceptibility to}); AR (Hypertriglyceridemia, transient infantile); AR (Citrullinemia, adult-onset type II); AR (Citrullinemia, type II, neonatal-onset)",
GPHN,"AR (Molybdenum cofactor deficiency C); AD (Wiedemann-Steiner syndrome); AR (Molybdenum cofactor deficiency A); Intellectual developmental disorder, X-linked syndromic 34; {Autism susceptibility, X-linked 1}",
GPI,"AR (Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities); AR (Anemia, congenital, nonspherocytic hemolytic, 4, glucose phosphate isomerase deficient); AD (Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline); AD (Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder); AR (Hyperphosphatasia with impaired intellectual development syndrome 4); AR (Hyperphosphatasia with impaired intellectual development syndrome 3); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
GPIHBP1,"AR (Hyperlipoproteinemia, type 1D); AR ([High density lipoprotein cholesterol level QTL 11]); AD (Combined hyperlipidemia, familial); AR (Lipoprotein lipase deficiency)",
GPLD1,"{Alkaline phosphatase, plasma level of, QTL3}",
GPM6A,AR (Retinitis pigmentosa 29),
GPNMB,"AR (Amyloidosis, primary localized cutaneous, 3); AD (Ocular pigment dispersion with or without glaucoma)",
GPR101,"Pituitary adenoma 2, GH-secreting; Chromosome Xq26.3 duplication syndrome",
GPR143,"Nystagmus 6, congenital, X-linked; Ocular albinism, type I, Nettleship-Falls type; Hypothyroidism, congenital, nongoitrous, 8; {Melanoma, cutaneous malignant, susceptibility to, 8}; AR (COMMAD syndrome); AD (Tietz albinism-deafness syndrome); AD (Waardenburg syndrome, type 2A); AD ([Skin/hair/eye pigmentation 3, blue/green eyes]); AD ([Skin/hair/eye pigmentation 3, light/dark/freckling skin]); AD ({Melanoma, cutaneous malignant, susceptibility to, 8}); AR (Albinism, oculocutaneous, type IA); AR (Albinism, oculocutaneous, type IB)",
GPR156,"AR (Deafness, autosomal recessive 121)",
GPR158,"AR (Night blindness, congenital stationary (complete), 1E, autosomal recessive)",
GPR161,"AR ({Medulloblastoma predisposition syndrome}); AR (Hepatorenocardiac degenerative fibrosis); AD ({Aortic aneurysm, familial thoracic 11, susceptibility to}); AR (Anterior segment dysgenesis 2, multiple subtypes); AR (Cataract 34, multiple types); AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58)",
GPR17,"Rhabdomyosarcoma, alveolar",
GPR171,AD (Nizon-Isidor syndrome),
GPR179,"AR (Night blindness, congenital stationary (complete), 1E, autosomal recessive); AR (Night blindness, congenital stationary (complete), 1F, autosomal recessive)",
GPR180,"AD (Microcoria, congenital)",
GPR183,"AR (?Immunodeficiency 39); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity)",
GPR31,"{Coronary artery disease, resistance to}; {Macular degeneration, age-related, 12}; {Rapid progression to AIDS from HIV1 infection}",
GPR35,AD (Chromosome 2q37 deletion syndrome),
GPR37,"Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2)",
GPR39,"AR ({Obesity, susceptibility to})",
GPR4,"AR (Amelogenesis imperfecta, hypomaturation type, IIA6)",
GPR50,"AD ({Diabetes mellitus, type 2, susceptibility to}); {?Major affective disorder 2}; AD ({Atrial fibrillation 8, susceptibility to}); Prostate cancer, somatic; AD (Spinocerebellar ataxia 4)",
GPR65,"AR (Amelogenesis imperfecta, hypomaturation type, IIA6)",
GPR68,"AR (Amelogenesis imperfecta, hypomaturation type, IIA6)",
GPR78,"AD (Cardiomyopathy, familial hypertrophic); AD (Creatine phosphokinase, elevated serum); AD (Long QT syndrome 9); AD (Myopathy, distal, Tateyama type); AD (Rippling muscle disease 2)",
GPR87,AD (Nizon-Isidor syndrome),
GPR88,"AR (?Chorea, childhood-onset, with psychomotor retardation)",
GPRASP1,"?Deafness, X-linked 7",
GPRASP2,"?Deafness, X-linked 7; AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome)",
GPRC5B,"AD (Megalencephalic leukoencephalopathy with subcortical cysts 3); AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting); [Body mass index QTL1]",
GPRC5C,AD (Megalencephalic leukoencephalopathy with subcortical cysts 3),
GPRIN1,"{Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant",
GPRIN2,"AD ({Attention deficit-hyperactivity disorder, susceptibility to}); AD ({Blepharospasm, primary benign}); {Bone mineral density QTL 12, osteoporosis}",
GPS2,"Hypothyroidism, congenital, nongoitrous, 8; AD (Intellectual developmental disorder, autosomal dominant 41); AD (Pierpont syndrome)",
GPSM1,AR (Chudley-McCullough syndrome),
GPSM2,AR (Chudley-McCullough syndrome),
GPSM3,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome)",
GPT,"AR (Neurodevelopmental disorder with microcephaly and spastic paraplegia); AR (Congenital disorder of glycosylation, type Ij); AR (Myasthenic syndrome, congenital, 13, with tubular aggregates); AR (Anemia, congenital, nonspherocytic hemolytic, 3, adenylate kinase deficient); [Blood group, ABO system]; Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic",
GPT2,AR (Neurodevelopmental disorder with microcephaly and spastic paraplegia),
GPX1,"AR (Hemolytic anemia due to glutathione peroxidase deficiency); {Microvascular complications of diabetes 6}; Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic; AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive); AD (Tubulointerstitial kidney disease, autosomal dominant, 2); AR (Parkinson disease 7, autosomal recessive early-onset); AD (Erythrocytosis, familial, 4)",
GPX2,"AR (Spondylometaphyseal dysplasia, Sedaghatian type)",
GPX3,"AR (Thyroid hormone metabolism, abnormal, 3); AR (Spondylometaphyseal dysplasia, Sedaghatian type); AD (Treacher Collins syndrome 1); AR (Thyroid hormone metabolism, abnormal, 1)",
GPX4,"AR (Spondylometaphyseal dysplasia, Sedaghatian type); AD (Corneal dystrophy, Fuchs endothelial, 6); AD (Corneal dystrophy, posterior polymorphous, 3)",
GRAMD1B,"{Leukemia, chronic lymphocytic susceptibility to, 5}",
GRAMD2B,"AD (Microcephaly 26, primary, autosomal dominant); AD (Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typical); AD (Leukodystrophy, demyelinating, adult-onset, autosomal dominant, atypical)",
GRAP,"AR (Deafness, autosomal recessive 114)",
GRAP2,"AR (Microphthalmia, syndromic 12); AR (?Tumoral calcinosis, hyperphosphatemic, familial, 3); AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); AR (?Immunodeficiency 123 with HPV-related verrucosis)",
GRB10,"{Parkinson disease 11}; AD (Silver-Russell syndrome 2); AR (Insulin-like growth factor I, resistance to); Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AR (?Spermatogenic failure 66)",
GRB7,AR (Hyperphosphatasia with impaired intellectual development syndrome 4),
GREB1,"AD (Deafness, autosomal dominant 80); AD (Renal hypodysplasia/aplasia 3)",
GREB1L,"AD (Deafness, autosomal dominant 80); AD (Renal hypodysplasia/aplasia 3)",
GREM1,"AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD ({Colorectal cancer, susceptibility to, 4}); AD (Polyposis syndrome, hereditary mixed 1); AD (Microphthalmia, syndromic 6); AD (Orofacial cleft 11); AD (Hypogonadotropic hypogonadism 6 with or without anosmia); AD (Cleft palate, cardiac defects, and impaired intellectual development)",
GREM2,"AD (Tooth agenesis, selective, 9)",
GRHL1,"AD (van der Woude syndrome 2); AD (Corneal dystrophy, posterior polymorphous, 4); AD (Deafness, autosomal dominant 28); AR (Ectodermal dysplasia/short stature syndrome)",
GRHL2,"AD (Corneal dystrophy, posterior polymorphous, 4); AD (Deafness, autosomal dominant 28); AR (Ectodermal dysplasia/short stature syndrome); {Age-related hearing impairment 1}; AD (van der Woude syndrome 2)",
GRHL3,"AD (van der Woude syndrome 2); AD (Corneal dystrophy, posterior polymorphous, 4); AD (Deafness, autosomal dominant 28); AR (Ectodermal dysplasia/short stature syndrome); AD (?Seborrhea-like dermatitis with psoriasiform elements); AD (ADULT syndrome); AD (Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3); AD (Hay-Wells syndrome); AD (Limb-mammary syndrome); Orofacial cleft 8; AD (Premature ovarian failure 21); AD (Rapp-Hodgkin syndrome); AD (Split-hand/foot malformation 4)",
GRHPR,"AR (Hyperoxaluria, primary, type II); AR (Hyperoxaluria, primary, type III)",
GRIA1,"AR (?Intellectual developmental disorder, autosomal recessive 76); AD (Intellectual developmental disorder, autosomal dominant 67); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; AD (Neurodevelopmental disorder with language impairment and behavioral abnormalities); Intellectual developmental disorder, X-linked syndromic, Wu type; Intellectual developmental disorder, X-linked syndromic, Billuart type; AR (?Intellectual developmental disorder, autosomal recessive 63); AD (Intellectual developmental disorder, autosomal dominant 53)",
GRIA2,"AD (Neurodevelopmental disorder with language impairment and behavioral abnormalities); Intellectual developmental disorder, X-linked syndromic, Wu type; Coffin-Lowry syndrome; Intellectual developmental disorder, X-linked 19; AR (Neurodevelopmental disorder with hypotonia, microcephaly, and seizures); AR (Hyperekplexia 4); AR (?Intellectual developmental disorder, autosomal recessive 76); AD (Intellectual developmental disorder, autosomal dominant 67)",
GRIA3,"Intellectual developmental disorder, X-linked syndromic, Wu type; Xq25 duplication syndrome; AR (?Intellectual developmental disorder, autosomal recessive 76); AD (Intellectual developmental disorder, autosomal dominant 67); AD (Neurodevelopmental disorder with motor abnormalities, and facial dysmorphism); Intellectual developmental disorder, X-linked 82; AD (Neurodevelopmental disorder with language impairment and behavioral abnormalities); AR (Developmental and epileptic encephalopathy 4)",
GRIA4,"AD (Neurodevelopmental disorder with or without seizures and gait abnormalities); AD (Neurodevelopmental disorder with language impairment and behavioral abnormalities); AR (?Intellectual developmental disorder, autosomal recessive 76); AD (Intellectual developmental disorder, autosomal dominant 67)",
GRID1,Chromosome 10q22.3-q23.2 deletion syndrome,
GRID2,"AR (Spinocerebellar ataxia, autosomal recessive 18)",
GRIFIN,"AR (Cataract 9, multiple types)",
GRIK1,"AR (Intellectual developmental disorder, autosomal recessive 6); AD (Neurodevelopmental disorder with impaired language and ataxia and with or without seizures); AD (Neurodevelopmental disorder with or without seizures and gait abnormalities); AD (Developmental and epileptic encephalopathy 27); AD (Intellectual developmental disorder, autosomal dominant 6, with or without seizures); AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development); AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13)",
GRIK2,"AR (Intellectual developmental disorder, autosomal recessive 6); AD (Neurodevelopmental disorder with impaired language and ataxia and with or without seizures); AD (Charcot-Marie-Tooth disease, dominant intermediate F); AR (Night blindness, congenital stationary (complete), 1F, autosomal recessive); AD (Neurodevelopmental disorder with language impairment and behavioral abnormalities)",
GRIK3,"AR (Intellectual developmental disorder, autosomal recessive 6); AD (Neurodevelopmental disorder with impaired language and ataxia and with or without seizures)",
GRIK4,"{Migraine with aura, susceptibility to, 9}",
GRIN1,"AR (Developmental and epileptic encephalopathy 101); AD (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant); AR (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive); AD (Developmental and epileptic encephalopathy 27); AD (Intellectual developmental disorder, autosomal dominant 6, with or without seizures); AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development); AR (Intellectual developmental disorder, autosomal recessive 77); AR (Joubert syndrome 25)",
GRIN2A,"AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development); AD (Developmental and epileptic encephalopathy 27); AD (Intellectual developmental disorder, autosomal dominant 6, with or without seizures); AR (Developmental and epileptic encephalopathy 101); AD (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant); AR (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive); ?Rolandic epilepsy, impaired intellectual development, and speech dyspraxia; AD ({Melanoma, cutaneous malignant, 1}); AD (Erythrokeratodermia variabilis et progressiva 6); AD (Progressive familial heart block, type IB); AD (Spinocerebellar ataxia 48); AR (Spinocerebellar ataxia, autosomal recessive 16)",
GRIN2B,"AD (Developmental and epileptic encephalopathy 27); AD (Intellectual developmental disorder, autosomal dominant 6, with or without seizures); AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development); AR (Developmental and epileptic encephalopathy 101); AD (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant); AR (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 6); AD (Progressive familial heart block, type IB); AR (Phosphoenolpyruvate carboxykinase deficiency, cytosolic)",
GRIN2C,"AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development); AD (Developmental and epileptic encephalopathy 46)",
GRIN2D,"AD (Developmental and epileptic encephalopathy 46); AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development)",
GRIN3A,"AR (Developmental and epileptic encephalopathy 101); AD (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant); AR (Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive); AR (Cardiomyopathy, dilated, 2K)",
GRIP1,"AR (Fraser syndrome 3); AR (Hyperekplexia 4); AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair); AR (Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures)",
GRIP2,"AR (Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures)",
GRK1,"Oguchi disease-2; AD (Night blindness, congenital stationary, autosomal dominant 1); AR (Retinitis pigmentosa 4, autosomal dominant or recessive); AR (Retinitis punctata albescens)",
GRK2,"Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AD ({Alzheimer disease, late-onset, susceptibility to}); {Coronary artery spasm 1, susceptibility to}; AD ({Hypertension, pregnancy-induced}); {Hypertension, susceptibility to}; {Ischemic stroke, susceptibility to}; {Placental abruption}; AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); Capillary malformations, congenital, 1, somatic, mosaic; Sturge-Weber syndrome, somatic, mosaic; Basal cell carcinoma, somatic; AD (Basal cell nevus syndrome 1); AD (Holoprosencephaly 7); Basal cell carcinoma, somatic; Curry-Jones syndrome, somatic mosaic; AR (Pallister-Hall-like syndrome)",
GRK5,"AR (Deafness, autosomal recessive 93)",
GRM1,"AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13); Intellectual developmental disorder, X-linked 104; AR (Intellectual developmental disorder, autosomal recessive 68); AD ({Hypogonadotropic hypogonadism 16 with or without anosmia})",
GRM2,"AD (Megalencephalic leukoencephalopathy with subcortical cysts 3); AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13)",
GRM3,"AD ({Melanoma, cutaneous malignant, 1}); AD (Intellectual developmental disorder, autosomal dominant 59); AD (Developmental and epileptic encephalopathy 27); AD (Intellectual developmental disorder, autosomal dominant 6, with or without seizures); AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development); AR (?Bleeding disorder, platelet-type, 19); Pituitary tumor, invasive; AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13)",
GRM4,"AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13)",
GRM5,"Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; Intellectual developmental disorder, X-linked 104; AD (Neurodevelopmental disorder with infantile epileptic spasms); ?Focal cortical dysplasia, type II, somatic; Lymphangioleiomyomatosis, somatic; AD (Tuberous sclerosis-2); AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13); AD (?Deafness, autosomal dominant 68)",
GRM6,"AR (Night blindness, congenital stationary (complete), 1B, autosomal recessive); AR (Night blindness, congenital stationary (complete), 1C, autosomal recessive); AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13)",
GRM7,"AR (Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities); {Age-related hearing impairment 2}; AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13)",
GRM8,"{Autism susceptibility 1}; AD (Spinocerebellar ataxia 44); AR (Spinocerebellar ataxia, autosomal recessive 13); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6)",
GRN,"AR (Aphasia, primary progressive); AR (Ceroid lipofuscinosis, neuronal, 11); AR (Frontotemporal dementia 2); AD (Leukodystrophy, hypomyelinating, 16); AD (Congenital disorder of glycosylation, type Iw, autosomal dominant); AR (Congenital disorder of glycosylation, type Iw, autosomal recessive)",
GRP,AR (Achromatopsia 7); ?Isolated growth hormone deficiency due to defect in GHRF; Gigantism due to GHRF hypersecretion,
GRPR,"?Retinitis pigmentosa 23; Joubert syndrome 10; Orofaciodigital syndrome I; Simpson-Golabi-Behmel syndrome, type 2; AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1)",
GRSF1,"AR (Spondylometaphyseal dysplasia, Sedaghatian type)",
GRWD1,"AR (?Diarrhea 14, congenital)",
GRXCR1,"AR (Deafness, autosomal recessive 25); AR (?Deafness, autosomal recessive 101)",
GRXCR2,"AR (?Deafness, autosomal recessive 101)",
GSC,"AR (Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities); {Malaria, resistance to}; GLOW syndrome, somatic mosaic; AD (Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors); AD (Pleuropulmonary blastoma); Rhabdomyosarcoma, embryonal, 2",
GSDMA,"AR (Deafness, autosomal recessive 59)",
GSDMB,"{Asthma-related traits, susceptibility to, 6}",
GSDMC,"Burkitt lymphoma, somatic",
GSDMD,"AR (Hatipoglu immunodeficiency syndrome); AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic; AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AR (Autoinflammation with episodic fever and immune dysregulation); AD (Autoinflammation with episodic fever and lymphadenopathy); AR (Immunodeficiency 57 with autoinflammation)",
GSDME,"AD (Deafness, autosomal dominant 5)",
GSE1,AD (Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities),
GSK3A,"AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); {Rheumatoid arthritis, susceptibility to}; Lymphoproliferative syndrome, X-linked, 1",
GSK3B,"AR (?Seckel syndrome 7); AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AR (Portal hypertension, noncirrhotic, 2); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic",
GSKIP,"AD ({Myeloproliferative neoplasms, familial, susceptibility to})",
GSN,"AD (Amyloidosis, Finnish type); AR (Nephrotic syndrome, type 21); AD (?Myopathy, scapulohumeroperoneal); AD (Congenital myopathy 2A, typical, autosomal dominant); AR (Congenital myopathy 2B, severe infantile, autosomal recessive); AD (Congenital myopathy 2C, severe infantile, autosomal dominant); AR (Intellectual developmental disorder, autosomal recessive 54)",
GSPT1,"AR (Alzahrani-Kuwahara syndrome); AR (Heart and brain malformation syndrome); AR (Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies)",
GSR,"AR (Anemia, congenital, nonspherocytic hemolytic, 10, glutathione reductase deficient); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AR (Myopathy, myofibrillar, 8); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia)",
GSS,"AR (Anemia, congenital, nonspherocytic hemolytic, 6, glutatione synthetase deficient); AR (Glutathione synthetase deficiency); {Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features); AR (5-oxoprolinase deficiency); AR (Leukotriene C4 synthase deficiency)",
GSTA1,"AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical)",
GSTA2,"AD (Deafness, autosomal dominant 22); AD (Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy); AR (Deafness, autosomal recessive 37)",
GSTM1,"AR (Leukodystrophy, hypomyelinating, 17)",
GSTO1,"AD (?Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2)",
GSTP1,"AD (Preeclampsia/eclampsia 1); AR (Mitochondrial complex I deficiency, nuclear type 4); AD (Vitamin D-dependent rickets, type 3); Cervical carcinoma",
GSTZ1,AR ([Maleylacetoacetate isomerase deficiency]),
GSX2,AR (Diencephalic-mesencephalic junction dysplasia syndrome 2),
GTF2A1,"AR (Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy); AR (Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia)",
GTF2B,"AR (Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy); AR (Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia)",
GTF2E1,AR (Alazami-Yuan syndrome),
GTF2E2,"AR (Trichothiodystrophy 6, nonphotosensitive); AR (Alazami-Yuan syndrome)",
GTF2F1,"AR (Leukodystrophy, hypomyelinating, 21); AR (Alazami-Yuan syndrome); AR (Congenital cataracts, facial dysmorphism, and neuropathy)",
GTF2F2,"AR (Alazami-Yuan syndrome); AR (Congenital cataracts, facial dysmorphism, and neuropathy)",
GTF2H1,"AR (Trichothiodystrophy 2, photosensitive); AR (Xeroderma pigmentosum, group B)",
GTF2H2,"AR (Cockayne syndrome, type A); AR (UV-sensitive syndrome 2); AR (?Cerebrooculofacioskeletal syndrome 2); AR (Trichothiodystrophy 1, photosensitive); AR (Xeroderma pigmentosum, group D); AR (Trichothiodystrophy 2, photosensitive); AR (Xeroderma pigmentosum, group B)",
GTF2H4,"AR (Trichothiodystrophy 2, photosensitive); AR (Xeroderma pigmentosum, group B); Panbronchiolitis, diffuse",
GTF2H5,"AR (Trichothiodystrophy 3, photosensitive)",
GTF2I,"AD (Williams-Beuren syndrome); AD (Chromosome 7q11.23 duplication syndrome); {Hyperlipidemia, familial combined, susceptibility to}",
GTF2IRD1,AD (Williams-Beuren syndrome),
GTF2IRD2,"AR (Chronic granulomatous disease 1, autosomal recessive); AD (Williams-Beuren syndrome)",
GTF3A,"AR (Cerebellofaciodental syndrome); AD (Intellectual developmental disorder, autosomal dominant 64)",
GTF3C1,"AR (Charcot-Marie-Tooth disease, axonal, type 2S); AR (Neuronopathy, distal hereditary motor, autosomal recessive 1); AR (Cerebellofaciodental syndrome)",
GTF3C3,"AR (Neurodevelopmental disorder with dysmorphic facies, brain anomalies, and seizures)",
GTPBP1,AR (Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1); AR (Jaberi-Elahi syndrome),
GTPBP2,AR (Jaberi-Elahi syndrome); AR (Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1),
GTPBP3,AR (Combined oxidative phosphorylation deficiency 23),
GUCA1A,"AD (Cone dystrophy-3); AD (Cone-rod dystrophy 14); AD (?Choroidal dystrophy, central areolar 1); AR (Cone-rod dystrophy 6); AR (Leber congenital amaurosis 1); AR (Night blindness, congenital stationary, type 1I); AR (Leber congenital amaurosis 12); AD (Retinitis pigmentosa 48)",
GUCA1B,"AD (Retinitis pigmentosa 48); AD (?Choroidal dystrophy, central areolar 1); AR (Cone-rod dystrophy 6); AR (Leber congenital amaurosis 1); AR (Night blindness, congenital stationary, type 1I); AD (Cone dystrophy-3); AD (Cone-rod dystrophy 14); AR (Leber congenital amaurosis 12)",
GUCA2B,AR (Bronchiectasis and nasal polyposis),
GUCY1A1,AR (Moyamoya 6 with achalasia),
GUCY1A2,AR (Moyamoya 6 with achalasia),
GUCY2C,AD (Diarrhea 6); AR (Meconium ileus),
GUCY2D,"AD (?Choroidal dystrophy, central areolar 1); AR (Cone-rod dystrophy 6); AR (Leber congenital amaurosis 1); AR (Night blindness, congenital stationary, type 1I); AR (Leber congenital amaurosis 12); AR (Leber congenital amaurosis 5)",
GUCY2F,"AMME complex; AD (?Choroidal dystrophy, central areolar 1); AR (Cone-rod dystrophy 6); AR (Leber congenital amaurosis 1); AR (Night blindness, congenital stationary, type 1I); AR (Leber congenital amaurosis 12)",
GUF1,AR (?Developmental and epileptic encephalopathy 40),
GUK1,AR (Mitochondrial DNA depletion syndrome 21),
GUSB,"AR (Mucopolysaccharidosis VII); AR (Congenital disorder of glycosylation, type Ix); AR (Retinitis pigmentosa 86); {Transcription of plasminogen activator inhibitor, modulator of}; AR (Plasminogen activator inhibitor-1 deficiency)",
GYG1,AR (?Glycogen storage disease XV); AR (Polyglucosan body myopathy 2),
GYG2,AR (?Glycogen storage disease XV); AR (Polyglucosan body myopathy 2),
GYPA,"[Blood group, MNSs system]; {Malaria, resistance to}; [Blood group, Ss]; {Malaria, resistance to}; AR (Afibrinogenemia, congenital); AD (Dysfibrinogenemia, congenital); AR (Hypofibrinogenemia, congenital); [Blood group, OK]; [Blood group, Gerbich]; {Malaria, resistance to}; Fabry disease; Fabry disease, cardiac variant",
GYPB,"[Blood group, Ss]; {Malaria, resistance to}; [Blood group, MNSs system]; {Malaria, resistance to}; AR (Afibrinogenemia, congenital); AD (Dysfibrinogenemia, congenital); AR (Hypofibrinogenemia, congenital); [Blood group, Gerbich]; {Malaria, resistance to}; Fabry disease; Fabry disease, cardiac variant",
GYPC,"[Blood group, Gerbich]; {Malaria, resistance to}; AR (Spherocytosis, type 1)",
GYPE,"[Blood group, MNSs system]; {Malaria, resistance to}; [Blood group, Ss]; {Malaria, resistance to}",
GYS1,"AR (Glycogen storage disease 0, muscle); AR (Myoclonic epilepsy of Lafora 2); AR (Myoclonic epilepsy of Lafora 1); AR (Glycogen storage disease II); AR (Glycogen storage disease 0, liver)",
GYS2,"AR (Glycogen storage disease 0, liver); AR (Glycogen storage disease 0, muscle)",
GZF1,"AR (Joint laxity, short stature, and myopia)",
GZMA,"AD (Intellectual developmental disorder, autosomal dominant 58); AR (Haim-Munk syndrome); AR (Papillon-Lefevre syndrome); AR (Periodontitis 1, juvenile); AD ({Systemic lupus erythematosus, susceptibility to}); AR (Aicardi-Goutieres syndrome 1, dominant and recessive); AD (Chilblain lupus); AD (Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations); AR (Mitochondrial complex I deficiency, nuclear type 8)",
GZMB,"Hepatocellular carcinoma, somatic; AR (Haim-Munk syndrome); AR (Papillon-Lefevre syndrome); AR (Periodontitis 1, juvenile); AD ({Systemic lupus erythematosus, susceptibility to}); AR (Aicardi-Goutieres syndrome 1, dominant and recessive); AD (Chilblain lupus); AD (Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations)",
GZMM,"AD (Neutropenia, cyclic); AD (Neutropenia, severe congenital 1, autosomal dominant)",
Gene Symbol,Phenotype,
H1-4,AD (Rahman syndrome),
H1-8,AD (Rahman syndrome),
H2AX,"Aplastic anemia; Leukemia, acute lymphoblastic; AR (Nijmegen breakage syndrome); AD (Houge-Janssens syndrome 3); AD (Oocyte/zygote/embryo maturation arrest 21); AR (Jawad syndrome); Pancreatic carcinoma, somatic; AR (Seckel syndrome 2); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; AR (Immunodeficiency with hyper-IgM, type 2); AR (Immunodeficiency 124, severe combined); AR (Microphthalmia/coloboma 13)",
H3-3A,AD (Bryant-Li-Bhoj neurodevelopmental syndrome 1); AD (Bryant-Li-Bhoj neurodevelopmental syndrome 2),
H3-3B,AD (Bryant-Li-Bhoj neurodevelopmental syndrome 2); AD (Bryant-Li-Bhoj neurodevelopmental syndrome 1),
H4C1,"Spermatogenic failure, X-linked, 9",
H4C11,AD (?Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 2),
H4C3,AD (Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 1),
H4C5,AD (Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3),
H4C9,AD (Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 4),
H6PD,"AR (Cortisone reductase deficiency 1); AD (Cortisone reductase deficiency 2); {Multiple sclerosis, susceptibility to, 4}; AD (Polycystic ovary syndrome 1)",
HAAO,"AR (Vertebral, cardiac, renal, and limb defects syndrome 1)",
HABP2,"AD ({?Thyroid cancer, nonmedullary, 5}); AD ({Venous thromboembolism, susceptibility to})",
HACD1,AR (Congenital myopathy 11),
HACD2,AR (Congenital myopathy 11),
HACD3,AR (Congenital myopathy 11),
HACD4,AR (Congenital myopathy 11),
HACE1,AR (Spastic paraplegia and psychomotor retardation with or without seizures),
HADH,"AR (3-hydroxyacyl-CoA dehydrogenase deficiency); AR (Hyperinsulinemic hypoglycemia, familial, 4); HSD10 mitochondrial disease; AD (Diabetes mellitus, noninsulin-dependent); AR (Diabetes mellitus, permanent neonatal 3); AD (Diabetes mellitus, transient neonatal 2); AR (Hyperinsulinemic hypoglycemia, familial, 1); AD (Hypoglycemia of infancy, leucine-sensitive); AD (Maturity-onset diabetes of the young, type 12)",
HADHA,"AR (Fatty liver, acute, of pregnancy); AR (HELLP syndrome, maternal, of pregnancy); AR (LCHAD deficiency); AR (Mitochondrial trifunctional protein deficiency 1); AR (Mitochondrial trifunctional protein deficiency 2); AD (?Fanconi renotubular syndrome 3); AR (Glutaric acidemia IIC); [Cholesterol level QTL 2]",
HADHB,"AR (Mitochondrial trifunctional protein deficiency 2); AR (Fatty liver, acute, of pregnancy); AR (HELLP syndrome, maternal, of pregnancy); AR (LCHAD deficiency); AR (Mitochondrial trifunctional protein deficiency 1); AD (?Fanconi renotubular syndrome 3); AR (Glutaric acidemia IIC); [Cholesterol level QTL 2]",
HAGH,AD ([Glyoxalase II deficiency]); AD (Paroxysmal nonkinesigenic dyskinesia 1),
HAL,"AR ([Histidinemia]); {Leukemia, acute lymphocytic, susceptibility to, 1}; AD (?Amyloidosis, primary localized cutaneous, 2); AR (?Urocanase deficiency); AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-; AR (Glutamate formiminotransferase deficiency)",
HAMP,"AR (Hemochromatosis, type 2B); AR (Hemochromatosis, type 1); AD ({Iron overload, susceptibility to}); AR (Iron-refractory iron deficiency anemia); AR (Hemochromatosis, type 2A)",
HAND1,"AD (Atrial septal defect 1); {Atrioventricular septal defect, susceptibility to, 1}",
HAND2,"AD ({Migraine, resistance to}); AD (Mandibulofacial dysostosis with alopecia); AD (Craniosynostosis 1); AD (Robinow-Sorauf syndrome); AD (Saethre-Chotzen syndrome with or without eyelid anomalies); AD (Sweeney-Cox syndrome)",
HAP1,"AR (Joubert syndrome 3); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome); AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1); AR ({Amyotrophic lateral sclerosis, susceptibility to}); AD (Neuronopathy, distal hereditary motor, autosomal dominant 14); AD (Perry syndrome); AR (Congenital disorder of deglycosylation 2)",
HAPLN1,"AR (Brittle cornea syndrome 2); [Blood group, Indian system]; AR (Brittle cornea syndrome 1)",
HARS1,"AD (Charcot-Marie-Tooth disease, axonal, type 2W); AR (Usher syndrome type 3B); AR (Perrault syndrome 2)",
HARS2,"AR (Perrault syndrome 2); AD (Charcot-Marie-Tooth disease, axonal, type 2W); AR (Usher syndrome type 3B)",
HAS2,AR (Muggenthaler-Chowdhury-Chioza syndrome),
HAT1,"AD (Neurodevelopmental disorder with central hypotonia and dysmorphic facies); AD (?Auriculocondylar syndrome 4); Cornelia de Lange syndrome 5; ?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia",
HAUS6,"AD (Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development)",
HAVCR1,"AR (T-cell lymphoma, subcutaneous panniculitis-like)",
HAVCR2,"AR (T-cell lymphoma, subcutaneous panniculitis-like); AR (Hemophagocytic lymphohistiocytosis, familial, 1)",
HAX1,"AR (Neutropenia, severe congenital 3, autosomal recessive); AD (Polycystic kidney disease 2); AD (3-methylglutaconic aciduria, type VIIA, autosomal dominant); AR (3-methylglutaconic aciduria, type VIIB, autosomal recessive); AD (Neutropenia, severe congenital, 9, autosomal dominant); {Parkinson disease 13}; AR (3-methylglutaconic aciduria, type VIII); AD (Neutropenia, cyclic); AD (Neutropenia, severe congenital 1, autosomal dominant)",
HBA1,"AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-; AD (Erythrocytosis, familial, 7); AD (Heinz body anemia); Hemoglobin H disease, deletional and nondeletional; Thalassemia, alpha-; {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta",
HBA2,"AD (Erythrocytosis, familial, 7); AD (Heinz body anemia); Hemoglobin H disease, deletional and nondeletional; Thalassemia, alpha-; AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-; {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; Thalassemia due to Hb Lepore; Thalassemia, delta-; AR (Thrombophilia 7 due to antithrombin III deficiency)",
HBB,"{Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; Thalassemia due to Hb Lepore; Thalassemia, delta-; AD ([Hereditary persistence of fetal hemoglobin]); AR (Anemia, congenital dyserythropoietic, type IVb); AD (Anemia, dyserythropoietic congenital, type IVa); AD (Blood group--Lutheran inhibitor); AR (Hypoparathyroidism, familial isolated 1); AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic",
HBD,"Thalassemia due to Hb Lepore; Thalassemia, delta-; {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy; AD (Pseudohypoaldosteronism type I, autosomal dominant); AD (Fetal hemoglobin quantitative trait locus 1); AR (Heimler syndrome 2); AR (Peroxisome biogenesis disorder 4A (Zellweger)); AR (Peroxisome biogenesis disorder 4B)",
HBE1,"Thalassemia, Hispanic gamma-delta-beta; AD (Fetal hemoglobin quantitative trait locus 1)",
HBEGF,"{Diphtheria, susceptibility to}; AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); AD (Adiponectin deficiency); AD (Corneal fleck dystrophy)",
HBG1,"AD (Fetal hemoglobin quantitative trait locus 1); AD (Cyanosis, transient neonatal); AD (Fetal hemoglobin quantitative trait locus 1); AD ([Hereditary persistence of fetal hemoglobin]); AR (Anemia, congenital dyserythropoietic, type IVb); AD (Anemia, dyserythropoietic congenital, type IVa); AD (Blood group--Lutheran inhibitor); AD (Dias-Logan syndrome); AD ([Hereditary persistence of alpha-fetoprotein]); AR (Alpha-fetoprotein deficiency); AD (Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin); Chromosome 2p16.1-p15 deletion syndrome",
HBG2,"AD (Cyanosis, transient neonatal); AD (Fetal hemoglobin quantitative trait locus 1); AD ([Hereditary persistence of fetal hemoglobin]); AR (Anemia, congenital dyserythropoietic, type IVb); AD (Anemia, dyserythropoietic congenital, type IVa); AD (Blood group--Lutheran inhibitor); AD (Fetal hemoglobin quantitative trait locus 1); AD (Dias-Logan syndrome); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AD (Fetal hemoglobin quantitative trait locus 2); AD (Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin)",
HBM,"AR (?Methylmalonic aciduria and homocystinuria, cblL type); AD (Spinocerebellar ataxia 51); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; Alpha-thalassemia myelodysplasia syndrome, somatic; Alpha-thalassemia/impaired intellectual development syndrome; Intellectual disability-hypotonic facies syndrome, X-linked",
HBP1,"AD (ADULT syndrome); AD (Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3); AD (Hay-Wells syndrome); AD (Limb-mammary syndrome); Orofacial cleft 8; AD (Premature ovarian failure 21); AD (Rapp-Hodgkin syndrome); AD (Split-hand/foot malformation 4); Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic; Burkitt lymphoma, somatic; AD ({Alzheimer disease, susceptibility to}); {Lung cancer, protection against, in smokers}; AR (Myeloperoxidase deficiency); AR (Hyperlipoproteinemia, type 1D)",
HBQ1,"AD (Erythrocytosis, familial, 7); AD (Heinz body anemia); Hemoglobin H disease, deletional and nondeletional; Thalassemia, alpha-",
HBS1L,"AD (Fetal hemoglobin quantitative trait locus 2); [Hematocrit/hemoglobin quantitative trait locus 1]; AD (Cyanosis, transient neonatal); AD (Fetal hemoglobin quantitative trait locus 1); AD ([Fetal hemoglobin QTL5]); Mean platelet volume QTL5",
HBZ,"AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-",
HCCS,"Linear skin defects with multiple congenital anomalies 1; ?Caudal duplication anomaly; AR (Craniometadiaphyseal osteosclerosis with hip dysplasia); Hepatocellular carcinoma, somatic; AR (Heterotaxy, visceral, 10, autosomal, with male infertility)",
HCFC1,"Methylmalonic aciduria and homocysteinemia, cblX type; AR (?Methylmalonic aciduria and homocystinuria, cblL type); AD (Spinocerebellar ataxia 51); Intellectual developmental disorder, X-linked 106; AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1)",
HCFC1R1,"Methylmalonic aciduria and homocysteinemia, cblX type",
HCK,"AD (Autoinflammation with pulmonary and cutaneous vasculitis); Neutropenia, severe congenital, X-linked; Thrombocytopenia, X-linked; Thrombocytopenia, X-linked, intermittent; Wiskott-Aldrich syndrome; AR (Wiskott-Aldrich syndrome 2); Agammaglobulinemia, X-linked 1; Isolated growth hormone deficiency, type III, with agammaglobulinemia; AD (?Thrombocytopenia 6); Colon cancer, advanced, somatic; ?Immunodeficiency 61",
HCLS1,"AR (Neutropenia, severe congenital 3, autosomal recessive)",
HCN1,"AD (Developmental and epileptic encephalopathy 24); AD (Generalized epilepsy with febrile seizures plus, type 10); AD (Developmental and epileptic encephalopathy 74); AD (Febrile seizures, familial, 8); AD (Generalized epilepsy with febrile seizures plus, type 3); AD ({Epilepsy, idiopathic generalized, susceptibility to, 18}); Brugada syndrome 8; AD (Sick sinus syndrome 2); AD ({Epilepsy, idiopathic generalized, susceptibility to, 17}); AD (Febrile seizures, familial, 2); AD (Generalized epilepsy with febrile seizures plus, type 11)",
HCN2,"AD ({Epilepsy, idiopathic generalized, susceptibility to, 17}); AD (Febrile seizures, familial, 2); AD (Generalized epilepsy with febrile seizures plus, type 11); AD (Episodic pain syndrome, familial, 2); AD ({Epilepsy, idiopathic generalized, susceptibility to, 18}); Brugada syndrome 8; AD (Sick sinus syndrome 2); Atrial fibrillation, familial, 4; AD (Long QT syndrome 6); AD (Febrile seizures, familial, 1); AD ({Epilepsy, idiopathic generalized, susceptibility to, 1}); AD (Developmental and epileptic encephalopathy 24); AD (Generalized epilepsy with febrile seizures plus, type 10)",
HCN4,"AD ({Epilepsy, idiopathic generalized, susceptibility to, 18}); Brugada syndrome 8; AD (Sick sinus syndrome 2); AD (Atrial fibrillation, familial, 11); AD (Atrial standstill, digenic (GJA5/SCN5A)); AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; AD (Developmental and epileptic encephalopathy 24); AD (Generalized epilepsy with febrile seizures plus, type 10); AD (Atrial septal defect 7, with or without AV conduction defects); Conotruncal heart malformations, variable; AD (Hypoplastic left heart syndrome 2); AD (Hypothyroidism, congenital nongoitrous, 5); AD (Tetralogy of Fallot); AD (Ventricular septal defect 3)",
HCRT,"AD (?Narcolepsy 1); AD (Panic disorder syndrome 1); {Obesity, susceptibility to, BMIQ4}; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections)",
HCRTR1,AD (?Narcolepsy 1); AD (Panic disorder syndrome 1),
HCRTR2,AD (?Narcolepsy 1),
HDAC1,"AD (Radio-Tartaglia syndrome); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD (Autoinflammatory disease, familial, Behcet-like-3); AD (Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities)",
HDAC11,"AR (Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities)",
HDAC2,"AD (Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant); AD (Neuropathy, hereditary sensory, type IE); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features)",
HDAC3,"Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type; Hypothyroidism, congenital, nongoitrous, 8; AD (Autoinflammatory disease, familial, Behcet-like-3); AD (Neurodevelopmental disorder with central hypotonia and dysmorphic facies)",
HDAC4,"AD (Neurodevelopmental disorder with central hypotonia and dysmorphic facies); AD (Chromosome 2q37 deletion syndrome); AD (?Auriculocondylar syndrome 4); AR (?Spondyloepimetaphyseal dysplasia, Krakow type); AR (MHC class II deficiency 2)",
HDAC5,"AD (Neurodevelopmental disorder with central hypotonia and dysmorphic facies); AR ([Bone mineral density QTL 15]); AD (Developmental and epileptic encephalopathy 30); AD (KBG syndrome); AD (Chromosome 5q14.3 deletion syndrome); AD (Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language)",
HDAC6,"?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia; AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD ({Colon cancer, susceptibility to}); AD (Familial Mediterranean fever, AD); AR (Familial Mediterranean fever, AR); AD (Neutrophilic dermatosis, acute febrile)",
HDAC7,Shukla-Vernon syndrome; AR (?Spermatogenic failure 14),
HDAC8,"Cornelia de Lange syndrome 5; AD (Pseudohypoaldosteronism, type IIB)",
HDAC9,AD (?Auriculocondylar syndrome 4); AD (Craniosynostosis 1); AD (Robinow-Sorauf syndrome); AD (Saethre-Chotzen syndrome with or without eyelid anomalies); AD (Sweeney-Cox syndrome); {Autism susceptibility 1},
HDC,"AD ({Gilles de la Tourette syndrome, susceptibility to})",
HDX,"AD (Deafness, autosomal dominant 87)",
HEATR3,AR (Diamond-Blackfan anemia 21),
HEBP1,"AR (Ceroid lipofuscinosis, neuronal, 10)",
HECTD1,"AD (HDL deficiency, familial, 1); AR (Tangier disease); Leukemia, acute promyelocytic; Adenoma, periampullary, somatic; AD (Adenomatous polyposis coli); AD (Brain tumor-polyposis syndrome 2); Colorectal cancer, somatic; AD (Desmoid disease, hereditary); AD (Gardner syndrome); AD (Gastric adenocarcinoma and proximal polyposis of the stomach); Gastric cancer, somatic; Hepatoblastoma, somatic",
HECTD4,"AR (Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum); AR (Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities)",
HECW1,"AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive)",
HECW2,"AD (Neurodevelopmental disorder with hypotonia, seizures, and absent language); AR (Ciliary dyskinesia, primary, 47, and lissencephaly)",
HEG1,AD (Cerebral cavernous malformations-2),
HELLS,AR (Immunodeficiency-centromeric instability-facial anomalies syndrome 4); AR (Immunodeficiency-centromeric instability-facial anomalies syndrome 3),
HELQ,"AR (?Fanconi anemia, complementation group U); AR (?Premature ovarian failure 17); AR (Spermatogenic failure 50); {Breast-ovarian cancer, familial, susceptibility to, 3}; AR (Fanconi anemia, complementation group O); {Breast-ovarian cancer, familial, susceptibility to, 4}; AR (Ovarian dysgenesis 11)",
HEMGN,"AD (Orofacial cleft-1); AD ({Thyroid cancer, nonmedullary, 4}); AR (Bamforth-Lazarus syndrome); AD (Orofacial cleft-1); AD ({Thyroid cancer, nonmedullary, 4}); AR (Bamforth-Lazarus syndrome)",
HEPACAM,"AR (Megalencephalic leukoencephalopathy with subcortical cysts 2A); AD (Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development); AR (Megalencephalic leukoencephalopathy with subcortical cysts 1); AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting); [Blood pressure regulation QTL]; AD (Long QT syndrome 12); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3); AR (Megalencephalic leukoencephalopathy with subcortical cysts 2A); AD (Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development); AR (Megalencephalic leukoencephalopathy with subcortical cysts 1); AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting); [Blood pressure regulation QTL]; AD (Long QT syndrome 12); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3)",
HEPACAM2,"AD (MIRAGE syndrome); AD (Monosomy 7 myelodysplasia and leukemia syndrome 2); AR (Tumoral calcinosis, familial, normophosphatemic); AD (?Spinocerebellar ataxia 49); AD (Ataxia-pancytopenia syndrome); AD (Monosomy 7 myelodysplasia and leukemia syndrome 1); AD (MIRAGE syndrome); AD (Monosomy 7 myelodysplasia and leukemia syndrome 2); AR (Tumoral calcinosis, familial, normophosphatemic); AD (?Spinocerebellar ataxia 49); AD (Ataxia-pancytopenia syndrome); AD (Monosomy 7 myelodysplasia and leukemia syndrome 1)",
HEPH,"AR (Aceruloplasminemia); AR (?Abnormal hair, joint laxity, and developmental delay); AR (Aceruloplasminemia); AR (?Abnormal hair, joint laxity, and developmental delay)",
HEPHL1,"AR (?Abnormal hair, joint laxity, and developmental delay); AR (?Abnormal hair, joint laxity, and developmental delay)",
HEPN1,"AR (Megalencephalic leukoencephalopathy with subcortical cysts 2A); AD (Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development); AR (Megalencephalic leukoencephalopathy with subcortical cysts 2A); AD (Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development)",
HERC1,"AR (Macrocephaly, dysmorphic facies, and psychomotor retardation); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38); AR (Macrocephaly, dysmorphic facies, and psychomotor retardation); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38)",
HERC2,"AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38); AD (Angelman syndrome); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Albinism, brown oculocutaneous); AR (Albinism, oculocutaneous, type II); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AD (Prader-Willi syndrome); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38); AD (Angelman syndrome); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Albinism, brown oculocutaneous); AR (Albinism, oculocutaneous, type II); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AD (Prader-Willi syndrome)",
HERC3,"AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38)",
HERC5,AR (Immunodeficiency 38); AR (Immunodeficiency 38),
HERPUD1,AD (Polycystic kidney disease 2); AD (Polycystic liver disease 1); AD (Polycystic kidney disease 2); AD (Polycystic liver disease 1),
HES1,"AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AR (Fanconi anemia, complementation group G); AR (Fanconi anemia, complementation group A); AR (Fanconi anemia, complementation group F); AR (Fanconi anemia, complementation group L); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AR (Fanconi anemia, complementation group G); AR (Fanconi anemia, complementation group A); AR (Fanconi anemia, complementation group F); AR (Fanconi anemia, complementation group L)",
HES5,"AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD ({Osteoporosis, early-onset, susceptibility to, autosomal dominant}); AR (Osteogenesis imperfecta, type XV); AD (?Myofibromatosis, infantile 2); AD (Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1); AD (Lateral meningocele syndrome); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD ({Osteoporosis, early-onset, susceptibility to, autosomal dominant}); AR (Osteogenesis imperfecta, type XV); AD (?Myofibromatosis, infantile 2); AD (Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1); AD (Lateral meningocele syndrome); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2)",
HES7,"AR (Spondylocostal dysostosis 4, autosomal recessive); AR (Spondylocostal dysostosis 3, autosomal recessive); AR (Spondylocostal dysostosis 1, autosomal recessive); AR (Spondylocostal dysostosis 2, autosomal recessive); AR (Spondylocostal dysostosis 5); AR (Spondylocostal dysostosis 4, autosomal recessive); AR (Spondylocostal dysostosis 3, autosomal recessive); AR (Spondylocostal dysostosis 1, autosomal recessive); AR (Spondylocostal dysostosis 2, autosomal recessive); AR (Spondylocostal dysostosis 5)",
HESX1,"AR (Growth hormone deficiency with pituitary anomalies); AR (Pituitary hormone deficiency, combined, 5); AR (Septooptic dysplasia); AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); AR (Pituitary hormone deficiency, combined or isolated, 1); AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system); AR (Growth hormone deficiency with pituitary anomalies); AR (Pituitary hormone deficiency, combined, 5); AR (Septooptic dysplasia); AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); AR (Pituitary hormone deficiency, combined or isolated, 1); AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system)",
HEXA,"AR ([Hex A pseudodeficiency]); AR (GM2-gangliosidosis, several forms); AR (Tay-Sachs disease); AR (Sandhoff disease, infantile, juvenile, and adult forms); {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); {Follicular lymphoma, susceptibility to, 1}; AR (Glycogen storage disease XI); AR ([Hex A pseudodeficiency]); AR (GM2-gangliosidosis, several forms); AR (Tay-Sachs disease); AR (Sandhoff disease, infantile, juvenile, and adult forms); {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); {Follicular lymphoma, susceptibility to, 1}; AR (Glycogen storage disease XI)",
HEXB,"AR (Sandhoff disease, infantile, juvenile, and adult forms); AR ([Hex A pseudodeficiency]); AR (GM2-gangliosidosis, several forms); AR (Tay-Sachs disease); Macrocytic anemia, refractory, due to 5q deletion, somatic; AR (?Infantile liver failure syndrome 1); AD ({Schizophrenia}); AR (Sandhoff disease, infantile, juvenile, and adult forms); AR ([Hex A pseudodeficiency]); AR (GM2-gangliosidosis, several forms); AR (Tay-Sachs disease); Macrocytic anemia, refractory, due to 5q deletion, somatic; AR (?Infantile liver failure syndrome 1); AD ({Schizophrenia})",
HEXIM1,AD (Cornelia de Lange syndrome 6); AR (Alazami syndrome); AD (Cornelia de Lange syndrome 6); AR (Alazami syndrome),
HEY1,"AD (Adams-Oliver syndrome 3); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Spinocerebellar ataxia 1); AD ({Osteoporosis, early-onset, susceptibility to, autosomal dominant}); AR (Osteogenesis imperfecta, type XV); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2); AD (Adams-Oliver syndrome 3); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Spinocerebellar ataxia 1); AD ({Osteoporosis, early-onset, susceptibility to, autosomal dominant}); AR (Osteogenesis imperfecta, type XV); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2)",
HEY2,"AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AD (Atrial septal defect 7, with or without AV conduction defects); Conotruncal heart malformations, variable; AD (Hypoplastic left heart syndrome 2); AD (Hypothyroidism, congenital nongoitrous, 5); AD (Tetralogy of Fallot); AD (Ventricular septal defect 3); AD (Holt-Oram syndrome); AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AD (Atrial septal defect 7, with or without AV conduction defects); Conotruncal heart malformations, variable; AD (Hypoplastic left heart syndrome 2); AD (Hypothyroidism, congenital nongoitrous, 5); AD (Tetralogy of Fallot); AD (Ventricular septal defect 3); AD (Holt-Oram syndrome)",
HFE,"AR (Hemochromatosis, type 1); AR (Hemochromatosis, type 2B); AR (Hemochromatosis, type 3); AR (Hemochromatosis, type 2A); AD ({Iron overload, susceptibility to}); AR (Anemia, hypochromic microcytic, with iron overload 1); AR (Hemochromatosis, type 1); AR (Hemochromatosis, type 2B); AR (Hemochromatosis, type 3); AR (Hemochromatosis, type 2A); AD ({Iron overload, susceptibility to}); AR (Anemia, hypochromic microcytic, with iron overload 1)",
HFM1,AR (Premature ovarian failure 9); AR (Premature ovarian failure 9),
HGD,"AR (Alkaptonuria); {HIV infection, susceptibility/resistance to}; AR (Polycystic lung disease); {Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}; AR (Alkaptonuria); {HIV infection, susceptibility/resistance to}; AR (Polycystic lung disease); {Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}",
HGF,"AR (Deafness, autosomal recessive 39); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AD (?Arthrogryposis, distal, type 11); AR (?Deafness, autosomal recessive 97); AD ({Osteofibrous dysplasia, susceptibility to}); Hepatocellular carcinoma, childhood type, somatic; Renal cell carcinoma, papillary, 1, familial and somatic; AD ({Melanoma, cutaneous malignant, 1}); AR (Deafness, autosomal recessive 39); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AD (?Arthrogryposis, distal, type 11); AR (?Deafness, autosomal recessive 97); AD ({Osteofibrous dysplasia, susceptibility to}); Hepatocellular carcinoma, childhood type, somatic; Renal cell carcinoma, papillary, 1, familial and somatic; AD ({Melanoma, cutaneous malignant, 1})",
HGFAC,"AR (Diarrhea 3, secretory sodium, congenital, syndromic); AR (Diarrhea 3, secretory sodium, congenital, syndromic)",
HGS,"AD (?Immunodeficiency 85 and autoimmunity); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); {Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AR (?Meier-Gorlin syndrome 8); Pituitary adenoma 4, ACTH-secreting, somatic; AD (?Immunodeficiency 85 and autoimmunity); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); {Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AR (?Meier-Gorlin syndrome 8); Pituitary adenoma 4, ACTH-secreting, somatic",
HGSNAT,AR (Mucopolysaccharidosis type IIIC (Sanfilippo C)); AR (Retinitis pigmentosa 73); AR (Mucopolysaccharidosis type IIIC (Sanfilippo C)); AR (Retinitis pigmentosa 73),
HHAT,AR (Nivelon-Nivelon-Mabille syndrome); AR (Nivelon-Nivelon-Mabille syndrome),
HHEX,"Leukemia, acute T-cell; AR (Bleeding disorder, platelet-type, 21); AD (Lymphatic malformation 14); AD ({Diabetes mellitus, type 2, susceptibility to}); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); [Birth weight QTL4]; Leukemia, acute T-cell; AR (Bleeding disorder, platelet-type, 21); AD (Lymphatic malformation 14); AD ({Diabetes mellitus, type 2, susceptibility to}); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); [Birth weight QTL4]",
HHIP,"Pulmonary disease, chronic obstructive, severe early-onset; {Stature QTL 12}; AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AR (Acrocapitofemoral dysplasia); AD (Brachydactyly, type A1); AR (Microcephaly, short stature, and polymicrogyria with seizures); Basal cell carcinoma, somatic; AD (Basal cell nevus syndrome 1); AD (Holoprosencephaly 7); Pulmonary disease, chronic obstructive, severe early-onset; {Stature QTL 12}; AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AR (Acrocapitofemoral dysplasia); AD (Brachydactyly, type A1); AR (Microcephaly, short stature, and polymicrogyria with seizures); Basal cell carcinoma, somatic; AD (Basal cell nevus syndrome 1); AD (Holoprosencephaly 7)",
HIBCH,AR (3-hydroxyisobutryl-CoA hydrolase deficiency); AR (Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency); AR (3-hydroxyisobutryl-CoA hydrolase deficiency); AR (Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency),
HIC1,AD (Lissencephaly 1); AD (Subcortical laminar heterotopia); AD (Miller-Dieker lissencephaly syndrome); AD (Lissencephaly 1); AD (Subcortical laminar heterotopia); AD (Miller-Dieker lissencephaly syndrome),
HID1,AR (Developmental and epileptic encephalopathy 105 with hypopituitarism); AR (Developmental and epileptic encephalopathy 105 with hypopituitarism),
HIF1A,"AR (Erythrocytosis, familial, 2); Hemangioblastoma, cerebellar, somatic; AD (Pheochromocytoma); Renal cell carcinoma, somatic; AD (von Hippel-Lindau syndrome); AD (Erythrocytosis, familial, 4); AD (Atrial septal defect 8); AD (Ventricular septal defect 2); AR (Erythrocytosis, familial, 2); Hemangioblastoma, cerebellar, somatic; AD (Pheochromocytoma); Renal cell carcinoma, somatic; AD (von Hippel-Lindau syndrome); AD (Erythrocytosis, familial, 4); AD (Atrial septal defect 8); AD (Ventricular septal defect 2)",
HIF1AN,"AR (Nephronophthisis 16); AR (Nephronophthisis 2, infantile); AR (Meckel syndrome 7); AR (Nephronophthisis 3); AR (Renal-hepatic-pancreatic dysplasia 1); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2); AR (Erythrocytosis, familial, 2); Hemangioblastoma, cerebellar, somatic; AD (Pheochromocytoma); Renal cell carcinoma, somatic; AD (von Hippel-Lindau syndrome); AR (Nephronophthisis 16); AR (Nephronophthisis 2, infantile); AR (Meckel syndrome 7); AR (Nephronophthisis 3); AR (Renal-hepatic-pancreatic dysplasia 1); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2); AR (Erythrocytosis, familial, 2); Hemangioblastoma, cerebellar, somatic; AD (Pheochromocytoma); Renal cell carcinoma, somatic; AD (von Hippel-Lindau syndrome)",
HIF3A,"AD (Pheochromocytoma/paraganglioma syndrome 7); AD (Erythrocytosis, familial, 4); AD ([Hemoglobin, high altitude adaptation]); AD (Erythrocytosis, familial, 3); AD (Pheochromocytoma/paraganglioma syndrome 7); AD (Erythrocytosis, familial, 4); AD ([Hemoglobin, high altitude adaptation]); AD (Erythrocytosis, familial, 3)",
HIGD1A,"AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease)",
HIKESHI,"AR (Leukodystrophy, hypomyelinating, 13); AR (Leukodystrophy, hypomyelinating, 13)",
HINT1,"AR (Neuromyotonia and axonal neuropathy, autosomal recessive); AR (Neuromyotonia and axonal neuropathy, autosomal recessive)",
HIP1,"AD (?Ocular pterygium-digital keloid dysplasia syndrome); AD (Basal ganglia calcification, idiopathic, 4); AD (Kosaki overgrowth syndrome); AD (Myofibromatosis, infantile, 1); AD (Premature aging syndrome, Penttinen type); AR (?Orofaciodigital syndrome XVIII); AD (Intellectual developmental disorder, autosomal dominant 56); AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic; Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb; AD (?Ocular pterygium-digital keloid dysplasia syndrome); AD (Basal ganglia calcification, idiopathic, 4); AD (Kosaki overgrowth syndrome); AD (Myofibromatosis, infantile, 1); AD (Premature aging syndrome, Penttinen type); AR (?Orofaciodigital syndrome XVIII); AD (Intellectual developmental disorder, autosomal dominant 56); AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic; Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb",
HIPK2,"AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); AD (Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome); AD ({Type 2 diabetes mellitus, susceptibility to}); AR (Pontocerebellar hypoplasia, type 8); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); AD (Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome); AD ({Type 2 diabetes mellitus, susceptibility to}); AR (Pontocerebellar hypoplasia, type 8)",
HIRA,"AR (Multiple mitochondrial dysfunctions syndrome 1); AR (Spastic paraplegia 93, autosomal recessive); AD (Bryant-Li-Bhoj neurodevelopmental syndrome 1); AR (Fanconi anemia, complementation group T); AR (Multiple mitochondrial dysfunctions syndrome 1); AR (Spastic paraplegia 93, autosomal recessive); AD (Bryant-Li-Bhoj neurodevelopmental syndrome 1); AR (Fanconi anemia, complementation group T)",
HIVEP1,"AD (Intellectual developmental disorder, autosomal dominant 43); AD (Intellectual developmental disorder, autosomal dominant 43)",
HIVEP2,"AD (Intellectual developmental disorder, autosomal dominant 43); AD (Corneal dystrophy, Fuchs endothelial, 3); AD (Pitt-Hopkins syndrome); AD (Intellectual developmental disorder, autosomal dominant 43); AD (Corneal dystrophy, Fuchs endothelial, 3); AD (Pitt-Hopkins syndrome)",
HIVEP3,"{Parkinson disease 10}; AD (Intellectual developmental disorder, autosomal dominant 43); {Parkinson disease 10}; AD (Intellectual developmental disorder, autosomal dominant 43)",
HJV,"AR (Hemochromatosis, type 2A); AR (Iron-refractory iron deficiency anemia); AD ({Iron overload, susceptibility to}); AR (Hemochromatosis, type 2B); AR ({HFE hemochromatosis, modifier of}); AD (Brachydactyly, type A2); AD (Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic; AD (?Hyperostosis cranalis interna); AR (Hypermanganesemia with dystonia 2); AR (Hemochromatosis, type 2A); AR (Iron-refractory iron deficiency anemia); AD ({Iron overload, susceptibility to}); AR (Hemochromatosis, type 2B); AR ({HFE hemochromatosis, modifier of}); AD (Brachydactyly, type A2); AD (Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic; AD (?Hyperostosis cranalis interna); AR (Hypermanganesemia with dystonia 2)",
HK1,"AR (Anemia, congenital, nonspherocytic hemolytic, 5, hexokinase deficient); AD (Neurodevelopmental disorder with visual defects and brain anomalies); AR (Neuropathy, hereditary motor and sensory, Russe type); AD (Retinitis pigmentosa 79); AR (Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum); Arteriovenous malformation of the brain, somatic; Bladder cancer, somatic; Breast cancer, somatic; AD (Cardiofaciocutaneous syndrome 2); Gastric cancer, somatic; Leukemia, acute myeloid, somatic; Lung cancer, somatic; AD (Noonan syndrome 3); Oculoectodermal syndrome, somatic; Pancreatic carcinoma, somatic; AD (RAS-associated autoimmune leukoproliferative disorder); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; AR (Anemia, congenital, nonspherocytic hemolytic, 5, hexokinase deficient); AD (Neurodevelopmental disorder with visual defects and brain anomalies); AR (Neuropathy, hereditary motor and sensory, Russe type); AD (Retinitis pigmentosa 79); AR (Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum); Arteriovenous malformation of the brain, somatic; Bladder cancer, somatic; Breast cancer, somatic; AD (Cardiofaciocutaneous syndrome 2); Gastric cancer, somatic; Leukemia, acute myeloid, somatic; Lung cancer, somatic; AD (Noonan syndrome 3); Oculoectodermal syndrome, somatic; Pancreatic carcinoma, somatic; AD (RAS-associated autoimmune leukoproliferative disorder); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic",
HK2,"AD (Atrial fibrillation, familial, 7); ?Azoospermia, obstructive, with nephrolithiasis; AD (Spondyloepiphyseal dysplasia, Nishimura type); AR (Spinocerebellar ataxia, autosomal recessive 28); AR (?Orofaciodigital syndrome II); AD ({Amyotrophic lateral sclerosis, susceptibility to, 24}); AR (Short-rib thoracic dysplasia 6 with or without polydactyly); AD (Atrial fibrillation, familial, 7); ?Azoospermia, obstructive, with nephrolithiasis; AD (Spondyloepiphyseal dysplasia, Nishimura type); AR (Spinocerebellar ataxia, autosomal recessive 28); AR (?Orofaciodigital syndrome II); AD ({Amyotrophic lateral sclerosis, susceptibility to, 24}); AR (Short-rib thoracic dysplasia 6 with or without polydactyly)",
HK3,"AR (Anemia, congenital, nonspherocytic hemolytic, 5, hexokinase deficient); AD (Neurodevelopmental disorder with visual defects and brain anomalies); AR (Neuropathy, hereditary motor and sensory, Russe type); AD (Retinitis pigmentosa 79); {Menopause, natural, age at, QTL4}; AR (Anemia, congenital, nonspherocytic hemolytic, 5, hexokinase deficient); AD (Neurodevelopmental disorder with visual defects and brain anomalies); AR (Neuropathy, hereditary motor and sensory, Russe type); AD (Retinitis pigmentosa 79); {Menopause, natural, age at, QTL4}",
HKDC1,AR (Retinitis pigmentosa 92); AR (Retinitis pigmentosa 92),
HLA-A,"{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; {Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}; {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AD ({Asthma, susceptibility to}); {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; {Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}; {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AD ({Asthma, susceptibility to})",
HLA-B,"{Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}; {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; [Blood group, Rodgers]; AR (C4a deficiency); AR (?Complement factor B deficiency); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 4}); {Macular degeneration, age-related, 14, reduced risk of}; {Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}; {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; [Blood group, Rodgers]; AR (C4a deficiency); AR (?Complement factor B deficiency); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 4}); {Macular degeneration, age-related, 14, reduced risk of}",
HLA-C,"{HIV-1 viremia, susceptibility to}; {Psoriasis susceptibility 1}; AD (Hypotrichosis 2); AR (Peeling skin syndrome 1); {Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}; AD (Preeclampsia/eclampsia 1); {HIV-1 viremia, susceptibility to}; {Psoriasis susceptibility 1}; AD (Hypotrichosis 2); AR (Peeling skin syndrome 1); {Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}; AD (Preeclampsia/eclampsia 1)",
HLA-DPA1,"{Beryllium disease, chronic, susceptibility to}; AD (Deafness, autosomal dominant 13); AR (Deafness, autosomal recessive 53); AR (Fibrochondrogenesis 2); AD (Otospondylomegaepiphyseal dysplasia, autosomal dominant); AR (Otospondylomegaepiphyseal dysplasia, autosomal recessive); {Beryllium disease, chronic, susceptibility to}; AD (Deafness, autosomal dominant 13); AR (Deafness, autosomal recessive 53); AR (Fibrochondrogenesis 2); AD (Otospondylomegaepiphyseal dysplasia, autosomal dominant); AR (Otospondylomegaepiphyseal dysplasia, autosomal recessive)",
HLA-DPB1,"{Beryllium disease, chronic, susceptibility to}; {Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}; Granulomatosis with polyangiitis; AR ({Graves disease, susceptibility to, 1}); {Beryllium disease, chronic, susceptibility to}; {Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}; Granulomatosis with polyangiitis; AR ({Graves disease, susceptibility to, 1})",
HLA-DQA1,"AR ({Celiac disease, susceptibility to}); AR ({Celiac disease, susceptibility to}); AD ({Creutzfeldt-Jakob disease, variant, resistance to}); {Multiple sclerosis, susceptibility to, 1}; {?Membranous nephropathy, susceptibility to}; {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AR ({Vitiligo-associated multiple autoimmune disease susceptibility 6}); AD (Intellectual developmental disorder, autosomal dominant 21); AR ({Celiac disease, susceptibility to}); AR ({Celiac disease, susceptibility to}); AD ({Creutzfeldt-Jakob disease, variant, resistance to}); {Multiple sclerosis, susceptibility to, 1}; {?Membranous nephropathy, susceptibility to}; {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AR ({Vitiligo-associated multiple autoimmune disease susceptibility 6}); AD (Intellectual developmental disorder, autosomal dominant 21)",
HLA-DQB1,"AR ({Celiac disease, susceptibility to}); AD ({Creutzfeldt-Jakob disease, variant, resistance to}); {Multiple sclerosis, susceptibility to, 1}; {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AD (Biliary cirrhosis, primary, 1); {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; {Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}; AR ({Celiac disease, susceptibility to}); AD ({Creutzfeldt-Jakob disease, variant, resistance to}); {Multiple sclerosis, susceptibility to, 1}; {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AD (Biliary cirrhosis, primary, 1); {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; {Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}",
HLA-DRA,"AR (MHC class II deficiency 2); AR (MHC class II deficiency 4); AR (?MHC class II deficiency 5); AR (MHC class II deficiency 3); {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AR (MHC class II deficiency 2); AR (MHC class II deficiency 4); AR (?MHC class II deficiency 5); AR (MHC class II deficiency 3); {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1})",
HLA-DRB1,"{Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AR ({Celiac disease, susceptibility to}); AD ({Creutzfeldt-Jakob disease, variant, resistance to}); {Multiple sclerosis, susceptibility to, 1}; {?Allergy and asthma susceptibility}; {Microvascular complications of diabetes 6}; {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AR ({Celiac disease, susceptibility to}); AD ({Creutzfeldt-Jakob disease, variant, resistance to}); {Multiple sclerosis, susceptibility to, 1}; {?Allergy and asthma susceptibility}; {Microvascular complications of diabetes 6}",
HLA-DRB5,AD ({Inflammatory bowel disease 3}); AD ({Inflammatory bowel disease 3}),
HLA-E,"{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; {HIV-1 viremia, susceptibility to}; {Psoriasis susceptibility 1}; AD (Cortical dysplasia, complex, with other brain malformations 6); AD (Symmetric circumferential skin creases, congenital, 1); {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; {HIV-1 viremia, susceptibility to}; {Psoriasis susceptibility 1}; AD (Cortical dysplasia, complex, with other brain malformations 6); AD (Symmetric circumferential skin creases, congenital, 1)",
HLA-F,"AD ({Asthma, susceptibility to}); AD (?Narcolepsy 7); {Nasopharyngeal carcinoma, susceptibility to, 2}; AR (Hemochromatosis, type 1); AD ({Asthma, susceptibility to}); AD (?Narcolepsy 7); {Nasopharyngeal carcinoma, susceptibility to, 2}; AR (Hemochromatosis, type 1)",
HLA-G,"AD ({Asthma, susceptibility to}); {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; AD (Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome); AD ({Asthma, susceptibility to}); {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; AD (Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome)",
HLCS,AR (Holocarboxylase synthetase deficiency); AR (Holocarboxylase synthetase deficiency),
HLF,"AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); ?Rolandic epilepsy, impaired intellectual development, and speech dyspraxia; AR (Oocyte/zygote/embryo maturation arrest 15); {T-cell acute lymphoblastic leukemia}; AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); ?Rolandic epilepsy, impaired intellectual development, and speech dyspraxia; AR (Oocyte/zygote/embryo maturation arrest 15); {T-cell acute lymphoblastic leukemia}",
HLTF,"AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38)",
HLX,"AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); Diaphragmatic hernia 1; Chromosome 1q41-q42 deletion syndrome; AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); Diaphragmatic hernia 1; Chromosome 1q41-q42 deletion syndrome",
HM13,Renal cell carcinoma; Renal cell carcinoma,
HMBS,"AR (Encephalopathy, porphyria-related); AR (Leukoencephalopathy, porphyria-related); AD (Porphyria, acute intermittent); AD (Porphyria, acute intermittent, nonerythroid variant); AD (Intellectual developmental disorder with impaired language and dysmorphic facies); AR (Encephalopathy, porphyria-related); AR (Leukoencephalopathy, porphyria-related); AD (Porphyria, acute intermittent); AD (Porphyria, acute intermittent, nonerythroid variant); AD (Intellectual developmental disorder with impaired language and dysmorphic facies)",
HMCN1,"AD ({Macular degeneration, age-related, 1}); AD (Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses); AD ({Macular degeneration, age-related, 1}); AD (Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses)",
HMCN2,"AD (Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses); AD ({Macular degeneration, age-related, 1}); AD (Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses); AD ({Macular degeneration, age-related, 1})",
HMG20B,"AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features)",
HMGA1,"AD ({Type 2 diabetes mellitus, susceptibility to}); Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); AD (Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline); AD (Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder); {Stature QTL 19}; AD ({Type 2 diabetes mellitus, susceptibility to}); Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); AD (Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline); AD (Neurodevelopmental disorder with language impairment, autism, and attention deficit-hyperactivity disorder); {Stature QTL 19}",
HMGA2,AD (Silver-Russell syndrome 5); {Stature QTL 9}; AD (Silver-Russell syndrome 5); {Stature QTL 9},
HMGB1,"AR (Dystonia 33); AD (Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome); ?Microphthalmia, syndromic 13; AD ({Melanoma, cutaneous malignant, 1}); AD ({Migraine with or without aura, susceptibility to, 1}); AR (Dystonia 33); AD (Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome); ?Microphthalmia, syndromic 13; AD ({Melanoma, cutaneous malignant, 1}); AD ({Migraine with or without aura, susceptibility to, 1})",
HMGB2,"?Microphthalmia, syndromic 13; AD (Leukemia, acute myeloid); AD (Platelet disorder, familial, with associated myeloid malignancy); AD (Facioscapulohumeral muscular dystrophy 1); Colorectal cancer, somatic; AD (Menke-Hennekam syndrome 2); AD (Rubinstein-Taybi syndrome 2); ?Microphthalmia, syndromic 13; AD (Leukemia, acute myeloid); AD (Platelet disorder, familial, with associated myeloid malignancy); AD (Facioscapulohumeral muscular dystrophy 1); Colorectal cancer, somatic; AD (Menke-Hennekam syndrome 2); AD (Rubinstein-Taybi syndrome 2)",
HMGB3,"?Microphthalmia, syndromic 13; ?Microphthalmia, syndromic 13",
HMGCL,AR (HMG-CoA lyase deficiency); {Microvascular complications of diabetes 6}; AR (HMG-CoA lyase deficiency); {Microvascular complications of diabetes 6},
HMGCR,"[Low density lipoprotein cholesterol level QTL 3]; [Statins, response to]; AR (Muscular dystrophy, limb-girdle, autosomal recessive 28); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AR (Spastic paraplegia 89, autosomal recessive); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); [Low density lipoprotein cholesterol level QTL 3]; [Statins, response to]; AR (Muscular dystrophy, limb-girdle, autosomal recessive 28); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AR (Spastic paraplegia 89, autosomal recessive); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
HMGCS1,"AR (Intellectual developmental disorder with poor growth and with or without seizures or ataxia); AR (HMG-CoA synthase-2 deficiency); [Ezetimibe, nonresponse to]; [Low density lipoprotein cholesterol level QTL 7]; AR (Intellectual developmental disorder with poor growth and with or without seizures or ataxia); AR (HMG-CoA synthase-2 deficiency); [Ezetimibe, nonresponse to]; [Low density lipoprotein cholesterol level QTL 7]",
HMGCS2,AR (HMG-CoA synthase-2 deficiency); AR (HMG-CoA synthase-2 deficiency),
HMGN1,Down syndrome; Down syndrome,
HMGN3,AR (Glycine encephalopathy with normal serum glycine); AR (Glycine encephalopathy with normal serum glycine),
HMMR,"AD ({Breast cancer, susceptibility to}); AR (?Braddock-Carey syndrome 2); AD ({Breast cancer, susceptibility to}); AR (?Braddock-Carey syndrome 2)",
HMOX1,"{Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; Pulmonary disease, chronic obstructive, severe early-onset; {Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; Pulmonary disease, chronic obstructive, severe early-onset",
HMOX2,"{Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AD (Menke-Hennekam syndrome 1); AD (Rubinstein-Taybi syndrome 1); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); {Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AD (Menke-Hennekam syndrome 1); AD (Rubinstein-Taybi syndrome 1); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
HMX1,AR (Oculoauricular syndrome); AR (Oculoauricular syndrome),
HMX2,AD (Chromosome 10q26 deletion syndrome); [Respiratory rhythmicity in sleep]; AD (Chromosome 10q26 deletion syndrome); [Respiratory rhythmicity in sleep],
HMX3,AD (Chromosome 10q26 deletion syndrome); AD (Chromosome 10q26 deletion syndrome),
HNF1A,"AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I); {Renal cell carcinoma}; AD (Renal cysts and diabetes syndrome); AD (Type 2 diabetes mellitus); AD (Congenital disorder of glycosylation, type IIw); AR (Glycogen storage disease Ib); AR (Glycogen storage disease Ic); AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II); AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I); {Renal cell carcinoma}; AD (Renal cysts and diabetes syndrome); AD (Type 2 diabetes mellitus); AD (Congenital disorder of glycosylation, type IIw); AR (Glycogen storage disease Ib); AR (Glycogen storage disease Ic); AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II)",
HNF1B,"{Renal cell carcinoma}; AD (Renal cysts and diabetes syndrome); AD (Type 2 diabetes mellitus); {Prostate cancer, hereditary, 11}; AR (Hyperphenylalaninemia, BH4-deficient, D); AD (Chromosome 17q12 deletion syndrome); {Renal cell carcinoma}; AD (Renal cysts and diabetes syndrome); AD (Type 2 diabetes mellitus); {Prostate cancer, hereditary, 11}; AR (Hyperphenylalaninemia, BH4-deficient, D); AD (Chromosome 17q12 deletion syndrome)",
HNF4A,"AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I); AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II); AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I); AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II)",
HNF4G,"AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I); AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I)",
HNMT,"AD ({Asthma, susceptibility to}); AR (Intellectual developmental disorder, autosomal recessive 51); AD ({Asthma, susceptibility to}); AR (Intellectual developmental disorder, autosomal recessive 51)",
HNRNPA1,"AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); [Low density lipoprotein cholesterol level QTL 3]; [Statins, response to]; AR (Muscular dystrophy, limb-girdle, autosomal recessive 28); AR ({Spinal muscular atrophy, type III, modifier of}); Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia; AD (Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); [Low density lipoprotein cholesterol level QTL 3]; [Statins, response to]; AR (Muscular dystrophy, limb-girdle, autosomal recessive 28); AR ({Spinal muscular atrophy, type III, modifier of}); Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia; AD (Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities)",
HNRNPA2B1,"AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20)",
HNRNPA3,"AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia; AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia",
HNRNPAB,"AR (Elliptocytosis-1); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); {Prostate cancer, hereditary, 15}; AR (Elliptocytosis-1); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); {Prostate cancer, hereditary, 15}",
HNRNPC,"AD (Intellectual developmental disorder, autosomal dominant 74); Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect; AR (?Visceral neuropathy, familial, 2, autosomal recessive); Adenocarcinoma of lung, somatic; Gastric cancer, somatic; Glioblastoma, somatic; Ovarian cancer, somatic; AD (Intellectual developmental disorder, autosomal dominant 74); Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect; AR (?Visceral neuropathy, familial, 2, autosomal recessive); Adenocarcinoma of lung, somatic; Gastric cancer, somatic; Glioblastoma, somatic; Ovarian cancer, somatic",
HNRNPD,"{Celiac disease, susceptibility to, 8}; AD (Muscular dystrophy, limb-girdle, autosomal dominant 3); {Celiac disease, susceptibility to, 8}; AD (Muscular dystrophy, limb-girdle, autosomal dominant 3)",
HNRNPDL,"AD (Muscular dystrophy, limb-girdle, autosomal dominant 3); AD (Muscular dystrophy, limb-girdle, autosomal dominant 3)",
HNRNPF,"AD (Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects); Intellectual developmental disorder, X-linked syndromic, Bain type; AD (Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects); Intellectual developmental disorder, X-linked syndromic, Bain type",
HNRNPH1,"AD (Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects); Intellectual developmental disorder, X-linked syndromic, Bain type; AD (Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects); Intellectual developmental disorder, X-linked syndromic, Bain type",
HNRNPH2,"Intellectual developmental disorder, X-linked syndromic, Bain type; AD (Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects); Intellectual developmental disorder, X-linked syndromic, Bain type; AD (Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects)",
HNRNPK,"AD (Au-Kline syndrome); AR (Immunodeficiency 105, severe combined); {Autism, susceptibility to, 19}; AD (Au-Kline syndrome); AR (Immunodeficiency 105, severe combined); {Autism, susceptibility to, 19}",
HNRNPL,"AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AR (Immunodeficiency 105, severe combined); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); AD ({Epilepsy, idiopathic generalized, susceptibility to, 12}); AD (Dystonia 9); AR (GLUT1 deficiency syndrome 1, infantile onset, severe); AD (GLUT1 deficiency syndrome 2, childhood onset); AD (Stomatin-deficient cryohydrocytosis with neurologic defects); {Microvascular complications of diabetes 1}; AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AR (Immunodeficiency 105, severe combined); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); AD ({Epilepsy, idiopathic generalized, susceptibility to, 12}); AD (Dystonia 9); AR (GLUT1 deficiency syndrome 1, infantile onset, severe); AD (GLUT1 deficiency syndrome 2, childhood onset); AD (Stomatin-deficient cryohydrocytosis with neurologic defects); {Microvascular complications of diabetes 1}",
HNRNPLL,"AR (Immunodeficiency 105, severe combined); AR (Immunodeficiency 105, severe combined)",
HNRNPR,"AD (Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities); AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); AD (Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities); AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4)",
HNRNPU,"AD (Developmental and epileptic encephalopathy 54); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia; AD (Developmental and epileptic encephalopathy 54); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia",
HNRNPUL1,"AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
HOGA1,"AR (Hyperoxaluria, primary, type III); AR (Hyperoxaluria, primary, type III)",
HOMER1,"AD (?Deafness, autosomal dominant 68); Intellectual developmental disorder, X-linked 104; AD (?Deafness, autosomal dominant 68); Intellectual developmental disorder, X-linked 104",
HOMER2,"AD (?Deafness, autosomal dominant 68); AD (Chromosome 15q25 deletion syndrome); AD (?Deafness, autosomal dominant 68); AD (Chromosome 15q25 deletion syndrome)",
HOMER3,"AD (?Deafness, autosomal dominant 68); AD ({Amyotrophic lateral sclerosis, susceptibility to, 13}); AD ({Parkinson disease, late-onset, susceptibility to}); AD (Spinocerebellar ataxia 2); AD (?Deafness, autosomal dominant 68); AD ({Amyotrophic lateral sclerosis, susceptibility to, 13}); AD ({Parkinson disease, late-onset, susceptibility to}); AD (Spinocerebellar ataxia 2)",
HOOK1,"AR (Ceroid lipofuscinosis, neuronal, 3); AR (Spastic paraplegia 50, autosomal recessive); AR (Ceroid lipofuscinosis, neuronal, 3); AR (Spastic paraplegia 50, autosomal recessive)",
HOOK2,"AR (Spastic paraplegia 50, autosomal recessive); AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AR (Intellectual developmental disorder, autosomal recessive 56); AR (Spastic paraplegia 50, autosomal recessive); AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AR (Intellectual developmental disorder, autosomal recessive 56)",
HOOK3,"AR (Spastic paraplegia 50, autosomal recessive); AD (Charcot-Marie-Tooth disease, axonal, type 2O); AD (Cortical dysplasia, complex, with other brain malformations 13); AD (Spinal muscular atrophy, lower extremity-predominant 1, AD); AR ({Amyotrophic lateral sclerosis, susceptibility to}); AD (Neuronopathy, distal hereditary motor, autosomal dominant 14); AD (Perry syndrome); AR (Spastic paraplegia 50, autosomal recessive); AD (Charcot-Marie-Tooth disease, axonal, type 2O); AD (Cortical dysplasia, complex, with other brain malformations 13); AD (Spinal muscular atrophy, lower extremity-predominant 1, AD); AR ({Amyotrophic lateral sclerosis, susceptibility to}); AD (Neuronopathy, distal hereditary motor, autosomal dominant 14); AD (Perry syndrome)",
HORMAD2,AR (Mosaic variegated aneuploidy syndrome 3); AR (Oocyte/zygote/embryo maturation arrest 9); AR (Mosaic variegated aneuploidy syndrome 3); AR (Oocyte/zygote/embryo maturation arrest 9),
HOXA1,"AR (Athabaskan brainstem dysgenesis syndrome); AR (Bosley-Salih-Alorainy syndrome); AD (Duane retraction syndrome 1); AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1); AR (Cone-rod dystrophy 19); AR (Athabaskan brainstem dysgenesis syndrome); AR (Bosley-Salih-Alorainy syndrome); AD (Duane retraction syndrome 1); AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1); AR (Cone-rod dystrophy 19)",
HOXA10,AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); Schizencephaly; AD (Wiedemann-Steiner syndrome); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); Schizencephaly; AD (Wiedemann-Steiner syndrome),
HOXA11,"AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD ({Pelvic organ prolapse, susceptibility to, 1}); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD ({Pelvic organ prolapse, susceptibility to, 1})",
HOXA13,"AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Greig cephalopolysyndactyly syndrome); AD (Pallister-Hall syndrome); AD (Polydactyly, postaxial, types A1 and B); AD (Polydactyly, preaxial, type IV); AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Greig cephalopolysyndactyly syndrome); AD (Pallister-Hall syndrome); AD (Polydactyly, postaxial, types A1 and B); AD (Polydactyly, preaxial, type IV)",
HOXA2,"AR (?Microtia, hearing impairment, and cleft palate (AR)); AR (Microtia with or without hearing impairment (AD)); AD (Glass syndrome); {Prostate cancer, hereditary, 15}; AD (Hypogonadotropic hypogonadism 6 with or without anosmia); AR (?Microtia, hearing impairment, and cleft palate (AR)); AR (Microtia with or without hearing impairment (AD)); AD (Glass syndrome); {Prostate cancer, hereditary, 15}; AD (Hypogonadotropic hypogonadism 6 with or without anosmia)",
HOXA4,AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AR (?Mirror movements 3); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AR (?Mirror movements 3),
HOXA5,"AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Craniosynostosis 1); AD (Robinow-Sorauf syndrome); AD (Saethre-Chotzen syndrome with or without eyelid anomalies); AD (Sweeney-Cox syndrome); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Vesicoureteral reflux 3); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Craniosynostosis 1); AD (Robinow-Sorauf syndrome); AD (Saethre-Chotzen syndrome with or without eyelid anomalies); AD (Sweeney-Cox syndrome); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Vesicoureteral reflux 3)",
HOXA6,AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1),
HOXA7,AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Wiedemann-Steiner syndrome); AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Wiedemann-Steiner syndrome); AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome),
HOXA9,"{Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); AR (?Mirror movements 3); Adrenal adenoma, somatic; Angiofibroma, somatic; Carcinoid tumor of lung; Lipoma, somatic; AD (Multiple endocrine neoplasia 1); Parathyroid adenoma, somatic; {Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); AR (?Mirror movements 3); Adrenal adenoma, somatic; Angiofibroma, somatic; Carcinoid tumor of lung; Lipoma, somatic; AD (Multiple endocrine neoplasia 1); Parathyroid adenoma, somatic",
HOXB1,"AR (Facial paresis, hereditary congenital, 3); AR (Athabaskan brainstem dysgenesis syndrome); AR (Bosley-Salih-Alorainy syndrome); AD (?Moebius syndrome); AD (?Deafness, autosomal dominant 89); AD (Facial paresis, hereditary congenital, 1); AR (Facial paresis, hereditary congenital, 3); AR (Athabaskan brainstem dysgenesis syndrome); AR (Bosley-Salih-Alorainy syndrome); AD (?Moebius syndrome); AD (?Deafness, autosomal dominant 89); AD (Facial paresis, hereditary congenital, 1)",
HOXB13,"{Prostate cancer, hereditary, 9}; AR (Mitchell-Riley syndrome); AR (Otofacial neurodevelopmental syndrome); {Prostate cancer, hereditary, 9}; AR (Mitchell-Riley syndrome); AR (Otofacial neurodevelopmental syndrome)",
HOXB2,"AR (?Microtia, hearing impairment, and cleft palate (AR)); AR (Microtia with or without hearing impairment (AD)); AD (Amyotrophic lateral sclerosis 19); AR (?Microtia, hearing impairment, and cleft palate (AR)); AR (Microtia with or without hearing impairment (AD)); AD (Amyotrophic lateral sclerosis 19)",
HOXB4,"Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
HOXB6,"{Myocardial infarction, susceptibility to}; AD (Bleeding disorder, platelet-type, 24, autosomal dominant); AR (Glanzmann thrombasthenia 2); Purpura, posttransfusion; Thrombocytopenia, neonatal alloimmune; AD (Bleeding disorder, platelet-type, 16, autosomal dominant); AR (Glanzmann thrombasthenia 1); Thrombocytopenia, neonatal alloimmune, BAK antigen related; AR (Intellectual developmental disorder, autosomal recessive 35); {Myocardial infarction, susceptibility to}; AD (Bleeding disorder, platelet-type, 24, autosomal dominant); AR (Glanzmann thrombasthenia 2); Purpura, posttransfusion; Thrombocytopenia, neonatal alloimmune; AD (Bleeding disorder, platelet-type, 16, autosomal dominant); AR (Glanzmann thrombasthenia 1); Thrombocytopenia, neonatal alloimmune, BAK antigen related; AR (Intellectual developmental disorder, autosomal recessive 35)",
HOXB7,"{Leukemia, chronic lymphocytic, susceptibility to, 3}; AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); {Leukemia, chronic lymphocytic, susceptibility to, 3}; AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay)",
HOXB8,AD (Weiss-Kruszka syndrome); AD (Weiss-Kruszka syndrome),
HOXB9,"[Blood group, Sid system]; Sd(a) polyagglutination syndrome; AD (Meier-Gorlin syndrome 6); {Prostate cancer, hereditary, 9}; AD (Luo-Schoch-Yamamoto syndrome); [Blood group, Sid system]; Sd(a) polyagglutination syndrome; AD (Meier-Gorlin syndrome 6); {Prostate cancer, hereditary, 9}; AD (Luo-Schoch-Yamamoto syndrome)",
HOXC10,"AD (Arboleda-Tham syndrome); AD (Holt-Oram syndrome); AR (Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome); AD (Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension); AD (Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly); AD (Arboleda-Tham syndrome); AD (Holt-Oram syndrome); AR (Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome); AD (Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension); AD (Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly)",
HOXC11,"AD (Arboleda-Tham syndrome); AD (Holt-Oram syndrome); AR (Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome); AD (Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension); AD (Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly); AD (Arboleda-Tham syndrome); AD (Holt-Oram syndrome); AR (Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome); AD (Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension); AD (Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly)",
HOXC13,"AR (Ectodermal dysplasia 9, hair/nail type); AR (Ectodermal dysplasia 9, hair/nail type)",
HOXC8,"AR (Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type); AD ({Kaposi sarcoma, susceptibility to}); AD (Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies); AR (Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type); AD ({Kaposi sarcoma, susceptibility to}); AD (Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies)",
HOXD1,AR (Athabaskan brainstem dysgenesis syndrome); AR (Bosley-Salih-Alorainy syndrome); AR (Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum); AR (Athabaskan brainstem dysgenesis syndrome); AR (Bosley-Salih-Alorainy syndrome); AR (Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum),
HOXD10,"AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1)",
HOXD11,"?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Mesomelic dysplasia, Kantaputra type); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); Leukemia, acute promyelocytic, PL2F/RARA type; ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital); AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 1); AD (Mesomelic dysplasia, Kantaputra type); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); Leukemia, acute promyelocytic, PL2F/RARA type",
HOXD12,"?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Mesomelic dysplasia, Kantaputra type); AR (?Tibial hemimelia); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Mesomelic dysplasia, Kantaputra type); AR (?Tibial hemimelia); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital)",
HOXD13,"?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome); AD (Robinow syndrome, autosomal dominant 1); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome); AD (Robinow syndrome, autosomal dominant 1)",
HOXD3,"?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Bleeding disorder, platelet-type, 16, autosomal dominant); AR (Glanzmann thrombasthenia 1); Thrombocytopenia, neonatal alloimmune, BAK antigen related; AD (Chromosome 2q31.1 duplication syndrome); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Bleeding disorder, platelet-type, 16, autosomal dominant); AR (Glanzmann thrombasthenia 1); Thrombocytopenia, neonatal alloimmune, BAK antigen related; AD (Chromosome 2q31.1 duplication syndrome); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital)",
HOXD9,"AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); Split-hand/foot malformation 5; AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Charcot-Marie-Tooth disease, foot deformity of); AD (Vertical talus, congenital); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); Split-hand/foot malformation 5",
HP,[Anhaptoglobinemia]; [Hypohaptoglobinemia]; Pallister-Killian syndrome; [Anhaptoglobinemia]; [Hypohaptoglobinemia]; Pallister-Killian syndrome,
HP1BP3,AR (Brittle cornea syndrome 2); AR (Brittle cornea syndrome 2),
HPCA,"AR (Dystonia 2, torsion, autosomal recessive); AR (Dystonia 2, torsion, autosomal recessive)",
HPD,"AD (Hawkinsinuria); AR (Tyrosinemia, type III); AR (Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities); AR (Spastic paraplegia 83, autosomal recessive); AR (Bone marrow failure syndrome 3); AR (Hyperphenylalaninemia, mild, non-BH4-deficient); AD (Hawkinsinuria); AR (Tyrosinemia, type III); AR (Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities); AR (Spastic paraplegia 83, autosomal recessive); AR (Bone marrow failure syndrome 3); AR (Hyperphenylalaninemia, mild, non-BH4-deficient)",
HPDL,"AR (Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities); AR (Spastic paraplegia 83, autosomal recessive); AR (Developmental and epileptic encephalopathy 89); AR (Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities); AR (Spastic paraplegia 83, autosomal recessive); AR (Developmental and epileptic encephalopathy 89)",
HPGD,"AR (?Digital clubbing, isolated congenital); AR (Cranioosteoarthropathy); AR (Hypertrophic osteoarthropathy, primary, autosomal recessive 1); AD (Hypertrophic osteoarthropathy, primary, autosomal dominant); AR (PHOAR2-enteropathy syndrome); AR (?Digital clubbing, isolated congenital); AR (Cranioosteoarthropathy); AR (Hypertrophic osteoarthropathy, primary, autosomal recessive 1); AD (Hypertrophic osteoarthropathy, primary, autosomal dominant); AR (PHOAR2-enteropathy syndrome)",
HPGDS,"{Asthma, susceptibility to, 1}; AR (Huppke-Brendel syndrome); AD (Spastic paraplegia 42, autosomal dominant); {Asthma, susceptibility to, 1}; AR (Huppke-Brendel syndrome); AD (Spastic paraplegia 42, autosomal dominant)",
HPN,AR (Hyperprolactinemia); AD (Multiple fibroadenomas of the breast); AR (Neurodevelopmental disorder with spasticity and poor growth); AR (Hyperprolactinemia); AD (Multiple fibroadenomas of the breast); AR (Neurodevelopmental disorder with spasticity and poor growth),
HPR,"[Anhaptoglobinemia]; [Hypohaptoglobinemia]; AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to}); AD (Cortical dysplasia, complex, with other brain malformations 3); [Anhaptoglobinemia]; [Hypohaptoglobinemia]; AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to}); AD (Cortical dysplasia, complex, with other brain malformations 3)",
HPRT1,"Hyperuricemia, HRPT-related; Lesch-Nyhan syndrome; Arts syndrome; Charcot-Marie-Tooth disease, X-linked recessive, 5; Deafness, X-linked 1; Gout, PRPS-related; Phosphoribosylpyrophosphate synthetase superactivity; AR (Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature); Dent disease 2; Lowe syndrome; Hyperuricemia, HRPT-related; Lesch-Nyhan syndrome; Arts syndrome; Charcot-Marie-Tooth disease, X-linked recessive, 5; Deafness, X-linked 1; Gout, PRPS-related; Phosphoribosylpyrophosphate synthetase superactivity; AR (Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature); Dent disease 2; Lowe syndrome",
HPS1,"AR (Hermansky-Pudlak syndrome 1); AR (Hermansky-Pudlak syndrome 4); {Asthma-related traits, susceptibility to, 7}; AD ({Schizophrenia, susceptibility to}); AR (Hermansky-Pudlak syndrome 2); AR (Hermansky-Pudlak syndrome 1); AR (Hermansky-Pudlak syndrome 4); {Asthma-related traits, susceptibility to, 7}; AD ({Schizophrenia, susceptibility to}); AR (Hermansky-Pudlak syndrome 2)",
HPS3,AR (Hermansky-Pudlak syndrome 3); AR (Hermansky-Pudlak syndrome 7); AR (Hermansky-Pudlak syndrome 3); AR (Hermansky-Pudlak syndrome 7),
HPS4,AR (Hermansky-Pudlak syndrome 4); AR (Hermansky-Pudlak syndrome 1); AR (Hermansky-Pudlak syndrome 7); AR (Hermansky-Pudlak syndrome 8); AR (Hermansky-Pudlak syndrome 4); AR (Hermansky-Pudlak syndrome 1); AR (Hermansky-Pudlak syndrome 7); AR (Hermansky-Pudlak syndrome 8),
HPS5,AR (Hermansky-Pudlak syndrome 5); AR (Hermansky-Pudlak syndrome 7); AR (Hermansky-Pudlak syndrome 6); AR (Hermansky-Pudlak syndrome 8); AR (Hermansky-Pudlak syndrome 5); AR (Hermansky-Pudlak syndrome 7); AR (Hermansky-Pudlak syndrome 6); AR (Hermansky-Pudlak syndrome 8),
HPS6,AR (Hermansky-Pudlak syndrome 6); AR (Hermansky-Pudlak syndrome 5); AR (Hermansky-Pudlak syndrome 7); AR (Hermansky-Pudlak syndrome 6); AR (Hermansky-Pudlak syndrome 5); AR (Hermansky-Pudlak syndrome 7),
HPSE,AR (Urofacial syndrome 1); AR (Urofacial syndrome 1),
HPSE2,AR (Urofacial syndrome 1); AR (Urofacial syndrome 1),
HPX,AR (Atransferrinemia); AR (Atransferrinemia),
HR,"AR (Alopecia universalis); AR (Atrichia with papular lesions); AD (Hypotrichosis 4); AD ({Breast cancer, susceptibility to}); {Melanoma, cutaneous malignant, 6}; AD ({Breast cancer, susceptibility to}); AD (Fanconi anemia, complementation group R); AD (Mirror movements 2); AD (Alopecia, androgenetic, 1); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Alopecia universalis); AR (Atrichia with papular lesions); AD (Hypotrichosis 4); AD ({Breast cancer, susceptibility to}); {Melanoma, cutaneous malignant, 6}; AD ({Breast cancer, susceptibility to}); AD (Fanconi anemia, complementation group R); AD (Mirror movements 2); AD (Alopecia, androgenetic, 1); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S)",
HRAS,"Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic; AR (Lipodystrophy, familial partial, type 9); Arteriovenous malformation of the brain, somatic; Bladder cancer, somatic; Breast cancer, somatic; AD (Cardiofaciocutaneous syndrome 2); Gastric cancer, somatic; Leukemia, acute myeloid, somatic; Lung cancer, somatic; AD (Noonan syndrome 3); Oculoectodermal syndrome, somatic; Pancreatic carcinoma, somatic; AD (RAS-associated autoimmune leukoproliferative disorder); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic; Colorectal cancer, somatic; Epidermal nevus, somatic; Melanocytic nevus syndrome, congenital, somatic; Neurocutaneous melanosis, somatic; AD (Noonan syndrome 6); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Thyroid carcinoma, follicular, somatic; AR (Nephrotic syndrome, type 3); Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic; AR (Lipodystrophy, familial partial, type 9); Arteriovenous malformation of the brain, somatic; Bladder cancer, somatic; Breast cancer, somatic; AD (Cardiofaciocutaneous syndrome 2); Gastric cancer, somatic; Leukemia, acute myeloid, somatic; Lung cancer, somatic; AD (Noonan syndrome 3); Oculoectodermal syndrome, somatic; Pancreatic carcinoma, somatic; AD (RAS-associated autoimmune leukoproliferative disorder); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic; Colorectal cancer, somatic; Epidermal nevus, somatic; Melanocytic nevus syndrome, congenital, somatic; Neurocutaneous melanosis, somatic; AD (Noonan syndrome 6); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Thyroid carcinoma, follicular, somatic; AR (Nephrotic syndrome, type 3)",
HRC,"AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1); Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic; AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1); Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic",
HRG,"AD (Thrombophilia 11 due to HRG deficiency); {?Schizophrenia, susceptibility to}; AR (?Alopecia-intellectual disability syndrome 1); AR ([High molecular weight kininogen deficiency]); AR ([Kininogen deficiency]); AD (Angioedema, hereditary, 6); AD (Angioedema, hereditary, 3); AR (Factor XII deficiency); AD (Thrombophilia 11 due to HRG deficiency); {?Schizophrenia, susceptibility to}; AR (?Alopecia-intellectual disability syndrome 1); AR ([High molecular weight kininogen deficiency]); AR ([Kininogen deficiency]); AD (Angioedema, hereditary, 6); AD (Angioedema, hereditary, 3); AR (Factor XII deficiency)",
HRK,"AR (Microcephaly, short stature, and impaired glucose metabolism 2); AR (Microcephaly, short stature, and impaired glucose metabolism 2)",
HRNR,AR (Peeling skin syndrome 6); AR (Peeling skin syndrome 6),
HROB,"AR (Ovarian dysgenesis 11); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11); AR (Ovarian dysgenesis 11); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11)",
HRURF,AD (Hypotrichosis 4); AR (Alopecia universalis); AR (Atrichia with papular lesions); AD (Hypotrichosis 4); AR (Alopecia universalis); AR (Atrichia with papular lesions),
HS1BP3,"AD (Essential tremor, hereditary, 2); AD (Essential tremor, hereditary, 2)",
HS2ST1,AR (Neurofacioskeletal syndrome with or without renal agenesis); AR (Neurofacioskeletal syndrome with or without renal agenesis),
HS3ST3A1,"Scoliosis, idiopathic 2; Scoliosis, idiopathic 2",
HS3ST3B1,"Scoliosis, idiopathic 2; Scoliosis, idiopathic 2",
HS3ST5,"AD (?Angioedema, hereditary, 8); AD (?Angioedema, hereditary, 8)",
HS3ST6,"AD (?Angioedema, hereditary, 8); AD (?Angioedema, hereditary, 8)",
HS6ST1,"AD ({Hypogonadotropic hypogonadism 15 with or without anosmia}); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Hypogonadotropic hypogonadism 9 with or without anosmia); AD (Hypogonadotropic hypogonadism 20 with or without anosmia); AD (Hypogonadotropic hypogonadism 21 with anosmia); AD ({Hypogonadotropic hypogonadism 15 with or without anosmia}); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Hypogonadotropic hypogonadism 9 with or without anosmia); AD (Hypogonadotropic hypogonadism 20 with or without anosmia); AD (Hypogonadotropic hypogonadism 21 with anosmia)",
HS6ST2,?Paganini-Miozzo syndrome; ?Paganini-Miozzo syndrome,
HSBP1,"AD (Charcot-Marie-Tooth disease, axonal, type 2F); AD (Neuronopathy, distal hereditary motor, autosomal dominant 3); AD (Charcot-Marie-Tooth disease, axonal, type 2F); AD (Neuronopathy, distal hereditary motor, autosomal dominant 3)",
HSCB,"AR (?Anemia, sideroblastic, 5); AR (?Anemia, sideroblastic, 5)",
HSD11B1,AD (Cortisone reductase deficiency 2); AR (Cortisone reductase deficiency 1); AR (Apparent mineralocorticoid excess); AD (Polycystic ovary syndrome 1); AD (Cortisone reductase deficiency 2); AR (Cortisone reductase deficiency 1); AR (Apparent mineralocorticoid excess); AD (Polycystic ovary syndrome 1),
HSD11B2,"AR (Apparent mineralocorticoid excess); AR (?Digital clubbing, isolated congenital); AR (Cranioosteoarthropathy); AR (Hypertrophic osteoarthropathy, primary, autosomal recessive 1); Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete; AD (Glucocorticoid resistance); AD (Cortisone reductase deficiency 2); AR (17-alpha-hydroxylase/17,20-lyase deficiency); AR (17,20-lyase deficiency, isolated); AR (Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency); AR (Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency); AR (Apparent mineralocorticoid excess); AR (?Digital clubbing, isolated congenital); AR (Cranioosteoarthropathy); AR (Hypertrophic osteoarthropathy, primary, autosomal recessive 1); Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete; AD (Glucocorticoid resistance); AD (Cortisone reductase deficiency 2); AR (17-alpha-hydroxylase/17,20-lyase deficiency); AR (17,20-lyase deficiency, isolated); AR (Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency); AR (Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency)",
HSD17B1,"AR (D-bifunctional protein deficiency); AR (Perrault syndrome 1); AR (Pseudohermaphroditism, male, with gynecomastia); AD (?Charcot-Marie-Tooth disease, axonal, type 2V); AR (Mucopolysaccharidosis type IIIB (Sanfilippo B)); AR (D-bifunctional protein deficiency); AR (Perrault syndrome 1); AR (Pseudohermaphroditism, male, with gynecomastia); AD (?Charcot-Marie-Tooth disease, axonal, type 2V); AR (Mucopolysaccharidosis type IIIB (Sanfilippo B))",
HSD17B10,"HSD10 mitochondrial disease; Xp11.22 microduplication syndrome; Intellectual developmental disorder, X-linked syndromic, Turner type; AR (Combined oxidative phosphorylation deficiency 54); AR (Combined oxidative phosphorylation deficiency 30); HSD10 mitochondrial disease; Xp11.22 microduplication syndrome; Intellectual developmental disorder, X-linked syndromic, Turner type; AR (Combined oxidative phosphorylation deficiency 54); AR (Combined oxidative phosphorylation deficiency 30)",
HSD17B11,"AD ({Fatty liver disease, protection from}); AD ({Fatty liver disease, protection from})",
HSD17B13,"AD ({Fatty liver disease, protection from}); AD ({Fatty liver disease, protection from})",
HSD17B2,"AR (D-bifunctional protein deficiency); AR (Perrault syndrome 1); AR (Pseudohermaphroditism, male, with gynecomastia); AR (Apparent mineralocorticoid excess); AR (D-bifunctional protein deficiency); AR (Perrault syndrome 1); AR (Pseudohermaphroditism, male, with gynecomastia); AR (Apparent mineralocorticoid excess)",
HSD17B3,"AR (Pseudohermaphroditism, male, with gynecomastia); AR (Pseudovaginal perineoscrotal hypospadias); AR (D-bifunctional protein deficiency); AR (Perrault syndrome 1); AR (Pseudohermaphroditism, male, with gynecomastia); AR (Pseudovaginal perineoscrotal hypospadias); AR (D-bifunctional protein deficiency); AR (Perrault syndrome 1)",
HSD17B4,"AR (D-bifunctional protein deficiency); AR (Perrault syndrome 1); AR (Pseudohermaphroditism, male, with gynecomastia); AD (?Fanconi renotubular syndrome 3); AD (Mitchell syndrome); AR (Peroxisomal acyl-CoA oxidase deficiency); AR (D-bifunctional protein deficiency); AR (Perrault syndrome 1); AR (Pseudohermaphroditism, male, with gynecomastia); AD (?Fanconi renotubular syndrome 3); AD (Mitchell syndrome); AR (Peroxisomal acyl-CoA oxidase deficiency)",
HSD3B1,"AR (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency); AR (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency)",
HSD3B2,"AR (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency); AR (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency)",
HSD3B7,"AR (Bile acid synthesis defect, congenital, 1); AR (Bile acid synthesis defect, congenital, 1)",
HSF1,"Rhabdomyosarcoma, alveolar; AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; {Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features); Rhabdomyosarcoma, alveolar; AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; {Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features)",
HSF2,"AR (Premature ovarian failure 19); AD (Cataract 5, multiple types); {Rheumatoid arthritis, susceptibility to}; {Diabetes mellitus, insulin-dependent, 5}; AR (Premature ovarian failure 19); AD (Cataract 5, multiple types); {Rheumatoid arthritis, susceptibility to}; {Diabetes mellitus, insulin-dependent, 5}",
HSF2BP,AR (Premature ovarian failure 19); AR (Premature ovarian failure 19),
HSF4,"AD (Cataract 5, multiple types); AD (Cataract 5, multiple types)",
HSP90AA1,"AD ({?Parkinson disease 5, susceptibility to}); AD (Spastic paraplegia 79A, autosomal dominant); AR (Spastic paraplegia 79B, autosomal recessive); AD (Leber congenital amaurosis 11); AD (Retinitis pigmentosa 10); AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3); AD ({?Parkinson disease 5, susceptibility to}); AD (Spastic paraplegia 79A, autosomal dominant); AR (Spastic paraplegia 79B, autosomal recessive); AD (Leber congenital amaurosis 11); AD (Retinitis pigmentosa 10); AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3)",
HSP90AB1,"AD ({Parkinson disease 18}); Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AD ({Parkinson disease 18}); Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome)",
HSP90B1,"AD (Maturity-onset diabetes of the young, type VIII); {Leprosy, protection against}; {Leprosy, susceptibility to, 5}; AR (Intellectual developmental disorder, autosomal recessive 44); AD (Maturity-onset diabetes of the young, type VIII); {Leprosy, protection against}; {Leprosy, susceptibility to, 5}; AR (Intellectual developmental disorder, autosomal recessive 44)",
HSPA1A,"AD (Tubulointerstitial kidney disease, autosomal dominant, 1); AD (Charcot-Marie-Tooth disease, axonal, type 2L); AD (Myopathy, myofibrillar, 13, with rimmed vacuoles); AD (Neuronopathy, distal hereditary motor, autosomal dominant 2); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); AD (Tubulointerstitial kidney disease, autosomal dominant, 1); AD (Charcot-Marie-Tooth disease, axonal, type 2L); AD (Myopathy, myofibrillar, 13, with rimmed vacuoles); AD (Neuronopathy, distal hereditary motor, autosomal dominant 2); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3)",
HSPA1L,"Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AR (Garg-Mishra progeroid syndrome); AR (Parkinson disease 6, early onset); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AR (Garg-Mishra progeroid syndrome); AR (Parkinson disease 6, early onset)",
HSPA2,AR (?Spermatogenic failure 73); AR (?Spermatogenic failure 73),
HSPA5,"AR (Achromatopsia 7); AR (Marinesco-Sjogren syndrome); AD (Polycystic kidney disease 6 with or without polycystic liver disease); AR (Spastic paraplegia 92, autosomal recessive); AR (Achromatopsia 7); AR (Marinesco-Sjogren syndrome); AD (Polycystic kidney disease 6 with or without polycystic liver disease); AR (Spastic paraplegia 92, autosomal recessive)",
HSPA6,"AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3); AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3)",
HSPA8,"AR (Bone marrow failure syndrome 3); AD ({?Parkinson disease 5, susceptibility to}); AD (Spastic paraplegia 79A, autosomal dominant); AR (Spastic paraplegia 79B, autosomal recessive); AR (Immunodeficiency 26, with or without neurologic abnormalities); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AD (Myelokathexis, isolated); AD (WHIM syndrome 1); AR (Bone marrow failure syndrome 3); AD ({?Parkinson disease 5, susceptibility to}); AD (Spastic paraplegia 79A, autosomal dominant); AR (Spastic paraplegia 79B, autosomal recessive); AR (Immunodeficiency 26, with or without neurologic abnormalities); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AD (Myelokathexis, isolated); AD (WHIM syndrome 1)",
HSPA9,"AD (Anemia, sideroblastic, 4); AR (Even-plus syndrome); AR (?Anemia, sideroblastic, 5); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR (?Combined oxidative phosphorylation deficiency 19); AD (Anemia, sideroblastic, 4); AR (Even-plus syndrome); AR (?Anemia, sideroblastic, 5); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR (?Combined oxidative phosphorylation deficiency 19)",
HSPB1,"AD (Charcot-Marie-Tooth disease, axonal, type 2F); AD (Neuronopathy, distal hereditary motor, autosomal dominant 3); AD (Charcot-Marie-Tooth disease, dominant intermediate G); AR (Charcot-Marie-Tooth disease, type 1F); AD (Charcot-Marie-Tooth disease, type 2E); AD (Charcot-Marie-Tooth disease, axonal, type 2L); AD (Myopathy, myofibrillar, 13, with rimmed vacuoles); AD (Neuronopathy, distal hereditary motor, autosomal dominant 2); AD (?Neuronopathy, distal hereditary motor, autosomal dominant 4); AD (Charcot-Marie-Tooth disease, axonal, type 2F); AD (Neuronopathy, distal hereditary motor, autosomal dominant 3); AD (Charcot-Marie-Tooth disease, dominant intermediate G); AR (Charcot-Marie-Tooth disease, type 1F); AD (Charcot-Marie-Tooth disease, type 2E); AD (Charcot-Marie-Tooth disease, axonal, type 2L); AD (Myopathy, myofibrillar, 13, with rimmed vacuoles); AD (Neuronopathy, distal hereditary motor, autosomal dominant 2); AD (?Neuronopathy, distal hereditary motor, autosomal dominant 4)",
HSPB3,"AD (?Neuronopathy, distal hereditary motor, autosomal dominant 4); AD (Neuronopathy, distal hereditary motor, autosomal dominant 1); AD (?Neuronopathy, distal hereditary motor, autosomal dominant 4); AD (Neuronopathy, distal hereditary motor, autosomal dominant 1)",
HSPB6,"AR (?Dystonia 35, childhood-onset); AR (Neurodevelopmental disorder with dystonia and seizures); AR (?Dystonia 35, childhood-onset); AR (Neurodevelopmental disorder with dystonia and seizures)",
HSPB8,"AD (Charcot-Marie-Tooth disease, axonal, type 2L); AD (Myopathy, myofibrillar, 13, with rimmed vacuoles); AD (Neuronopathy, distal hereditary motor, autosomal dominant 2); AD (?Neuronopathy, distal hereditary motor, autosomal dominant 15); AD (Cardiomyopathy, dilated, 1HH); AD (Charcot-Marie-Tooth disease, axonal, type 2JJ); AD (Myopathy, myofibrillar, 6); AD (?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome); AD (Neuronopathy, distal hereditary motor, autosomal dominant 1); AD (Charcot-Marie-Tooth disease, axonal, type 2L); AD (Myopathy, myofibrillar, 13, with rimmed vacuoles); AD (Neuronopathy, distal hereditary motor, autosomal dominant 2); AD (?Neuronopathy, distal hereditary motor, autosomal dominant 15); AD (Cardiomyopathy, dilated, 1HH); AD (Charcot-Marie-Tooth disease, axonal, type 2JJ); AD (Myopathy, myofibrillar, 6); AD (?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome); AD (Neuronopathy, distal hereditary motor, autosomal dominant 1)",
HSPB9,"AD (Charcot-Marie-Tooth disease, axonal, type 2L); AD (Myopathy, myofibrillar, 13, with rimmed vacuoles); AD (Neuronopathy, distal hereditary motor, autosomal dominant 2); AD (Charcot-Marie-Tooth disease, axonal, type 2L); AD (Myopathy, myofibrillar, 13, with rimmed vacuoles); AD (Neuronopathy, distal hereditary motor, autosomal dominant 2)",
HSPBP1,"AD (Spinocerebellar ataxia 48); AR (Spinocerebellar ataxia, autosomal recessive 16); AR (Marinesco-Sjogren syndrome); {Menopause, natural, age at, QTL2}; AD (Spinocerebellar ataxia 48); AR (Spinocerebellar ataxia, autosomal recessive 16); AR (Marinesco-Sjogren syndrome); {Menopause, natural, age at, QTL2}",
HSPD1,"AR (Leukodystrophy, hypomyelinating, 4); AD (Spastic paraplegia 13, autosomal dominant); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR (Acyl-CoA dehydrogenase, medium chain, deficiency of); AR (Maple syrup urine disease, type Ia); AR (Leukodystrophy, hypomyelinating, 4); AD (Spastic paraplegia 13, autosomal dominant); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR (Acyl-CoA dehydrogenase, medium chain, deficiency of); AR (Maple syrup urine disease, type Ia)",
HSPE1,"AR (Leukodystrophy, hypomyelinating, 4); AD (Spastic paraplegia 13, autosomal dominant); AR (Acyl-CoA dehydrogenase, medium chain, deficiency of); AR (Maple syrup urine disease, type Ia); AR (Leukodystrophy, hypomyelinating, 4); AD (Spastic paraplegia 13, autosomal dominant); AR (Acyl-CoA dehydrogenase, medium chain, deficiency of); AR (Maple syrup urine disease, type Ia)",
HSPG2,"AR (Dyssegmental dysplasia, Silverman-Handmaker type); AR (Schwartz-Jampel syndrome, type 1); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9); AR (Dyssegmental dysplasia, Silverman-Handmaker type); AR (Schwartz-Jampel syndrome, type 1); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9)",
HSPH1,"AR (Leukodystrophy, hypomyelinating, 13); AR (Leukodystrophy, hypomyelinating, 13)",
HTR1A,"AD (?Periodic fever, menstrual cycle dependent); Pituitary adenoma 2, GH-secreting; {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; AR (Kaya-Barakat-Masson syndrome); AD (?Periodic fever, menstrual cycle dependent); Pituitary adenoma 2, GH-secreting; {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; AR (Kaya-Barakat-Masson syndrome)",
HTR1B,"AD (Deafness, autosomal dominant 22); AD (Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy); AR (Deafness, autosomal recessive 37); AD (Intellectual developmental disorder, autosomal dominant 26); AD ([Bone mineral density variability 1, high bone mass]); AD (Endosteal hyperostosis); AR (Exudative vitreoretinopathy 4); AD (Osteopetrosis, autosomal dominant 1); AR (Osteoporosis-pseudoglioma syndrome); AD (Polycystic liver disease 4 with or without kidney cysts); AD (Deafness, autosomal dominant 22); AD (Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy); AR (Deafness, autosomal recessive 37); AD (Intellectual developmental disorder, autosomal dominant 26); AD ([Bone mineral density variability 1, high bone mass]); AD (Endosteal hyperostosis); AR (Exudative vitreoretinopathy 4); AD (Osteopetrosis, autosomal dominant 1); AR (Osteoporosis-pseudoglioma syndrome); AD (Polycystic liver disease 4 with or without kidney cysts)",
HTR2A,"{Major depressive disorder, response to citalopram therapy in}; AD ({Obsessive-compulsive disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to}); AD (Gastroesophageal reflux); {Major depressive disorder, response to citalopram therapy in}; AD ({Obsessive-compulsive disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to}); AD (Gastroesophageal reflux)",
HTR2B,"Brunner syndrome; {Major depressive disorder, response to citalopram therapy in}; AD ({Obsessive-compulsive disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to}); Brunner syndrome; {Major depressive disorder, response to citalopram therapy in}; AD ({Obsessive-compulsive disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to})",
HTR2C,"AD (Prader-Willi syndrome); {Major depressive disorder, response to citalopram therapy in}; AD ({Obsessive-compulsive disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to}); AD (Prader-Willi syndrome); {Major depressive disorder, response to citalopram therapy in}; AD ({Obsessive-compulsive disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to})",
HTR4,"AD ({Major affective disorder 1}); AR ({?Obesity, susceptibility to}); AD ({Major affective disorder 1}); AR ({?Obesity, susceptibility to})",
HTR7,Alzheimer disease 6; Alzheimer disease 6,
HTRA1,"{Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2); AR (Emphysema due to AAT deficiency); AR (Emphysema-cirrhosis, due to AAT deficiency); AR (Hemorrhagic diathesis due to antithrombin Pittsburgh); {Macular degeneration, age-related, 8}; AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2); AR (Emphysema due to AAT deficiency); AR (Emphysema-cirrhosis, due to AAT deficiency); AR (Hemorrhagic diathesis due to antithrombin Pittsburgh); {Macular degeneration, age-related, 8}; AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type)",
HTRA2,"{Parkinson disease 13}; AR (3-methylglutaconic aciduria, type VIII); AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AR ({Spinal muscular atrophy, type III, modifier of}); AR (Neutropenia, severe congenital 3, autosomal recessive); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; {Parkinson disease 13}; AR (3-methylglutaconic aciduria, type VIII); AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AR ({Spinal muscular atrophy, type III, modifier of}); AR (Neutropenia, severe congenital 3, autosomal recessive); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
HTRA3,"AD (Vitreoretinopathy, neovascular inflammatory); AD (Vitreoretinopathy, neovascular inflammatory)",
HTT,{Anxiety-related personality traits}; AD ({Obsessive-compulsive disorder}); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome); AR (Insulin-like growth factor I deficiency); AD (Menke-Hennekam syndrome 1); AD (Rubinstein-Taybi syndrome 1); {Anxiety-related personality traits}; AD ({Obsessive-compulsive disorder}); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome); AR (Insulin-like growth factor I deficiency); AD (Menke-Hennekam syndrome 1); AD (Rubinstein-Taybi syndrome 1),
HUS1,"AR (Warsaw breakage syndrome); AD (?Cutaneous telangiectasia and cancer syndrome, familial); AR (Seckel syndrome 1); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; AR (Warsaw breakage syndrome); AD (?Cutaneous telangiectasia and cancer syndrome, familial); AR (Seckel syndrome 1); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic",
HUWE1,"Intellectual developmental disorder, X-linked syndromic, Turner type; Xp11.22 microduplication syndrome; HSD10 mitochondrial disease; AR (Immunodeficiency 46); AD (Rauch-Steindl syndrome); Intellectual developmental disorder, X-linked syndromic, Turner type; Xp11.22 microduplication syndrome; HSD10 mitochondrial disease; AR (Immunodeficiency 46); AD (Rauch-Steindl syndrome)",
HVCN1,"AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib; AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib; AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to})",
HYAL1,AR (Mucopolysaccharidosis type IX); AR (Muggenthaler-Chowdhury-Chioza syndrome); AR (Mucopolysaccharidosis type IX); AR (Muggenthaler-Chowdhury-Chioza syndrome),
HYAL2,AR (Muggenthaler-Chowdhury-Chioza syndrome); AR (Mucopolysaccharidosis type IX); AR (Muggenthaler-Chowdhury-Chioza syndrome); AR (Mucopolysaccharidosis type IX),
HYAL3,AR (Mucopolysaccharidosis type IX); AR (Mucopolysaccharidosis type IX),
HYCC1,"AR (Leukodystrophy, hypomyelinating, 5); AR (Leukodystrophy, hypomyelinating, 5)",
HYCC2,"AR (Gastrointestinal defects and immunodeficiency syndrome 2); AR (Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis); AR (Spastic paraplegia 84, autosomal recessive); AR (Leukodystrophy, hypomyelinating, 5); AR (Gastrointestinal defects and immunodeficiency syndrome 2); AR (Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis); AR (Spastic paraplegia 84, autosomal recessive); AR (Leukodystrophy, hypomyelinating, 5)",
HYDIN,"AR (Ciliary dyskinesia, primary, 5); AR (Retinitis pigmentosa 82 with or without situs inversus); {Autism susceptibility 1}; AD (Chromosome 1q21.1 deletion syndrome); AD (Chromosome 1q21.1 duplication syndrome); AR (Ciliary dyskinesia, primary, 5); AR (Retinitis pigmentosa 82 with or without situs inversus); {Autism susceptibility 1}; AD (Chromosome 1q21.1 deletion syndrome); AD (Chromosome 1q21.1 duplication syndrome)",
HYLS1,AR (Hydrolethalus syndrome); AR (Hydrolethalus syndrome),
HYOU1,AR (?Immunodeficiency 59 and hypoglycemia); AR (Marinesco-Sjogren syndrome); AR (?Immunodeficiency 59 and hypoglycemia); AR (Marinesco-Sjogren syndrome),
IAPP,"AD (ADULT syndrome); AD (Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3); AD (Hay-Wells syndrome); AD (Limb-mammary syndrome); Orofacial cleft 8; AD (Premature ovarian failure 21); AD (Rapp-Hodgkin syndrome); AD (Split-hand/foot malformation 4); AR (Ciliary dyskinesia, primary, 47, and lissencephaly); AR (?Lymphatic malformation 8); AD ({Osteoporosis, postmenopausal, susceptibility}); AD (ADULT syndrome); AD (Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3); AD (Hay-Wells syndrome); AD (Limb-mammary syndrome); Orofacial cleft 8; AD (Premature ovarian failure 21); AD (Rapp-Hodgkin syndrome); AD (Split-hand/foot malformation 4); AR (Ciliary dyskinesia, primary, 47, and lissencephaly); AR (?Lymphatic malformation 8); AD ({Osteoporosis, postmenopausal, susceptibility})",
IARS1,"AR (Growth retardation, impaired intellectual development, hypotonia, and hepatopathy); AR (Growth retardation, impaired intellectual development, hypotonia, and hepatopathy)",
IARS2,"AR (Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia); AR (Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia)",
IBA57,"AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3); AR (Multiple mitochondrial dysfunctions syndrome 4); AR (Multiple mitochondrial dysfunctions syndrome 5); AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3); AR (Multiple mitochondrial dysfunctions syndrome 4); AR (Multiple mitochondrial dysfunctions syndrome 5)",
IBSP,"AR (Hypophosphatemic rickets, AR); AD (Deafness, autosomal dominant 39, with dentinogenesis); AD (Dentin dysplasia, type II); AD (Dentinogenesis imperfecta, Shields type II); AD (Dentinogenesis imperfecta, Shields type III); AD (Glass syndrome); AD (Parietal foramina 3); AR (Hypophosphatemic rickets, AR); AD (Deafness, autosomal dominant 39, with dentinogenesis); AD (Dentin dysplasia, type II); AD (Dentinogenesis imperfecta, Shields type II); AD (Dentinogenesis imperfecta, Shields type III); AD (Glass syndrome); AD (Parietal foramina 3)",
ICAM1,"{Malaria, cerebral, susceptibility to}; AD (Candidiasis, familial, 3); AR ({Graves disease, susceptibility to, 1}); AR (Leukocyte adhesion deficiency, type III); {Malaria, cerebral, susceptibility to}; AD (Candidiasis, familial, 3); AR ({Graves disease, susceptibility to, 1}); AR (Leukocyte adhesion deficiency, type III)",
ICAM2,"AR (Leukocyte adhesion deficiency); AD (46XY sex reversal 9); Diaphragmatic hernia 3; AD (Tetralogy of Fallot); [Blood group, Landsteiner-Wiener]; AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AR (Thrombocytopenia 3); AR (Immunodeficiency 129); AR (Leukocyte adhesion deficiency); AD (46XY sex reversal 9); Diaphragmatic hernia 3; AD (Tetralogy of Fallot); [Blood group, Landsteiner-Wiener]; AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AR (Thrombocytopenia 3); AR (Immunodeficiency 129)",
ICAM3,"{Dengue fever, protection against}; {HIV type 1, susceptibility to}; {Mycobacterium tuberculosis, susceptibility to}; AR (Leukocyte adhesion deficiency); {Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}; AR (Immunodeficiency 129); [Blood group, Landsteiner-Wiener]; {Dengue fever, protection against}; {HIV type 1, susceptibility to}; {Mycobacterium tuberculosis, susceptibility to}; AR (Leukocyte adhesion deficiency); {Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}; AR (Immunodeficiency 129); [Blood group, Landsteiner-Wiener]",
ICAM4,"[Blood group, Landsteiner-Wiener]; [Blood group, RH system]; {Hemolytic disease of fetus and newborn, RH-induced}; AR (Anemia, hemolytic, Rh-null, regulator type); AD (Overhydrated hereditary stomatocytosis); [Blood group, Landsteiner-Wiener]; [Blood group, RH system]; {Hemolytic disease of fetus and newborn, RH-induced}; AR (Anemia, hemolytic, Rh-null, regulator type); AD (Overhydrated hereditary stomatocytosis)",
ICAM5,"AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease)",
ICMT,"AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2); AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2)",
ICOS,"AR (Immunodeficiency, common variable, 1); AR (?Immunodeficiency 119); AR (?Immune dysregulation and systemic hyperinflammation syndrome); AR (?Immunodeficiency 123 with HPV-related verrucosis); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (Immunodeficiency, common variable, 1); AR (?Immunodeficiency 119); AR (?Immune dysregulation and systemic hyperinflammation syndrome); AR (?Immunodeficiency 123 with HPV-related verrucosis); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}",
ICOSLG,"AR (?Immunodeficiency 119); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity); AR ({Diabetes mellitus, insulin-dependent-1}); {Myocardial infarction, susceptibility to}; AR (Immunodeficiency, common variable, 1); AR (?Immunodeficiency 119); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity); AR ({Diabetes mellitus, insulin-dependent-1}); {Myocardial infarction, susceptibility to}; AR (Immunodeficiency, common variable, 1)",
ID1,"AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic; Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); AD (Myelokathexis, isolated); AD (WHIM syndrome 1); AR (?Oculomotor-abducens synkinesis); AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic; Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); AD (Myelokathexis, isolated); AD (WHIM syndrome 1); AR (?Oculomotor-abducens synkinesis)",
ID2,"AD (Intellectual developmental disorder, autosomal dominant 7); AD (Erythrocytosis, familial, 4); AD (Abdominal obesity-metabolic syndrome 3); AD (Polycystic kidney disease 2); AD (Polycystic kidney disease 1); AD (Atrial septal defect 7, with or without AV conduction defects); Conotruncal heart malformations, variable; AD (Hypoplastic left heart syndrome 2); AD (Hypothyroidism, congenital nongoitrous, 5); AD (Tetralogy of Fallot); AD (Ventricular septal defect 3); AD (Holt-Oram syndrome); AD (Intellectual developmental disorder, autosomal dominant 7); AD (Erythrocytosis, familial, 4); AD (Abdominal obesity-metabolic syndrome 3); AD (Polycystic kidney disease 2); AD (Polycystic kidney disease 1); AD (Atrial septal defect 7, with or without AV conduction defects); Conotruncal heart malformations, variable; AD (Hypoplastic left heart syndrome 2); AD (Hypothyroidism, congenital nongoitrous, 5); AD (Tetralogy of Fallot); AD (Ventricular septal defect 3); AD (Holt-Oram syndrome)",
ID3,"AR (?Nystagmus 8, congenital, autosomal recessive); AR (Neurooculorenal syndrome); AD (Pituitary hormone deficiency, combined or isolated, 8); AD (Intellectual developmental disorder, autosomal dominant 22); AR (?Nystagmus 8, congenital, autosomal recessive); AR (Neurooculorenal syndrome); AD (Pituitary hormone deficiency, combined or isolated, 8); AD (Intellectual developmental disorder, autosomal dominant 22)",
ID4,"AR (?Nystagmus 8, congenital, autosomal recessive); AR (Neurooculorenal syndrome); AD (Pituitary hormone deficiency, combined or isolated, 8); AR (?Nystagmus 8, congenital, autosomal recessive); AR (Neurooculorenal syndrome); AD (Pituitary hormone deficiency, combined or isolated, 8)",
IDE,"Alzheimer disease 6; AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); AR (Acromesomelic dysplasia 3); AD (Brachydactyly, type A1, D); AD (Brachydactyly, type A2); AD ([Dystransthyretinemic hyperthyroxinemia]); AD (Amyloidosis, hereditary, transthyretin-related); AD (Carpal tunnel syndrome, familial); AR (Nephrotic syndrome, type 15); Alzheimer disease 6; AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); AR (Acromesomelic dysplasia 3); AD (Brachydactyly, type A1, D); AD (Brachydactyly, type A2); AD ([Dystransthyretinemic hyperthyroxinemia]); AD (Amyloidosis, hereditary, transthyretin-related); AD (Carpal tunnel syndrome, familial); AR (Nephrotic syndrome, type 15)",
IDH1,"{Glioma, susceptibility to, somatic}; D-2-hydroxyglutaric aciduria 2; {Glioma, susceptibility to, somatic}; D-2-hydroxyglutaric aciduria 2",
IDH2,"D-2-hydroxyglutaric aciduria 2; {Glioma, susceptibility to, somatic}; D-2-hydroxyglutaric aciduria 2; {Glioma, susceptibility to, somatic}",
IDH3A,AR (Retinitis pigmentosa 90); AR (Retinitis pigmentosa 46); D-2-hydroxyglutaric aciduria 2; AR (Retinitis pigmentosa 90); AR (Retinitis pigmentosa 46); D-2-hydroxyglutaric aciduria 2,
IDH3B,AR (Retinitis pigmentosa 46); AR (Retinitis pigmentosa 46),
IDH3G,"Retinitis pigmentosa 99; Congenital disorder of glycosylation, type Iy; AR (Retinitis pigmentosa 90); AR (Retinitis pigmentosa 46); ?FG syndrome 2; Cardiac valvular dysplasia, X-linked; Congenital short bowel syndrome; Frontometaphyseal dysplasia 1; Heterotopia, periventricular, 1; Intestinal pseudoobstruction, neuronal; Melnick-Needles syndrome; Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Terminal osseous dysplasia; Retinitis pigmentosa 99; Congenital disorder of glycosylation, type Iy; AR (Retinitis pigmentosa 90); AR (Retinitis pigmentosa 46); ?FG syndrome 2; Cardiac valvular dysplasia, X-linked; Congenital short bowel syndrome; Frontometaphyseal dysplasia 1; Heterotopia, periventricular, 1; Intestinal pseudoobstruction, neuronal; Melnick-Needles syndrome; Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Terminal osseous dysplasia",
IDO1,AR ([?Hypertryptophanemia]); AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3); AR ([?Hypertryptophanemia]); AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3),
IDO2,AR ([?Hypertryptophanemia]); AR ([?Hypertryptophanemia]),
IDS,"Mucopolysaccharidosis II; Myopathy, centronuclear, X-linked; AR (Mucopolysaccharidosis Ih); AR (Mucopolysaccharidosis Ih/s); AR (Mucopolysaccharidosis Is); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); Chromosome Xq27.3-q28 duplication syndrome; Polydactyly, postaxial, type A4; Mucopolysaccharidosis II; Myopathy, centronuclear, X-linked; AR (Mucopolysaccharidosis Ih); AR (Mucopolysaccharidosis Ih/s); AR (Mucopolysaccharidosis Is); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); Chromosome Xq27.3-q28 duplication syndrome; Polydactyly, postaxial, type A4",
IDUA,"AR (Mucopolysaccharidosis Ih); AR (Mucopolysaccharidosis Ih/s); AR (Mucopolysaccharidosis Is); AD (Night blindness, congenital stationary, autosomal dominant 2); AR (Retinitis pigmentosa-40); AR (Mucopolysaccharidosis Ih); AR (Mucopolysaccharidosis Ih/s); AR (Mucopolysaccharidosis Is); AD (Night blindness, congenital stationary, autosomal dominant 2); AR (Retinitis pigmentosa-40)",
IER3IP1,"AR (Microcephaly, epilepsy, and diabetes syndrome); AR (Microcephaly, epilepsy, and diabetes syndrome)",
IER5,"Leukemia, T-cell acute lymphocytic, somatic; Leukemia, T-cell acute lymphocytic, somatic",
IFI16,"AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); AD ({Kaposi sarcoma, susceptibility to}); AD (Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); AD ({Kaposi sarcoma, susceptibility to}); AD (Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies)",
IFI27,AD (?Otosclerosis 12); AD ({Rhabdoid tumor predisposition syndrome 2}); AD (Coffin-Siris syndrome 4); AD (?Otosclerosis 12); AD ({Rhabdoid tumor predisposition syndrome 2}); AD (Coffin-Siris syndrome 4),
IFI44,"AD ({Systemic lupus erythematosus, susceptibility to}); AR (Aicardi-Goutieres syndrome 1, dominant and recessive); AD (Chilblain lupus); AD (Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations); AD ({Systemic lupus erythematosus, susceptibility to}); AR (Aicardi-Goutieres syndrome 1, dominant and recessive); AD (Chilblain lupus); AD (Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations)",
IFI44L,"AR ({Hemolytic uremic syndrome, atypical, susceptibility to, 2}); AR ({Hemolytic uremic syndrome, atypical, susceptibility to, 2})",
IFIH1,"AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1); {Diabetes mellitus, insulin-dependent, 19}; AR (Immunoglobulin A deficiency); AR ({Graves disease, susceptibility to, 1}); AD (Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant); AD (Neuropathy, hereditary sensory, type IE); AR (Aicardi-Goutieres syndrome 6); AD (Dyschromatosis symmetrica hereditaria); AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1); {Diabetes mellitus, insulin-dependent, 19}; AR (Immunoglobulin A deficiency); AR ({Graves disease, susceptibility to, 1}); AD (Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant); AD (Neuropathy, hereditary sensory, type IE); AR (Aicardi-Goutieres syndrome 6); AD (Dyschromatosis symmetrica hereditaria)",
IFIT1,"AD ({Systemic lupus erythematosus, susceptibility to}); AR (Aicardi-Goutieres syndrome 1, dominant and recessive); AD (Chilblain lupus); AD (Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations); AD ({Systemic lupus erythematosus, susceptibility to}); AR (Aicardi-Goutieres syndrome 1, dominant and recessive); AD (Chilblain lupus); AD (Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations)",
IFIT2,"AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2)",
IFIT3,"AR (Immunodeficiency 65, susceptibility to viral infections); AR (Immunodeficiency 65, susceptibility to viral infections)",
IFITM1,"{Influenza, severe, susceptibility to}; AD (Osteogenesis imperfecta, type V); AD (?Otosclerosis 12); AD ({Rhabdoid tumor predisposition syndrome 2}); AD (Coffin-Siris syndrome 4); AR (Immunodeficiency, common variable, 3); AR (?Immunodeficiency, common variable, 7); {Systemic lupus erythematosus, susceptibility to, 9}; AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1); AD (Coffin-Siris syndrome 6); {Influenza, severe, susceptibility to}; AD (Osteogenesis imperfecta, type V); AD (?Otosclerosis 12); AD ({Rhabdoid tumor predisposition syndrome 2}); AD (Coffin-Siris syndrome 4); AR (Immunodeficiency, common variable, 3); AR (?Immunodeficiency, common variable, 7); {Systemic lupus erythematosus, susceptibility to, 9}; AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1); AD (Coffin-Siris syndrome 6)",
IFITM2,"{Influenza, severe, susceptibility to}; AD (Osteogenesis imperfecta, type V); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1); {Influenza, severe, susceptibility to}; AD (Osteogenesis imperfecta, type V); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1)",
IFITM3,"{Influenza, severe, susceptibility to}; AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1); AD (Osteogenesis imperfecta, type V); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; {Influenza, severe, susceptibility to}; AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1); AD (Osteogenesis imperfecta, type V); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
IFITM5,"AD (Osteogenesis imperfecta, type V); {Influenza, severe, susceptibility to}; AD (Osteogenesis imperfecta, type V); {Influenza, severe, susceptibility to}",
IFNA1,"Interferon, alpha, deficiency; AR (Immunodeficiency 44); AR (Pseudo-TORCH syndrome 3); AR (Autoinflammatory-pancytopenia syndrome); Gastric cancer, somatic; AR (Immunodeficiency 117, mycobacteriosis, autosomal recessive); Nonsmall cell lung cancer, somatic; AR (Immunodeficiency 35); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); Interferon, alpha, deficiency; AR (Immunodeficiency 44); AR (Pseudo-TORCH syndrome 3); AR (Autoinflammatory-pancytopenia syndrome); Gastric cancer, somatic; AR (Immunodeficiency 117, mycobacteriosis, autosomal recessive); Nonsmall cell lung cancer, somatic; AR (Immunodeficiency 35); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45)",
IFNA2,"AR (Immunodeficiency 106, susceptibility to viral infections); {Hepatitis C virus infection, response to therapy of}; AR (Immunodeficiency 106, susceptibility to viral infections); {Hepatitis C virus infection, response to therapy of}",
IFNA21,"{Coronary heart disease, susceptibility to, 8}; {Coronary heart disease, susceptibility to, 8}",
IFNA4,AR (Bone marrow failure syndrome 4); AR (Bone marrow failure syndrome 4),
IFNAR1,"AR (Immunodeficiency 106, susceptibility to viral infections); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); AR (Immunodeficiency 35); AR (Immunodeficiency 28, mycobacteriosis); AD (Immunodeficiency 77); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR (Immunodeficiency 106, susceptibility to viral infections); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); AR (Immunodeficiency 35); AR (Immunodeficiency 28, mycobacteriosis); AD (Immunodeficiency 77); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive)",
IFNAR2,"{Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); AD (Immunodeficiency 77); AR (Immunodeficiency 106, susceptibility to viral infections); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR (Immunodeficiency 44); AR (Pseudo-TORCH syndrome 3); AR (Pseudo-TORCH syndrome 2); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); AD (Immunodeficiency 77); AR (Immunodeficiency 106, susceptibility to viral infections); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR (Immunodeficiency 44); AR (Pseudo-TORCH syndrome 3); AR (Pseudo-TORCH syndrome 2)",
IFNB1,"AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1); AD (STING-associated vasculopathy, infantile-onset); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); Interferon, alpha, deficiency; AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1); AD (STING-associated vasculopathy, infantile-onset); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); Interferon, alpha, deficiency",
IFNG,"AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; AD (?Chilblain lupus 2); AR (Aicardi-Goutieres syndrome 5); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); {H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AD (Autoinflammatory syndrome, familial, with or without immunodeficiency); AR (Immunodeficiency 28, mycobacteriosis); AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; AD (?Chilblain lupus 2); AR (Aicardi-Goutieres syndrome 5); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); {H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AD (Autoinflammatory syndrome, familial, with or without immunodeficiency); AR (Immunodeficiency 28, mycobacteriosis)",
IFNGR1,"{H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD); {Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}; AR (Immunodeficiency 28, mycobacteriosis); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); {H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD); {Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}; AR (Immunodeficiency 28, mycobacteriosis); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant)",
IFNGR2,"AR (Immunodeficiency 28, mycobacteriosis); AR (Immunodeficiency 106, susceptibility to viral infections); {H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Immunodeficiency 30); AR (Immunodeficiency 28, mycobacteriosis); AR (Immunodeficiency 106, susceptibility to viral infections); {H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Immunodeficiency 30)",
IFNK,AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1),
IFNL1,"{HIV1 infection, resistance to}; AR ({Immunodeficiency 83, susceptibility to viral infections}); {Hepatitis C virus infection, response to therapy of}; AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}); {HIV1 infection, resistance to}; AR ({Immunodeficiency 83, susceptibility to viral infections}); {Hepatitis C virus infection, response to therapy of}; AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6})",
IFNL3,"{Hepatitis C virus infection, response to therapy of}; AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}); {Hepatitis C virus infection, response to therapy of}; AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6})",
IFNLR1,"{Hepatitis C virus infection, response to therapy of}; {Hepatitis C virus infection, response to therapy of}",
IFNW1,"{Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45)",
IFRD1,"AD (Spinocerebellar ataxia 18); ?Intellectual developmental disorder, X-linked 113; AD (Spinocerebellar ataxia 18); ?Intellectual developmental disorder, X-linked 113",
IFT122,"AR (Cranioectodermal dysplasia 1); AR (?Cranioectodermal dysplasia 3); AR (?Retinitis pigmentosa 81); AR (Short-rib thoracic dysplasia 18 with polydactyly); AR (Ciliary dyskinesia, primary, 54); AR (Spermatogenic failure 98); AR (Short-rib thoracic dysplasia 3 with or without polydactyly); AR (Cranioectodermal dysplasia 2); AR (Short-rib thoracic dysplasia 7 with or without polydactyly); AR (Cranioectodermal dysplasia 1); AR (?Cranioectodermal dysplasia 3); AR (?Retinitis pigmentosa 81); AR (Short-rib thoracic dysplasia 18 with polydactyly); AR (Ciliary dyskinesia, primary, 54); AR (Spermatogenic failure 98); AR (Short-rib thoracic dysplasia 3 with or without polydactyly); AR (Cranioectodermal dysplasia 2); AR (Short-rib thoracic dysplasia 7 with or without polydactyly)",
IFT140,"AD ({Polycystic kidney disease 9, susceptibility to}); AR (Cranioectodermal dysplasia 5); AR (Retinitis pigmentosa 80); AR (Short-rib thoracic dysplasia 9 with or without polydactyly); AD (?Mitral valve prolapse 3); AR (Spermatogenic failure 47); AR (Short-rib thoracic dysplasia 1 with or without polydactyly); AD ({Polycystic kidney disease 9, susceptibility to}); AR (Cranioectodermal dysplasia 5); AR (Retinitis pigmentosa 80); AR (Short-rib thoracic dysplasia 9 with or without polydactyly); AD (?Mitral valve prolapse 3); AR (Spermatogenic failure 47); AR (Short-rib thoracic dysplasia 1 with or without polydactyly)",
IFT172,AR (Bardet-Biedl syndrome 20); AR (Retinitis pigmentosa 71); AR (Short-rib thoracic dysplasia 10 with or without polydactyly); AR (Short-rib thoracic dysplasia 1 with or without polydactyly); AR (Short-rib thoracic dysplasia 3 with or without polydactyly); AR (Bardet-Biedl syndrome 20); AR (Retinitis pigmentosa 71); AR (Short-rib thoracic dysplasia 10 with or without polydactyly); AR (Short-rib thoracic dysplasia 1 with or without polydactyly); AR (Short-rib thoracic dysplasia 3 with or without polydactyly),
IFT20,"AR (Spermatogenic failure 43); AR (Nephronophthisis 18); AR (Ciliary dyskinesia, primary, 54); AR (Spermatogenic failure 98); AD (Polycystic kidney disease 2); AD (Polycystic kidney disease 1); AR (Achondrogenesis, type IA); AR (Odontochondrodysplasia 1); AR (Spermatogenic failure 43); AR (Nephronophthisis 18); AR (Ciliary dyskinesia, primary, 54); AR (Spermatogenic failure 98); AD (Polycystic kidney disease 2); AD (Polycystic kidney disease 1); AR (Achondrogenesis, type IA); AR (Odontochondrodysplasia 1)",
IFT22,"AR ({Bardet-Biedl syndrome 1, modifier of}); AR (Bardet-Biedl syndrome 3); AR (Retinitis pigmentosa 55); AR ({Bardet-Biedl syndrome 1, modifier of}); AR (Bardet-Biedl syndrome 3); AR (Retinitis pigmentosa 55)",
IFT25,AR (Bardet-Biedl syndrome 19); AR (Short-rib thoracic dysplasia 19 with or without polydactyly); AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58); AR (Bardet-Biedl syndrome 19); AR (Short-rib thoracic dysplasia 19 with or without polydactyly); AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58),
IFT27,AR (Bardet-Biedl syndrome 19); AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58); AR (Short-rib thoracic dysplasia 19 with or without polydactyly); AR (Bardet-Biedl syndrome 19); AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58); AR (Short-rib thoracic dysplasia 19 with or without polydactyly),
IFT43,AR (?Cranioectodermal dysplasia 3); AR (?Retinitis pigmentosa 81); AR (Short-rib thoracic dysplasia 18 with polydactyly); AR (Cranioectodermal dysplasia 2); AR (Short-rib thoracic dysplasia 7 with or without polydactyly); AR (Cranioectodermal dysplasia 1); AR (Short-rib thoracic dysplasia 1 with or without polydactyly); AR (?Cranioectodermal dysplasia 3); AR (?Retinitis pigmentosa 81); AR (Short-rib thoracic dysplasia 18 with polydactyly); AR (Cranioectodermal dysplasia 2); AR (Short-rib thoracic dysplasia 7 with or without polydactyly); AR (Cranioectodermal dysplasia 1); AR (Short-rib thoracic dysplasia 1 with or without polydactyly),
IFT46,"AR (Ciliary dyskinesia, primary, 52); AR (Short-rib thoracic dysplasia 16 with or without polydactyly); AR (Joubert syndrome 36); AR (Ciliary dyskinesia, primary, 52); AR (Short-rib thoracic dysplasia 16 with or without polydactyly); AR (Joubert syndrome 36)",
IFT52,"AR (Short-rib thoracic dysplasia 16 with or without polydactyly); AR (Spermatogenic failure 76); AR (Ciliary dyskinesia, primary, 54); AR (Spermatogenic failure 98); AR (Short-rib thoracic dysplasia 1 with or without polydactyly); AR (Short-rib thoracic dysplasia 16 with or without polydactyly); AR (Spermatogenic failure 76); AR (Ciliary dyskinesia, primary, 54); AR (Spermatogenic failure 98); AR (Short-rib thoracic dysplasia 1 with or without polydactyly)",
IFT56,"AR (Biliary, renal, neurologic, and skeletal syndrome); AR (Biliary, renal, neurologic, and skeletal syndrome)",
IFT57,AR (?Orofaciodigital syndrome XVIII); AR (Short-rib thoracic dysplasia 16 with or without polydactyly); AR (Short-rib thoracic dysplasia 3 with or without polydactyly); AR (Short-rib thoracic dysplasia 15 with polydactyly); AR (?Orofaciodigital syndrome XVIII); AR (Short-rib thoracic dysplasia 16 with or without polydactyly); AR (Short-rib thoracic dysplasia 3 with or without polydactyly); AR (Short-rib thoracic dysplasia 15 with polydactyly),
IFT74,AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58); AR (Short-rib thoracic dysplasia 19 with or without polydactyly); AR (Bardet-Biedl syndrome 19); AR (Morbid obesity and spermatogenic failure); AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58); AR (Short-rib thoracic dysplasia 19 with or without polydactyly); AR (Bardet-Biedl syndrome 19); AR (Morbid obesity and spermatogenic failure),
IFT80,AR (Short-rib thoracic dysplasia 2 with or without polydactyly); AR (Short-rib thoracic dysplasia 1 with or without polydactyly); AR (Cranioectodermal dysplasia 1); AR (Short-rib thoracic dysplasia 2 with or without polydactyly); AR (Short-rib thoracic dysplasia 1 with or without polydactyly); AR (Cranioectodermal dysplasia 1),
IFT81,AR (Short-rib thoracic dysplasia 19 with or without polydactyly); AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58); AR (Bardet-Biedl syndrome 19); AR (Morbid obesity and spermatogenic failure); Myeloproliferative disorder; AR (Short-rib thoracic dysplasia 19 with or without polydactyly); AR (Bardet-Biedl syndrome 22); AR (Joubert syndrome 40); AR (Spermatogenic failure 58); AR (Bardet-Biedl syndrome 19); AR (Morbid obesity and spermatogenic failure); Myeloproliferative disorder,
IFT88,AR (Short-rib thoracic dysplasia 15 with polydactyly); AR (?Cranioectodermal dysplasia 3); AR (?Retinitis pigmentosa 81); AR (Short-rib thoracic dysplasia 18 with polydactyly); AR (Short-rib thoracic dysplasia 16 with or without polydactyly); AR (Orofaciodigital syndrome XIV); AD (?Mitral valve prolapse 3); AR (Spermatogenic failure 47); AR (Nephronophthisis 12); AR (Short-rib thoracic dysplasia 4 with or without polydactyly); AR (Short-rib thoracic dysplasia 15 with polydactyly); AR (?Cranioectodermal dysplasia 3); AR (?Retinitis pigmentosa 81); AR (Short-rib thoracic dysplasia 18 with polydactyly); AR (Short-rib thoracic dysplasia 16 with or without polydactyly); AR (Orofaciodigital syndrome XIV); AD (?Mitral valve prolapse 3); AR (Spermatogenic failure 47); AR (Nephronophthisis 12); AR (Short-rib thoracic dysplasia 4 with or without polydactyly),
IGBP1,"?Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia; Opitz GBBB syndrome; AD (Houge-Janssens syndrome 3); ?Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia; Opitz GBBB syndrome; AD (Houge-Janssens syndrome 3)",
IGF1,"AR (Insulin-like growth factor I deficiency); AR (Insulin-like growth factor I, resistance to); AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); AR ({Hypercholesterolemia, familial, modifier of}); AD (Growth hormone insensitivity, partial); AD (Increased responsiveness to growth hormone); AR (Laron dwarfism); AR (Insulin-like growth factor I deficiency); AR (Insulin-like growth factor I, resistance to); AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); AR ({Hypercholesterolemia, familial, modifier of}); AD (Growth hormone insensitivity, partial); AD (Increased responsiveness to growth hormone); AR (Laron dwarfism)",
IGF1R,"AR (Insulin-like growth factor I, resistance to); Chromosome 15q26-qter deletion syndrome; AR (Insulin-like growth factor I deficiency); AD ({Neuroblastoma, susceptibility to, 1}); AD (Charcot-Marie-Tooth disease, type 2A1); AD (Silver-Russell syndrome 3); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Insulin-like growth factor I, resistance to); Chromosome 15q26-qter deletion syndrome; AR (Insulin-like growth factor I deficiency); AD ({Neuroblastoma, susceptibility to, 1}); AD (Charcot-Marie-Tooth disease, type 2A1); AD (Silver-Russell syndrome 3); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S)",
IGF2,"AD (Silver-Russell syndrome 3); AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Beckwith-Wiedemann syndrome); AD (Silver-Russell syndrome 1); AD (Wilms tumor 2); AD (Silver-Russell syndrome 3); AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Beckwith-Wiedemann syndrome); AD (Silver-Russell syndrome 1); AD (Wilms tumor 2)",
IGF2BP1,"Burkitt lymphoma, somatic; AR (Myopathy with lactic acidosis, hereditary); AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); Burkitt lymphoma, somatic; AR (Myopathy with lactic acidosis, hereditary); AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to})",
IGF2BP2,"AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5)",
IGF2BP3,"AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to})",
IGF2R,"Hepatocellular carcinoma, somatic; AD (Silver-Russell syndrome 3); Colorectal cancer, hereditary nonpolyposis, type 6; Esophageal cancer, somatic; AD (Loeys-Dietz syndrome 2); AD (Beckwith-Wiedemann syndrome); AD (Silver-Russell syndrome 1); AD (Wilms tumor 2); AR (Insulin-like growth factor I, resistance to); Hepatocellular carcinoma, somatic; AD (Silver-Russell syndrome 3); Colorectal cancer, hereditary nonpolyposis, type 6; Esophageal cancer, somatic; AD (Loeys-Dietz syndrome 2); AD (Beckwith-Wiedemann syndrome); AD (Silver-Russell syndrome 1); AD (Wilms tumor 2); AR (Insulin-like growth factor I, resistance to)",
IGFALS,"AR (Acid-labile subunit, deficiency of); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); Malignant fibrous histiocytoma; AR (Acid-labile subunit, deficiency of); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); Malignant fibrous histiocytoma",
IGFBP1,"AD (Silver-Russell syndrome 2); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AR (Growth hormone deficiency, isolated, type IV); AD (Silver-Russell syndrome 2); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AR (Growth hormone deficiency, isolated, type IV)",
IGFBP2,"AR (Growth hormone deficiency, isolated, type IV); AR (Retinitis pigmentosa 38); AR (Acid-labile subunit, deficiency of); AR (Growth hormone deficiency, isolated, type IV); AR (Retinitis pigmentosa 38); AR (Acid-labile subunit, deficiency of)",
IGFBP3,"AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); AR (Insulin-like growth factor I deficiency); AR (Acid-labile subunit, deficiency of); AR (Atransferrinemia); AR (Short stature, Dauber-Argente type); AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); AR (Insulin-like growth factor I deficiency); AR (Acid-labile subunit, deficiency of); AR (Atransferrinemia); AR (Short stature, Dauber-Argente type)",
IGFBP4,"AR (Acid-labile subunit, deficiency of); {Stature QTL 1}; AR (Acid-labile subunit, deficiency of); {Stature QTL 1}",
IGFBP5,"AR (Short stature, Dauber-Argente type); Branchiootorenal syndrome 2; AR (Short stature, Dauber-Argente type); Branchiootorenal syndrome 2",
IGFBP6,"AR (Acid-labile subunit, deficiency of); AR (Acid-labile subunit, deficiency of)",
IGFBP7,"AR (Retinal arterial macroaneurysm with supravalvular pulmonic stenosis); AD (?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type); AR (Kyphomelic dysplasia); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2); AD ({Hyperemesis gravidarum, susceptibility to}); AR (Retinal arterial macroaneurysm with supravalvular pulmonic stenosis); AD (?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type); AR (Kyphomelic dysplasia); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2); AD ({Hyperemesis gravidarum, susceptibility to})",
IGH,"AR (Immunodeficiency with hyper-IgM, type 2); AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); {Leukemia, acute lymphoblastic, susceptibility to, 3}; AR (Immunodeficiency with hyper-IgM, type 2); AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); {Leukemia, acute lymphoblastic, susceptibility to, 3}",
IGHMBP2,"AR (Charcot-Marie-Tooth disease, axonal, type 2S); AR (Neuronopathy, distal hereditary motor, autosomal recessive 1); AR (Neuronopathy, distal hereditary motor, autosomal recessive 3); AD (Amyotrophic lateral sclerosis 4, juvenile); AR (Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2); AR (Charcot-Marie-Tooth disease, axonal, type 2S); AR (Neuronopathy, distal hereditary motor, autosomal recessive 1); AR (Neuronopathy, distal hereditary motor, autosomal recessive 3); AD (Amyotrophic lateral sclerosis 4, juvenile); AR (Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2)",
IGK,"AR (Kappa light chain deficiency); AD (Gabriele-de Vries syndrome); AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); AR (Agammaglobulinemia 1); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity; AR (Combined cellular and humoral immune defects with granulomas); AR (Omenn syndrome); AR (Severe combined immunodeficiency, B cell-negative); AR (Kappa light chain deficiency); AD (Gabriele-de Vries syndrome); AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); AR (Agammaglobulinemia 1); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity; AR (Combined cellular and humoral immune defects with granulomas); AR (Omenn syndrome); AR (Severe combined immunodeficiency, B cell-negative)",
IGL,"[Gamma-glutamyltransferase, familial high serum]; AR (Agammaglobulinemia 1); AR (Kappa light chain deficiency); AD (Myopathy, sarcoplasmic body); AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related); AR (Short stature, microcephaly, and endocrine dysfunction); {Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); [Gamma-glutamyltransferase, familial high serum]; AR (Agammaglobulinemia 1); AR (Kappa light chain deficiency); AD (Myopathy, sarcoplasmic body); AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related); AR (Short stature, microcephaly, and endocrine dysfunction); {Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to})",
IGLL1,"AR (Agammaglobulinemia 2); Agammaglobulinemia, X-linked 1; Isolated growth hormone deficiency, type III, with agammaglobulinemia; AR (Argininosuccinic aciduria); AR (Agammaglobulinemia 2); Agammaglobulinemia, X-linked 1; Isolated growth hormone deficiency, type III, with agammaglobulinemia; AR (Argininosuccinic aciduria)",
IGSF1,"Hypothyroidism, central, and testicular enlargement; Bazex-Dupre-Christol syndrome; Hypothyroidism, central, and testicular enlargement; Bazex-Dupre-Christol syndrome",
IGSF10,AD (Nizon-Isidor syndrome); AD (Nizon-Isidor syndrome),
IGSF3,AR (?Lacrimal duct defect); AR (?Lacrimal duct defect),
IHH,"AR (Acrocapitofemoral dysplasia); AD (Brachydactyly, type A1); AR (Immunodeficiency 124, severe combined); AR (Microphthalmia/coloboma 13); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Craniosynostosis, Philadelphia type, with syndactyly); AD (Syndactyly, type 1); AR (Holoprosencephaly 10); AD (Cleidocranial dysplasia); AD (Cleidocranial dysplasia, forme fruste, dental anomalies only); AD (Cleidocranial dysplasia, forme fruste, with brachydactyly); AD (Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly); AR (Acrocapitofemoral dysplasia); AD (Brachydactyly, type A1); AR (Immunodeficiency 124, severe combined); AR (Microphthalmia/coloboma 13); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Craniosynostosis, Philadelphia type, with syndactyly); AD (Syndactyly, type 1); AR (Holoprosencephaly 10); AD (Cleidocranial dysplasia); AD (Cleidocranial dysplasia, forme fruste, dental anomalies only); AD (Cleidocranial dysplasia, forme fruste, with brachydactyly); AD (Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly)",
IHO1,AR (Oocyte/zygote/embryo maturation arrest 10); AR (Oocyte/zygote/embryo maturation arrest 10),
IK,"AR (Usher syndrome, type IK); AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AR (Congenital disorder of glycosylation, type Ik); AR (Jervell and Lange-Nielsen syndrome 2); AD (Long QT syndrome 5); AD (?Long QT syndrome 11); AR (Usher syndrome, type IK); AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AR (Congenital disorder of glycosylation, type Ik); AR (Jervell and Lange-Nielsen syndrome 2); AD (Long QT syndrome 5); AD (?Long QT syndrome 11)",
IKBKB,"AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); AR (Intellectual developmental disorder, autosomal recessive 13); AD (Immunodeficiency, common variable, 12); AD (B-cell expansion with NFKB and T-cell anergy); AR (Immunodeficiency 11A); AD (Immunodeficiency 11B with atopic dermatitis); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}); AR (Autoinflammation with arthritis and vasculitis); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 4); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AD (Cardiospondylocarpofacial syndrome); AD (Frontometaphyseal dysplasia 2); AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); AR (Intellectual developmental disorder, autosomal recessive 13); AD (Immunodeficiency, common variable, 12); AD (B-cell expansion with NFKB and T-cell anergy); AR (Immunodeficiency 11A); AD (Immunodeficiency 11B with atopic dermatitis); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}); AR (Autoinflammation with arthritis and vasculitis); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 4); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AD (Cardiospondylocarpofacial syndrome); AD (Frontometaphyseal dysplasia 2)",
IKBKE,"AD (Immunodeficiency, common variable, 10); AD (Immunodeficiency 132A); AD (Immunodeficiency 132B); AD (?Frontotemporal dementia and/or amyotrophic lateral sclerosis 8); AD (Brooke-Spiegler syndrome); AD (Cylindromatosis, familial); AD (Trichoepithelioma, multiple familial, 1); AD (STING-associated vasculopathy, infantile-onset); AD (Immunodeficiency, common variable, 10); AD (Immunodeficiency 132A); AD (Immunodeficiency 132B); AD (?Frontotemporal dementia and/or amyotrophic lateral sclerosis 8); AD (Brooke-Spiegler syndrome); AD (Cylindromatosis, familial); AD (Trichoepithelioma, multiple familial, 1); AD (STING-associated vasculopathy, infantile-onset)",
IKBKG,"Autoinflammatory disease, systemic, X-linked; Ectodermal dysplasia and immunodeficiency 1; Immunodeficiency 33; Incontinentia pigmenti; AD (Immunodeficiency, common variable, 12); AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); Chromosome Xq28 duplication syndrome; {Resistance to malaria due to G6PD deficiency}; Anemia, congenital, nonspherocytic hemolytic, 1, G6PD deficient; AR (Immunodeficiency with hyper-IgM, type 3); Autoinflammatory disease, systemic, X-linked; Ectodermal dysplasia and immunodeficiency 1; Immunodeficiency 33; Incontinentia pigmenti; AD (Immunodeficiency, common variable, 12); AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); Chromosome Xq28 duplication syndrome; {Resistance to malaria due to G6PD deficiency}; Anemia, congenital, nonspherocytic hemolytic, 1, G6PD deficient; AR (Immunodeficiency with hyper-IgM, type 3)",
IKZF1,"AD (Immunodeficiency, common variable, 13); AD (?Immunodeficiency 84); {Leukemia, acute lymphoblastic, susceptibility to, 2}; {Leukemia, acute lymphocytic, susceptibility to, 1}; {Leukemia, acute lymphoblastic, susceptibility to, 3}; AR (Intellectual developmental disorder, autosomal recessive 2); Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic; Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic; AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib; AD (Immunodeficiency, common variable, 13); AD (?Immunodeficiency 84); {Leukemia, acute lymphoblastic, susceptibility to, 2}; {Leukemia, acute lymphocytic, susceptibility to, 1}; {Leukemia, acute lymphoblastic, susceptibility to, 3}; AR (Intellectual developmental disorder, autosomal recessive 2); Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic; Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic; AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib",
IKZF3,"AD (?Immunodeficiency 84); AD (Immunodeficiency, common variable, 13); AR (Intellectual developmental disorder, autosomal recessive 2); AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); AD (White-Kernohan syndrome); {Leukemia, acute lymphoblastic, susceptibility to, 3}; AD (?Immunodeficiency 84); AD (Immunodeficiency, common variable, 13); AR (Intellectual developmental disorder, autosomal recessive 2); AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); AD (White-Kernohan syndrome); {Leukemia, acute lymphoblastic, susceptibility to, 3}",
IKZF4,"AD (Thrombocytopenia, autosomal dominant, 7); Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked; AD (Thrombocytopenia, autosomal dominant, 7); Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked",
IKZF5,"AD (Thrombocytopenia, autosomal dominant, 7); AD (Thrombocytopenia, autosomal dominant, 7)",
IL10,"{Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (Inflammatory bowel disease 28, early onset, autosomal recessive); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (Inflammatory bowel disease 28, early onset, autosomal recessive); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}",
IL10RA,"AR (Inflammatory bowel disease 28, early onset, autosomal recessive); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (Immunodeficiency 54); AR (Inflammatory bowel disease 28, early onset, autosomal recessive); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (Immunodeficiency 54)",
IL10RB,"{Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); {Hepatitis B virus, susceptibility to}; AR (Immunodeficiency 45); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}",
IL11,"AR (Craniosynostosis and dental anomalies); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); Aromatase deficiency; AR (Craniosynostosis and dental anomalies); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); Aromatase deficiency",
IL11RA,"AR (Craniosynostosis and dental anomalies); AR (Galactosemia); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR (Intellectual developmental disorder with or without peripheral neuropathy); {Stature QTL 1}; AD (?Aneurysm, intracranial berry, 12); AR (Lymphatic malformation 13); AR (Craniosynostosis and dental anomalies); AR (Galactosemia); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR (Intellectual developmental disorder with or without peripheral neuropathy); {Stature QTL 1}; AD (?Aneurysm, intracranial berry, 12); AR (Lymphatic malformation 13)",
IL12A,"AR (Immunodeficiency 29, mycobacteriosis); AD (Biliary cirrhosis, primary, 1); {Celiac disease, susceptibility to, 10}; AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); AR (Immunodeficiency 30); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Immunodeficiency 29, mycobacteriosis); AD (Biliary cirrhosis, primary, 1); {Celiac disease, susceptibility to, 10}; AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); AR (Immunodeficiency 30); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections)",
IL12B,"AR (Immunodeficiency 29, mycobacteriosis); {Psoriasis susceptibility 11}; AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); {Psoriasis susceptibility 7}; {Diabetes mellitus, insulin-dependent, 18}; Gastric cancer, somatic; AR (Immunodeficiency 117, mycobacteriosis, autosomal recessive); Nonsmall cell lung cancer, somatic; AR (Immunodeficiency 29, mycobacteriosis); {Psoriasis susceptibility 11}; AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); {Psoriasis susceptibility 7}; {Diabetes mellitus, insulin-dependent, 18}; Gastric cancer, somatic; AR (Immunodeficiency 117, mycobacteriosis, autosomal recessive); Nonsmall cell lung cancer, somatic",
IL12RB1,"AR (Immunodeficiency 30); AR (Immunodeficiency 29, mycobacteriosis); {Inflammatory bowel disease 17, protection against}; {Psoriasis, protection against}; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Immunodeficiency 30); AR (Immunodeficiency 29, mycobacteriosis); {Inflammatory bowel disease 17, protection against}; {Psoriasis, protection against}; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections)",
IL12RB2,"AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AR (Immunodeficiency 30); {Inflammatory bowel disease 17, protection against}; {Psoriasis, protection against}; AD (Biliary cirrhosis, primary, 1); AR (Immunodeficiency 29, mycobacteriosis); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AR (Immunodeficiency 30); {Inflammatory bowel disease 17, protection against}; {Psoriasis, protection against}; AD (Biliary cirrhosis, primary, 1); AR (Immunodeficiency 29, mycobacteriosis)",
IL13,"{Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR (Craniosynostosis and dental anomalies); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR (Craniosynostosis and dental anomalies)",
IL13RA1,"{Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; AR (Immunodeficiency 56); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; AR (Immunodeficiency 56)",
IL13RA2,"{Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to})",
IL15,"AR (?Immunodeficiency, common variable, 11); AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity); AR (Immunodeficiency 56); AR (Lymphoproliferative syndrome 1); AR (?Immunodeficiency, common variable, 11); AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity); AR (Immunodeficiency 56); AR (Lymphoproliferative syndrome 1)",
IL15RA,"Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked",
IL16,"{Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}; {Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}",
IL17A,"AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AR (Immunodeficiency 51); {Autism susceptibility 1}; AR (Immunodeficiency 42); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AR (Immunodeficiency 51); {Autism susceptibility 1}; AR (Immunodeficiency 42)",
IL17B,"?Candidiasis, familial, 6, autosomal dominant; ?Candidiasis, familial, 6, autosomal dominant",
IL17C,"?Candidiasis, familial, 6, autosomal dominant; ?Candidiasis, familial, 6, autosomal dominant",
IL17F,"?Candidiasis, familial, 6, autosomal dominant; AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AR (Immunodeficiency 51); AR (Immunodeficiency 42); ?Candidiasis, familial, 6, autosomal dominant; AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AR (Immunodeficiency 51); AR (Immunodeficiency 42)",
IL17RA,"AR (Immunodeficiency 51); ?Candidiasis, familial, 6, autosomal dominant; AR (Candidiasis, familial, 9); AR (?Candidiasis, familial, 8); {Psoriasis susceptibility 13}; {Autism susceptibility 1}; AR (Immunodeficiency 51); ?Candidiasis, familial, 6, autosomal dominant; AR (Candidiasis, familial, 9); AR (?Candidiasis, familial, 8); {Psoriasis susceptibility 13}; {Autism susceptibility 1}",
IL17RB,"AR (?Candidiasis, familial, 8); {Psoriasis susceptibility 13}; AR (?Candidiasis, familial, 8); {Psoriasis susceptibility 13}",
IL17RC,"AR (Candidiasis, familial, 9); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); ?Candidiasis, familial, 6, autosomal dominant; AR (Immunodeficiency 51); AR (?Candidiasis, familial, 8); {Psoriasis susceptibility 13}; AD (Candidiasis, familial, 1, autosomal dominant); AR (Candidiasis, familial, 9); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); ?Candidiasis, familial, 6, autosomal dominant; AR (Immunodeficiency 51); AR (?Candidiasis, familial, 8); {Psoriasis susceptibility 13}; AD (Candidiasis, familial, 1, autosomal dominant)",
IL17RD,"AR (Hypogonadotropic hypogonadism 18 with or without anosmia); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (?Precocious puberty, central, 1); AR (Hypogonadotropic hypogonadism 8 with or without anosmia); AD (Hypogonadotropic hypogonadism 19 with or without anosmia); AD (Hypogonadotropic hypogonadism 20 with or without anosmia); AD (Hypogonadotropic hypogonadism 21 with anosmia); AR (Hypogonadotropic hypogonadism 18 with or without anosmia); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (?Precocious puberty, central, 1); AR (Hypogonadotropic hypogonadism 8 with or without anosmia); AD (Hypogonadotropic hypogonadism 19 with or without anosmia); AD (Hypogonadotropic hypogonadism 20 with or without anosmia); AD (Hypogonadotropic hypogonadism 21 with anosmia)",
IL17REL,{Inflammatory bowel disease 11}; {Inflammatory bowel disease 7}; {Inflammatory bowel disease 23}; {Inflammatory bowel disease 11}; {Inflammatory bowel disease 7}; {Inflammatory bowel disease 23},
IL18,"AR ({?Hepatitis, fulminant viral, susceptibility to}); AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AR ({?Hepatitis, fulminant viral, susceptibility to}); AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis)",
IL18BP,"AR ({?Hepatitis, fulminant viral, susceptibility to}); AR ({?Hepatitis, fulminant viral, susceptibility to})",
IL18R1,"{Celiac disease, susceptibility to, 8}; AD (?Chronic recurrent multifocal osteomyelitis 3); AR ({?Hepatitis, fulminant viral, susceptibility to}); {Celiac disease, susceptibility to, 8}; AD (?Chronic recurrent multifocal osteomyelitis 3); AR ({?Hepatitis, fulminant viral, susceptibility to})",
IL18RAP,"{Celiac disease, susceptibility to, 8}; {Leprosy, paucibacillary type, susceptibility to}; AR ({Diabetes mellitus, insulin-dependent-1}); {Celiac disease, susceptibility to, 8}; {Leprosy, paucibacillary type, susceptibility to}; AR ({Diabetes mellitus, insulin-dependent-1})",
IL19,"AR ({Diabetes mellitus, insulin-dependent-1}); AR ({Diabetes mellitus, insulin-dependent-1})",
IL1A,"{Gastric cancer risk after H. pylori infection}; {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); AR (Psoriasis 14, pustular); {Gastric cancer risk after H. pylori infection}; {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); AR (Psoriasis 14, pustular)",
IL1B,"{Gastric cancer risk after H. pylori infection}; AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); Autoinflammatory disease, systemic, X-linked; Ectodermal dysplasia and immunodeficiency 1; Immunodeficiency 33; Incontinentia pigmenti; AD (Ectodermal dysplasia and immunodeficiency 2); {Gastric cancer risk after H. pylori infection}; AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); Autoinflammatory disease, systemic, X-linked; Ectodermal dysplasia and immunodeficiency 1; Immunodeficiency 33; Incontinentia pigmenti; AD (Ectodermal dysplasia and immunodeficiency 2)",
IL1F10,"{Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; {Inflammatory bowel disease 11}; AR (Psoriasis 14, pustular); AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; {Inflammatory bowel disease 11}; AR (Psoriasis 14, pustular); AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31)",
IL1R1,"AD (?Chronic recurrent multifocal osteomyelitis 3); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); AD ({Autoimmune lymphoproliferative syndrome}); AD (Autoimmune lymphoproliferative syndrome, type IA); Squamous cell carcinoma, burn scar-related, somatic; AD ({Lung cancer, susceptibility to}); AD (Autoimmune lymphoproliferative syndrome, type IB); AR (Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities); AD (?Chronic recurrent multifocal osteomyelitis 3); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); AD ({Autoimmune lymphoproliferative syndrome}); AD (Autoimmune lymphoproliferative syndrome, type IA); Squamous cell carcinoma, burn scar-related, somatic; AD ({Lung cancer, susceptibility to}); AD (Autoimmune lymphoproliferative syndrome, type IB); AR (Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities)",
IL1R2,"AR (Metaphyseal anadysplasia 2); {Gastric cancer risk after H. pylori infection}; AD (?Chronic recurrent multifocal osteomyelitis 3); {Malaria, resistance to}; AR (Metaphyseal anadysplasia 2); {Gastric cancer risk after H. pylori infection}; AD (?Chronic recurrent multifocal osteomyelitis 3); {Malaria, resistance to}",
IL1RAP,"AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; AR (Psoriasis 14, pustular); Intellectual developmental disorder, X-linked 21; AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; AR (Psoriasis 14, pustular); Intellectual developmental disorder, X-linked 21",
IL1RAPL1,"Intellectual developmental disorder, X-linked 21; Intellectual developmental disorder, X-linked 21",
IL1RAPL2,"Intellectual developmental disorder, X-linked 21; Intellectual developmental disorder, X-linked 21",
IL1RL1,"AD (?Chronic recurrent multifocal osteomyelitis 3); AR (Chronic granulomatous disease 1, autosomal recessive); AD (?Chronic recurrent multifocal osteomyelitis 3); AR (Chronic granulomatous disease 1, autosomal recessive)",
IL1RL2,"AD (?Chronic recurrent multifocal osteomyelitis 3); AR (Psoriasis 14, pustular); AD (?Chronic recurrent multifocal osteomyelitis 3); AR (Psoriasis 14, pustular)",
IL1RN,"{Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AD (?Chronic recurrent multifocal osteomyelitis 3); AR (Psoriasis 14, pustular); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AD (?Chronic recurrent multifocal osteomyelitis 3); AR (Psoriasis 14, pustular)",
IL2,"{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity); AR (Lymphoproliferative syndrome 1); AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; AR (?Immunodeficiency, common variable, 11); Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked; AR (Immunodeficiency, common variable, 1); AR (Immunodeficiency 56); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity); AR (Lymphoproliferative syndrome 1); AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; AR (?Immunodeficiency, common variable, 11); Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked; AR (Immunodeficiency, common variable, 1); AR (Immunodeficiency 56)",
IL20,"{Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR ({Diabetes mellitus, insulin-dependent-1}); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR ({Diabetes mellitus, insulin-dependent-1})",
IL20RA,"{Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive)",
IL21,"AR (?Immunodeficiency, common variable, 11); AR (Immunodeficiency 56); {Psoriasis susceptibility 3}; {Autoimmune disease, susceptibility to, 5}; {Celiac disease, susceptibility to, 6}; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant); AR (?Immunodeficiency, common variable, 11); AR (Immunodeficiency 56); {Psoriasis susceptibility 3}; {Autoimmune disease, susceptibility to, 5}; {Celiac disease, susceptibility to, 6}; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant)",
IL21R,"AR (Immunodeficiency 56); AR (?Immunodeficiency, common variable, 11); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Immunodeficiency 56); AR (?Immunodeficiency, common variable, 11); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections)",
IL22,"AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AR (Immunodeficiency 42); AR (Immunodeficiency 29, mycobacteriosis); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AR (Immunodeficiency 42); AR (Immunodeficiency 29, mycobacteriosis)",
IL22RA1,"{Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR (Hemochromatosis, type 2B); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR (Hemochromatosis, type 2B)",
IL23A,"AR (Immunodeficiency 29, mycobacteriosis); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; AR (Immunodeficiency 29, mycobacteriosis); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17",
IL23R,"{Inflammatory bowel disease 17, protection against}; {Psoriasis, protection against}; {Psoriasis susceptibility 7}; {Psoriasis susceptibility 11}; {Inflammatory bowel disease 7}; AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); {Inflammatory bowel disease 17, protection against}; {Psoriasis, protection against}; {Psoriasis susceptibility 7}; {Psoriasis susceptibility 11}; {Inflammatory bowel disease 7}; AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant)",
IL24,"{Multiple sclerosis, susceptibility to, 5}; AD (Periodic fever, familial); AR (Kindler syndrome); {Multiple sclerosis, susceptibility to, 5}; AD (Periodic fever, familial); AR (Kindler syndrome)",
IL25,"{Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); ?Candidiasis, familial, 6, autosomal dominant; {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); ?Candidiasis, familial, 6, autosomal dominant",
IL26,"{Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR ({Diabetes mellitus, insulin-dependent-1}); {Hepatitis B virus, susceptibility to}; AR (Inflammatory bowel disease 25, early onset, autosomal recessive); AR ({Diabetes mellitus, insulin-dependent-1})",
IL27,"AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); AR ({Diabetes mellitus, insulin-dependent-1}); {Inflammatory bowel disease 8}; AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); AR ({Diabetes mellitus, insulin-dependent-1}); {Inflammatory bowel disease 8}",
IL2RA,"{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity); {Multiple sclerosis, susceptibility to, 2}; AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity); {Multiple sclerosis, susceptibility to, 2}; AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked",
IL2RB,"AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity); AR (Immunodeficiency 56); AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}; AR (Immunodeficiency 41 with lymphoproliferation and autoimmunity); AR (Immunodeficiency 56)",
IL2RG,"Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; Leukemia, acute T-cell; AR (Immunodeficiency 56); AR (Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant); Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; Leukemia, acute T-cell; AR (Immunodeficiency 56); AR (Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant)",
IL3,"AR (Surfactant metabolism dysfunction, pulmonary, 5); AD (Leukemia, acute myeloid); AD (Platelet disorder, familial, with associated myeloid malignancy); AR (Surfactant metabolism dysfunction, pulmonary, 5); AD (Leukemia, acute myeloid); AD (Platelet disorder, familial, with associated myeloid malignancy)",
IL31,"AD (?Amyloidosis, primary localized cutaneous, 2); AD (Amyloidosis, primary localized cutaneous, 1); AD (?Amyloidosis, primary localized cutaneous, 2); AD (Amyloidosis, primary localized cutaneous, 1)",
IL31RA,"AD (?Amyloidosis, primary localized cutaneous, 2); AD (Amyloidosis, primary localized cutaneous, 1); AD (?Amyloidosis, primary localized cutaneous, 2); AD (Amyloidosis, primary localized cutaneous, 1)",
IL33,"{Dengue fever, protection against}; {HIV type 1, susceptibility to}; {Mycobacterium tuberculosis, susceptibility to}; {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); AD (Intellectual developmental disorder, autosomal dominant 48); {Gastric cancer risk after H. pylori infection}; {Dengue fever, protection against}; {HIV type 1, susceptibility to}; {Mycobacterium tuberculosis, susceptibility to}; {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); AD (Intellectual developmental disorder, autosomal dominant 48); {Gastric cancer risk after H. pylori infection}",
IL34,"AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 5}); {Macular degeneration, age-related, 9}; AR (C3 deficiency); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 5}); {Macular degeneration, age-related, 9}; AR (C3 deficiency)",
IL36A,"AR (Psoriasis 14, pustular); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31); AR (Psoriasis 14, pustular); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31)",
IL36B,"AR (Psoriasis 14, pustular); AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AR (Psoriasis 14, pustular); AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}",
IL36G,"{Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AR (Psoriasis 14, pustular); AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31); AD (Pityriasis rubra pilaris); AD (Psoriasis 2); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AR (Psoriasis 14, pustular); AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31); AD (Pityriasis rubra pilaris); AD (Psoriasis 2)",
IL36RN,"AR (Psoriasis 14, pustular); AD (Pityriasis rubra pilaris); AD (Psoriasis 2); AD ({Psoriasis 15, pustular, susceptibility to}); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AR (Psoriasis 14, pustular); AD (Pityriasis rubra pilaris); AD (Psoriasis 2); AD ({Psoriasis 15, pustular, susceptibility to}); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}",
IL37,"AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AR (Psoriasis 14, pustular); AR (?Inflammatory bowel disease (infantile ulcerative colitis) 31); {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); {Gastric cancer risk after H. pylori infection}; AR (Psoriasis 14, pustular)",
IL3RA,"Raynaud-Claes syndrome; AR (Surfactant metabolism dysfunction, pulmonary, 5); AD (Leukemia, acute myeloid); AD (Platelet disorder, familial, with associated myeloid malignancy); AR (Amegakaryocytic thrombocytopenia, congenital, 1); Myelofibrosis with myeloid metaplasia, somatic; AD (Thrombocythemia 2); Raynaud-Claes syndrome; AR (Surfactant metabolism dysfunction, pulmonary, 5); AD (Leukemia, acute myeloid); AD (Platelet disorder, familial, with associated myeloid malignancy); AR (Amegakaryocytic thrombocytopenia, congenital, 1); Myelofibrosis with myeloid metaplasia, somatic; AD (Thrombocythemia 2)",
IL4,"AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AR (Immunodeficiency 56); AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AR (Immunodeficiency 56)",
IL4I1,"AR (Immunodeficiency 42); AR (Striatonigral degeneration, infantile); AR (Immunodeficiency 42); AR (Striatonigral degeneration, infantile)",
IL4R,"AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); {H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD); AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); {H. pylori infection, susceptibility to}; {Hepatitis B virus infection, susceptibility to}; {Tuberculosis infection, protection against}; {Tuberculosis, susceptibility to}; AR (Immunodeficiency 27A, mycobacteriosis, AR); AD (Immunodeficiency 27B, mycobacteriosis, AD)",
IL5,"AD (Hypoparathyroidism, sensorineural deafness, and renal dysplasia); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR (Surfactant metabolism dysfunction, pulmonary, 5); AD (den Hoed-de Boer-Voisin syndrome); AD (Developmental delay with dysmorphic facies and dental anomalies); AD (Hypoparathyroidism, sensorineural deafness, and renal dysplasia); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR (Surfactant metabolism dysfunction, pulmonary, 5); AD (den Hoed-de Boer-Voisin syndrome); AD (Developmental delay with dysmorphic facies and dental anomalies)",
IL5RA,AD (Coffin-Siris syndrome 10); AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24); AD (Coffin-Siris syndrome 10); AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24),
IL6,"{Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); [Interleukin 6, serum level of, QTL]; [Interleukin-6 receptor, soluble, serum level of, QTL]; AR (Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections); AD ({Colorectal cancer, susceptibility to}); AD ({Leprosy, susceptibility to}); {Mycobacterium tuberculosis, susceptibility to}; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); [Interleukin 6, serum level of, QTL]; [Interleukin-6 receptor, soluble, serum level of, QTL]; AR (Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections); AD ({Colorectal cancer, susceptibility to}); AD ({Leprosy, susceptibility to}); {Mycobacterium tuberculosis, susceptibility to}; AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections)",
IL6R,"[Interleukin 6, serum level of, QTL]; [Interleukin-6 receptor, soluble, serum level of, QTL]; AR (Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); AR (Craniosynostosis and dental anomalies); [Interleukin 6, serum level of, QTL]; [Interleukin-6 receptor, soluble, serum level of, QTL]; AR (Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); AR (Craniosynostosis and dental anomalies)",
IL6ST,"AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); AD (?Amyloidosis, primary localized cutaneous, 2); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); [Interleukin 6, serum level of, QTL]; [Interleukin-6 receptor, soluble, serum level of, QTL]; AR (Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); AD (?Amyloidosis, primary localized cutaneous, 2); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); [Interleukin 6, serum level of, QTL]; [Interleukin-6 receptor, soluble, serum level of, QTL]; AR (Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in)",
IL7,"AR (Immunodeficiency 130 with HPV-related verrucosis); AR (Immunodeficiency 104, severe combined); AR (Deafness, autosomal recessive 39); Colorectal cancer, somatic; T-cell acute lymphoblastic leukemia, somatic; Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked; AR (Immunodeficiency 130 with HPV-related verrucosis); AR (Immunodeficiency 104, severe combined); AR (Deafness, autosomal recessive 39); Colorectal cancer, somatic; T-cell acute lymphoblastic leukemia, somatic; Combined immunodeficiency, X-linked, moderate; Severe combined immunodeficiency, X-linked",
IL7R,"AR (Immunodeficiency 104, severe combined); AR (Immunodeficiency 130 with HPV-related verrucosis); {Multiple sclerosis, susceptibility to, 3}; {Leukemia, acute lymphocytic, susceptibility to, 1}; AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant); AD (?Juvenile myelomonocytic leukemia); AD (Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia); AR (Immunodeficiency 104, severe combined); AR (Immunodeficiency 130 with HPV-related verrucosis); {Multiple sclerosis, susceptibility to, 3}; {Leukemia, acute lymphocytic, susceptibility to, 1}; AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant); AD (?Juvenile myelomonocytic leukemia); AD (Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia)",
IL9,"[Skin/hair/eye pigmentation, variation in, 8]; AR (Immunodeficiency 131); [Skin/hair/eye pigmentation 7, blond/brown hair]; AD (Deafness, autosomal dominant 69, unilateral or asymmetric); AD (Hyperpigmentation with or without hypopigmentation); AR (Waardenburg syndrome, type 2F); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); AD (Agammaglobulinemia 10, autosomal dominant); [Skin/hair/eye pigmentation, variation in, 8]; AR (Immunodeficiency 131); [Skin/hair/eye pigmentation 7, blond/brown hair]; AD (Deafness, autosomal dominant 69, unilateral or asymmetric); AD (Hyperpigmentation with or without hypopigmentation); AR (Waardenburg syndrome, type 2F); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); AD (Agammaglobulinemia 10, autosomal dominant)",
ILDR1,"AR (Deafness, autosomal recessive 42); AR (Deafness, autosomal recessive 42)",
ILK,"AR (?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue); Intellectual developmental disorder, X-linked 103; AR (?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue); Intellectual developmental disorder, X-linked 103",
ILKAP,"Coffin-Lowry syndrome; Intellectual developmental disorder, X-linked 19; Coffin-Lowry syndrome; Intellectual developmental disorder, X-linked 19",
IMMP1L,"AD (Deafness, autosomal dominant 64); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); AD (Chromosome 11p13 deletion syndrome, distal); AD (Deafness, autosomal dominant 64); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); AD (Chromosome 11p13 deletion syndrome, distal)",
IMMP2L,"AD (Deafness, autosomal dominant 64); AD (Deafness, autosomal dominant 64)",
IMMT,"AR (Mandibuloacral dysplasia progeroid syndrome); AR (Neuropathy, hereditary motor and sensory, type VIB); AR (Pontocerebellar hypoplasia, type 1E); AR (Mandibuloacral dysplasia progeroid syndrome); AR (Neuropathy, hereditary motor and sensory, type VIB); AR (Pontocerebellar hypoplasia, type 1E)",
IMP3,"AR (Immunodeficiency 86, mycobacteriosis); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5); AR (Immunodeficiency 86, mycobacteriosis); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to}); AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5)",
IMPA1,"AR (Intellectual developmental disorder, autosomal recessive 59); AR (Intellectual developmental disorder, autosomal recessive 59)",
IMPA2,"AD (Febrile seizures, familial, 6); AD (Febrile seizures, familial, 9); AD (Febrile seizures, familial, 6); AD (Febrile seizures, familial, 9)",
IMPACT,"AD (Polydactyly, preaxial II); AR (Tibia, hypoplasia or aplasia of, with polydactyly); AD (Triphalangeal thumb); {Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features); AR ({Hypercholesterolemia, familial, modifier of}); AD (Growth hormone insensitivity, partial); AD (Increased responsiveness to growth hormone); AR (Laron dwarfism); AR (Obesity, morbid, due to leptin deficiency); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; {Multiple myeloma, resistance to}; AR (LIG4 syndrome); AR (Hypercholanemia, familial 3); AD (Polydactyly, preaxial II); AR (Tibia, hypoplasia or aplasia of, with polydactyly); AD (Triphalangeal thumb); {Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features); AR ({Hypercholesterolemia, familial, modifier of}); AD (Growth hormone insensitivity, partial); AD (Increased responsiveness to growth hormone); AR (Laron dwarfism); AR (Obesity, morbid, due to leptin deficiency); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; {Multiple myeloma, resistance to}; AR (LIG4 syndrome); AR (Hypercholanemia, familial 3)",
IMPDH1,"AD (Leber congenital amaurosis 11); AD (Retinitis pigmentosa 10); [IMPDH2 enzyme activity, variation in]; AD (Leber congenital amaurosis 11); AD (Retinitis pigmentosa 10); [IMPDH2 enzyme activity, variation in]",
IMPDH2,"[IMPDH2 enzyme activity, variation in]; AD (Leber congenital amaurosis 11); AD (Retinitis pigmentosa 10); AD (Immunodeficiency, common variable, 12); AD ({Colorectal cancer, susceptibility to}); AD ({Leprosy, susceptibility to}); {Mycobacterium tuberculosis, susceptibility to}; AR (Homocystinuria, B6-responsive and nonresponsive types); AR (Thrombosis, hyperhomocysteinemic); [IMPDH2 enzyme activity, variation in]; AD (Leber congenital amaurosis 11); AD (Retinitis pigmentosa 10); AD (Immunodeficiency, common variable, 12); AD ({Colorectal cancer, susceptibility to}); AD ({Leprosy, susceptibility to}); {Mycobacterium tuberculosis, susceptibility to}; AR (Homocystinuria, B6-responsive and nonresponsive types); AR (Thrombosis, hyperhomocysteinemic)",
IMPG1,"AR (Macular dystrophy, vitelliform, 4); AD (Retinitis pigmentosa 91); AD (Macular dystrophy, vitelliform, 5); AR (Retinitis pigmentosa 56); AR (Macular dystrophy, vitelliform, 4); AD (Retinitis pigmentosa 91); AD (Macular dystrophy, vitelliform, 5); AR (Retinitis pigmentosa 56)",
IMPG2,"AD (Macular dystrophy, vitelliform, 5); AR (Retinitis pigmentosa 56); AR (Macular dystrophy, vitelliform, 4); AD (Retinitis pigmentosa 91); AD (Macular dystrophy, vitelliform, 5); AR (Retinitis pigmentosa 56); AR (Macular dystrophy, vitelliform, 4); AD (Retinitis pigmentosa 91)",
INA,"[Blood group, Indian system]; {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; AD (Marbach-Schaaf neurodevelopmental syndrome); AD (Atrial fibrillation, familial, 14); {Myocardial infarction, susceptibility to}; [Blood group, Indian system]; {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}; {Alcohol dependence, protection against}; AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; AD (Marbach-Schaaf neurodevelopmental syndrome); AD (Atrial fibrillation, familial, 14); {Myocardial infarction, susceptibility to}",
INAVA,AD ({Inflammatory bowel disease 29}); AD ({Inflammatory bowel disease 29}),
INCENP,"AR (Deafness, autosomal recessive 32, with or without immotile sperm); AR (Spermatogenic failure 5); AD (White-Sutton syndrome); AR (Deafness, autosomal recessive 32, with or without immotile sperm); AR (Spermatogenic failure 5); AD (White-Sutton syndrome)",
INF2,"AD (Charcot-Marie-Tooth disease, dominant intermediate E); Glomerulosclerosis, focal segmental, 5; AR (Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1); AD (Optic atrophy 5); AR (Nephrotic syndrome, type 24); AD (Charcot-Marie-Tooth disease, dominant intermediate E); Glomerulosclerosis, focal segmental, 5; AR (Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1); AD (Optic atrophy 5); AR (Nephrotic syndrome, type 24)",
ING1,"Squamous cell carcinoma, head and neck, somatic; Squamous cell carcinoma, head and neck, somatic",
ING3,"AD (Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities); AD (Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities)",
ING4,"AD ([Hemoglobin, high altitude adaptation]); AD (Erythrocytosis, familial, 3); AD ([Hemoglobin, high altitude adaptation]); AD (Erythrocytosis, familial, 3)",
ING5,AD (Intellectual developmental disorder with dysmorphic facies and ptosis); AD (Intellectual developmental disorder with dysmorphic facies and ptosis),
INHA,"AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; Branchiootorenal syndrome 2; AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; Branchiootorenal syndrome 2",
INHBA,"Hypothyroidism, central, and testicular enlargement; {Menarche, age at, QTL2}; {Menarche, age at, QTL3}; AD (Telangiectasia, hereditary hemorrhagic, type 4); Hypothyroidism, central, and testicular enlargement; {Menarche, age at, QTL2}; {Menarche, age at, QTL3}; AD (Telangiectasia, hereditary hemorrhagic, type 4)",
INHBB,Branchiootorenal syndrome 2; Branchiootorenal syndrome 2,
INHBE,"AR (Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1); AR (Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1)",
INO80,"AD (Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities); AD (Floating-Harbor syndrome); AR (Grange syndrome); AD (Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities); AD (Floating-Harbor syndrome); AR (Grange syndrome)",
INO80B,AD (Preeclampsia/eclampsia 1); AD (?Retinitis pigmentosa 9); AD (Preeclampsia/eclampsia 1); AD (?Retinitis pigmentosa 9),
INPP5A,"?Uruguay faciocardiomusculoskeletal syndrome; Emery-Dreifuss muscular dystrophy 6, X-linked; Myopathy, X-linked, with postural muscle atrophy; Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset; Reducing body myopathy, X-linked 1b, with late childhood or adult onset; Scapuloperoneal myopathy, X-linked dominant; ?Uruguay faciocardiomusculoskeletal syndrome; Emery-Dreifuss muscular dystrophy 6, X-linked; Myopathy, X-linked, with postural muscle atrophy; Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset; Reducing body myopathy, X-linked 1b, with late childhood or adult onset; Scapuloperoneal myopathy, X-linked dominant",
INPP5B,Dent disease 2; Lowe syndrome; Dent disease 2; Lowe syndrome,
INPP5D,"Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; AD (STING-associated vasculopathy, infantile-onset); Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; AD (STING-associated vasculopathy, infantile-onset)",
INPP5E,"AR (Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome); AR (Joubert syndrome 1); AR (Joubert syndrome 22); AR (Joubert syndrome 8); AR (Joubert syndrome 35); AD (Retinitis pigmentosa 83); AR (Hepatorenocardiac degenerative fibrosis); AR (Nephronophthisis 15); AR (Spinocerebellar ataxia, autosomal recessive 2); AR (Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome); AR (Joubert syndrome 1); AR (Joubert syndrome 22); AR (Joubert syndrome 8); AR (Joubert syndrome 35); AD (Retinitis pigmentosa 83); AR (Hepatorenocardiac degenerative fibrosis); AR (Nephronophthisis 15); AR (Spinocerebellar ataxia, autosomal recessive 2)",
INPP5K,"AR (Muscular dystrophy, congenital, with cataracts and intellectual disability); AD (Miller-Dieker lissencephaly syndrome); AR (Marinesco-Sjogren syndrome); AR (Muscular dystrophy, congenital, with cataracts and intellectual disability); AD (Miller-Dieker lissencephaly syndrome); AR (Marinesco-Sjogren syndrome)",
INPPL1,AR (Opsismodysplasia); AD (EDICT syndrome); AR (Opsismodysplasia); AD (EDICT syndrome),
INS,"AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AD (Silver-Russell syndrome 3); Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect; AR (Segawa syndrome, recessive); Dyskeratosis congenita, digenic; AD ({Bronchiectasis with or without elevated sweat chloride 1, modifier of}); {Hypertrypsinemia, neonatal}; AD ({Pancreatitis, hereditary}); AR (Congenital bilateral absence of vas deferens); AR (Cystic fibrosis); Sweat chloride elevation without CF; AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AD (Silver-Russell syndrome 3); Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect; AR (Segawa syndrome, recessive); Dyskeratosis congenita, digenic; AD ({Bronchiectasis with or without elevated sweat chloride 1, modifier of}); {Hypertrypsinemia, neonatal}; AD ({Pancreatitis, hereditary}); AR (Congenital bilateral absence of vas deferens); AR (Cystic fibrosis); Sweat chloride elevation without CF",
INSC,"AR (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency); AR (Hemochromatosis, type 3); AR (Chudley-McCullough syndrome); AR (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency); AR (Hemochromatosis, type 3); AR (Chudley-McCullough syndrome)",
INSIG1,"[Low density lipoprotein cholesterol level QTL 3]; [Statins, response to]; AR (Muscular dystrophy, limb-girdle, autosomal recessive 28); AR (Spastic paraplegia 89, autosomal recessive); Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AR (Phosphoenolpyruvate carboxykinase deficiency, cytosolic); AD (Ichthyosis, follicular, with atrichia and photophobia syndrome 2); AD (Mucoepithelial dysplasia, hereditary); Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies; Renal cell carcinoma, papillary, 1; [Low density lipoprotein cholesterol level QTL 3]; [Statins, response to]; AR (Muscular dystrophy, limb-girdle, autosomal recessive 28); AR (Spastic paraplegia 89, autosomal recessive); Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AR (Phosphoenolpyruvate carboxykinase deficiency, cytosolic); AD (Ichthyosis, follicular, with atrichia and photophobia syndrome 2); AD (Mucoepithelial dysplasia, hereditary); Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies; Renal cell carcinoma, papillary, 1",
INSIG2,"[Body mass index QTL13]; Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AR (Phosphoenolpyruvate carboxykinase deficiency, cytosolic); [Body mass index QTL13]; Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AR (Phosphoenolpyruvate carboxykinase deficiency, cytosolic)",
INSL3,AD (Cryptorchidism); AD (Cryptorchidism),
INSR,"Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); AD ({Type 2 diabetes mellitus, susceptibility to}); AD ({Type 2 diabetes mellitus, susceptibility to}); AR (Insulin-like growth factor I, resistance to); AD (Polycystic ovary syndrome 1); AR (Methylmalonic aciduria and homocystinuria, cblF type); Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); AD ({Type 2 diabetes mellitus, susceptibility to}); AD ({Type 2 diabetes mellitus, susceptibility to}); AR (Insulin-like growth factor I, resistance to); AD (Polycystic ovary syndrome 1); AR (Methylmalonic aciduria and homocystinuria, cblF type)",
INTS1,"AR (Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies); AR (Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies)",
INTS11,"AR (Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities); AR (Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies); AR (?Neurodevelopmental disorder with cerebellar hypoplasia and spasticity); AR (Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities); AR (Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies); AR (?Neurodevelopmental disorder with cerebellar hypoplasia and spasticity)",
INTS3,D-2-hydroxyglutaric aciduria 2; AD (Optic atrophy 13 with retinal and foveal abnormalities); D-2-hydroxyglutaric aciduria 2; AD (Optic atrophy 13 with retinal and foveal abnormalities),
INTS8,AR (?Neurodevelopmental disorder with cerebellar hypoplasia and spasticity); AR (?Neurodevelopmental disorder with cerebellar hypoplasia and spasticity),
INTS9,"AR (Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities); AR (Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities)",
INTU,"AR (?Orofaciodigital syndrome XVII); AR (?Short-rib thoracic dysplasia 20 with polydactyly); AD ({Polycystic kidney disease 9, susceptibility to}); AR (Cranioectodermal dysplasia 5); AR (Retinitis pigmentosa 80); AR (Short-rib thoracic dysplasia 9 with or without polydactyly); AD ({Neural tube defects, susceptibility to}); AR (Bardet-Biedl syndrome 15); AR (Congenital heart defects, hamartomas of tongue, and polysyndactyly); AR (Cranioectodermal dysplasia 2); AR (Short-rib thoracic dysplasia 7 with or without polydactyly); AR (?Orofaciodigital syndrome XVII); AR (?Short-rib thoracic dysplasia 20 with polydactyly); AD ({Polycystic kidney disease 9, susceptibility to}); AR (Cranioectodermal dysplasia 5); AR (Retinitis pigmentosa 80); AR (Short-rib thoracic dysplasia 9 with or without polydactyly); AD ({Neural tube defects, susceptibility to}); AR (Bardet-Biedl syndrome 15); AR (Congenital heart defects, hamartomas of tongue, and polysyndactyly); AR (Cranioectodermal dysplasia 2); AR (Short-rib thoracic dysplasia 7 with or without polydactyly)",
INVS,"AR (Nephronophthisis 2, infantile); AR (Meckel syndrome 7); AR (Nephronophthisis 3); AR (Renal-hepatic-pancreatic dysplasia 1); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2); AR (Nephronophthisis 16); AD (Ciliary dyskinesia, primary, 43); AR (Nephronophthisis 2, infantile); AR (Meckel syndrome 7); AR (Nephronophthisis 3); AR (Renal-hepatic-pancreatic dysplasia 1); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2); AR (Nephronophthisis 16); AD (Ciliary dyskinesia, primary, 43)",
IPO13,"Developmental and epileptic encephalopathy 1; Hydranencephaly with abnormal genitalia; Intellectual developmental disorder, X-linked 29; Lissencephaly, X-linked 2; Partington syndrome; Proud syndrome; Developmental and epileptic encephalopathy 1; Hydranencephaly with abnormal genitalia; Intellectual developmental disorder, X-linked 29; Lissencephaly, X-linked 2; Partington syndrome; Proud syndrome",
IPO5,"AR (Diarrhea 12, with microvillus atrophy); AR (Retinal dystrophy and microvillus inclusion disease); AR (Diarrhea 12, with microvillus atrophy); AR (Retinal dystrophy and microvillus inclusion disease)",
IPO7,"AR (Nephrotic syndrome, type 12); AD (Noonan syndrome 13); AR (Nephrotic syndrome, type 12); AD (Noonan syndrome 13)",
IPO8,AR (VISS syndrome); AR (VISS syndrome),
IPO9,AD (Houge-Janssens syndrome 2); AD (Houge-Janssens syndrome 2),
IPP,"{Hypertension, essential, salt-sensitive}; AR (?Spermatogenic failure 73); AR (?Congenital disorder of glycosylation, type 1bb); AD (Developmental delay and seizures with or without movement abnormalities); AR (Retinitis pigmentosa 59); {Hypertension, essential, salt-sensitive}; AR (?Spermatogenic failure 73); AR (?Congenital disorder of glycosylation, type 1bb); AD (Developmental delay and seizures with or without movement abnormalities); AR (Retinitis pigmentosa 59)",
IQCB1,"AR (Senior-Loken syndrome 5); AR (Achromatopsia 2); AD (Deafness, autosomal dominant 11); AR (Deafness, autosomal recessive 2); AR (Usher syndrome, type 1B); AR (Alstrom syndrome); AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6); AR (Senior-Loken syndrome 5); AR (Achromatopsia 2); AD (Deafness, autosomal dominant 11); AR (Deafness, autosomal recessive 2); AR (Usher syndrome, type 1B); AR (Alstrom syndrome); AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6)",
IQCE,"AR (Polydactyly, postaxial, type A7); AD (?Weyers acrofacial dysostosis); AR (Ellis-van Creveld syndrome); AR (Ellis-van Creveld syndrome); AD (Weyers acrofacial dysostosis); AR (Polydactyly, postaxial, type A7); AD (?Weyers acrofacial dysostosis); AR (Ellis-van Creveld syndrome); AR (Ellis-van Creveld syndrome); AD (Weyers acrofacial dysostosis)",
IQCH,{Stature QTL 16}; {Stature QTL 16},
IQCN,AR (Spermatogenic failure 78); AR (Spermatogenic failure 78),
IQGAP1,"Adenoma, periampullary, somatic; AD (Adenomatous polyposis coli); AD (Brain tumor-polyposis syndrome 2); Colorectal cancer, somatic; AD (Desmoid disease, hereditary); AD (Gardner syndrome); AD (Gastric adenocarcinoma and proximal polyposis of the stomach); Gastric cancer, somatic; Hepatoblastoma, somatic; AR (?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma); AD (Dyschromatosis universalis hereditaria 1); Adenoma, periampullary, somatic; AD (Adenomatous polyposis coli); AD (Brain tumor-polyposis syndrome 2); Colorectal cancer, somatic; AD (Desmoid disease, hereditary); AD (Gardner syndrome); AD (Gastric adenocarcinoma and proximal polyposis of the stomach); Gastric cancer, somatic; Hepatoblastoma, somatic; AR (?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma); AD (Dyschromatosis universalis hereditaria 1)",
IQGAP2,{Age-related hearing impairment 2}; AD (Intellectual developmental disorder with autism and macrocephaly); {Age-related hearing impairment 2}; AD (Intellectual developmental disorder with autism and macrocephaly),
IQSEC1,AR (Intellectual developmental disorder with short stature and behavioral abnormalities); AR (Intellectual developmental disorder with short stature and behavioral abnormalities),
IQSEC2,"Intellectual developmental disorder, X-linked 1; Intellectual developmental disorder, X-linked 1",
IRAK1,"AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; AR (Immunodeficiency 67); {Systemic lupus erythematosus, susceptibility to, 15}; {Asthma susceptibility 5}; AR (Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction); AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; AR (Immunodeficiency 67); {Systemic lupus erythematosus, susceptibility to, 15}; {Asthma susceptibility 5}; AR (Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction)",
IRAK2,"AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; AR (Immunodeficiency 67); {Asthma susceptibility 5}; {Bacteremia, protection against}; {Malaria, protection against}; {Tuberculosis, protection against}; AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}); AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; AR (Immunodeficiency 67); {Asthma susceptibility 5}; {Bacteremia, protection against}; {Malaria, protection against}; {Tuberculosis, protection against}; AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6})",
IRAK3,"{Asthma susceptibility 5}; Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; {Asthma susceptibility 5}; Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17",
IRAK4,"AR (Immunodeficiency 67); AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; Autoinflammatory disease, systemic, X-linked; Ectodermal dysplasia and immunodeficiency 1; Immunodeficiency 33; Incontinentia pigmenti; {Asthma susceptibility 5}; AR (Immunodeficiency 67); AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; Autoinflammatory disease, systemic, X-linked; Ectodermal dysplasia and immunodeficiency 1; Immunodeficiency 33; Incontinentia pigmenti; {Asthma susceptibility 5}",
IREB2,"AR (Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia); Pulmonary disease, chronic obstructive, severe early-onset; AR (Auditory neuropathy and optic atrophy); AR (Multiple mitochondrial dysfunctions syndrome 9B); AR (Immunodeficiency 46); AR (Myopathy with lactic acidosis, hereditary); AR (Polyglucosan body myopathy 1 with or without immunodeficiency); AR (?Combined oxidative phosphorylation deficiency 19); AR (Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia); Pulmonary disease, chronic obstructive, severe early-onset; AR (Auditory neuropathy and optic atrophy); AR (Multiple mitochondrial dysfunctions syndrome 9B); AR (Immunodeficiency 46); AR (Myopathy with lactic acidosis, hereditary); AR (Polyglucosan body myopathy 1 with or without immunodeficiency); AR (?Combined oxidative phosphorylation deficiency 19)",
IRF1,"Gastric cancer, somatic; AR (Immunodeficiency 117, mycobacteriosis, autosomal recessive); Nonsmall cell lung cancer, somatic; {Autoimmune thyroid disease, susceptibility to, 3}; AR (Thyroid dyshormonogenesis 3); AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AR (Fanconi anemia, complementation group C); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}); Gastric cancer, somatic; AR (Immunodeficiency 117, mycobacteriosis, autosomal recessive); Nonsmall cell lung cancer, somatic; {Autoimmune thyroid disease, susceptibility to, 3}; AR (Thyroid dyshormonogenesis 3); AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AR (Fanconi anemia, complementation group C); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7})",
IRF2,"AD (?Immunodeficiency, common variable, 14); Gastric cancer, somatic; AR (Immunodeficiency 117, mycobacteriosis, autosomal recessive); Nonsmall cell lung cancer, somatic; AD (Deafness, autosomal dominant 17); AD (Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss); AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}); AD (?Immunodeficiency, common variable, 14); Gastric cancer, somatic; AR (Immunodeficiency 117, mycobacteriosis, autosomal recessive); Nonsmall cell lung cancer, somatic; AD (Deafness, autosomal dominant 17); AD (Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss); AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7})",
IRF2BP1,"AD (?Immunodeficiency, common variable, 14); AD (?Immunodeficiency, common variable, 14)",
IRF2BP2,"AD (?Immunodeficiency, common variable, 14); AR (?Joint contracture, osteochondromas, and B-cell lymphoma); AR (?Lissencephaly 7 with cerebellar hypoplasia); AD (?Immunodeficiency, common variable, 14); AR (?Joint contracture, osteochondromas, and B-cell lymphoma); AR (?Lissencephaly 7 with cerebellar hypoplasia)",
IRF2BPL,"AD (Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures); AD (Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures)",
IRF3,"AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}); AD (STING-associated vasculopathy, infantile-onset); AR (?Immunodeficiency 39); AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}); AR (Autoinflammation with arthritis and vasculitis); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 4); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}); AD (STING-associated vasculopathy, infantile-onset); AR (?Immunodeficiency 39); AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}); AR (Autoinflammation with arthritis and vasculitis); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 4)",
IRF4,"[Skin/hair/eye pigmentation, variation in, 8]; AR (Immunodeficiency 131); AR (Immunodeficiency 87 and autoimmunity); {Leukemia, chronic lymphocytic susceptibility to, 4}; [Skin/hair/eye pigmentation, variation in, 8]; AR (Immunodeficiency 131); AR (Immunodeficiency 87 and autoimmunity); {Leukemia, chronic lymphocytic susceptibility to, 4}",
IRF5,"{Inflammatory bowel disease 14}; {Systemic lupus erythematosus, susceptibility to, 10}; AD (Biliary cirrhosis, primary, 1); [Skin/hair/eye pigmentation, variation in, 8]; AR (Immunodeficiency 131); Biliary cirrhosis, primary, 4; {Inflammatory bowel disease 14}; {Systemic lupus erythematosus, susceptibility to, 10}; AD (Biliary cirrhosis, primary, 1); [Skin/hair/eye pigmentation, variation in, 8]; AR (Immunodeficiency 131); Biliary cirrhosis, primary, 4",
IRF6,"AD ({Orofacial cleft 6}); AD (Popliteal pterygium syndrome 1); AD (van der Woude syndrome 1); AR (CHAND syndrome); AR (Popliteal pterygium syndrome, Bartsocas-Papas type 1); AR (Muscular dystrophy, limb-girdle, autosomal recessive 27); AD (van der Woude syndrome 2); AD (?Facial clefting, oblique, 1); AD (Teebi hypertelorism syndrome 1); AD ({Orofacial cleft 6}); AD (Popliteal pterygium syndrome 1); AD (van der Woude syndrome 1); AR (CHAND syndrome); AR (Popliteal pterygium syndrome, Bartsocas-Papas type 1); AR (Muscular dystrophy, limb-girdle, autosomal recessive 27); AD (van der Woude syndrome 2); AD (?Facial clefting, oblique, 1); AD (Teebi hypertelorism syndrome 1)",
IRF7,"AR (?Immunodeficiency 39); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}); AR (Achalasia-progeroid syndrome); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AR (?Immunodeficiency 39); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}); AR (Achalasia-progeroid syndrome); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2)",
IRF8,"AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AD (Agammaglobulinemia 10, autosomal dominant); AR (Multiple pterygium syndrome, lethal type); AD (Myasthenic syndrome, congenital, 1A, slow-channel); AR (Myasthenic syndrome, congenital, 1B, fast-channel); AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AD (Agammaglobulinemia 10, autosomal dominant); AR (Multiple pterygium syndrome, lethal type); AD (Myasthenic syndrome, congenital, 1A, slow-channel); AR (Myasthenic syndrome, congenital, 1B, fast-channel)",
IRF9,"AR (Immunodeficiency 65, susceptibility to viral infections); AR (Immunodeficiency 44); AR (Pseudo-TORCH syndrome 3); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AD (?Immunodeficiency, common variable, 14); AR (Immunodeficiency 65, susceptibility to viral infections); AR (Immunodeficiency 44); AR (Pseudo-TORCH syndrome 3); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AD (?Immunodeficiency, common variable, 14)",
IRGM,"{Inflammatory bowel disease (Crohn disease) 19}; {Mycobacterium tuberculosis, protection against}; AR ({Diabetes mellitus, insulin-dependent-1}); {Inflammatory bowel disease 12}; {Inflammatory bowel disease 20}; {Inflammatory bowel disease (Crohn disease) 19}; {Mycobacterium tuberculosis, protection against}; AR ({Diabetes mellitus, insulin-dependent-1}); {Inflammatory bowel disease 12}; {Inflammatory bowel disease 20}",
IRS1,"AD ({Type 2 diabetes mellitus, susceptibility to}); AD ({Diabetes mellitus, noninsulin-dependent}); Hypothyroidism, congenital, nongoitrous, 9; AR (?Fanconi anemia, complementation group U); AR (?Premature ovarian failure 17); AR (Spermatogenic failure 50); AD (Chung-Jansen syndrome); AD ({Type 2 diabetes mellitus, susceptibility to}); AD ({Diabetes mellitus, noninsulin-dependent}); Hypothyroidism, congenital, nongoitrous, 9; AR (?Fanconi anemia, complementation group U); AR (?Premature ovarian failure 17); AR (Spermatogenic failure 50); AD (Chung-Jansen syndrome)",
IRS2,"AD ({Diabetes mellitus, noninsulin-dependent}); AD ({Type 2 diabetes mellitus, susceptibility to}); AD (Ichthyosis, follicular, with atrichia and photophobia syndrome 2); AD (Mucoepithelial dysplasia, hereditary); Hypothyroidism, congenital, nongoitrous, 9; AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II); AR (Obesity, morbid, due to leptin deficiency); AD ({Diabetes mellitus, noninsulin-dependent}); AD ({Type 2 diabetes mellitus, susceptibility to}); AD (Ichthyosis, follicular, with atrichia and photophobia syndrome 2); AD (Mucoepithelial dysplasia, hereditary); Hypothyroidism, congenital, nongoitrous, 9; AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II); AR (Obesity, morbid, due to leptin deficiency)",
IRS4,"Hypothyroidism, congenital, nongoitrous, 9; Hypothyroidism, congenital, nongoitrous, 9",
IRX1,"AD (Macular dystrophy, retinal, 3); AR (Hamamy syndrome); Kyphoscoliosis 1; AD (Chorioretinal atrophy, progressive bifocal); AD (Macular dystrophy 1); AD (Macular dystrophy, retinal, 3); AR (Hamamy syndrome); Kyphoscoliosis 1; AD (Chorioretinal atrophy, progressive bifocal); AD (Macular dystrophy 1)",
IRX2,AR (Hamamy syndrome); Kyphoscoliosis 1; AR (Hamamy syndrome); Kyphoscoliosis 1,
IRX3,"AR ({Obesity, susceptibility to, BMIQ14}); AR (Growth retardation, developmental delay, facial dysmorphism); AR (Hamamy syndrome); AR (?SERKAL syndrome); AD (Mullerian aplasia and hyperandrogenism); AR ({Obesity, susceptibility to, BMIQ14}); AR (Growth retardation, developmental delay, facial dysmorphism); AR (Hamamy syndrome); AR (?SERKAL syndrome); AD (Mullerian aplasia and hyperandrogenism)",
IRX4,Kyphoscoliosis 1; Kyphoscoliosis 1,
IRX5,"AR (Hamamy syndrome); AR ({Obesity, susceptibility to, BMIQ14}); AR (Growth retardation, developmental delay, facial dysmorphism); AD (Chromosome 16q12 duplication syndrome); AR (Hamamy syndrome); AR ({Obesity, susceptibility to, BMIQ14}); AR (Growth retardation, developmental delay, facial dysmorphism); AD (Chromosome 16q12 duplication syndrome)",
IRX6,"AD (Chromosome 16q12 duplication syndrome); AR (Multicentric osteolysis, nodulosis, and arthropathy); AR (Hamamy syndrome); AD (Chromosome 16q12 duplication syndrome); AR (Multicentric osteolysis, nodulosis, and arthropathy); AR (Hamamy syndrome)",
ISCA1,"AR (Multiple mitochondrial dysfunctions syndrome 5); AR (Multiple mitochondrial dysfunctions syndrome 4); AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3); AR (Multiple mitochondrial dysfunctions syndrome 5); AR (Multiple mitochondrial dysfunctions syndrome 4); AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3)",
ISCA2,"AR (Multiple mitochondrial dysfunctions syndrome 4); AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3); AR (Multiple mitochondrial dysfunctions syndrome 5); AR (Multiple mitochondrial dysfunctions syndrome 4); AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3); AR (Multiple mitochondrial dysfunctions syndrome 5)",
ISCU,"AR (Myopathy with lactic acidosis, hereditary); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR (Combined oxidative phosphorylation deficiency 52); AR (?Anemia, sideroblastic, 5); AD (Anemia, sideroblastic, 4); AR (Even-plus syndrome); AR (Anemia, sideroblastic, 3, pyridoxine-refractory); AR (Spasticity, childhood-onset, with hyperglycinemia); AR (?Combined oxidative phosphorylation deficiency 19); AR (Multiple mitochondrial dysfunctions syndrome 1); AR (Spastic paraplegia 93, autosomal recessive); AR (Myopathy with lactic acidosis, hereditary); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR (Combined oxidative phosphorylation deficiency 52); AR (?Anemia, sideroblastic, 5); AD (Anemia, sideroblastic, 4); AR (Even-plus syndrome); AR (Anemia, sideroblastic, 3, pyridoxine-refractory); AR (Spasticity, childhood-onset, with hyperglycinemia); AR (?Combined oxidative phosphorylation deficiency 19); AR (Multiple mitochondrial dysfunctions syndrome 1); AR (Spastic paraplegia 93, autosomal recessive)",
ISG15,"AR (Immunodeficiency 38); AR (Pseudo-TORCH syndrome 2); Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; AR (Immunodeficiency 65, susceptibility to viral infections); AR (Immunodeficiency 38); AR (Pseudo-TORCH syndrome 2); Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; AR (Immunodeficiency 65, susceptibility to viral infections)",
ISL1,"AR (Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis); AR (Pituitary hormone deficiency, combined, 3); AD (Denys-Drash syndrome); AD (Frasier syndrome); AD (Meacham syndrome); Mesothelioma, somatic; AD (Nephrotic syndrome, type 4); AD (Wilms tumor, type 1); AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1); AR (Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis); AR (Pituitary hormone deficiency, combined, 3); AD (Denys-Drash syndrome); AD (Frasier syndrome); AD (Meacham syndrome); Mesothelioma, somatic; AD (Nephrotic syndrome, type 4); AD (Wilms tumor, type 1); AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1)",
ISL2,"AR (Pituitary hormone deficiency, combined, 3); AR (Pituitary hormone deficiency, combined, 3)",
ISLR2,"AD ({Exfoliation syndrome, susceptibility to}); AD ({Exfoliation syndrome, susceptibility to})",
IST1,"AD (CIMDAG syndrome); AR (Pontocerebellar hypoplasia, type 8); AR (Troyer syndrome); AD (Spastic paraplegia 4, autosomal dominant); AD (CIMDAG syndrome); AR (Pontocerebellar hypoplasia, type 8); AR (Troyer syndrome); AD (Spastic paraplegia 4, autosomal dominant)",
ISX,"[High density lipoprotein cholesterol level QTL6]; AD (?Hypercarotenemia and vitamin A deficiency, autosomal dominant); [High density lipoprotein cholesterol level QTL6]; AD (?Hypercarotenemia and vitamin A deficiency, autosomal dominant)",
ITCH,"AR (Autoimmune disease, multisystem, with facial dysmorphism); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AR (Autoimmune disease, multisystem, with facial dysmorphism); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
ITFG2,"AR (Intellectual developmental disorder, autosomal recessive 83); AR (Developmental and epileptic encephalopathy 18); AR (Intellectual developmental disorder, autosomal recessive 41); AR (Intellectual developmental disorder, autosomal recessive 83); AR (Developmental and epileptic encephalopathy 18); AR (Intellectual developmental disorder, autosomal recessive 41)",
ITGA11,"Usher syndrome, type 1H; Usher syndrome, type 1H",
ITGA2,"AD (Bleeding disorder, platelet-type, 9); Leukemia, T-cell acute lymphoblastoid; AR (Ehlers-Danlos syndrome, musculocontractural type 1); Synesthesia; AR (?Braddock-Carey syndrome 2); AD (Bleeding disorder, platelet-type, 9); Leukemia, T-cell acute lymphoblastoid; AR (Ehlers-Danlos syndrome, musculocontractural type 1); Synesthesia; AR (?Braddock-Carey syndrome 2)",
ITGA2B,"AD (Bleeding disorder, platelet-type, 16, autosomal dominant); AR (Glanzmann thrombasthenia 1); Thrombocytopenia, neonatal alloimmune, BAK antigen related; {Myocardial infarction, susceptibility to}; AD (Bleeding disorder, platelet-type, 24, autosomal dominant); AR (Glanzmann thrombasthenia 2); Purpura, posttransfusion; Thrombocytopenia, neonatal alloimmune; AR (?Bleeding disorder, platelet-type, 22); {Prostate cancer/brain cancer susceptibility, somatic}; AR (Aphasia, primary progressive); AR (Ceroid lipofuscinosis, neuronal, 11); AR (Frontotemporal dementia 2); AR (Bleeding disorder, platelet-type, 21); AD (Bleeding disorder, platelet-type, 16, autosomal dominant); AR (Glanzmann thrombasthenia 1); Thrombocytopenia, neonatal alloimmune, BAK antigen related; {Myocardial infarction, susceptibility to}; AD (Bleeding disorder, platelet-type, 24, autosomal dominant); AR (Glanzmann thrombasthenia 2); Purpura, posttransfusion; Thrombocytopenia, neonatal alloimmune; AR (?Bleeding disorder, platelet-type, 22); {Prostate cancer/brain cancer susceptibility, somatic}; AR (Aphasia, primary progressive); AR (Ceroid lipofuscinosis, neuronal, 11); AR (Frontotemporal dementia 2); AR (Bleeding disorder, platelet-type, 21)",
ITGA3,"AR (Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome); [Blood group, Raph]; AR (Epidermolysis bullosa simplex 7, with nephropathy and deafness); AD (Spinocerebellar ataxia 37); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); AR (Epidermolysis bullosa, junctional 6, with pyloric atresia); AR (Muscular dystrophy, congenital, due to ITGA7 deficiency); AR (Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome); [Blood group, Raph]; AR (Epidermolysis bullosa simplex 7, with nephropathy and deafness); AD (Spinocerebellar ataxia 37); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); AR (Epidermolysis bullosa, junctional 6, with pyloric atresia); AR (Muscular dystrophy, congenital, due to ITGA7 deficiency)",
ITGA4,"AR (Basal ganglia calcification, idiopathic, 8, autosomal recessive); AD (Wagner syndrome 1); AD (?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type); AR (Kyphomelic dysplasia); AD ({Chronic infections, due to MBL deficiency}); AR (Basal ganglia calcification, idiopathic, 8, autosomal recessive); AD (Wagner syndrome 1); AD (?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type); AR (Kyphomelic dysplasia); AD ({Chronic infections, due to MBL deficiency})",
ITGA5,"AD (Lymphatic malformation 10); AR (Multicentric osteolysis, nodulosis, and arthropathy); Immunodeficiency 50; AR (Leukocyte adhesion deficiency); AD (Lymphatic malformation 11); AD (Lymphatic malformation 10); AR (Multicentric osteolysis, nodulosis, and arthropathy); Immunodeficiency 50; AR (Leukocyte adhesion deficiency); AD (Lymphatic malformation 11)",
ITGA6,"AR (Epidermolysis bullosa, junctional 6, with pyloric atresia); [Blood group, Raph]; AR (Epidermolysis bullosa simplex 7, with nephropathy and deafness); AD (Cardiomyopathy, dilated, 1JJ); AR (?Bent bone dysplasia syndrome 2); AR (Nephrotic syndrome, type 26); AR (Epidermolysis bullosa, junctional 5A, intermediate); AR (Epidermolysis bullosa, junctional 5B, with pyloric atresia); AR (Muscular dystrophy, congenital, due to ITGA7 deficiency); AR (Epidermolysis bullosa, junctional 6, with pyloric atresia); [Blood group, Raph]; AR (Epidermolysis bullosa simplex 7, with nephropathy and deafness); AD (Cardiomyopathy, dilated, 1JJ); AR (?Bent bone dysplasia syndrome 2); AR (Nephrotic syndrome, type 26); AR (Epidermolysis bullosa, junctional 5A, intermediate); AR (Epidermolysis bullosa, junctional 5B, with pyloric atresia); AR (Muscular dystrophy, congenital, due to ITGA7 deficiency)",
ITGA7,"AR (Muscular dystrophy, congenital, due to ITGA7 deficiency); Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy; AR (Infantile-onset multisystem neurologic, endocrine, and pancreatic disease); AR (Muscular dystrophy, congenital, due to ITGA7 deficiency); Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy; AR (Infantile-onset multisystem neurologic, endocrine, and pancreatic disease)",
ITGA8,AR (Renal hypodysplasia/aplasia 1); AR (Renal hypodysplasia/aplasia 1),
ITGA9,"AR (Arterial tortuosity-bone fragility syndrome); AD (Neuronopathy, distal hereditary motor, autosomal dominant 10); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); AR (Arterial tortuosity-bone fragility syndrome); AD (Neuronopathy, distal hereditary motor, autosomal dominant 10); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type)",
ITGAE,"AR (?Immunodeficiency 125); AD (?Neutropenia, nonimmune chronic idiopathic, of adults); AD (Neutropenia, severe congenital 2, autosomal dominant); Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AD (Cohen-Gibson syndrome); AR (?Immunodeficiency 125); AD (?Neutropenia, nonimmune chronic idiopathic, of adults); AD (Neutropenia, severe congenital 2, autosomal dominant); Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AD (Cohen-Gibson syndrome)",
ITGAL,"AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); {Rheumatoid arthritis, systemic juvenile, susceptibility to}; AR (Leukocyte adhesion deficiency); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); {Rheumatoid arthritis, systemic juvenile, susceptibility to}; AR (Leukocyte adhesion deficiency)",
ITGAM,"{Systemic lupus erythematosus, susceptibility to, 6}; Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; Surfactant metabolism dysfunction, pulmonary, 4; AR (Immunodeficiency 106, susceptibility to viral infections); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); {Systemic lupus erythematosus, susceptibility to, 6}; Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; Surfactant metabolism dysfunction, pulmonary, 4; AR (Immunodeficiency 106, susceptibility to viral infections); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3)",
ITGAV,"AR (Amelogenesis imperfecta, type IH); AR (Cone-rod dystrophy 9); AR (Multicentric osteolysis, nodulosis, and arthropathy); AD (?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type); AR (Kyphomelic dysplasia); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); AR (Cleft palate, proliferative retinopathy, and developmental delay); AR (Amelogenesis imperfecta, type IH); AR (Cone-rod dystrophy 9); AR (Multicentric osteolysis, nodulosis, and arthropathy); AD (?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type); AR (Kyphomelic dysplasia); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); AR (Cleft palate, proliferative retinopathy, and developmental delay)",
ITGAX,"{Systemic lupus erythematosus, susceptibility to, 6}; AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AR (Immunodeficiency, common variable, 3); {Systemic lupus erythematosus, susceptibility to, 6}; AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AR (Immunodeficiency, common variable, 3)",
ITGB1,"AR (Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome); AD (Cavernous malformations of CNS and retina); AD (Cerebral cavernous malformations-1); AD (Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations); [Blood group, Raph]; AR (Epidermolysis bullosa simplex 7, with nephropathy and deafness); AR (?Bent bone dysplasia syndrome 2); AR (Nephrotic syndrome, type 26); AR (?Attention deficit-hyperactivity disorder 8); AD (Agenesis of corpus callosum, cardiac, ocular, and genital syndrome); AD (Arrhythmogenic right ventricular dysplasia 14); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type); AR (Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome); AD (Cavernous malformations of CNS and retina); AD (Cerebral cavernous malformations-1); AD (Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations); [Blood group, Raph]; AR (Epidermolysis bullosa simplex 7, with nephropathy and deafness); AR (?Bent bone dysplasia syndrome 2); AR (Nephrotic syndrome, type 26); AR (?Attention deficit-hyperactivity disorder 8); AD (Agenesis of corpus callosum, cardiac, ocular, and genital syndrome); AD (Arrhythmogenic right ventricular dysplasia 14); AD (Glomerulopathy with fibronectin deposits 2); AD (Spondylometaphyseal dysplasia, corner fracture type)",
ITGB1BP2,"Myopathy, congenital, with fiber-type disproportion, X-linked; Myopathy, congenital, with fiber-type disproportion, X-linked",
ITGB2,"AR (Leukocyte adhesion deficiency); AR (Leukocyte adhesion deficiency, type III); AR (Leukocyte adhesion deficiency); AR (Leukocyte adhesion deficiency, type III)",
ITGB3,"{Myocardial infarction, susceptibility to}; AD (Bleeding disorder, platelet-type, 24, autosomal dominant); AR (Glanzmann thrombasthenia 2); Purpura, posttransfusion; Thrombocytopenia, neonatal alloimmune; AD (Bleeding disorder, platelet-type, 16, autosomal dominant); AR (Glanzmann thrombasthenia 1); Thrombocytopenia, neonatal alloimmune, BAK antigen related; {Autism susceptibility 7}; {Myocardial infarction, susceptibility to}; AD (Bleeding disorder, platelet-type, 24, autosomal dominant); AR (Glanzmann thrombasthenia 2); Purpura, posttransfusion; Thrombocytopenia, neonatal alloimmune; AD (Bleeding disorder, platelet-type, 16, autosomal dominant); AR (Glanzmann thrombasthenia 1); Thrombocytopenia, neonatal alloimmune, BAK antigen related; {Autism susceptibility 7}",
ITGB3BP,Omphalocele due to duplication of 1p31.3; Omphalocele due to duplication of 1p31.3,
ITGB4,"AR (Epidermolysis bullosa, junctional 5A, intermediate); AR (Epidermolysis bullosa, junctional 5B, with pyloric atresia); [Blood group, Raph]; AR (Epidermolysis bullosa simplex 7, with nephropathy and deafness); AR (Epidermolysis bullosa, junctional 6, with pyloric atresia); AR (?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive); AD (Epidermolysis bullosa simplex 5A, Ogna type); AR (Epidermolysis bullosa simplex 5B, with muscular dystrophy); AR (Epidermolysis bullosa simplex 5C, with pyloric atresia); AR (Muscular dystrophy, limb-girdle, autosomal recessive 17); AD (Amelogenesis imperfecta, type IA); AR (Epidermolysis bullosa, junctional 1A, intermediate); AR (Epidermolysis bullosa, junctional 1B, severe); AR (Epidermolysis bullosa, junctional 5A, intermediate); AR (Epidermolysis bullosa, junctional 5B, with pyloric atresia); [Blood group, Raph]; AR (Epidermolysis bullosa simplex 7, with nephropathy and deafness); AR (Epidermolysis bullosa, junctional 6, with pyloric atresia); AR (?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive); AD (Epidermolysis bullosa simplex 5A, Ogna type); AR (Epidermolysis bullosa simplex 5B, with muscular dystrophy); AR (Epidermolysis bullosa simplex 5C, with pyloric atresia); AR (Muscular dystrophy, limb-girdle, autosomal recessive 17); AD (Amelogenesis imperfecta, type IA); AR (Epidermolysis bullosa, junctional 1A, intermediate); AR (Epidermolysis bullosa, junctional 1B, severe)",
ITGB5,"AR (Cone-rod dystrophy 9); AD (Neurodevelopmental disorder with eye movement abnormalities and ataxia); AR (Amelogenesis imperfecta, type IH); AR (Cone-rod dystrophy 9); AD (Neurodevelopmental disorder with eye movement abnormalities and ataxia); AR (Amelogenesis imperfecta, type IH)",
ITGB6,"AR (Amelogenesis imperfecta, type IH); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); AR (Cleft palate, proliferative retinopathy, and developmental delay); AR (Amelogenesis imperfecta, type IH); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); AR (Cleft palate, proliferative retinopathy, and developmental delay)",
ITGB7,"AD (Cohen-Gibson syndrome); AD ({Colorectal cancer, susceptibility to}); {Multiple myeloma, susceptibility to}; AD ({von Hippel-Lindau syndrome, modifier of}); AD (Wagner syndrome 1); AR (Leukocyte adhesion deficiency); Facioscapulohumeral muscular dystrophy 4, digenic; AR (Immunodeficiency-centromeric instability-facial anomalies syndrome 1); AD (Cohen-Gibson syndrome); AD ({Colorectal cancer, susceptibility to}); {Multiple myeloma, susceptibility to}; AD ({von Hippel-Lindau syndrome, modifier of}); AD (Wagner syndrome 1); AR (Leukocyte adhesion deficiency); Facioscapulohumeral muscular dystrophy 4, digenic; AR (Immunodeficiency-centromeric instability-facial anomalies syndrome 1)",
ITK,"AR (Lymphoproliferative syndrome 1); AD (Hypoparathyroidism, sensorineural deafness, and renal dysplasia); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AR (Immunodeficiency 22); Agammaglobulinemia, X-linked 1; Isolated growth hormone deficiency, type III, with agammaglobulinemia; AR (Lymphoproliferative syndrome 1); AD (Hypoparathyroidism, sensorineural deafness, and renal dysplasia); AR (?Immunodeficiency 88); AR ({Asthma, aspirin-induced, susceptibility to}); AR (Asthma and nasal polyps); AR (Immunodeficiency 22); Agammaglobulinemia, X-linked 1; Isolated growth hormone deficiency, type III, with agammaglobulinemia",
ITM2B,"AD (?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities); AD (Dementia, familial British); AD (Dementia, familial Danish); AD (?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities); AD (Dementia, familial British); AD (Dementia, familial Danish)",
ITPA,[Inosine triphosphatase deficiency]; AR (Developmental and epileptic encephalopathy 35); [Inosine triphosphatase deficiency]; AR (Developmental and epileptic encephalopathy 35),
ITPR1,"AR (Gillespie syndrome); AD (Spinocerebellar ataxia 15); AD (Spinocerebellar ataxia 29, congenital nonprogressive); AR (Spinocerebellar ataxia, autosomal recessive 34); AD (Thrombocytopenia 4); AR (Gillespie syndrome); AD (Spinocerebellar ataxia 15); AD (Spinocerebellar ataxia 29, congenital nonprogressive); AR (Spinocerebellar ataxia, autosomal recessive 34); AD (Thrombocytopenia 4)",
ITPR2,"AR (?Anhidrosis, isolated, with normal sweat glands); AR ({Diabetes, type 1, susceptibility to}); AD (Charcot-Marie-Tooth disease, demyelinating, type 1J); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91); AR (Gillespie syndrome); AD (Spinocerebellar ataxia 15); AD (Spinocerebellar ataxia 29, congenital nonprogressive); AR (?Anhidrosis, isolated, with normal sweat glands); AR ({Diabetes, type 1, susceptibility to}); AD (Charcot-Marie-Tooth disease, demyelinating, type 1J); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91); AR (Gillespie syndrome); AD (Spinocerebellar ataxia 15); AD (Spinocerebellar ataxia 29, congenital nonprogressive)",
ITPR3,"AR ({Diabetes, type 1, susceptibility to}); AD (Charcot-Marie-Tooth disease, demyelinating, type 1J); AR (?Anhidrosis, isolated, with normal sweat glands); AR ({Diabetes mellitus, insulin-dependent-1}); AR (Gillespie syndrome); AD (Spinocerebellar ataxia 15); AD (Spinocerebellar ataxia 29, congenital nonprogressive); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91); AR ({Diabetes, type 1, susceptibility to}); AD (Charcot-Marie-Tooth disease, demyelinating, type 1J); AR (?Anhidrosis, isolated, with normal sweat glands); AR ({Diabetes mellitus, insulin-dependent-1}); AR (Gillespie syndrome); AD (Spinocerebellar ataxia 15); AD (Spinocerebellar ataxia 29, congenital nonprogressive); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91)",
ITSN1,"AR (Bartter syndrome, type 2); AD (Pseudohypoaldosteronism, type IIB); AR (Neuropathy, hereditary sensory and autonomic, type II); AD (Pseudohypoaldosteronism, type IIC); AR (Bartter syndrome, type 2); AD (Pseudohypoaldosteronism, type IIB); AR (Neuropathy, hereditary sensory and autonomic, type II); AD (Pseudohypoaldosteronism, type IIC)",
IVD,"AR (Isovaleric acidemia); {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2); AR (Isobutyryl-CoA dehydrogenase deficiency); AR (Isovaleric acidemia); {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2); AR (Isobutyryl-CoA dehydrogenase deficiency)",
IVL,"AR (Peeling skin syndrome 2); {Psoriasis susceptibility 4}; AR (Ichthyosis, congenital, autosomal recessive 8); AD ({Dermatitis, atopic, susceptibility to, 2}); AR (Ichthyosis vulgaris); AR (Ichthyosis, congenital, autosomal recessive 1); AR (?Uncombable hair syndrome 3); AR (Peeling skin syndrome 2); {Psoriasis susceptibility 4}; AR (Ichthyosis, congenital, autosomal recessive 8); AD ({Dermatitis, atopic, susceptibility to, 2}); AR (Ichthyosis vulgaris); AR (Ichthyosis, congenital, autosomal recessive 1); AR (?Uncombable hair syndrome 3)",
IVNS1ABP,AD (Immunodeficiency 70); AD (Immunodeficiency 70),
IYD,AR (Thyroid dyshormonogenesis 4); AR (Thyroid dyshormonogenesis 4),
JAG1,"AD (?Deafness, congenital heart defects, and posterior embryotoxon); AD (Alagille syndrome 1); AD (Charcot-Marie-Tooth disease, axonal, type 2HH); AD (Tetralogy of Fallot); AD (Alagille syndrome 2); AD (Hajdu-Cheney syndrome); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy; AD (?Deafness, congenital heart defects, and posterior embryotoxon); AD (Alagille syndrome 1); AD (Charcot-Marie-Tooth disease, axonal, type 2HH); AD (Tetralogy of Fallot); AD (Alagille syndrome 2); AD (Hajdu-Cheney syndrome); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy",
JAG2,"AR (Muscular dystrophy, limb-girdle, autosomal recessive 27); AD ({Orofacial cleft 6}); AD (Popliteal pterygium syndrome 1); AD (van der Woude syndrome 1); AD (Orofacial cleft-1); AR (Traboulsi syndrome); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (?Deafness, congenital heart defects, and posterior embryotoxon); AD (Alagille syndrome 1); AD (Charcot-Marie-Tooth disease, axonal, type 2HH); AD (Tetralogy of Fallot); AR (Muscular dystrophy, limb-girdle, autosomal recessive 27); AD ({Orofacial cleft 6}); AD (Popliteal pterygium syndrome 1); AD (van der Woude syndrome 1); AD (Orofacial cleft-1); AR (Traboulsi syndrome); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (?Deafness, congenital heart defects, and posterior embryotoxon); AD (Alagille syndrome 1); AD (Charcot-Marie-Tooth disease, axonal, type 2HH); AD (Tetralogy of Fallot)",
JAGN1,"AR (Neutropenia, severe congenital, 6, autosomal recessive); AR (Neutropenia, severe congenital, 6, autosomal recessive)",
JAK1,"AD (Autoinflammation, immune dysregulation, and eosinophilia); AR (Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Immunodeficiency 106, susceptibility to viral infections); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AD (Autoinflammation, immune dysregulation, and eosinophilia); AR (Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Immunodeficiency 106, susceptibility to viral infections); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant)",
JAK2,"{Budd-Chiari syndrome, somatic}; Erythrocytosis, somatic; Leukemia, acute myeloid, somatic; Myelofibrosis, somatic; Polycythemia vera, somatic; AD (Thrombocythemia 3); Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); AD (Autoinflammatory syndrome, familial, with or without immunodeficiency); AR (Immunodeficiency 75); Myelodysplastic syndrome, somatic; AR ({Hypercholesterolemia, familial, modifier of}); AD (Growth hormone insensitivity, partial); AD (Increased responsiveness to growth hormone); AR (Laron dwarfism); Myelofibrosis, somatic; Thrombocythemia, somatic; {Budd-Chiari syndrome, somatic}; Erythrocytosis, somatic; Leukemia, acute myeloid, somatic; Myelofibrosis, somatic; Polycythemia vera, somatic; AD (Thrombocythemia 3); Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); AD (Autoinflammatory syndrome, familial, with or without immunodeficiency); AR (Immunodeficiency 75); Myelodysplastic syndrome, somatic; AR ({Hypercholesterolemia, familial, modifier of}); AD (Growth hormone insensitivity, partial); AD (Increased responsiveness to growth hormone); AR (Laron dwarfism); Myelofibrosis, somatic; Thrombocythemia, somatic",
JAK3,"AR (Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type); {Celiac disease, susceptibility to, 3}; {Diabetes mellitus, insulin-dependent, 12}; AD ({Hashimoto thyroiditis}); AD ({Systemic lupus erythematosus, susceptibility to}); AD (Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant); AD (Intellectual developmental disorder, autosomal dominant 29); AD (Schinzel-Giedion midface retraction syndrome); AR (Immunodeficiency 104, severe combined); AR (Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type); {Celiac disease, susceptibility to, 3}; {Diabetes mellitus, insulin-dependent, 12}; AD ({Hashimoto thyroiditis}); AD ({Systemic lupus erythematosus, susceptibility to}); AD (Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant); AD (Intellectual developmental disorder, autosomal dominant 29); AD (Schinzel-Giedion midface retraction syndrome); AR (Immunodeficiency 104, severe combined)",
JAM2,"AR (Basal ganglia calcification, idiopathic, 8, autosomal recessive); AR (Hemorrhagic destruction of the brain, subependymal calcification, and cataracts); AR (Basal ganglia calcification, idiopathic, 8, autosomal recessive); AR (Hemorrhagic destruction of the brain, subependymal calcification, and cataracts)",
JAM3,"AR (Hemorrhagic destruction of the brain, subependymal calcification, and cataracts); AR (Basal ganglia calcification, idiopathic, 8, autosomal recessive); Jacobsen syndrome; AR (Hemorrhagic destruction of the brain, subependymal calcification, and cataracts); AR (Basal ganglia calcification, idiopathic, 8, autosomal recessive); Jacobsen syndrome",
JARID2,AD (Developmental delay with variable intellectual disability and dysmorphic facies); AD (Imagawa-Matsumoto syndrome); AD (Developmental delay with variable intellectual disability and dysmorphic facies); AD (Imagawa-Matsumoto syndrome),
JAZF1,"AD (Imagawa-Matsumoto syndrome); {Stature QTL 17}; {Systemic lupus erythematosus, susceptibility to, 11}; AD (Disabling pansclerotic morphea of childhood); {Systemic lupus erythematosus, susceptibility to, 13}; AD (Imagawa-Matsumoto syndrome); {Stature QTL 17}; {Systemic lupus erythematosus, susceptibility to, 11}; AD (Disabling pansclerotic morphea of childhood); {Systemic lupus erythematosus, susceptibility to, 13}",
JDP2,"Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic; Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic",
JMJD1C,"{Alkaline phosphatase, plasma level of, QTL4}; AD (Intellectual developmental disorder, autosomal dominant 65); {Alkaline phosphatase, plasma level of, QTL4}; AD (Intellectual developmental disorder, autosomal dominant 65)",
JMJD6,"AD (Developmental delay, dysmorphic facies, and brain anomalies); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); AD (Developmental delay, dysmorphic facies, and brain anomalies); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2)",
JMY,AR (Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism); AR (Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism),
JPH1,"AR ({?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}); AR (Congenital myopathy 25); AR (Cardiomyopathy, dilated, 2E); AD (Cardiomyopathy, hypertrophic, 17); AR (Cardiac arrhythmia syndrome, with or without skeletal muscle weakness); AR (Charcot-Marie-Tooth disease, axonal, type 2K); AR (Charcot-Marie-Tooth disease, axonal, with vocal cord paresis); AR (Charcot-Marie-Tooth disease, recessive intermediate, A); AR (Charcot-Marie-Tooth disease, type 4A); AR ({?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}); AR (Congenital myopathy 25); AR (Cardiomyopathy, dilated, 2E); AD (Cardiomyopathy, hypertrophic, 17); AR (Cardiac arrhythmia syndrome, with or without skeletal muscle weakness); AR (Charcot-Marie-Tooth disease, axonal, type 2K); AR (Charcot-Marie-Tooth disease, axonal, with vocal cord paresis); AR (Charcot-Marie-Tooth disease, recessive intermediate, A); AR (Charcot-Marie-Tooth disease, type 4A)",
JPH2,"AR (Cardiomyopathy, dilated, 2E); AD (Cardiomyopathy, hypertrophic, 17); AD (Cardiomyopathy, dilated, 1S); AD (Cardiomyopathy, hypertrophic, 1); AD (Congenital myopathy 7A, myosin storage, autosomal dominant); AR (Congenital myopathy 7B, myosin storage, autosomal recessive); AD (Laing distal myopathy); AD (Left ventricular noncompaction 5); AR ({?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}); AR (Congenital myopathy 25); AR (Cardiomyopathy, dilated, 2E); AD (Cardiomyopathy, hypertrophic, 17); AD (Cardiomyopathy, dilated, 1S); AD (Cardiomyopathy, hypertrophic, 1); AD (Congenital myopathy 7A, myosin storage, autosomal dominant); AR (Congenital myopathy 7B, myosin storage, autosomal recessive); AD (Laing distal myopathy); AD (Left ventricular noncompaction 5); AR ({?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}); AR (Congenital myopathy 25)",
JPH3,"AD (Huntington disease-like 2); AR (Cardiomyopathy, dilated, 2E); AD (Cardiomyopathy, hypertrophic, 17); AD ({Parkinson disease, susceptibility to}); AD (Spinocerebellar ataxia 17); AR ({?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}); AR (Congenital myopathy 25); AD (Huntington disease-like 2); AR (Cardiomyopathy, dilated, 2E); AD (Cardiomyopathy, hypertrophic, 17); AD ({Parkinson disease, susceptibility to}); AD (Spinocerebellar ataxia 17); AR ({?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, modifier of}); AR (Congenital myopathy 25)",
JPH4,AD (Huntington disease-like 2); AD (Huntington disease-like 2),
JRK,"AD ({Epilepsy, idiopathic generalized, susceptibility to, 1}); AD (Epilepsy, childhood absence, 1); AD ({Epilepsy, idiopathic generalized, susceptibility to, 1}); AD (Epilepsy, childhood absence, 1)",
JUNB,{Psoriasis susceptibility 6}; {Psoriasis susceptibility 4}; AD (Malan syndrome); AD (Marshall-Smith syndrome); {Psoriasis susceptibility 6}; {Psoriasis susceptibility 4}; AD (Malan syndrome); AD (Marshall-Smith syndrome),
JUND,"Adrenal adenoma, somatic; Angiofibroma, somatic; Carcinoid tumor of lung; Lipoma, somatic; AD (Multiple endocrine neoplasia 1); Parathyroid adenoma, somatic; AD (Wiedemann-Steiner syndrome); AD (Malan syndrome); AD (Marshall-Smith syndrome); AD (Exostoses, multiple, type 3); Adrenal adenoma, somatic; Angiofibroma, somatic; Carcinoid tumor of lung; Lipoma, somatic; AD (Multiple endocrine neoplasia 1); Parathyroid adenoma, somatic; AD (Wiedemann-Steiner syndrome); AD (Malan syndrome); AD (Marshall-Smith syndrome); AD (Exostoses, multiple, type 3)",
JUP,"AD (?Arrhythmogenic right ventricular dysplasia 12); AR (Naxos disease); AD (Arrhythmogenic right ventricular dysplasia 8); AR (Cardiomyopathy, dilated, with woolly hair and keratoderma); AD (Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis); AR (Epidermolysis bullosa, lethal acantholytic); AD (Keratosis palmoplantaris striata II); AR (Arrhythmogenic right ventricular dysplasia 11); AR (Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair); AR (Ectodermal dysplasia/skin fragility syndrome); AD (Macular dystrophy, patterned, 2); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; AD (?Arrhythmogenic right ventricular dysplasia 12); AR (Naxos disease); AD (Arrhythmogenic right ventricular dysplasia 8); AR (Cardiomyopathy, dilated, with woolly hair and keratoderma); AD (Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis); AR (Epidermolysis bullosa, lethal acantholytic); AD (Keratosis palmoplantaris striata II); AR (Arrhythmogenic right ventricular dysplasia 11); AR (Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair); AR (Ectodermal dysplasia/skin fragility syndrome); AD (Macular dystrophy, patterned, 2); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic",
KALRN,"{Coronary heart disease, susceptibility to, 5}; AR (Developmental delay with short stature, dysmorphic facial features, and sparse hair 2); ?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia; {Coronary heart disease, susceptibility to, 5}; AR (Developmental delay with short stature, dysmorphic facial features, and sparse hair 2); ?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia",
KANK1,"Cerebral palsy, spastic quadriplegic, 2; Cerebral palsy, spastic quadriplegic, 2",
KANK2,"AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair); AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair)",
KANK3,"AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair); AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair)",
KANK4,"AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair); AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair)",
KANSL1,"AD (Koolen-De Vries syndrome); AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AD (Li-Ghorgani-Weisz-Hubshman syndrome); AD (Koolen-De Vries syndrome); AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AD (Li-Ghorgani-Weisz-Hubshman syndrome)",
KARS1,"AR (?Charcot-Marie-Tooth disease, recessive intermediate, B); AR (Deafness, autosomal recessive 89); AR (Deafness, congenital, and adult-onset progressive leukoencephalopathy); AR (Leukoencephalopathy, progressive, infantile-onset, with or without deafness); AR (?Charcot-Marie-Tooth disease, recessive intermediate, B); AR (Deafness, autosomal recessive 89); AR (Deafness, congenital, and adult-onset progressive leukoencephalopathy); AR (Leukoencephalopathy, progressive, infantile-onset, with or without deafness)",
KASH5,AR (Premature ovarian failure 22); AR (Spermatogenic failure 88); AR (Spermatogenic failure 60); AR (?Spermatogenic failure 59); AR (Premature ovarian failure 22); AR (Spermatogenic failure 88); AR (Spermatogenic failure 60); AR (?Spermatogenic failure 59),
KAT2A,"AD ({Melanoma, cutaneous malignant, 3}); AD (Autoinflammatory disease, familial, Behcet-like-3); AD ({Colorectal cancer, susceptibility to}); {Multiple myeloma, susceptibility to}; AD ({von Hippel-Lindau syndrome, modifier of}); AD (Spinocerebellar ataxia 7); AD ({Melanoma, cutaneous malignant, 3}); AD (Autoinflammatory disease, familial, Behcet-like-3); AD ({Colorectal cancer, susceptibility to}); {Multiple myeloma, susceptibility to}; AD ({von Hippel-Lindau syndrome, modifier of}); AD (Spinocerebellar ataxia 7)",
KAT2B,"AR (Cerebral palsy, spastic quadriplegic, 3); AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9); AD (?Epilepsy, myoclonic, familial adult, 4); AR (Cerebral palsy, spastic quadriplegic, 3); AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9); AD (?Epilepsy, myoclonic, familial adult, 4)",
KAT5,"AD (Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); AD (?Leukemia, acute myeloid); Leukemia, acute myeloid, somatic; AR (Joubert syndrome 19); AR (Nephronophthisis 14); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; AD (Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); AD (?Leukemia, acute myeloid); Leukemia, acute myeloid, somatic; AR (Joubert syndrome 19); AR (Nephronophthisis 14); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic",
KAT6A,"AD (Arboleda-Tham syndrome); AD (Intellectual developmental disorder with dysmorphic facies and ptosis); AD (Wiedemann-Steiner syndrome); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome); AD (Kabuki syndrome 1); AD (Arboleda-Tham syndrome); AD (Intellectual developmental disorder with dysmorphic facies and ptosis); AD (Wiedemann-Steiner syndrome); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome); AD (Kabuki syndrome 1)",
KAT6B,AD (Genitopatellar syndrome); AD (SBBYSS syndrome); AD (Intellectual developmental disorder with dysmorphic facies and ptosis); AD (Genitopatellar syndrome); AD (SBBYSS syndrome); AD (Intellectual developmental disorder with dysmorphic facies and ptosis),
KAT7,AD (Intellectual developmental disorder with dysmorphic facies and ptosis); AD (Intellectual developmental disorder with dysmorphic facies and ptosis),
KAT8,"AD (Li-Ghorgani-Weisz-Hubshman syndrome); AD (Koolen-De Vries syndrome); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7})",
KATNA1,"AR (Lissencephaly 6, with microcephaly); AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE); AR (Joubert syndrome 26)",
KATNAL2,{Autism susceptibility 1},
KATNB1,"AR (Lissencephaly 6, with microcephaly)",
KATNBL1,AR (Joubert syndrome 26),
KATNIP,AR (Joubert syndrome 26),
KBTBD13,"AD (Nemaline myopathy 6, autosomal dominant)",
KBTBD8,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE); AD (Treacher Collins syndrome 1)",
KCMF1,"AD (Long QT syndrome 14); AD (Ventricular tachycardia, catecholaminergic polymorphic, 4); AD (?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome)",
KCNA1,"AD (Episodic ataxia/myokymia syndrome); AD (Epilepsy, familial temporal lobe, 1); AD (Atrial fibrillation, familial, 7); AR (Congenital myopathy 12); AD (?Myasthenic syndrome, congenital, 18)",
KCNA2,"AD (Developmental and epileptic encephalopathy 32); AD (Episodic ataxia/myokymia syndrome); AR (Congenital myopathy 12); AR (Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects); AD (Charcot-Marie-Tooth disease, axonal, type 2FF)",
KCNA4,"AR (Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum); AD (Episodic ataxia/myokymia syndrome); AD (Atrial fibrillation, familial, 7)",
KCNA5,"AD (Atrial fibrillation, familial, 7); AD (Episodic ataxia/myokymia syndrome); AD (Atrial fibrillation, familial, 1)",
KCNA6,"AD (Episodic ataxia/myokymia syndrome); AD (Developmental and epileptic encephalopathy 32); AD (Atrial fibrillation, familial, 7)",
KCNA7,"AD (Atrial fibrillation, familial, 13); Brugada syndrome 5; Cardiac conduction defect, nonspecific; AR (Developmental and epileptic encephalopathy 52); AD (Generalized epilepsy with febrile seizures plus, type 1)",
KCNAB1,"AD (Epilepsy, familial temporal lobe, 1); AD (Epilepsy, familial temporal lobe, 6)",
KCNAB2,"Chromosome 1p36 deletion syndrome, distal",
KCNAB3,AD (Chromosome 17p13.1 deletion syndrome),
KCNB1,"AD (Developmental and epileptic encephalopathy 26); AR (Retinal cone dystrophy 3B); AR (?Amyotrophic lateral sclerosis 16, juvenile); AR (?Neuronopathy, distal hereditary motor, autosomal recessive 2)",
KCNB2,"AD (Brachydactyly, type E2)",
KCNC1,"AD (Epilepsy, progressive myoclonic 7); AD (Optic atrophy 12); AR (Spastic ataxia 5, autosomal recessive); AD (Spinocerebellar ataxia 28)",
KCNC2,"AD (Developmental and epileptic encephalopathy 103); AD (Atrial fibrillation, familial, 13); Brugada syndrome 5; Cardiac conduction defect, nonspecific; AR (Developmental and epileptic encephalopathy 52); AD (Generalized epilepsy with febrile seizures plus, type 1)",
KCNC3,"AD (Spinocerebellar ataxia 13); AD (Atrial fibrillation, familial, 13); Brugada syndrome 5; Cardiac conduction defect, nonspecific; AR (Developmental and epileptic encephalopathy 52); AD (Generalized epilepsy with febrile seizures plus, type 1); AD (Episodic ataxia, type 7)",
KCNC4,AD (Developmental and epileptic encephalopathy 32); ?Brugada syndrome 6,
KCND1,"AD ({Ventricular fibrillation, paroxysmal familial, 2}); AD (Intellectual developmental disorder, autosomal dominant 33); AD (Brugada syndrome 9); AD (Spinocerebellar ataxia 19)",
KCND2,AD (Brugada syndrome 9); AD (Spinocerebellar ataxia 19); AR (Hamamy syndrome); {Autism susceptibility 1},
KCND3,AD (Brugada syndrome 9); AD (Spinocerebellar ataxia 19); ?Brugada syndrome 6,
KCNE1,"AR (Jervell and Lange-Nielsen syndrome 2); AD (Long QT syndrome 5); AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); Atrial fibrillation, familial, 4; AD (Long QT syndrome 6); AD (Long QT syndrome 2); Short QT syndrome 1; AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; ?Brugada syndrome 6",
KCNE2,"Atrial fibrillation, familial, 4; AD (Long QT syndrome 6); AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AR (Jervell and Lange-Nielsen syndrome 2); AD (Long QT syndrome 5); AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; AD (Brugada syndrome 3); AD (Long QT syndrome 8); AD (Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures); AD (Timothy syndrome); AD (Long QT syndrome 2); Short QT syndrome 1",
KCNE3,"?Brugada syndrome 6; AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AR (Jervell and Lange-Nielsen syndrome 2); AD (Long QT syndrome 5)",
KCNE4,"?Brugada syndrome 6; AD ({Epilepsy, juvenile myoclonic, susceptibility to, 9})",
KCNE5,"?Brugada syndrome 6; AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AMME complex",
KCNF1,"AR (Deafness, neurosensory, autosomal recessive 47)",
KCNG3,AD (Developmental and epileptic encephalopathy 26),
KCNG4,AD (Developmental and epileptic encephalopathy 26),
KCNH1,"AD (Temple-Baraitser syndrome); AD (Zimmermann-Laband syndrome 1); AD (Developmental and epileptic encephalopathy 112); AD (Progressive familial heart block, type II); AD (Deafness, congenital, with onychodystrophy, autosomal dominant); AD (Zimmermann-Laband syndrome 2)",
KCNH2,"AD (Long QT syndrome 2); Short QT syndrome 1; AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AR (Jervell and Lange-Nielsen syndrome 2); AD (Long QT syndrome 5); AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; Atrial fibrillation, familial, 4; AD (Long QT syndrome 6)",
KCNH5,AD (Developmental and epileptic encephalopathy 112),
KCNH7,"AD ({Major affective disorder 1}); {Diabetes mellitus, insulin-dependent, 19}",
KCNIP3,"AR (Ceroid lipofuscinosis, neuronal, 3)",
KCNJ1,"AR (Bartter syndrome, type 2); AD ({?Epilepsy idiopathic generalized, susceptibility to, 8}); AR (Hyperparathyroidism, neonatal); AD (Hypocalcemia, autosomal dominant); AD (Hypocalcemia, autosomal dominant, with Bartter syndrome); AD (Hypocalciuric hypercalcemia, type I); AD (Andersen syndrome); AD (Atrial fibrillation, familial, 9); AD (Short QT syndrome 3); AR (Neuropathy, hereditary sensory and autonomic, type II); AD (Pseudohypoaldosteronism, type IIC); AR (Gitelman syndrome); AD (Pseudohypoaldosteronism, type IIB)",
KCNJ10,"AR (Enlarged vestibular aqueduct, digenic); AR (SESAME syndrome); AR (Hypokalemic tubulopathy and deafness); AR (Deafness, autosomal recessive 4, with enlarged vestibular aqueduct); AR (Pendred syndrome); [Blood pressure regulation QTL]; AD (Long QT syndrome 12); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3); AR (Distal renal tubular acidosis 3, with or without sensorineural hearing loss)",
KCNJ11,"AD (Diabetes mellitus, transient neonatal 3); AD (Diabetes, permanent neonatal 2, with or without neurologic features); AR (Hyperinsulinemic hypoglycemia, familial, 2); AD (Maturity-onset diabetes of the young, type 13); AD (Diabetes mellitus, noninsulin-dependent); AR (Diabetes mellitus, permanent neonatal 3); AD (Diabetes mellitus, transient neonatal 2); AR (Hyperinsulinemic hypoglycemia, familial, 1); AD (Hypoglycemia of infancy, leucine-sensitive); AD (Maturity-onset diabetes of the young, type 12); AR ({Diabetes mellitus, transient neonatal 1})",
KCNJ12,"AD ({Thyrotoxic periodic paralysis, susceptibility to, 2}); AR (Hypokalemic tubulopathy and deafness)",
KCNJ13,"AR (Leber congenital amaurosis 16); AD (Snowflake vitreoretinal degeneration); AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20))",
KCNJ14,AR (Hypokalemic tubulopathy and deafness),
KCNJ15,AR (Hypokalemic tubulopathy and deafness),
KCNJ16,"AR (Hypokalemic tubulopathy and deafness); AR (Enlarged vestibular aqueduct, digenic); AR (SESAME syndrome); {Thyrotoxic periodic paralysis, susceptibility to, 3}; AR (Hypertrichosis terminalis, generalized, with or without gingival hyperplasia); AD (Andersen syndrome); AD (Atrial fibrillation, familial, 9); AD (Short QT syndrome 3); AD (Intellectual developmental disorder, autosomal dominant 62); AR (Pierre Robin syndrome)",
KCNJ18,"AD ({Thyrotoxic periodic paralysis, susceptibility to, 2})",
KCNJ2,"AD (Andersen syndrome); AD (Atrial fibrillation, familial, 9); AD (Short QT syndrome 3); AR (Pierre Robin syndrome); AD (Hyperaldosteronism, familial, type III); AD (Long QT syndrome 13); {Thyrotoxic periodic paralysis, susceptibility to, 3}; AR (Hypokalemic tubulopathy and deafness)",
KCNJ3,"AD (Hyperaldosteronism, familial, type III); AD (Long QT syndrome 13)",
KCNJ4,"AD (Andersen syndrome); AD (Atrial fibrillation, familial, 9); AD (Short QT syndrome 3); AD (Hyperaldosteronism, familial, type III); AD (Long QT syndrome 13)",
KCNJ5,"AD (Hyperaldosteronism, familial, type III); AD (Long QT syndrome 13); AD (Primary aldosteronism, seizures, and neurologic abnormalities); AR (Sinoatrial node dysfunction and deafness); {Migraine with aura, susceptibility to, 9}",
KCNJ6,AD (Keppen-Lubinsky syndrome),
KCNJ8,"AD (?Atrial fibrillation, familial, 12); AD (Cardiomyopathy, dilated, 1O); AD (Hypertrichotic osteochondrodysplasia (Cantu syndrome)); AR (Intellectual disability and myopathy syndrome)",
KCNK1,"AD (Pulmonary hypertension, primary, 4); AD (?Episodic pain syndrome, familial, 1); AD ({Migraine, with or without aura, susceptibility to, 13}); AD (Congenital contractures of the limbs and face, hypotonia, and developmental delay); AR (Hypotonia, infantile, with psychomotor retardation and characteristic facies 1)",
KCNK18,"AD ({Migraine, with or without aura, susceptibility to, 13}); AD ({Migraine with or without aura, susceptibility to, 1})",
KCNK2,"AR (Muscular dystrophy, limb-girdle, autosomal recessive 26); AD (Pulmonary hypertension, primary, 4); AR (Muscular dystrophy, limb-girdle, autosomal recessive 25)",
KCNK3,"AD (Pulmonary hypertension, primary, 4); Birk-Barel syndrome; AD (Arrhythmogenic right ventricular dysplasia 5); AD (Auditory neuropathy, autosomal dominant 3); AD (Emery-Dreifuss muscular dystrophy 7, AD); AR (Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome); AD (Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension)",
KCNK4,"AD (Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome)",
KCNK7,"AD (Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome)",
KCNK9,"Birk-Barel syndrome; AD (Pulmonary hypertension, primary, 4); AD (Precocious puberty, central, 2); AD (Schaaf-Yang syndrome); {Menarche, age at, QTL}",
KCNMA1,"AD ({Epilepsy, idiopathic generalized, susceptibility to, 16}); AR (Cerebellar atrophy, developmental delay, and seizures); AD (Liang-Wang syndrome); AD (Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy); AR (Intellectual developmental disorder, autosomal recessive 2); AR (Deafness, autosomal recessive 8/10)",
KCNMB1,"AD ({Hypertension, diastolic, resistance to}); AD ({Epilepsy, idiopathic generalized, susceptibility to, 16}); AR (Cerebellar atrophy, developmental delay, and seizures); AD (Liang-Wang syndrome); AD (Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy)",
KCNMB2,"Febrile seizures, familial, 10",
KCNMB3,"Febrile seizures, familial, 10",
KCNMB4,"AD (?Dystonia 34, myoclonic); AD (Neurodevelopmental disorder with or without variable movement or behavioral abnormalities)",
KCNN1,AD (Zimmermann-Laband syndrome 3),
KCNN2,"AD (?Dystonia 34, myoclonic); AD (Neurodevelopmental disorder with or without variable movement or behavioral abnormalities); AD (Long QT syndrome 14); AD (Ventricular tachycardia, catecholaminergic polymorphic, 4)",
KCNN3,"AD (Zimmermann-Laband syndrome 3); AD (Atrial fibrillation, familial, 1); AD (Dehydrated hereditary stomatocytosis 2); AD (?Dystonia 34, myoclonic); AD (Neurodevelopmental disorder with or without variable movement or behavioral abnormalities); {Atrial fibrillation, familial, 5}",
KCNN4,"AD (Dehydrated hereditary stomatocytosis 2); AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5); AD (Zimmermann-Laband syndrome 3); AD (?Dystonia 34, myoclonic); AD (Neurodevelopmental disorder with or without variable movement or behavioral abnormalities)",
KCNQ1,"AD (Beckwith-Wiedemann syndrome); AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AR (Jervell and Lange-Nielsen syndrome 2); AD (Long QT syndrome 5); AD (Long QT syndrome 2); Short QT syndrome 1; Atrial fibrillation, familial, 4; AD (Long QT syndrome 6)",
KCNQ2,"AD (Developmental and epileptic encephalopathy 7); AD (Myokymia); AD (Seizures, benign neonatal, 1); AD (Seizures, benign neonatal, 2); {Nicotine addiction, susceptibility to}; AD (Epilepsy, nocturnal frontal lobe, 1); AD (Intellectual developmental disorder, autosomal dominant 46); {Autism susceptibility 1}",
KCNQ3,"AD (Seizures, benign neonatal, 2); AD (Developmental and epileptic encephalopathy 7); AD (Myokymia); AD (Seizures, benign neonatal, 1); AD (Deafness, autosomal dominant 2A); AD (Intellectual developmental disorder, autosomal dominant 46); AD ({Epilepsy, idiopathic generalized, susceptibility to, 1}); AR (Neurodevelopmental disorder with central and peripheral motor dysfunction)",
KCNQ4,"AD (Deafness, autosomal dominant 2A); ?Brugada syndrome 6; AD (Intellectual developmental disorder, autosomal dominant 46)",
KCNQ5,"AD (Intellectual developmental disorder, autosomal dominant 46); AD (Seizures, benign neonatal, 2)",
KCNT1,"AD (Developmental and epileptic encephalopathy 14); AD (Epilepsy nocturnal frontal lobe, 5); AD (Developmental and epileptic encephalopathy 57)",
KCNT2,AD (Developmental and epileptic encephalopathy 57),
KCNU1,AR (Spermatogenic failure 79),
KCNV2,AR (Retinal cone dystrophy 3B); AD (Developmental and epileptic encephalopathy 26); {Restless legs syndrome 3},
KCTD1,AD (Scalp-ear-nipple syndrome),
KCTD10,AR (Joubert syndrome 3); AR (Bardet-Biedl syndrome 13); AR (Joubert syndrome 28); AR (Meckel syndrome 1); AR (?Meckel syndrome 9); AR (Joubert syndrome 27); AR (COACH syndrome 2); AR (Joubert syndrome 9); AR (Meckel syndrome 6); AR (Retinitis pigmentosa 93); AR (Joubert syndrome 20); AR (Meckel syndrome 11),
KCTD13,"AD ({Autism susceptibility 14A}); AD (Chromosome 16p11.2 deletion syndrome, 593kb); AD ({Autism, susceptibility to, 14B}); AD (Chromosome 16p11.2 duplication syndrome)",
KCTD15,AD (Branchiooculofacial syndrome),
KCTD17,"AD (Dystonia 26, myoclonic)",
KCTD3,{Autism susceptibility 15}; AR (Pitt-Hopkins like syndrome 1),
KCTD6,"AR (Spherocytosis, type 1)",
KCTD7,"AR (Epilepsy, progressive myoclonic 3, with or without intracellular inclusions)",
KDELR1,"AR (Osteogenesis imperfecta, type XXI); AR (?Immunodeficiency 128)",
KDELR2,"AR (Osteogenesis imperfecta, type XXI)",
KDF1,"AD (?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type)",
KDM1A,"AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD (Adams-Oliver syndrome 3); AD (Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities); AD (Ayme-Gripp syndrome); AD (Cataract 21, multiple types); AR (El Hayek-Chahrour neurodevelopmental syndrome)",
KDM1B,"AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD (Intellectual developmental disorder, autosomal dominant 43)",
KDM3B,AD (Diets-Jongmans syndrome),
KDM4A,AR (Tayoun-Maawali syndrome),
KDM4B,"AD (Intellectual developmental disorder, autosomal dominant 65); AR (Tayoun-Maawali syndrome)",
KDM4C,"D-2-hydroxyglutaric aciduria 2; {Glioma, susceptibility to, somatic}",
KDM5A,"AR (El Hayek-Chahrour neurodevelopmental syndrome); AD (Dystonia 28, childhood-onset); AD (Intellectual developmental disorder, autosomal dominant 68); AR (Intellectual developmental disorder, autosomal recessive 65); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features)",
KDM5B,"AR (Intellectual developmental disorder, autosomal recessive 65); AR (El Hayek-Chahrour neurodevelopmental syndrome); AD (Dystonia 28, childhood-onset); AD (Intellectual developmental disorder, autosomal dominant 68); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features)",
KDM5C,"Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type; Developmental and epileptic encephalopathy 1; Hydranencephaly with abnormal genitalia; Intellectual developmental disorder, X-linked 29; Lissencephaly, X-linked 2; Partington syndrome; Proud syndrome; Aarskog-Scott syndrome; AD (Cornelia de Lange syndrome 6)",
KDM5D,"Spermatogenic failure, Y-linked, 2",
KDM6A,"Kabuki syndrome 2; AD (Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome); AD (Kabuki syndrome 1); AD (Stolerman neurodevelopmental syndrome); {Leukemia, acute lymphocytic, susceptibility to, 1}",
KDM6B,"AD (Stolerman neurodevelopmental syndrome); ?Candidiasis, familial, 6, autosomal dominant; Kabuki syndrome 2; AR (Intellectual developmental disorder, autosomal recessive 33); {Leukemia, acute lymphocytic, susceptibility to, 1}",
KDM7A,"AD (Blepharocheilodontic syndrome 1); Breast cancer, lobular, somatic; AD (Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate); Endometrial carcinoma, somatic; Ovarian cancer, somatic; Intellectual developmental disorder, X-linked syndromic, Siderius type",
KDR,"AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic; {Microvascular complications of diabetes 1}; AD (Congenital heart defects, multiple types, 7); Hemangioma, capillary infantile, somatic; AD (Lymphatic malformation 1); AD (Total anomalous pulmonary venous return); AD (Lymphatic malformation 4)",
KDSR,AR (Erythrokeratodermia variabilis et progressiva 4),
KEAP1,"AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); AD ({Epilepsy, idiopathic generalized, susceptibility to, 19}); AR (Parkinson disease 7, autosomal recessive early-onset); AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
KEL,"[Blood group, Kell]; AD (Tubulointerstitial kidney disease, autosomal dominant, 2); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta",
KERA,"AR (Cornea plana 2, autosomal recessive); AD (Corneal dystrophy, posterior amorphous); AD (Cornea plana 1, autosomal dominant); AR (Factor XIIIB deficiency)",
KHDC1,"AR (Hydatidiform mole, recurrent, 2)",
KHDC3L,"AR (Hydatidiform mole, recurrent, 2); AR (Oocyte/zygote/embryo maturation arrest 15); AR (Oocyte/zygote/embryo maturation arrest 19); AR (Hydatidiform mole, recurrent, 1); AR (Hydatidiform mole, recurrent, 3); AR (Hydatidiform mole, recurrent, 4); AR (Oocyte/zygote/embryo maturation arrest 10)",
KHK,"AR (?[Fructosuria, essential]); Myelodysplastic syndrome, somatic; AR (Arterial tortuosity-bone fragility syndrome); AD (Neuronopathy, distal hereditary motor, autosomal dominant 10); [Fasting plasma glucose level QTL 5]",
KHSRP,AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4),
KIAA0040,"{Leprosy, protection against}; {Leprosy, susceptibility to, 5}; AD (Mandibulofacial dysostosis, Guion-Almeida type)",
KIAA0319,"AD ({Dyslexia, susceptibility to, 2})",
KIAA0586,AR (Joubert syndrome 23); AR (Short-rib thoracic dysplasia 14 with polydactyly); AR (Short-rib thoracic dysplasia 1 with or without polydactyly),
KIAA0753,AR (?Joubert syndrome 38); AR (?Orofaciodigital syndrome XV); AR (Short-rib thoracic dysplasia 21 without polydactyly); AR (?Seckel syndrome 6); AR (Short-rib thoracic dysplasia 1 with or without polydactyly),
KIAA0825,"AR (Polydactyly, postaxial, type A10)",
KIAA1328,"Cornelia de Lange syndrome 2; Developmental and epileptic encephalopathy 85, with or without midline brain defects",
KIAA1549,"AR (Retinitis pigmentosa 86); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); AD (Cardiomyopathy, dilated, 1NN); AD (LEOPARD syndrome 2); AD (Noonan syndrome 5)",
KICS2,"AR (Intellectual developmental disorder, autosomal recessive 83)",
KIDINS220,"AD (Spastic paraplegia, intellectual disability, nystagmus, and obesity); AR (Ventriculomegaly and arthrogryposis); AD (Congenital heart defects and ectodermal dysplasia)",
KIF11,"AD (Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development); AR (?Braddock-Carey syndrome 2); AD (CEBALID syndrome); AD (Meningioma); AD ({Diabetes mellitus, type 2, susceptibility to})",
KIF12,"AR (Cholestasis, progressive familial intrahepatic, 8); AR (Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss); AR (Neurodevelopmental disorder with variable familial hypercholanemia)",
KIF13B,"AD (Spastic paraplegia 37, autosomal dominant)",
KIF14,"AR (?Meckel syndrome 12); AR (Microcephaly 20, primary, autosomal recessive)",
KIF15,AR (?Braddock-Carey syndrome 2); AD (Braddock-Carey syndrome 1),
KIF17,"AD (Developmental and epileptic encephalopathy 27); AD (Intellectual developmental disorder, autosomal dominant 6, with or without seizures); FG syndrome 4; Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia; Intellectual developmental disorder, with or without nystagmus",
KIF18A,"AD (Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development)",
KIF1A,"AD (NESCAV syndrome); AR (Neuropathy, hereditary sensory, type IIC); AD (Spastic paraplegia 30, autosomal dominant); AR (Spastic paraplegia 30, autosomal recessive); AD (Intellectual developmental disorder with autistic features and language delay, with or without seizures)",
KIF1B,"AD ({Neuroblastoma, susceptibility to, 1}); AD (Charcot-Marie-Tooth disease, type 2A1); {Multiple sclerosis, susceptibility to, 4}; AD (Charcot-Marie-Tooth disease, axonal, type 2A2A); AR (Charcot-Marie-Tooth disease, axonal, type 2A2B); AD (Hereditary motor and sensory neuropathy VIA); AR (Lipomatosis, multiple symmetric, with or without peripheral neuropathy); AD (Oculopharyngodistal myopathy 2)",
KIF1C,"AR (Spastic ataxia 2, autosomal recessive)",
KIF20A,"AR (?Cardiomyopathy, familial restrictive, 6); Intellectual developmental disorder, X-linked 100; Taurodontism, microdontia, and dens invaginatus; AR (?Meckel syndrome 12); AR (Microcephaly 20, primary, autosomal recessive)",
KIF21A,"AD (Fibrosis of extraocular muscles, congenital, 1); AD (Fibrosis of extraocular muscles, congenital, 3B); AR (Congenital myopathy 19); Rhabdomyosarcoma 2, alveolar; AD (Cortical dysplasia, complex, with other brain malformations 1); AD (Fibrosis of extraocular muscles, congenital, 3A)",
KIF21B,"AD (Fibrosis of extraocular muscles, congenital, 1); AD (Fibrosis of extraocular muscles, congenital, 3B)",
KIF22,"AD (Spondyloepimetaphyseal dysplasia with joint laxity, type 2)",
KIF23,"AD (Anemia, congenital dyserythropoietic, type IIIA); AR (Anemia, congenital dyserythropoietic, type IIIb, autosomal recessive); Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic; AR (?Cardiomyopathy, familial restrictive, 6); AR (Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly)",
KIF26A,"AR (Cortical dysplasia, complex, with other brain malformations 11)",
KIF27,"AR (?Al-Gazali-Bakalinova syndrome); AR (?Hydrolethalus syndrome 2); AR (Acrocallosal syndrome); AR (Joubert syndrome 12); AR ({Medulloblastoma}); AD ({Meningioma, familial, susceptibility to}); Basal cell nevus syndrome 2; AR (Joubert syndrome 32); AR (?Ciliary dyskinesia, primary, 46); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor)",
KIF2A,"AD (Cortical dysplasia, complex, with other brain malformations 3); AR (?Seckel syndrome 4); AR (Microcephaly 6, primary, autosomal recessive); AD (Charcot-Marie-Tooth disease, axonal, type 2O); AD (Cortical dysplasia, complex, with other brain malformations 13); AD (Spinal muscular atrophy, lower extremity-predominant 1, AD); AD (Cortical dysplasia, complex, with other brain malformations 4); AD (Cortical dysplasia, complex, with other brain malformations 2); AR (Cortical dysplasia, complex, with other brain malformations 12)",
KIF2B,"AD (Cortical dysplasia, complex, with other brain malformations 3)",
KIF2C,"AD (Cortical dysplasia, complex, with other brain malformations 3); AR (Goldberg-Shprintzen megacolon syndrome)",
KIF3A,"AR (Nephronophthisis 7); AR (Heterotaxy, visceral, 9, autosomal, with male infertility); AD (Polycystic kidney disease 2); AD (Retinitis pigmentosa 89); AD (Cornelia de Lange syndrome 3)",
KIF3B,"AD (Retinitis pigmentosa 89); AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive); AR (Stromme syndrome); AD (Dowling-Degos disease 2); AD (Cornelia de Lange syndrome 3); AD (Bohring-Opitz syndrome); Myelodysplastic syndrome, somatic; AD (Shashi-Pena syndrome)",
KIF3C,"Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; AD ({Osteoarthritis susceptibility 2}); AD (Epiphyseal dysplasia, multiple, 5); AR (Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type); AD (Shashi-Pena syndrome)",
KIF4A,"Intellectual developmental disorder, X-linked 100; Taurodontism, microdontia, and dens invaginatus; Facioscapulohumeral muscular dystrophy 4, digenic; AR (Immunodeficiency-centromeric instability-facial anomalies syndrome 1); AD (Cortical dysplasia, complex, with other brain malformations 2); AR (?Cardiomyopathy, familial restrictive, 6)",
KIF4B,"Intellectual developmental disorder, X-linked 100; Taurodontism, microdontia, and dens invaginatus",
KIF5A,"AD ({Amyotrophic lateral sclerosis, susceptibility to, 25}); AD (Myoclonus, intractable, neonatal); AD (Spastic paraplegia 10, autosomal dominant); AR (Spastic paraplegia 26, autosomal recessive); AD (Cortical dysplasia, complex, with other brain malformations 2)",
KIF5B,"AD ({Encephalopathy, acute, infection-induced, 3, susceptibility to}); AD ({Amyotrophic lateral sclerosis, susceptibility to, 25}); AD (Myoclonus, intractable, neonatal); AD (Spastic paraplegia 10, autosomal dominant); AD (Cortical dysplasia, complex, with other brain malformations 2); AR (Spastic paraplegia, optic atrophy, and neuropathy)",
KIF5C,"AD (Cortical dysplasia, complex, with other brain malformations 2); AD ({Encephalopathy, acute, infection-induced, 3, susceptibility to}); AR ({Encephalopathy, acute, infection-induced, susceptibility to, 9}); Leukemia, acute myeloid, somatic; Leukemia, T-cell acute lymphoblastic, somatic; AD (Charcot-Marie-Tooth disease, axonal, type 2O); AD (Cortical dysplasia, complex, with other brain malformations 13); AD (Spinal muscular atrophy, lower extremity-predominant 1, AD); AD (Cortical dysplasia, complex, with other brain malformations 4); AD (Cortical dysplasia, complex, with other brain malformations 3); AD ({Amyotrophic lateral sclerosis, susceptibility to, 25}); AD (Myoclonus, intractable, neonatal); AD (Spastic paraplegia 10, autosomal dominant)",
KIF6,"{Coronary heart disease, susceptibility to}",
KIF7,"AR (?Al-Gazali-Bakalinova syndrome); AR (?Hydrolethalus syndrome 2); AR (Acrocallosal syndrome); AR (Joubert syndrome 12); AR (?RHYNS syndrome); AR ({Bardet-Biedl syndrome 14, modifier of}); AR (COACH syndrome 1); AR (Joubert syndrome 6); AR (Meckel syndrome 3); AR (Nephronophthisis 11); AR (Joubert syndrome 15)",
KIFAP3,"AR (Myasthenic syndrome, congenital, 6, presynaptic); AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive); Cone-rod dystrophy, X-linked, 1; Macular degeneration, X-linked atrophic; Retinitis pigmentosa 3; Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness",
KIFBP,AR (Goldberg-Shprintzen megacolon syndrome),
KIFC1,AR (Goldberg-Shprintzen megacolon syndrome),
KIFC3,AR (Retinitis pigmentosa 45),
KIN,"AR (Nephrotic syndrome, type 23); AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-",
KIR2DL1,"{HIV-1 viremia, susceptibility to}; {Psoriasis susceptibility 1}; {Rheumatoid arthritis, susceptibility to}; AD (Preeclampsia/eclampsia 1); AR ({Alzhieimer disease 17, susceptibility to}); AR (Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2)",
KIR2DL3,"{HIV-1 viremia, susceptibility to}; {Psoriasis susceptibility 1}",
KIR3DL1,"{Ankylosing spondylitis, susceptibility to, 1}; {Severe cutaneous adverse reaction, susceptibility to}; {Stevens-Johnson syndrome, susceptibility to}; {Toxic epidermal necrolysis, susceptibility to}",
KIRREL1,"AR (Nephrotic syndrome, type 23)",
KIRREL3,"AD (Intellectual developmental disorder, autosomal dominant 4); AD (Intellectual developmental disorder, autosomal dominant 3)",
KISS1,"AR (?Hypogonadotropic hypogonadism 13 with or without anosmia); AD (?Precocious puberty, central, 1); AR (Hypogonadotropic hypogonadism 8 with or without anosmia); Mucoepidermoid salivary gland carcinoma; AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay); AR (?Hypogonadotropic hypogonadism 27 without anosmia)",
KISS1R,"AD (?Precocious puberty, central, 1); AR (Hypogonadotropic hypogonadism 8 with or without anosmia); AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay); AR (?Hypogonadotropic hypogonadism 13 with or without anosmia); AR (Hypogonadotropic hypogonadism 18 with or without anosmia)",
KIT,"AD (Gastrointestinal stromal tumor, familial); Germ cell tumors, somatic; Leukemia, acute myeloid, somatic; AD (Mastocytosis, cutaneous); Mastocytosis, systemic, somatic; AD (Piebaldism); [Skin/hair/eye pigmentation 7, blond/brown hair]; AD (Deafness, autosomal dominant 69, unilateral or asymmetric); AD (Hyperpigmentation with or without hypopigmentation); AR (Waardenburg syndrome, type 2F); Leukemia, acute lymphoblastic, somatic; Leukemia, acute myeloid, reduced survival in, somatic; Leukemia, acute myeloid, somatic; AD (Neurodevelopmental disorder with absent language and variable seizures); AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic",
KITLG,"[Skin/hair/eye pigmentation 7, blond/brown hair]; AD (Deafness, autosomal dominant 69, unilateral or asymmetric); AD (Hyperpigmentation with or without hypopigmentation); AR (Waardenburg syndrome, type 2F); AR (Metaphyseal anadysplasia 2); AD (Myelokathexis, isolated); AD (WHIM syndrome 1); {AIDS, resistance to}; AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic",
KIZ,AR (Retinitis pigmentosa 69),
KL,"AR (?Tumoral calcinosis, hyperphosphatemic, familial, 3); [Skin/hair/eye pigmentation 7, blond/brown hair]; AD (Deafness, autosomal dominant 69, unilateral or asymmetric); AD (Hyperpigmentation with or without hypopigmentation); AR (Waardenburg syndrome, type 2F); AD (Gastrointestinal stromal tumor, familial); Germ cell tumors, somatic; Leukemia, acute myeloid, somatic; AD (Mastocytosis, cutaneous); Mastocytosis, systemic, somatic; AD (Piebaldism); {Pulmonary hypertension, neonatal, susceptibility to}; AR (Carbamoylphosphate synthetase I deficiency); ?Focal cortical dysplasia, type II, somatic; Lymphangioleiomyomatosis, somatic; AD (Tuberous sclerosis-2); AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development)",
KLB,"AR (?Tumoral calcinosis, hyperphosphatemic, familial, 3)",
KLC1,"AR (Spastic paraplegia, optic atrophy, and neuropathy); AD (Spastic paraplegia, intellectual disability, nystagmus, and obesity); AR (Ventriculomegaly and arthrogryposis); AD ({Encephalopathy, acute, infection-induced, 3, susceptibility to}); AR (Deafness, autosomal recessive 76); AR ({Encephalopathy, acute, infection-induced, susceptibility to, 9}); Leukemia, acute myeloid, somatic; Leukemia, T-cell acute lymphoblastic, somatic; AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1",
KLC2,"AR (Spastic paraplegia, optic atrophy, and neuropathy); AR (?Neurodegeneration, early-childhood-onset, with retinitis pigmentosa, sensorineural hearing loss, and demyelinating peripheral neuropathy); AR ({Encephalopathy, acute, infection-induced, susceptibility to, 9}); Leukemia, acute myeloid, somatic; Leukemia, T-cell acute lymphoblastic, somatic; {Autism susceptibility 1}; AD ({Encephalopathy, acute, infection-induced, 3, susceptibility to}); AD (Congenital heart defects, multiple types, 8, with or without heterotaxy); AD (Loeys-Dietz syndrome 6)",
KLC4,"AR (?Neurodegeneration, early-childhood-onset, with retinitis pigmentosa, sensorineural hearing loss, and demyelinating peripheral neuropathy)",
KLF1,"AD ([Hereditary persistence of fetal hemoglobin]); AR (Anemia, congenital dyserythropoietic, type IVb); AD (Anemia, dyserythropoietic congenital, type IVa); AD (Blood group--Lutheran inhibitor); AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-; {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AD (Dias-Logan syndrome)",
KLF10,"AD (Corneal dystrophy, Avellino type); AD (Corneal dystrophy, epithelial basement membrane); AD (Corneal dystrophy, Groenouw type I); AD (Corneal dystrophy, lattice type I); AD (Corneal dystrophy, lattice type IIIA); AD (Corneal dystrophy, Reis-Bucklers type); AD (Corneal dystrophy, Thiel-Behnke type); Maturity-onset diabetes of the young, type VII",
KLF11,"Maturity-onset diabetes of the young, type VII",
KLF12,AD (Branchiooculofacial syndrome),
KLF13,"Maturity-onset diabetes of the young, type VII; AD (Amelogenesis imperfecta, type IK); Chromosome 15q13.3 microdeletion syndrome; AR (Neurodevelopmental disorder with hypotonia and seizures)",
KLF14,"AD (Amelogenesis imperfecta, type IK); Maturity-onset diabetes of the young, type VII; {Basal cell carcinoma, susceptibility to, 6}",
KLF15,"AD (Facioscapulohumeral muscular dystrophy 1); AD (Facial paresis, hereditary congenital, 1)",
KLF2,"{Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}; AD (Cerebral cavernous malformations-2); Autoinflammatory syndrome, familial, X-linked, Behcet-like 2",
KLF4,"Burkitt lymphoma, somatic; AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system); AD (Ulnar-mammary syndrome); Autoinflammatory syndrome, familial, X-linked, Behcet-like 2",
KLF5,AD (?IVIC syndrome); AD (Duane-radial ray syndrome),
KLF6,"Gastric cancer, somatic; Prostate cancer, somatic",
KLF7,"AD (Neuronopathy, distal hereditary motor, autosomal dominant 6)",
KLF9,"Leukemia, acute promyelocytic, PL2F/RARA type; AD (Hypothyroidism, congenital, nongoitrous, 6); AD (Otosclerosis 8)",
KLHDC8B,"AR ({Hodgkin lymphoma, susceptibility to}); AR (Beck-Fahrner syndrome)",
KLHDC9,AR (Combined oxidative phosphorylation deficiency 53),
KLHL1,"AD ({Parkinson disease, susceptibility to}); AD (Spinocerebellar ataxia 8)",
KLHL10,AD (Spermatogenic failure 11); AD (?Premature ovarian failure 16),
KLHL11,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
KLHL12,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE); AD ({Attention deficit-hyperactivity disorder}); Autonomic nervous system dysfunction; AR (?Halperin-Birk syndrome)",
KLHL13,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
KLHL14,"{Dystonia-1, modifier of}; AR (Arthrogryposis multiplex congenita 5); AD (Dystonia-1, torsion)",
KLHL15,"Intellectual developmental disorder, X-linked 103",
KLHL2,"AR (Pseudohypoaldosteronism, type IID)",
KLHL21,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
KLHL22,"AR (Developmental and epileptic encephalopathy 111); AD (Epilepsy, familial focal, with variable foci 1); AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
KLHL24,"AR (Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies); AD (Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy)",
KLHL25,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
KLHL3,"AR (Pseudohypoaldosteronism, type IID); AD (Pseudohypoaldosteronism, type IIB); AD (Pseudohypoaldosteronism, type IIA)",
KLHL40,"AR (Nemaline myopathy 8, autosomal recessive)",
KLHL41,AR (Nemaline myopathy 9),
KLHL42,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
KLHL7,AR (PERCHING syndrome); AD (Retinitis pigmentosa 42),
KLHL9,"AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE)",
KLK1,"[Kallikrein, decreased urinary activity of]; AD (Angioedema, hereditary, 4); AR (Dysplasminogenemia); AR (Plasminogen deficiency, type I); AD ({Alzheimer disease, late-onset, susceptibility to}); AD (Quebec platelet disorder); AD (Ichthyosis with erythrokeratoderma)",
KLK10,AD (Ichthyosis with erythrokeratoderma),
KLK11,AD (Ichthyosis with erythrokeratoderma),
KLK12,AD (Ichthyosis with erythrokeratoderma),
KLK14,AD (Ichthyosis with erythrokeratoderma),
KLK15,"[Kallikrein, decreased urinary activity of]; {Prostate cancer, hereditary, 15}",
KLK2,"[Kallikrein, decreased urinary activity of]; {Prostate cancer, hereditary, 15}; AR (Amelogenesis imperfecta, type IIA1)",
KLK3,"AR (Fletcher factor (prekallikrein) deficiency); {Prostate cancer, hereditary, 15}; AD (Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD); AR (Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2); {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; Down syndrome",
KLK4,"AR (Amelogenesis imperfecta, type IIA1); AR (Amelogenesis imperfecta, type IIA2)",
KLK5,AD (Ichthyosis with erythrokeratoderma),
KLK6,"AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4)",
KLK7,"AD ({Otitis media, susceptibility to})",
KLK9,"[Kallikrein, decreased urinary activity of]",
KLKB1,"AR (Fletcher factor (prekallikrein) deficiency); AD (Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD); AR (Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2); AD (Facioscapulohumeral muscular dystrophy 1)",
KLLN,Cowden syndrome 4,
KLRB1,"{Myocardial infarction, susceptibility to}; AR (Immunodeficiency 42)",
KLRC1,"{Aspergillosis, susceptibility to}",
KLRC2,"{Aspergillosis, susceptibility to}",
KLRC4,"{Aspergillosis, susceptibility to}",
KLRD1,"{Myocardial infarction, susceptibility to}; {Aspergillosis, susceptibility to}",
KLRG1,"AD (Blepharocheilodontic syndrome 1); Breast cancer, lobular, somatic; AD (Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate); Endometrial carcinoma, somatic; Ovarian cancer, somatic; AR (?Attention deficit-hyperactivity disorder 8); AD (Agenesis of corpus callosum, cardiac, ocular, and genital syndrome); AD (Arrhythmogenic right ventricular dysplasia 14)",
KLRK1,AR (Immunodeficiency 58),
KMT2A,"AD (Wiedemann-Steiner syndrome); AR (Suleiman-El-Hattab syndrome); {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Arboleda-Tham syndrome); AD (Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome); AD (Kabuki syndrome 1)",
KMT2B,"AD (Dystonia 28, childhood-onset); AD (Intellectual developmental disorder, autosomal dominant 68); AD (Chromosome 19q13.11 deletion syndrome, distal); AR (El Hayek-Chahrour neurodevelopmental syndrome); AD (Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome); AD (Kabuki syndrome 1); AR (Intellectual developmental disorder, autosomal recessive 65); AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features)",
KMT2C,AD (Kleefstra syndrome 2),
KMT2D,"AD (Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome); AD (Kabuki syndrome 1); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AD (Dystonia 28, childhood-onset); AD (Intellectual developmental disorder, autosomal dominant 68); AR (Suleiman-El-Hattab syndrome); AD (Wiedemann-Steiner syndrome)",
KMT2E,AD (O'Donnell-Luria-Rodan syndrome),
KMT5B,"AD (Intellectual developmental disorder, autosomal dominant 51)",
KNG1,"AR ([High molecular weight kininogen deficiency]); AR ([Kininogen deficiency]); AD (Angioedema, hereditary, 6); [Kallikrein, decreased urinary activity of]; AD (Thrombophilia 11 due to HRG deficiency); AD (Angioedema, hereditary, 3); AR (Factor XII deficiency)",
KNL1,"AR (Microcephaly 4, primary, autosomal recessive); AR (Cholestasis, progressive familial intrahepatic, 9)",
KNSTRN,"?Roifman-Chitayat syndrome, digenic; ?Roifman-Chitayat syndrome, digenic; AD (Immunodeficiency 14A, autosomal dominant); AR (Immunodeficiency 14B, autosomal recessive)",
KPNA1,"Congenital heart defects, nonsyndromic, multiple types, 1, X-linked; Heterotaxy, visceral, 1, X-linked; VACTERL association, X-linked; AD (?Giant axonal neuropathy 2, autosomal dominant)",
KPNA2,"AR (Oocyte/zygote/embryo maturation arrest 17); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}); AD (Spinocerebellar ataxia 14); AD (Spastic paraplegia 88, autosomal dominant)",
KPNA3,"AD (Spastic paraplegia 88, autosomal dominant)",
KPNA4,"AD (Spastic paraplegia 88, autosomal dominant); AR (Polyhydramnios, megalencephaly, and symptomatic epilepsy)",
KPNA5,"AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant)",
KPNA6,"Congenital heart defects, nonsyndromic, multiple types, 1, X-linked; Heterotaxy, visceral, 1, X-linked; VACTERL association, X-linked",
KPNA7,AR (Oocyte/zygote/embryo maturation arrest 17); {Inflammatory bowel disease 11},
KPNB1,"AR (Oocyte/zygote/embryo maturation arrest 17); AD (?Giant axonal neuropathy 2, autosomal dominant); 46XX sex reversal 1; 46XY sex reversal 1",
KPTN,"AR (Intellectual developmental disorder, autosomal recessive 41); AR (Intellectual developmental disorder, autosomal recessive 83); AR (Developmental and epileptic encephalopathy 18)",
KRAS,"Arteriovenous malformation of the brain, somatic; Bladder cancer, somatic; Breast cancer, somatic; AD (Cardiofaciocutaneous syndrome 2); Gastric cancer, somatic; Leukemia, acute myeloid, somatic; Lung cancer, somatic; AD (Noonan syndrome 3); Oculoectodermal syndrome, somatic; Pancreatic carcinoma, somatic; AD (RAS-associated autoimmune leukoproliferative disorder); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic; Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic; Colorectal cancer, somatic; Epidermal nevus, somatic; Melanocytic nevus syndrome, congenital, somatic; Neurocutaneous melanosis, somatic; AD (Noonan syndrome 6); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Thyroid carcinoma, follicular, somatic",
KREMEN1,"AR (Ectodermal dysplasia 13, hair/tooth type)",
KRIT1,"AD (Cavernous malformations of CNS and retina); AD (Cerebral cavernous malformations-1); AD (Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations); AD (Cerebral cavernous malformations-2); AD (Cerebral cavernous malformations-3); Basal cell carcinoma, somatic; AD (Capillary malformation-arteriovenous malformation 1)",
KRT1,"AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic); AD (?Ichthyosis histrix, Lambert type); AD (Epidermolytic hyperkeratosis 2A, autosomal dominant); AR (Epidermolytic hyperkeratosis 2B, autosomal recessive); AD (Ichthyosis with confetti); AD (Ichthyosis, annular epidermolytic 1); AD (Ichthyosis bullosa of Siemens)",
KRT10,"AD (?Ichthyosis histrix, Lambert type); AD (Epidermolytic hyperkeratosis 2A, autosomal dominant); AR (Epidermolytic hyperkeratosis 2B, autosomal recessive); AD (Ichthyosis with confetti); AD (Ichthyosis, annular epidermolytic 1); AD (Ichthyosis bullosa of Siemens)",
KRT12,AD (Meesmann corneal dystrophy 1); AD (Meesmann corneal dystrophy 2),
KRT13,"AD (White sponge nevus 2); AD (?Ichthyosis histrix, Lambert type); AD (Epidermolytic hyperkeratosis 2A, autosomal dominant); AR (Epidermolytic hyperkeratosis 2B, autosomal recessive); AD (Ichthyosis with confetti); AD (Ichthyosis, annular epidermolytic 1)",
KRT14,"AD (Dermatopathia pigmentosa reticularis); AD (Epidermolysis bullosa simplex 1A, generalized severe); AD (Epidermolysis bullosa simplex 1B, generalized intermediate); AD (Epidermolysis bullosa simplex 1C, localized); AR (Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive); AD (Naegeli-Franceschetti-Jadassohn syndrome); AR (Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies); AD (Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy); AD (Dowling-Degos disease 1); AD (Epidermolysis bullosa simplex 2A, generalized severe); AD (Epidermolysis bullosa simplex 2B, generalized intermediate); AD (Epidermolysis bullosa simplex 2C, localized); AR (Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive); AD (Epidermolysis bullosa simplex 2E, with migratory circinate erythema); AD (Epidermolysis bullosa simplex 2F, with mottled pigmentation)",
KRT15,"AD (Dowling-Degos disease 1); AD (Epidermolysis bullosa simplex 2A, generalized severe); AD (Epidermolysis bullosa simplex 2B, generalized intermediate); AD (Epidermolysis bullosa simplex 2C, localized); AR (Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive); AD (Epidermolysis bullosa simplex 2E, with migratory circinate erythema); AD (Epidermolysis bullosa simplex 2F, with mottled pigmentation); AD (White sponge nevus 2); AD (?Ichthyosis histrix, Lambert type); AD (Epidermolytic hyperkeratosis 2A, autosomal dominant); AR (Epidermolytic hyperkeratosis 2B, autosomal recessive); AD (Ichthyosis with confetti); AD (Ichthyosis, annular epidermolytic 1); AD (White sponge nevus 1); AR (?Arthrogryposis, Perthes disease, and upward gaze palsy); AR (Lethal congenital contracture syndrome 10); Nevus comedonicus, somatic; AR (Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies); AD (Epidermolysis bullosa simplex 6, generalized intermediate, with or without cardiomyopathy)",
KRT16,"AD (Pachyonychia congenita 1); AD (Palmoplantar keratoderma, nonepidermolytic, focal); AD (?Ichthyosis histrix, Lambert type); AD (Epidermolytic hyperkeratosis 2A, autosomal dominant); AR (Epidermolytic hyperkeratosis 2B, autosomal recessive); AD (Ichthyosis with confetti); AD (Ichthyosis, annular epidermolytic 1); AD (Pachyonychia congenita 3); AD (Pachyonychia congenita 4); AD (Dermatopathia pigmentosa reticularis); AD (Epidermolysis bullosa simplex 1A, generalized severe); AD (Epidermolysis bullosa simplex 1B, generalized intermediate); AD (Epidermolysis bullosa simplex 1C, localized); AR (Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive); AD (Naegeli-Franceschetti-Jadassohn syndrome); AD (Ichthyosis bullosa of Siemens)",
KRT17,"AD (Pachyonychia congenita 2); AD (Steatocystoma multiplex); AD (Culler-Jones syndrome); AD (Holoprosencephaly 9); AD (Pachyonychia congenita 4); AD (?Ichthyosis histrix, Lambert type); AD (Epidermolytic hyperkeratosis 2A, autosomal dominant); AR (Epidermolytic hyperkeratosis 2B, autosomal recessive); AD (Ichthyosis with confetti); AD (Ichthyosis, annular epidermolytic 1); AD (Dowling-Degos disease 1); AD (Epidermolysis bullosa simplex 2A, generalized severe); AD (Epidermolysis bullosa simplex 2B, generalized intermediate); AD (Epidermolysis bullosa simplex 2C, localized); AR (Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive); AD (Epidermolysis bullosa simplex 2E, with migratory circinate erythema); AD (Epidermolysis bullosa simplex 2F, with mottled pigmentation); AD (Pachyonychia congenita 3); AD (White sponge nevus 2)",
KRT18,"AR ({Cirrhosis, noncryptogenic, susceptibility to}); AR (Cirrhosis, cryptogenic); AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic); AD (Polycystic kidney disease 1); AR (FINCA syndrome)",
KRT19,"AD (White sponge nevus 2); AR ({Cirrhosis, noncryptogenic, susceptibility to}); AR (Cirrhosis, cryptogenic); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3)",
KRT2,"AD (Ichthyosis bullosa of Siemens); AD (Meesmann corneal dystrophy 2); AD (?Ichthyosis histrix, Lambert type); AD (Epidermolytic hyperkeratosis 2A, autosomal dominant); AR (Epidermolytic hyperkeratosis 2B, autosomal recessive); AD (Ichthyosis with confetti); AD (Ichthyosis, annular epidermolytic 1); AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic)",
KRT25,"AR (Woolly hair, autosomal recessive 3)",
KRT3,AD (Meesmann corneal dystrophy 2),
KRT32,Developmental and epileptic encephalopathy 36,
KRT35,"AR (Ectodermal dysplasia 9, hair/nail type)",
KRT4,"AD (White sponge nevus 1); AD (Pachyonychia congenita 3); AD (White sponge nevus 2); AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic)",
KRT5,"AD (Dowling-Degos disease 1); AD (Epidermolysis bullosa simplex 2A, generalized severe); AD (Epidermolysis bullosa simplex 2B, generalized intermediate); AD (Epidermolysis bullosa simplex 2C, localized); AR (Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive); AD (Epidermolysis bullosa simplex 2E, with migratory circinate erythema); AD (Epidermolysis bullosa simplex 2F, with mottled pigmentation); AD (Dermatopathia pigmentosa reticularis); AD (Epidermolysis bullosa simplex 1A, generalized severe); AD (Epidermolysis bullosa simplex 1B, generalized intermediate); AD (Epidermolysis bullosa simplex 1C, localized); AR (Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive); AD (Naegeli-Franceschetti-Jadassohn syndrome)",
KRT6A,"AD (Pachyonychia congenita 3); AD (Pachyonychia congenita 4); AD (Palmoplantar keratoderma, nonepidermolytic, focal or diffuse); AD (Dowling-Degos disease 1); AD (Epidermolysis bullosa simplex 2A, generalized severe); AD (Epidermolysis bullosa simplex 2B, generalized intermediate); AD (Epidermolysis bullosa simplex 2C, localized); AR (Epidermolysis bullosa simplex 2D, generalized, intermediate or severe, autosomal recessive); AD (Epidermolysis bullosa simplex 2E, with migratory circinate erythema); AD (Epidermolysis bullosa simplex 2F, with mottled pigmentation); AD (Pachyonychia congenita 1); AD (Palmoplantar keratoderma, nonepidermolytic, focal)",
KRT6B,"AD (Pachyonychia congenita 4); AD (Pachyonychia congenita 2); AD (Steatocystoma multiplex); AD (Palmoplantar keratoderma, nonepidermolytic, focal or diffuse); AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic); AD (Ichthyosis bullosa of Siemens)",
KRT6C,"AD (Palmoplantar keratoderma, nonepidermolytic, focal or diffuse)",
KRT7,"AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic)",
KRT71,AD (?Hypotrichosis 13); AR (Trichomegaly); AR (?Humerofemoral hypoplasia with radiotibial ray deficiency); AR (Tetraamelia syndrome 2),
KRT74,"AR (?Ectodermal dysplasia 7, hair/nail type); AD (?Hypotrichosis 3); AD (Woolly hair, autosomal dominant); AD (?Hypotrichosis 13)",
KRT75,"{Pseudofolliculitis barbae, susceptibility to}",
KRT8,"AR ({Cirrhosis, noncryptogenic, susceptibility to}); AR (Cirrhosis, cryptogenic); AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AD (Polycystic kidney disease 1)",
KRT81,AD (Monilethrix 2); AD (Monilethrix 1); AR (Erythrokeratodermia variabilis et progressiva 5); AD (Monilethrix 3); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor),
KRT83,AR (Erythrokeratodermia variabilis et progressiva 5); AD (Monilethrix 3); AD (Monilethrix 2),
KRT84,AR (Erythrokeratodermia variabilis et progressiva 5); AD (Monilethrix 3),
KRT85,"AR (Ectodermal dysplasia 4, hair/nail type); AR (Ectodermal dysplasia 9, hair/nail type); AD (Monilethrix 2); AR (Erythrokeratodermia variabilis et progressiva 5); AD (Monilethrix 3); AD (Monilethrix 1)",
KRT86,"AD (Monilethrix 1); AD (Monilethrix 2); AR (Erythrokeratodermia variabilis et progressiva 5); AD (Monilethrix 3); AR (Ectodermal dysplasia 4, hair/nail type)",
KRT9,"AD (Palmoplantar keratoderma, epidermolytic, 1); AD (Ichthyosis bullosa of Siemens); AD (?Guttmacher syndrome); AD (Hand-foot-genital syndrome); AR ({Cirrhosis, noncryptogenic, susceptibility to}); AR (Cirrhosis, cryptogenic)",
KRTAP11-1,"AR (Ectodermal dysplasia 9, hair/nail type)",
KRTCAP2,"AD (Congenital disorder of glycosylation, type Iw, autosomal dominant); AR (Congenital disorder of glycosylation, type Iw, autosomal recessive); AR (Congenital disorder of glycosylation, type Ix)",
KSR1,"AR (?Visual impairment and progressive phthisis bulbi); AD (Noonan syndrome-like with loose anagen hair 1); Intellectual developmental disorder, X-linked syndromic, Houge type",
KSR2,"AD (Cardiofaciocutaneous syndrome 3); Melorheostosis, isolated, somatic mosaic; Lung cancer, somatic; Cerebral cavernous malformations 5",
KTN1,"AR (Neurodevelopmental disorder with thin corpus callosum, hypotonia, and absent language)",
KXD1,"AR (Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities)",
KY,"AR (Myopathy, myofibrillar, 7); AD (Arrhythmogenic right ventricular dysplasia, familial); AD (Cardiomyopathy, familial hypertrophic, 26); AD (Cardiomyopathy, familial restrictive 5); AD (Myopathy, distal, 4); AD (Myopathy, myofibrillar, 5); AD (Cardiomyopathy, dilated, 1I); AR (Myopathy, myofibrillar, 1); AD (Scapuloperoneal syndrome, neurogenic, Kaeser type); {?Schizophrenia, susceptibility to}; AD (Silver-Russell syndrome 5); AD ({Schizophrenia})",
KYNU,"AR (?Hydroxykynureninuria); AR (Vertebral, cardiac, renal, and limb defects syndrome 2); AR (Hoxha-Aliu syndrome); AR (Spondyloepimetaphyseal dysplasia, Guo-Campeau type)",
L1CAM,"?Corpus callosum, partial agenesis of; Hydrocephalus, congenital, X-linked; MASA syndrome; {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; AD (Cardiac arrhythmia, ankyrin-B-related); AD (Long QT syndrome 4); AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5); AD (Intellectual developmental disorder, autosomal dominant 7); Microphthalmia, syndromic 1; Ogden syndrome",
L2HGDH,AR (L-2-hydroxyglutaric aciduria),
L3MBTL3,"AD (Adams-Oliver syndrome 3); AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system)",
LACC1,"AR (Juvenile arthritis); {Leprosy, susceptibility to, 6}",
LACTB,"AR ([High density lipoprotein cholesterol level QTL 11]); AD (Combined hyperlipidemia, familial); AR (Lipoprotein lipase deficiency); AR (Liberfarb syndrome); AR (Dyskeratosis congenita, autosomal recessive 8); AR (Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3); AR (Neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities)",
LAD1,"AR (Leukocyte adhesion deficiency); AR (Leukocyte adhesion deficiency, type III); AR (Cone-rod dystrophy 19)",
LAG3,"AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4)",
LAGE3,"Galloway-Mowat syndrome 2, X-linked; AR (Galloway-Mowat syndrome 4); AR (Galloway-Mowat syndrome 5); AR (Galloway-Mowat syndrome 3); AR (Galloway-Mowat syndrome 9)",
LAIR1,"AR (Diarrhea 5, with tufting enteropathy, congenital); AD (Lynch syndrome 8); AR (Bleeding disorder, platelet-type, 11)",
LAIR2,"AR (Diarrhea 5, with tufting enteropathy, congenital); AD (Lynch syndrome 8)",
LAMA1,"AR (Poretti-Boltshauser syndrome); AR (Muscular dystrophy, congenital, merosin deficient or partially deficient); AR (Muscular dystrophy, limb-girdle, autosomal recessive 23); AR (?Bent bone dysplasia syndrome 2); AR (Nephrotic syndrome, type 26); AR (Lissencephaly 5); AR (Nephrotic syndrome, type 5, with or without ocular abnormalities); AR (Pierson syndrome)",
LAMA2,"AR (Muscular dystrophy, congenital, merosin deficient or partially deficient); AR (Muscular dystrophy, limb-girdle, autosomal recessive 23); Colorectal cancer, somatic; T-cell acute lymphoblastic leukemia, somatic; AR (Muscular dystrophy, congenital, 1B); Leukemia/lymphoma, B-cell, 2; AR (Poretti-Boltshauser syndrome); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9)",
LAMA3,"AR (Epidermolysis bullosa, junctional 2A, intermediate); AR (Epidermolysis bullosa, junctional 2B, severe); AR (Epidermolysis bullosa, junctional 2C, laryngoonychocutaneous); AD (Cardiomyopathy, dilated, 1JJ); AD (Amelogenesis imperfecta, type IA); AR (Epidermolysis bullosa, junctional 1A, intermediate); AR (Epidermolysis bullosa, junctional 1B, severe); AR (Epidermolysis bullosa, junctional 3A, intermediate); AR (Epidermolysis bullosa, junctional 3B, severe); AR (Osteogenesis imperfecta, type XIII)",
LAMA4,"AD (Cardiomyopathy, dilated, 1JJ); AR (?Bent bone dysplasia syndrome 2); AR (Nephrotic syndrome, type 26); AR (Poretti-Boltshauser syndrome); AR (Muscular dystrophy, congenital, merosin deficient or partially deficient); AR (Muscular dystrophy, limb-girdle, autosomal recessive 23); AD ({Epilepsy, familial temporal lobe, 7}); AR (Lissencephaly 2 (Norman-Roberts type)); AD (Spinocerebellar ataxia 37)",
LAMA5,"AR (?Bent bone dysplasia syndrome 2); AR (Nephrotic syndrome, type 26); AR (Muscular dystrophy, congenital, merosin deficient or partially deficient); AR (Muscular dystrophy, limb-girdle, autosomal recessive 23); AD (Cardiomyopathy, dilated, 1JJ); [Blood group, Auberger system]; AR ([Blood group, Lutheran null]); [Blood group, Lutheran system]",
LAMB1,"AR (Lissencephaly 5); AR (Poretti-Boltshauser syndrome); AR (Nephrotic syndrome, type 5, with or without ocular abnormalities); AR (Pierson syndrome); AD (Bethlem myopathy 1A); AR (Ullrich congenital muscular dystrophy 1A); AD (Amelogenesis imperfecta, type IA); AR (Epidermolysis bullosa, junctional 1A, intermediate); AR (Epidermolysis bullosa, junctional 1B, severe); AR (Muscular dystrophy, congenital, merosin deficient or partially deficient); AR (Muscular dystrophy, limb-girdle, autosomal recessive 23); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9); AD (Cardiomyopathy, dilated, 1JJ)",
LAMB2,"AR (Nephrotic syndrome, type 5, with or without ocular abnormalities); AR (Pierson syndrome); AR (Epidermolysis bullosa, junctional 3A, intermediate); AR (Epidermolysis bullosa, junctional 3B, severe); AR (Poretti-Boltshauser syndrome); AR (Muscular dystrophy, congenital, merosin deficient or partially deficient); AR (Muscular dystrophy, limb-girdle, autosomal recessive 23); AD (Developmental and epileptic encephalopathy 42); AD (Episodic ataxia, type 2); AD (Migraine, familial hemiplegic, 1); AD (Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia); AD (Spinocerebellar ataxia 6)",
LAMB3,"AD (Amelogenesis imperfecta, type IA); AR (Epidermolysis bullosa, junctional 1A, intermediate); AR (Epidermolysis bullosa, junctional 1B, severe); AR (Epidermolysis bullosa, junctional 4, intermediate); AD (Epithelial recurrent erosion dystrophy); AR (Epidermolysis bullosa, junctional 3A, intermediate); AR (Epidermolysis bullosa, junctional 3B, severe); AR (Epidermolysis bullosa, junctional 5A, intermediate); AR (Epidermolysis bullosa, junctional 5B, with pyloric atresia); AD (Ectodermal dysplasia and immunodeficiency 2); Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic",
LAMB4,"Cardiomyopathy, dilated, 1Q",
LAMC1,"AR (Epidermolysis bullosa, junctional 3A, intermediate); AR (Epidermolysis bullosa, junctional 3B, severe); AD ({Pelvic organ prolapse, susceptibility to, 1}); AR (?Ullrich congenital muscular dystrophy 2); AD (Bethlem myopathy 2); AR (Poretti-Boltshauser syndrome); AR (Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus)",
LAMC2,"AR (Epidermolysis bullosa, junctional 3A, intermediate); AR (Epidermolysis bullosa, junctional 3B, severe); AD (Amelogenesis imperfecta, type IA); AR (Epidermolysis bullosa, junctional 1A, intermediate); AR (Epidermolysis bullosa, junctional 1B, severe); AR (Osteogenesis imperfecta, type XIII)",
LAMC3,"AR (Cortical malformations, occipital); AR (Lissencephaly 5); AR (Poretti-Boltshauser syndrome); {Autism susceptibility 1}",
LAMP1,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9); Danon disease; AR (Sialidosis, type I); AR (Sialidosis, type II); AR (Spinocerebellar ataxia, autosomal recessive 29); AR (?Congenital disorder of glycosylation, type 1aa); AD (Intellectual developmental disorder, autosomal dominant 55, with seizures); AR (Spinocerebellar ataxia, autosomal recessive 15)",
LAMP2,"Danon disease; AR (?Polymicrogyria, bilateral temporooccipital); AD (Amyotrophic lateral sclerosis 11); AR (Charcot-Marie-Tooth disease, type 4J); AR (Yunis-Varon syndrome); AR (Striatonigral degeneration, childhood-onset); AR (Spinocerebellar ataxia, autosomal recessive 29)",
LAMP3,"AR (Hermansky-Pudlak syndrome 5); AR (Surfactant metabolism dysfunction, pulmonary, 3); AR (Hermansky-Pudlak syndrome 6)",
LAMTOR2,AR (Immunodeficiency due to defect in MAPBP-interacting protein),
LAP3,"AD (Myelokathexis, isolated); AD (WHIM syndrome 1)",
LARGE1,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6)",
LARGE2,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13)",
LARP4,AR (Alazami syndrome),
LARP6,AR (Alazami syndrome),
LARP7,AR (Alazami syndrome); AR (Neurodevelopmental disorder with variable familial hypercholanemia),
LARS1,AR (?Infantile liver failure syndrome 1),
LARS2,"AR (Hydrops, lactic acidosis, and sideroblastic anemia); AR (Perrault syndrome 4); AR (?Infantile liver failure syndrome 1); AR (?Charcot-Marie-Tooth disease, recessive intermediate, B); AR (Deafness, autosomal recessive 89); AR (Deafness, congenital, and adult-onset progressive leukoencephalopathy); AR (Leukoencephalopathy, progressive, infantile-onset, with or without deafness)",
LAS1L,Wilson-Turner syndrome,
LASP1,AD (Wiedemann-Steiner syndrome),
LAT,"AR (Immunodeficiency 52); AR (Immunodeficiency 19, severe combined); [Memory, enhanced, QTL]",
LAT2,Allan-Herndon-Dudley syndrome,
LATS1,"AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development); [Memory, enhanced, QTL]",
LATS2,"[Memory, enhanced, QTL]; AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development)",
LBP,AD (?Fanconi renotubular syndrome 3),
LBR,"AD (?Reynolds syndrome); AR (Greenberg skeletal dysplasia); AD (Pelger-Huet anomaly); AR (Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly); X-inactivation, familial skewed; AR (Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly)",
LBX1,"AR (?Central hypoventilation syndrome, congenital, 3); AD (Split-hand/foot malformation 3, gene duplication syndrome)",
LCA5,"AR (Leber congenital amaurosis 5); ?Retinitis pigmentosa 23; Joubert syndrome 10; Orofaciodigital syndrome I; Simpson-Golabi-Behmel syndrome, type 2",
LCAT,"AR (Fish-eye disease); AR (Norum disease); Amyloidosis, hereditary systemic 3; AR (Hypoalphalipoproteinemia, primary, 2); AD (Hypoalphalipoproteinemia, primary, 2, intermediate); AR (Auriculocondylar syndrome 3); AD (Question mark ears, isolated); AD (Blepharocheilodontic syndrome 1); Breast cancer, lobular, somatic; AD (Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate); Endometrial carcinoma, somatic; Ovarian cancer, somatic; [High density lipoprotein cholesterol level QTL7]",
LCE1A,{Psoriasis susceptibility 4},
LCE3B,{Psoriasis susceptibility 4},
LCE3C,{Psoriasis susceptibility 4},
LCK,"AR (Immunodeficiency 22); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 3); AD (Myopathy, distal, with rimmed vacuoles); AR (Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset); AD (Paget disease of bone 3); AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24); AR ({Diabetes mellitus, insulin-dependent-1}); AD (?Frontotemporal dementia and/or amyotrophic lateral sclerosis 8); AD (Brooke-Spiegler syndrome); AD (Cylindromatosis, familial); AD (Trichoepithelioma, multiple familial, 1); AR (Immunodeficiency 105, severe combined)",
LCN2,"AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20)); AR (Hemochromatosis, type 1)",
LCORL,{Stature QTL 13}; [Birth weight QTL 1]; [Fasting plasma glucose level QTL 2],
LCP1,"Bone mineral density QTL18, osteoporosis; Diaphragmatic hernia 5, X-linked; AD ({Amyotrophic lateral sclerosis, susceptibility to, 13}); AD ({Parkinson disease, late-onset, susceptibility to}); AD (Spinocerebellar ataxia 2); AD (Deafness, autosomal dominant 76); AR (Osteosclerotic metaphyseal dysplasia); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome)",
LCP2,"AR (Immunodeficiency 81); AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); AR (Immunodeficiency 19, severe combined); AR (Thrombocytopenia 3)",
LCT,"AR (Lactase deficiency, congenital); AD (Lactase persistence/nonpersistence); AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma; AR (Congenital heart defects, multiple types, 5); AR (?Lymphatic malformation 8)",
LCTL,"AR (?Muscular dystrophy, congenital, Davignon-Chauveau type); AR (Spinal muscular atrophy with congenital bone fractures 1)",
LDB1,"AD (Focal segmental glomerulosclerosis 10); AD (Nail-patella syndrome); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (?Hypogonadotropic hypogonadism 27 without anosmia); Leukemia, acute T-cell",
LDB3,"AD (Cardiomyopathy, dilated, 1C, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 24); AD (Left ventricular noncompaction 3); AD (Myopathy, myofibrillar, 4); Barth syndrome; AD (Myotonic dystrophy 1); AD (Cardiomyopathy, dilated, 1AA, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 23, with or without LVNC); AD (Congenital myopathy 8); AD (Myopathy, distal, 6, adult onset); AR ([Alpha-actinin-3 deficiency]); AR ([Sprinting performance])",
LDHA,"AR (Glycogen storage disease XI); [Lactate dehydrogenase-B deficiency]; {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AR (?Lysosomal acid phosphatase deficiency)",
LDHB,[Lactate dehydrogenase-B deficiency]; AR (Glycogen storage disease XI); AR (Hemolytic anemia due to triosephosphate isomerase deficiency); Pallister-Killian syndrome,
LDHC,AR (Glycogen storage disease XI),
LDHD,AR (D-lactic aciduria with susceptibility to gout),
LDLR,"AR (Hypercholesterolemia, familial, 1); AR (LDL cholesterol level QTL2); AR (Hypercholesterolemia, familial, 4); AD (Amyotrophic lateral sclerosis 28); AD (Oculopharyngodistal myopathy 1); AD ({Low density lipoprotein cholesterol level QTL 1}); AD (Hypercholesterolemia, familial, 3); AD (Hypercholesterolemia, familial, 2); AR (Hypobetalipoproteinemia); AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease)",
LDLRAD3,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AR (Autoimmune disease, multisystem, with facial dysmorphism)",
LDLRAP1,"AR (Hypercholesterolemia, familial, 4); AR (Donnai-Barrow syndrome); AR (Sitosterolemia 2)",
LEF1,"Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; AD ({Diabetes mellitus, type 2, susceptibility to}); [Hair morphology 1, hair thickness]; AD (Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant); AR (Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive)",
LEFTY1,"AD (Heterotaxy, visceral, 5); AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea); AR (Heterotaxy, visceral, 13, autosomal); Acute myeloid leukemia, somatic; AD (Heyn-Sproul-Jackson syndrome); AD (Tatton-Brown-Rahman syndrome); AD (Congenital heart defects, multiple types, 6); AR (Right atrial isomerism (Ivemark)); Facioscapulohumeral muscular dystrophy 4, digenic; AR (Immunodeficiency-centromeric instability-facial anomalies syndrome 1); AR (Nephronophthisis 2, infantile)",
LEFTY2,"AR (Microcephaly 7, primary, autosomal recessive); AD (Heterotaxy, visceral, 5); AR (Nephronophthisis 2, infantile); AD (Ciliary dyskinesia, primary, 43); Acute myeloid leukemia, somatic; AD (Heyn-Sproul-Jackson syndrome); AD (Tatton-Brown-Rahman syndrome); AD (Congenital heart defects, multiple types, 6); AR (Right atrial isomerism (Ivemark)); Facioscapulohumeral muscular dystrophy 4, digenic; AR (Immunodeficiency-centromeric instability-facial anomalies syndrome 1); AD (Retinitis pigmentosa 89)",
LEKR1,[Birth weight QTL 2],
LEMD2,"AR (Cataract 46, juvenile-onset); AD (Marbach-Rustad progeroid syndrome); Emery-Dreifuss muscular dystrophy 1, X-linked",
LEMD3,"AD (Buschke-Ollendorff syndrome); AD (Osteopoikilosis with or without melorheostosis); AR (Cataract 46, juvenile-onset); AD (Marbach-Rustad progeroid syndrome)",
LEO1,"{Autism susceptibility 1}; AD (Hyperparathyroidism-jaw tumor syndrome); AD (Hyperparathyroidism, familial primary); AD (Parathyroid adenoma with cystic changes); Parathyroid carcinoma",
LEP,"AR (Obesity, morbid, due to leptin deficiency); AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; {Leprosy, paucibacillary type, susceptibility to}; AD (Silver-Russell syndrome 3); AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); AD (Pseudohypoparathyroidism Ib)",
LEPR,"AR (Obesity, morbid, due to leptin receptor deficiency); AR (Obesity, morbid, due to leptin deficiency); AR (Bardet-Biedl syndrome 2); AR (Retinitis pigmentosa 74); AD (Cleidocranial dysplasia); AD (Cleidocranial dysplasia, forme fruste, dental anomalies only); AD (Cleidocranial dysplasia, forme fruste, with brachydactyly); AD (Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly); {Leprosy, paucibacillary type, susceptibility to}",
LETM1,"AR (Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction); Wolf-Hirschhorn syndrome",
LFNG,"AR (Spondylocostal dysostosis 3, autosomal recessive); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AR (Spondylocostal dysostosis 4, autosomal recessive); AD ({Osteoporosis, early-onset, susceptibility to, autosomal dominant}); AR (Osteogenesis imperfecta, type XV); AR (Spondylocostal dysostosis 2, autosomal recessive); AD (?Myofibromatosis, infantile 2); AD (Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1); AD (Lateral meningocele syndrome); AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3)",
LGALS1,"{Myocardial infarction, susceptibility to}; AD (PCWH syndrome); AD (Waardenburg syndrome, type 2E, with or without neurologic involvement); AD (Waardenburg syndrome, type 4C); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2)",
LGALS2,"{Myocardial infarction, susceptibility to}",
LGALS3,"AD (Tubulointerstitial kidney disease, autosomal dominant, 2); {Asthma-related traits, susceptibility to, 7}; AD ({Schizophrenia, susceptibility to}); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AD (Cohen-Gibson syndrome)",
LGALS4,"AR (Joint laxity, short stature, and myopia)",
LGALS8,"AR (Lipodystrophy, familial partial, type 9)",
LGALS9,"AR (T-cell lymphoma, subcutaneous panniculitis-like)",
LGI1,"AD (Epilepsy, familial temporal lobe, 1); AR (Developmental and epileptic encephalopathy 61); AR (Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects); AR (Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect); AD (?Febrile seizures, familial, 4); AR (Usher syndrome, type 2C); AR (Usher syndrome, type 2C, GPR98/PDZD7 digenic)",
LGI2,"AR (Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects); AR (Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect)",
LGI3,"AR (Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects); AR (Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect)",
LGI4,"AR (Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect); AR (Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects)",
LGMN,"AD (Intellectual developmental disorder, autosomal dominant 58)",
LGR4,"AD ({Bone mineral density, low, susceptibility to}); AD (Delayed puberty, self-limited); AD (Wilms tumor, aniridia, genitourinary anomalies and impaired intellectual development syndrome); AR (?Tetra-amelia syndrome 1); AR (?Humerofemoral hypoplasia with radiotibial ray deficiency); AR (Tetraamelia syndrome 2); AD (Sessile serrated polyposis cancer syndrome)",
LGR5,"Colorectal cancer, somatic; AD (Oligodontia-colorectal cancer syndrome); AD ({Bone mineral density, low, susceptibility to}); AD (Delayed puberty, self-limited); AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development); {Basal cell carcinoma, susceptibility to, 1}; AR (?Humerofemoral hypoplasia with radiotibial ray deficiency); AR (Tetraamelia syndrome 2); AD (?Deafness, autosomal dominant 89)",
LGR6,"AD ({Bone mineral density, low, susceptibility to}); AD (Delayed puberty, self-limited); AR (Fanconi anemia, complementation group T)",
LHB,AR (Hypogonadotropic hypogonadism 23 with or without anosmia); AR (Hypogonadotropic hypogonadism 24 without anosmia),
LHCGR,"Leydig cell adenoma, somatic, with precocious puberty; AR (Leydig cell hypoplasia with hypergonadotropic hypogonadism); AR (Leydig cell hypoplasia with pseudohermaphroditism); AR (Luteinizing hormone resistance, female); AD (Precocious puberty, male); AR (Hypogonadotropic hypogonadism 7 without anosmia); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); AR (Ovarian dysgenesis 1); AD (Ovarian hyperstimulation syndrome); AD (Hyperthyroidism, familial gestational); AD (Hyperthyroidism, nonautoimmune); AR (Hypothyroidism, congenital, nongoitrous, 1); Thyroid adenoma, hyperfunctioning, somatic; Thyroid carcinoma with thyrotoxicosis, somatic",
LHFPL3,"AR (Deafness, autosomal recessive 67)",
LHFPL4,"AR (Deafness, autosomal recessive 67); AD (3p- syndrome)",
LHFPL5,"AR (Deafness, autosomal recessive 67); AD (Deafness, autosomal dominant 36); AR (Deafness, autosomal recessive 7); AR (Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2); AR (Hydrocephalus, congenital, 3, with brain anomalies)",
LHX1,"AD (Chromosome 17q12 deletion syndrome); AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (?Spermatogenic failure 97); AD (Chromosome 17q12 duplication syndrome); {Autism susceptibility 1}",
LHX2,"AR (Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay); Tonne-Kalscheuer syndrome; AR (Focal segmental glomerulosclerosis 9); AR (Ventriculomegaly with cystic kidney disease)",
LHX3,"AR (Pituitary hormone deficiency, combined, 3); AD (Pituitary hormone deficiency, combined, 4); Tonne-Kalscheuer syndrome; AR (Bardet-Biedl syndrome 20); AR (Retinitis pigmentosa 71); AR (Short-rib thoracic dysplasia 10 with or without polydactyly); {Stature QTL 1}; AR (Pituitary hormone deficiency, combined or isolated, 1)",
LHX4,"AD (Pituitary hormone deficiency, combined, 4); AR (Pituitary hormone deficiency, combined, 3); AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); AR (Bardet-Biedl syndrome 20); AR (Retinitis pigmentosa 71); AR (Short-rib thoracic dysplasia 10 with or without polydactyly)",
LHX5,"AD (Holt-Oram syndrome); AD (Ulnar-mammary syndrome); AD (Greig cephalopolysyndactyly syndrome); AD (Pallister-Hall syndrome); AD (Polydactyly, postaxial, types A1 and B); AD (Polydactyly, preaxial, type IV); AR (Intellectual developmental disorder, autosomal recessive 43)",
LHX6,"AD (Tolchin-Le Caignec syndrome); AD (?Deafness, autosomal dominant 74)",
LHX8,AR (Ovarian dysgenesis 5); AD (Spermatogenic failure 32); AR (Orofacial cleft 14); AD (Glass syndrome),
LHX9,"AD (?Deafness, autosomal dominant 89); AD (46XX sex reversal 4); AD (46XY sex reversal 3); AD (Adrenocortical insufficiency); AD (Premature ovarian failure 7); AD (Spermatogenic failure 8); AD (Denys-Drash syndrome); AD (Frasier syndrome); AD (Meacham syndrome); Mesothelioma, somatic; AD (Nephrotic syndrome, type 4); AD (Wilms tumor, type 1); AD (Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities); AR (Focal segmental glomerulosclerosis 9); AR (Ventriculomegaly with cystic kidney disease)",
LIAS,"AR (Hyperglycinemia, lactic acidosis, and seizures); AR (Multiple mitochondrial dysfunctions syndrome 1); AR (Spastic paraplegia 93, autosomal recessive); AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3); AR (Multiple mitochondrial dysfunctions syndrome 4); AR (Multiple mitochondrial dysfunctions syndrome 5); AR (Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia)",
LIF,"AR (Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Aplasia cutis-enamel dysplasia syndrome); AD (Ulnar-mammary syndrome); AR (?Deafness, autosomal recessive 26)",
LIFR,"AR (Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome); AD (Aplasia cutis-enamel dysplasia syndrome); AD (Amyloidosis, primary localized cutaneous, 1)",
LIG1,"AR (Immunodeficiency 96); AR (?Ataxia-telangiectasia-like disorder 2); AR (Immunodeficiency with hyper IgM, type 5); AR (?Spinocerebellar ataxia, autosomal recessive 26); AR (Mitochondrial DNA depletion syndrome 20 (MNGIE type))",
LIG3,"AR (Mitochondrial DNA depletion syndrome 20 (MNGIE type)); AR (?Spinocerebellar ataxia, autosomal recessive 26); AR (Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia); AD (Spinocerebellar ataxia 48); AR (Spinocerebellar ataxia, autosomal recessive 16)",
LIG4,"{Multiple myeloma, resistance to}; AR (LIG4 syndrome); AR (Short stature, microcephaly, and endocrine dysfunction); AR (Ataxia-telangiectasia-like disorder 1); AR (Immunodeficiency 124, severe combined); AR (Microphthalmia/coloboma 13)",
LILRB2,"AR (Hypobetalipoproteinemia, familial, 2); AD (Plasma triglyceride level QTL, low)",
LILRB3,"{Leukemia, acute lymphoblastic, susceptibility to, 3}",
LIM2,"AR (Cataract 19, multiple types); AD (Focal segmental glomerulosclerosis 10); AD (Nail-patella syndrome); ?Uruguay faciocardiomusculoskeletal syndrome; Emery-Dreifuss muscular dystrophy 6, X-linked; Myopathy, X-linked, with postural muscle atrophy; Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset; Reducing body myopathy, X-linked 1b, with late childhood or adult onset; Scapuloperoneal myopathy, X-linked dominant; AR (Pituitary hormone deficiency, combined, 3); AD (Cataract 1, multiple types); AR (?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue); AD (Cataract 10, multiple types); AD (Cataract 3, multiple types)",
LIMA1,[Low density lipoprotein cholesterol level QTL 8],
LIMD1,"AR (Hydrops, lactic acidosis, and sideroblastic anemia); AR (Perrault syndrome 4)",
LIMK1,"AD (Williams-Beuren syndrome); AD (Aneurysm, intracranial berry, 1)",
LIMS1,"AR (?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue)",
LIMS2,"AR (?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue)",
LIN28B,"{Menarche, age at, QTL2}; AD (Feingold syndrome 1); AD (Megalencephaly-polydactyly syndrome); {Stature QTL 1}; AD (Dias-Logan syndrome)",
LIN7A,"FG syndrome 4; Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia; Intellectual developmental disorder, with or without nystagmus",
LIN7C,"AD (Intellectual developmental disorder, autosomal dominant 62)",
LINGO1,"AR (Intellectual developmental disorder, autosomal recessive 64)",
LINS1,"AR (Intellectual developmental disorder, autosomal recessive 27)",
LIPA,"AR (Cholesteryl ester storage disease); AR (Wolman disease); Aspartate aminotransferase, serum level of, QTL1",
LIPC,"[High density lipoprotein cholesterol level QTL 12]; AD ({Diabetes mellitus, noninsulin-dependent}); AR (Hepatic lipase deficiency); AD (Abdominal obesity-metabolic syndrome 1); [High density lipoprotein cholesterol level QTL 1]",
LIPE,"AR (Lipodystrophy, familial partial, type 6); AD (Spinocerebellar ataxia 14); AD (Dyskinesia with orofacial involvement, autosomal dominant); AR (Dyskinesia with orofacial involvement, autosomal recessive); AR (Neurodevelopmental disorder with hyperkinetic movements and dyskinesia)",
LIPF,AR (Cholesteryl ester storage disease); AR (Wolman disease),
LIPG,"AR (Hypotrichosis 7); AR (Woolly hair, autosomal recessive 2 with or without hypotrichosis)",
LIPH,"AR (Hypotrichosis 7); AR (Woolly hair, autosomal recessive 2 with or without hypotrichosis); [High density lipoprotein cholesterol level QTL 12]; AD ({Diabetes mellitus, noninsulin-dependent}); AR (Hepatic lipase deficiency); AR (Hypotrichosis 15); AR (Hypotrichosis 8); AR (Woolly hair, autosomal recessive 1, with or without hypotrichosis); AD (?Hypotrichosis 13)",
LIPN,"AR (Ichthyosis, congenital, autosomal recessive 8)",
LIPT1,AR (Lipoyltransferase 1 deficiency),
LIPT2,"AR (Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities)",
LITAF,"AD (Charcot-Marie-Tooth disease, type 1C); AD (Charcot-Marie-Tooth disease, type 1D); AR (Dejerine-Sottas disease); AR (Hypomyelinating neuropathy, congenital, 1); AD (?Neuropathy, inflammatory demyelinating); AD (Charcot-Marie-Tooth disease, type 1A); AD (Charcot-Marie-Tooth disease, type 1E); AR (Dejerine-Sottas disease); AD (Neuropathy, recurrent, with pressure palsies); AD (Roussy-Levy syndrome)",
LLGL1,"AR (Cardiomyopathy, dilated, 2J); AR (Microcephaly 16, primary, autosomal recessive)",
LMAN1,"AR (Combined factor V and VIII deficiency); Factor V and factor VIII, combined deficiency of; AR (Muscular dystrophy, congenital, with rapid progression)",
LMAN2,"AD (?Intellectual developmental disorder, autosomal dominant 69); AR (?Intellectual developmental disorder, autosomal recessive 52); AR (Combined factor V and VIII deficiency)",
LMAN2L,"AD (?Intellectual developmental disorder, autosomal dominant 69); AR (?Intellectual developmental disorder, autosomal recessive 52); AR (Combined factor V and VIII deficiency)",
LMBR1,"AR (Acheiropody); AD (Laurin-Sandrow syndrome); AD (Syndactyly, type IV); AD (Triphalangeal thumb-polysyndactyly syndrome); AR (Methylmalonic aciduria and homocystinuria, cblF type); AD (Developmental delay with variable neurologic and brain abnormalities); AD (Polydactyly, preaxial II); AR (Tibia, hypoplasia or aplasia of, with polydactyly); AD (Triphalangeal thumb); AD (Neuronopathy, distal hereditary motor, autosomal dominant 1)",
LMBRD1,"AR (Methylmalonic aciduria and homocystinuria, cblF type); AR (Methylmalonic aciduria and homocystinuria, cblJ type)",
LMBRD2,AD (Developmental delay with variable neurologic and brain abnormalities),
LMF1,"AR (Lipase deficiency, combined); AR (Hyperlipoproteinemia, type 1D)",
LMNA,"AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2); AR (Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis); AR (Mandibuloacral dysplasia with type B lipodystrophy); AR (Restrictive dermopathy 1)",
LMNB1,"AD (Microcephaly 26, primary, autosomal dominant); AD (Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typical); AD (Leukodystrophy, demyelinating, adult-onset, autosomal dominant, atypical); AR (?Epilepsy, progressive myoclonic, 9); AD ({Lipodystrophy, partial, acquired, susceptibility to}); AD (Microcephaly 27, primary, autosomal dominant); AR (Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2); AD (Cardiomyopathy, dilated, 1I); AR (Myopathy, myofibrillar, 1); AD (Scapuloperoneal syndrome, neurogenic, Kaeser type); AD (?Reynolds syndrome); AR (Greenberg skeletal dysplasia); AD (Pelger-Huet anomaly); AR (Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly)",
LMNB2,"AR (?Epilepsy, progressive myoclonic, 9); AD ({Lipodystrophy, partial, acquired, susceptibility to}); AD (Microcephaly 27, primary, autosomal dominant); AD (Microcephaly 26, primary, autosomal dominant); AD (?Reynolds syndrome); AR (Greenberg skeletal dysplasia); AD (Pelger-Huet anomaly); AR (Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly)",
LMO1,"Leukemia, T-cell acute lymphoblastic; {Neuroblastoma, susceptibility to, 7}; AR (Microcephaly 7, primary, autosomal recessive); Leukemia, T-cell acute lymphocytic, somatic; Leukemia, acute T-cell",
LMO2,"Leukemia, acute T-cell; AR (Bleeding disorder, platelet-type, 21); AD (Lymphatic malformation 14); AR (?Hypogonadotropic hypogonadism 27 without anosmia); AD (Diets-Jongmans syndrome)",
LMO3,"Leukemia, acute T-cell; {Neuroblastoma, susceptibility to, 7}",
LMO4,"AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Jawad syndrome); Pancreatic carcinoma, somatic; AR (Seckel syndrome 2); Tonne-Kalscheuer syndrome; {Neuroblastoma, susceptibility to, 7}",
LMO7,"AD (?Premature ovarian failure 16); AR (Intellectual developmental disorder with short stature, facial anomalies, and speech defects)",
LMOD1,AR (?Megacystis-microcolon-intestinal hypoperistalsis syndrome 3),
LMOD2,"AR (Cardiomyopathy, dilated, 2G); AR (Nemaline myopathy 10); AR (?Megacystis-microcolon-intestinal hypoperistalsis syndrome 3)",
LMOD3,"AR (Nemaline myopathy 10); AR (Nemaline myopathy 8, autosomal recessive)",
LMTK2,"{Prostate cancer, susceptibility to, 4}",
LMX1A,"AD (Deafness, autosomal dominant 7); AD (Ectodermal dysplasia 3, Witkop type); AD (Orofacial cleft 5); AD (Tooth agenesis, selective, 1, with or without orofacial cleft); AD (Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism)",
LMX1B,AD (Focal segmental glomerulosclerosis 10); AD (Nail-patella syndrome),
LNP1,AR (Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum),
LNPEP,"AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); AD (Corneal fleck dystrophy); {Diabetes mellitus, noninsulin-dependent, 5}",
LNPK,AR (Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum),
LNX2,AR (Treacher Collins syndrome 2),
LONP1,AR (CODAS syndrome),
LORICRIN,"AD (Vohwinkel syndrome with ichthyosis); AR (?Ectodermal dysplasia 15, hypohidrotic/hair type); AD ({Dermatitis, atopic, susceptibility to, 2}); AR (Ichthyosis vulgaris); AD (Epidermolytic hyperkeratosis 1); AD (Ichthyosis histrix, Curth-Macklin type); AD (Ichthyosis, annular epidermolytic 2); Keratosis palmoplantaris striata III; AD (Palmoplantar keratoderma, epidermolytic, 2); AD (Palmoplantar keratoderma, nonepidermolytic); AR (?Uncombable hair syndrome 3)",
LOX,"AD (Aortic aneurysm, familial thoracic 10); AR (Ichthyosis, congenital, autosomal recessive 2); AR (Ichthyosis, congenital, autosomal recessive 3); AD ({Exfoliation syndrome, susceptibility to}); AR (Arterial tortuosity-bone fragility syndrome); AD (Neuronopathy, distal hereditary motor, autosomal dominant 10); AR (Cutis laxa, autosomal recessive, type IB); {Myocardial infarction, susceptibility to}",
LOXHD1,"AR (Deafness, autosomal recessive 77)",
LOXL1,"AD ({Exfoliation syndrome, susceptibility to})",
LOXL2,"AR (Myopia 28, autosomal recessive)",
LOXL3,"AR (Myopia 28, autosomal recessive); AD (Myopia 2)",
LPA,"AD ([LPA deficiency, congenital]); AD ({Coronary artery disease, susceptibility to}); AD (Hypercholesterolemia, familial, 2); AR (Hypobetalipoproteinemia)",
LPAR4,"AR (Hypotrichosis 8); AR (Woolly hair, autosomal recessive 1, with or without hypotrichosis)",
LPAR5,"AR (Hypotrichosis 8); AR (Woolly hair, autosomal recessive 1, with or without hypotrichosis)",
LPAR6,"AR (Hypotrichosis 8); AR (Woolly hair, autosomal recessive 1, with or without hypotrichosis); AR (Polydactyly, postaxial, type A5); AR (Hypotrichosis 7); AR (Woolly hair, autosomal recessive 2 with or without hypotrichosis)",
LPIN1,"AR (Myoglobinuria, acute recurrent, autosomal recessive); Majeed syndrome; {Dystonia-1, modifier of}; AR (Arthrogryposis multiplex congenita 5); AD (Dystonia-1, torsion); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3)",
LPIN2,"Majeed syndrome; AR (Myoglobinuria, acute recurrent, autosomal recessive)",
LPIN3,"Majeed syndrome; AR (Myoglobinuria, acute recurrent, autosomal recessive)",
LPL,"AR ([High density lipoprotein cholesterol level QTL 11]); AD (Combined hyperlipidemia, familial); AR (Lipoprotein lipase deficiency); AR (Hyperlipoproteinemia, type 1D); AD (Plasma triglyceride level QTL, low); AR (Lipase deficiency, combined)",
LPO,"AR ([Eosinophil peroxidase deficiency]); AR (Anterior segment dysgenesis 7, with sclerocornea)",
LPP,"AD (Leukemia, acute myeloid); Lipoma; AD (Wiedemann-Steiner syndrome); AD (Silver-Russell syndrome 5); {Celiac disease, susceptibility to, 11}",
LRAT,"AR (Leber congenital amaurosis 14); AR (Retinal dystrophy, early-onset severe); AR (Retinitis pigmentosa, juvenile); AR (Leber congenital amaurosis 2); AR (Retinitis pigmentosa 20); AD (Retinitis pigmentosa 87 with choroidal involvement); AD (Night blindness, congenital stationary, autosomal dominant 3); AR (Night blindness, congenital stationary, type 1G); AR (Ectopia lentis et pupillae); AR (Ectopia lentis, isolated, autosomal recessive); AR (Microphthalmia, isolated, with coloboma 8); AR (Microphthalmia, syndromic 9)",
LRBA,"AR (Immunodeficiency, common variable, 8, with autoimmunity); {Celiac disease, susceptibility to, 3}; {Diabetes mellitus, insulin-dependent, 12}; AD ({Hashimoto thyroiditis}); AD ({Systemic lupus erythematosus, susceptibility to}); AD (Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation); AR (Gray platelet syndrome)",
LRG1,"AD (Telangiectasia, hereditary hemorrhagic, type 1)",
LRIF1,"?Facioscapulohumeral muscular dystrophy 3, digenic; AD (Facioscapulohumeral muscular dystrophy 1)",
LRIG1,AR (Urofacial syndrome 2),
LRIG2,AR (Urofacial syndrome 2),
LRIG3,AR (Urofacial syndrome 2),
LRIT3,"AR (Night blindness, congenital stationary (complete), 1F, autosomal recessive)",
LRMDA,"AR (Albinism, oculocutaneous, type VII)",
LRP1,"AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); AR (Myopia 23, autosomal recessive); AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
LRP12,AD (Amyotrophic lateral sclerosis 28); AD (Oculopharyngodistal myopathy 1),
LRP1B,"AD (Intellectual developmental disorder, autosomal dominant 7)",
LRP2,"AR (Donnai-Barrow syndrome); {Autism susceptibility 1}; AR (Myopia 23, autosomal recessive); Dent disease 2; Lowe syndrome; AD (Deafness, autosomal dominant 22); AD (Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy); AR (Deafness, autosomal recessive 37); AR ([Proteinuria, chronic benign]); AR (Imerslund-Grasbeck syndrome 1); AD (Oculopharyngodistal myopathy 2)",
LRP3,AD (Amyotrophic lateral sclerosis 28); AD (Oculopharyngodistal myopathy 1),
LRP4,"AR (?Myasthenic syndrome, congenital, 17); AR (Cenani-Lenz syndactyly syndrome); AR (Sclerosteosis 2); AD (Craniodiaphyseal dysplasia, autosomal dominant); AR (Sclerosteosis 1); AR (Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects); AR (Fetal akinesia deformation sequence 1); AR (Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency)",
LRP5,"AD ([Bone mineral density variability 1, high bone mass]); AD (Endosteal hyperostosis); AR (Exudative vitreoretinopathy 4); AD (Osteopetrosis, autosomal dominant 1); AR (Osteoporosis-pseudoglioma syndrome); AD (Polycystic liver disease 4 with or without kidney cysts); AD ({Coronary artery disease, autosomal dominant, 2}); AD (Tooth agenesis, selective, 7); ?Caudal duplication anomaly; AR (Craniometadiaphyseal osteosclerosis with hip dysplasia); Hepatocellular carcinoma, somatic",
LRP6,"AD ({Coronary artery disease, autosomal dominant, 2}); AD (Tooth agenesis, selective, 7); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3); AR (?Myasthenic syndrome, congenital, 17); AR (Cenani-Lenz syndactyly syndrome); AR (Sclerosteosis 2); AD (Robinow syndrome, autosomal dominant 2)",
LRP8,"{Myocardial infarction, susceptibility to}; AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AD (Spinocerebellar ataxia 37); AR (?SERKAL syndrome); AD (Mullerian aplasia and hyperandrogenism)",
LRPAP1,"AR (Myopia 23, autosomal recessive); AR (Donnai-Barrow syndrome); AR (?Keratosis pilaris atrophicans); AD (Developmental dysplasia of the hip 3); Myelofibrosis, somatic; Thrombocythemia, somatic; AD (Myopia 2); AD (Abdominal obesity-metabolic syndrome 1)",
LRPPRC,"AR (Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian)); AR (Ethylmalonic encephalopathy)",
LRRC14,"AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); AR (Baller-Gerold syndrome); AR (RAPADILINO syndrome); AR (Rothmund-Thomson syndrome, type 2)",
LRRC15,"Ewing sarcoma; Neuroepithelioma; AD (Denys-Drash syndrome); AD (Frasier syndrome); AD (Meacham syndrome); Mesothelioma, somatic; AD (Nephrotic syndrome, type 4); AD (Wilms tumor, type 1)",
LRRC23,AR (Spermatogenic failure 92),
LRRC26,"AD ({Epilepsy, idiopathic generalized, susceptibility to, 16}); AR (Cerebellar atrophy, developmental delay, and seizures); AD (Liang-Wang syndrome); AD (Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy)",
LRRC32,"AR (Cleft palate, proliferative retinopathy, and developmental delay)",
LRRC42,AD (GAND syndrome),
LRRC51,"AR (Deafness, autosomal recessive 63)",
LRRC52,AR (Spermatogenic failure 79),
LRRC56,"AR (Ciliary dyskinesia, primary, 39)",
LRRC8A,AD (?Agammaglobulinemia 5); AD (TIMES syndrome),
LRRC8C,AD (TIMES syndrome),
LRRC8E,AD (?Agammaglobulinemia 5),
LRRFIP1,AD (Developmental and epileptic encephalopathy 41),
LRRFIP2,Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome),
LRRK1,AR (Osteosclerotic metaphyseal dysplasia),
LRRK2,"AD ({Parkinson disease 8}); AD (Robinow syndrome, autosomal dominant 2); AD (EDICT syndrome); AD (Lessel-Kreienkamp syndrome); AD ({Parkinson disease 26, autosomal dominant, susceptibility to})",
LRRN1,AD (3p- syndrome),
LRSAM1,"AR (Charcot-Marie-Tooth disease, axonal, type 2P)",
LRWD1,AD (Meier-Gorlin syndrome 6); AR (Meier-Gorlin syndrome 4),
LSAMP,"Ovarian cancer, somatic; AD (Bosch-Boonstra-Schaaf optic atrophy syndrome); AD (Chromosome 3q13.31 deletion syndrome)",
LSM1,AR (FICUS syndrome); AR (Leukodystrophy and cerebellar atrophy),
LSM10,AR (?Aicardi-Goutieres syndrome 8); AR (Aicardi-Goutieres syndrome 9),
LSM11,AR (?Aicardi-Goutieres syndrome 8),
LSM14A,"AD (Intellectual developmental disorder with impaired language and dysmorphic facies); AD (Chromosome 19q13.11 deletion syndrome, distal)",
LSM2,AR (Leukodystrophy and cerebellar atrophy); AR (FICUS syndrome),
LSM3,AR (FICUS syndrome); AR (Leukodystrophy and cerebellar atrophy),
LSM4,AR (FICUS syndrome); AR (Leukodystrophy and cerebellar atrophy),
LSM5,AR (FICUS syndrome); AR (Leukodystrophy and cerebellar atrophy),
LSM6,AR (FICUS syndrome); AR (Leukodystrophy and cerebellar atrophy),
LSM7,AR (Leukodystrophy and cerebellar atrophy); AR (FICUS syndrome),
LSM8,AR (FICUS syndrome); AR (Leukodystrophy and cerebellar atrophy),
LSP1,"AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor)",
LSR,"{Deep venous thrombosis, protection against}; {Warfarin sensitivity}; Hemophilia B; Thrombophilia 8, X-linked, due to factor IX defect; AR (Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss); AR (Deafness, autosomal recessive 42); AR (Cholestasis, progressive familial intrahepatic, 8); AR (Neurodevelopmental disorder with variable familial hypercholanemia)",
LSS,"AR (Alopecia-intellectual disability syndrome 4); AR (Cataract 44); AR (Hypotrichosis 14); AR (Acheiropody); AD (Laurin-Sandrow syndrome); AD (Syndactyly, type IV); AD (Triphalangeal thumb-polysyndactyly syndrome); AR (Squalene synthase deficiency); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor)",
LST1,"Hyperbilirubinemia, Rotor type, digenic; {Malaria, mild, susceptibility to}",
LTA,"{Leprosy, susceptibility to, 4}; {Myocardial infarction, susceptibility to}; {Psoriatic arthritis, susceptibility to}; AD ({Colorectal cancer, susceptibility to}); AD ({Leprosy, susceptibility to}); {Mycobacterium tuberculosis, susceptibility to}; AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; {Myocardial infarction, susceptibility to}; {HIV1 infection, resistance to}; AR ({Immunodeficiency 83, susceptibility to viral infections}); AR (Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia)",
LTA4H,"{Leprosy, paucibacillary type, susceptibility to}; AD ({Asthma, diminished response to antileukotriene treatment in}); {Atherosclerosis, susceptibility to}; {Aspergillosis, susceptibility to}; AR (Candidiasis, familial, 4, autosomal recessive); {Dengue fever, protection against}; {HIV type 1, susceptibility to}; {Mycobacterium tuberculosis, susceptibility to}",
LTB,"Ectodermal dysplasia 1, hypohidrotic, X-linked; Tooth agenesis, selective, X-linked 1; {Leprosy, susceptibility to, 4}; {Myocardial infarction, susceptibility to}; {Psoriatic arthritis, susceptibility to}; AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}; AR (Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia); AR (Immunodeficiency 112)",
LTB4R,"AR (Obesity, morbid, due to leptin deficiency)",
LTB4R2,"AD (?Deafness, autosomal dominant 77)",
LTBP1,"AR (Cutis laxa, autosomal recessive, type IIE); AR (Cleft palate, proliferative retinopathy, and developmental delay); AR (?Weill-Marchesani syndrome 3, recessive); Glaucoma 3, primary congenital, D; AR (Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma); AR (Geleophysic dysplasia 1); AR (Dental anomalies and short stature); AD (Geleophysic dysplasia 3)",
LTBP2,"AR (?Weill-Marchesani syndrome 3, recessive); Glaucoma 3, primary congenital, D; AR (Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma); AR (Dental anomalies and short stature); AD (Geleophysic dysplasia 3); AR (Anterior segment dysgenesis 6, multiple subtypes); AR (Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset)",
LTBP3,"AR (Dental anomalies and short stature); AD (Geleophysic dysplasia 3); AR (?Weill-Marchesani syndrome 3, recessive); Glaucoma 3, primary congenital, D; AR (Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma)",
LTBP4,"AR (Cutis laxa, autosomal recessive, type IC); AD (?Cutis laxa, autosomal dominant 2); AD (Charcot-Marie-Tooth disease, demyelinating, type 1H); AR (Cutis laxa, autosomal recessive, type IA); AD (Macular degeneration, age-related, 3); {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2)",
LTBR,"{Leprosy, susceptibility to, 4}; {Myocardial infarction, susceptibility to}; {Psoriatic arthritis, susceptibility to}; AD (Immunodeficiency, common variable, 10); AR (Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia); AR (Immunodeficiency 112); AD ({IgA nephropathy, susceptibility to, 1}); AR (Immunodeficiency 42)",
LTC4S,AR (Leukotriene C4 synthase deficiency),
LTF,AR (Donnai-Barrow syndrome); AR (Atransferrinemia); AR (?Immunodeficiency 108 with autoinflammation); AR (Specific granule deficiency),
LTK,"AD (Cryptorchidism); AR (Glycosylphosphatidylinositol biosynthesis defect 17); Agammaglobulinemia, X-linked 1; Isolated growth hormone deficiency, type III, with agammaglobulinemia",
LTN1,AR (Intellectual developmental disorder with speech delay and axonal peripheral neuropathy),
LTV1,AR (Inflammatory poikiloderma with hair abnormalities and acral keratoses),
LUC7L,"AD (Erythrocytosis, familial, 7); AD (Heinz body anemia); Hemoglobin H disease, deletional and nondeletional; Thalassemia, alpha-",
LUC7L2,AR (Orofaciodigital syndrome XIX),
LUM,"AD (Corneal dystrophy, posterior amorphous); AD (Myopia-3); AD ({Asthma, diminished response to antileukotriene treatment in}); {Atherosclerosis, susceptibility to}",
LURAP1,AD (Chilton-Okur-Chung neurodevelopmental syndrome),
LUZP1,[Low density lipoprotein cholesterol level QTL 8],
LXN,AD (Weaver syndrome),
LY6L,AR (Meleda disease),
LY6S,"AR (Meleda disease); AR (Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy); AR (Hyperlipoproteinemia, type 1D)",
LY75,"AR (Immunodeficiency 29, mycobacteriosis)",
LY86,Chromosome 6pter-p24 deletion syndrome,
LY9,"{Rheumatoid arthritis, susceptibility to}; Lymphoproliferative syndrome, X-linked, 1",
LY96,"AD (Deafness, autosomal dominant 56)",
LYAR,AD (Fetal hemoglobin quantitative trait locus 1),
LYL1,"Leukemia, T-cell acute lymphoblastoid; Leukemia, T-cell acute lymphocytic, somatic; Leukemia, T-cell acute lymphocytic, somatic; Autoinflammatory disease, systemic, X-linked; Ectodermal dysplasia and immunodeficiency 1; Immunodeficiency 33; Incontinentia pigmenti",
LYN,"AD (Autoinflammatory disease, systemic, with vasculitis); AR (Immunodeficiency, common variable, 3)",
LYNX1,AR (Meleda disease),
LYPLA2,"AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections)",
LYRM4,"AR (?Combined oxidative phosphorylation deficiency 19); AR (Combined oxidative phosphorylation deficiency 14); AR (Spastic paraplegia 77, autosomal recessive); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes)",
LYRM7,"AR (Mitochondrial complex III deficiency, nuclear type 8); AR (Mitochondrial complex III deficiency, nuclear type 10)",
LYSET,"AR (Dysostosis multiplex, Ain-Naz type)",
LYST,"AR (Chediak-Higashi syndrome); AR (Gray platelet syndrome); AR (Immunodeficiency, common variable, 8, with autoimmunity); AR (Farber lipogranulomatosis); AR (Spinal muscular atrophy with progressive myoclonic epilepsy); {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; AR (Krabbe disease)",
LYZ,"Amyloidosis, hereditary systemic 5; AR ([Chitotriosidase deficiency])",
LZTFL1,AR (Bardet-Biedl syndrome 17); AR (Bardet-Biedl syndrome 4); AR (Bardet-Biedl syndrome 1); AR (Bardet-Biedl syndrome 7); AR (Bardet-Biedl syndrome 2); AR (Retinitis pigmentosa 74); AR (Bardet-Biedl syndrome 5); AR (?Retinitis pigmentosa 51); AR (Bardet-Biedl syndrome 8); AR (Bardet-Biedl syndrome 9),
LZTR1,"AD ({Schwannomatosis-2, susceptibility to}); AD (Noonan syndrome 10); AR (Noonan syndrome 2); AD (Cardiomyopathy, dilated, 1NN); AD (LEOPARD syndrome 2); AD (Noonan syndrome 5); AD (Noonan syndrome-like disorder with loose anagen hair 2); AD (Noonan syndrome-like with loose anagen hair 1); AD (Noonan syndrome 8)",
LZTS1,"Esophageal squamous cell carcinoma, somatic",
M1AP,AR (Spermatogenic failure 48),
M6PR,"Hepatocellular carcinoma, somatic; AR (Arthrogryposis, renal dysfunction, and cholestasis 2); Pituitary adenoma 4, ACTH-secreting, somatic; AD (Schuurs-Hoeijmakers syndrome)",
MAB21L1,"AR (Cerebellar, ocular, craniofacial, and genital syndrome); AR (Microphthalmia/coloboma and skeletal dysplasia syndrome); {Autism susceptibility 3}",
MAB21L2,"AR (Microphthalmia/coloboma and skeletal dysplasia syndrome); AR (Cerebellar, ocular, craniofacial, and genital syndrome)",
MACF1,"AD (Lissencephaly 9 with complex brainstem malformation); ?Caudal duplication anomaly; AR (Craniometadiaphyseal osteosclerosis with hip dysplasia); Hepatocellular carcinoma, somatic",
MACIR,AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24),
MACROD2,AD (Hypogonadotropic hypogonadism 21 with anosmia),
MACROH2A1,AR (El Hayek-Chahrour neurodevelopmental syndrome),
MAD1L1,"Lymphoma, B-cell, somatic; AR (Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition); Prostate cancer, somatic; AD ({Breast cancer, susceptibility to}); AR (Mitochondrial DNA depletion syndrome 17); AD (Developmental delay with or without intellectual impairment or behavioral abnormalities)",
MAD2L1,"AR (?Fanconi anemia, complementation group V); Lymphoma, B-cell, somatic; AR (Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition); Prostate cancer, somatic; AR (?Inflammatory skin and bowel disease, neonatal, 1); AR (Hydatidiform mole, recurrent, 2)",
MAD2L1BP,AR (Mosaic variegated aneuploidy syndrome 3); AR (Oocyte/zygote/embryo maturation arrest 9),
MAD2L2,"AR (?Fanconi anemia, complementation group V); AD (Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features); AR (Cone-rod dystrophy 9); AR (Ruijs-Aalfs syndrome)",
MADCAM1,"Cholangitis, primary sclerosing",
MADD,"AR (DEEAH syndrome); AR (Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia); AR (Glutaric acidemia IIC)",
MAF,"AD (Ayme-Gripp syndrome); AD (Cataract 21, multiple types); AD (Duane retraction syndrome 3); AD (Multicentric carpotarsal osteolysis syndrome); AD (Insulinomatosis and diabetes mellitus); AR (?Deafness, autosomal recessive 98); AR (Ectodermal dysplasia 14, hypohidrotic/hair/tooth/nail type); AR (Tooth agenesis, selective, 10)",
MAFA,"AD (Insulinomatosis and diabetes mellitus); AR (Insulin-like growth factor I, resistance to); AR (Insulin-like growth factor I deficiency); Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); AD (Diabetes mellitus, insulin-dependent, 2); AR (Diabetes mellitus, permanent neonatal 4); AD (Hyperproinsulinemia); AD (Maturity-onset diabetes of the young, type 10); AR ({Diabetes mellitus, insulin-dependent-1}); AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1); AD (Duane retraction syndrome 3); AD (Multicentric carpotarsal osteolysis syndrome)",
MAFB,"AD (Duane retraction syndrome 3); AD (Multicentric carpotarsal osteolysis syndrome); AD (Orofacial cleft-1); AD (Ayme-Gripp syndrome); AD (Cataract 21, multiple types); AD (Duane retraction syndrome 1)",
MAFK,AD (Immunodeficiency 60 and autoimmunity),
MAG,"AR (Spastic paraplegia 75, autosomal recessive); AD ({Schizophrenia, susceptibility to}); AR (Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract)",
MAGEA10,"Bartter syndrome, type 5, antenatal, transient",
MAGEA6,"AD (Congenital contractures of the limbs and face, hypotonia, and developmental delay); AR (Hypotonia, infantile, with psychomotor retardation and characteristic facies 1); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic",
MAGEC1,"AR (Ehlers-Danlos syndrome, musculocontractural type 2)",
MAGED1,"Bartter syndrome, type 5, antenatal, transient; Chromosome Xp11.23-p11.22 duplication syndrome",
MAGED2,"Bartter syndrome, type 5, antenatal, transient",
MAGEL2,"AD (Schaaf-Yang syndrome); AD (Prader-Willi syndrome); AD (Hao-Fountain syndrome); AD (Precocious puberty, central, 2); Birk-Barel syndrome; {Menarche, age at, QTL}",
MAGI1,"AD (Glomerulosclerosis, focal segmental, 1); AR (Nephrotic syndrome, type 15)",
MAGI2,"AR (Nephrotic syndrome, type 15); Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb; AR (Usher syndrome, type 1G); AD (?Intellectual developmental disorder, autosomal dominant 10); AD (Williams-Beuren syndrome); AD (Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations); AD (Developmental and epileptic encephalopathy 108)",
MAGI3,"AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2); AD (Neural tube defects); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AD (Exudative vitreoretinopathy 1); AD (Retinopathy of prematurity); AD (Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations); AD (Developmental and epileptic encephalopathy 108)",
MAGOH,"AR (Thrombocytopenia-absent radius syndrome); Intellectual developmental disorder, X-linked syndromic 14; AR (Robin sequence with cleft mandible and limb anomalies)",
MAGOHB,"AD (Dystonia 28, childhood-onset); AD (Intellectual developmental disorder, autosomal dominant 68)",
MAGT1,"Congenital disorder of glycosylation, type Icc; Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia; AR (Intellectual developmental disorder, autosomal recessive 7); Intellectual developmental disorder, X-linked 95",
MAIP1,"AD (Optic atrophy 12); AR (Spastic ataxia 5, autosomal recessive); AD (Spinocerebellar ataxia 28)",
MAJIN,AR (Spermatogenic failure 60); AR (?Spermatogenic failure 59),
MAK,"AR (Retinitis pigmentosa 62); AD ({Epilepsy, juvenile myoclonic, susceptibility to, 10}); AR (Endocrine-cerebroosteodysplasia); AR (Cardiomyopathy, familial hypertrophic 27); AD (CEBALID syndrome); AD (Meningioma); AR (Immunodeficiency 7, TCR-alpha/beta deficient); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AR (?Immunodeficiency 119)",
MAL,"AR (?Leukodystrophy, hypomyelinating, 28); AR (?Immunodeficiency 66); {Bacteremia, protection against}; {Malaria, protection against}; {Tuberculosis, protection against}; AR (Meleda disease)",
MAL2,"AR (?Leukodystrophy, hypomyelinating, 28); AD (Charcot-Marie-Tooth disease, dominant intermediate E); Glomerulosclerosis, focal segmental, 5",
MALL,"AD (?Liddle syndrome 3); AD (Bronchiectasis with or without elevated sweat chloride 2); AR (Pseudohypoaldosteronism, type IB1, autosomal recessive); AD (Bronchiectasis with or without elevated sweat chloride 1); AD (Liddle syndrome 1); AR (Pseudohypoaldosteronism, type IB2, autosomal recessive); AD (Bronchiectasis with or without elevated sweat chloride 3); AD (Liddle syndrome 2); AR (Pseudohypoaldosteronism, type IB3, autosomal recessive); AR (Joubert syndrome 4); AR (Nephronophthisis 1, juvenile); AR (Senior-Loken syndrome-1); AD (Intellectual developmental disorder, autosomal dominant 39); AR (Microcephaly 16, primary, autosomal recessive)",
MALT1,"AR (Immunodeficiency 12); AR (?Immunodeficiency 37); {Lymphoma, follicular, somatic}; {Male germ cell tumor, somatic}; {Mesothelioma, somatic}; {Sezary syndrome, somatic}; Lymphoma, MALT, somatic; AD (B-cell expansion with NFKB and T-cell anergy); AR (Immunodeficiency 11A); AD (Immunodeficiency 11B with atopic dermatitis); AD (Autoinflammatory syndrome, familial, Behcet-like 1); AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); {Aspergillosis, susceptibility to}; AR (Candidiasis, familial, 4, autosomal recessive); AR (Immunodeficiency 103, susceptibility to fungal infection)",
MAML1,"Mucoepidermoid salivary gland carcinoma; AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (?Deafness, congenital heart defects, and posterior embryotoxon); AD (Alagille syndrome 1); AD (Charcot-Marie-Tooth disease, axonal, type 2HH); AD (Tetralogy of Fallot); Mucoepidermoid salivary gland carcinoma",
MAML2,Mucoepidermoid salivary gland carcinoma; AD (Wiedemann-Steiner syndrome); Mucoepidermoid salivary gland carcinoma,
MAML3,Mucoepidermoid salivary gland carcinoma,
MAMLD1,"Hypospadias 2, X-linked; AD (46XX sex reversal 4); AD (46XY sex reversal 3); AD (Adrenocortical insufficiency); AD (Premature ovarian failure 7); AD (Spermatogenic failure 8)",
MAN1B1,"AR (Rafiq syndrome); AR (Muscular dystrophy, limb-girdle, autosomal recessive 3)",
MAN2A1,"AR (Al-Gazali syndrome); AR (Ehlers-Danlos syndrome, spondylodysplastic type, 2); AR (Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures)",
MAN2B1,"AR (Mannosidosis, alpha-, types I and II); AR (Mannosidosis, beta)",
MAN2B2,AR (Congenital disorder of glycosylation type 1EE with or without immunodeficiency),
MAN2C1,AR (Congenital disorder of deglycosylation 2),
MANBA,"AR (Mannosidosis, beta); AR (Mannosidosis, alpha-, types I and II)",
MANEA,"AD (Hao-Fountain syndrome); AR (Diarrhea 4, malabsorptive, congenital)",
MANF,"AR (Diabetes, deafness, developmental delay, and short stature syndrome)",
MAOA,"Brunner syndrome; AD ({Panic disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to}); AD ({Restless legs syndrome 1}); AD ({Attention deficit-hyperactivity disorder}); Autonomic nervous system dysfunction; {Anorexia nervosa, susceptibility to, 1}",
MAOB,"Brunner syndrome; AD ({Panic disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to}); AD ({Restless legs syndrome 1}); Optic atrophy 2, X-linked",
MAP1A,"AR (?Retinal dystrophy and obesity); {Schizophrenia 9, susceptibility to}; AD (?Deafness, autosomal dominant 83); AD (Periventricular nodular heterotopia 9)",
MAP1B,"AD (?Deafness, autosomal dominant 83); AD (Periventricular nodular heterotopia 9); AR (Giant axonal neuropathy-1); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; AD (Intellectual developmental disorder, autosomal dominant 7); AD (Bosch-Boonstra-Schaaf optic atrophy syndrome)",
MAP1LC3A,"AD (?Microcephaly 18, primary, autosomal dominant); {Glaucoma, normal tension, susceptibility to}; AR (Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia); AD (Glaucoma 1, open angle, E); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1)",
MAP1LC3B,"AR (Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1)",
MAP1LC3C,"AR (Deafness, autosomal recessive 45)",
MAP2,"AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AR (Developmental and epileptic encephalopathy 76); AD (Intellectual developmental disorder with severe speech and ambulation defects); AR (Diencephalic-mesencephalic junction dysplasia syndrome 2)",
MAP2K1,"AD (Cardiofaciocutaneous syndrome 3); Melorheostosis, isolated, somatic mosaic; AR (Oocyte/zygote/embryo maturation arrest 20); AD (Noonan syndrome 13); AD (Cardiofaciocutaneous syndrome 4); AD ({Melanoma, cutaneous malignant, 1}); AR (Hyperbiliverdinemia)",
MAP2K2,"AD (Cardiofaciocutaneous syndrome 4); AD (Cardiofaciocutaneous syndrome 3); Melorheostosis, isolated, somatic mosaic; AD ({Melanoma, cutaneous malignant, 1}); AR (Oocyte/zygote/embryo maturation arrest 20); Colorectal cancer, somatic; Esophageal carcinoma, somatic; AR (Gaze palsy, familial horizontal, with progressive scoliosis, 2); AD (Mirror movements 1 and/or agenesis of the corpus callosum); AR (Congenital myopathy 6 with ophthalmoplegia)",
MAP2K3,"AD (Intellectual developmental disorder, autosomal dominant 48); Cerebral cavernous malformations 5; AR (Spastic ataxia 2, autosomal recessive); AD (Abdominal obesity-metabolic syndrome 3)",
MAP2K4,"AD (Developmental and epileptic encephalopathy 17); AD (Neurodevelopmental disorder with involuntary movements); AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor)",
MAP2K5,AD ({Restless legs syndrome 1}); {Restless legs syndrome 7},
MAP2K6,"AR (Hypertrichosis terminalis, generalized, with or without gingival hyperplasia); AR (Pierre Robin syndrome); AD (Developmental delay with or without intellectual impairment or behavioral abnormalities)",
MAP2K7,AR (Centronuclear myopathy 6 with fiber-type disproportion); AR (Split-foot malformation with mesoaxial polydactyly),
MAP3K1,"AD (46XY sex reversal 6); AR (Deafness, autosomal recessive 93); AR (Immunodeficiency with hyper-IgM, type 3); AD (Leukemia, acute myeloid); AD (Platelet disorder, familial, with associated myeloid malignancy); AR (Congenital myopathy 6 with ophthalmoplegia); AD (Autoinflammatory syndrome, familial, Behcet-like 1)",
MAP3K10,AR (Centronuclear myopathy 6 with fiber-type disproportion); AR (Split-foot malformation with mesoaxial polydactyly),
MAP3K11,"AR (Spastic paraplegia 76, autosomal recessive)",
MAP3K14,"AR (Immunodeficiency 112); AD (Immunodeficiency, common variable, 10); AR (Intellectual developmental disorder, autosomal recessive 13); AR (?Candidiasis, familial, 8); {Psoriasis susceptibility 13}",
MAP3K2,Cerebral cavernous malformations 5,
MAP3K20,"AR (Centronuclear myopathy 6 with fiber-type disproportion); AR (Split-foot malformation with mesoaxial polydactyly); AR (?Respiratory papillomatosis, juvenile recurrent, congenital); {Vitiligo-associated multiple autoimmune disease susceptibility 1}; AR (Autoinflammation with arthritis and dyskeratosis); AD (Palmoplantar carcinoma, multiple self-healing)",
MAP3K3,"Cerebral cavernous malformations 5; Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AD (Intellectual developmental disorder, autosomal dominant 48); AD (Cardiac, facial, and digital anomalies with developmental delay)",
MAP3K4,AD (46XY sex reversal 6),
MAP3K5,"AD ({Melanoma, cutaneous malignant, 1}); AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive)",
MAP3K7,"AD (Cardiospondylocarpofacial syndrome); AD (Frontometaphyseal dysplasia 2); AD (Congenital heart defects, nonsyndromic, 2)",
MAP3K8,"Lung cancer, somatic; {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AR (Immunodeficiency 29, mycobacteriosis); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); Cerebral cavernous malformations 5",
MAP3K9,"AD ({Melanoma, cutaneous malignant, 1}); AR (Centronuclear myopathy 6 with fiber-type disproportion); AR (Split-foot malformation with mesoaxial polydactyly)",
MAP4,"?Roifman-Chitayat syndrome, digenic; AR (Senior-Loken syndrome 9); AR (?Visual impairment and progressive phthisis bulbi); ?Roifman-Chitayat syndrome, digenic; AD (Immunodeficiency 14A, autosomal dominant); AR (Immunodeficiency 14B, autosomal recessive)",
MAP4K4,"Immunodeficiency 50; AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AD (Deafness, autosomal dominant 90); AR (Deafness, autosomal recessive 30); AD (Autoinflammation with episodic fever and lymphadenopathy); AR (Immunodeficiency 57 with autoinflammation)",
MAPK1,"AD (Noonan syndrome 13); AR (Oocyte/zygote/embryo maturation arrest 20); AD (46XY sex reversal 6); AD (Cardiofaciocutaneous syndrome 3); Melorheostosis, isolated, somatic mosaic; AR (Developmental and epileptic encephalopathy 50); AR (Acromesomelic dysplasia 4); AR (Spondylometaphyseal dysplasia, Pagnamenta type); AR (Neurofacioskeletal syndrome with or without renal agenesis)",
MAPK10,"AR (Nephronophthisis 20); {Inflammatory bowel disease 14}; {Systemic lupus erythematosus, susceptibility to, 10}; AD (Neurodevelopmental disorder with or without variable brain abnormalities)",
MAPK11,AR (Neurocardiofaciodigital syndrome),
MAPK14,"AD (Cardiospondylocarpofacial syndrome); AD (Frontometaphyseal dysplasia 2); AD (46XY sex reversal 6); AR (Autoimmune lymphoproliferative syndrome, type III); AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related)",
MAPK3,"AR (Oocyte/zygote/embryo maturation arrest 20); AD (Cardiofaciocutaneous syndrome 3); Melorheostosis, isolated, somatic mosaic; AD (46XY sex reversal 6); AR (Acromesomelic dysplasia 4); AR (Spondylometaphyseal dysplasia, Pagnamenta type); AR (Neurofacioskeletal syndrome with or without renal agenesis); AD (Noonan syndrome 13)",
MAPK6,"{Autism susceptibility 1}; AR (Neurocardiofaciodigital syndrome); {Rheumatoid arthritis, susceptibility to}; Lymphoproliferative syndrome, X-linked, 1",
MAPK7,"AR (?Deafness, autosomal recessive 26); AR (Centronuclear myopathy 6 with fiber-type disproportion); AR (Split-foot malformation with mesoaxial polydactyly)",
MAPK8,"Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); AD (Aortic aneurysm, familial abdominal 1); AR (Immunodeficiency with hyper-IgM, type 3); AD (Autoinflammatory disease, familial, Behcet-like-3); AR (Brain abnormalities, neurodegeneration, and dysosteosclerosis); AD (Leukoencephalopathy, diffuse hereditary, with spheroids 1)",
MAPK8IP1,"AD ({Diabetes mellitus, noninsulin-dependent}); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5); AR (?Deafness, autosomal recessive 66); AR (Nephronophthisis 19); AR (Sclerosing cholangitis, neonatal)",
MAPK8IP3,AD (Neurodevelopmental disorder with or without variable brain abnormalities),
MAPK9,"AR (Nephronophthisis 20); AR (Intellectual developmental disorder, autosomal recessive 54)",
MAPKAP1,"Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic",
MAPKAPK2,"AD (?Macular dystrophy, patterned, 3); AR (Neurocardiofaciodigital syndrome)",
MAPKAPK3,"AD (?Macular dystrophy, patterned, 3)",
MAPKAPK5,"AR (Neurocardiofaciodigital syndrome); AD (Charcot-Marie-Tooth disease, axonal, type 2F); AD (Neuronopathy, distal hereditary motor, autosomal dominant 3)",
MAPKBP1,AR (Nephronophthisis 20),
MAPRE1,"AD (Symmetric circumferential skin creases, congenital, 2); ?Premature ovarian failure 2A",
MAPRE2,"AD (Symmetric circumferential skin creases, congenital, 2); AD (Cortical dysplasia, complex, with other brain malformations 6); AD (Symmetric circumferential skin creases, congenital, 1)",
MAPRE3,"AD (Symmetric circumferential skin creases, congenital, 2); AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical)",
MAPT,"AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
MARCHF6,"AD (Epilepsy, familial adult myoclonic, 3)",
MARCKS,"AR (Autoimmune lymphoproliferative syndrome, type III); {Hypertension, essential, salt-sensitive}",
MARCO,"AD ({Epilepsy, familial temporal lobe, 7}); AR (Lissencephaly 2 (Norman-Roberts type)); AR (Dworschak-Punetha neurodevelopmental syndrome); AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia)",
MARK1,"{Autism susceptibility 11}; AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AD (Developmental delay with or without intellectual impairment or behavioral abnormalities)",
MARK2,"AR (Cortical dysplasia, complex, with other brain malformations 12); AD (Robinow syndrome, autosomal dominant 2)",
MARK3,"AR (?Visual impairment and progressive phthisis bulbi); AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); Osteosarcoma, somatic; Prostate cancer, somatic; Tumor predisposition syndrome 4, breast/prostate/colorectal",
MARS1,"AR (?Trichothiodystrophy 9, nonphotosensitive); AD (Charcot-Marie-Tooth disease, axonal, type 2U); AR (Interstitial lung and liver disease); AR (Spastic paraplegia 70, autosomal recessive); AD (?Leukoencephalopathy, hereditary diffuse, with spheroids 2); AD (Charcot-Marie-Tooth disease, axonal, type 2N); AR (Developmental and epileptic encephalopathy 29); AR (Trichothiodystrophy 8, nonphotosensitive)",
MARS2,"AR (?Combined oxidative phosphorylation deficiency 25); AR (Spastic ataxia 3, autosomal recessive); AR (Combined oxidative phosphorylation deficiency 40)",
MARVELD1,"AR (Deafness, autosomal recessive 49)",
MARVELD2,"AR (Deafness, autosomal recessive 49)",
MAS1,"AR (Immunodeficiency with hyper IgM, type 5)",
MASP1,"AR (3MC syndrome 1); AR (3MC syndrome 2); AR (MASP2 deficiency); AD ({Diabetes mellitus, type 2, susceptibility to}); AR (Angioedema, hereditary, 1 and 2); AD (Complement component 4, partial deficiency of)",
MASP2,"AR (MASP2 deficiency); AR (3MC syndrome 1); AR (Angioedema, hereditary, 1 and 2); AD (Complement component 4, partial deficiency of); AR (Immunodeficiency due to ficolin 3 deficiency)",
MAST1,"AD (Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations); Chromosome 19p13.13 deletion syndrome; Chromosome 19p13.13 duplication syndrome; AD (Developmental and epileptic encephalopathy 108); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AR (Nephrotic syndrome, type 15)",
MAST2,"AD (Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations); AR (?Premature ovarian failure 12); AR (?Spermatogenic failure 15); AD (Developmental and epileptic encephalopathy 108); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AR (Nephrotic syndrome, type 15)",
MAST3,"AD (Developmental and epileptic encephalopathy 108); AD (Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AR (Nephrotic syndrome, type 15)",
MAST4,AD (Developmental and epileptic encephalopathy 108),
MASTL,AD (Houge-Janssens syndrome 3),
MAT1A,"AR (Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency); AR (Methionine adenosyltransferase deficiency, autosomal recessive); AR (Niemann-Pick disease, type A); AR (Niemann-Pick disease, type B)",
MAT2A,"AR (Bowen-Conradi syndrome); Aortic aneurysm, familial thoracic 1; AR (Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency); AR (Methionine adenosyltransferase deficiency, autosomal recessive)",
MATN1,"AD ({Osteoarthritis susceptibility 2}); AD (Epiphyseal dysplasia, multiple, 5); AR (Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type)",
MATN3,"AD ({Osteoarthritis susceptibility 2}); AD (Epiphyseal dysplasia, multiple, 5); AR (Spondyloepimetaphyseal dysplasia, Borochowitz-Cormier-Daire type); AR (Short-rib thoracic dysplasia 19 with or without polydactyly)",
MATR3,"AD (Amyotrophic lateral sclerosis 21); AR (Pituitary hormone deficiency, combined or isolated, 1); X-inactivation, familial skewed",
MAU2,"AD (Cornelia de Lange syndrome 1); AD (Cornelia de Lange syndrome 3); AD (Intellectual developmental disorder, autosomal dominant 47); Cornelia de Lange syndrome 2; Developmental and epileptic encephalopathy 85, with or without midline brain defects; Holoprosencephaly 13, X-linked; Mullegama-Klein-Martinez syndrome",
MAVS,"AD (STING-associated vasculopathy, infantile-onset); AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}); AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1)",
MAX,"AD ({Pheochromocytoma, susceptibility to}); AD (Polydactyly-macrocephaly syndrome); Neurofibrosarcoma, somatic; Prostate cancer, somatic; AD (Premature ovarian failure 26); Burkitt lymphoma, somatic",
MAZ,"Barrett esophagus/esophageal adenocarcinoma; AR (Spinal muscular atrophy with congenital bone fractures 2); AR (?Muscular dystrophy, congenital, Davignon-Chauveau type); AR (Spinal muscular atrophy with congenital bone fractures 1); AD (Spondyloepimetaphyseal dysplasia with joint laxity, type 2)",
MB,"AD (Myopathy, sarcoplasmic body); AD (Williams-Beuren syndrome); Chromosome 16p12.2-p11.2 deletion syndrome; AD (Chromosome 17q11.2 deletion syndrome, 1.4Mb); Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb; AD (Chromosome 1q21.1 deletion syndrome); Chromosome 16p11 inversion; AD (Chromosome 17q11.2 duplication syndrome, 1.4-Mb); AD (?Neuropathy, inflammatory demyelinating); AD (Charcot-Marie-Tooth disease, type 1A); AD (Charcot-Marie-Tooth disease, type 1E); AR (Dejerine-Sottas disease); AD (Neuropathy, recurrent, with pressure palsies); AD (Roussy-Levy syndrome); AD (Chromosome 6q25-q25 deletion syndrome)",
MBD1,"Leukemia, acute promyelocytic; {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant",
MBD2,"AD (GAND syndrome); AD ({Uveal melanoma, susceptibility to, 1}); AR (Tumor predisposition syndrome 2); AR (Xeroderma pigmentosum, group A)",
MBD3,AD (GAND syndrome); AD (Sifrim-Hitz-Weiss syndrome),
MBD4,"AD ({Uveal melanoma, susceptibility to, 1}); AR (Tumor predisposition syndrome 2); AD (Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant); AD (Neuropathy, hereditary sensory, type IE); Acute myeloid leukemia, somatic; AD (Heyn-Sproul-Jackson syndrome); AD (Tatton-Brown-Rahman syndrome)",
MBD5,"AD (Intellectual developmental disorder, autosomal dominant 1); AD (Kleefstra syndrome 2)",
MBD6,"AD (Intellectual developmental disorder, autosomal dominant 1); AD (Lessel-Kreienkamp syndrome)",
MBIP,"AD (?Epilepsy, myoclonic, familial adult, 4)",
MBL2,"AD ({Chronic infections, due to MBL deficiency}); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy)",
MBNL1,"AD (Myotonic dystrophy 1); AD ({Parkinson disease, susceptibility to}); AD (Spinocerebellar ataxia 8); AD (Corneal dystrophy, Fuchs endothelial, 3); AD (Pitt-Hopkins syndrome); AD (Hydrocephalus, congenital, 4)",
MBOAT4,"AR ({Obesity, susceptibility to})",
MBOAT7,"AR (Intellectual developmental disorder, autosomal recessive 57)",
MBP,"AD ({Chronic infections, due to MBL deficiency}); AR (Pontocerebellar hypoplasia, type 1C); AD (Chromosome 18q deletion syndrome); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1",
MBTPS1,"AR (?Spondyloepiphyseal dysplasia, Kondo-Fu type); AD (Hypertriglyceridemia 2)",
MBTPS2,"?Olmsted syndrome, X-linked; IFAP syndrome with or without BRESHECK syndrome; Keratosis follicularis spinulosa decalvans, X-linked; Osteogenesis imperfecta, type XIX; AD (Hypertriglyceridemia 2)",
MC1R,"[Analgesia from kappa-opioid receptor agonist, female-specific]; AR ([Skin/hair/eye pigmentation 2, blond hair/fair skin]); AR ([Skin/hair/eye pigmentation 2, red hair/fair skin]); AR ({Albinism, oculocutaneous, type II, modifier of}); {Melanoma, cutaneous malignant, 5}; AR ({UV-induced skin damage}); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); AD ({Melanoma and neural system tumor syndrome}); AD ({Melanoma-pancreatic cancer syndrome}); AD ({Melanoma, cutaneous malignant, 2}); [Skin/hair/eye pigmentation 9, brown/nonbrown eyes]; [Skin/hair/eye pigmentation 9, dark/light hair]; AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Albinism, brown oculocutaneous); AR (Albinism, oculocutaneous, type II)",
MC2R,"AR (Glucocorticoid deficiency, due to ACTH unresponsiveness); AD ({?Obesity, susceptibility to, BMIQ18}); AR (Glucocorticoid deficiency 2); AR (Glucocorticoid deficiency 3); AD ({ACTH-independent macronodular adrenal hyperplasia 2})",
MC3R,"{Obesity, severe, susceptibility to, BMIQ9}; AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20)); {Type 2 diabetes mellitus 3}; {Mycobacterium tuberculosis, susceptibility to, 3}; AR ({Leanness, inherited}); AR ({Obesity, late-onset}); [Body mass index QTL1]",
MC4R,"AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20)); {Obesity, severe, susceptibility to, BMIQ9}; AD ({?Obesity, susceptibility to, BMIQ18}); AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay); AR (Leber congenital amaurosis 16); AD (Snowflake vitreoretinal degeneration)",
MCAT,"AR (Optic atrophy 15); AR (Intellectual developmental disorder, autosomal recessive 69)",
MCC,"Colorectal cancer, somatic; AR (3-Methylcrotonyl-CoA carboxylase 1 deficiency); AR (Oocyte/zygote/embryo maturation arrest 14); AR (Ciliary dyskinesia, primary, 42); Adenoma, periampullary, somatic; AD (Adenomatous polyposis coli); AD (Brain tumor-polyposis syndrome 2); Colorectal cancer, somatic; AD (Desmoid disease, hereditary); AD (Gardner syndrome); AD (Gastric adenocarcinoma and proximal polyposis of the stomach); Gastric cancer, somatic; Hepatoblastoma, somatic",
MCCC1,AR (3-Methylcrotonyl-CoA carboxylase 1 deficiency); AR (3-Methylcrotonyl-CoA carboxylase 2 deficiency); AR (Holocarboxylase synthetase deficiency); AR (Biotinidase deficiency),
MCCC2,AR (3-Methylcrotonyl-CoA carboxylase 2 deficiency); AR (3-Methylcrotonyl-CoA carboxylase 1 deficiency),
MCEE,"AR (Methylmalonyl-CoA epimerase deficiency); AR (Dystonia, dopa-responsive, due to sepiapterin reductase deficiency)",
MCF2,"AD (Cataract 6, multiple types); AR (?Immunodeficiency 62); {Deep venous thrombosis, protection against}; {Warfarin sensitivity}; Hemophilia B; Thrombophilia 8, X-linked, due to factor IX defect; AR (Muscular dystrophy, limb-girdle, autosomal recessive 25)",
MCFD2,"Factor V and factor VIII, combined deficiency of; AR (Combined factor V and VIII deficiency)",
MCHR1,AR (Bardet-Biedl syndrome 4); AR (Bardet-Biedl syndrome 2); AR (Retinitis pigmentosa 74),
MCHR2,"{Menarche, age at, QTL2}; {Menarche, age at, QTL3}",
MCIDAS,"AR (Ciliary dyskinesia, primary, 42); AR (Ciliary dyskinesia, primary, 29); AD (Ciliary dyskinesia, primary, 43)",
MCL1,"AD (Developmental delay, hypotonia, and impaired language); Intellectual developmental disorder, X-linked 99; Intellectual developmental disorder, X-linked 99, syndromic, female-restricted; AR (?Retinitis pigmentosa 67)",
MCM10,AR (Immunodeficiency 80 with or without cardiomyopathy),
MCM2,"AD (?Deafness, autosomal dominant 70); AR (Immunodeficiency 54); AR (?Meier-Gorlin syndrome 8); AR (Ovarian dysgenesis 4); AD (Lactase persistence/nonpersistence)",
MCM3,"AR (Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development); AD (?Deafness, autosomal dominant 70); AR (?Meier-Gorlin syndrome 8); AD (Houge-Janssens syndrome 3); AR (Myoectodermal gonadal dysgenesis syndrome); AD (Spermatogenic failure 36)",
MCM3AP,"AR (Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development); AD (Houge-Janssens syndrome 3); AR (Myoectodermal gonadal dysgenesis syndrome); AD (Spermatogenic failure 36)",
MCM4,"AR (Immunodeficiency 54); AR (Immunodeficiency 26, with or without neurologic abnormalities); AD (Lactase persistence/nonpersistence); AR (?Premature ovarian failure 10)",
MCM5,"AR (?Meier-Gorlin syndrome 8); AD (?Deafness, autosomal dominant 70); {Pulmonary disease, chronic obstructive, susceptibility to}; AR (Heme oxygenase-1 deficiency); AD (?Immunodeficiency 85 and autoimmunity); AD (Lactase persistence/nonpersistence); AR (Meier-Gorlin syndrome 1)",
MCM6,"AD (Lactase persistence/nonpersistence); AR (Lactase deficiency, congenital); {Stature QTL 1}; AR (?Premature ovarian failure 10); AR (Immunodeficiency 54); AR (?Meier-Gorlin syndrome 8)",
MCM7,"AD (Charcot-Marie-Tooth disease, type 2Y); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 6); AD (Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1); AD (?Deafness, autosomal dominant 70); AR (Meier-Gorlin syndrome 7); AR (Immunodeficiency 55)",
MCM8,AR (?Premature ovarian failure 10); AR (Ovarian dysgenesis 11); AR (Ovarian dysgenesis 4); AR (Combined oxidative phosphorylation deficiency 57),
MCM9,AR (Ovarian dysgenesis 4); AR (?Premature ovarian failure 10); AR (Ovarian dysgenesis 11),
MCMBP,AD (Lactase persistence/nonpersistence); AR (Immunodeficiency 54); AR (?Meier-Gorlin syndrome 8),
MCOLN1,"AD (Lisch epithelial corneal dystrophy); AR (Mucolipidosis IV); AR (?Laurence-Moon syndrome); AR (Boucher-Neuhauser syndrome); AR (Oliver-McFarlane syndrome); AR (Spastic paraplegia 39, autosomal recessive); AR (Ataxia, cerebellar, Cayman type); AD (Leukodystrophy, hypomyelinating, 25)",
MCOLN2,AD (Lisch epithelial corneal dystrophy); AR (Mucolipidosis IV),
MCOLN3,AD (Lisch epithelial corneal dystrophy); AR (Mucolipidosis IV),
MCPH1,"AR (Microcephaly 1, primary, autosomal recessive); AD (?Cutaneous telangiectasia and cancer syndrome, familial); AR (Seckel syndrome 1); AR (Microcephaly 5, primary, autosomal recessive)",
MCRS1,"AD (Sifrim-Hitz-Weiss syndrome); AD (Neurodegeneration, childhood-onset, with brain atrophy)",
MCTS1,"Immunodeficiency 118, mycobacteriosis; Intellectual developmental disorder, X-linked syndromic, Cabezas type",
MCU,"AR (Myopathy with extrapyramidal signs); AD (Optic atrophy 12); AR (Spastic ataxia 5, autosomal recessive); AD (Spinocerebellar ataxia 28); AR (?Intellectual developmental disorder, autosomal recessive 63); AD (Intellectual developmental disorder, autosomal dominant 53)",
MDC1,"AD (Rauch-Steindl syndrome); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38); AR (Nephronophthisis 15); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (?Fanconi anemia, complementation group V)",
MDFI,AR (Lymphatic malformation 12),
MDFIC,AR (Lymphatic malformation 12); AD (Speech-language disorder-1),
MDH1,"AR (?Developmental and epileptic encephalopathy 88); AR (Galactosemia IV); {Glioma, susceptibility to, somatic}; AR (Developmental and epileptic encephalopathy 51); AD (Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia)",
MDH2,AR (Developmental and epileptic encephalopathy 51); AR (?Developmental and epileptic encephalopathy 88),
MDK,"AD (Mesomelic dysplasia, Kantaputra type); [Blood group, OK]; AD (Erythermalgia, primary); AR (Insensitivity to pain, congenital); AR (Neuropathy, hereditary sensory and autonomic, type IID); AD (Paroxysmal extreme pain disorder); AD (Small fiber neuropathy)",
MDM1,"AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to})",
MDM2,"AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD ({Melanoma and neural system tumor syndrome}); AD ({Melanoma-pancreatic cancer syndrome}); AD ({Melanoma, cutaneous malignant, 2}); AD (Diamond-Blackfan anemia 7); AD (?Bone marrow failure syndrome 6)",
MDM4,"AD (?Bone marrow failure syndrome 6); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); {Atrioventricular septal defect, susceptibility to, 1}",
ME1,"AD (?Hypertrichosis universalis congenita, Ambras type); AD (Trichorhinophalangeal syndrome, type I); AD (Trichorhinophalangeal syndrome, type III); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}",
ME2,"AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities); {Myocardial infarction, protection against}; AD ({Venous thrombosis, protection against}); AR (Factor XIIIA deficiency); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4)",
ME3,"AR (Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency)",
MEAF6,AD (Intellectual developmental disorder with dysmorphic facies and ptosis),
MECOM,AD (Radioulnar synostosis with amegakaryocytic thrombocytopenia 2); AD (Intellectual developmental disorder with dysmorphic facies and ptosis); AD (Cohen-Gibson syndrome),
MECP2,"{Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant; Developmental and epileptic encephalopathy 2; AD (Angelman syndrome); AD (Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant); AD (Neuropathy, hereditary sensory, type IE); AR (?Split-hand/foot malformation 1 with sensorineural hearing loss); AD (Split-hand/foot malformation 1)",
MECR,"AR (Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities); AR (Optic atrophy 16)",
MED1,"AD ({Uveal melanoma, susceptibility to, 1}); AR (Tumor predisposition syndrome 2); Anemia, congenital, nonspherocytic hemolytic, 9; Anemia, X-linked, with/without neutropenia and/or platelet abnormalities; Leukemia, megakaryoblastic, with or without Down syndrome, somatic; Thrombocytopenia with beta-thalassemia, X-linked; Thrombocytopenia, X-linked, with or without dyserythropoietic anemia; AD (Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome); AD (Kabuki syndrome 1)",
MED10,"AR (Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities)",
MED11,"AR (Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities)",
MED12,"Hardikar syndrome; Lujan-Fryns syndrome; Ohdo syndrome, X-linked; Opitz-Kaveggia syndrome; AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5)",
MED12L,AD (Nizon-Isidor syndrome); AD (Intellectual developmental disorder with hypotonia and behavioral abnormalities); AD (Developmental and epileptic encephalopathy 87),
MED13,"AD (Intellectual developmental disorder, autosomal dominant 61); AD (Intellectual developmental disorder with hypotonia and behavioral abnormalities); Methylmalonic aciduria and homocysteinemia, cblX type",
MED13L,AD (Impaired intellectual development and distinctive facial features with or without cardiac defects); AD (Baker-Gordon syndrome); AD (Intellectual developmental disorder with hypotonia and behavioral abnormalities); AD (Developmental and epileptic encephalopathy 87),
MED15,"AD (Ichthyosis, follicular, with atrichia and photophobia syndrome 2); AD (Mucoepithelial dysplasia, hereditary)",
MED17,"AR (Microcephaly, postnatal progressive, with seizures and brain atrophy); AD (Intellectual developmental disorder with hypotonia and behavioral abnormalities); Hardikar syndrome; Lujan-Fryns syndrome; Ohdo syndrome, X-linked; Opitz-Kaveggia syndrome",
MED22,"AR (Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities)",
MED23,"AR (Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy)",
MED25,"AR (Basel-Vanagait-Smirin-Yosef syndrome); AR (?Charcot-Marie-Tooth disease, type 2B2); AR (Ataxia-oculomotor apraxia 4); AR (Microcephaly, seizures, and developmental delay)",
MED27,"AR (Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia)",
MED28,"AR (Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities)",
MED6,AR (Basel-Vanagait-Smirin-Yosef syndrome),
MED8,"AR (Developmental and epileptic encephalopathy 18); Cornelia de Lange syndrome 2; Developmental and epileptic encephalopathy 85, with or without midline brain defects; AD (Cornelia de Lange syndrome 1)",
MEF2A,"AD ({Coronary artery disease, autosomal dominant, 1}); AD (Chromosome 5q14.3 deletion syndrome); AD (Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language); AR (Congenital myopathy 6 with ophthalmoplegia)",
MEF2B,"AR (Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities); AD ({Coronary artery disease, autosomal dominant, 1}); AD (Chromosome 5q14.3 deletion syndrome); AD (Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language); AD (Congenital heart defects, multiple types, 6); AR (Right atrial isomerism (Ivemark))",
MEF2C,"AD (Chromosome 5q14.3 deletion syndrome); AD (Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language); AR (?Spermatogenic failure 73); AD ({Coronary artery disease, autosomal dominant, 1}); AD (Neurodevelopmental disorder with central hypotonia and dysmorphic facies); Intellectual developmental disorder, X-linked 114",
MEF2D,"AD ({Coronary artery disease, autosomal dominant, 1})",
MEFV,"AD (Familial Mediterranean fever, AD); AR (Familial Mediterranean fever, AR); AD (Neutrophilic dermatosis, acute febrile); AD (Autoinflammatory syndrome with cytopenia, hyperzincemia, and hypercalprotectinemia); AD (Pyogenic sterile arthritis, pyoderma gangrenosum, and acne)",
MEGF10,"AR (Congenital myopathy 10A, severe variant); AR (Congenital myopathy 10B, mild variant); AR (Muscular dystrophy, limb-girdle, autosomal recessive 27); AR (Retinitis pigmentosa 38)",
MEGF11,"AR (Congenital myopathy 10A, severe variant); AR (Congenital myopathy 10B, mild variant)",
MEGF6,"AR (Congenital myopathy 10A, severe variant); AR (Congenital myopathy 10B, mild variant)",
MEGF8,AR (Carpenter syndrome 2),
MEI1,"AR (Hydatidiform mole, recurrent, 3)",
MEI4,AR (Oocyte/zygote/embryo maturation arrest 10),
MEIG1,AR (Spermatogenic failure 83),
MEIOB,AR (Premature ovarian failure 23); AR (Spermatogenic failure 22); AR (Premature ovarian failure 25); AR (Spermatogenic failure 96),
MEIOSIN,AD (Premature ovarian failure 26),
MEIS1,"AD (Cleft palate, cardiac defects, and impaired intellectual development); {Restless legs syndrome 7}; AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); AD (CEBALID syndrome); AD (Meningioma); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia)",
MEIS2,"AD (Cleft palate, cardiac defects, and impaired intellectual development); AD (Chromosome 15q14 deletion syndrome); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); AD (Retinal dystrophy and iris coloboma with or without cataract); AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); AD (White-Kernohan syndrome); AR (Intellectual developmental disorder, autosomal recessive 2)",
MEN1,"Adrenal adenoma, somatic; Angiofibroma, somatic; Carcinoid tumor of lung; Lipoma, somatic; AD (Multiple endocrine neoplasia 1); Parathyroid adenoma, somatic; AR (Spondylometaphyseal dysplasia with corneal dystrophy); AD (Hyperparathyroidism-jaw tumor syndrome); AD (Hyperparathyroidism, familial primary); AD (Parathyroid adenoma with cystic changes); Parathyroid carcinoma",
MEOX1,AR (Klippel-Feil syndrome 2); AR (van Buchem disease),
MEOX2,AR (Klippel-Feil syndrome 2),
MEP1A,"AR (Enterokinase deficiency); Amelogenesis imperfecta, type 1E",
MEPE,"AD (Deafness, autosomal dominant 39, with dentinogenesis); AD (Dentin dysplasia, type II); AD (Dentinogenesis imperfecta, Shields type II); AD (Dentinogenesis imperfecta, Shields type III); AR (Hypophosphatemic rickets, AR)",
MERTK,"AR (Retinitis pigmentosa 38); AR (Congenital myopathy 10A, severe variant); AR (Congenital myopathy 10B, mild variant); AR (Leber congenital amaurosis 2); AR (Retinitis pigmentosa 20); AD (Retinitis pigmentosa 87 with choroidal involvement); AD (Thrombophilia 5 due to protein S deficiency, autosomal dominant); AR (Thrombophilia 5 due to protein S deficiency, autosomal recessive)",
MESD,"AR (Osteogenesis imperfecta, type XX)",
MESP1,"AR (Spondylocostal dysostosis 2, autosomal recessive); AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3); AD (Lymphedema-distichiasis syndrome); AD (Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus); AD (Vesicoureteral reflux 3)",
MESP2,"AR (Spondylocostal dysostosis 2, autosomal recessive); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AR (Spondylocostal dysostosis 5); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AR (Spondylocostal dysostosis 3, autosomal recessive); AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3)",
MEST,"AR (Joubert syndrome 15); AR (Oocyte/zygote/embryo maturation arrest 19); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in)",
MET,"AD (?Arthrogryposis, distal, type 11); AR (?Deafness, autosomal recessive 97); AD ({Osteofibrous dysplasia, susceptibility to}); Hepatocellular carcinoma, childhood type, somatic; Renal cell carcinoma, papillary, 1, familial and somatic; AD ([Dystransthyretinemic hyperthyroxinemia]); AD (Amyloidosis, hereditary, transthyretin-related); AD (Carpal tunnel syndrome, familial); AD ({Panic disorder, susceptibility to}); AD ({Schizophrenia, susceptibility to}); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta",
METAP2,"Burkitt lymphoma, somatic",
METTL1,"AR (Galloway-Mowat syndrome 6); AR (Microcephaly, growth deficiency, seizures, and brain malformations); AR (Vitamin D-dependent rickets, type I)",
METTL13,"AD ({?Deafness, autosomal recessive 26, modifier of}); AR (?Deafness, autosomal recessive 26)",
METTL14,"AD (Congenital heart defects, multiple types, 8, with or without heterotaxy); AD (Loeys-Dietz syndrome 6); AD (Loeys-Dietz syndrome 3); AD (Diets-Jongmans syndrome)",
METTL22,"AR (Intellectual developmental disorder, autosomal recessive 44)",
METTL23,"AR (Intellectual developmental disorder, autosomal recessive 44)",
METTL2A,AR (?Developmental and epileptic encephalopathy 86),
METTL2B,AR (?Developmental and epileptic encephalopathy 86),
METTL3,"AD (Cornelia de Lange syndrome 6); AD (Congenital heart defects, multiple types, 8, with or without heterotaxy); AD (Loeys-Dietz syndrome 6); AD (Loeys-Dietz syndrome 3); X-inactivation, familial skewed",
METTL5,"AR (Intellectual developmental disorder, autosomal recessive 72)",
MEX3C,"{Hypertension, essential, susceptibility to, 8}; AR (Multiple congenital anomalies-hypotonia-seizures syndrome 1)",
MFAP2,"AD (Aortic aneurysm, familial thoracic 9); AD (Wagner syndrome 1); Meester-Loeys syndrome; Spondyloepimetaphyseal dysplasia, X-linked; AD (Corneal dystrophy, congenital stromal)",
MFAP5,"AD (Aortic aneurysm, familial thoracic 9); Meester-Loeys syndrome; Spondyloepimetaphyseal dysplasia, X-linked; AD (Corneal dystrophy, congenital stromal); Aortic aneurysm, familial thoracic 1",
MFF,"AR (Encephalopathy due to defective mitochondrial and peroxisomal fission 2); AR ({Obesity, early-onset, susceptibility to}); AR (Obesity, adrenal insufficiency, and red hair due to POMC deficiency); AD (Optic atrophy 14); AR (?Combined oxidative phosphorylation deficiency 49)",
MFGE8,"{Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features)",
MFHAS1,"Malignant fibrous histiocytoma; AR (Hoxha-Aliu syndrome); AR (Spondyloepimetaphyseal dysplasia, Guo-Campeau type)",
MFN1,"AD (Charcot-Marie-Tooth disease, axonal, type 2A2A); AR (Charcot-Marie-Tooth disease, axonal, type 2A2B); AD (Hereditary motor and sensory neuropathy VIA); AR (Lipomatosis, multiple symmetric, with or without peripheral neuropathy); AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AD (Optic atrophy 14); AR (?Combined oxidative phosphorylation deficiency 49); AD (Charcot-Marie-Tooth disease, axonal, type 2O); AD (Cortical dysplasia, complex, with other brain malformations 13); AD (Spinal muscular atrophy, lower extremity-predominant 1, AD); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AR (Immunodeficiency 44); AR (Pseudo-TORCH syndrome 3); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2)",
MFN2,"AD (Charcot-Marie-Tooth disease, axonal, type 2A2A); AR (Charcot-Marie-Tooth disease, axonal, type 2A2B); AD (Hereditary motor and sensory neuropathy VIA); AR (Lipomatosis, multiple symmetric, with or without peripheral neuropathy); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AR (Parkinson disease 6, early onset)",
MFNG,"AR (Spondylocostal dysostosis 3, autosomal recessive)",
MFRP,"AR (Microphthalmia, isolated 5); AR (Nanophthalmos 2); AD (Retinal degeneration, late-onset, autosomal dominant); AR (Microphthalmia, isolated 1); AR (Enhanced S-cone syndrome); AR (Retinitis pigmentosa 37)",
MFSD2A,"AR (Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities)",
MFSD8,"AR (Ceroid lipofuscinosis, neuronal, 7); AR (Macular dystrophy with central cone involvement)",
MGA,"AD (Premature ovarian failure 26); AR (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome)",
MGAT1,AR (Congenital disorder of glycosylation with defective fucosylation 1),
MGAT2,"AR (Congenital disorder of glycosylation, type IIa)",
MGAT3,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3); AR (Retinitis pigmentosa 76); AD (Blepharocheilodontic syndrome 1); Breast cancer, lobular, somatic; AD (Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate); Endometrial carcinoma, somatic; Ovarian cancer, somatic",
MGAT4B,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3); AR (Retinitis pigmentosa 76)",
MGAT5,"AR (Arthrogryposis, impaired intellectual development, and seizures); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3); AR (Retinitis pigmentosa 76); AD (Blepharocheilodontic syndrome 1); Breast cancer, lobular, somatic; AD (Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate); Endometrial carcinoma, somatic; Ovarian cancer, somatic",
MGME1,AR (Mitochondrial DNA depletion syndrome 11),
MGP,"AR (Keutel syndrome); Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency; AR (Vitamin K-dependent clotting factors, combined deficiency of, 1); AR (Arterial calcification, generalized, of infancy, 2); AR (Pseudoxanthoma elasticum); AD (Pseudoxanthoma elasticum, forme fruste)",
MIA,AR (?Ondontochondrodysplasia 2 with hearing loss and diabetes); {Autism susceptibility 1}; AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal),
MIA3,AR (?Ondontochondrodysplasia 2 with hearing loss and diabetes),
MIB1,"AD (Left ventricular noncompaction 7); AD (Charcot-Marie-Tooth disease, type 2D); AD (Neuronopathy, distal hereditary motor, autosomal dominant 5); AD (Spinal muscular atrophy, infantile, James type)",
MIB2,AD (Autoinflammation with episodic fever and lymphadenopathy); AR (Immunodeficiency 57 with autoinflammation); AD (Left ventricular noncompaction 7),
MICAL3,"{Leukemia, acute lymphoblastic, susceptibility to, 3}; AR (Auriculocondylar syndrome 3); AD (Question mark ears, isolated)",
MICALL1,"AD (?Thrombocytopenia 6); Colon cancer, advanced, somatic",
MICOS13,AR (Combined oxidative phosphorylation deficiency 37),
MICU1,AR (Myopathy with extrapyramidal signs),
MICU2,AR (Myopathy with extrapyramidal signs),
MID1,"Opitz GBBB syndrome; AR (Retinitis pigmentosa 32); ?Intellectual developmental disorder, X-linked 101; ?Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia; Linear skin defects with multiple congenital anomalies 1",
MID1IP1,AR (Acetyl-CoA carboxylase deficiency); Opitz GBBB syndrome,
MID2,"?Intellectual developmental disorder, X-linked 101",
MIDN,"AD (Diabetes mellitus, noninsulin-dependent, late onset); AR (Diabetes mellitus, permanent neonatal 1); AD (Hyperinsulinemic hypoglycemia, familial, 3); AD (MODY, type II)",
MIEF1,AD (Optic atrophy 14); AR (?Combined oxidative phosphorylation deficiency 49),
MIEF2,AR (?Combined oxidative phosphorylation deficiency 49); AD (Optic atrophy 14),
MIF,"{Rheumatoid arthritis, systemic juvenile, susceptibility to}; AR (Persistent Mullerian duct syndrome, type I)",
MINAR1,"AR (Deafness, autosomal recessive 120)",
MINAR2,"AR (Deafness, autosomal recessive 120)",
MINK1,"AR (Myasthenic syndrome, congenital, 4A, slow-channel); AR (Myasthenic syndrome, congenital, 4B, fast-channel); AR (Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency); AD (Fliedner-Zweier syndrome)",
MINPP1,"AD ({Thyroid carcinoma, follicular}); AR (Pontocerebellar hypoplasia, type 16)",
MIOS,"AD (Epilepsy, familial focal, with variable foci 3); AD (Epilepsy, familial focal, with variable foci 2); Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome)",
MIP,"AD (Cataract 15, multiple types); AR (Combined oxidative phosphorylation deficiency 31); {HIV infection, resistance to}; {Diabetes mellitus, insulin-dependent, 22}; {Hepatitis C virus, resistance to}; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}",
MIPEP,"AR (Combined oxidative phosphorylation deficiency 31); Myopia 20, autosomal dominant",
MIPOL1,"AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea)",
MIS12,"AR (Microcephaly 4, primary, autosomal recessive)",
MITF,"{Melanoma, cutaneous malignant, susceptibility to, 8}; AR (COMMAD syndrome); AD (Tietz albinism-deafness syndrome); AD (Waardenburg syndrome, type 2A); AD (PCWH syndrome); AD (Waardenburg syndrome, type 2E, with or without neurologic involvement); AD (Waardenburg syndrome, type 4C); AD (Craniofacial-deafness-hand syndrome); Rhabdomyosarcoma 2, alveolar; AD (Waardenburg syndrome, type 1); AR (Waardenburg syndrome, type 3); Leukemia/lymphoma, B-cell, 2; AR (Pycnodysostosis)",
MKI67,"Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; {Gastric cancer risk after H. pylori infection}; {Microvascular complications of diabetes 4}; AR (Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis); AR (Interleukin 1 receptor antagonist deficiency); AD (Dermatopathia pigmentosa reticularis); AD (Epidermolysis bullosa simplex 1A, generalized severe); AD (Epidermolysis bullosa simplex 1B, generalized intermediate); AD (Epidermolysis bullosa simplex 1C, localized); AR (Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive); AD (Naegeli-Franceschetti-Jadassohn syndrome); AD (Pachyonychia congenita 2); AD (Steatocystoma multiplex); AD ({Melanoma, cutaneous malignant, 1}); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7)",
MKKS,"AR (Bardet-Biedl syndrome 6); AR (McKusick-Kaufman syndrome); AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6); AR (Bardet-Biedl syndrome 2); AR (Retinitis pigmentosa 74); AD (Cardiofaciocutaneous syndrome 3); Melorheostosis, isolated, somatic mosaic",
MKNK1,"AD (Noonan syndrome 13); {Autism, susceptibility to, 19}; AD ({Parkinson disease 18})",
MKNK2,"AD (Noonan syndrome 13); {Autism, susceptibility to, 19}",
MKRN3,"AD (Precocious puberty, central, 2); AD (Schaaf-Yang syndrome); Birk-Barel syndrome",
MKS1,"AR (Bardet-Biedl syndrome 13); AR (Joubert syndrome 28); AR (Meckel syndrome 1); AR (?Meckel syndrome 9); AR (Joubert syndrome 27); AR (?Meckel syndrome 10); AR (Joubert syndrome 34); AR (?RHYNS syndrome); AR ({Bardet-Biedl syndrome 14, modifier of}); AR (COACH syndrome 1); AR (Joubert syndrome 6); AR (Meckel syndrome 3); AR (Nephronophthisis 11); AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6)",
MLANA,"Nystagmus 6, congenital, X-linked; Ocular albinism, type I, Nettleship-Falls type; AR (Nivelon-Nivelon-Mabille syndrome)",
MLC1,"AR (Megalencephalic leukoencephalopathy with subcortical cysts 1); AR (Megalencephalic leukoencephalopathy with subcortical cysts 2A); AD (Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without impaired intellectual development); [Blood pressure regulation QTL]; AR (?Megalencephalic leukoencephalopathy with subcortical cysts 4, remitting); AD (Long QT syndrome 12); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3); AR (Enlarged vestibular aqueduct, digenic); AR (SESAME syndrome); AD (?Avascular necrosis of femoral head, primary, 2); [Sodium serum level QTL 1]; AD (Brachyolmia type 3); AD (Digital arthropathy-brachydactyly, familial); AD (Hereditary motor and sensory neuropathy, type IIc); AD (Metatropic dysplasia); AD (Neuronopathy, distal hereditary motor, autosomal dominant 8); AD (Parastremmatic dwarfism); AD (Scapuloperoneal spinal muscular atrophy); AD (SED, Maroteaux type); AD (Spondylometaphyseal dysplasia, Kozlowski type); AD (Megalencephalic leukoencephalopathy with subcortical cysts 3)",
MLDHR,"AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic",
MLEC,"[Aquaporin-1 deficiency]; [Blood group, Colton]",
MLF1,"AR (Intellectual developmental disorder, autosomal recessive 70); AD (Muscular dystrophy, limb-girdle, autosomal dominant 1)",
MLH1,"Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome); AD (Lynch syndrome 1); AR (Mismatch repair cancer syndrome 2); AD (Muir-Torre syndrome); AD ({Endometrial cancer, familial}); AD (Lynch syndrome 5); AR (Mismatch repair cancer syndrome 3); Lynch syndrome 4; AR (Mismatch repair cancer syndrome 4); AD ({Endometrial cancer, susceptibility to}); Colorectal cancer, hereditary nonpolyposis, type 7; Colorectal cancer, somatic",
MLH3,"AD ({Endometrial cancer, susceptibility to}); Colorectal cancer, hereditary nonpolyposis, type 7; Colorectal cancer, somatic; AR (Premature ovarian failure 20); AR (Spermatogenic failure 2); AD ({Endometrial cancer, familial}); AD (Lynch syndrome 5); AR (Mismatch repair cancer syndrome 3); AR (Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome); AR (?Ataxia-telangiectasia-like disorder 2); AR (?Premature ovarian failure 13); AR (Spermatogenic failure 74)",
MLIP,"AR (Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis)",
MLKL,"AD (Autoinflammation with episodic fever and lymphadenopathy); AR (Immunodeficiency 57 with autoinflammation); AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic; AR (Mitochondrial DNA depletion syndrome 4A (Alpers type)); AR (Mitochondrial DNA depletion syndrome 4B (MNGIE type)); AR (Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)); AD (Progressive external ophthalmoplegia, autosomal dominant 1); AR (Progressive external ophthalmoplegia, autosomal recessive 1); AR (Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1); AD (Optic atrophy 5); AR (Polyglucosan body myopathy 1 with or without immunodeficiency)",
MLLT1,"AD (Wiedemann-Steiner syndrome); AD (Coffin-Siris syndrome 2); Adrenal adenoma, somatic; Angiofibroma, somatic; Carcinoid tumor of lung; Lipoma, somatic; AD (Multiple endocrine neoplasia 1); Parathyroid adenoma, somatic; AD (Coffin-Siris syndrome 1); AD (Hydrocephalus, congenital, 4)",
MLLT10,"AD (Leukemia, acute myeloid); AD (Wiedemann-Steiner syndrome); AR (Pontocerebellar hypoplasia, type 10)",
MLLT6,"Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; AD (Intellectual developmental disorder with dysmorphic facies and ptosis); AR (Neurodevelopmental disorder with impaired speech and hyperkinetic movements)",
MLN,"AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections)",
MLPH,"AR (Griscelli syndrome, type 3); AR (Griscelli syndrome, type 1); AD (Orofacial cleft-1)",
MLST8,"Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AR (Hypotonia, infantile, with psychomotor retardation and characteristic facies 3); AR (You-Hoover-Fong syndrome); AR (Neurodevelopmental disorder with microcephaly and movement abnormalities); AR (Intellectual developmental disorder, autosomal recessive 39)",
MLYCD,AR (Malonyl-CoA decarboxylase deficiency),
MMAA,"AR (Methylmalonic aciduria, vitamin B12-responsive, cblA type); AR (Methylmalonyl-CoA epimerase deficiency)",
MMAB,"AR (Methylmalonic aciduria, vitamin B12-responsive, cblB type)",
MMACHC,"AR (Methylmalonic aciduria and homocystinuria, cblC type); AR (Methylmalonic aciduria and homocystinuria, cblC type, digenic); AR (?Methylmalonic aciduria and homocystinuria, cblL type); AD (Spinocerebellar ataxia 51); Methylmalonic aciduria and homocysteinemia, cblX type",
MMADHC,"AR (Homocystinuria-megaloblastic anemia, cblD type); AR (Methylmalonic aciduria and homocystinuria, cblD type); AR (Methylmalonic aciduria, cblD type)",
MMD,"AD (Corneal dystrophy, Fuchs endothelial, 6); AD (Corneal dystrophy, posterior polymorphous, 3)",
MMD2,Miyoshi muscular dystrophy 2,
MME,"AD (?Spinocerebellar ataxia 43); AR (Charcot-Marie-Tooth disease, axonal, type 2T); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease)",
MMEL1,"AD (Biliary cirrhosis, primary, 1); Biliary cirrhosis, primary, 4; Biliary cirrhosis, primary, 5",
MMP1,"AR (Epidermolysis bullosa dystrophica inversa); AD (Epidermolysis bullosa dystrophica, autosomal dominant); AR (Epidermolysis bullosa dystrophica, autosomal recessive); AD (Epidermolysis bullosa dystrophica, Bart type); AR (Epidermolysis bullosa dystrophica, localisata variant); AR (Epidermolysis bullosa pruriginosa); AR (Epidermolysis bullosa, pretibial); AD (Nail disorder, nonsyndromic congenital, 8); AR (Transient bullous of the newborn); AD (?Spondyloepimetaphyseal dysplasia, Missouri type); AD (Metaphyseal anadysplasia 1); AR (Metaphyseal dysplasia, Spahr type); AR (Immunodeficiency 38); {Coronary heart disease, susceptibility to, 6}",
MMP10,"AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome); {Coronary heart disease, susceptibility to, 6}; AD (?Spondyloepimetaphyseal dysplasia, Missouri type); AD (Metaphyseal anadysplasia 1); AR (Metaphyseal dysplasia, Spahr type); AD (Cataract 6, multiple types)",
MMP11,"{Coronary heart disease, susceptibility to, 6}",
MMP12,"AR (Metaphyseal anadysplasia 2); AR (Amelogenesis imperfecta, type IH); {Allergic rhinitis, susceptibility to}; AD ({Asthma, susceptibility to}); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); Pulmonary disease, chronic obstructive, severe early-onset; {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); {Coronary heart disease, susceptibility to, 6}",
MMP13,"AD (?Spondyloepimetaphyseal dysplasia, Missouri type); AD (Metaphyseal anadysplasia 1); AR (Metaphyseal dysplasia, Spahr type); AR (Metaphyseal anadysplasia 2); AD (Aortic aneurysm, familial abdominal 1); AD (Erythrocytosis, familial, 4); AD (Cleidocranial dysplasia); AD (Cleidocranial dysplasia, forme fruste, dental anomalies only); AD (Cleidocranial dysplasia, forme fruste, with brachydactyly); AD (Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly)",
MMP14,"AR (Winchester syndrome); AR (Multicentric osteolysis, nodulosis, and arthropathy); AR (Metaphyseal anadysplasia 2); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome)",
MMP19,"AD (Cavitary optic disc anomalies); AR (Amelogenesis imperfecta, type IIA2)",
MMP2,"AR (Multicentric osteolysis, nodulosis, and arthropathy); AR (Metaphyseal anadysplasia 2); AR (Winchester syndrome); {Coronary heart disease, susceptibility to, 6}; AD (Lymphatic malformation 10)",
MMP20,"AR (Amelogenesis imperfecta, type IIA2); AR (Amelogenesis imperfecta, type IIA1); AR (Hypomagnesemia 3, renal)",
MMP21,"AR (Heterotaxy, visceral, 7, autosomal)",
MMP23B,AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome),
MMP3,"{Coronary heart disease, susceptibility to, 6}; AD (Aortic aneurysm, familial abdominal 1); AR (Metaphyseal anadysplasia 2); AR (Multicentric osteolysis, nodulosis, and arthropathy); AD (?Spondyloepimetaphyseal dysplasia, Missouri type); AD (Metaphyseal anadysplasia 1); AR (Metaphyseal dysplasia, Spahr type); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus})",
MMP7,"{Coronary heart disease, susceptibility to, 6}; AD (?Spondyloepimetaphyseal dysplasia, Missouri type); AD (Metaphyseal anadysplasia 1); AR (Metaphyseal dysplasia, Spahr type)",
MMP8,"AD ({Melanoma, cutaneous malignant, 1}); AD (?Spondyloepimetaphyseal dysplasia, Missouri type); AD (Metaphyseal anadysplasia 1); AR (Metaphyseal dysplasia, Spahr type); {Preterm premature rupture of the membranes, susceptibility to}; AR (Osteogenesis imperfecta, type X); {Coronary heart disease, susceptibility to, 6}",
MMP9,"AR (Metaphyseal anadysplasia 2); AR (Multicentric osteolysis, nodulosis, and arthropathy); Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy; {Gastric cancer risk after H. pylori infection}; AD (?Spondyloepimetaphyseal dysplasia, Missouri type); AD (Metaphyseal anadysplasia 1); AR (Metaphyseal dysplasia, Spahr type); [Skin/hair/eye pigmentation 7, blond/brown hair]; AD (Deafness, autosomal dominant 69, unilateral or asymmetric); AD (Hyperpigmentation with or without hypopigmentation); AR (Waardenburg syndrome, type 2F)",
MMRN1,"AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4)",
MMS19,AR (Multiple mitochondrial dysfunctions syndrome 10),
MMS22L,"AR (Spondyloepimetaphyseal dysplasia, sponastrime type)",
MMUT,"AR (Methylmalonic aciduria, mut(0) type); AR (Methylmalonic aciduria, vitamin B12-responsive, cblB type)",
MN1,"AD (CEBALID syndrome); AD (Meningioma); Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6); AR (46XY gonadal dysgenesis with minifascicular neuropathy); AR (46XY sex reversal 7)",
MNAT1,"AR (?Cerebrooculofacioskeletal syndrome 2); AR (Trichothiodystrophy 1, photosensitive); AR (Xeroderma pigmentosum, group D); AD (Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities)",
MND1,"AR (Ovarian dysgenesis 3); AD ({Breast cancer, susceptibility to}); AD (Fanconi anemia, complementation group R); AD (Mirror movements 2)",
MNS1,"AR (Heterotaxy, visceral, 9, autosomal, with male infertility); AD (Charcot-Marie-Tooth disease, axonal, type 2A2A); AR (Charcot-Marie-Tooth disease, axonal, type 2A2B); AD (Hereditary motor and sensory neuropathy VIA); AR (Lipomatosis, multiple symmetric, with or without peripheral neuropathy)",
MNT,"AD (Miller-Dieker lissencephaly syndrome); Burkitt lymphoma, somatic; Nystagmus 6, congenital, X-linked; Ocular albinism, type I, Nettleship-Falls type; AD (Beckwith-Wiedemann syndrome); AD (Silver-Russell syndrome 1); AD (Wilms tumor 2)",
MNX1,"AD (Currarino syndrome); AD (Neuronopathy, distal hereditary motor, autosomal dominant 1)",
MOB3B,AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1),
MOBP,"AR (Pontocerebellar hypoplasia, type 1C)",
MOCOS,"AR (Xanthinuria, type II)",
MOCS1,AR (Molybdenum cofactor deficiency A); AR (Molybdenum cofactor deficiency B); AR (Molybdenum cofactor deficiency C),
MOCS2,AR (Molybdenum cofactor deficiency B); AR (Molybdenum cofactor deficiency A); AR (Molybdenum cofactor deficiency C),
MOG,"AD (?Narcolepsy 7); AR (Immunodeficiency 29, mycobacteriosis); AR (Immunodeficiency 42)",
MOGS,"AR (Congenital disorder of glycosylation, type IIb)",
MOK,"AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AD (Corneal dystrophy, Fuchs endothelial, 1); AD (Corneal dystrophy, posterior polymorphous 2); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in); AR (Mucopolysaccharidosis type IIID)",
MORC2,"AD (Charcot-Marie-Tooth disease, axonal, type 2Z); AD (Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy); AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay)",
MORF4L1,"AD (Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities); Bladder cancer, somatic; Osteosarcoma, somatic; AD (Retinoblastoma); AD (Retinoblastoma, trilateral); Small cell cancer of the lung, somatic",
MORN1,"AR (Cardiomyopathy, dilated, 2E); AD (Cardiomyopathy, hypertrophic, 17)",
MORN2,"AR (Cardiomyopathy, dilated, 2E); AD (Cardiomyopathy, hypertrophic, 17)",
MORN4,"AD (Deafness, autosomal dominant 90); AR (Deafness, autosomal recessive 30)",
MOS,AR (Oocyte/zygote/embryo maturation arrest 20); AR (Oocyte/zygote/embryo maturation arrest 22); AR (Oocyte/zygote/embryo maturation arrest 12); AR (Spermatogenic failure 64); AR (Spermatogenic failure 5),
MOV10,AR (?Spermatogenic failure 73); AD (Global developmental delay with speech and behavioral abnormalities),
MOV10L1,AR (?Spermatogenic failure 73),
MPC1,AR (Mitochondrial pyruvate carrier deficiency); AR (?Combined oxidative phosphorylation deficiency 43),
MPC2,AR (Mitochondrial pyruvate carrier deficiency); AR (?Combined oxidative phosphorylation deficiency 43),
MPDU1,"AR (Congenital disorder of glycosylation, type If); AD (Snijders Blok-Campeau syndrome); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic; AD (Chromosome 17p13.1 deletion syndrome)",
MPDZ,"AR (Hydrocephalus, congenital, 2, with or without brain or eye anomalies); {Restless legs syndrome 3}",
MPEG1,AD (Immunodeficiency 77),
MPG,"AR (Cholestasis, progressive familial intrahepatic, 10); AR (Diarrhea 2, with microvillus atrophy, with or without cholestasis); AD (Megacystis-microcolon-intestinal hypoperistalsis syndrome 5); AD (Visceral myopathy 1); {Obesity, susceptibility to, BMIQ12}; AR (Endocrinopathy due to proprotein convertase 1/3 deficiency); AR (Diarrhea 8, secretory sodium, congenital); AR (Diarrhea 5, with tufting enteropathy, congenital); AD (Lynch syndrome 8); AR (Trichohepatoenteric syndrome 2); AR (Bile acid synthesis defect, congenital, 3); AR (Spastic paraplegia 5A, autosomal recessive)",
MPHOSPH8,"AD (Charcot-Marie-Tooth disease, axonal, type 2Z); AD (Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy)",
MPI,"AR (Congenital disorder of glycosylation, type Ib); AR ([Hex A pseudodeficiency]); AR (GM2-gangliosidosis, several forms); AR (Tay-Sachs disease); AR (Anemia, congenital, nonspherocytic hemolytic, 4, glucose phosphate isomerase deficient); {Lung cancer susceptibility 2}; AR (Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT)",
MPIG6B,"AR (?Thrombocytopenia, anemia, and myelofibrosis)",
MPL,"AR (Amegakaryocytic thrombocytopenia, congenital, 1); Myelofibrosis with myeloid metaplasia, somatic; AD (Thrombocythemia 2); AR (Amegakaryocytic thrombocytopenia, congenital, 2); AD (Thrombocythemia 1); AD (Thrombocytopenia 9); Myelofibrosis, somatic; Thrombocythemia, somatic; {T-cell acute lymphoblastic leukemia}",
MPLKIP,"AR (Trichothiodystrophy 4, nonphotosensitive)",
MPO,"AD ({Alzheimer disease, susceptibility to}); {Lung cancer, protection against, in smokers}; AR (Myeloperoxidase deficiency); AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AD (Muscular dystrophy, limb-girdle, autosomal dominant 3)",
MPP1,"?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1; Dyskeratosis congenita, X-linked; AR (Yuksel-Vogel-Bauser syndrome); Retinitis pigmentosa 34",
MPP4,"AD (Intellectual developmental disorder, autosomal dominant 62)",
MPPED2,"AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia)",
MPRIP,"AR (Cardiomyopathy, dilated, 2K)",
MPV17,"AR (Charcot-Marie-Tooth disease, axonal, type 2EE); AR (Mitochondrial DNA depletion syndrome 6 (hepatocerebral type))",
MPZ,"AD (Charcot-Marie-Tooth disease, dominant intermediate D); AD (Charcot-Marie-Tooth disease, type 1B); AD (Charcot-Marie-Tooth disease, type 2I); AD (Charcot-Marie-Tooth disease, type 2J); AR (Dejerine-Sottas disease); AD (Hypomyelinating neuropathy, congenital, 2); AD (Roussy-Levy syndrome)",
MPZL1,"AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1)",
MPZL2,"AR (Deafness, autosomal recessive 111)",
MR1,"AD (Paroxysmal nonkinesigenic dyskinesia 1); AR (Hemochromatosis, type 1); AD (Paroxysmal nonkinesigenic dyskinesia 2)",
MRAP,"AR (Glucocorticoid deficiency 2); AR (Myopia 23, autosomal recessive); AD ({?Obesity, susceptibility to, BMIQ18}); AD (Ocular pigment dispersion with or without glaucoma); AR (Glucocorticoid deficiency 3)",
MRAP2,"AD ({?Obesity, susceptibility to, BMIQ18}); AR (Glucocorticoid deficiency 2); {Obesity, severe, susceptibility to, BMIQ9}; [Body mass index QTL1]",
MRAS,"AD (Noonan syndrome 11); AD (Noonan syndrome-like with loose anagen hair 1); AD (Noonan syndrome-like disorder with loose anagen hair 2); AR (Congenital heart defects, multiple types, 9)",
MRC1,"{Dengue fever, protection against}; {HIV type 1, susceptibility to}; {Mycobacterium tuberculosis, susceptibility to}; {Aspergillosis, susceptibility to}; AR (Candidiasis, familial, 4, autosomal recessive); AD ({Chronic infections, due to MBL deficiency})",
MRE11,"AR (Ataxia-telangiectasia-like disorder 1); Aplastic anemia; Leukemia, acute lymphoblastic; AR (Nijmegen breakage syndrome); AR (Nijmegen breakage syndrome-like disorder); AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S)",
MRFAP1,"Bladder cancer, somatic; Osteosarcoma, somatic; AD (Retinoblastoma); AD (Retinoblastoma, trilateral); Small cell cancer of the lung, somatic",
MRGPRD,"AR (?Central hypoventilation syndrome, congenital, 3)",
MRM2,AR (Mitochondrial DNA depletion syndrome 17),
MRNIP,"AR (Ataxia-telangiectasia-like disorder 1); AR (Nijmegen breakage syndrome-like disorder); Aplastic anemia; Leukemia, acute lymphoblastic; AR (Nijmegen breakage syndrome)",
MRO,"AD (?Melkersson-Rosenthal syndrome); {Leprosy, protection against}; {Leprosy, susceptibility to, 5}; AD ({Colorectal cancer, susceptibility to}); AD ({Leprosy, susceptibility to}); {Mycobacterium tuberculosis, susceptibility to}; AR (Mitochondrial complex III deficiency, nuclear type 3)",
MRPL12,AR (?Combined oxidative phosphorylation deficiency 45); AR (Combined oxidative phosphorylation deficiency 31),
MRPL13,"AR (Leukodystrophy, hypomyelinating, 15)",
MRPL28,AR (Combined oxidative phosphorylation deficiency 59),
MRPL3,AR (Combined oxidative phosphorylation deficiency 9),
MRPL39,AR (Combined oxidative phosphorylation deficiency 59),
MRPL43,"AR (Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)); AR (Perrault syndrome 5); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3)",
MRPL44,AR (Combined oxidative phosphorylation deficiency 16); AR (Combined oxidative phosphorylation deficiency 59),
MRPL45,AR (Combined oxidative phosphorylation deficiency 59),
MRPL49,AR (Combined oxidative phosphorylation deficiency 60),
MRPL54,"?Macular degeneration, age-related, 6; AD (Cone-rod dystrophy 11); AR (Retinitis pigmentosa 95)",
MRPL9,AR (Combined oxidative phosphorylation deficiency 59),
MRPS12,AR (Combined oxidative phosphorylation deficiency 32),
MRPS14,AR (?Combined oxidative phosphorylation deficiency 38),
MRPS15,AR (Combined oxidative phosphorylation deficiency 51),
MRPS16,AR (Combined oxidative phosphorylation deficiency 2); AR (Combined oxidative phosphorylation deficiency 59),
MRPS17,AR (Combined oxidative phosphorylation deficiency 59),
MRPS2,AR (Combined oxidative phosphorylation deficiency 36),
MRPS22,"AR (Combined oxidative phosphorylation deficiency 5); AR (Ovarian dysgenesis 7); AR (Blepharophimosis, epicanthus inversus, and ptosis, type 1); AR (Blepharophimosis, epicanthus inversus, and ptosis, type 2); AD (Premature ovarian failure 3); AR (Combined oxidative phosphorylation deficiency 2)",
MRPS23,AR (?Combined oxidative phosphorylation deficiency 46),
MRPS25,AR (?Combined oxidative phosphorylation deficiency 50),
MRPS28,AR (?Combined oxidative phosphorylation deficiency 47),
MRPS33,"AR (Deafness, autosomal recessive 13)",
MRPS34,AR (Combined oxidative phosphorylation deficiency 32); AR (Combined oxidative phosphorylation deficiency 59),
MRPS35,AR (?Combined oxidative phosphorylation deficiency 47); AR (Combined oxidative phosphorylation deficiency 59),
MRPS7,AR (?Combined oxidative phosphorylation deficiency 34); AR (Perrault syndrome 7); AR (Combined oxidative phosphorylation deficiency 59),
MRPS9,AR (Perrault syndrome 7),
MRRF,AR (Combined oxidative phosphorylation deficiency 39); AR (Combined oxidative phosphorylation deficiency 1),
MRTFA,"AR (?Immunodeficiency 66); AD (Atrial septal defect 5); AD (Cardiomyopathy, dilated, 1R); AD (Cardiomyopathy, hypertrophic, 11); AD (Left ventricular noncompaction 4); Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy",
MRTFB,"AD (Atrial septal defect 5); AD (Cardiomyopathy, dilated, 1R); AD (Cardiomyopathy, hypertrophic, 11); AD (Left ventricular noncompaction 4)",
MS4A1,"AR (?Immunodeficiency, common variable, 5); AR (Immunodeficiency, common variable, 3)",
MS4A4E,"AD ({Alzheimer disease 9, susceptibility to})",
MS4A6A,"AD ({Alzheimer disease 9, susceptibility to})",
MSC,"{Budd-Chiari syndrome, somatic}; Erythrocytosis, somatic; Leukemia, acute myeloid, somatic; Myelofibrosis, somatic; Polycythemia vera, somatic; AD (Thrombocythemia 3)",
MSH2,"AD (Lynch syndrome 1); AR (Mismatch repair cancer syndrome 2); AD (Muir-Torre syndrome); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome); AD ({Endometrial cancer, familial}); AD (Lynch syndrome 5); AR (Mismatch repair cancer syndrome 3); AR (Diarrhea 5, with tufting enteropathy, congenital); AD (Lynch syndrome 8)",
MSH3,"Endometrial carcinoma, somatic; AR (Familial adenomatous polyposis 4); AD ({Endometrial cancer, familial}); AD (Lynch syndrome 5); AR (Mismatch repair cancer syndrome 3); AD (Myotonic dystrophy 1); AR (Fanconi anemia, complementation group P); AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance)",
MSH4,"AR (Premature ovarian failure 20); AR (Spermatogenic failure 2); AR (?Premature ovarian failure 13); AR (Spermatogenic failure 74); AD ({Endometrial cancer, susceptibility to}); Colorectal cancer, hereditary nonpolyposis, type 7; Colorectal cancer, somatic; AR (Immunoglobulin A deficiency); AR (?Spermatogenic failure 62); Recombination rate QTL 1; AR (Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome)",
MSH5,"AR (?Premature ovarian failure 13); AR (Spermatogenic failure 74); AR (Premature ovarian failure 20); AR (Spermatogenic failure 2); AR (Immunoglobulin A deficiency); AR (Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome); AR (?Ataxia-telangiectasia-like disorder 2)",
MSH6,"AD ({Endometrial cancer, familial}); AD (Lynch syndrome 5); AR (Mismatch repair cancer syndrome 3); AD (Lynch syndrome 1); AR (Mismatch repair cancer syndrome 2); AD (Muir-Torre syndrome); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome); Lynch syndrome 4; AR (Mismatch repair cancer syndrome 4); Endometrial carcinoma, somatic; AR (Familial adenomatous polyposis 4); AD (Myotonic dystrophy 1)",
MSI1,"AR (Oocyte/zygote/embryo maturation arrest 20); Spermatogenic failure, X-linked, 9",
MSI2,"AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3); AR (Anterior segment dysgenesis 6, multiple subtypes); AR (Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset)",
MSL1,Basilicata-Akhtar syndrome; AD (Li-Ghorgani-Weisz-Hubshman syndrome); AD (Karayol-Borroto-Haghshenas neurodevelopmental syndrome); AD (Koolen-De Vries syndrome),
MSL2,AD (Karayol-Borroto-Haghshenas neurodevelopmental syndrome); AD (Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia); AR (Welander distal myopathy); Basilicata-Akhtar syndrome; AD (Li-Ghorgani-Weisz-Hubshman syndrome),
MSL3,Basilicata-Akhtar syndrome; AD (Li-Ghorgani-Weisz-Hubshman syndrome); AD (Karayol-Borroto-Haghshenas neurodevelopmental syndrome),
MSMB,"{Prostate cancer, hereditary, 13}",
MSMO1,"AR (Microcephaly, congenital cataract, and psoriasiform dermatitis)",
MSN,"Immunodeficiency 50; Intellectual developmental disorder, X-linked syndromic, Pilorge type; AR (Intellectual developmental disorder with autism and dysmorphic facies); AR (Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency); AR (Neuropathy, hereditary sensory and autonomic, type VI)",
MSR1,"Barrett esophagus/esophageal adenocarcinoma; AD (Charcot-Marie-Tooth disease, axonal, type 2F); AD (Neuronopathy, distal hereditary motor, autosomal dominant 3); {Myocardial infarction, susceptibility to}; AR (Enterokinase deficiency)",
MSRA,"AR (Spinocerebellar ataxia, autosomal recessive 30); AD (Occult macular dystrophy); AR (Retinitis pigmentosa 88)",
MSRB1,"AR (Deafness, autosomal recessive 74)",
MSRB3,"AR (Deafness, autosomal recessive 74)",
MST1,"AR (T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations); {Inflammatory bowel disease 12}; Cholangitis, primary sclerosing; [Memory, enhanced, QTL]",
MST1R,"AD ({Nasopharyngeal carcinoma, susceptibility to, 3}); AD (Neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities); AR (Muggenthaler-Chowdhury-Chioza syndrome); {Nasopharyngeal carcinoma 1}",
MSTN,"AR (?Muscle hypertrophy); AD (?Vertebral hypersegmentation and orofacial anomalies); AD (Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome); AD (Myhre syndrome); Pancreatic cancer, somatic; AD (Polyposis, juvenile intestinal); AR (?Acromesomelic dysplasia 2C, Hunter-Thompson type); {Osteoarthritis-5}; AR (Acromesomelic dysplasia 2A); AR (Acromesomelic dysplasia 2B); AR (Brachydactyly, type A1, C); AD (Brachydactyly, type A2); AD (Brachydactyly, type C); AD (Multiple synostoses syndrome 2); AD (Symphalangism, proximal, 1B)",
MSTO1,"AR (Myopathy, mitochondrial, and ataxia)",
MSX1,"AD (Ectodermal dysplasia 3, Witkop type); AD (Orofacial cleft 5); AD (Tooth agenesis, selective, 1, with or without orofacial cleft); AD ({Thyroid cancer, nonmedullary, 4}); AR (Bamforth-Lazarus syndrome); AD (Orofacial cleft-1); AR (Congenital myopathy 17)",
MSX2,"AD (Craniosynostosis 2); AD (Parietal foramina 1); AD (Parietal foramina with cleidocranial dysplasia); AD (Radio-Tartaglia syndrome); AD ({Craniosynostosis 5, susceptibility to}); AR (Frontonasal dysplasia 2); AD (Parietal foramina 2); AR (?Split-hand/foot malformation 1 with sensorineural hearing loss); AD (Split-hand/foot malformation 1)",
MT1A,"AD (?Neuronopathy, distal hereditary motor, autosomal dominant 15); AD (Cardiomyopathy, dilated, 1HH); AD (Charcot-Marie-Tooth disease, axonal, type 2JJ); AD (Myopathy, myofibrillar, 6); AR (Ehlers-Danlos syndrome, spondylodysplastic type, 3)",
MTA1,"AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance); AR (Hengel-Maroofian-Schols syndrome); AD (?Leukemia, acute myeloid); Leukemia, acute myeloid, somatic; AR (Metaphyseal anadysplasia 2); AD (Sifrim-Hitz-Weiss syndrome)",
MTA2,"AD (Sifrim-Hitz-Weiss syndrome); AD (Immunodeficiency 49, severe combined); AD (Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities)",
MTAP,"AD (Diaphyseal medullary stenosis with malignant fibrous histiocytoma); Interferon, alpha, deficiency; AD ({Melanoma, cutaneous malignant, 1})",
MTBP,"AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to})",
MTCP1,"Leukemia/lymphoma, T-cell; Hemophilia A; Thrombophilia 13, X-linked, due to factor VIII defect; Moyamoya disease 4",
MTDH,"Leukemia, acute promyelocytic, PL2F/RARA type",
MTERF2,AR (CODAS syndrome),
MTF1,"AD (Zinc deficiency, transient neonatal)",
MTF2,AR (Otofacial neurodevelopmental syndrome),
MTFMT,"AR (Combined oxidative phosphorylation deficiency 15); AR (Mitochondrial complex I deficiency, nuclear type 27)",
MTFR1,"AR (Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay)",
MTHFD1,"AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia); AD (Cornelia de Lange syndrome 6)",
MTHFD1L,"AR (Spastic paraplegia 56, autosomal recessive)",
MTHFD2,"AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia); Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome)",
MTHFD2L,"AR (Intellectual developmental disorder, autosomal recessive 69)",
MTHFR,"AR ({Neural tube defects, susceptibility to}); AD ({Schizophrenia, susceptibility to}); AD ({Thromboembolism, susceptibility to}); {Vascular disease, susceptibility to}; AR (Homocystinuria due to MTHFR deficiency); AD (Preeclampsia/eclampsia 1); {Pulmonary hypertension, neonatal, susceptibility to}; AR (Carbamoylphosphate synthetase I deficiency); AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Homocystinuria-megaloblastic anemia, cbl E type)",
MTHFS,"AR (Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination)",
MTHFSD,"AD (Amyotrophic lateral sclerosis 10, with or without FTD); AD (Frontotemporal lobar degeneration, TARDBP-related); AD (Singleton-Merten syndrome 2)",
MTLN,"AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
MTM1,"Myopathy, centronuclear, X-linked; Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AR (Centronuclear myopathy 2); AR (Charcot-Marie-Tooth disease, type 4B3); Hypospadias 2, X-linked; AD ({Centronuclear myopathy, autosomal, modifier of}); AR (Charcot-Marie-Tooth disease, type 4B1)",
MTMR1,"Myopathy, centronuclear, X-linked; Hypospadias 2, X-linked; AR (Charcot-Marie-Tooth disease, type 4B1); AD (Facioscapulohumeral muscular dystrophy 1)",
MTMR10,AR (Short-rib thoracic dysplasia 1 with or without polydactyly),
MTMR14,"AD ({Centronuclear myopathy, autosomal, modifier of}); AD (Centronuclear myopathy 1); AD (Charcot-Marie-Tooth disease, axonal type 2M); AD (Charcot-Marie-Tooth disease, dominant intermediate B); AR (Lethal congenital contracture syndrome 5)",
MTMR2,"AR (Charcot-Marie-Tooth disease, type 4B1); AR (Charcot-Marie-Tooth disease, type 4B2); AR (Charcot-Marie-Tooth disease, type 4B3); AD (Charcot-Marie-Tooth disease, dominant intermediate G); AR (Charcot-Marie-Tooth disease, type 1F); AD (Charcot-Marie-Tooth disease, type 2E); Myopathy, centronuclear, X-linked",
MTMR3,"Myopathy, centronuclear, X-linked",
MTMR4,"Myopathy, centronuclear, X-linked",
MTMR6,"Myopathy, centronuclear, X-linked",
MTMR7,"Myopathy, centronuclear, X-linked",
MTMR8,"Myopathy, centronuclear, X-linked",
MTMR9,"[Body mass index QTL1]; Myopathy, centronuclear, X-linked",
MTNR1A,"AD ({Diabetes mellitus, type 2, susceptibility to})",
MTNR1B,"AD ({Diabetes mellitus, type 2, susceptibility to}); [Fasting plasma glucose level QTL 3]; [Fasting plasma glucose level QTL 1]; [Birth weight QTL 1]; [Fasting plasma glucose level QTL 2]",
MTO1,AR (Combined oxidative phosphorylation deficiency 10),
MTOR,"Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome); AR (Immunodeficiency due to defect in MAPBP-interacting protein)",
MTPAP,"AR (?Spastic ataxia 4, autosomal recessive)",
MTPN,"AD (Thyroid hormone resistance); AR (Thyroid hormone resistance, autosomal recessive); AD (Thyroid hormone resistance, selective pituitary)",
MTR,"AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Homocystinuria-megaloblastic anemia, cblG complementation type); AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Homocystinuria-megaloblastic anemia, cbl E type)",
MTRES1,"AR (Combined oxidative phosphorylation deficiency 7); AR (Spastic paraplegia 55, autosomal recessive)",
MTRFR,"AR (Combined oxidative phosphorylation deficiency 7); AR (Spastic paraplegia 55, autosomal recessive)",
MTRR,"AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Homocystinuria-megaloblastic anemia, cbl E type); AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Homocystinuria-megaloblastic anemia, cblG complementation type); AR ({Neural tube defects, susceptibility to}); AD ({Schizophrenia, susceptibility to}); AD ({Thromboembolism, susceptibility to}); {Vascular disease, susceptibility to}; AR (Homocystinuria due to MTHFR deficiency)",
MTSS1,AD (Intellectual developmental disorder with ocular anomalies and distinctive facial features),
MTSS2,AD (Intellectual developmental disorder with ocular anomalies and distinctive facial features),
MTTP,AR (Abetalipoproteinemia),
MTX1,AR (Mandibuloacral dysplasia progeroid syndrome),
MTX2,"AR (Mandibuloacral dysplasia progeroid syndrome); AD (Mesomelic dysplasia, Kantaputra type); AR (Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum); AD (Chromosome 2q31.1 duplication syndrome)",
MUC1,"AD (Tubulointerstitial kidney disease, autosomal dominant, 2); AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance); AD ({Asthma, protection against})",
MUC2,"AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal); AD ({Pulmonary fibrosis, idiopathic, susceptibility to}); AD (Tubulointerstitial kidney disease, autosomal dominant, 2); AD (Deafness, autosomal dominant 8/12); AR (Deafness, autosomal recessive 21)",
MUC21,"AR ({Graves disease, susceptibility to, 1})",
MUC3A,{Inflammatory bowel disease 11},
MUC5AC,"AD ({Pulmonary fibrosis, idiopathic, susceptibility to}); AD (?Deafness, autosomal dominant 89); AR (Congenital disorder of glycosylation, type IIt)",
MUC5B,"AD ({Pulmonary fibrosis, idiopathic, susceptibility to}); AR (Spastic ataxia, Charlevoix-Saguenay type)",
MUC6,"AD (?Deafness, autosomal dominant 89); AD ({Asthma, protection against}); AD ({Pulmonary fibrosis, idiopathic, susceptibility to})",
MUC7,"AD ({Asthma, protection against}); {Colorectal cancer, susceptibility to, 1}",
MUS81,"AR (Fanconi anemia, complementation group P); AR (Immunodeficiency 122); AR (Bloom syndrome); AR (Werner syndrome)",
MUSK,"AR (Fetal akinesia deformation sequence 1); AR (Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency); AR (?Myasthenic syndrome, congenital, 17); AR (Cenani-Lenz syndactyly syndrome); AR (Sclerosteosis 2); AR (Fetal akinesia deformation sequence 3); AR (Myasthenic syndrome, congenital, 10); AR (Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects); AD (Robinow syndrome, autosomal dominant 2); AR (Fetal akinesia deformation sequence 2); AR (Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency)",
MUSTN1,"?Cardiomyopathy, dilated, 1M; AD (Cardiomyopathy, hypertrophic, 12)",
MUTYH,"AR (Adenomas, multiple colorectal); Gastric cancer, somatic; AR (Pontocerebellar hypoplasia, type 7)",
MVD,"AD (Porokeratosis 7, multiple types); AR (Hyper-IgD syndrome); AR (Mevalonic aciduria); AD (Porokeratosis 3, multiple types)",
MVK,"AR (Hyper-IgD syndrome); AR (Mevalonic aciduria); AD (Porokeratosis 3, multiple types); AD (Porokeratosis 7, multiple types); Porokeratosis 4, disseminated superficial actinic; Porokeratosis 5, disseminated superficial actinic",
MVP,"AD (Mitral valve prolapse, myxomatous 1); AD ({Epilepsy, idiopathic generalized, susceptibility to, 18}); Brugada syndrome 8; AD (Sick sinus syndrome 2); AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic",
MX1,"Alopecia areata 1; Down syndrome; AR (Immunodeficiency 65, susceptibility to viral infections); AD (Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia); Burkitt lymphoma, somatic; AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant)",
MXD1,"AD ({Pheochromocytoma, susceptibility to}); AD (Polydactyly-macrocephaly syndrome); Coffin-Lowry syndrome; Intellectual developmental disorder, X-linked 19; AR (?Atrial fibrillation 15); AR (Nephrotic syndrome, type 12); AR (?Nephrotic syndrome, type 13)",
MXI1,"Neurofibrosarcoma, somatic; Prostate cancer, somatic; AR (Erythrocytosis, familial, 2); Hemangioblastoma, cerebellar, somatic; AD (Pheochromocytoma); Renal cell carcinoma, somatic; AD (von Hippel-Lindau syndrome)",
MYB,{T-cell acute lymphoblastic leukemia}; AR (Bone marrow failure syndrome 4); AD (Fetal hemoglobin quantitative trait locus 2); AD (Snijders Blok-Campeau syndrome),
MYBL2,"Bladder cancer, somatic; Osteosarcoma, somatic; AD (Retinoblastoma); AD (Retinoblastoma, trilateral); Small cell cancer of the lung, somatic",
MYBPC1,"AD (Arthrogryposis, distal, type 1B); AD (Congenital myopathy 16); AR (Lethal congenital contracture syndrome 4); AD ({Epilepsy, idiopathic generalized, susceptibility to, 19}); AD (Arrhythmogenic right ventricular dysplasia, familial); AD (Cardiomyopathy, familial hypertrophic, 26); AD (Cardiomyopathy, familial restrictive 5); AD (Myopathy, distal, 4); AD (Myopathy, myofibrillar, 5)",
MYBPC2,"AD (Arthrogryposis, distal, type 1B); AD (Congenital myopathy 16); AR (Lethal congenital contracture syndrome 4)",
MYBPC3,"AD (Cardiomyopathy, dilated, 1MM); AR (Cardiomyopathy, hypertrophic, 4); AD (Left ventricular noncompaction 10); AD (Cardiomyopathy, dilated, 1S); AD (Cardiomyopathy, hypertrophic, 1); AD (Congenital myopathy 7A, myosin storage, autosomal dominant); AR (Congenital myopathy 7B, myosin storage, autosomal recessive); AD (Laing distal myopathy); AD (Left ventricular noncompaction 5); AD (Arthrogryposis, distal, type 1B); AD (Congenital myopathy 16); AR (Lethal congenital contracture syndrome 4); AD (Cardiomyopathy, dilated, 1G); AD (Cardiomyopathy, familial hypertrophic, 9); AR (Congenital myopathy 5 with cardiomyopathy); AR (Muscular dystrophy, limb-girdle, autosomal recessive 10); AD (Myopathy, myofibrillar, 9, with early respiratory failure); AD (Tibial muscular dystrophy, tardive); AD (Cardiomyopathy, dilated, 1D); AD (Cardiomyopathy, familial restrictive, 3); AD (Cardiomyopathy, hypertrophic, 2); AD (Left ventricular noncompaction 6); ?Cardiomyopathy, dilated, 1M; AD (Cardiomyopathy, hypertrophic, 12)",
MYC,"Burkitt lymphoma, somatic; AD (Feingold syndrome 1); AD (Megalencephaly-polydactyly syndrome); AD ({Pheochromocytoma, susceptibility to}); AD (Polydactyly-macrocephaly syndrome)",
MYCBP,AR (Spermatogenic failure 51),
MYCBP2,AD (Myopia 2),
MYCN,"AD (Feingold syndrome 1); AD (Megalencephaly-polydactyly syndrome); AR (Infantile liver failure syndrome 2); AR (Short stature, optic nerve atrophy, and Pelger-Huet anomaly)",
MYD88,"AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; {Bacteremia, protection against}; {Malaria, protection against}; {Tuberculosis, protection against}; AD ({Colorectal cancer, susceptibility to}); AD ({Leprosy, susceptibility to}); {Mycobacterium tuberculosis, susceptibility to}; AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}); AR (Immunodeficiency 67)",
MYEOV,"{Prostate cancer, hereditary, 14}",
MYF5,"AR (Ophthalmoplegia, external, with rib and vertebral anomalies); AR (Congenital myopathy 17); AD (Branchiootic syndrome 3); AD (Deafness, autosomal dominant 23); AD (?Otofaciocervical syndrome); AD (Anterior segment anomalies with or without cataract); AD (Branchiootic syndrome 1); AD (Branchiootorenal syndrome 1, with or without cataracts); Conotruncal anomaly face syndrome; AD (DiGeorge syndrome); AD (Tetralogy of Fallot); AD (Velocardiofacial syndrome)",
MYF6,"AR (Ophthalmoplegia, external, with rib and vertebral anomalies); AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); AD (Craniosynostosis 3); AR (Hypogonadotropic hypogonadism 26 with or without anosmia); Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy",
MYH1,"AR (Congenital myopathy 6 with ophthalmoplegia); AD (Arthrogryposis, distal, type 2A (Freeman-Sheldon)); AD (Arthrogryposis, distal, type 2B3 (Sheldon-Hall)); AD (Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A); AR (Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B); Carney complex variant; AD (Trismus-pseudocamptodactyly syndrome); AD (Aortic aneurysm, familial thoracic 4); AR (Megacystis-microcolon-intestinal hypoperistalsis syndrome 2); AD (Visceral myopathy 2); AR (Glycogen storage disease XIII)",
MYH10,"AD (?Peripheral neuropathy, myopathy, hoarseness, and hearing loss); AD (Deafness, autosomal dominant 4A); AR (Bleeding disorder, platelet-type, 21); ?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia",
MYH11,"AD (Aortic aneurysm, familial thoracic 4); AR (Megacystis-microcolon-intestinal hypoperistalsis syndrome 2); AD (Visceral myopathy 2); AD (Cleidocranial dysplasia 2); AD (Aortic aneurysm, familial thoracic 6); Moyamoya disease 5; AD (Smooth muscle dysfunction syndrome); AD (Corneal dystrophy, Fuchs endothelial, 6); AD (Corneal dystrophy, posterior polymorphous, 3); AR (Arterial calcification, generalized, of infancy, 2); AR (Pseudoxanthoma elasticum); AD (Pseudoxanthoma elasticum, forme fruste)",
MYH14,"AD (?Peripheral neuropathy, myopathy, hoarseness, and hearing loss); AD (Deafness, autosomal dominant 4A); AD (Deafness, autosomal dominant 4B); AR (Deafness, autosomal recessive 113)",
MYH16,"{Sepsis, susceptibility to}",
MYH2,"AR (Congenital myopathy 6 with ophthalmoplegia); AD ({Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}); AR (Nemaline myopathy 5A, autosomal recessive, severe infantile); AR (Nemaline myopathy 5B, autosomal recessive, childhood-onset); AD (Nemaline myopathy 5C, autosomal dominant)",
MYH3,"AD (Arthrogryposis, distal, type 2A (Freeman-Sheldon)); AD (Arthrogryposis, distal, type 2B3 (Sheldon-Hall)); AD (Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A); AR (Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B); AR (Congenital myopathy 6 with ophthalmoplegia)",
MYH6,"AD (?Atrial septal defect 3); {Sick sinus syndrome 3}; AD (Cardiomyopathy, dilated, 1EE); AD (Cardiomyopathy, hypertrophic, 14); AD (Cardiomyopathy, dilated, 1S); AD (Cardiomyopathy, hypertrophic, 1); AD (Congenital myopathy 7A, myosin storage, autosomal dominant); AR (Congenital myopathy 7B, myosin storage, autosomal recessive); AD (Laing distal myopathy); AD (Left ventricular noncompaction 5); AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AD (?Otosclerosis 12); AD ({Rhabdoid tumor predisposition syndrome 2}); AD (Coffin-Siris syndrome 4)",
MYH7,"AD (Cardiomyopathy, dilated, 1S); AD (Cardiomyopathy, hypertrophic, 1); AD (Congenital myopathy 7A, myosin storage, autosomal dominant); AR (Congenital myopathy 7B, myosin storage, autosomal recessive); AD (Laing distal myopathy); AD (Left ventricular noncompaction 5); AD (Cardiomyopathy, dilated, 1MM); AR (Cardiomyopathy, hypertrophic, 4); AD (Left ventricular noncompaction 10); AD (?Atrial septal defect 3); {Sick sinus syndrome 3}; AD (Cardiomyopathy, dilated, 1EE); AD (Cardiomyopathy, hypertrophic, 14)",
MYH7B,"{Melanoma, cutaneous malignant, 7}",
MYH8,"Carney complex variant; AD (Trismus-pseudocamptodactyly syndrome); AD (Arthrogryposis, distal, type 2A (Freeman-Sheldon)); AD (Arthrogryposis, distal, type 2B3 (Sheldon-Hall)); AD (Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A); AR (Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B)",
MYH9,"AD (Deafness, autosomal dominant 17); AD (Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss); AD ({Glomerulosclerosis, focal segmental, 4, susceptibility to}); AD (Orofacial cleft-1); AD (?Peripheral neuropathy, myopathy, hoarseness, and hearing loss); AD (Deafness, autosomal dominant 4A); AR (Retinitis pigmentosa 78)",
MYL1,AR (Congenital myopathy 14),
MYL11,"AR (Arthrogryposis, distal, type 1C)",
MYL2,"AD (Cardiomyopathy, hypertrophic, 10); AR (Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy); AR (Cardiomyopathy, hypertrophic, 8); Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic; AD (Aortic aneurysm, familial thoracic 7); AR (Megacystis-microcolon-intestinal hypoperistalsis syndrome 1)",
MYL3,"AR (Cardiomyopathy, hypertrophic, 8); AD (Cardiomyopathy, hypertrophic, 10); AR (Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy); AD (?Atrial fibrillation, familial, 18); AD (Cardiomyopathy, dilated, 1MM); AR (Cardiomyopathy, hypertrophic, 4); AD (Left ventricular noncompaction 10)",
MYL4,"AD (?Atrial fibrillation, familial, 18); AR (Congenital myopathy 14); AR (Cardiomyopathy, hypertrophic, 8); AD (Atrial fibrillation, familial, 1)",
MYL5,"AD (Primary lateral sclerosis, adult, 1)",
MYL9,AR (?Megacystis-microcolon-intestinal hypoperistalsis syndrome 4); AR (Retinitis pigmentosa 78),
MYLIP,"AR (Hypercholesterolemia, familial, 1); AR (LDL cholesterol level QTL2)",
MYLK,"AD (Aortic aneurysm, familial thoracic 7); AR (Megacystis-microcolon-intestinal hypoperistalsis syndrome 1); AD (Capillary malformation-arteriovenous malformation 2); AD (Lymphatic malformation 7); AR (Pseudo-TORCH syndrome 1); AD (?Knobloch syndrome 2); AD (Megabladder, congenital); AR (Neurodegeneration, childhood-onset, with cerebellar atrophy)",
MYLK2,"AD (Cardiomyopathy, hypertrophic, 1, digenic); AD (Cardiomyopathy, dilated, 1S); AD (Cardiomyopathy, hypertrophic, 1); AD (Congenital myopathy 7A, myosin storage, autosomal dominant); AR (Congenital myopathy 7B, myosin storage, autosomal recessive); AD (Laing distal myopathy); AD (Left ventricular noncompaction 5); AD (Cardiomyopathy, hypertrophic, 10); AR (Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy)",
MYMK,AR (Carey-Fineman-Ziter syndrome); AR (Carey-Fineman-Ziter syndrome 2),
MYMX,AR (Carey-Fineman-Ziter syndrome 2); AR (Carey-Fineman-Ziter syndrome),
MYO10,"AR (Glomerulosclerosis, focal segmental, 6); Microphthalmia with coloboma 1; Synesthesia",
MYO15A,"AR (Deafness, autosomal recessive 3); AR (?Deafness, autosomal recessive 102); AR (Deafness, autosomal recessive 31); AR (Usher syndrome, type 2D); AR (Deafness, autosomal recessive 85); AR (Deafness autosomal recessive 106)",
MYO18A,"AD (?Ocular pterygium-digital keloid dysplasia syndrome); AD (Basal ganglia calcification, idiopathic, 4); AD (Kosaki overgrowth syndrome); AD (Myofibromatosis, infantile, 1); AD (Premature aging syndrome, Penttinen type); AD (Chilton-Okur-Chung neurodevelopmental syndrome); Chromosome 8p11 myeloproliferative syndrome",
MYO18B,"AR (Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism); AR (Congenital myopathy 20)",
MYO1A,"AR (?Diarrhea 15, congenital); AD (Deafness, autosomal dominant 48); AR (Glomerulosclerosis, focal segmental, 6)",
MYO1C,"AR (Glomerulosclerosis, focal segmental, 6); AD (Miller-Dieker lissencephaly syndrome); AR (?Diarrhea 15, congenital); AD (Chromosome 17p13.3 duplication syndrome)",
MYO1E,"AR (Glomerulosclerosis, focal segmental, 6); AR (Intellectual developmental disorder, autosomal recessive 64)",
MYO1F,"AR (Glomerulosclerosis, focal segmental, 6); AD (Deafness, autosomal dominant 11); AR (Deafness, autosomal recessive 2); AR (Usher syndrome, type 1B)",
MYO1H,"AR (?Central hypoventilation syndrome, congenital, 2, and autonomic dysfunction)",
MYO3A,"AD (Deafness, autosomal dominant 90); AR (Deafness, autosomal recessive 30); AR (?Usher syndrome, type 1M); AR (Deafness, autosomal recessive 36); AR (Deafness, neurosensory, without vestibular involvement, autosomal dominant)",
MYO3B,"AR (?Usher syndrome, type 1M); AR (Deafness, autosomal recessive 36); AR (Deafness, neurosensory, without vestibular involvement, autosomal dominant); AD (Deafness, autosomal dominant 90); AR (Deafness, autosomal recessive 30)",
MYO5A,"AR (Griscelli syndrome, type 1); AR (Griscelli syndrome, type 2); AR (Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia); AR (Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia)",
MYO5B,"AR (Cholestasis, progressive familial intrahepatic, 10); AR (Diarrhea 2, with microvillus atrophy, with or without cholestasis); AR (Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease)",
MYO6,"AD (Deafness, autosomal dominant 22); AD (Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy); AR (Deafness, autosomal recessive 37); AD (Oculopharyngodistal myopathy 2); AR (Auditory neuropathy, autosomal recessive, 1); AR (Deafness, autosomal recessive 9); AD (Deafness, autosomal dominant 11); AR (Deafness, autosomal recessive 2); AR (Usher syndrome, type 1B); AR (Deafness, autosomal recessive 3)",
MYO7A,"AD (Deafness, autosomal dominant 11); AR (Deafness, autosomal recessive 2); AR (Usher syndrome, type 1B); AR (Deafness, autosomal recessive 18A); AR (Usher syndrome, type 1C); AD (Deafness, autosomal dominant 22); AD (Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy); AR (Deafness, autosomal recessive 37); AD ({Pituitary adenoma 5, multiple types}); AR (Deafness, autosomal recessive 12); AR (Usher syndrome, type 1D); AR (Usher syndrome, type 1D/F digenic); AR (Deafness, autosomal recessive 3)",
MYO9A,"AR (Myasthenic syndrome, congenital, 24, presynaptic)",
MYO9B,"AD (Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures); AR (Myasthenic syndrome, congenital, 24, presynaptic); {Celiac disease, susceptibility to, 4}",
MYOC,"AD (Glaucoma 1A, primary open angle); AR (Anterior segment dysgenesis 6, multiple subtypes); AR (Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset); {Glaucoma, normal tension, susceptibility to}; AR (Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia); AD (Glaucoma 1, open angle, E); AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AR (Peroxisome biogenesis disorder 2A (Zellweger)); AR (Peroxisome biogenesis disorder 2B); AR (Rhizomelic chondrodysplasia punctata, type 5); AD (Microcoria, congenital)",
MYOCD,"AD (Megabladder, congenital); AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1)",
MYOD1,"AR (Congenital myopathy 17); AR (Ophthalmoplegia, external, with rib and vertebral anomalies); AR (Ceroid lipofuscinosis, neuronal, 10)",
MYOF,"AD (?Angioedema, hereditary, 7); AR (Miyoshi muscular dystrophy 1); AR (Muscular dystrophy, limb-girdle, autosomal recessive 2); AR (Myopathy, distal, with anterior tibial onset)",
MYOG,"Kabuki syndrome 2; AD (Branchiootic syndrome 3); AD (Deafness, autosomal dominant 23); AD (?Deafness, congenital heart defects, and posterior embryotoxon); AD (Alagille syndrome 1); AD (Charcot-Marie-Tooth disease, axonal, type 2HH); AD (Tetralogy of Fallot); AD (Megabladder, congenital); Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy; AD ({Malignant hyperthermia susceptibility 5}); AD ({Thyrotoxic periodic paralysis, susceptibility to, 1}); AR (Congenital myopathy 18 due to dihydropyridine receptor defect); AD (Hypokalemic periodic paralysis, type 1)",
MYORG,"AR (Basal ganglia calcification, idiopathic, 7, autosomal recessive); AR (Basal ganglia calcification, idiopathic, 9, autosomal recessive)",
MYOT,"AD (Myopathy, myofibrillar, 3); AD (Cardiomyopathy, dilated, 1C, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 24); AD (Left ventricular noncompaction 3); AD (Myopathy, myofibrillar, 4)",
MYOZ1,"AD (Cardiomyopathy, hypertrophic, 16); AD (Cardiomyopathy, dilated, 1C, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 24); AD (Left ventricular noncompaction 3); AD (Myopathy, myofibrillar, 4)",
MYOZ2,"AD (Cardiomyopathy, hypertrophic, 16); AD (Cardiomyopathy, hypertrophic, 25); AR (Muscular dystrophy, limb-girdle, autosomal recessive 7); AR (Renal tubular dysgenesis); AD (Cardiomyopathy, dilated, 1C, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 24); AD (Left ventricular noncompaction 3); AD (Myopathy, myofibrillar, 4)",
MYOZ3,"AD (Cardiomyopathy, hypertrophic, 16); AD (Cardiomyopathy, dilated, 1C, with or without LVNC); AD (Cardiomyopathy, hypertrophic, 24); AD (Left ventricular noncompaction 3); AD (Myopathy, myofibrillar, 4)",
MYPN,"AD (Cardiomyopathy, dilated, 1KK); AD (Cardiomyopathy, familial restrictive, 4); AD (Cardiomyopathy, hypertrophic, 22); AR (Congenital myopathy 24); AD (Cardiomyopathy, dilated, 1G); AD (Cardiomyopathy, familial hypertrophic, 9); AR (Congenital myopathy 5 with cardiomyopathy); AR (Muscular dystrophy, limb-girdle, autosomal recessive 10); AD (Myopathy, myofibrillar, 9, with early respiratory failure); AD (Tibial muscular dystrophy, tardive); AR (Coenzyme Q10 deficiency, primary, 6)",
MYRF,"AD (Cardiac-urogenital syndrome); AD (Encephalitis/encephalopathy, mild, with reversible myelin vacuolization); AD (Nanophthalmos 1)",
MYSM1,AR (Bone marrow failure syndrome 4),
MYT1,"AD ({ACTH-independent macronodular adrenal hyperplasia 3}); AD (Cleft palate, psychomotor retardation, and distinctive facial features); AD (?Anemia, hypochromic microcytic, with iron overload 2); AD (Intellectual developmental disorder, autosomal dominant 39)",
MYT1L,"AD (Intellectual developmental disorder, autosomal dominant 39); AD ({Type 2 diabetes mellitus, susceptibility to}); Maturity-onset diabetes of the young 6; AD (Developmental and epileptic encephalopathy 72)",
MYZAP,"AR (Cardiomyopathy, dilated, 2K)",
MZF1,"AD (Polycystic kidney disease 2); {Alzheimer disease 18, susceptibility to}; AD (Reticulate acropigmentation of Kitamura); AR (Diarrhea 10, protein-losing enteropathy type); AD (Polycystic kidney disease 1)",
N4BP2L2,"AD (Neutropenia, cyclic); AD (Neutropenia, severe congenital 1, autosomal dominant)",
NAA10,"Microphthalmia, syndromic 1; Ogden syndrome; AR (?Auroneurodental syndrome); AD (Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities)",
NAA15,"AD (Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities); Microphthalmia, syndromic 1; Ogden syndrome",
NAA20,"AR (Intellectual developmental disorder, autosomal recessive 73); AR (?Auroneurodental syndrome)",
NAA25,"AR (Intellectual developmental disorder, autosomal recessive 73)",
NAA50,"Microphthalmia, syndromic 1; Ogden syndrome",
NAA60,"AR (Basal ganglia calcification, idiopathic, 9, autosomal recessive)",
NAA80,AR (?Auroneurodental syndrome),
NAB2,"AD (Hyper-IgE syndrome 6, autosomal dominant, with recurrent infections); AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4); AR (Intellectual developmental disorder, autosomal recessive 56)",
NACA,"AD (Cardiac arrhythmia, ankyrin-B-related); AD (Long QT syndrome 4); AD (Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome); AD (Ventricular tachycardia, catecholaminergic polymorphic, 1); AD (?Febrile seizures, familial, 4); AR (Usher syndrome, type 2C); AR (Usher syndrome, type 2C, GPR98/PDZD7 digenic)",
NACA2,"AD (Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome); AD (Ventricular tachycardia, catecholaminergic polymorphic, 1); AD (?Febrile seizures, familial, 4); AR (Usher syndrome, type 2C); AR (Usher syndrome, type 2C, GPR98/PDZD7 digenic); AD (Short QT syndrome 7); AD (Deafness, autosomal dominant 78); AD (Delpire-McNeill syndrome); AR (Kilquist syndrome)",
NACC1,"AD (Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination)",
NACC2,"AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to})",
NADK,"AR (2,4-dienoyl-CoA reductase deficiency)",
NADK2,"AR (2,4-dienoyl-CoA reductase deficiency)",
NADSYN1,"AR (Vertebral, cardiac, renal, and limb defects syndrome 3)",
NAE1,AR (Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia),
NAF1,"AD (Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7); AR (Wolfram syndrome 2); AR (?Dystonia 35, childhood-onset); AR (Neurodevelopmental disorder with dystonia and seizures)",
NAGA,"AR (Kanzaki disease); AR (Schindler disease, type I); AR (Schindler disease, type III); AR (Infantile cerebellar-retinal degeneration); AR (Optic atrophy 9); AR (Metachromatic leukodystrophy)",
NAGLU,"AD (?Charcot-Marie-Tooth disease, axonal, type 2V); AR (Mucopolysaccharidosis type IIIB (Sanfilippo B)); AR (Mucopolysaccharidosis type IIIA (Sanfilippo A))",
NAGPA,"Stuttering, familial persistent, 2; AR (Spastic paraplegia 51, autosomal recessive); AD (Stuttering, familial persistent, 1); AR (Mucolipidosis II alpha/beta); AR (Mucolipidosis III alpha/beta)",
NAGS,AR (N-acetylglutamate synthase deficiency),
NAIP,"AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive)",
NALCN,"AD (Congenital contractures of the limbs and face, hypotonia, and developmental delay); AR (Hypotonia, infantile, with psychomotor retardation and characteristic facies 1); AR (Hypotonia, infantile, with psychomotor retardation and characteristic facies 2); AD (?Episodic pain syndrome, familial, 1)",
NANOG,"AR (Immunodeficiency 75); Myelodysplastic syndrome, somatic; AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system); Burkitt lymphoma, somatic",
NANOS1,AD (Spermatogenic failure 12),
NANOS3,AD (Spermatogenic failure 12),
NANS,"AR (Spondyloepimetaphyseal dysplasia, Genevieve type)",
NAP1L1,AR (Sudden infant death with dysgenesis of the testes syndrome),
NAPB,AR (Developmental and epileptic encephalopathy 107),
NAPEPLD,[Longevity 1],
NARF,"AD ({Diabetes mellitus, type 2, susceptibility to})",
NARS1,"AR (Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive); AD (Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant)",
NARS2,"AR (?Deafness, autosomal recessive 94); AR (Combined oxidative phosphorylation deficiency 24); AR (Developmental and epileptic encephalopathy 75)",
NAT1,"AD (?Orthostatic intolerance); AR (Developmental and epileptic encephalopathy 102); AD (Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities); AR ([Acetylation, slow]); AD ({Schizophrenia})",
NAT10,AR (Neurodevelopmental disorder with speech delay and variable ocular anomalies); AR (?Mosaic variegated aneuploidy syndrome 4),
NAT2,"AR ([Acetylation, slow]); AD (Orofacial cleft-1)",
NAT8,AR (?N-acetylaspartate deficiency),
NAT8L,AR (?N-acetylaspartate deficiency),
NAT9,"AD (Nephrolithiasis/osteoporosis, hypophosphatemic, 2)",
NAV1,"AD (Developmental and epileptic encephalopathy 6B, non-Dravet); AD (Dravet syndrome); AD (Febrile seizures, familial, 3A); AD (Generalized epilepsy with febrile seizures plus, type 2); AD (Migraine, familial hemiplegic, 3); AD (Developmental and epileptic encephalopathy 11); AD (Episodic ataxia, type 9); AD (Seizures, benign familial infantile, 3); AD (Developmental and epileptic encephalopathy 62); AD (Epilepsy, familial focal, with variable foci 4); AR ({Sudden infant death syndrome, susceptibility to}); AD (Atrial fibrillation, familial, 10); AD (Brugada syndrome 1); AD (Cardiomyopathy, dilated, 1E); AD (Heart block, nonprogressive); AD (Heart block, progressive, type IA); AD (Long QT syndrome 3); AR (Sick sinus syndrome 1); Ventricular fibrillation, familial, 1; AD (?Myoclonus, familial, 2); AD (Cognitive impairment with or without cerebellar ataxia); AD (Developmental and epileptic encephalopathy 13); AD (Seizures, benign familial infantile, 5); AD (Erythermalgia, primary); AR (Insensitivity to pain, congenital); AR (Neuropathy, hereditary sensory and autonomic, type IID); AD (Paroxysmal extreme pain disorder); AD (Small fiber neuropathy); AR (Congenital myopathy 22A, classic); AR (Congenital myopathy 22B, severe fetal); AD (Hyperkalemic periodic paralysis); AD (Hypokalemic periodic paralysis, type 2); AR (Myasthenic syndrome, congenital, 16); AD (Myotonia congenita, atypical, acetazolamide-responsive); AD (Paramyotonia congenita); AD (Episodic pain syndrome, familial, 2); AD (Episodic pain syndrome, familial, 3); AD (Neuropathy, hereditary sensory and autonomic, type VII)",
NAV2,"AR (Neurodevelopmental disorder with poor or absent speech, dysmorphic facies, and behavioral abnormalities)",
NAV3,"AR (Neurodevelopmental disorder with poor or absent speech, dysmorphic facies, and behavioral abnormalities)",
NAXD,"AR (Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2); AR (Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy)",
NAXE,"AR (Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy); AR (?Intellectual developmental disorder, autosomal recessive 50); AR (Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2)",
NBAS,"AR (Infantile liver failure syndrome 2); AR (Short stature, optic nerve atrophy, and Pelger-Huet anomaly); AR (Infantile liver failure syndrome 3)",
NBEA,AD (Neurodevelopmental disorder with or without early-onset generalized epilepsy); {Autism susceptibility 1}; {Autism susceptibility 3}; AR (Gray platelet syndrome),
NBEAL1,AR (Gray platelet syndrome),
NBEAL2,AR (Gray platelet syndrome),
NBL1,AR (Temtamy preaxial brachydactyly syndrome),
NBN,"Aplastic anemia; Leukemia, acute lymphoblastic; AR (Nijmegen breakage syndrome); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Nijmegen breakage syndrome-like disorder); AD (Optic atrophy 13 with retinal and foveal abnormalities); AR (Ataxia-telangiectasia-like disorder 1)",
NBPF1,"AD ({Attention deficit-hyperactivity disorder, susceptibility to}); AD ({Blepharospasm, primary benign}); {Bone mineral density QTL 12, osteoporosis}",
NBPF19,"AD (Neuronal intranuclear inclusion disease); AD (Oculopharyngodistal myopathy 3); AD (Tremor, hereditary essential, 6)",
NBPF3,"{Alkaline phosphatase, plasma level of, QTL 2}; {Vitamin B6 plasma level QTL 1}",
NBR1,"AD (Cardiomyopathy, dilated, 1G); AD (Cardiomyopathy, familial hypertrophic, 9); AR (Congenital myopathy 5 with cardiomyopathy); AR (Muscular dystrophy, limb-girdle, autosomal recessive 10); AD (Myopathy, myofibrillar, 9, with early respiratory failure); AD (Tibial muscular dystrophy, tardive); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AD (Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant)",
NCAM1,"AD (?Thrombocytopenia 6); Colon cancer, advanced, somatic; Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AR (?Attention deficit-hyperactivity disorder 8); AD (Agenesis of corpus callosum, cardiac, ocular, and genital syndrome); AD (Arrhythmogenic right ventricular dysplasia 14)",
NCAPD2,"AR (Microcephaly 21, primary, autosomal recessive); AR (Microcephaly 22, primary, autosomal recessive)",
NCAPD3,"AR (Microcephaly 22, primary, autosomal recessive); Intellectual developmental disorder, X-linked syndromic, Siderius type; AR (Khan-Khan-Katsanis syndrome)",
NCAPG2,"AR (Khan-Khan-Katsanis syndrome); Intellectual developmental disorder, X-linked syndromic, Siderius type; AR (Microcephaly 22, primary, autosomal recessive)",
NCAPH,"AR (?Microcephaly 23, primary, autosomal recessive)",
NCAPH2,"AR (Microcephaly 22, primary, autosomal recessive); AR (Khan-Khan-Katsanis syndrome)",
NCBP1,"AD (Spastic paraplegia 88, autosomal dominant)",
NCBP2,"AD (Spastic paraplegia 88, autosomal dominant)",
NCDN,AD (Neurodevelopmental disorder with infantile epileptic spasms),
NCF1,"AR (Chronic granulomatous disease 1, autosomal recessive); AD (Williams-Beuren syndrome); AR (Chronic granulomatous disease 3, autosomal recessive); Chronic granulomatous disease, X-linked; Immunodeficiency 34, mycobacteriosis, X-linked; AR (Chronic granulomatous disease 2, autosomal recessive)",
NCF2,"AR (Chronic granulomatous disease 2, autosomal recessive); AR (Chronic granulomatous disease 3, autosomal recessive); AR (Chronic granulomatous disease 1, autosomal recessive); AD (Intellectual developmental disorder, autosomal dominant 48)",
NCF4,"AR (Chronic granulomatous disease 3, autosomal recessive); Chronic granulomatous disease, X-linked; Immunodeficiency 34, mycobacteriosis, X-linked; AR (Chronic granulomatous disease 1, autosomal recessive); AR (Chronic granulomatous disease 2, autosomal recessive); {Inflammatory bowel disease 15}",
NCK1,"AR (Wiskott-Aldrich syndrome 2); Lymphoproliferative syndrome, X-linked, 1; AR (Autoimmune disease, multisystem, infantile-onset, 3); AR (Nephrotic syndrome, type 1)",
NCK2,"AR (Nephrotic syndrome, type 1)",
NCKAP1,"AR (Immunodeficiency 72 with autoinflammation); AD (Intellectual developmental disorder, autosomal dominant 48)",
NCKAP1L,AR (Immunodeficiency 72 with autoinflammation),
NCKIPSD,"AR (Osteogenesis imperfecta, type IX)",
NCL,"AR (Ceroid lipofuscinosis, neuronal, 7); AR (Macular dystrophy with central cone involvement); AR (Ceroid lipofuscinosis, neuronal, 1); AR (Ceroid lipofuscinosis, neuronal, 6A); AR (Ceroid lipofuscinosis, neuronal, 6B (Kufs type))",
NCLN,"AR (Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly)",
NCOA1,"AD (KBG syndrome); AD ({Atrial fibrillation 8, susceptibility to}); Prostate cancer, somatic; AD (Spinocerebellar ataxia 4); AR (?Muscular dystrophy, congenital, Davignon-Chauveau type); AR (Spinal muscular atrophy with congenital bone fractures 1); {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1",
NCOA2,"AD (Chromosome 5q14.3 deletion syndrome); AD (Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language); AD (Glucocorticoid resistance); AD ({Atrial fibrillation 8, susceptibility to}); Prostate cancer, somatic; AD (Spinocerebellar ataxia 4); AD (Arboleda-Tham syndrome); {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; AD (KBG syndrome)",
NCOA3,"AD ({Atrial fibrillation 8, susceptibility to}); Prostate cancer, somatic; AD (Spinocerebellar ataxia 4); AD (Megabladder, congenital); AD (KBG syndrome); AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair)",
NCOA4,"AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9); AD (Hyperferritinemia-cataract syndrome); AR (L-ferritin deficiency, dominant and recessive); AD (Neurodegeneration with brain iron accumulation 3); {Prostate cancer, hereditary, 13}; {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1",
NCOA6,"AR (Microcephaly 10, primary, autosomal recessive); AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe)",
NCOA7,"AR (Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay)",
NCOR1,"Hypothyroidism, congenital, nongoitrous, 8; AD (Developmental delay with variable intellectual impairment and behavioral abnormalities)",
NCOR2,"AD (Neurodevelopmental disorder with central hypotonia and dysmorphic facies); Leukemia, acute promyelocytic; AD (Adams-Oliver syndrome 3); AD (Meier-Gorlin syndrome 6); AR (?Muscular dystrophy, congenital, Davignon-Chauveau type); AR (Spinal muscular atrophy with congenital bone fractures 1)",
NCR1,"{Malaria, mild, susceptibility to}; AR (Immunodeficiency 29, mycobacteriosis)",
NCR2,"AR (Immunodeficiency 104, severe combined); AR (Immunodeficiency 42); {Malaria, mild, susceptibility to}; AR (Immunodeficiency 29, mycobacteriosis)",
NCR3,"{Malaria, mild, susceptibility to}; AR (Immunodeficiency 29, mycobacteriosis)",
NCS1,"AD (Deafness, autosomal dominant 87); Intellectual developmental disorder, X-linked 21",
NCSTN,"AD (Acne inversa, familial, 1); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (Acne inversa, familial, 2, with or without Dowling-Degos disease); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1)",
NDC1,AR (?Atrial fibrillation 15),
NDC80,"AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (?Nephrotic syndrome, type 19); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11)",
NDE1,"AR (Lissencephaly 4 (with microcephaly)); AR (Microhydranencephaly); AD (Lissencephaly 1); AD (Subcortical laminar heterotopia); {Schizophrenia 9, susceptibility to}; AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III)",
NDEL1,"AD (Lissencephaly 1); AD (Subcortical laminar heterotopia); {Schizophrenia 9, susceptibility to}; AD ({Colon cancer, susceptibility to}); AR (Lissencephaly 4 (with microcephaly)); AR (Microhydranencephaly); AD (Charcot-Marie-Tooth disease, axonal, type 2O); AD (Cortical dysplasia, complex, with other brain malformations 13); AD (Spinal muscular atrophy, lower extremity-predominant 1, AD); AR (Lissencephaly 6, with microcephaly); AD (Takenouchi-Kosaki syndrome)",
NDFIP1,"AR (Anemia, hypochromic microcytic, with iron overload 1); AD (Spinocerebellar ataxia 31)",
NDFIP2,"AR (Anemia, hypochromic microcytic, with iron overload 1)",
NDN,"AD (Schaaf-Yang syndrome); AD (Prader-Willi syndrome); AR (Lung disease, immunodeficiency, and chromosome breakage syndrome); AD (Angelman syndrome)",
NDNF,AD (Hypogonadotropic hypogonadism 25 with anosmia),
NDOR1,AR (Al-Raqad syndrome),
NDP,"Exudative vitreoretinopathy 2, X-linked; Norrie disease; AR (?Ciliary dyskinesia, primary, 6); AD ([Bone mineral density variability 1, high bone mass]); AD (Endosteal hyperostosis); AR (Exudative vitreoretinopathy 4); AD (Osteopetrosis, autosomal dominant 1); AR (Osteoporosis-pseudoglioma syndrome); AD (Polycystic liver disease 4 with or without kidney cysts)",
NDRG1,"AR (Charcot-Marie-Tooth disease, type 4D)",
NDRG2,[Blood pressure regulation QTL]; AD (?Ovarian dysgenesis 8),
NDST1,"AR (Intellectual developmental disorder, autosomal recessive 46); AD (Aortic valve disease 3); AD (Exostoses, multiple, type 2); AR (Seizures, scoliosis, and macrocephaly syndrome)",
NDST2,"AR (Intellectual developmental disorder, autosomal recessive 46); AR (Deafness, autosomal recessive 23); AR (Usher syndrome, type 1D/F digenic); AR (Usher syndrome, type 1F)",
NDST3,"AR (Intellectual developmental disorder, autosomal recessive 46)",
NDST4,"AR (Intellectual developmental disorder, autosomal recessive 46)",
NDUFA1,"Mitochondrial complex I deficiency, nuclear type 12; {Microvascular complications of diabetes 6}; AR (Mitochondrial complex I deficiency, nuclear type 13)",
NDUFA10,"AR (Mitochondrial complex I deficiency, nuclear type 22); AR (Parkinson disease 6, early onset); AR (?Mitochondrial complex I deficiency, nuclear type 35)",
NDUFA11,"AR (Mitochondrial complex I deficiency, nuclear type 14)",
NDUFA12,"AR (Mitochondrial complex I deficiency, nuclear type 23); AR (Mitochondrial complex I deficiency, nuclear type 10)",
NDUFA13,"{Thyroid carcinoma, Hurthle cell}; AR (Mitochondrial complex I deficiency, nuclear type 28); AR (Mitochondrial complex I deficiency, nuclear type 31); Thyroid carcinoma, nonmedullary, with cell oxyphilia; AR (Combined oxidative phosphorylation deficiency 5); AR (Ovarian dysgenesis 7); AR (Combined oxidative phosphorylation deficiency 44); AR (Combined oxidative phosphorylation deficiency 12)",
NDUFA2,"AR (Mitochondrial complex I deficiency, nuclear type 13); AR (Carnitine deficiency, systemic primary); AR (Mitochondrial complex I deficiency, nuclear type 32); AR (Mitochondrial complex I deficiency, nuclear type 2); AR (Mitochondrial complex I deficiency, nuclear type 26); AR (Mitochondrial complex I deficiency, nuclear type 22)",
NDUFA4,"AR (?Mitochondrial complex IV deficiency, nuclear type 21)",
NDUFA5,"AR (Mitochondrial complex I deficiency, nuclear type 5); AR (Mitochondrial complex I deficiency, nuclear type 13)",
NDUFA6,"AR (Mitochondrial complex I deficiency, nuclear type 33); AR (Mitochondrial complex I deficiency, nuclear type 13); AR (Mitochondrial complex I deficiency, nuclear type 32); AR (Mitochondrial complex I deficiency, nuclear type 2)",
NDUFA7,"AR (Mitochondrial complex I deficiency, nuclear type 13); AR (Mitochondrial complex I deficiency, nuclear type 22); AR (Mitochondrial complex I deficiency, nuclear type 33); AR (Mitochondrial complex I deficiency, nuclear type 32); AR (Mitochondrial complex I deficiency, nuclear type 2); AR (Leber-like hereditary optic neuropathy, autosomal recessive 1)",
NDUFA8,"AR (Mitochondrial complex I deficiency, nuclear type 37); AR (?Mitochondrial complex I deficiency, nuclear type 39)",
NDUFA9,"AR (Mitochondrial complex I deficiency, nuclear type 26); AR (Mitochondrial complex I deficiency, nuclear type 31); AR (Optic atrophy 7)",
NDUFAB1,AR (Combined malonic and methylmalonic aciduria); AR (Optic atrophy 15),
NDUFAF1,"AR (Mitochondrial complex I deficiency, nuclear type 11); AR (Fanconi renotubular syndrome 5); AR (Mitochondrial complex I deficiency, nuclear type 17); AR (Mitochondrial complex I deficiency, nuclear type 29)",
NDUFAF2,"AR (Mitochondrial complex I deficiency, nuclear type 10)",
NDUFAF3,"AR (Mitochondrial complex I deficiency, nuclear type 18)",
NDUFAF4,"AR (Mitochondrial complex I deficiency, nuclear type 15); AR (Mitochondrial complex I deficiency, nuclear type 18)",
NDUFAF5,"AR (Mitochondrial complex I deficiency, nuclear type 16); AR (Mitochondrial complex I deficiency, nuclear type 34)",
NDUFAF6,"AR (Fanconi renotubular syndrome 5); AR (Mitochondrial complex I deficiency, nuclear type 17)",
NDUFAF7,"AR (?Leber-like hereditary optic neuropathy, autosomal recessive 2); AR (Mitochondrial complex I deficiency, nuclear type 6)",
NDUFAF8,"AR (Mitochondrial complex I deficiency, nuclear type 34)",
NDUFB10,"AR (?Mitochondrial complex I deficiency, nuclear type 35); AR (Mitochondrial complex I deficiency, nuclear type 22)",
NDUFB11,"?Mitochondrial complex I deficiency, nuclear type 30; Linear skin defects with multiple congenital anomalies 3",
NDUFB2,"AR (Deafness, autosomal recessive 13); AR (Mitochondrial complex I deficiency, nuclear type 22)",
NDUFB3,"AR (Mitochondrial complex I deficiency, nuclear type 25); AR (Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities); AD (Neuronopathy, distal hereditary motor, autosomal dominant 9)",
NDUFB4,"AR (Mitochondrial complex I deficiency, nuclear type 22)",
NDUFB7,"AR (?Mitochondrial complex I deficiency, nuclear type 39); AR (Mitochondrial complex I deficiency, nuclear type 37); AR (Mitochondrial complex I deficiency, nuclear type 23)",
NDUFB8,"AR (Mitochondrial complex I deficiency, nuclear type 32); AR (Combined oxidative phosphorylation deficiency 51); AR (?Mitochondrial complex I deficiency, nuclear type 39); AR (Mitochondrial complex I deficiency, nuclear type 13); AR (Mitochondrial complex I deficiency, nuclear type 31); AR (Optic atrophy 15)",
NDUFB9,"AR (?Mitochondrial complex I deficiency, nuclear type 24)",
NDUFC2,"AR (Mitochondrial complex I deficiency, nuclear type 36)",
NDUFS1,"AR (Mitochondrial complex I deficiency, nuclear type 5); AR (Mitochondrial complex I deficiency, nuclear type 8); AR (Mitochondrial complex I deficiency, nuclear type 9); AR (Multiple mitochondrial dysfunctions syndrome 5); AR (Mitochondrial complex I deficiency, nuclear type 4)",
NDUFS2,"AR (?Leber-like hereditary optic neuropathy, autosomal recessive 2); AR (Mitochondrial complex I deficiency, nuclear type 6); AR (Mitochondrial complex I deficiency, nuclear type 8); AR (Mitochondrial complex I deficiency, nuclear type 7); AR (Mitochondrial complex I deficiency, nuclear type 37)",
NDUFS3,"AR (Mitochondrial complex I deficiency, nuclear type 8); AR (?Leber-like hereditary optic neuropathy, autosomal recessive 2); AR (Mitochondrial complex I deficiency, nuclear type 6); AR (?Mitochondrial complex I deficiency, nuclear type 39); AR (Mitochondrial complex I deficiency, nuclear type 9); {Thyroid carcinoma, Hurthle cell}; AR (Mitochondrial complex I deficiency, nuclear type 28); AR (Mitochondrial complex I deficiency, nuclear type 16)",
NDUFS4,"AR (Mitochondrial complex I deficiency, nuclear type 1); AR (Leber-like hereditary optic neuropathy, autosomal recessive 1); AR (?Leber-like hereditary optic neuropathy, autosomal recessive 2); AR (Mitochondrial complex I deficiency, nuclear type 6); AR (?Sudden cardiac failure, alcohol-induced); AR (Sudden cardiac failure, infantile); AR (Mitochondrial complex I deficiency, nuclear type 5)",
NDUFS5,"AR (Mitochondrial complex I deficiency, nuclear type 5)",
NDUFS6,"AR (Mitochondrial complex I deficiency, nuclear type 9); AR (?Leber-like hereditary optic neuropathy, autosomal recessive 2); AR (Mitochondrial complex I deficiency, nuclear type 6); AR (Mitochondrial complex I deficiency, nuclear type 8); AR (Mitochondrial complex I deficiency, nuclear type 5); AR (Mitochondrial complex I deficiency, nuclear type 13); AR (Mitochondrial complex I deficiency, nuclear type 1); AR (Leber-like hereditary optic neuropathy, autosomal recessive 1)",
NDUFS7,"AR (Mitochondrial complex I deficiency, nuclear type 3); AR (Mitochondrial complex I deficiency, nuclear type 8)",
NDUFS8,"AR (Mitochondrial complex I deficiency, nuclear type 2); AR (Mitochondrial complex I deficiency, nuclear type 13); AR (Leber-like hereditary optic neuropathy, autosomal recessive 1); AR (Mitochondrial complex I deficiency, nuclear type 8); AR (Mitochondrial complex I deficiency, nuclear type 33)",
NDUFV1,"AR (Mitochondrial complex I deficiency, nuclear type 4); AD (Alexander disease); AR (?Mitochondrial complex I deficiency, nuclear type 39); AR (Mitochondrial complex I deficiency, nuclear type 8); AR (Mitochondrial complex I deficiency, nuclear type 5); AR (Mitochondrial complex I deficiency, nuclear type 7); AR (Mitochondrial complex I deficiency, nuclear type 13)",
NDUFV2,"AR (Mitochondrial complex I deficiency, nuclear type 7); AR (Mitochondrial complex I deficiency, nuclear type 8); AR (Mitochondrial complex I deficiency, nuclear type 4); AR (Mitochondrial complex I deficiency, nuclear type 13); AR (Combined oxidative phosphorylation deficiency 31)",
NDUFV3,"AR (Mitochondrial complex I deficiency, nuclear type 4); AR (Mitochondrial complex I deficiency, nuclear type 7); Down syndrome; AR (Mitochondrial complex I deficiency, nuclear type 13); AR (Leber-like hereditary optic neuropathy, autosomal recessive 1)",
NEB,"AR (Arthrogryposis multiplex congenita 6); AR (Nemaline myopathy 2, autosomal recessive); AR (Nemaline myopathy 8, autosomal recessive); AD (Cardiomyopathy, dilated, 1G); AD (Cardiomyopathy, familial hypertrophic, 9); AR (Congenital myopathy 5 with cardiomyopathy); AR (Muscular dystrophy, limb-girdle, autosomal recessive 10); AD (Myopathy, myofibrillar, 9, with early respiratory failure); AD (Tibial muscular dystrophy, tardive); AD (Ehlers-Danlos syndrome, vascular type); AR (Polymicrogyria with or without vascular-type EDS); AD (Diamond-Blackfan anemia 7); AD (Cardiomyopathy, dilated, 1KK); AD (Cardiomyopathy, familial restrictive, 4); AD (Cardiomyopathy, hypertrophic, 22); AR (Congenital myopathy 24)",
NEBL,"DiGeorge syndrome/velocardiofacial syndrome complex-2; AD (Cardiomyopathy, dilated, 1KK); AD (Cardiomyopathy, familial restrictive, 4); AD (Cardiomyopathy, hypertrophic, 22); AR (Congenital myopathy 24)",
NECAP1,AR (Developmental and epileptic encephalopathy 21),
NECTIN1,"AR (Cleft lip/palate-ectodermal dysplasia syndrome); AR (Orofacial cleft 7); AR (Ectodermal dysplasia-syndactyly syndrome 1); AD (Orofacial cleft-1); AD (Charcot-Marie-Tooth disease, axonal, type 2FF)",
NECTIN2,"AD (Charcot-Marie-Tooth disease, axonal, type 2FF)",
NECTIN3,"AD (Charcot-Marie-Tooth disease, axonal, type 2FF); AR (Cleft lip/palate-ectodermal dysplasia syndrome); AR (Orofacial cleft 7)",
NECTIN4,AR (Ectodermal dysplasia-syndactyly syndrome 1); AR (Cleft lip/palate-ectodermal dysplasia syndrome); AR (Orofacial cleft 7),
NEDD4,"AD (Periventricular nodular heterotopia 7); AD (Spinocerebellar ataxia 31); AD (Neurodevelopmental disorder with hypotonia, seizures, and absent language)",
NEDD4L,"AD (Periventricular nodular heterotopia 7); AR (Autoimmune disease, multisystem, with facial dysmorphism); AR (Neuropathy, hereditary sensory and autonomic, type II); AD (Pseudohypoaldosteronism, type IIC); AR (Charcot-Marie-Tooth disease, axonal, type 2P)",
NEDD8,"AR (Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia); AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to})",
NEDD9,"AD ({Colon cancer, susceptibility to}); ?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia; Melanoma, malignant, somatic; Pancreatic cancer, somatic; AD (Peutz-Jeghers syndrome); Testicular tumor, somatic",
NEFH,"AR ({?Amyotrophic lateral sclerosis, susceptibility to}); AD (Charcot-Marie-Tooth disease, axonal, type 2CC); AR (?Lissencephaly 7 with cerebellar hypoplasia); AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive); Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia; AD (Essential tremor, hereditary, 4); AD (Charcot-Marie-Tooth disease, dominant intermediate G); AR (Charcot-Marie-Tooth disease, type 1F); AD (Charcot-Marie-Tooth disease, type 2E)",
NEFL,"AD (Charcot-Marie-Tooth disease, dominant intermediate G); AR (Charcot-Marie-Tooth disease, type 1F); AD (Charcot-Marie-Tooth disease, type 2E); AR ({?Amyotrophic lateral sclerosis, susceptibility to}); AD (Charcot-Marie-Tooth disease, axonal, type 2CC); AD (Charcot-Marie-Tooth disease, axonal, type 2F); AD (Neuronopathy, distal hereditary motor, autosomal dominant 3); AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive)",
NEFM,"AR ({?Amyotrophic lateral sclerosis, susceptibility to}); AD (Charcot-Marie-Tooth disease, axonal, type 2CC); AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive)",
NEIL1,AD (Abdominal obesity-metabolic syndrome 1),
NEIL3,AR (Seckel syndrome 9),
NEK1,"AR (?Orofaciodigital syndrome II); AD ({Amyotrophic lateral sclerosis, susceptibility to, 24}); AR (Short-rib thoracic dysplasia 6 with or without polydactyly); AR (Retinal dystrophy with macular staphyloma); AR (Spondylometaphyseal dysplasia, axial); AR (Short-rib thoracic dysplasia 3 with or without polydactyly); AR (?Retinitis pigmentosa 67)",
NEK10,"AR (Ciliary dyskinesia, primary, 44)",
NEK11,AR (?Retinitis pigmentosa 67),
NEK2,"AR (?Retinitis pigmentosa 67); AR (Cone-rod dystrophy and hearing loss 2); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic; Cone-rod dystrophy, X-linked, 1; Macular degeneration, X-linked atrophic; Retinitis pigmentosa 3; Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness",
NEK3,"AR (?Retinitis pigmentosa 67); AR (?Arthrogryposis, Perthes disease, and upward gaze palsy); AR (Lethal congenital contracture syndrome 10); Nevus comedonicus, somatic",
NEK4,"AR (?Arthrogryposis, Perthes disease, and upward gaze palsy); AR (Lethal congenital contracture syndrome 10); Nevus comedonicus, somatic",
NEK6,"AR (?Arthrogryposis, Perthes disease, and upward gaze palsy); AR (Lethal congenital contracture syndrome 10); Nevus comedonicus, somatic; AR (Focal segmental glomerulosclerosis 9); AR (Ventriculomegaly with cystic kidney disease); AR (Ciliary dyskinesia, primary, 44)",
NEK7,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AR (?Arthrogryposis, Perthes disease, and upward gaze palsy); AR (Lethal congenital contracture syndrome 10); Nevus comedonicus, somatic; Agammaglobulinemia, X-linked 1; Isolated growth hormone deficiency, type III, with agammaglobulinemia; AR (Focal segmental glomerulosclerosis 9); AR (Ventriculomegaly with cystic kidney disease); AR (Ciliary dyskinesia, primary, 44)",
NEK8,"?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2); AR (Nephronophthisis 16); AR (Nephronophthisis 2, infantile); AR (Meckel syndrome 7); AR (Nephronophthisis 3); AR (Renal-hepatic-pancreatic dysplasia 1); AR (?Arthrogryposis, Perthes disease, and upward gaze palsy); AR (Lethal congenital contracture syndrome 10); Nevus comedonicus, somatic; AD (Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant); AD (Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant)",
NEK9,"AR (?Arthrogryposis, Perthes disease, and upward gaze palsy); AR (Lethal congenital contracture syndrome 10); Nevus comedonicus, somatic; AD (Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant); AD (Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2)",
NELFA,Wolf-Hirschhorn syndrome,
NELL1,"AD (Gnathodiaphyseal dysplasia); AR (Miyoshi muscular dystrophy 3); AR (Muscular dystrophy, limb-girdle, autosomal recessive 12); AR (Scott syndrome); {Inflammatory bowel disease 18}",
NELL2,"AR (Gaze palsy, familial horizontal, with progressive scoliosis, 1); AD (Gnathodiaphyseal dysplasia); AR (Miyoshi muscular dystrophy 3); AR (Muscular dystrophy, limb-girdle, autosomal recessive 12); AR (Scott syndrome)",
NEMF,AR (Intellectual developmental disorder with speech delay and axonal peripheral neuropathy),
NEO1,"AD (Mirror movements 4); Colorectal cancer, somatic; Esophageal carcinoma, somatic; AR (Gaze palsy, familial horizontal, with progressive scoliosis, 2); AD (Mirror movements 1 and/or agenesis of the corpus callosum); AD (Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities)",
NES,"AR (Methylmalonic aciduria and homocystinuria, cblF type); AR (Inflammatory poikiloderma with hair abnormalities and acral keratoses); AR (Muscular dystrophy, limb-girdle, autosomal recessive 29); AR (Congenital arthrogryposis with anterior horn cell disease); AR (Lethal congenital contracture syndrome 1)",
NET1,AD (?Orthostatic intolerance),
NEU1,"AR (Sialidosis, type I); AR (Sialidosis, type II); AD (?Deafness, autosomal dominant 72); AR (Galactosialidosis); AR (GM1-gangliosidosis, type I); AR (GM1-gangliosidosis, type II); AR (GM1-gangliosidosis, type III); AR (Mucopolysaccharidosis type IVB (Morquio)); AD ({Parkinson disease 24, autosomal dominant, susceptibility to}); AR (Combined SAP deficiency); Gaucher disease, atypical; AR (Krabbe disease, atypical); AR (Metachromatic leukodystrophy due to SAP-b deficiency)",
NEURL2,AD (Left ventricular noncompaction 7),
NEURL4,"AD (Epilepsy, early-onset, 2, with or without developmental delay); AD (Neurodevelopmental disorder with speech impairment and dysmorphic facies)",
NEUROD1,"AD ({Type 2 diabetes mellitus, susceptibility to}); Maturity-onset diabetes of the young 6; AR (Diarrhea 4, malabsorptive, congenital); AR (Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay)",
NEUROD2,"AD (Developmental and epileptic encephalopathy 72); AR (Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay); AR (Oocyte/zygote/embryo maturation arrest 14); AR (Rothmund-Thomson syndrome, type 1)",
NEUROD4,"AR (Pituitary hormone deficiency, combined, 3); AD (Coffin-Siris syndrome 7)",
NEUROG1,"AR (Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay); AR (Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay); AD (?Deafness, autosomal dominant 89)",
NEUROG2,"AR (Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); AD (?Deafness, autosomal dominant 89); Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency; Panhypopituitarism, X-linked; AD (Ectodermal dysplasia 3, Witkop type); AD (Orofacial cleft 5); AD (Tooth agenesis, selective, 1, with or without orofacial cleft); AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system); AD (Deafness, autosomal dominant 7)",
NEUROG3,"AR (Diarrhea 4, malabsorptive, congenital); Rhabdomyosarcoma, alveolar; AR (Mitchell-Riley syndrome); AD (Insulinomatosis and diabetes mellitus)",
NEXMIF,"Intellectual developmental disorder, X-linked 98; Chromosome Xq13 duplication syndrome",
NEXN,"AD (Cardiomyopathy, dilated, 1CC); AD (Cardiomyopathy, hypertrophic, 20)",
NF1,"AD (Leukemia, juvenile myelomonocytic); AD (Neurofibromatosis-Noonan syndrome); AD (Neurofibromatosis, familial spinal); AD (Neurofibromatosis, type 1); AD (Watson syndrome); AD (Chromosome 17q11.2 deletion syndrome, 1.4Mb); AD (Chromosome 17q11.2 duplication syndrome, 1.4-Mb); AD (Imagawa-Matsumoto syndrome); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome)",
NF2,"Meningioma, NF2-related, somatic; Schwannomatosis, somatic; AD (Schwannomatosis, vestibular); AD ({Rhabdoid tumor predisposition syndrome 1}); AD ({Schwannomatosis-1, susceptibility to}); AD (Coffin-Siris syndrome 3); Rhabdoid tumors, somatic; AD ({Schwannomatosis-2, susceptibility to}); AD (Noonan syndrome 10); AR (Noonan syndrome 2); AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development)",
NFASC,"AR (Neurodevelopmental disorder with central and peripheral motor dysfunction); AR (Congenital myopathy 12); AR (Neurodevelopmental disorder with neuromuscular and skeletal abnormalities); AR (Hypomyelinating neuropathy, congenital, 3); AR (Lethal congenital contracture syndrome 7)",
NFAT5,"Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AR (?Joint contracture, osteochondromas, and B-cell lymphoma)",
NFATC1,"AD ({Atrioventricular septal defect, susceptibility to, 2}); AD (Atrioventricular septal defect, partial, with heterotaxy syndrome); AR (Jeffries-Lakhani neurodevelopmental syndrome); AR (?Joint contracture, osteochondromas, and B-cell lymphoma); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91); AR (Insulin-like growth factor I deficiency); Autoinflammatory disease, multisystem, with immune dysregulation, X-linked",
NFATC2,"AR (?Joint contracture, osteochondromas, and B-cell lymphoma); AR (?Immunodeficiency, common variable, 11); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91)",
NFATC2IP,"AR (Immunodeficiency, common variable, 3)",
NFATC3,"AR (?Joint contracture, osteochondromas, and B-cell lymphoma); AD (Charcot-Marie-Tooth disease, type 1D); AR (Dejerine-Sottas disease); AR (Hypomyelinating neuropathy, congenital, 1); AR (Immunodeficiency 52)",
NFATC4,"AD (PCWH syndrome); AD (Waardenburg syndrome, type 2E, with or without neurologic involvement); AD (Waardenburg syndrome, type 4C); AR (?Joint contracture, osteochondromas, and B-cell lymphoma); AD (Charcot-Marie-Tooth disease, type 1D); AR (Dejerine-Sottas disease); AR (Hypomyelinating neuropathy, congenital, 1); AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1)",
NFE2,"AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); AR (Autoimmune disease, multisystem, with facial dysmorphism); AR (Peroxisome biogenesis disorder 13A (Zellweger))",
NFE2L1,"AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); AR (Neurodevelopmental disorder with hypotonia and gross motor and speech delay); Focal cortical dysplasia, type II, somatic; Lymphangioleiomyomatosis; AD (Tuberous sclerosis-1); ?Focal cortical dysplasia, type II, somatic; Lymphangioleiomyomatosis, somatic; AD (Tuberous sclerosis-2)",
NFE2L2,"AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); AR (Retinal dystrophy with or without extraocular anomalies); AR (?Deafness, autosomal recessive 110); AD (Deafness, autosomal dominant 9)",
NFIA,"AD (Brain malformations with or without urinary tract defects); AD (Macrocephaly, acquired, with impaired intellectual development); AD (Malan syndrome); AD (Marshall-Smith syndrome); AD (Agammaglobulinemia 10, autosomal dominant)",
NFIB,"AD (Macrocephaly, acquired, with impaired intellectual development); AD (Brain malformations with or without urinary tract defects); AD (Malan syndrome); AD (Marshall-Smith syndrome)",
NFIC,"AD (Malan syndrome); AD (Marshall-Smith syndrome); AD (Brain malformations with or without urinary tract defects); AR (Pituitary hormone deficiency, combined or isolated, 1); AD (Macrocephaly, acquired, with impaired intellectual development)",
NFIL3,"AD (Mowat-Wilson syndrome); AR (Immunodeficiency 42); AD ([Short sleep, familial natural, 1]); AD (?Advanced sleep phase syndrome, familial, 1); AD (?Advanced sleep phase syndrome, familial, 3)",
NFIX,"AD (Malan syndrome); AD (Marshall-Smith syndrome); AD (Brain malformations with or without urinary tract defects); Chromosome 19p13.13 deletion syndrome; Chromosome 19p13.13 duplication syndrome; AD (Macrocephaly, acquired, with impaired intellectual development)",
NFKB1,"AD (Immunodeficiency, common variable, 12); AD (Immunodeficiency, common variable, 10); AD (Ectodermal dysplasia and immunodeficiency 2); Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AD (Immunodeficiency 15A); AR (Immunodeficiency 15B)",
NFKB2,"AD (Immunodeficiency, common variable, 10); AD (Immunodeficiency, common variable, 12); AR (Immunodeficiency 112); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AR (Immunodeficiency, common variable, 4); AD (Ectodermal dysplasia and immunodeficiency 2); AD (Glomerulosclerosis, focal segmental, 7); AD (Papillorenal syndrome)",
NFKBIA,"AD (Ectodermal dysplasia and immunodeficiency 2); AD (Immunodeficiency, common variable, 12); AD (Autoinflammatory disease, familial, Behcet-like-3); AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); AR (Immunodeficiency 12); AR (Intellectual developmental disorder, autosomal recessive 13); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
NFKBIB,"AD (Immunodeficiency, common variable, 12); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2); AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}); AR (Autoinflammation with arthritis and vasculitis); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 4); AD (Ectodermal dysplasia and immunodeficiency 2); AD (Immunodeficiency, common variable, 10)",
NFKBIL1,"{Rheumatoid arthritis, susceptibility to}; {Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}; {Beryllium disease, chronic, susceptibility to}; {Leprosy, susceptibility to, 4}; {Myocardial infarction, susceptibility to}; {Psoriatic arthritis, susceptibility to}; AR (?Immunodeficiency 127); AD ({Asthma, susceptibility to}); {Dementia, vascular, susceptibility to}; {Malaria, cerebral, susceptibility to}; AD ({Migraine without aura, susceptibility to}); {Septic shock, susceptibility to}",
NFKBIZ,"AR (?Candidiasis, familial, 8); {Psoriasis susceptibility 13}; AR (Immunodeficiency 75); Myelodysplastic syndrome, somatic; {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus})",
NFS1,"AR (Combined oxidative phosphorylation deficiency 52); AR (?Combined oxidative phosphorylation deficiency 19); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes); AR (Xanthinuria, type II); AR (Myopathy with lactic acidosis, hereditary); AD (Anemia, sideroblastic, 4); AR (Even-plus syndrome)",
NFU1,"AR (Multiple mitochondrial dysfunctions syndrome 1); AR (Spastic paraplegia 93, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia); AR (?Spastic paraplegia 74, autosomal recessive); AR (Multiple mitochondrial dysfunctions syndrome 3)",
NFX1,AR (Immunodeficiency 91 and hyperinflammation),
NFYA,"{Rheumatoid arthritis, susceptibility to}; AR (MHC class II deficiency 1); AR (Achromatopsia 7)",
NFYB,"DNA topoisomerase II, resistance to inhibition of, by amsacrine; {Rheumatoid arthritis, susceptibility to}; AR (MHC class II deficiency 1); AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9)",
NFYC,"AD (Global developmental delay with or without impaired intellectual development); {Rheumatoid arthritis, susceptibility to}; AR (MHC class II deficiency 1)",
NGB,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
NGEF,AD (Takenouchi-Kosaki syndrome); AR (Developmental and epileptic encephalopathy 76); AD (Intellectual developmental disorder with severe speech and ambulation defects),
NGF,"AR (Neuropathy, hereditary sensory and autonomic, type V); AR (Insensitivity to pain, congenital, with anhidrosis); Glaucoma 1, open angle, 1O; AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay)",
NGFR,"AR (Insensitivity to pain, congenital, with anhidrosis); AD ({Schizophrenia, susceptibility to}); AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
NGLY1,AR (Congenital disorder of deglycosylation 1),
NHEJ1,"AR (Immunodeficiency 124, severe combined); AR (Microphthalmia/coloboma 13); AR (Acrocapitofemoral dysplasia); AD (Brachydactyly, type A1); AD (Craniosynostosis, Philadelphia type, with syndactyly); AD (Syndactyly, type 1); AR (Short stature, microcephaly, and endocrine dysfunction); Microphthalmia with coloboma 1",
NHERF1,"AD (Nephrolithiasis/osteoporosis, hypophosphatemic, 2); AR (Diarrhea 8, secretory sodium, congenital); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AR (Chondrodysplasia, Blomstrand type); AR (Eiken syndrome); AD (Failure of tooth eruption, primary); AD (Metaphyseal chondrodysplasia, Murk Jansen type); AR ({Deafness, autosomal recessive 12, modifier of}); AD (Deafness, autosomal dominant 82)",
NHERF2,"AR ({Deafness, autosomal recessive 12, modifier of}); AD (Deafness, autosomal dominant 82); AD (Nephrolithiasis/osteoporosis, hypophosphatemic, 2); AR (Chondrodysplasia, Blomstrand type); AR (Eiken syndrome); AD (Failure of tooth eruption, primary); AD (Metaphyseal chondrodysplasia, Murk Jansen type); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AR (Diarrhea 8, secretory sodium, congenital)",
NHLH1,AR (?Hypogonadotropic hypogonadism 27 without anosmia),
NHLH2,"AR (?Hypogonadotropic hypogonadism 27 without anosmia); Leukemia, acute T-cell",
NHLRC1,AR (Myoclonic epilepsy of Lafora 2); AR (Myoclonic epilepsy of Lafora 1); AR (Glycogen storage disease IIIa); AR (Glycogen storage disease IIIb),
NHLRC2,AR (FINCA syndrome),
NHP2,"AR (Dyskeratosis congenita, autosomal recessive 2); ?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1; Dyskeratosis congenita, X-linked; AR (?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 2); AR (?Dyskeratosis congenita, autosomal recessive 1); AD (?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 9); AR (?Dystonia 35, childhood-onset); AR (Neurodevelopmental disorder with dystonia and seizures); AD (Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7)",
NHS,"Cataract 40, X-linked; Nance-Horan syndrome; Developmental and epileptic encephalopathy 2; AD (Epilepsy, early-onset, 2, with or without developmental delay); AD (Neurodevelopmental disorder with speech impairment and dysmorphic facies)",
NID1,"AD (NESCAV syndrome); AR (Neuropathy, hereditary sensory, type IIC); AD (Spastic paraplegia 30, autosomal dominant); AR (Spastic paraplegia 30, autosomal recessive)",
NID2,"AR (Cutis laxa, autosomal recessive, type IB)",
NIN,"AR (?Seckel syndrome 7); AD ({Colon cancer, susceptibility to}); AR (Nephronophthisis 15)",
NINL,"AR (Retinitis pigmentosa 39); AR (Usher syndrome, type 2A); AR (Leber congenital amaurosis 5)",
NIPA1,"AD (Spastic paraplegia 6, autosomal dominant); AD (Pulmonary hypertension, familial primary, 1, with or without HHT); AD (Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated); AD (Pulmonary venoocclusive disease 1); AD (Chromosome 15q11.2 deletion syndrome)",
NIPA2,"AD (Spastic paraplegia 6, autosomal dominant); AD (Chromosome 15q11.2 deletion syndrome); AD (Epilepsy, childhood absence, 1)",
NIPAL4,"AR (Ichthyosis, congenital, autosomal recessive 6); AR (Ichthyosis, congenital, autosomal recessive 5); AR (Ichthyosis, congenital, autosomal recessive 1)",
NIPBL,"AD (Cornelia de Lange syndrome 1); AD (Cornelia de Lange syndrome 6); Cornelia de Lange syndrome 2; Developmental and epileptic encephalopathy 85, with or without midline brain defects; {Atrioventricular septal defect, susceptibility to, 1}; AD (Cornelia de Lange syndrome 3); Chromosome 5p13 duplication syndrome",
NIPSNAP1,"AR (Hyperparathyroidism, transient neonatal)",
NISCH,"AR (Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis)",
NKAIN3,"AD (Epilepsy, early-onset, 3, with or without developmental delay)",
NKAP,"Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type",
NKD1,"AD ({Osteoporosis, early-onset, susceptibility to, autosomal dominant}); AR (Osteogenesis imperfecta, type XV); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
NKX2-1,"AD ({Thyroid cancer, nonmedullary, 1}); AD (Chorea, hereditary benign); AD (Choreoathetosis, hypothyroidism, and neonatal respiratory distress); AR (Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism); AR (Pontocerebellar hypoplasia, type 17); AD (Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia)",
NKX2-3,{Inflammatory bowel disease 20},
NKX2-4,"AD ({Thyroid cancer, nonmedullary, 1}); AD (Chorea, hereditary benign); AD (Choreoathetosis, hypothyroidism, and neonatal respiratory distress)",
NKX2-5,"AD (Atrial septal defect 7, with or without AV conduction defects); Conotruncal heart malformations, variable; AD (Hypoplastic left heart syndrome 2); AD (Hypothyroidism, congenital nongoitrous, 5); AD (Tetralogy of Fallot); AD (Ventricular septal defect 3); AD (Holt-Oram syndrome); Atrial septal defect 4; AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); Wolf-Hirschhorn syndrome",
NKX2-6,Conotruncal heart malformations; Persistent truncus arteriosus,
NKX3-2,AR (Spondylo-megaepiphyseal-metaphyseal dysplasia); AR (Otofaciocervical syndrome 2 with T-cell deficiency),
NKX6-1,"AR (Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy)",
NKX6-2,"AR (Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy)",
NLGN1,"AD ({Autism, susceptibility to, 20}); {Autism susceptibility 1}; AR (Nephrotic syndrome, type 15); {Autism susceptibility, X-linked 1}; {Autism susceptibility, X-linked 2}; Intellectual developmental disorder, X-linked; {Schizophrenia, susceptibility to, 17}; AR (Pitt-Hopkins-like syndrome 2); AD (Epilepsy, familial temporal lobe, 6)",
NLGN2,"AD ({Autism, susceptibility to, 20}); {Autism susceptibility, X-linked 1}; {Autism susceptibility, X-linked 2}; Intellectual developmental disorder, X-linked; {Schizophrenia, susceptibility to, 17}; AR (Pitt-Hopkins-like syndrome 2)",
NLGN3,"{Autism susceptibility, X-linked 1}; {Autism susceptibility 1}; {Autism susceptibility, X-linked 2}; Intellectual developmental disorder, X-linked; {Schizophrenia, susceptibility to, 17}; AR (Pitt-Hopkins-like syndrome 2); AD ({Autism, susceptibility to, 20})",
NLGN4X,"{Autism susceptibility, X-linked 2}; Intellectual developmental disorder, X-linked",
NLK,"AR (Anemia, congenital, nonspherocytic hemolytic, 4, glucose phosphate isomerase deficient); AD ({Diabetes mellitus, type 2, susceptibility to}); Autoinflammatory disease, systemic, X-linked; Ectodermal dysplasia and immunodeficiency 1; Immunodeficiency 33; Incontinentia pigmenti",
NLRC3,"AD (STING-associated vasculopathy, infantile-onset)",
NLRC4,"AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AR (Autoimmune lymphoproliferative syndrome, type III); AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); {Legionnaire disease, susceptibility to}; AD ({Melioidosis, susceptibility to}); {Systemic lupus erythematosus, resistance to}; {Systemic lupus erythematosus, susceptibility to, 1}",
NLRC5,"AR (?Respiratory papillomatosis, juvenile recurrent, congenital); {Vitiligo-associated multiple autoimmune disease susceptibility 1}; AR (Autoinflammation with arthritis and dyskeratosis); AD (Palmoplantar carcinoma, multiple self-healing)",
NLRP1,"AR (?Respiratory papillomatosis, juvenile recurrent, congenital); {Vitiligo-associated multiple autoimmune disease susceptibility 1}; AR (Autoinflammation with arthritis and dyskeratosis); AD (Palmoplantar carcinoma, multiple self-healing); AR (Hatipoglu immunodeficiency syndrome); AD (?Inflammatory bowel disease (Crohn disease) 30); AR (Centronuclear myopathy 6 with fiber-type disproportion); AR (Split-foot malformation with mesoaxial polydactyly); AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome)",
NLRP12,AD (Familial cold autoinflammatory syndrome 2),
NLRP14,"AR (?Respiratory papillomatosis, juvenile recurrent, congenital); {Vitiligo-associated multiple autoimmune disease susceptibility 1}; AR (Autoinflammation with arthritis and dyskeratosis); AD (Palmoplantar carcinoma, multiple self-healing)",
NLRP2,"AR (Oocyte/zygote/embryo maturation arrest 18); AR (Hydatidiform mole, recurrent, 1); AR (Oocyte/zygote/embryo maturation arrest 19)",
NLRP3,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); Agammaglobulinemia, X-linked 1; Isolated growth hormone deficiency, type III, with agammaglobulinemia; {Gastric cancer risk after H. pylori infection}; AD (?Inflammatory bowel disease (Crohn disease) 30); AD (Immunodeficiency 82 with systemic inflammation); AD ({?Epilepsy idiopathic generalized, susceptibility to, 8}); AR (Hyperparathyroidism, neonatal); AD (Hypocalcemia, autosomal dominant); AD (Hypocalcemia, autosomal dominant, with Bartter syndrome); AD (Hypocalciuric hypercalcemia, type I)",
NLRP5,"AR (Oocyte/zygote/embryo maturation arrest 19); AR (Oocyte/zygote/embryo maturation arrest 15); AR (Hydatidiform mole, recurrent, 2); AR (Oocyte/zygote/embryo maturation arrest 18); AR (Oocyte/zygote/embryo maturation arrest 4)",
NLRP6,"{Fatty liver disease, susceptibility to, 1}",
NLRP7,"AR (Hydatidiform mole, recurrent, 1); AR (Hydatidiform mole, recurrent, 2); AR (Hydatidiform mole, recurrent, 3); AR (Hydatidiform mole, recurrent, 4); AR (Oocyte/zygote/embryo maturation arrest 10)",
NLRX1,"AR (?Respiratory papillomatosis, juvenile recurrent, congenital); {Vitiligo-associated multiple autoimmune disease susceptibility 1}; AR (Autoinflammation with arthritis and dyskeratosis); AD (Palmoplantar carcinoma, multiple self-healing); AD (?Cardiomyopathy, dilated, 1J); AD (Deafness, autosomal dominant 10)",
NMB,"AR (Amyloidosis, primary localized cutaneous, 3)",
NME1,"AR (Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies); AD ({Systemic lupus erythematosus, susceptibility to}); AR (Aicardi-Goutieres syndrome 1, dominant and recessive); AD (Chilblain lupus); AD (Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations); AR (Mitochondrial complex I deficiency, nuclear type 8); AR (Anauxetic dysplasia 1); AR (Cartilage-hair hypoplasia); AR (Metaphyseal dysplasia without hypotrichosis)",
NME4,"AR (Basal ganglia calcification, idiopathic, 10, autosomal recessive); Alpha-thalassemia myelodysplasia syndrome, somatic; Alpha-thalassemia/impaired intellectual development syndrome; Intellectual disability-hypotonic facies syndrome, X-linked",
NME5,"AR (Ciliary dyskinesia, primary, 48, without situs inversus); AR (Ciliary dyskinesia, primary, 32)",
NME8,"AR (?Ciliary dyskinesia, primary, 6)",
NMNAT1,"AR (Leber congenital amaurosis 9); AR (Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis)",
NMNAT2,"AR (Leber congenital amaurosis 9); AR (Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis)",
NMNAT3,"AR (Leber congenital amaurosis 9); AR (Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis); {Alzheimer disease-15}",
NMS,"AD (Neurodevelopmental disorder with central hypotonia and dysmorphic facies); AR (?Spondyloepimetaphyseal dysplasia, Krakow type)",
NNAT,"ACTH-independent macronodular adrenal hyperplasia 1, somatic; McCune-Albright syndrome, somatic mosaic; AD (Osseous heteroplasia, progressive); Pituitary adenoma 3, multiple types, somatic; AD (Pseudohypoparathyroidism Ia); AD (Pseudohypoparathyroidism Ib); AD (Pseudohypoparathyroidism Ic); AD (Pseudopseudohypoparathyroidism)",
NNMT,Homocysteine plasma level,
NNT,"AR (Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency)",
NOB1,AR (Inflammatory poikiloderma with hair abnormalities and acral keratoses),
NOBOX,AD (Premature ovarian failure 5); AR (Ovarian dysgenesis 5); AD (Spermatogenic failure 32),
NOCT,"{Epilepsy, childhood absence, susceptibility to, 5}; AD (Developmental and epileptic encephalopathy 43)",
NOD1,"{Inflammatory bowel disease 1, Crohn disease}; {Yao syndrome}; AD (Blau syndrome); AD (Takenouchi-Kosaki syndrome); AD (Intellectual developmental disorder, autosomal dominant 48); AR (?Respiratory papillomatosis, juvenile recurrent, congenital); {Vitiligo-associated multiple autoimmune disease susceptibility 1}; AR (Autoinflammation with arthritis and dyskeratosis); AD (Palmoplantar carcinoma, multiple self-healing)",
NOD2,"{Inflammatory bowel disease 1, Crohn disease}; {Yao syndrome}; AD (Blau syndrome); Lymphoproliferative syndrome, X-linked, 2; {Leprosy, paucibacillary type, susceptibility to}; {Inflammatory bowel disease (Crohn disease) 10}",
NODAL,"AD (Heterotaxy, visceral, 5); AD (Polycystic kidney disease 2); AR (Heterotaxy, visceral, 13, autosomal)",
NOG,"AD (Brachydactyly, type B2); AD (Multiple synostoses syndrome 1); AD (Stapes ankylosis with broad thumbs and toes); AD (Symphalangism, proximal, 1A); AD (Tarsal-carpal coalition syndrome); AR (?Acromesomelic dysplasia 2C, Hunter-Thompson type); {Osteoarthritis-5}; AR (Acromesomelic dysplasia 2A); AR (Acromesomelic dysplasia 2B); AR (Brachydactyly, type A1, C); AD (Brachydactyly, type A2); AD (Brachydactyly, type C); AD (Multiple synostoses syndrome 2); AD (Symphalangism, proximal, 1B); AD (Klippel-Feil syndrome 1, autosomal dominant); AR (Leber congenital amaurosis 17); AD (Microphthalmia with coloboma 6, digenic); Microphthalmia, isolated 4; AD (Multiple synostoses syndrome 4)",
NOL3,"AD (?Myoclonus, familial, 1); AD ({Amyotrophic lateral sclerosis, susceptibility to, 25}); AD (Myoclonus, intractable, neonatal); AD (Spastic paraplegia 10, autosomal dominant); AD (Cortical dysplasia, complex, with other brain malformations 2); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy",
NOL4L,"{Leukemia, acute lymphoblastic, susceptibility to, 3}",
NOL6,"AR (?Microcephaly 28, primary, autosomal recessive)",
NOL9,"Wilson-Turner syndrome; AR (Pontocerebellar hypoplasia, type 10)",
NOLC1,"AD (Treacher Collins syndrome 1); AD (Neurodevelopmental disorder with or without autism or seizures); AD (Pseudohypoaldosteronism, type IIE); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4)",
NOM1,"AR (Insulin-like growth factor I, resistance to); AD (Neuronopathy, distal hereditary motor, autosomal dominant 1)",
NOMO2,"AR (Neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-Pelger-Huet anomaly)",
NONO,"Intellectual developmental disorder, X-linked syndromic 34; [Blood group, ABO system]; AD (Feingold syndrome 1); AD (Megalencephaly-polydactyly syndrome)",
NOP10,"AR (?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 2); AR (?Dyskeratosis congenita, autosomal recessive 1); AD (?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 9); ?Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 1; Dyskeratosis congenita, X-linked; AR (Dyskeratosis congenita, autosomal recessive 2); AD (Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7); AR (?Dystonia 35, childhood-onset); AR (Neurodevelopmental disorder with dystonia and seizures)",
NOP14,AR (Bowen-Conradi syndrome),
NOP2,"AR (Intellectual developmental disorder, autosomal recessive 5); AR (Intellectual developmental disorder, autosomal recessive 82); AR (Combined oxidative phosphorylation deficiency 48)",
NOP56,AD (Spinocerebellar ataxia 36); AD (Treacher Collins syndrome 1),
NOS1,"AD (Spermatogenic failure 12); AR (Nephrotic syndrome, type 22); AD (Pyloric stenosis, infantile hypertrophic 1); AD ({Alzheimer disease, late-onset, susceptibility to}); {Coronary artery spasm 1, susceptibility to}; AD ({Hypertension, pregnancy-induced}); {Hypertension, susceptibility to}; {Ischemic stroke, susceptibility to}; {Placental abruption}; AR (Metaphyseal anadysplasia 2); AR (Xanthinuria, type I)",
NOS1AP,"AR (Nephrotic syndrome, type 22); [QT interval, variation in]; AR (BDV syndrome)",
NOS2,"{Malaria, resistance to}; AD (Hemochromatosis, type 4); {Inflammatory bowel disease (Crohn disease) 19}; {Mycobacterium tuberculosis, protection against}; AR (Immunodeficiency 29, mycobacteriosis); {Systemic lupus erythematosus, susceptibility to, 11}; AD (Disabling pansclerotic morphea of childhood); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
NOS3,"AD ({Alzheimer disease, late-onset, susceptibility to}); {Coronary artery spasm 1, susceptibility to}; AD ({Hypertension, pregnancy-induced}); {Hypertension, susceptibility to}; {Ischemic stroke, susceptibility to}; {Placental abruption}; AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay); AD (Preeclampsia/eclampsia 1); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3)",
NOSIP,"AD ({Alzheimer disease, late-onset, susceptibility to}); {Coronary artery spasm 1, susceptibility to}; AD ({Hypertension, pregnancy-induced}); {Hypertension, susceptibility to}; {Ischemic stroke, susceptibility to}; {Placental abruption}; AD (Houge-Janssens syndrome 3)",
NOTCH1,"AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Adams-Oliver syndrome 6); AD (Developmental delay, hypotonia, and impaired language); {Leukemia, acute lymphocytic, susceptibility to, 1}; AD (Alagille syndrome 2); AD (Hajdu-Cheney syndrome); AD (Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies)",
NOTCH2,"AD (Alagille syndrome 2); AD (Hajdu-Cheney syndrome); AD (Neuronal intranuclear inclusion disease); AD (Oculopharyngodistal myopathy 3); AD (Tremor, hereditary essential, 6); AR (Deafness, autosomal recessive 120); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
NOTCH2NLA,"AD (Neuronal intranuclear inclusion disease); AD (Oculopharyngodistal myopathy 3); AD (Tremor, hereditary essential, 6); AD (Neutropenia, cyclic); AD (Neutropenia, severe congenital 1, autosomal dominant)",
NOTCH2NLB,"AD (Neuronal intranuclear inclusion disease); AD (Oculopharyngodistal myopathy 3); AD (Tremor, hereditary essential, 6)",
NOTCH2NLC,"AD (Neuronal intranuclear inclusion disease); AD (Oculopharyngodistal myopathy 3); AD (Tremor, hereditary essential, 6)",
NOTCH2NLR,"AD (Neuronal intranuclear inclusion disease); AD (Oculopharyngodistal myopathy 3); AD (Tremor, hereditary essential, 6)",
NOTCH3,"AD (?Myofibromatosis, infantile 2); AD (Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1); AD (Lateral meningocele syndrome); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Alagille syndrome 2); AD (Hajdu-Cheney syndrome); AR (Spondylocostal dysostosis 3, autosomal recessive)",
NOTCH4,"AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD ({Schizophrenia}); AD (Developmental delay, hypotonia, and impaired language); Mucoepidermoid salivary gland carcinoma; Mucoepidermoid salivary gland carcinoma; AD (Blepharophimosis-impaired intellectual development syndrome); AD (Nicolaides-Baraitser syndrome); AD (Adams-Oliver syndrome 6)",
NOTO,"AR (Hypobetalipoproteinemia, familial, 2); Alzheimer disease 8; {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; {Macular degeneration, age-related, 11}; AD (Cerebral amyloid angiopathy)",
NOVA1,"AD (Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities); Intellectual developmental disorder, X-linked syndromic, Pilorge type; {Schizophrenia, susceptibility to, 17}; AR (Pitt-Hopkins-like syndrome 2)",
NOVA2,"AD (Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities); AD (Developmental and epileptic encephalopathy 6B, non-Dravet); AD (Dravet syndrome); AD (Febrile seizures, familial, 3A); AD (Generalized epilepsy with febrile seizures plus, type 2); AD (Migraine, familial hemiplegic, 3); AR (Ichthyosis prematurity syndrome); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1",
NOX1,"AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive); Chronic granulomatous disease, X-linked; Immunodeficiency 34, mycobacteriosis, X-linked; AR (Intellectual developmental disorder, autosomal recessive 71); AR (Multicentric osteolysis, nodulosis, and arthropathy); {Aspergillosis, susceptibility to}; AR (Candidiasis, familial, 4, autosomal recessive)",
NOX4,"{Neuroblastoma, susceptibility to, 3}; AR ({Diabetes mellitus, ketosis-prone, susceptibility to}); AD (Diabetes mellitus, type 2); Maturity-onset diabetes of the young, type IX; AD (?Retinitis pigmentosa 97); {Stature QTL 1}; AD (Adiponectin deficiency)",
NOX5,"AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib",
NPAS2,"AD (?Advanced sleep phase syndrome, familial, 1); AD ({Delayed sleep phase disorder, susceptibility to}); AD ([Short sleep, familial natural, 1])",
NPAS3,AR (Combined oxidative phosphorylation deficiency 54),
NPAS4,{?Autism susceptibility 16},
NPAT,"AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; AR (Alpha-methylacetoacetic aciduria)",
NPC1,"AR (Niemann-Pick disease, type C1); AR (Niemann-Pick disease, type D); [Ezetimibe, nonresponse to]; [Low density lipoprotein cholesterol level QTL 7]; AR (Niemann-pick disease, type C2); AD (HDL deficiency, familial, 1); AR (Tangier disease); AR (?Dystonia 32); AR (Leukodystrophy, hypomyelinating, 12); AR (Mucopolysaccharidosis-plus syndrome)",
NPC1L1,"[Ezetimibe, nonresponse to]; [Low density lipoprotein cholesterol level QTL 7]; [Low density lipoprotein cholesterol level QTL 8]; AR (Niemann-Pick disease, type C1); AR (Niemann-Pick disease, type D)",
NPC2,"AR (Niemann-pick disease, type C2); AR (Niemann-Pick disease, type C1); AR (Niemann-Pick disease, type D); AR (?Congenital disorder of glycosylation, type 1aa); AD (Intellectual developmental disorder, autosomal dominant 55, with seizures); AR (?Congenital disorder of glycosylation, type 1bb); AD (Developmental delay and seizures with or without movement abnormalities); AR (Retinitis pigmentosa 59); AD (Developmental and epileptic encephalopathy 26)",
NPEPPS,"AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AD ({Attention deficit-hyperactivity disorder, susceptibility to}); AD ({Blepharospasm, primary benign}); {Bone mineral density QTL 12, osteoporosis}",
NPHP1,"AR (Joubert syndrome 4); AR (Nephronophthisis 1, juvenile); AR (Senior-Loken syndrome-1); AR (Joubert syndrome 3); AR (Nephronophthisis 4); AR (Senior-Loken syndrome 4); AR (Oculomotor apraxia, congenital, Cogan-type)",
NPHP3,"AR (Meckel syndrome 7); AR (Nephronophthisis 3); AR (Renal-hepatic-pancreatic dysplasia 1); AR (Nephronophthisis 2, infantile); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2); AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24); AR (Nephronophthisis 16); AR (Senior-Loken syndrome 3)",
NPHP4,"AR (Nephronophthisis 4); AR (Senior-Loken syndrome 4); AR (Joubert syndrome 4); AR (Nephronophthisis 1, juvenile); AR (Senior-Loken syndrome-1); AR (?COACH syndrome 3); AR (Joubert syndrome 7); AR (Meckel syndrome 5); AR (Cone-rod dystrophy 13); AR (Leber congenital amaurosis 6); AR (Meckel syndrome 7); AR (Nephronophthisis 3); AR (Renal-hepatic-pancreatic dysplasia 1)",
NPHS1,"AR (Nephrotic syndrome, type 1); AR (Nephrotic syndrome, type 2); AR (Nephrotic syndrome, type 15); AR (Focal segmental glomerulosclerosis 9); AR (Ventriculomegaly with cystic kidney disease)",
NPHS2,"AR (Nephrotic syndrome, type 2); AR (Nephrotic syndrome, type 1); AR (Nephrotic syndrome, type 23); AR (?Nephrotic syndrome, type 19)",
NPL,"AD ({Major affective disorder 1}); {Prostate cancer, susceptibility to, 3}; {Prostate cancer, susceptibility to}; {Psoriasis susceptibility 7}; {Anorexia nervosa, susceptibility to, 1}; {Restless legs syndrome 3}; AR ({Graves disease, susceptibility to, 1}); {Diabetes mellitus, insulin-dependent, 6}",
NPLOC4,AR (Ruijs-Aalfs syndrome),
NPM1,"Leukemia, acute myeloid, somatic; {Neuroblastoma, susceptibility to, 3}; Leukemia, acute lymphoblastic, somatic; Leukemia, acute myeloid, reduced survival in, somatic; Leukemia, acute myeloid, somatic; AD (Cardiomyopathy, dilated, 1LL); AD (Left ventricular noncompaction 8); Wilson-Turner syndrome",
NPM2,"Leukemia, acute myeloid, somatic",
NPM3,AD (Hypogonadotropic hypogonadism 6 with or without anosmia); AD (Hypoplastic femurs and pelvis),
NPPA,"AD (Atrial fibrillation, familial, 6); AR (Atrial standstill 2); AD (Atrial septal defect 7, with or without AV conduction defects); Conotruncal heart malformations, variable; AD (Hypoplastic left heart syndrome 2); AD (Hypothyroidism, congenital nongoitrous, 5); AD (Tetralogy of Fallot); AD (Ventricular septal defect 3); AD (Holt-Oram syndrome); AD ({Long QT syndrome 1, acquired, susceptibility to}); AD (Atrial fibrillation, familial, 3); AR (Jervell and Lange-Nielsen syndrome); AD (Long QT syndrome 1); AD (Short QT syndrome 2); AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AR (Acromesomelic dysplasia 1, Maroteaux type); AD (Epiphyseal chondrodysplasia, Miura type); AD (Short stature with nonspecific skeletal abnormalities)",
NPPB,"[Bone mineral density QTL 3]; Langer mesomelic dysplasia; Leri-Weill dyschondrosteosis; Short stature, idiopathic familial; AR (Acromesomelic dysplasia 1, Maroteaux type); AD (Epiphyseal chondrodysplasia, Miura type); AD (Short stature with nonspecific skeletal abnormalities); AR (?Deafness, autosomal recessive 26); {Melanoma, cutaneous malignant, susceptibility to, 8}; AR (COMMAD syndrome); AD (Tietz albinism-deafness syndrome); AD (Waardenburg syndrome, type 2A); AD (Cardiomyopathy, dilated, 1D); AD (Cardiomyopathy, familial restrictive, 3); AD (Cardiomyopathy, hypertrophic, 2); AD (Left ventricular noncompaction 6); Capillary malformations, congenital, 1, somatic, mosaic; Sturge-Weber syndrome, somatic, mosaic",
NPPC,"AR (Acromesomelic dysplasia 1, Maroteaux type); AD (Epiphyseal chondrodysplasia, Miura type); AD (Short stature with nonspecific skeletal abnormalities); {Stature QTL 21}; {Stature QTL 1}",
NPR1,"AD (Nephropathy-hypertension); AR (Boudin-Mortier syndrome); AR (Acromesomelic dysplasia 1, Maroteaux type); AD (Epiphyseal chondrodysplasia, Miura type); AD (Short stature with nonspecific skeletal abnormalities); [Hyperproreninemia]; AR (Renal tubular dysgenesis); AD (Tubulointerstitial kidney disease, autosomal dominant, 4); AD (?Choroidal dystrophy, central areolar 1); AR (Cone-rod dystrophy 6); AR (Leber congenital amaurosis 1); AR (Night blindness, congenital stationary, type 1I)",
NPR2,"AD (Epilepsy, familial focal, with variable foci 2); AR (Acromesomelic dysplasia 1, Maroteaux type); AD (Epiphyseal chondrodysplasia, Miura type); AD (Short stature with nonspecific skeletal abnormalities); AR (Boudin-Mortier syndrome); AD (Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies)",
NPR3,"AR (Boudin-Mortier syndrome); AR (Acromesomelic dysplasia 1, Maroteaux type); AD (Epiphyseal chondrodysplasia, Miura type); AD (Short stature with nonspecific skeletal abnormalities); {Stature QTL 1}; {Stature QTL 21}; AD (?Choroidal dystrophy, central areolar 1); AR (Cone-rod dystrophy 6); AR (Leber congenital amaurosis 1); AR (Night blindness, congenital stationary, type 1I)",
NPRL2,"AD (Epilepsy, familial focal, with variable foci 2); AD (Epilepsy, familial focal, with variable foci 3); AR (Developmental and epileptic encephalopathy 111); AD (Epilepsy, familial focal, with variable foci 1)",
NPRL3,"AD (Epilepsy, familial focal, with variable foci 3); AD (Epilepsy, familial focal, with variable foci 2); AR (Developmental and epileptic encephalopathy 111); AD (Epilepsy, familial focal, with variable foci 1)",
NPS,AD (Focal segmental glomerulosclerosis 10); AD (Nail-patella syndrome),
NPSR1,"{Asthma-related traits, susceptibilty to, 2}; {Asthma-related traits, susceptibility to, 8}; AD (Deafness, autosomal dominant 56)",
NPTX1,AD (Spinocerebellar ataxia 50),
NPTX2,"AD (Amyotrophic lateral sclerosis 10, with or without FTD); AD (Frontotemporal lobar degeneration, TARDBP-related); AD (?Narcolepsy 1); AD (Spinocerebellar ataxia 50)",
NPY,"AD (Myelokathexis, isolated); AD (WHIM syndrome 1); AR ({Obesity, susceptibility to}); AR ({Leanness, inherited}); AR ({Obesity, late-onset}); AR (Obesity, morbid, due to leptin deficiency); AR ({Obesity, early-onset, susceptibility to}); AR (Obesity, adrenal insufficiency, and red hair due to POMC deficiency)",
NPY1R,"Panic disorder 3; AD (Myelokathexis, isolated); AD (WHIM syndrome 1)",
NPY2R,"AD (Myelokathexis, isolated); AD (WHIM syndrome 1)",
NQO1,"AD ({?Breast cancer susceptibility}); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); AR ([Maleylacetoacetate isomerase deficiency])",
NQO2,AD ({?Breast cancer susceptibility}),
NR0B1,"46XY sex reversal 2, dosage-sensitive; Adrenal hypoplasia, congenital; AR (Obesity, mild, early-onset); AD (46XX sex reversal 4); AD (46XY sex reversal 3); AD (Adrenocortical insufficiency); AD (Premature ovarian failure 7); AD (Spermatogenic failure 8); Chromosome Xp21 deletion syndrome; Aromatase deficiency; Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete; AD (Denys-Drash syndrome); AD (Frasier syndrome); AD (Meacham syndrome); Mesothelioma, somatic; AD (Nephrotic syndrome, type 4); AD (Wilms tumor, type 1)",
NR0B2,"AR (Obesity, mild, early-onset); 46XY sex reversal 2, dosage-sensitive; Adrenal hypoplasia, congenital; AR (Cholestasis, progressive familial intrahepatic, 5); AR (Cholestasis, benign recurrent intrahepatic); AD (Cholestasis, intrahepatic, of pregnancy, 1); AR (Cholestasis, progressive familial intrahepatic 1)",
NR1D1,"AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V); AR (Enhanced S-cone syndrome); AR (Retinitis pigmentosa 37); AR (Immunodeficiency 42); AD ([Short sleep, familial natural, 1]); AD (?Advanced sleep phase syndrome, familial, 1)",
NR1D2,"AD ([Short sleep, familial natural, 1]); AR (Immunodeficiency 42); AD (?Advanced sleep phase syndrome, familial, 1); AD (?Advanced sleep phase syndrome, familial, 3)",
NR1H2,"AD (Ichthyosis, follicular, with atrichia and photophobia syndrome 2); AD (Mucoepithelial dysplasia, hereditary); AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3)",
NR1H3,"AR (Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome); AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AR (Obesity, mild, early-onset)",
NR1H4,"AR (Cholestasis, progressive familial intrahepatic, 5); AR (Bile acid synthesis defect, congenital, 3); AR (Spastic paraplegia 5A, autosomal recessive); AR (Obesity, mild, early-onset); Hyperbilirubinemia, Rotor type, digenic; AD (Abdominal obesity-metabolic syndrome 1); AR ({Diabetes mellitus, insulin-dependent}); AD ({Diabetes mellitus, noninsulin-dependent, 2}); Diabetes mellitus, insulin-dependent, 20; Hepatic adenoma, somatic; AD (MODY, type III); Renal cell carcinoma",
NR1I2,"AR (Niemann-Pick disease, type C1); AR (Niemann-Pick disease, type D); AR (Cholestasis, progressive familial intrahepatic, 5); Hyperbilirubinemia, Rotor type, digenic; AD ({Diabetes mellitus, noninsulin-dependent}); AD (Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young); AD (MODY, type I)",
NR1I3,"AD (Kleefstra syndrome 2); AR (Obesity, mild, early-onset)",
NR2C1,AD (?Congenital anomalies of kidney and urinary tract 3),
NR2C2,"AD (Sotos syndrome); AD (Congenital heart defects, nonsyndromic, 2); AR (Short-rib thoracic dysplasia 11 with or without polydactyly); AD (Immunodeficiency, common variable, 12)",
NR2E3,"AR (Enhanced S-cone syndrome); AR (Retinitis pigmentosa 37); Retinal degeneration, autosomal recessive, clumped pigment type; AD (Retinitis pigmentosa 27); AR (Macular dystrophy with or without cone dysfunction); AR (Microphthalmia, isolated 5); AR (Nanophthalmos 2); Glaucoma 1, open angle, N",
NR2F1,"AD (Bosch-Boonstra-Schaaf optic atrophy syndrome); Periventricular nodular heterotopia 5; AR (Congenital disorder of glycosylation, type Ic); AD (Intellectual developmental disorder with dysmorphic facies and ptosis)",
NR2F2,"AD (46XX sex reversal 5); AD (Congenital heart defects, multiple types, 4); Diaphragmatic hernia 1; AD (Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart); Colorectal cancer, somatic; AD (Menke-Hennekam syndrome 2); AD (Rubinstein-Taybi syndrome 2); AD (Dias-Logan syndrome); AD (Immunodeficiency 49, severe combined); AD (Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities)",
NR3C1,"AD (Glucocorticoid resistance); Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy; AD (Pseudohypoaldosteronism type I, autosomal dominant); AR (PEHO syndrome); AR (?Muscular dystrophy, congenital, Davignon-Chauveau type); AR (Spinal muscular atrophy with congenital bone fractures 1); AD (Immunodeficiency, common variable, 13)",
NR3C2,"Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy; AD (Pseudohypoaldosteronism type I, autosomal dominant); {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; AD (KBG syndrome); AR (Apparent mineralocorticoid excess); AR (Nephrotic syndrome, type 8); AD (Intellectual developmental disorder, autosomal dominant 48)",
NR4A1,"Chondrosarcoma, extraskeletal myxoid; AD (Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism); AR (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency)",
NR4A2,"AD (Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism); Chondrosarcoma, extraskeletal myxoid; AD ({Epilepsy, idiopathic generalized, susceptibility to, 11}); AD ({Epilepsy, juvenile absence, susceptibility to, 2}); AD ({Epilepsy, juvenile myoclonic, susceptibility to, 8}); AD (Hyperaldosteronism, familial, type II); AR (Leukoencephalopathy with ataxia)",
NR4A3,"Chondrosarcoma, extraskeletal myxoid; Ewing sarcoma; Neuroepithelioma; AD (Craniosynostosis 3); AR (Hypogonadotropic hypogonadism 26 with or without anosmia); Chondrosarcoma, extraskeletal myxoid; AR (?Spastic paraplegia 57, autosomal recessive); AD (Hereditary motor and sensory neuropathy, Okinawa type); AD (Holoprosencephaly 2); Schizencephaly; AD (Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism)",
NR5A1,"AD (46XX sex reversal 4); AD (46XY sex reversal 3); AD (Adrenocortical insufficiency); AD (Premature ovarian failure 7); AD (Spermatogenic failure 8); 46XY sex reversal 2, dosage-sensitive; Adrenal hypoplasia, congenital; AD (?Testicular anomalies with or without congenital heart disease); AD (Atrial septal defect 2); AD (Atrioventricular septal defect 4); AD (Tetralogy of Fallot); AD (Ventricular septal defect 1); AD (46XY sex reversal 9); Diaphragmatic hernia 3; AD (Tetralogy of Fallot)",
NR5A2,"AR (Cholestasis, progressive familial intrahepatic, 5); AR (Obesity, mild, early-onset); AD (Nystagmus 7, congenital, autosomal dominant)",
NRAP,"AD (?Epilepsy, familial adult myoclonic, 7)",
NRARP,"AD ({Osteoporosis, early-onset, susceptibility to, autosomal dominant}); AR (Osteogenesis imperfecta, type XV); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
NRAS,"?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic; Colorectal cancer, somatic; Epidermal nevus, somatic; Melanocytic nevus syndrome, congenital, somatic; Neurocutaneous melanosis, somatic; AD (Noonan syndrome 6); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Thyroid carcinoma, follicular, somatic; Arteriovenous malformation of the brain, somatic; Bladder cancer, somatic; Breast cancer, somatic; AD (Cardiofaciocutaneous syndrome 2); Gastric cancer, somatic; Leukemia, acute myeloid, somatic; Lung cancer, somatic; AD (Noonan syndrome 3); Oculoectodermal syndrome, somatic; Pancreatic carcinoma, somatic; AD (RAS-associated autoimmune leukoproliferative disorder); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic; Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7)",
NRBP2,AD (Verheij syndrome),
NRCAM,"AR (Neurodevelopmental disorder with neuromuscular and skeletal abnormalities); AR (Lethal congenital contracture syndrome 11); AR (Neurodevelopmental disorder with central and peripheral motor dysfunction); AR (Intellectual developmental disorder, autosomal recessive 37); AD (Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects)",
NRF1,"AR (Neurodevelopmental disorder with hypotonia and gross motor and speech delay); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; AD (Myelokathexis, isolated); AD (WHIM syndrome 1)",
NRG1,"{?Schizophrenia, susceptibility to}; AD (Amyotrophic lateral sclerosis 19); AD ({Schizophrenia}); AD (?Thrombocytopenia 6); Colon cancer, advanced, somatic; AR (?Lethal congenital contractural syndrome 2); AD ({?Erythroleukemia, familial, susceptibility to}); AR (Visceral neuropathy, familial, 1, autosomal recessive); {Schizophrenia 9, susceptibility to}",
NRG2,"AD (Glaucoma 1, open angle, M); {?Schizophrenia, susceptibility to}; AR (?Lethal congenital contractural syndrome 2); AD ({?Erythroleukemia, familial, susceptibility to}); AR (Visceral neuropathy, familial, 1, autosomal recessive); AD (Amyotrophic lateral sclerosis 19)",
NRG3,"AD ({Schizophrenia}); AD (Intellectual developmental disorder, autosomal dominant 26); Chromosome 10q22.3-q23.2 deletion syndrome; {?Schizophrenia, susceptibility to}; AR (?Lethal congenital contractural syndrome 2); AD ({?Erythroleukemia, familial, susceptibility to}); AR (Visceral neuropathy, familial, 1, autosomal recessive); AD (Amyotrophic lateral sclerosis 19); AD (Intellectual developmental disorder, autosomal dominant 7)",
NRG4,"AR (?Lethal congenital contractural syndrome 2); AD ({?Erythroleukemia, familial, susceptibility to}); AR (Visceral neuropathy, familial, 1, autosomal recessive); AD (Amyotrophic lateral sclerosis 19); {?Schizophrenia, susceptibility to}",
NRGN,"AD (Blepharophimosis-impaired intellectual development syndrome); AD (Nicolaides-Baraitser syndrome); Jacobsen syndrome; Allan-Herndon-Dudley syndrome; AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5)",
NRIP1,"AD (?Congenital anomalies of kidney and urinary tract 3); AD (Glucocorticoid resistance); Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy; AD (Pseudohypoaldosteronism type I, autosomal dominant)",
NRK,AR (Hyperphosphatasia with impaired intellectual development syndrome 3),
NRL,"Retinal degeneration, autosomal recessive, clumped pigment type; AD (Retinitis pigmentosa 27); AR (Retinitis pigmentosa 77); AR (Leber congenital amaurosis 2); AR (Retinitis pigmentosa 20); AD (Retinitis pigmentosa 87 with choroidal involvement); AR (Enhanced S-cone syndrome); AR (Retinitis pigmentosa 37); AD (Spinocerebellar ataxia 7); Retinitis pigmentosa 30",
NRN1,Chromosome 6pter-p24 deletion syndrome,
NRP1,"AD ({Hypogonadotropic hypogonadism 16 with or without anosmia}); AR (Dworschak-Punetha neurodevelopmental syndrome); AR (Cone-rod dystrophy 10); AR (Retinitis pigmentosa 35); AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic; AD (Charcot-Marie-Tooth disease, type 2D); AD (Neuronopathy, distal hereditary motor, autosomal dominant 5); AD (Spinal muscular atrophy, infantile, James type); {Microvascular complications of diabetes 1}; AD (?Leukoencephalopathy, hereditary diffuse, with spheroids 2); AD (Charcot-Marie-Tooth disease, axonal, type 2N); AR (Developmental and epileptic encephalopathy 29); AR (Trichothiodystrophy 8, nonphotosensitive)",
NRP2,"AD ({Kaposi sarcoma, susceptibility to}); AD (Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies); AD (Congenital heart defects, multiple types, 7); Hemangioma, capillary infantile, somatic; AD (Lymphatic malformation 1); AD (?Myoclonus, familial, 2); AD (Cognitive impairment with or without cerebellar ataxia); AD (Developmental and epileptic encephalopathy 13); AD (Seizures, benign familial infantile, 5); AR (Dworschak-Punetha neurodevelopmental syndrome)",
NRROS,"AR (Seizures, early-onset, with neurodegeneration and brain calcification)",
NRTN,"AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma)",
NRXN1,"{Schizophrenia, susceptibility to, 17}; AR (Pitt-Hopkins-like syndrome 2); AD ({Autism, susceptibility to, 20}); {Autism susceptibility 1}; {Autism susceptibility, X-linked 1}; {Autism susceptibility, X-linked 2}; Intellectual developmental disorder, X-linked",
NRXN2,"{Schizophrenia, susceptibility to, 17}; AR (Pitt-Hopkins-like syndrome 2); {Autism susceptibility 1}; AR (Leukocyte adhesion deficiency, type III); AR (Molybdenum cofactor deficiency C)",
NRXN3,"{Schizophrenia, susceptibility to, 17}; AR (Pitt-Hopkins-like syndrome 2); {Autism susceptibility 1}",
NSD1,"AD (Sotos syndrome); AR (Cortical dysplasia, complex, with other brain malformations 10); AR (Intellectual developmental disorder, autosomal recessive 74); Acute myeloid leukemia, somatic; AD (Heyn-Sproul-Jackson syndrome); AD (Tatton-Brown-Rahman syndrome)",
NSD2,"AD (Rauch-Steindl syndrome); {Leukemia, acute lymphocytic, susceptibility to, 1}; AD (Sotos syndrome); Acute myeloid leukemia, somatic; AD (Heyn-Sproul-Jackson syndrome); AD (Tatton-Brown-Rahman syndrome)",
NSDHL,"CHILD syndrome; CK syndrome; Chondrodysplasia punctata, X-linked dominant; MEND syndrome; {Migraine, familial typical, susceptibility to, 2}",
NSF,"AR (Developmental and epileptic encephalopathy 107); AD (Developmental and epileptic encephalopathy 96); AD ({Parkinson disease 8}); AR (Epilepsy, progressive myoclonic 6); AR (Muscular dystrophy, congenital, with or without seizures); AR (Developmental and epileptic encephalopathy 4); AR (Developmental and epileptic encephalopathy 63)",
NSFL1C,"AD (Charcot-Marie-Tooth disease, type 2Y); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 6); AD (Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1)",
NSG1,AR (Ellis-van Creveld syndrome); AD (Weyers acrofacial dysostosis),
NSMAF,AD (Neurodevelopmental disorder with or without early-onset generalized epilepsy),
NSMCE1,"AR (Lung disease, immunodeficiency, and chromosome breakage syndrome); AR (Seckel syndrome 10)",
NSMCE2,"AR (Seckel syndrome 10); AR (Lung disease, immunodeficiency, and chromosome breakage syndrome)",
NSMCE3,"AR (Lung disease, immunodeficiency, and chromosome breakage syndrome); AR (Seckel syndrome 10)",
NSMCE4A,"AR (Lung disease, immunodeficiency, and chromosome breakage syndrome); AR (Neurodevelopmental disorder with central and peripheral motor dysfunction); AR (Seckel syndrome 10)",
NSMF,AD (Hypogonadotropic hypogonadism 9 with or without anosmia),
NSRP1,"AR (Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities)",
NSUN2,"AR (Intellectual developmental disorder, autosomal recessive 5)",
NSUN3,AR (Combined oxidative phosphorylation deficiency 48),
NSUN5,AD (Williams-Beuren syndrome),
NSUN6,"AR (Intellectual developmental disorder, autosomal recessive 82)",
NT5C2,"AR (Spastic paraplegia 45, autosomal recessive); {Leukemia, acute lymphocytic, susceptibility to, 1}",
NT5C3A,"AR (Anemia, congenital, nonspherocytic hemolytic, 8)",
NT5E,"AR (Calcification of joints and arteries); AD (Denys-Drash syndrome); AD (Frasier syndrome); AD (Meacham syndrome); Mesothelioma, somatic; AD (Nephrotic syndrome, type 4); AD (Wilms tumor, type 1); AR (Spastic paraplegia 64, autosomal recessive)",
NT5M,"AR (Basal ganglia calcification, idiopathic, 10, autosomal recessive)",
NTAN1,AR (Johanson-Blizzard syndrome),
NTAQ1,AR (Johanson-Blizzard syndrome),
NTF3,"AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay); AR (Insensitivity to pain, congenital, with anhidrosis); AD ({Hirschsprung disease, susceptibility to, 3}); AD (Mowat-Wilson syndrome)",
NTF4,"Glaucoma 1, open angle, 1O; AR (Insensitivity to pain, congenital, with anhidrosis); AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay); AD ({Hirschsprung disease, susceptibility to, 3})",
NTHL1,"AR (Familial adenomatous polyposis 3); ?Focal cortical dysplasia, type II, somatic; Lymphangioleiomyomatosis, somatic; AD (Tuberous sclerosis-2)",
NTM,"Aneurysm, intracranial berry, 7; {Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features)",
NTN1,"AD (Mirror movements 4); Colorectal cancer, somatic; Esophageal carcinoma, somatic; AR (Gaze palsy, familial horizontal, with progressive scoliosis, 2); AD (Mirror movements 1 and/or agenesis of the corpus callosum); AD (Noonan syndrome 13)",
NTN4,AD (Mirror movements 4),
NTNG1,"AR (Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia); {Autism susceptibility 1}",
NTNG2,"AR (Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia)",
NTRK1,"AR (Insensitivity to pain, congenital, with anhidrosis); AD (Congenital myopathy 4A, autosomal dominant); AR (Congenital myopathy 4B, autosomal recessive); AR (?Spastic paraplegia 57, autosomal recessive); AD (Hereditary motor and sensory neuropathy, Okinawa type); AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay); AD (Spastic paraplegia, intellectual disability, nystagmus, and obesity); AR (Ventriculomegaly and arthrogryposis); AD (Leukemia, acute myeloid); AD (Platelet disorder, familial, with associated myeloid malignancy)",
NTRK2,"AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay); Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1)",
NTRK3,"Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); AD (Developmental and epileptic encephalopathy 58); AD (Obesity, hyperphagia, and developmental delay)",
NTS,"AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); AD ({Restless legs syndrome 1}); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1",
NUAK2,AR (?Anencephaly 2),
NUB1,"AR (Cone-rod dystrophy); AR (Leber congenital amaurosis 4); AR (Retinitis pigmentosa, juvenile)",
NUBP1,"AR (Multiple mitochondrial dysfunctions syndrome 10); AR (Mitochondrial complex I deficiency, nuclear type 19)",
NUBP2,AR (Multiple mitochondrial dysfunctions syndrome 10),
NUBPL,"AR (Mitochondrial complex I deficiency, nuclear type 21); AR (Mitochondrial complex I deficiency, nuclear type 10); AR (Mitochondrial complex I deficiency, nuclear type 19)",
NUCKS1,{Parkinson disease 16},
NUDC,AD (Lissencephaly 1); AD (Subcortical laminar heterotopia),
NUDT10,"{Prostate cancer, hereditary, X-linked 2}",
NUDT11,"{Prostate cancer, hereditary, X-linked 2}",
NUDT15,"AD ({Thiopurines, poor metabolism of, 2})",
NUDT18,"AD ({Thiopurines, poor metabolism of, 2})",
NUDT2,AR (Intellectual developmental disorder with or without peripheral neuropathy),
NUFIP1,Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; AD (Chromosome 13q14 deletion syndrome),
NUFIP2,Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1,
NUMA1,"Leukemia, acute promyelocytic; AR ({?Hepatitis, fulminant viral, susceptibility to}); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant); AR (Microcephaly 9, primary, autosomal recessive); AR (Seckel syndrome 5); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome)",
NUMB,"AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
NUP107,"AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11); AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (Nephrotic syndrome, type 17); AR (?Microcephaly 24, primary, autosomal recessive); AR (?Nephrotic syndrome, type 19)",
NUP133,"AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11); AR (?Spermatogenic failure 97); AR (?Nephrotic syndrome, type 19)",
NUP153,"AD (Congenital heart defects, multiple types, 8, with or without heterotaxy); AD (Loeys-Dietz syndrome 6); AR (?Spermatogenic failure 97); AD ({Autoinflammation and autoimmunity, systemic, with immune dysregulation}); AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (?Nephrotic syndrome, type 19); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11); AD (Noonan syndrome 13)",
NUP155,"AR (?Atrial fibrillation 15); AR (Congenital arthrogryposis with anterior horn cell disease); AR (Lethal congenital contracture syndrome 1); AR (Nephrotic syndrome, type 12); AR (?Nephrotic syndrome, type 13); AR (?Nephrotic syndrome, type 19); AD (Atrial fibrillation, familial, 1); Chromosome 5p13 duplication syndrome",
NUP160,"AR (?Nephrotic syndrome, type 19); AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (Nephrotic syndrome, type 17); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11); AR (?Microcephaly 24, primary, autosomal recessive)",
NUP188,"AR (Sandestig-Stefanova syndrome); AR (Nephrotic syndrome, type 12); AR (?Nephrotic syndrome, type 13); AR (?Retinitis pigmentosa 67); Colorectal cancer, hereditary nonpolyposis, type 6; Esophageal cancer, somatic; AD (Loeys-Dietz syndrome 2)",
NUP205,"AR (?Nephrotic syndrome, type 13); AR (Nephrotic syndrome, type 12); AR (?Atrial fibrillation 15); AR (Sandestig-Stefanova syndrome)",
NUP210,AR (?Spermatogenic failure 97),
NUP210L,"AR (?Spermatogenic failure 97); AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18)",
NUP214,"AR ({Encephalopathy, acute, infection-induced, susceptibility to, 9}); Leukemia, acute myeloid, somatic; Leukemia, T-cell acute lymphoblastic, somatic; Leukemia, acute nonlymphocytic; AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib; {Leukemia, acute lymphocytic, susceptibility to, 1}; AD (Congenital heart defects, multiple types, 8, with or without heterotaxy); AD (Loeys-Dietz syndrome 6); AR (Spastic paraplegia, optic atrophy, and neuropathy); AD ({Encephalopathy, acute, infection-induced, 3, susceptibility to}); AR (Striatonigral degeneration, infantile)",
NUP35,"AR (?Atrial fibrillation 15); AR (Nephrotic syndrome, type 12); AR (?Nephrotic syndrome, type 13)",
NUP37,"AR (?Microcephaly 24, primary, autosomal recessive); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11); AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (?Nephrotic syndrome, type 19); AR (Nephrotic syndrome, type 17)",
NUP43,"AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (?Nephrotic syndrome, type 19); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11); AR (?Microcephaly 24, primary, autosomal recessive); AR (Nephrotic syndrome, type 17)",
NUP54,"AR (Dystonia 37, early-onset, with striatal lesions); AR (Striatonigral degeneration, infantile)",
NUP58,"AR (Dystonia 37, early-onset, with striatal lesions); AR (Striatonigral degeneration, infantile)",
NUP62,"AR (Striatonigral degeneration, infantile); AR (Dystonia 37, early-onset, with striatal lesions); AR ({Encephalopathy, acute, infection-induced, susceptibility to, 9}); Leukemia, acute myeloid, somatic; Leukemia, T-cell acute lymphoblastic, somatic",
NUP85,"AR (Nephrotic syndrome, type 17); AR (?Galloway-Mowat syndrome 8); AR (Nephrotic syndrome, type 18); AR (?Nephrotic syndrome, type 19); AR (?Ovarian dysgenesis 6); AR (Galloway-Mowat syndrome 7); AR (Nephrotic syndrome, type 11); AR (?Microcephaly 24, primary, autosomal recessive)",
NUP88,"AR (Fetal akinesia deformation sequence 4); AR ({Encephalopathy, acute, infection-induced, susceptibility to, 9}); Leukemia, acute myeloid, somatic; Leukemia, T-cell acute lymphoblastic, somatic; AR (Spastic paraplegia, optic atrophy, and neuropathy); AD ({Encephalopathy, acute, infection-induced, 3, susceptibility to})",
NUP93,"AR (Nephrotic syndrome, type 12); AR (?Nephrotic syndrome, type 13); AR (?Atrial fibrillation 15); AR (Sandestig-Stefanova syndrome); AR (Dystonia 37, early-onset, with striatal lesions)",
NUP98,"AD (Sotos syndrome); AD (Intellectual developmental disorder, autosomal dominant 29); AD (Schinzel-Giedion midface retraction syndrome); DNA topoisomerase I, camptothecin-resistant; AR (Ectodermal dysplasia 9, hair/nail type)",
NUS1,"AR (?Congenital disorder of glycosylation, type 1aa); AD (Intellectual developmental disorder, autosomal dominant 55, with seizures); AR (?Congenital disorder of glycosylation, type 1bb); AD (Developmental delay and seizures with or without movement abnormalities); AR (Retinitis pigmentosa 59); AR (Niemann-pick disease, type C2)",
NUTM2B,AD (?Oculopharyngeal myopathy with leukoencephalopathy 1),
NXF1,Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1,
NXF2,Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1,
NXF5,Developmental and epileptic encephalopathy 36,
NXN,"AR (Robinow syndrome, autosomal recessive 2)",
NXNL1,"AR (Microphthalmia, isolated 2); AR (Microphthalmia/coloboma 3)",
NXPH4,"{Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant",
NXT1,"AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 1); Intellectual developmental disorder, X-linked syndromic, Snijders Blok type",
NXT2,AMME complex,
NYX,"Night blindness, congenital stationary (complete), 1A, X-linked; AR (Night blindness, congenital stationary (complete), 1C, autosomal recessive)",
OAS1,"AD (Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia); AR (Pseudo-TORCH syndrome 2); Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; AR ({Diabetes mellitus, insulin-dependent-1}); AR (Aicardi-Goutieres syndrome 6); AD (Dyschromatosis symmetrica hereditaria)",
OAS2,AD (Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia),
OAS3,AD (Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia); AD (Prostate cancer 1),
OAT,"AR (Gyrate atrophy of choroid and retina with or without ornithinemia); AR (Hypouricemia, renal); AR (Friedreich ataxia); AR (Friedreich ataxia with retained reflexes)",
OAZ3,AR (Spermatogenic failure 69),
OBSCN,"AR ({Rhabdomyolysis, susceptibility to, 1}); AR (Spherocytosis, type 1); AD (Cardiomyopathy, dilated, 1G); AD (Cardiomyopathy, familial hypertrophic, 9); AR (Congenital myopathy 5 with cardiomyopathy); AR (Muscular dystrophy, limb-girdle, autosomal recessive 10); AD (Myopathy, myofibrillar, 9, with early respiratory failure); AD (Tibial muscular dystrophy, tardive)",
OBSL1,AR (3-M syndrome 2); AR (3-M syndrome 3),
OCA2,"AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Albinism, brown oculocutaneous); AR (Albinism, oculocutaneous, type II); AR ([Skin/hair/eye pigmentation 1, blond/brown hair]); AR ([Skin/hair/eye pigmentation 1, blue/nonblue eyes]); AR (Intellectual developmental disorder, autosomal recessive 38); [Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]; AR (Albinism, oculocutaneous, type III); [Analgesia from kappa-opioid receptor agonist, female-specific]; AR ([Skin/hair/eye pigmentation 2, blond hair/fair skin]); AR ([Skin/hair/eye pigmentation 2, red hair/fair skin]); AR ({Albinism, oculocutaneous, type II, modifier of}); {Melanoma, cutaneous malignant, 5}; AR ({UV-induced skin damage}); AD ([Skin/hair/eye pigmentation 3, blue/green eyes]); AD ([Skin/hair/eye pigmentation 3, light/dark/freckling skin]); AD ({Melanoma, cutaneous malignant, susceptibility to, 8}); AR (Albinism, oculocutaneous, type IA); AR (Albinism, oculocutaneous, type IB)",
OCLN,"AR (Pseudo-TORCH syndrome 1); {Microvascular complications of diabetes 1}; AR (Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis); AR (Deafness, autosomal recessive 49); AR (Hartnup disorder)",
OCM,"AD (Deafness, autosomal dominant 50)",
OCRL,"Dent disease 2; Lowe syndrome; AR (Developmental and epileptic encephalopathy 53); AR (Parkinson disease 20, early-onset)",
ODAD1,"AR (Ciliary dyskinesia, primary, 20)",
ODAD2,"AR (Ciliary dyskinesia, primary, 23)",
ODAD3,"AR (Ciliary dyskinesia, primary, 30)",
ODAD4,"AR (Ciliary dyskinesia, primary, 35)",
ODAPH,"AR (Amelogenesis imperfecta, type IIA4)",
ODC1,"AD (Bachmann-Bupp syndrome); Burkitt lymphoma, somatic; AR (?Combined oxidative phosphorylation deficiency 43); AR (?Mitochondrial DNA depletion syndrome 18); {Pulmonary hypertension, neonatal, susceptibility to}; AR (Carbamoylphosphate synthetase I deficiency); AR (Argininemia)",
ODF1,AD (?Premature ovarian failure 16),
ODF2,AR (Spermatogenic failure 35); AR (Spermatogenic failure 94),
OFD1,"?Retinitis pigmentosa 23; Joubert syndrome 10; Orofaciodigital syndrome I; Simpson-Golabi-Behmel syndrome, type 2; AR (?Joubert syndrome 38); AR (?Orofaciodigital syndrome XV); AR (Short-rib thoracic dysplasia 21 without polydactyly); AR (Orofaciodigital syndrome XIV); AR (Bardet-Biedl syndrome 16); AR (Senior-Loken syndrome 7)",
OGA,"Intellectual developmental disorder, X-linked 106; AR (Aceruloplasminemia); AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2)",
OGDH,"AR (Oxoglutarate dehydrogenase deficiency); AR (Glutaricaciduria, type I); AD (?Charcot-Marie-Tooth disease, axonal, type 2Q); AR (Alpha-aminoadipic and alpha-ketoadipic aciduria); AR (Developmental and epileptic encephalopathy 80)",
OGFOD1,"AD (Brachycephaly, trichomegaly, and developmental delay)",
OGG1,"Renal cell carcinoma, clear cell, somatic; AR (?De Sanctis-Cacchione syndrome); AD ({Lung cancer, susceptibility to}); {Macular degeneration, age-related, susceptibility to, 5}; AR (Cerebrooculofacioskeletal syndrome 1); AR (Cockayne syndrome, type B); AD (Premature ovarian failure 11); AR (UV-sensitive syndrome 1); AR (Adenomas, multiple colorectal); Gastric cancer, somatic; AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome); AR (Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia); AD (Developmental and epileptic encephalopathy 67); AR (Xeroderma pigmentosum, variant type)",
OGN,{Lumbar disc degeneration}; AD ({Osteoarthritis susceptibility 3}); AD (Fibrodysplasia ossificans progressiva),
OGT,"Intellectual developmental disorder, X-linked 106; AR (Developmental and epileptic encephalopathy 68); AR (Immunodeficiency 75); Myelodysplastic syndrome, somatic; AR (Bardet-Biedl syndrome 4); AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1)",
OIP5,"AR (Pontocerebellar hypoplasia, type 1C)",
OLAH,"AD ({?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}); AD (Genitopatellar syndrome); AD (SBBYSS syndrome); AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AD ({Epilepsy, idiopathic generalized, susceptibility to, 14}); AR (Developmental and epileptic encephalopathy 34); AD (Oocyte/zygote/embryo maturation arrest 7)",
OLFM4,AR (Diarrhea 9),
OLIG1,"GLOW syndrome, somatic mosaic; AD (Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors); AD (Pleuropulmonary blastoma); Rhabdomyosarcoma, embryonal, 2",
OLIG2,"AD (Poirier-Bienvenu neurodevelopmental syndrome); {Schizophrenia 9, susceptibility to}; {?Schizophrenia, susceptibility to}",
OLR1,"{Myocardial infarction, susceptibility to}; {Aspergillosis, susceptibility to}; {Aspergillosis, susceptibility to}; AR (Candidiasis, familial, 4, autosomal recessive); AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe)",
OMA1,"AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AD (Optic atrophy 12); AR (Spastic ataxia 5, autosomal recessive); AD (Spinocerebellar ataxia 28); AR (Parkinson disease 6, early onset); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AD (?Myopathy, isolated mitochondrial, autosomal dominant); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 2); AD (Spinal muscular atrophy, Jokela type); AD (?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome); AR (?Optic atrophy 11)",
OMD,{Lumbar disc degeneration}; AD ({Osteoarthritis susceptibility 3}),
OMG,"AD (?Narcolepsy 7); AD (Chromosome 17q11.2 deletion syndrome, 1.4Mb); AD ({Schizophrenia, susceptibility to}); AR (Intellectual developmental disorder, autosomal recessive 64)",
OMP,"AR (Orotic aciduria); AD (Deafness, autosomal dominant 11); AR (Deafness, autosomal recessive 2); AR (Usher syndrome, type 1B)",
ONECUT1,"AD (Thrombophilia 3 due to protein C deficiency, autosomal dominant); AR (Thrombophilia 3 due to protein C deficiency, autosomal recessive); {Renal cell carcinoma}; AD (Renal cysts and diabetes syndrome); AD (Type 2 diabetes mellitus); AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1)",
OOEP,"AR (Hydatidiform mole, recurrent, 2); AR (Oocyte/zygote/embryo maturation arrest 15); AR (Oocyte/zygote/embryo maturation arrest 19)",
OPA1,"AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AD (Optic atrophy 12); AR (Spastic ataxia 5, autosomal recessive); AD (Spinocerebellar ataxia 28); AR (?Optic atrophy 11)",
OPA3,"AR (3-methylglutaconic aciduria, type III); AD (Optic atrophy 3 with cataract)",
OPCML,"Ovarian cancer, somatic",
OPHN1,"Intellectual developmental disorder, X-linked syndromic, Billuart type; Craniofrontonasal dysplasia; Xq25 duplication syndrome; AD (Chromosome 15q25 deletion syndrome); Intellectual developmental disorder, X-linked 77",
OPLAH,AR (5-oxoprolinase deficiency),
OPN1LW,"Blue cone monochromacy; Colorblindness, protan; Blue cone monochromacy; Colorblindness, deutan; {Autism, susceptibility to, X-linked 5}; Intellectual developmental disorder, X-linked syndromic 35; AD (Night blindness, congenital stationary, autosomal dominant 1); AR (Retinitis pigmentosa 4, autosomal dominant or recessive); AR (Retinitis punctata albescens); AD (Retinitis pigmentosa 70)",
OPN1MW,"Blue cone monochromacy; Colorblindness, deutan; Blue cone monochromacy; Colorblindness, protan; AR ({Bardet-Biedl syndrome 1, modifier of}); AR (Bardet-Biedl syndrome 3); AR (Retinitis pigmentosa 55); AD (Night blindness, congenital stationary, autosomal dominant 1); AR (Retinitis pigmentosa 4, autosomal dominant or recessive); AR (Retinitis punctata albescens)",
OPN1SW,"AD (Colorblindness, tritan); AR (?Retinitis pigmentosa 58); AD (Night blindness, congenital stationary, autosomal dominant 1); AR (Retinitis pigmentosa 4, autosomal dominant or recessive); AR (Retinitis punctata albescens); AD (Chromosome 16q12 duplication syndrome)",
OPN3,"AR (Deafness, autosomal recessive 45)",
OPN4,"AR (Leber congenital amaurosis 2); AR (Retinitis pigmentosa 20); AD (Retinitis pigmentosa 87 with choroidal involvement); {Microvascular complications of diabetes 1}; AR (Achromatopsia 2); AD (Night blindness, congenital stationary, autosomal dominant 3); AR (Night blindness, congenital stationary, type 1G)",
OPRD1,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); Beta-2-adrenoreceptor agonist, reduced response to; {Opioid dependence, susceptibility to, 1}",
OPRK1,"{Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant",
OPRM1,"AD ({Epilepsy, idiopathic generalized, susceptibility to, 1}); {Opioid dependence, susceptibility to, 1}; Interferon, alpha, deficiency",
OPTN,"{Glaucoma, normal tension, susceptibility to}; AR (Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia); AD (Glaucoma 1, open angle, E); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}); AR (Autoinflammation with arthritis and vasculitis); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 4); AD (Glaucoma 1A, primary open angle); AD (Autoinflammation with episodic fever and lymphadenopathy); AR (Immunodeficiency 57 with autoinflammation)",
OR13G1,"AD ({Pancreatic cancer, susceptibility to, 1})",
OR2J3,"AD ([C3HEX, ability to smell])",
OR4S2,AR (Extraoral halitosis due to MTO deficiency),
OR6A2,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome)",
ORAI1,"AR (Immunodeficiency 9); AD (Myopathy, tubular aggregate, 2); AR (Immunodeficiency 10); AD (Myopathy, tubular aggregate, 1); AD (Stormorken syndrome); AR (Spermatogenic failure 99)",
ORAI2,"AR (Immunodeficiency 9); AD (Myopathy, tubular aggregate, 2); AR (Immunodeficiency 10); AD (Myopathy, tubular aggregate, 1); AD (Stormorken syndrome)",
ORAI3,"AR (Immunodeficiency 9); AD (Myopathy, tubular aggregate, 2); AR (Immunodeficiency 10); AD (Myopathy, tubular aggregate, 1); AD (Stormorken syndrome)",
ORC1,AR (Meier-Gorlin syndrome 1); AR (Meier-Gorlin syndrome 5); AD (Meier-Gorlin syndrome 6); AR (Meier-Gorlin syndrome 4),
ORC2,AR (Immunodeficiency 80 with or without cardiomyopathy); AD (Meier-Gorlin syndrome 6); AR (Meier-Gorlin syndrome 4); AR (Meier-Gorlin syndrome 2); AR (Meier-Gorlin syndrome 1),
ORC4,AR (Meier-Gorlin syndrome 2); AR (Meier-Gorlin syndrome 1); AR (Meier-Gorlin syndrome 4),
ORC6,AR (Meier-Gorlin syndrome 3); AR (Meier-Gorlin syndrome 1),
ORMDL3,"{Asthma-related traits, susceptibility to, 6}; AD (?Spastic paraplegia 90B, autosomal recessive); AD (Spastic paraplegia 90A, autosomal dominant); {Inflammatory bowel disease 22}",
OS9,"AD (Cole-Carpenter syndrome 1); AR (?Neurodevelopmental disorder with poor growth, absent speech, progressive ataxia, and dysmorphic facies); AR (Neurodevelopmental disorder with hypotonia, poor growth, dysmorphic facies, and agammaglobulinemia); AD (Charcot-Marie-Tooth disease, type 2Y); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 6); AD (Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1)",
OSBP,"AD (Deafness, autosomal dominant 67)",
OSBP2,"AD (Deafness, autosomal dominant 67)",
OSBPL11,"AD (Acrofacial dysostosis, Cincinnati type); AR (Leukodystrophy, hypomyelinating, 27)",
OSBPL2,"AD (Deafness, autosomal dominant 67)",
OSBPL8,"AD (Amyotrophic lateral sclerosis 8); AD (Spinal muscular atrophy, late-onset, Finkel type)",
OSCAR,"AD (Angioedema, hereditary, 3); AR (Factor XII deficiency); AR (Anterior segment dysgenesis 6, multiple subtypes); AR (Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset)",
OSGEP,"AR (Galloway-Mowat syndrome 3); Galloway-Mowat syndrome 2, X-linked; AR (Galloway-Mowat syndrome 4); AR (Galloway-Mowat syndrome 5)",
OSM,"AD (Cerebral cavernous malformations-2); AD (?Immunodeficiency 94 with autoinflammation and dysmorphic facies); AD (Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections); AR (Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections); AR (Stuve-Wiedemann syndrome 2); AD (Amyloidosis, primary localized cutaneous, 1); Cerebral cavernous malformations 5; AD (Intellectual developmental disorder, autosomal dominant 48); AR (Growth hormone insensitivity with immune dysregulation 1, autosomal recessive); AD (Growth hormone insensitivity with immune dysregulation 2, autosomal dominant)",
OSMR,"AD (Amyloidosis, primary localized cutaneous, 1); AD (?Amyloidosis, primary localized cutaneous, 2); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in)",
OSR1,"AR (Neuropathy, hereditary sensory and autonomic, type II); AD (Pseudohypoaldosteronism, type IIC); AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); AD (Pseudohypoaldosteronism, type IIB); AR (Amelogenesis imperfecta, type IIIC); AR (Pseudohypoaldosteronism, type IID)",
OSR2,"AD (Ectodermal dysplasia 3, Witkop type); AD (Orofacial cleft 5); AD (Tooth agenesis, selective, 1, with or without orofacial cleft); AR (Blepharophimosis, epicanthus inversus, and ptosis, types 1 and 2); AD (Premature ovarian failure 3)",
OST4,"AD (Congenital disorder of glycosylation, type Iw, autosomal dominant); AR (Congenital disorder of glycosylation, type Iw, autosomal recessive); AR (Congenital disorder of glycosylation, type Ix)",
OSTF1,AD ([Phenylthiocarbamide tasting]),
OSTM1,"AR (Osteopetrosis, autosomal recessive 5); AD (Hypopigmentation, organomegaly, and delayed myelination and development); AD (Osteopetrosis, autosomal dominant 2); AR (Osteopetrosis, autosomal recessive 4); AD (Ceroid lipofuscinosis, neuronal, 15)",
OSTN,"AD (Chromosome 5q14.3 deletion syndrome); AD (Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language)",
OTC,"Ornithine transcarbamylase deficiency; Pyruvate dehydrogenase E1-alpha deficiency; Chromosome Xp21 deletion syndrome; AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
OTOA,"AR (Deafness, autosomal recessive 22)",
OTOF,"AR (Auditory neuropathy, autosomal recessive, 1); AR (Deafness, autosomal recessive 9); AD (Deafness, autosomal dominant 22); AD (Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy); AR (Deafness, autosomal recessive 37); AR (Miyoshi muscular dystrophy 1); AR (Muscular dystrophy, limb-girdle, autosomal recessive 2); AR (Myopathy, distal, with anterior tibial onset); AR (Deafness, autosomal recessive 4, with enlarged vestibular aqueduct); AR (Pendred syndrome)",
OTOG,"AR (Deafness, autosomal recessive 18B); AR (Deafness, autosomal recessive 84B); AR (Deafness, autosomal recessive 22); AR (Congenital myopathy 17)",
OTOGL,"AR (Deafness, autosomal recessive 84B)",
OTOP2,AR (Bronchiectasis and nasal polyposis),
OTP,"AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea); AR (Microphthalmia, syndromic 16)",
OTUB1,"AR (RIDDLE syndrome); AD ({Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection}); AD (Autoinflammation, panniculitis, and dermatosis syndrome, autosomal dominant); AR (Autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive)",
OTUB2,AR (Neurodevelopmental disorder with hypotonia and seizures),
OTUD4,AR (Cerebellar ataxia and hypogonadotropic hypogonadism),
OTUD5,"Multiple congenital anomalies-neurodevelopmental syndrome, X-linked",
OTUD6B,"AR (Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies)",
OTUD7A,AR (Neurodevelopmental disorder with hypotonia and seizures); Chromosome 15q13.3 microdeletion syndrome,
OTUD7B,AD (Immunodeficiency 132A); AD (Immunodeficiency 132B),
OTULIN,"AD ({Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection}); AD (Autoinflammation, panniculitis, and dermatosis syndrome, autosomal dominant); AR (Autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive); AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic",
OTX1,"Schizencephaly; AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); AD (Deafness, autosomal dominant 50)",
OTX2,"AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system); AD (Cone-rod retinal dystrophy-2); Leber congenital amaurosis 7; AD (Leukemia, juvenile myelomonocytic); AD (Neurofibromatosis-Noonan syndrome); AD (Neurofibromatosis, familial spinal); AD (Neurofibromatosis, type 1); AD (Watson syndrome)",
OVCA2,"AR (Developmental delay with short stature, dysmorphic facial features, and sparse hair)",
OVOL2,"AD (Corneal dystrophy, posterior polymorphous, 1)",
OXA1L,"AR (Charcot-Marie-Tooth disease, type 4K); AR (Mitochondrial complex IV deficiency, nuclear type 1); AR (Combined oxidative phosphorylation deficiency 7); AR (Spastic paraplegia 55, autosomal recessive); AR (Combined oxidative phosphorylation deficiency 31)",
OXCT1,AR (Succinyl CoA:3-oxoacid CoA transferase deficiency),
OXGR1,"AD (Nephrolithiasis, calcium oxalate, 2, with nephrocalcinosis)",
OXR1,"AR (Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay)",
OXSR1,"AD (Pseudohypoaldosteronism, type IIB); AR (Amelogenesis imperfecta, type IIIC); AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); AR (Neuropathy, hereditary sensory and autonomic, type II); AD (Pseudohypoaldosteronism, type IIC); AR (Pseudohypoaldosteronism, type IID)",
OXT,"AD (Diabetes insipidus, neurohypophyseal); AD (?Ovarian dysgenesis 8)",
OXTR,"AD (Cardiomyopathy, familial hypertrophic); AD (Creatine phosphokinase, elevated serum); AD (Long QT syndrome 9); AD (Myopathy, distal, Tateyama type); AD (Rippling muscle disease 2); AD (Corneal dystrophy, Fuchs endothelial, 6); AD (Corneal dystrophy, posterior polymorphous, 3); AD (Mowat-Wilson syndrome)",
P2RX2,"AD (Deafness, autosomal dominant 41)",
P2RX4,AD (Abdominal obesity-metabolic syndrome 1),
P2RX7,"AR (Chronic granulomatous disease 5, autosomal recessive)",
P2RY1,"AR (Bleeding disorder, platelet-type, 8)",
P2RY11,Narcolepsy 6,
P2RY12,"AR (Bleeding disorder, platelet-type, 8); AR (Clopidogrel, impaired responsiveness to); AR (Mephenytoin poor metabolizer); AR (Omeprazole poor metabolizer); AR (Proguanil poor metabolizer); AD (Nizon-Isidor syndrome)",
P2RY13,AD (Nizon-Isidor syndrome),
P2RY14,"AR (Bleeding disorder, platelet-type, 8); AD (Nizon-Isidor syndrome)",
P2RY8,"Intellectual developmental disorder, X-linked 98; {Budd-Chiari syndrome, somatic}; Erythrocytosis, somatic; Leukemia, acute myeloid, somatic; Myelofibrosis, somatic; Polycythemia vera, somatic; AD (Thrombocythemia 3); {Leukemia, acute lymphocytic, susceptibility to, 1}",
P3H1,"AR (Osteogenesis imperfecta, type VIII); AR (Osteogenesis imperfecta, type VII); AR (Osteogenesis imperfecta, type IX); {Preterm premature rupture of the membranes, susceptibility to}; AR (Osteogenesis imperfecta, type X); AR (Myopia, high, with cataract and vitreoretinal degeneration)",
P3H2,"AR (Myopia, high, with cataract and vitreoretinal degeneration); AR (Joint laxity, short stature, and myopia)",
P4HA1,"AD (Myopia 25, autosomal dominant); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AR (Myasthenic syndrome, congenital, 19); AD (Cole-Carpenter syndrome 1); AR (Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities); AD (Lessel-Kreienkamp syndrome)",
P4HA2,"AD (Myopia 25, autosomal dominant); {Inflammatory bowel disease 5}; AD (Myopia 2)",
P4HB,"AD (Cole-Carpenter syndrome 1); AD (Myopia 25, autosomal dominant); AR (Abetalipoproteinemia); AD (Acromicric dysplasia); AD (Ectopia lentis, familial); AD (Geleophysic dysplasia 2); AD (Marfan lipodystrophy syndrome); AD (Marfan syndrome); AD (MASS syndrome); AD (Stiff skin syndrome); AD (Weill-Marchesani syndrome 2, dominant)",
P4HTM,"AR (Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities)",
PA2G4,AR (Bone marrow failure syndrome 3),
PABPC1,"AR (Oocyte/zygote/embryo maturation arrest 22); Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia; AD (Essential tremor, hereditary, 4)",
PABPC1L,AR (Oocyte/zygote/embryo maturation arrest 22),
PABPC3,AR (Oocyte/zygote/embryo maturation arrest 22),
PABPN1,AD (Oculopharyngeal muscular dystrophy),
PACRG,"Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); {Leprosy, susceptibility to, 2}; AR (Spermatogenic failure 83)",
PACS1,AD (Schuurs-Hoeijmakers syndrome); AD (Developmental and epileptic encephalopathy 66),
PACS2,AD (Developmental and epileptic encephalopathy 66); AD (Schuurs-Hoeijmakers syndrome),
PACSIN1,"AR (?Impaired intellectual development, anterior maxillary protrusion, and strabismus)",
PACSIN2,"AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3); AD ({Lung cancer, susceptibility to}); AD (Autoimmune lymphoproliferative syndrome, type IB)",
PACSIN3,"AD ({Epilepsy, idiopathic generalized, susceptibility to, 12}); AD (Dystonia 9); AR (GLUT1 deficiency syndrome 1, infantile onset, severe); AD (GLUT1 deficiency syndrome 2, childhood onset); AD (Stomatin-deficient cryohydrocytosis with neurologic defects)",
PADI1,"AD ({Dermatitis, atopic, susceptibility to, 2}); AR (Ichthyosis vulgaris); AR (Oocyte/zygote/embryo maturation arrest 16); AR (Uncombable hair syndrome); AR (Peeling skin syndrome 6)",
PADI2,AR (Oocyte/zygote/embryo maturation arrest 16),
PADI3,AR (Uncombable hair syndrome); AR (?Uncombable hair syndrome 2); AR (?Uncombable hair syndrome 3); AR (Oocyte/zygote/embryo maturation arrest 16),
PADI4,AR (Oocyte/zygote/embryo maturation arrest 16); AR (Uncombable hair syndrome),
PADI6,"AR (Oocyte/zygote/embryo maturation arrest 16); {Basal cell carcinoma, susceptibility to, 1}",
PAF1,"AR (Peroxisome biogenesis disorder 5A (Zellweger)); AR (Peroxisome biogenesis disorder 5B); AD (Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities); AD (Hyperparathyroidism-jaw tumor syndrome); AD (Hyperparathyroidism, familial primary); AD (Parathyroid adenoma with cystic changes); Parathyroid carcinoma",
PAFAH1B1,AD (Lissencephaly 1); AD (Subcortical laminar heterotopia); AD (Chromosome 17p13.3 duplication syndrome); AD (Miller-Dieker lissencephaly syndrome); AR (Lissencephaly 4 (with microcephaly)); AR (Microhydranencephaly); AD (Lissencephaly 3),
PAFAH1B2,AD (Lissencephaly 1); AD (Subcortical laminar heterotopia); AR (Lissencephaly 4 (with microcephaly)); AR (Microhydranencephaly),
PAFAH1B3,"AD (Lissencephaly 1); AD (Subcortical laminar heterotopia); AR (Lipodystrophy, familial partial, type 6); AD (Intellectual developmental disorder, autosomal dominant 45)",
PAH,"AR ([Hyperphenylalaninemia, non-PKU mild]); AR (Phenylketonuria); AD (Vesicoureteral reflux 3); Colorectal cancer, somatic; T-cell acute lymphoblastic leukemia, somatic; AR (?Retinitis pigmentosa 85); AR (Foveal hypoplasia 3); AD (Pulmonary hypertension, familial primary, 1, with or without HHT); AD (Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated); AD (Pulmonary venoocclusive disease 1)",
PAICS,AR (?Phosphoribosylaminoimidazole carboxylase deficiency); AR (AICA-ribosiduria due to ATIC deficiency); AR (Adenylosuccinase deficiency),
PAIP2,{Microvascular complications of diabetes 1},
PAIP2B,"AD (Deafness, autosomal dominant 50)",
PAK1,"AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); ?FG syndrome 2; Cardiac valvular dysplasia, X-linked; Congenital short bowel syndrome; Frontometaphyseal dysplasia 1; Heterotopia, periventricular, 1; Intestinal pseudoobstruction, neuronal; Melnick-Needles syndrome; Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Terminal osseous dysplasia; AD (Intellectual developmental disorder, autosomal dominant 44, with microcephaly); AD (Intellectual developmental disorder, autosomal dominant 63, with macrocephaly)",
PAK2,"AD (?Knobloch syndrome 2); AD (Aortic aneurysm, familial thoracic 7); AR (Megacystis-microcolon-intestinal hypoperistalsis syndrome 1); AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); Chromosome 3q29 microdeletion syndrome",
PAK3,"Intellectual developmental disorder, X-linked 30; AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); AD (?Knobloch syndrome 2); Chromosome 3q29 microdeletion syndrome; AD (Intellectual developmental disorder, autosomal dominant 48)",
PAK4,"Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); Intellectual developmental disorder, X-linked 30; AD (?Knobloch syndrome 2)",
PAK5,"AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); Intellectual developmental disorder, X-linked 30; AD (?Knobloch syndrome 2)",
PAK6,"AD (Intellectual developmental disorder with macrocephaly, seizures, and speech delay); Intellectual developmental disorder, X-linked 30; AD (?Knobloch syndrome 2)",
PALB2,"AD ({Breast-ovarian cancer, familial, susceptibility to, 5}); AD ({Pancreatic cancer, susceptibility to, 3}); AR (Fanconi anemia, complementation group N); AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor); AD ({Melanoma and neural system tumor syndrome}); AD ({Melanoma-pancreatic cancer syndrome}); AD ({Melanoma, cutaneous malignant, 2})",
PALLD,"AD ({Pancreatic cancer, susceptibility to, 1})",
PALM3,"AR ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}); AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic",
PALS1,"AR (Joubert syndrome 4); AR (Nephronophthisis 1, juvenile); AR (Senior-Loken syndrome-1); AR (Nephronophthisis 4); AR (Senior-Loken syndrome 4); AD (Takenouchi-Kosaki syndrome); AR (Leber congenital amaurosis 8); AD (Pigmented paravenous chorioretinal atrophy); AR (Retinitis pigmentosa-12)",
PALS2,"AD (Charcot-Marie-Tooth disease, axonal, type 2FF)",
PAM,"AR (Orthostatic hypotension 2); Bladder cancer, somatic; Osteosarcoma, somatic; AD (Retinoblastoma); AD (Retinoblastoma, trilateral); Small cell cancer of the lung, somatic",
PAM16,"AR (Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type); AR (3-methylglutaconic aciduria, type V)",
PANK1,AD (?Cataract 49),
PANK2,"AR (Neurodegeneration with brain iron accumulation 1); AD (?Cataract 49); AR (Neurodegeneration with brain iron accumulation 6); AR (Pontocerebellar hypoplasia, type 12)",
PANK3,AR (Neurodegeneration with brain iron accumulation 1); AD (?Cataract 49),
PANK4,AD (?Cataract 49); AR (Neurodegeneration with brain iron accumulation 1),
PANO1,"AD ({Melanoma and neural system tumor syndrome}); AD ({Melanoma-pancreatic cancer syndrome}); AD ({Melanoma, cutaneous malignant, 2})",
PANX1,"AD (Oocyte/zygote/embryo maturation arrest 7); AD ({Migraine with or without aura, susceptibility to, 1})",
PANX2,AD (Oocyte/zygote/embryo maturation arrest 7),
PANX3,AD (Oocyte/zygote/embryo maturation arrest 7),
PAOX,Homocysteine plasma level,
PAPOLA,AD (Myopia 27),
PAPPA,"AR (Short stature, Dauber-Argente type); {Stature QTL 1}",
PAPPA2,"AR (Short stature, Dauber-Argente type)",
PAPSS1,AR (Brachyolmia 4 with mild epiphyseal and metaphyseal changes),
PAPSS2,"AR (Brachyolmia 4 with mild epiphyseal and metaphyseal changes); AR (Spondyloepimetaphyseal dysplasia, Genevieve type)",
PARD3,"AR (Neurodevelopmental disorder with language delay and seizures); AD (Robinow syndrome, autosomal dominant 1); AR (Ectodermal dysplasia, ectrodactyly, and macular dystrophy); AR (Hypotrichosis, congenital, with juvenile macular dystrophy); AD (Takenouchi-Kosaki syndrome); {Epilepsy, idiopathic generalized, susceptibility to, 5}; AD (Robinow syndrome, autosomal dominant 2)",
PARD6A,"AD (Robinow syndrome, autosomal dominant 1); AD (Robinow syndrome, autosomal dominant 2); Craniofrontonasal dysplasia; AR (Joubert syndrome 4); AR (Nephronophthisis 1, juvenile); AR (Senior-Loken syndrome-1); AR (Nephronophthisis 4); AR (Senior-Loken syndrome 4)",
PARG,"AR (Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures); Combined oxidative phosphorylation deficiency 6; Cowchock syndrome; Deafness, X-linked 5; Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy",
PARK7,"AR (Parkinson disease 7, autosomal recessive early-onset); AD (Dementia, Lewy body); AD (Parkinson disease 1); AD (Parkinson disease 4); AR (Parkinson disease 6, early onset)",
PARL,"AR (Parkinson disease 6, early onset); AD (Epilepsy, familial adult myoclonic, 2); AR (Neutropenia, severe congenital 3, autosomal recessive); {Parkinson disease 13}; AR (3-methylglutaconic aciduria, type VIII); AD (3-methylglutaconic aciduria, type VIIA, autosomal dominant); AR (3-methylglutaconic aciduria, type VIIB, autosomal recessive); AD (Neutropenia, severe congenital, 9, autosomal dominant); AR (Anterior segment dysgenesis 6, multiple subtypes); AR (Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset)",
PARN,"AR (Dyskeratosis congenita, autosomal recessive 6); AD (Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 4); AR (Spermatogenic failure 57); AD (Dyskeratosis congenita, autosomal dominant 1); AD (Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 2); AR (Dyskeratosis congenita, autosomal dominant 4); AR (Dyskeratosis congenita, autosomal recessive 5); AD (Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3)",
PARP1,"AR (Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia); Combined oxidative phosphorylation deficiency 6; Cowchock syndrome; Deafness, X-linked 5; Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy; AR (?Spinocerebellar ataxia, autosomal recessive 26)",
PARP10,"AR (?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive); AD (Epidermolysis bullosa simplex 5A, Ogna type); AR (Epidermolysis bullosa simplex 5B, with muscular dystrophy); AR (Epidermolysis bullosa simplex 5C, with pyloric atresia); AR (Muscular dystrophy, limb-girdle, autosomal recessive 17)",
PARS2,"AR (Developmental and epileptic encephalopathy 75); AR (?Deafness, autosomal recessive 94); AR (Combined oxidative phosphorylation deficiency 24)",
PASK,"Alpha-thalassemia myelodysplasia syndrome, somatic; Alpha-thalassemia/impaired intellectual development syndrome; Intellectual disability-hypotonic facies syndrome, X-linked; AD (Beckwith-Wiedemann syndrome); AD (Silver-Russell syndrome 1); AD (Wilms tumor 2)",
PATJ,"AR (Pseudo-TORCH syndrome 1); AR (Leber congenital amaurosis 8); AD (Pigmented paravenous chorioretinal atrophy); AR (Retinitis pigmentosa-12); AR (Joubert syndrome 4); AR (Nephronophthisis 1, juvenile); AR (Senior-Loken syndrome-1); AR (Nephronophthisis 4); AR (Senior-Loken syndrome 4); AD (Takenouchi-Kosaki syndrome); AR (Hemorrhagic destruction of the brain, subependymal calcification, and cataracts)",
PATL1,AD (Intellectual developmental disorder with impaired language and dysmorphic facies); AR (Oocyte/zygote/embryo maturation arrest 4); AR (FICUS syndrome),
PATL2,AR (Oocyte/zygote/embryo maturation arrest 4); AR (Oocyte/zygote/embryo maturation arrest 20); AR (Oocyte/zygote/embryo maturation arrest 19),
PAWR,"AD (Dystonia 6, torsion); AD (Telangiectasia, hereditary hemorrhagic, type 5); AR (Multiple mitochondrial dysfunctions syndrome 10)",
PAX1,"AR (Otofaciocervical syndrome 2 with T-cell deficiency); Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial; Hypereosinophilic syndrome, idiopathic, resistant to imatinib; AD (Tooth agenesis, selective, 3); {Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features)",
PAX2,"AD (Glomerulosclerosis, focal segmental, 7); AD (Papillorenal syndrome); AD (Vesicoureteral reflux 1); AR (?Visceral neuropathy, familial, 2, autosomal recessive); Adenocarcinoma of lung, somatic; Gastric cancer, somatic; Glioblastoma, somatic; Ovarian cancer, somatic",
PAX3,"AD (Craniofacial-deafness-hand syndrome); Rhabdomyosarcoma 2, alveolar; AD (Waardenburg syndrome, type 1); AR (Waardenburg syndrome, type 3); Rhabdomyosarcoma, alveolar; {Melanoma, cutaneous malignant, susceptibility to, 8}; AR (COMMAD syndrome); AD (Tietz albinism-deafness syndrome); AD (Waardenburg syndrome, type 2A); AR (Congenital myopathy 19); Rhabdomyosarcoma 2, alveolar; AD (PCWH syndrome); AD (Waardenburg syndrome, type 2E, with or without neurologic involvement); AD (Waardenburg syndrome, type 4C)",
PAX4,"AR ({Diabetes mellitus, ketosis-prone, susceptibility to}); AD (Diabetes mellitus, type 2); Maturity-onset diabetes of the young, type IX; Developmental and epileptic encephalopathy 1; Hydranencephaly with abnormal genitalia; Intellectual developmental disorder, X-linked 29; Lissencephaly, X-linked 2; Partington syndrome; Proud syndrome; AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5); {Neuroblastoma, susceptibility to, 3}",
PAX5,"{Leukemia, acute lymphoblastic, susceptibility to, 3}; {Leukemia, acute lymphocytic, susceptibility to, 1}; AD (Immunodeficiency, common variable, 13); AR (Auriculocondylar syndrome 3); AD (Question mark ears, isolated)",
PAX6,"AD (?Coloboma of optic nerve); AD (?Morning glory disc anomaly); AD (Aniridia); AD (Anterior segment dysgenesis 5, multiple subtypes); AD (Cataract with late-onset corneal dystrophy); AD (Foveal hypoplasia 1); AD (Keratitis); AD (Microphthalmia/coloboma 12); AD (Optic nerve hypoplasia); AD (?Aniridia 2); AD (Cleft palate, cardiac defects, and impaired intellectual development); Schizencephaly; AD (Bosch-Boonstra-Schaaf optic atrophy syndrome)",
PAX7,"AR (Congenital myopathy 19); Rhabdomyosarcoma 2, alveolar; Rhabdomyosarcoma, alveolar; AD (Facioscapulohumeral muscular dystrophy 1); AD (Craniofacial-deafness-hand syndrome); Rhabdomyosarcoma 2, alveolar; AD (Waardenburg syndrome, type 1); AR (Waardenburg syndrome, type 3); AR (Otofaciocervical syndrome 2 with T-cell deficiency)",
PAX8,"AD (Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia); AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AD ({Thyroid cancer, nonmedullary, 1}); AD (Chorea, hereditary benign); AD (Choreoathetosis, hypothyroidism, and neonatal respiratory distress); AD ({Thyroid cancer, nonmedullary, 4}); AR (Bamforth-Lazarus syndrome); ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic; Colorectal cancer, somatic; Epidermal nevus, somatic; Melanocytic nevus syndrome, congenital, somatic; Neurocutaneous melanosis, somatic; AD (Noonan syndrome 6); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Thyroid carcinoma, follicular, somatic; Bladder cancer, somatic; AD (Congenital myopathy with excess of muscle spindles); AD (Costello syndrome); Nevus sebaceous or woolly hair nevus, somatic; Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic; Spitz nevus or nevus spilus, somatic; Thyroid carcinoma, follicular, somatic",
PAX9,"AD (Tooth agenesis, selective, 3); AR (?Mitochondrial DNA depletion syndrome 18); AR (Otofaciocervical syndrome 2 with T-cell deficiency); AD (Glomerulosclerosis, focal segmental, 7); AD (Papillorenal syndrome); AR (Congenital myopathy 19); Rhabdomyosarcoma 2, alveolar",
PAXBP1,"AR (Congenital myopathy 19); Rhabdomyosarcoma 2, alveolar",
PAXIP1,AD (Alzheimer disease-10),
PAXX,"AR (Immunodeficiency 124, severe combined); AR (Microphthalmia/coloboma 13)",
PBRM1,"?Renal cell carcinoma, clear cell; AD ({Uveal melanoma, susceptibility to, 2}); AD (Kury-Isidor syndrome); AD (Tumor predisposition syndrome 1); AD (Coffin-Siris syndrome 2); AD (Prader-Willi syndrome)",
PBX1,"AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1); AD (Atrial septal defect 7, with or without AV conduction defects); Conotruncal heart malformations, variable; AD (Hypoplastic left heart syndrome 2); AD (Hypothyroidism, congenital nongoitrous, 5); AD (Tetralogy of Fallot); AD (Ventricular septal defect 3)",
PBX2,"AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); AD (CEBALID syndrome); AD (Meningioma)",
PBX3,"AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1); AD (Focal segmental glomerulosclerosis 10); AD (Nail-patella syndrome)",
PBXIP1,"AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance); AD (?Ovarian dysgenesis 8)",
PC,"AR (Pyruvate carboxylase deficiency); AD ({Diabetes mellitus, non-insulin-dependent, susceptibility to}); AR ({Obesity, susceptibility to}); AR (Arterial calcification, generalized, of infancy, 1); AD (Cole disease); AR (Hypophosphatemic rickets, autosomal recessive, 2); AR (Aphasia, primary progressive); AR (Ceroid lipofuscinosis, neuronal, 11); AR (Frontotemporal dementia 2); AD (Thrombophilia 3 due to protein C deficiency, autosomal dominant); AR (Thrombophilia 3 due to protein C deficiency, autosomal recessive)",
PCARE,AR (Retinitis pigmentosa 54); AR (Cone-rod dystrophy and hearing loss 2),
PCBD1,"AR (Hyperphenylalaninemia, BH4-deficient, D)",
PCBD2,AD (Abdominal obesity-metabolic syndrome 3),
PCBP1,"AD (?Hemochromatosis, type 5); AD (Neurodegeneration with brain iron accumulation 9); AD (Hyperferritinemia-cataract syndrome); AR (L-ferritin deficiency, dominant and recessive); AD (Neurodegeneration with brain iron accumulation 3); AD (?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2); AD (Oculopharyngeal muscular dystrophy 2); AD (Au-Kline syndrome)",
PCBP2,"AR (Immunodeficiency 105, severe combined); Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic; Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic; AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Au-Kline syndrome)",
PCCA,"AR (Propionicacidemia); AR (Propionicacidemia); AR (3-Methylcrotonyl-CoA carboxylase 1 deficiency); AR (Holocarboxylase synthetase deficiency); AR (Biotinidase deficiency); AR (Methylmalonic aciduria, mut(0) type)",
PCCB,"AR (Propionicacidemia); AR (Propionicacidemia); AR (Methylmalonic aciduria, mut(0) type)",
PCDH10,Developmental and epileptic encephalopathy 9,
PCDH11X,{Alzheimer disease 16}; Developmental and epileptic encephalopathy 9,
PCDH11Y,"Developmental and epileptic encephalopathy 9; Spermatogenic failure, Y-linked, 2; ?Deafness, Y-linked 2",
PCDH12,AR (Diencephalic-mesencephalic junction dysplasia syndrome 1),
PCDH15,"AR (Deafness, autosomal recessive 23); AR (Usher syndrome, type 1D/F digenic); AR (Usher syndrome, type 1F); AD ({Pituitary adenoma 5, multiple types}); AR (Deafness, autosomal recessive 12); AR (Usher syndrome, type 1D); AR (Usher syndrome, type 1D/F digenic); AD ({Alzheimer disease, late-onset, susceptibility to}); AD (Quebec platelet disorder); AD (Intellectual developmental disorder, autosomal dominant 59); AR (Usher syndrome, type IK)",
PCDH17,AD (Chromosome 13q14 deletion syndrome),
PCDH18,Developmental and epileptic encephalopathy 9,
PCDH19,"Developmental and epileptic encephalopathy 9; AR (?Attention deficit-hyperactivity disorder 8); AD (Agenesis of corpus callosum, cardiac, ocular, and genital syndrome); AD (Arrhythmogenic right ventricular dysplasia 14); AR (Elsahy-Waters syndrome); AD (Teebi hypertelorism syndrome 2)",
PCDH7,AR (Jaberi-Elahi syndrome),
PCDH8,Developmental and epileptic encephalopathy 9; AD (Chromosome 13q14 deletion syndrome),
PCF11,"AD (Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities); ?Intellectual developmental disorder, X-linked 113; AR (Pontocerebellar hypoplasia, type 10)",
PCGF1,"Microphthalmia, syndromic 2; Shukla-Vernon syndrome",
PCGF2,"AD (Turnpenny-Fry syndrome); Myelodysplastic syndrome, somatic",
PCGF3,"Microphthalmia, syndromic 2; Shukla-Vernon syndrome",
PCID2,"AD ({Breast cancer, male, susceptibility to}); AD ({Breast-ovarian cancer, familial, 2}); AR ({Glioblastoma 3}); AR ({Medulloblastoma}); {Pancreatic cancer 2}; AD ({Prostate cancer}); AR (Fanconi anemia, complementation group D1); AD (Wilms tumor)",
PCIF1,"AD (Nabais Sa-de Vries syndrome, type 1); AD (Nabais Sa-de Vries syndrome, type 2); AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1)",
PCK1,"AR (Phosphoenolpyruvate carboxykinase deficiency, cytosolic); Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; AD (Glucocorticoid resistance); AD ({Delayed sleep phase disorder, susceptibility to})",
PCK2,"AR (PEPCK deficiency, mitochondrial); AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe)",
PCLO,"AR (Pontocerebellar hypoplasia, type 3)",
PCM1,"AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6); AR (?Retinitis pigmentosa 51); AR (Bardet-Biedl syndrome 8); AR (Bardet-Biedl syndrome 4); {Schizophrenia 9, susceptibility to}; AR (Bardet-Biedl syndrome 2); AR (Retinitis pigmentosa 74); AR (Bardet-Biedl syndrome 5); AR (Bardet-Biedl syndrome 7)",
PCNA,"AR (?Ataxia-telangiectasia-like disorder 2); AR (Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome); AR (Ruijs-Aalfs syndrome); AD (Beckwith-Wiedemann syndrome); AD (IMAGE syndrome); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome)",
PCNT,"AR (Microcephalic osteodysplastic primordial dwarfism, type II); AR (Nephrotic syndrome, type 17); AR (?Microcephaly 13, primary, autosomal recessive); AR (Microcephaly 7, primary, autosomal recessive); AR (Cone-rod dystrophy and hearing loss 2); AR (Nephronophthisis 15); AR (Microcephaly 3, primary, autosomal recessive); AR (Short-rib thoracic dysplasia 8 with or without polydactyly)",
PCOLCE,"AR (Cutis laxa, autosomal recessive, type IB)",
PCP2,"AD ({Amyotrophic lateral sclerosis, susceptibility to, 13}); AD ({Parkinson disease, late-onset, susceptibility to}); AD (Spinocerebellar ataxia 2)",
PCP4,"AD ({Amyotrophic lateral sclerosis, susceptibility to, 13}); AD ({Parkinson disease, late-onset, susceptibility to}); AD (Spinocerebellar ataxia 2)",
PCSK1,"{Obesity, susceptibility to, BMIQ12}; AR (Endocrinopathy due to proprotein convertase 1/3 deficiency); AR (?Retinal dystrophy and obesity); [Body mass index QTL1]",
PCSK2,"AD (Developmental and epileptic encephalopathy 117); {Obesity, susceptibility to, BMIQ12}; AR (Endocrinopathy due to proprotein convertase 1/3 deficiency); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 6}); AD (Thrombophilia 12 due to thrombomodulin defect); {Menarche, age at, QTL2}; {Menarche, age at, QTL3}; Immunodeficiency 47",
PCSK4,AD (Silver-Russell syndrome 3),
PCSK5,"AD (?Vertebral hypersegmentation and orofacial anomalies); AD ({Low density lipoprotein cholesterol level QTL 1}); AD (Hypercholesterolemia, familial, 3)",
PCSK6,"AD (Erythrocytosis, familial, 4)",
PCSK9,"AD ({Low density lipoprotein cholesterol level QTL 1}); AD (Hypercholesterolemia, familial, 3); AR (Sitosterolemia 2); {Gallbladder disease 4}; AR (Sitosterolemia 1); AD ([Low density lipoprotein cholesterol level QTL6]); AR (Platelet-activating factor acetylhydrolase deficiency)",
PCTP,"AD (Epilepsy, familial adult myoclonic, 2)",
PCYT1A,"AR (Lipodystrophy, congenital generalized, type 5); AR (Spondylometaphyseal dysplasia with cone-rod dystrophy)",
PCYT1B,"AR (Lipodystrophy, congenital generalized, type 5); AR (Spondylometaphyseal dysplasia with cone-rod dystrophy)",
PCYT2,"AR (Spastic paraplegia 82, autosomal recessive); AR (Liberfarb syndrome)",
PDC,"Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; AR (Pyruvate dehydrogenase E1-beta deficiency)",
PDCD1,"AR (?Autoimmune disease with susceptibility to mycobacterium tuberculosis); {Malaria, resistance to}; AD ({Systemic lupus erythematosus, susceptibility to}); {Systemic lupus erythematosus, susceptibility to, 2}; AR (Immunodeficiency 130 with HPV-related verrucosis); AR (Immunodeficiency 63 with lymphoproliferation and autoimmunity)",
PDCD10,"AD (Cerebral cavernous malformations-3); AD (Cerebral cavernous malformations-2); AD (Cavernous malformations of CNS and retina); AD (Cerebral cavernous malformations-1); AD (Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic",
PDCD1LG2,"{Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (Immunodeficiency 64); {Asthma susceptibility 5}",
PDCD2,"AD ({Parkinson disease, susceptibility to}); AD (Spinocerebellar ataxia 17)",
PDCD4,"AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); AD (Pulmonary hypertension, familial primary, 1, with or without HHT); AD (Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated); AD (Pulmonary venoocclusive disease 1); AD (Loeys-Dietz syndrome 3); AD (Pulmonary hypertension, primary, 2); AD (Congenital heart defects, multiple types, 8, with or without heterotaxy); AD (Loeys-Dietz syndrome 6)",
PDCD6,"AR (?Microcephaly 29, primary, autosomal recessive)",
PDCD6IP,"AR (?Microcephaly 29, primary, autosomal recessive); AD (Spastic paraplegia 80, autosomal dominant); AR (Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly); AD (Cataract 31, multiple types); AD (Anemia, congenital dyserythropoietic, type IIIA); AR (Spermatogenic failure 23)",
PDE10A,"AR (Dyskinesia, limb and orofacial, infantile-onset); AD (Striatal degeneration, autosomal dominant); AR (Intellectual developmental disorder with paroxysmal dyskinesia or seizures); AD (Pigmented nodular adrenocortical disease, primary, 2)",
PDE11A,"AD (Pigmented nodular adrenocortical disease, primary, 2); AD (Pituitary adenoma 1, multiple types); AD (Pituitary adenoma predisposition)",
PDE1A,"AD (Hypertension and brachydactyly syndrome); AD (?Deafness, autosomal dominant 74)",
PDE1C,"AD (?Deafness, autosomal dominant 74)",
PDE2A,AR (Intellectual developmental disorder with paroxysmal dyskinesia or seizures); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1,
PDE3A,"AD (Hypertension and brachydactyly syndrome); {Hypertension, essential, susceptibility to, 4}",
PDE3B,"AR (Obesity, morbid, due to leptin deficiency); Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked; AR (Immunodeficiency 97 with autoinflammation)",
PDE4A,"AD (?Deafness, autosomal dominant 74); AD (Acrodysostosis 2, with or without hormone resistance)",
PDE4B,"{Schizophrenia 9, susceptibility to}; AD (Acrodysostosis 2, with or without hormone resistance)",
PDE4C,"AD (Acrodysostosis 2, with or without hormone resistance)",
PDE4D,"AD (Acrodysostosis 2, with or without hormone resistance); AD (Chromosome 5q12 deletion syndrome); {Stroke, susceptibility to, 1}; AD (Acrodysostosis 1, with or without hormone resistance); Adrenocortical tumor, somatic; AD (Carney complex, type 1); AD (Myxoma, intracardiac); AD (Pigmented nodular adrenocortical disease, primary, 1)",
PDE5A,"AR ({Diabetes, type 1, susceptibility to}); {Rheumatoid arthritis, susceptibility to}; AD ({Systemic lupus erythematosus susceptibility to}); AD (Aortic aneurysm, familial thoracic 8)",
PDE6A,"AR (Retinitis pigmentosa 43); AR (Retinitis pigmentosa 57); AR (Cone-rod dystrophy 15); AR (Macular dystrophy, retinal); AR (Retinitis pigmentosa 65); AD (Night blindness, congenital stationary, autosomal dominant 2); AR (Retinitis pigmentosa-40)",
PDE6B,"AD (Night blindness, congenital stationary, autosomal dominant 2); AR (Retinitis pigmentosa-40); AR (Retinitis pigmentosa 43); AR (Retinitis pigmentosa 57); AD (?Febrile seizures, familial, 4); AR (Usher syndrome, type 2C); AR (Usher syndrome, type 2C, GPR98/PDZD7 digenic); {Melanoma, cutaneous malignant, susceptibility to, 8}; AR (COMMAD syndrome); AD (Tietz albinism-deafness syndrome); AD (Waardenburg syndrome, type 2A); AR (Cone dystrophy 4)",
PDE6C,"AR (Cone dystrophy 4); AR (Achromatopsia 2); AR (Achromatopsia 3); AR (Neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities)",
PDE6D,"AR (Joubert syndrome 22); AR (Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome); AR (Joubert syndrome 1); AR (Joubert syndrome 8); AR (Nephronophthisis 15); AD (?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1); AD (?Immunodeficiency 13); AD (Cone-rod dystrophy 24); AR (Joubert syndrome 35); AD (Retinitis pigmentosa 83)",
PDE6G,"AR (Retinitis pigmentosa 57); AR (Retinitis pigmentosa 43); AD (Night blindness, congenital stationary, autosomal dominant 2); AR (Retinitis pigmentosa-40)",
PDE6H,AR (Achromatopsia 6); AR (Retinal cone dystrophy 3); AR (Retinal cone dystrophy 3B),
PDE7B,AR (Joubert syndrome 3),
PDE8A,"Pigmented nodular adrenocortical disease, primary, 3; AD (Striatal degeneration, autosomal dominant)",
PDE8B,"Pigmented nodular adrenocortical disease, primary, 3; AD (Striatal degeneration, autosomal dominant); [Thyroid-stimulating hormone level QTL 1]",
PDF,"AD ({Hyperemesis gravidarum, susceptibility to})",
PDGFA,"Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial; Hypereosinophilic syndrome, idiopathic, resistant to imatinib; {Microvascular complications of diabetes 1}; AD (Total anomalous pulmonary venous return); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic",
PDGFB,"AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related); AD ({Bone mineral density variation QTL, osteoporosis}); AD (Caffey disease); AD (Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1); AD (Ehlers-Danlos syndrome, arthrochalasia type, 1); AD (Osteogenesis imperfecta, type I); AD (Osteogenesis imperfecta, type II); AD (Osteogenesis imperfecta, type III); AD (Osteogenesis imperfecta, type IV); Dermatofibrosarcoma protuberans; {Gastric cancer risk after H. pylori infection}; Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial; Hypereosinophilic syndrome, idiopathic, resistant to imatinib",
PDGFC,"Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial; Hypereosinophilic syndrome, idiopathic, resistant to imatinib",
PDGFD,"AD (?Ocular pterygium-digital keloid dysplasia syndrome); AD (Basal ganglia calcification, idiopathic, 4); AD (Kosaki overgrowth syndrome); AD (Myofibromatosis, infantile, 1); AD (Premature aging syndrome, Penttinen type)",
PDGFRA,"Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial; Hypereosinophilic syndrome, idiopathic, resistant to imatinib; Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic; Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic; AD (Gastrointestinal stromal tumor, familial); Germ cell tumors, somatic; Leukemia, acute myeloid, somatic; AD (Mastocytosis, cutaneous); Mastocytosis, systemic, somatic; AD (Piebaldism)",
PDGFRB,"AD (?Ocular pterygium-digital keloid dysplasia syndrome); AD (Basal ganglia calcification, idiopathic, 4); AD (Kosaki overgrowth syndrome); AD (Myofibromatosis, infantile, 1); AD (Premature aging syndrome, Penttinen type); Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); AR (Achondrogenesis, type IA); AR (Odontochondrodysplasia 1)",
PDGFRL,"Colorectal cancer, somatic; Hepatocellular cancer, somatic; AR (Deafness, autosomal recessive 71)",
PDHA1,"Pyruvate dehydrogenase E1-alpha deficiency; AR (Spermatogenic failure 70); AR (Pyruvate dehydrogenase E1-beta deficiency); AD (?Myoclonus, familial, 2); AD (Cognitive impairment with or without cerebellar ataxia); AD (Developmental and epileptic encephalopathy 13); AD (Seizures, benign familial infantile, 5)",
PDHA2,"AR (Spermatogenic failure 70); AR (Acromesomelic dysplasia 3); AD (Brachydactyly, type A1, D); AD (Brachydactyly, type A2); Pyruvate dehydrogenase E1-alpha deficiency",
PDHB,AR (Pyruvate dehydrogenase E1-beta deficiency); Pyruvate dehydrogenase E1-alpha deficiency; AR (Lacticacidemia due to PDX1 deficiency),
PDHX,AR (Lacticacidemia due to PDX1 deficiency),
PDIA3,"Myelofibrosis, somatic; Thrombocythemia, somatic; AD (Cole-Carpenter syndrome 1)",
PDIA4,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2)",
PDIA5,AR (Achromatopsia 7),
PDK1,"?Charcot-Marie-Tooth disease, X-linked dominant, 6; Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7)",
PDK2,"?Charcot-Marie-Tooth disease, X-linked dominant, 6",
PDK3,"?Charcot-Marie-Tooth disease, X-linked dominant, 6; Myopathy, congenital, with fiber-type disproportion, X-linked",
PDK4,"?Charcot-Marie-Tooth disease, X-linked dominant, 6; {Coronary artery disease, susceptibility to}",
PDLIM4,"AD ({Osteoporosis, susceptibility to})",
PDP1,AR (Pyruvate dehydrogenase phosphatase deficiency); AR (Optic atrophy 6),
PDP2,"AR (Pyruvate dehydrogenase phosphatase deficiency); Adenocarcinoma of lung, somatic; AD (Cardiofaciocutaneous syndrome); Colorectal cancer, somatic; AD (LEOPARD syndrome 3); Melanoma, malignant, somatic; Nonsmall cell lung cancer, somatic; AD (Noonan syndrome 7); Pyruvate dehydrogenase E1-alpha deficiency",
PDPK1,"AD ({Type 2 diabetes mellitus, susceptibility to}); Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic; Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2); AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1)",
PDPN,"AD (Ayme-Gripp syndrome); AD (Cataract 21, multiple types)",
PDS5A,AR (Juberg-Hayward syndrome); AR (Roberts-SC phocomelia syndrome); AD (Cornelia de Lange syndrome 3),
PDS5B,AR (?Mungan syndrome); AD (Cornelia de Lange syndrome 4),
PDSS1,"AR (Coenzyme Q10 deficiency, primary, 2); AR (Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia); AR ({Multiple system atrophy, susceptibility to}); AR (Coenzyme Q10 deficiency, primary, 1); AR (Coenzyme Q10 deficiency, primary, 3)",
PDSS2,"AR (Coenzyme Q10 deficiency, primary, 3); AR (Coenzyme Q10 deficiency, primary, 2)",
PDX1,"AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1); AR (Lacticacidemia due to PDX1 deficiency); AD (Insulinomatosis and diabetes mellitus); AD (Nabais Sa-de Vries syndrome, type 1); AD (Nabais Sa-de Vries syndrome, type 2); AD (Tolchin-Le Caignec syndrome)",
PDXK,"AR (Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy)",
PDYN,"AD (Spinocerebellar ataxia 23); AD (?Narcolepsy 1); Intellectual developmental disorder, X-linked syndromic, Turner type",
PDZD2,AD (Myopia 19),
PDZD7,"AR ({Retinal disease in Usher syndrome type IIA, modifier of}); AR (Deafness, autosomal recessive 57); AR (Usher syndrome, type IIC, GPR98/PDZD7 digenic); AD (?Febrile seizures, familial, 4); AR (Usher syndrome, type 2C); AR (Usher syndrome, type 2C, GPR98/PDZD7 digenic); AR (Retinitis pigmentosa 39); AR (Usher syndrome, type 2A)",
PDZD8,AR (Intellectual developmental disorder with autism and dysmorphic facies); Immunodeficiency 50,
PDZK1,"AD ({Bronchiectasis with or without elevated sweat chloride 1, modifier of}); {Hypertrypsinemia, neonatal}; AD ({Pancreatitis, hereditary}); AR (Congenital bilateral absence of vas deferens); AR (Cystic fibrosis); Sweat chloride elevation without CF; AR (Nephrotic syndrome, type 23)",
PEA15,"{Parkinson disease 13}; AR (3-methylglutaconic aciduria, type VIII); AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic",
PEBP1,"AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}); AR (Autoinflammation with arthritis and vasculitis); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 4)",
PECAM1,"AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic; Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic",
PEG10,"AD (Telangiectasia, hereditary hemorrhagic, type 2); AR (?Split-hand/foot malformation 1 with sensorineural hearing loss); AD (Split-hand/foot malformation 1); {Autism susceptibility, X-linked 3}; Encephalopathy, neonatal severe; Intellectual developmental disorder, X-linked syndromic 13; Intellectual developmental disorder, X-linked syndromic, Lubs type; Rett syndrome; Rett syndrome, atypical; Rett syndrome, preserved speech variant",
PEG3,"AD (Gabriele-de Vries syndrome); AR (?Split-hand/foot malformation 1 with sensorineural hearing loss); AD (Split-hand/foot malformation 1); AR (Hydatidiform mole, recurrent, 1); AR ({Diabetes mellitus, transient neonatal 1})",
PELI1,"AR (Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures); AD (Vulto-van Silfout-de Vries syndrome)",
PELP1,"Wilson-Turner syndrome; AD (Tubulointerstitial kidney disease, autosomal dominant, 2); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Intellectual developmental disorder, autosomal dominant 58); AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance)",
PENK,"[Angiotensin I-converting enzyme, benign serum increase]; {Microvascular complications of diabetes 3}; {Myocardial infarction, susceptibility to}; {SARS, progression of}; {Stroke, hemorrhagic}; AR (Renal tubular dysgenesis); AD (Spinocerebellar ataxia 23)",
PEPD,"AR (Prolidase deficiency); AD ({Hemolytic uremic syndrome, atypical, susceptibility to, 5}); {Macular degeneration, age-related, 9}; AR (C3 deficiency); AR (Anemia, congenital, nonspherocytic hemolytic, 4, glucose phosphate isomerase deficient); AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AR (Hemolytic anemia due to triosephosphate isomerase deficiency); AD ({Lung cancer, resistance to}); {Nicotine addiction, protection from}; AD (Coumarin resistance)",
PER1,"Leukemia, acute myeloid, somatic; AD (Thrombocytopenia 5); AR (Hyperphosphatasia with impaired intellectual development syndrome 4); AD (?Advanced sleep phase syndrome, familial, 1); AD ({Delayed sleep phase disorder, susceptibility to}); AD (?Advanced sleep phase syndrome, familial, 3)",
PER2,"AD (?Advanced sleep phase syndrome, familial, 1); AD ({Delayed sleep phase disorder, susceptibility to}); AD (?Advanced sleep phase syndrome, familial, 3)",
PER3,"AD (?Advanced sleep phase syndrome, familial, 3); AD (Intellectual developmental disorder with or without epilepsy or cerebellar ataxia); AR (Immunodeficiency 42)",
PERCC1,"AR (Diarrhea 11, malabsorptive, congenital)",
PERP,"AR (Erythrokeratodermia variabilis et progressiva 7); AD (Olmsted syndrome 2); AD (ADULT syndrome); AD (Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3); AD (Hay-Wells syndrome); AD (Limb-mammary syndrome); Orofacial cleft 8; AD (Premature ovarian failure 21); AD (Rapp-Hodgkin syndrome); AD (Split-hand/foot malformation 4)",
PES1,"AD (Amyotrophic lateral sclerosis 10, with or without FTD); AD (Frontotemporal lobar degeneration, TARDBP-related)",
PET100,"AR (Mitochondrial complex IV deficiency, nuclear type 12)",
PET117,"AR (?Mitochondrial complex IV deficiency, nuclear type 19)",
PEX1,"AR (Heimler syndrome 1); AR (Peroxisome biogenesis disorder 1A (Zellweger)); AR (Peroxisome biogenesis disorder 1B (NALD/IRD)); AR (Heimler syndrome 2); AR (Peroxisome biogenesis disorder 4A (Zellweger)); AR (Peroxisome biogenesis disorder 4B); AR (Peroxisome biogenesis disorder 7A (Zellweger)); AR (Peroxisome biogenesis disorder 7B); AR (?Bile acid synthesis defect, congenital, 5); AR (Peroxisome biogenesis disorder 3A (Zellweger)); AR (Peroxisome biogenesis disorder 3B)",
PEX10,AR (Peroxisome biogenesis disorder 6A (Zellweger)); AR (Peroxisome biogenesis disorder 6B); AR (Peroxisome biogenesis disorder 5A (Zellweger)); AR (Peroxisome biogenesis disorder 5B); AR (Peroxisome biogenesis disorder 11A (Zellweger)); AR (Peroxisome biogenesis disorder 11B),
PEX11B,"AR (Peroxisome biogenesis disorder 14B); AR (Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1); AD (Optic atrophy 5)",
PEX12,AR (Peroxisome biogenesis disorder 3A (Zellweger)); AR (Peroxisome biogenesis disorder 3B); AR (Peroxisome biogenesis disorder 6A (Zellweger)); AR (Peroxisome biogenesis disorder 6B); AR (Peroxisome biogenesis disorder 5A (Zellweger)); AR (Peroxisome biogenesis disorder 5B),
PEX13,"AR (Peroxisome biogenesis disorder 11A (Zellweger)); AR (Peroxisome biogenesis disorder 11B); AR (Peroxisome biogenesis disorder 13A (Zellweger)); AR (Peroxisome biogenesis disorder 6A (Zellweger)); AR (Peroxisome biogenesis disorder 6B); AR (Peroxisome biogenesis disorder 9B); AR (Rhizomelic chondrodysplasia punctata, type 1)",
PEX14,"AR (Peroxisome biogenesis disorder 13A (Zellweger)); AR (?Peroxisome biogenesis disorder 10B); AR (Peroxisome biogenesis disorder 10A (Zellweger)); AR (Peroxisome biogenesis disorder 8A (Zellweger)); AR (Peroxisome biogenesis disorder 8B); AR (Peroxisome biogenesis disorder 9B); AR (Rhizomelic chondrodysplasia punctata, type 1)",
PEX16,AR (Peroxisome biogenesis disorder 8A (Zellweger)); AR (Peroxisome biogenesis disorder 8B); AR (?Peroxisome biogenesis disorder 10B); AR (Peroxisome biogenesis disorder 10A (Zellweger)); AR (Peroxisome biogenesis disorder 13A (Zellweger)); AR (Peroxisome biogenesis disorder 7A (Zellweger)); AR (Peroxisome biogenesis disorder 7B),
PEX19,AR (Peroxisome biogenesis disorder 12A (Zellweger)),
PEX2,"AR (Peroxisome biogenesis disorder 5A (Zellweger)); AR (Peroxisome biogenesis disorder 5B); AR (Peroxisome biogenesis disorder 6A (Zellweger)); AR (Peroxisome biogenesis disorder 6B); AR (?Bile acid synthesis defect, congenital, 5); AD (Chromosome 8q21.11 deletion syndrome)",
PEX26,AR (Peroxisome biogenesis disorder 7A (Zellweger)); AR (Peroxisome biogenesis disorder 7B),
PEX3,AR (?Peroxisome biogenesis disorder 10B); AR (Peroxisome biogenesis disorder 10A (Zellweger)); AR (Peroxisome biogenesis disorder 8A (Zellweger)); AR (Peroxisome biogenesis disorder 8B); AR (Peroxisome biogenesis disorder 13A (Zellweger)),
PEX5,"AR (Peroxisome biogenesis disorder 2A (Zellweger)); AR (Peroxisome biogenesis disorder 2B); AR (Rhizomelic chondrodysplasia punctata, type 5); AR (Heimler syndrome 2); AR (Peroxisome biogenesis disorder 4A (Zellweger)); AR (Peroxisome biogenesis disorder 4B); AR (Peroxisome biogenesis disorder 9B); AR (Rhizomelic chondrodysplasia punctata, type 1); AR (Peroxisome biogenesis disorder 13A (Zellweger))",
PEX5L,"AD (Developmental and epileptic encephalopathy 24); AD (Generalized epilepsy with febrile seizures plus, type 10)",
PEX6,AR (Heimler syndrome 2); AR (Peroxisome biogenesis disorder 4A (Zellweger)); AR (Peroxisome biogenesis disorder 4B); AR (Peroxisome biogenesis disorder 7A (Zellweger)); AR (Peroxisome biogenesis disorder 7B); AR (Glycine N-methyltransferase deficiency); AR (Heimler syndrome 1); AR (Peroxisome biogenesis disorder 1A (Zellweger)); AR (Peroxisome biogenesis disorder 1B (NALD/IRD)),
PEX7,"AR (Peroxisome biogenesis disorder 9B); AR (Rhizomelic chondrodysplasia punctata, type 1); AR (Peroxisome biogenesis disorder 2A (Zellweger)); AR (Peroxisome biogenesis disorder 2B); AR (Rhizomelic chondrodysplasia punctata, type 5); AR (Refsum disease); AR (Peroxisome biogenesis disorder 13A (Zellweger))",
PF4,"AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}",
PFAS,"AR ({Neural tube defects, folate-sensitive, susceptibility to}); AR (Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia); AR (AICA-ribosiduria due to ATIC deficiency); AR (Adenylosuccinase deficiency)",
PFKL,Hemolytic anemia due to phosphofructokinase deficiency; AD ({Major affective disorder 1}); AR (Glycogen storage disease VII); AD (Bethlem myopathy 1A); AR (Ullrich congenital muscular dystrophy 1A),
PFKM,"AR (Glycogen storage disease VII); Hemolytic anemia due to phosphofructokinase deficiency; AR (Anemia, congenital, nonspherocytic hemolytic, 3, adenylate kinase deficient)",
PFKP,"AR (Glycogen storage disease VII); Hemolytic anemia due to phosphofructokinase deficiency; AR (?Microcephaly 12, primary, autosomal recessive)",
PFN1,"Amyotrophic lateral sclerosis 18; Aplastic anemia; AR (Hemophagocytic lymphohistiocytosis, familial, 2); Lymphoma, non-Hodgkin; AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay)",
PGA4,"AR (?Immunodeficiency, common variable, 5)",
PGAM1,AR (Glycogen storage disease X),
PGAM2,AR (Glycogen storage disease X),
PGAM5,"AD (Autoinflammation with episodic fever and lymphadenopathy); AR (Immunodeficiency 57 with autoinflammation); AR (Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1); AD (Optic atrophy 5)",
PGAP1,"AR (Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities); AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); AR (?Glycosylphosphatidylinositol biosynthesis defect 25)",
PGAP2,AR (Hyperphosphatasia with impaired intellectual development syndrome 3); AR (Hyperphosphatasia with impaired intellectual development syndrome 4),
PGAP3,AR (Hyperphosphatasia with impaired intellectual development syndrome 4),
PGBD3,"AR (?De Sanctis-Cacchione syndrome); AD ({Lung cancer, susceptibility to}); {Macular degeneration, age-related, susceptibility to, 5}; AR (Cerebrooculofacioskeletal syndrome 1); AR (Cockayne syndrome, type B); AD (Premature ovarian failure 11); AR (UV-sensitive syndrome 1)",
PGC,"{AIDS, resistance to}; AR (?Oculomotor-abducens synkinesis)",
PGD,"AR (Congenital disorder of glycosylation, type It); AR (Cortisone reductase deficiency 1); AR (Hypophosphatasia, adult); AR (Hypophosphatasia, childhood); AR (Hypophosphatasia, infantile); AR (Odontohypophosphatasia); {Asthma, susceptibility to, 1}; AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal)",
PGF,"{Microvascular complications of diabetes 1}; AD ({Hemangioma, capillary infantile, susceptibility to}); Hemangioma, capillary infantile, somatic; AD (Preeclampsia/eclampsia 1); AR (Auriculocondylar syndrome 3); AD (Question mark ears, isolated)",
PGK1,"Phosphoglycerate kinase 1 deficiency; {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; AD (Immunodeficiency, developmental delay, and hypohomocysteinemia)",
PGK2,Phosphoglycerate kinase 1 deficiency,
PGLS,"AD (Gastrointestinal stromal tumor); AR (Mitochondrial complex II deficiency, nuclear type 4); Paraganglioma and gastric stromal sarcoma; AD (Pheochromocytoma/paraganglioma syndrome 4)",
PGLYRP1,"{Inflammatory bowel disease 1, Crohn disease}; {Yao syndrome}; AD (Blau syndrome)",
PGLYRP3,{Psoriasis susceptibility 4},
PGLYRP4,{Psoriasis susceptibility 4},
PGM1,"AR (Congenital disorder of glycosylation, type It); AR (Rh-null disease, amorph type); AR (Immunodeficiency 23); AR (C8 deficiency, type I); AR (Reticular dysgenesis); AR (Fucosidosis); AR (Neuropathy, hereditary sensory and autonomic, type V)",
PGM2,"AR (Congenital disorder of glycosylation, type It); AR (Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities); AR (Immunodeficiency 23); AR (Neuropathy, hereditary sensory and autonomic, type V); AR (Hypophosphatasia, adult); AR (Hypophosphatasia, childhood); AR (Hypophosphatasia, infantile); AR (Odontohypophosphatasia); {Diphtheria, susceptibility to}",
PGM2L1,"AR (Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities)",
PGM3,"AR (Immunodeficiency 23); {Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}; AR (Congenital disorder of glycosylation, type It); AR (Rh-null disease, amorph type); AR ({Lead poisoning, susceptibility to}); AR (Porphyria, acute hepatic)",
PGP,"AR (?WHIM syndrome 2); {AIDS, slow progression to}; {Colchicine resistance}; {Inflammatory bowel disease 13}; AR (Encephalopathy, acute transient); AD (Polycystic kidney disease 1); AD ({?Parkinson disease 5, susceptibility to}); AD (Spastic paraplegia 79A, autosomal dominant); AR (Spastic paraplegia 79B, autosomal recessive)",
PGR,"AR (?Progesterone resistance); AD ({Migraine, susceptibility to}); {Myocardial infarction, susceptibility to}; Breast cancer, somatic; AR (Estrogen resistance); AR (Acrocapitofemoral dysplasia); AD (Brachydactyly, type A1); AR (Osteootohepatoenteric syndrome)",
PHACTR1,AD (Developmental and epileptic encephalopathy 70),
PHAX,"AD (Leukodystrophy, demyelinating, adult-onset, autosomal dominant, atypical); AD (Microcephaly 26, primary, autosomal dominant); AD (Leukodystrophy, demyelinating, adult-onset, autosomal dominant, typical); AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4)",
PHB1,"AD ({Breast cancer, susceptibility to}); AR (Mitochondrial complex III deficiency, nuclear type 7)",
PHB2,"AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AD ({Breast cancer, susceptibility to}); AR (Mitochondrial complex III deficiency, nuclear type 7); AR (Lowry-Wood syndrome); AR (Microcephalic osteodysplastic primordial dwarfism, type I); AR (Roifman syndrome); AD (3-methylglutaconic aciduria, type VIIA, autosomal dominant); AR (3-methylglutaconic aciduria, type VIIB, autosomal recessive); AD (Neutropenia, severe congenital, 9, autosomal dominant)",
PHC1,"AR (?Microcephaly 11, primary, autosomal recessive); AD (Neurodevelopmental disorder with impaired language, behavioral abnormalities, and dysmorphic facies); AD (Meier-Gorlin syndrome 6); AD (Cohen-Gibson syndrome); AD (Imagawa-Matsumoto syndrome); AD (Luo-Schoch-Yamamoto syndrome); AR (Macular dystrophy with or without cone dysfunction)",
PHC2,AR (Macular dystrophy with or without cone dysfunction),
PHEX,"Hypophosphatemic rickets, X-linked dominant; Intellectual developmental disorder, X-linked syndromic, Snyder-Robinson type; AD (Hypophosphatemic rickets, autosomal dominant); AR (Tumoral calcinosis, hyperphosphatemic, familial, 2); AD ({Diabetes mellitus, non-insulin-dependent, susceptibility to}); AR ({Obesity, susceptibility to}); AR (Arterial calcification, generalized, of infancy, 1); AD (Cole disease); AR (Hypophosphatemic rickets, autosomal recessive, 2); [Blood group, Kell]; AR (Rickets, vitamin D-resistant, type IIA)",
PHF1,"AR (Pontocerebellar hypoplasia, type 8)",
PHF10,"AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5); AD (?Periventricular nodular heterotopia 6)",
PHF19,"AD (Blepharocheilodontic syndrome 1); Breast cancer, lobular, somatic; AD (Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate); Endometrial carcinoma, somatic; Ovarian cancer, somatic",
PHF2,AD (Developmental and epileptic encephalopathy 65),
PHF20L1,"AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system)",
PHF21A,AD (Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures); AD (Potocki-Shaffer syndrome),
PHF23,AR (El Hayek-Chahrour neurodevelopmental syndrome),
PHF6,"Borjeson-Forssman-Lehmann syndrome; {Leukemia, acute lymphocytic, susceptibility to, 1}",
PHF8,"Intellectual developmental disorder, X-linked syndromic, Siderius type",
PHGDH,"AR (Neu-Laxova syndrome 1); AR (Phosphoglycerate dehydrogenase deficiency); AR (Muscular dystrophy, congenital, with cataracts and intellectual disability); AR (Marinesco-Sjogren syndrome); AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia)",
PHIP,"AD (Chung-Jansen syndrome); [Junior blood group system]; AD ([Uric acid concentration, serum, QTL1]); AR (Ciliary dyskinesia, primary, 51)",
PHKA1,"Muscle glycogenosis; Glycogen storage disease, type IXa1; Glycogen storage disease, type IXa2; X-inactivation, familial skewed; AD (Asplenia, isolated congenital); AR (Phosphorylase kinase deficiency of liver and muscle, autosomal recessive); Intellectual developmental disorder, X-linked syndromic 34",
PHKA2,"Glycogen storage disease, type IXa1; Glycogen storage disease, type IXa2; AR (Phosphorylase kinase deficiency of liver and muscle, autosomal recessive); ?Retinitis pigmentosa 23; Joubert syndrome 10; Orofaciodigital syndrome I; Simpson-Golabi-Behmel syndrome, type 2; Muscle glycogenosis",
PHKB,"AR (Phosphorylase kinase deficiency of liver and muscle, autosomal recessive); Muscle glycogenosis; Glycogen storage disease, type IXa1; Glycogen storage disease, type IXa2",
PHKG1,"AR (Glycogen storage disease IXc); Muscle glycogenosis; AR (Phosphorylase kinase deficiency of liver and muscle, autosomal recessive); Glycogen storage disease, type IXa1; Glycogen storage disease, type IXa2",
PHKG2,"AR (Glycogen storage disease IXc); AR (Phosphorylase kinase deficiency of liver and muscle, autosomal recessive); Glycogen storage disease, type IXa1; Glycogen storage disease, type IXa2; Muscle glycogenosis",
PHLDA2,[Birth weight QTL 1]; [Fasting plasma glucose level QTL 2]; AD (Beckwith-Wiedemann syndrome),
PHLDB1,"AR (Osteogenesis imperfecta, type XXIII)",
PHLDB3,"AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
PHOX2A,"AR (Fibrosis of extraocular muscles, congenital, 2); {Neuroblastoma, susceptibility to, 2}; AD (Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease); Neuroblastoma with Hirschsprung disease; AR (Opsismodysplasia); AR (Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy)",
PHOX2B,"{Neuroblastoma, susceptibility to, 2}; AD (Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease); Neuroblastoma with Hirschsprung disease; AD ({Hirschsprung disease, protection against}); AD ({Hirschsprung disease, susceptibility to, 1}); AD (Medullary thyroid carcinoma); AD (Multiple endocrine neoplasia IIA); AD (Multiple endocrine neoplasia IIB); AD (Pheochromocytoma); AR (?Central hypoventilation syndrome, congenital, 2, and autonomic dysfunction); AR (Fibrosis of extraocular muscles, congenital, 2); AR (?Central hypoventilation syndrome, congenital, 3); AD ({Hirschsprung disease, susceptibility to, 3})",
PHYH,"AR (Refsum disease); AR (Peroxisome biogenesis disorder 9B); AR (Rhizomelic chondrodysplasia punctata, type 1)",
PHYHIP,AD (Meier-Gorlin syndrome 6),
PHYKPL,AR ([?Phosphohydroxylysinuria]),
PI3,"AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AR (?Agammaglobulinemia 7, autosomal recessive); AD (Immunodeficiency 36); AD (SHORT syndrome); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AD ({Breast cancer, susceptibility to}); AR (Ataxia-telangiectasia); Lymphoma, B-cell non-Hodgkin, somatic; Lymphoma, mantle cell, somatic; T-cell prolymphocytic leukemia, somatic; AD ({Type 2 diabetes mellitus, susceptibility to}); AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
PI4K2A,"AR (Neurodevelopmental disorder with hyperkinetic movements, seizures and structural brain abnormalities); AR (Epilepsy, progressive myoclonic 4, with or without renal failure); AD (Deafness, autosomal dominant 87); AD ({Coronary artery disease, autosomal dominant, 2}); AD (Tooth agenesis, selective, 7); AD ({Lewy body dementia, susceptibility to}); AD ({Parkinson disease, late-onset, susceptibility to}); AR (Gaucher disease, perinatal lethal); AR (Gaucher disease, type I); AR (Gaucher disease, type II); AR (Gaucher disease, type III); AR (Gaucher disease, type IIIC)",
PI4KA,"AR (Gastrointestinal defects and immunodeficiency syndrome 2); AR (Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis); AR (Spastic paraplegia 84, autosomal recessive); AR (Leukodystrophy, hypomyelinating, 5); AR (Gastrointestinal defects and immunodeficiency syndrome); AD (Fliedner-Zweier syndrome)",
PI4KB,"AD (Deafness, autosomal dominant 87); AD (STING-associated vasculopathy, infantile-onset); AR (Neurodevelopmental disorder with hyperkinetic movements, seizures and structural brain abnormalities); AR (Epilepsy, progressive myoclonic 4, with or without renal failure); AD ({Lewy body dementia, susceptibility to}); AD ({Parkinson disease, late-onset, susceptibility to}); AR (Gaucher disease, perinatal lethal); AR (Gaucher disease, type I); AR (Gaucher disease, type II); AR (Gaucher disease, type III); AR (Gaucher disease, type IIIC)",
PIAS1,"?Orofacial cleft 10; Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked; AD (Ectodermal dysplasia 3, Witkop type); AD (Orofacial cleft 5); AD (Tooth agenesis, selective, 1, with or without orofacial cleft); AD (Immunodeficiency 31A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive); AD (Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant); AR (?Progesterone resistance)",
PIAS2,"AR (Pontocerebellar hypoplasia, type 8); AD (Cataract 31, multiple types)",
PIAS3,"AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections)",
PIAS4,"?Orofacial cleft 10; AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S)",
PIBF1,AR (Joubert syndrome 33),
PICALM,"Leukemia, acute myeloid, somatic",
PICK1,"AD (Neurodevelopmental disorder with language impairment and behavioral abnormalities); AR (?Spermatogenic failure 67); AR (Fraser syndrome 3); AR (?Bleeding disorder, platelet-type, 22); {Prostate cancer/brain cancer susceptibility, somatic}",
PID1,"{Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features)",
PIDD1,"AR (Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly); AR (Intellectual developmental disorder, autosomal recessive 80, with variant lissencephaly)",
PIEZO1,"AR ([ER blood group system]); AD (Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema); AR (Lymphatic malformation 6); AD (?Marden-Walker syndrome); AD (Arthrogryposis, distal, type 3); AD (Arthrogryposis, distal, type 5); AR (Arthrogryposis, distal, with impaired proprioception and touch); AR (?Orofaciodigital syndrome II); AD ({Amyotrophic lateral sclerosis, susceptibility to, 24}); AR (Short-rib thoracic dysplasia 6 with or without polydactyly)",
PIEZO2,"AD (?Marden-Walker syndrome); AD (Arthrogryposis, distal, type 3); AD (Arthrogryposis, distal, type 5); AR (Arthrogryposis, distal, with impaired proprioception and touch); AR ([ER blood group system]); AD (Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema); AR (Lymphatic malformation 6); AD (Arthrogryposis, distal, type 1A); AD (Arthrogryposis, distal, type 2B4); AD (Congenital myopathy 23)",
PIGA,"Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic; AR (Multiple congenital anomalies-hypotonia-seizures syndrome 4); AR (Glycosylphosphatidylinositol biosynthesis defect 17); AR (Glycosylphosphatidylinositol biosynthesis defect 16); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta",
PIGB,"AR (Developmental and epileptic encephalopathy 80); AR (Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome); AR (Hyperphosphatasia with impaired intellectual development syndrome 1); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGC,"AR (Glycosylphosphatidylinositol biosynthesis defect 16); AR (Multiple congenital anomalies-hypotonia-seizures syndrome 4); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic; AR (Glycosylphosphatidylinositol biosynthesis defect 17)",
PIGF,"AR (Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome); AR (Hyperphosphatasia with impaired intellectual development syndrome 2); AR ([Blood group, EMM system]); AR (Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy); {Transcription of plasminogen activator inhibitor, modulator of}; AR (Plasminogen activator inhibitor-1 deficiency); AR (Rothmund-Thomson syndrome, type 3); {Microvascular complications of diabetes 1}; AR (Hyperphosphatasia with impaired intellectual development syndrome 1)",
PIGG,"AR ([Blood group, EMM system]); AR (Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy); AR (Ichthyosis, congenital, autosomal recessive 1); AR (Sjogren-Larsson syndrome); AR (Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome)",
PIGH,"AR (Glycosylphosphatidylinositol biosynthesis defect 17); AR (Multiple congenital anomalies-hypotonia-seizures syndrome 4); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic; AR (Glycosylphosphatidylinositol biosynthesis defect 16)",
PIGK,"AR (Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures); AR (Developmental and epileptic encephalopathy 95); AD (?Paroxysmal nocturnal hemoglobinuria 2); AR (Multiple congenital anomalies-hypotonia-seizures syndrome 3); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGL,"AR (CHIME syndrome); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGM,"AR (Glycosylphosphatidylinositol deficiency); AR (Emphysema due to AAT deficiency); AR (Emphysema-cirrhosis, due to AAT deficiency); AR (Hemorrhagic diathesis due to antithrombin Pittsburgh); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGN,"AR (Multiple congenital anomalies-hypotonia-seizures syndrome 1); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGO,"AR (Hyperphosphatasia with impaired intellectual development syndrome 2); AR (Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome); AR ([Blood group, EMM system]); AR (Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGP,"AR (Developmental and epileptic encephalopathy 55); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGQ,"AR (Multiple congenital anomalies-hypotonia-seizures syndrome 4); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic; AR (Glycosylphosphatidylinositol biosynthesis defect 17); AR (Glycosylphosphatidylinositol biosynthesis defect 16)",
PIGR,"AD ({IgA nephropathy, susceptibility to, 1})",
PIGS,"AR (Developmental and epileptic encephalopathy 95); AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (Gastrointestinal stromal tumor, familial); Germ cell tumors, somatic; Leukemia, acute myeloid, somatic; AD (Mastocytosis, cutaneous); Mastocytosis, systemic, somatic; AD (Piebaldism); AR ([Skeletal muscle glycogen content and metabolism QTL]); AD (Silver-Russell syndrome 3); AD (Silver-Russell syndrome 5)",
PIGT,"AD (?Paroxysmal nocturnal hemoglobinuria 2); AR (Multiple congenital anomalies-hypotonia-seizures syndrome 3); AR (Developmental and epileptic encephalopathy 95); AR (Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures); AR (Glycosylphosphatidylinositol biosynthesis defect 15); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGU,"AR (Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis); {Melanoma, cutaneous malignant, 7}; Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGV,"AR (Hyperphosphatasia with impaired intellectual development syndrome 1); AR (Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome); AR (Developmental and epileptic encephalopathy 80); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGW,"AR (Glycosylphosphatidylinositol biosynthesis defect 11); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGX,"Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIGY,"AR (Hyperphosphatasia with impaired intellectual development syndrome 6); Multiple congenital anomalies-hypotonia-seizures syndrome 2; Neurodevelopmental disorder with epilepsy and hemochromatosis; Paroxysmal nocturnal hemoglobinuria, somatic",
PIK3C2A,AR (Oculoskeletodental syndrome),
PIK3C2B,AR (Oculoskeletodental syndrome),
PIK3C3,"AR (Spinocerebellar ataxia, autosomal recessive 15); [Telomere length, mean leukocyte]",
PIK3CA,"Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AR (?Agammaglobulinemia 7, autosomal recessive); AD (Immunodeficiency 36); AD (SHORT syndrome); AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2)",
PIK3CB,"AR (Insulin-like growth factor I, resistance to); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; ?Roifman-Chitayat syndrome, digenic; AD (Immunodeficiency 14A, autosomal dominant); AR (Immunodeficiency 14B, autosomal recessive); AR (?Agammaglobulinemia 7, autosomal recessive); AD (Immunodeficiency 36); AD (SHORT syndrome); AD ({Nonsmall cell lung cancer, susceptibility to}); AD (Adenocarcinoma of lung, response to tyrosine kinase inhibitor in); AR (Neonatal nephrocutaneous inflammatory syndrome); AD (Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in)",
PIK3CD,"?Roifman-Chitayat syndrome, digenic; AD (Immunodeficiency 14A, autosomal dominant); AR (Immunodeficiency 14B, autosomal recessive); AR (?Agammaglobulinemia 7, autosomal recessive); AD (Immunodeficiency 36); AD (SHORT syndrome); ?Roifman-Chitayat syndrome, digenic; AR (Immunodeficiency 109 with lymphoproliferation); {Low renin hypertension, susceptibility to}; Aldosterone to renin ratio raised; AR (Hypoaldosteronism, congenital, due to CMO I deficiency); AR (Hypoaldosteronism, congenital, due to CMO II deficiency)",
PIK3CG,"AR (Immunodeficiency 97 with autoinflammation); AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; {Myocardial infarction, susceptibility to}; AD (Bleeding disorder, platelet-type, 24, autosomal dominant); AR (Glanzmann thrombasthenia 2); Purpura, posttransfusion; Thrombocytopenia, neonatal alloimmune",
PIK3R1,"AR (?Agammaglobulinemia 7, autosomal recessive); AD (Immunodeficiency 36); AD (SHORT syndrome); AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); ?Roifman-Chitayat syndrome, digenic; AD (Immunodeficiency 14A, autosomal dominant); AR (Immunodeficiency 14B, autosomal recessive); AR (?Immunodeficiency 123 with HPV-related verrucosis)",
PIK3R2,"AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1); Pituitary adenoma 4, ACTH-secreting, somatic; AR (?Agammaglobulinemia 7, autosomal recessive); AD (Immunodeficiency 36); AD (SHORT syndrome); AD (Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2); Breast cancer, somatic; Cerebral cavernous malformations 4, somatic; CLAPO syndrome, somatic; CLOVE syndrome, somatic; Colorectal cancer, somatic; Cowden syndrome 5; Gastric cancer, somatic; Hemifacial myohyperplasia, somatic; Hepatocellular carcinoma, somatic; Keratosis, seborrheic, somatic; Macrodactyly, somatic; Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic; Nevus, epidermal, somatic mosaic; Nonsmall cell lung cancer, somatic; Ovarian cancer, somatic; AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II); {Major affective disorder-7, susceptibility to}",
PIK3R3,"AR (Insulin-like growth factor I, resistance to); Diabetes mellitus, insulin-resistant, with acanthosis nigricans; AR (Donohue syndrome); AD (Hyperinsulinemic hypoglycemia, familial, 5); AR (Rabson-Mendenhall syndrome); AR (?Agammaglobulinemia 7, autosomal recessive); AD (Immunodeficiency 36); AD (SHORT syndrome); AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II)",
PIK3R4,"AR (Spinocerebellar ataxia, autosomal recessive 15)",
PIK3R5,AR (Ataxia-oculomotor apraxia 3); AR (Immunodeficiency 97 with autoinflammation),
PIKFYVE,"AD (Corneal fleck dystrophy); AR (Striatonigral degeneration, childhood-onset); AR (?Polymicrogyria, bilateral temporooccipital); AD (Amyotrophic lateral sclerosis 11); AR (Charcot-Marie-Tooth disease, type 4J); AR (Yunis-Varon syndrome)",
PIM1,"AD (?Retinitis pigmentosa 9); {Leukemia, acute lymphoblastic, susceptibility to, 3}; Burkitt lymphoma, somatic; AR (Immunodeficiency 129); AR (Agammaglobulinemia 6)",
PIM2,"AR (Emphysema due to AAT deficiency); AR (Emphysema-cirrhosis, due to AAT deficiency); AR (Hemorrhagic diathesis due to antithrombin Pittsburgh)",
PIN1,"AD ({Parkinson disease, susceptibility to}); AD (Frontotemporal dementia 1, with or without parkinsonism); AD (Pick disease); AD (Supranuclear palsy, progressive); AR (Supranuclear palsy, progressive atypical); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AR (Ataxia, cerebellar, Cayman type); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
PIN4,"AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II)",
PINK1,"AR (Parkinson disease 6, early onset); Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AR (Parkinson disease 7, autosomal recessive early-onset); AR (Mitochondrial complex I deficiency, nuclear type 22); AD (Charcot-Marie-Tooth disease, axonal, type 2A2A); AR (Charcot-Marie-Tooth disease, axonal, type 2A2B); AD (Hereditary motor and sensory neuropathy VIA); AR (Lipomatosis, multiple symmetric, with or without peripheral neuropathy)",
PINX1,"AD (Dyskeratosis congenita, autosomal dominant 3); AD (Revesz syndrome); AR (?Cerebroretinal microangiopathy with calcifications and cysts 3); AD (?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8); AD (Tumor predisposition syndrome 3)",
PIP,"AR (Ataxia with isolated vitamin E deficiency); AR (Ruijs-Aalfs syndrome); AR (Dyskeratosis congenita, autosomal dominant 4); AR (Dyskeratosis congenita, autosomal recessive 5); AD (Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 3); AR (?Ataxia-telangiectasia-like disorder 2); AR (Spondylometaphyseal dysplasia with corneal dystrophy)",
PIP5K1A,AR (Lethal congenital contractural syndrome 3); AD (Intellectual developmental disorder 60 with seizures),
PIP5K1C,AR (Lethal congenital contractural syndrome 3); AR (Congenital arthrogryposis with anterior horn cell disease); AR (Lethal congenital contracture syndrome 1); AD (Intellectual developmental disorder 60 with seizures),
PIR,"Retinitis pigmentosa 2; AD (?Deafness, autosomal dominant 81); AR (?Deafness, autosomal recessive 88); AD (Polycystic ovary syndrome 1)",
PISD,AR (Liberfarb syndrome),
PITPNA,AD (Miller-Dieker lissencephaly syndrome); AD (Chromosome 17p13.3 duplication syndrome),
PITPNC1,AR (Retinitis pigmentosa 38),
PITPNM1,"AD (Deafness, autosomal dominant 50)",
PITPNM3,AD (Cone-rod dystrophy 5),
PITRM1,"AR (Spinocerebellar ataxia, autosomal recessive 30)",
PITX1,"AD (Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly); AD (Liebenberg syndrome); AD (Holt-Oram syndrome); AR (Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome); AD (Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension); AR (Hypogonadotropic hypogonadism 23 with or without anosmia); ?Brachydactyly-syndactyly syndrome; AD (Brachydactyly, type D); AD (Brachydactyly, type E); AD (Syndactyly, type V); AD (Synpolydactyly 1); AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea)",
PITX2,"AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea); AD (Anterior segment dysgenesis 3, multiple subtypes); AD (Axenfeld-Rieger syndrome, type 3); AR (Microcephaly 7, primary, autosomal recessive)",
PITX3,"AD (Anterior segment dysgenesis 1, multiple subtypes); AR (Cataract 11, multiple types); AR (Cataract 11, syndromic, autosomal recessive); AD (Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism); AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea)",
PIWIL1,"AR (Spermatogenic failure 57); AR (?Spermatogenic failure 73); AD (Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures); AR (Spermatogenic failure 77)",
PIWIL2,AR (Oocyte/zygote/embryo maturation arrest 17); AR (?Spermatogenic failure 73); AR (Spermatogenic failure 57),
PIWIL4,AR (Spermatogenic failure 57); AR (?Spermatogenic failure 30),
PJA1,Craniofrontonasal dysplasia,
PJA2,"AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic",
PJVK,"AR (Deafness, autosomal recessive 59)",
PKD1,"AD (Polycystic kidney disease 1); AD (Polycystic kidney disease 2); ?Focal cortical dysplasia, type II, somatic; Lymphangioleiomyomatosis, somatic; AD (Tuberous sclerosis-2); AD (Polycystic kidney disease, infantile severe, with tuberous sclerosis); Focal cortical dysplasia, type II, somatic; Lymphangioleiomyomatosis; AD (Tuberous sclerosis-1); AD (Polycystic kidney disease 3); AD (Polycystic liver disease 1)",
PKD1L1,"AR (Heterotaxy, visceral, 8, autosomal); AD (Polycystic kidney disease 2); AR (Heterotaxy, visceral, 13, autosomal)",
PKD2,"AD (Polycystic kidney disease 2); AD (Polycystic kidney disease 1); AR (Heterotaxy, visceral, 8, autosomal); AD (Polycystic liver disease 1); ?Nephronophthisis 9; AD (Polycystic kidney disease 8); AR (Renal-hepatic-pancreatic dysplasia 2)",
PKD2L1,"AR (Heterotaxy, visceral, 8, autosomal)",
PKDCC,AR (Rhizomelic limb shortening with dysmorphic features),
PKHD1,"AR (Polycystic kidney disease 4, with or without hepatic disease); AR (Deafness, autosomal recessive 124); {Renal cell carcinoma}; AD (Renal cysts and diabetes syndrome); AD (Type 2 diabetes mellitus); AD (Polycystic kidney disease 2); AD (Polycystic kidney disease 1); AD (Polycystic liver disease 1)",
PKHD1L1,"AR (Deafness, autosomal recessive 124)",
PKIB,"AD (Amyotrophic lateral sclerosis 10, with or without FTD); AD (Frontotemporal lobar degeneration, TARDBP-related)",
PKLR,"AD ([Adenosine triphosphate, elevated, of erythrocytes]); AR (Anemia, congenital, nonspherocytic hemolytic, 2, pyruvate kinase deficient); AD ({Lewy body dementia, susceptibility to}); AD ({Parkinson disease, late-onset, susceptibility to}); AR (Gaucher disease, perinatal lethal); AR (Gaucher disease, type I); AR (Gaucher disease, type II); AR (Gaucher disease, type III); AR (Gaucher disease, type IIIC); AD ([Hereditary persistence of fetal hemoglobin]); AR (Anemia, congenital dyserythropoietic, type IVb); AD (Anemia, dyserythropoietic congenital, type IVa); AD (Blood group--Lutheran inhibitor); AR (Insensitivity to pain, congenital, with anhidrosis); AD (Erythrocytosis, familial, 7); AD (Heinz body anemia); Hemoglobin H disease, deletional and nondeletional; Thalassemia, alpha-",
PKM,"Pituitary tumor, invasive; [Memory, enhanced, QTL]",
PKN3,"Leukemia, juvenile myelomonocytic, somatic",
PKNOX1,"AD (CEBALID syndrome); AD (Meningioma); AD (Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay); Down syndrome",
PKNOX2,AR (Hydrolethalus syndrome),
PKP1,AR (Ectodermal dysplasia/skin fragility syndrome); AD (?Arrhythmogenic right ventricular dysplasia 12); AR (Naxos disease); AD (Arrhythmogenic right ventricular dysplasia 9),
PKP2,"AD (Arrhythmogenic right ventricular dysplasia 9); AR (Craniometaphyseal dysplasia, autosomal recessive); AD (Erythrokeratodermia variabilis et progressiva 3); AD (Oculodentodigital dysplasia); AR (Oculodentodigital dysplasia, autosomal recessive); AD (Palmoplantar keratoderma with congenital alopecia); AD (Syndactyly, type III); AD (Arrhythmogenic right ventricular dysplasia 13); AD (Arrhythmogenic right ventricular dysplasia 10); AR (Cardiomyopathy, dilated, 1BB); AR (?Cardiomyopathy, familial hypertrophic, 30, atrial); AD (Preeclampsia/eclampsia 5); AR (Cardiomyopathy, dilated, 2F)",
PLA2G1B,"AD ({?Colorectal cancer, susceptibility to}); AR (Gastrointestinal ulceration, recurrent, with dysfunctional platelets); AD (Abdominal obesity-metabolic syndrome 1)",
PLA2G2A,"AD ({?Colorectal cancer, susceptibility to}); AR (Gastrointestinal ulceration, recurrent, with dysfunctional platelets); AR ([Fleck retina, familial benign])",
PLA2G2C,"AR ([Fleck retina, familial benign])",
PLA2G4A,"AR (Gastrointestinal ulceration, recurrent, with dysfunctional platelets); AR (Ceroid lipofuscinosis, neuronal, 1); AD (Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities)",
PLA2G5,"AR ([Fleck retina, familial benign])",
PLA2G6,"AR (Infantile neuroaxonal dystrophy 1); AR (Neurodegeneration with brain iron accumulation 2B); AR (Parkinson disease 14, autosomal recessive); AD ({Melanoma, cutaneous malignant, 1}); AR (?Mitochondrial myopathy with lactic acidosis)",
PLA2G7,"AR (Platelet-activating factor acetylhydrolase deficiency); [Angiotensin I-converting enzyme, benign serum increase]; {Microvascular complications of diabetes 3}; {Myocardial infarction, susceptibility to}; {SARS, progression of}; {Stroke, hemorrhagic}; AR (Renal tubular dysgenesis)",
PLA2R1,"{?Membranous nephropathy, susceptibility to}; AR ({Celiac disease, susceptibility to})",
PLAA,"AR (Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies); [Memory, enhanced, QTL]",
PLAAT1,"AR (Lipodystrophy, familial partial, type 9)",
PLAAT3,"AR (Lipodystrophy, familial partial, type 9)",
PLAG1,"Adenomas, salivary gland pleomorphic, somatic; AD (Silver-Russell syndrome 4); AD (Silver-Russell syndrome 3)",
PLAGL1,"AR ({Diabetes mellitus, transient neonatal 1}); AR (Arterial calcification, generalized, of infancy, 2); AR (Pseudoxanthoma elasticum); AD (Pseudoxanthoma elasticum, forme fruste); AR (Oocyte/zygote/embryo maturation arrest 19)",
PLAGL2,AD (Dowling-Degos disease 2),
PLAT,"?Thrombophilia 9 due to decreased release of tissue plasminogen; AD (Angioedema, hereditary, 4); AR (Dysplasminogenemia); AR (Plasminogen deficiency, type I); AR (Deafness, autosomal recessive 77); [Kallikrein, decreased urinary activity of]; AD ({Alzheimer disease, late-onset, susceptibility to}); AD (Quebec platelet disorder); {Transcription of plasminogen activator inhibitor, modulator of}; AR (Plasminogen activator inhibitor-1 deficiency); AD (Polycystic kidney disease 2)",
PLAU,"AD ({Alzheimer disease, late-onset, susceptibility to}); AD (Quebec platelet disorder); Alzheimer disease 6; AD (Angioedema, hereditary, 4); AR (Dysplasminogenemia); AR (Plasminogen deficiency, type I); [Kallikrein, decreased urinary activity of]; {Transcription of plasminogen activator inhibitor, modulator of}; AR (Plasminogen activator inhibitor-1 deficiency); Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic",
PLAUR,"AR (Meleda disease); AD ({Alzheimer disease, late-onset, susceptibility to}); AD (Quebec platelet disorder)",
PLCB1,"AR (Developmental and epileptic encephalopathy 12); Platelet PLC beta-2 deficiency; AD ({Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}); {Autism susceptibility 1}",
PLCB2,Platelet PLC beta-2 deficiency; AR (Spondylometaphyseal dysplasia with corneal dystrophy); AD (Skraban-Deardorff syndrome); AD ([Phenylthiocarbamide tasting]),
PLCB3,AR (Spondylometaphyseal dysplasia with corneal dystrophy); Platelet PLC beta-2 deficiency,
PLCB4,AD (Auriculocondylar syndrome 2A); AR (Auriculocondylar syndrome 2B); AD (Auriculocondylar syndrome 1),
PLCD1,"AR (Nail disorder, nonsyndromic congenital, 3, (leukonychia)); AR (Holoprosencephaly 14); AR (Immunodeficiency 8)",
PLCE1,"AR (Nephrotic syndrome, type 3); AR (Nephrotic syndrome, type 21); AR (Nephrotic syndrome, type 16); AR (Palmoplantar keratoderma and woolly hair)",
PLCG1,"AD (?Immune dysregulation, autoimmunity, and autoinflammation); AD (Autoinflammation, antibody deficiency, and immune dysregulation syndrome); AD (Familial cold autoinflammatory syndrome 3); AR (Immunodeficiency 52); Congenital disorder of glycosylation, type Icc; Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia",
PLCG2,"AD (Autoinflammation, antibody deficiency, and immune dysregulation syndrome); AD (Familial cold autoinflammatory syndrome 3); AD (?Immune dysregulation, autoimmunity, and autoinflammation); AR (?Agammaglobulinemia 4)",
PLCH1,AR (Holoprosencephaly 14); AD (Holoprosencephaly 1),
PLCL1,AD (Glass syndrome),
PLCZ1,AR (Spermatogenic failure 17); AR (Spermatogenic failure 86); AR (Spermatogenic failure 53); AR (?Spermatogenic failure 87),
PLD1,"AR (Cardiac valvular dysplasia 1); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (Baraitser-Winter syndrome 2); AD (Deafness, autosomal dominant 20/26); AD (Baraitser-Winter syndrome 1); Becker nevus, syndromic or isolated, somatic mosaic; Congenital smooth muscle hamartoma with or without hemihypertrophy, somatic mosaic; AD (Dystonia-deafness syndrome 1); AD (Thrombocytopenia 8, with dysmorphic features and developmental delay)",
PLD2,AR (Cardiac valvular dysplasia 1); AR (Immunodeficiency 40),
PLD3,AD (?Spinocerebellar ataxia 46),
PLD4,AD (?Spinocerebellar ataxia 46),
PLEC,"AR (?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive); AD (Epidermolysis bullosa simplex 5A, Ogna type); AR (Epidermolysis bullosa simplex 5B, with muscular dystrophy); AR (Epidermolysis bullosa simplex 5C, with pyloric atresia); AR (Muscular dystrophy, limb-girdle, autosomal recessive 17)",
PLEK,"AD (Hiatt-Neu-Cooper neurodevelopmental syndrome); AR (Bardet-Biedl syndrome 4); AD (46XY sex reversal 6); AR (?Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy)",
PLEKHA1,"{Macular degeneration, age-related, 8}; {Macular degeneration, age-related, 7}; {Macular degeneration, age-related, neovascular type}; AR (CARASIL syndrome); AD (Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2); AR (Ichthyosis, spastic quadriplegia, and impaired intellectual development); AD (Spinocerebellar ataxia 34); AD (Stargardt disease 3)",
PLEKHG2,AR (Leukodystrophy and acquired microcephaly with or without dystonia),
PLEKHG4,AD (Spinocerebellar ataxia 1),
PLEKHG5,"AR (Charcot-Marie-Tooth disease, recessive intermediate C); AR (Neuronopathy, distal hereditary motor, autosomal recessive 4)",
PLEKHM1,"AR (?Osteopetrosis, autosomal recessive 6); AD (Osteopetrosis, autosomal dominant 3)",
PLEKHM3,"Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic",
PLG,"AD (Angioedema, hereditary, 4); AR (Dysplasminogenemia); AR (Plasminogen deficiency, type I); AD ([LPA deficiency, congenital]); AD ({Coronary artery disease, susceptibility to}); AR (Metaphyseal anadysplasia 2)",
PLIN1,"AD (Lipodystrophy, familial partial, type 4); AR (Chanarin-Dorfman syndrome); {Leprosy, paucibacillary type, susceptibility to}; AR (Neutral lipid storage disease with myopathy); AD (?Neuronopathy, distal hereditary motor, autosomal dominant 12); AR (Neuronopathy, distal hereditary motor, autosomal recessive 6); AD (Spastic paraplegia 31, autosomal dominant); AD (Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant)",
PLIN2,"AR (Chanarin-Dorfman syndrome); AR (Neutral lipid storage disease with myopathy); AD (Lipodystrophy, familial partial, type 4); {Leprosy, paucibacillary type, susceptibility to}",
PLIN4,"AD (Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant)",
PLIN5,AR (Chanarin-Dorfman syndrome); AR (Neutral lipid storage disease with myopathy),
PLK1,"AR (Trichothiodystrophy 4, nonphotosensitive); AD ({Colon cancer, susceptibility to}); AR (?Seckel syndrome 7)",
PLK4,"AR (Microcephaly and chorioretinopathy, autosomal recessive, 2); AR (Microcephaly 7, primary, autosomal recessive); AR (Microcephaly 9, primary, autosomal recessive); AR (Seckel syndrome 5); AR (Cone-rod dystrophy and hearing loss); AR (?Seckel syndrome 4); AR (Microcephaly 6, primary, autosomal recessive); AR (Microcephaly and chorioretinopathy, autosomal recessive, 1)",
PLN,"Cardiomyopathy, dilated, 1P; AD (Cardiomyopathy, hypertrophic, 18); AD (Acrokeratosis verruciformis); AD (Darier disease); AR (Combined oxidative phosphorylation deficiency 11); Pituitary tumor, invasive",
PLOD1,"AR (Ehlers-Danlos syndrome, kyphoscoliotic type, 1); AR (BCARD syndrome (lysyl hydroxylase 3 deficiency)); AR (Bruck syndrome 2); AD (Anterior segment dysgenesis 4); AD (Axenfeld-Rieger syndrome, type 1); AD (Ring dermoid of cornea); AD (Aortic aneurysm, familial abdominal 1)",
PLOD2,"AR (Bruck syndrome 2); AR (Bruck syndrome 1); AR (Osteogenesis imperfecta, type XI); AR (BCARD syndrome (lysyl hydroxylase 3 deficiency))",
PLOD3,AR (BCARD syndrome (lysyl hydroxylase 3 deficiency)); AR (Bruck syndrome 2),
PLP1,"Pelizaeus-Merzbacher disease; Spastic paraplegia 2, X-linked; AR (?Leukodystrophy, hypomyelinating, 28); AD (Charcot-Marie-Tooth disease, dominant intermediate D); AD (Charcot-Marie-Tooth disease, type 1B); AD (Charcot-Marie-Tooth disease, type 2I); AD (Charcot-Marie-Tooth disease, type 2J); AR (Dejerine-Sottas disease); AD (Hypomyelinating neuropathy, congenital, 2); AD (Roussy-Levy syndrome)",
PLPBP,"AR (Epilepsy, early-onset, 1, vitamin B6-dependent)",
PLS1,"AD (Deafness, autosomal dominant 76); AD (Primary lateral sclerosis, adult, 1); AD (?Cutaneous telangiectasia and cancer syndrome, familial); AR (Seckel syndrome 1)",
PLS3,"Bone mineral density QTL18, osteoporosis; Diaphragmatic hernia 5, X-linked; AR (Spinal muscular atrophy-1); AR (Spinal muscular atrophy-2); AR (Spinal muscular atrophy-3); AR (Spinal muscular atrophy-4); AD (Baraitser-Winter syndrome 2); AD (Deafness, autosomal dominant 20/26); AD ({Amyotrophic lateral sclerosis, susceptibility to, 13}); AD ({Parkinson disease, late-onset, susceptibility to}); AD (Spinocerebellar ataxia 2)",
PLSCR1,"?Hemolytic anemia, congenital, X-linked",
PLTP,"AR (Congenital disorder of glycosylation, type IIt); [High density lipoprotein cholesterol level QTL 1]; AR ([High density lipoprotein cholesterol level QTL 11]); AD (Combined hyperlipidemia, familial); AR (Lipoprotein lipase deficiency)",
PLVAP,"AR (Diarrhea 10, protein-losing enteropathy type); Colorectal cancer, somatic; AD (Exudative vitreoretinopathy 7); Hepatocellular carcinoma, somatic; Medulloblastoma, somatic; AD (Neurodevelopmental disorder with spastic diplegia and visual defects); Ovarian cancer, somatic; Pilomatricoma, somatic",
PLXNA1,"AR (Dworschak-Punetha neurodevelopmental syndrome); {Rheumatoid arthritis, susceptibility to}; AR (MHC class II deficiency 1); AD (Facial paresis, hereditary congenital, 1)",
PLXNA2,"AD (Atrial septal defect 9); AD (Atrioventricular septal defect 5); AD (Pancreatic agenesis and congenital heart defects); Persistent truncus arteriosus; AD (Tetralogy of Fallot); AD (Robinow syndrome, autosomal dominant 1); AD (Beckwith-Wiedemann syndrome); AD (Silver-Russell syndrome 1); AD (Wilms tumor 2)",
PLXNA3,AR (Neurodevelopmental disorder with neuromuscular and skeletal abnormalities),
PLXNA4,"AD (Epilepsy, progressive myoclonic, 11)",
PLXNB1,"AD (?Arthrogryposis, distal, type 11); AR (?Deafness, autosomal recessive 97); AD ({Osteofibrous dysplasia, susceptibility to}); Hepatocellular carcinoma, childhood type, somatic; Renal cell carcinoma, papillary, 1, familial and somatic",
PLXNB2,"AR (Congenital heart defects, multiple types, 9); AD (Hydrocephalus, congenital, 4)",
PLXNB3,"Adrenoleukodystrophy; Adrenomyeloneuropathy, adult; Retinitis pigmentosa 99",
PLXND1,"AR (Congenital heart defects, multiple types, 9); AD (Total anomalous pulmonary venous return); AD (?Moebius syndrome); AD (Facial paresis, hereditary congenital, 1)",
PM20D1,{Parkinson disease 16},
PMAIP1,"AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; AR (?Caspase 8 lymphadenopathy syndrome); AD ({Breast cancer, protection against}); AD ({Lung cancer, protection against}); Hepatocellular carcinoma, somatic; {Inflammatory bowel disease 14}; {Systemic lupus erythematosus, susceptibility to, 10}; AD (ADULT syndrome); AD (Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3); AD (Hay-Wells syndrome); AD (Limb-mammary syndrome); Orofacial cleft 8; AD (Premature ovarian failure 21); AD (Rapp-Hodgkin syndrome); AD (Split-hand/foot malformation 4); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
PMEL,"AD (Ocular pigment dispersion with or without glaucoma); AR (Oculocutaneous albinism, type VIII)",
PMF1,"AR (Spermatogenic failure 31); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia); AR (Microcephaly 4, primary, autosomal recessive)",
PMFBP1,AR (Spermatogenic failure 31),
PML,"Leukemia, acute promyelocytic; ?Orofacial cleft 10; AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities)",
PMM1,"AR (Congenital disorder of glycosylation, type Ia); AD (Menke-Hennekam syndrome 1); AD (Rubinstein-Taybi syndrome 1)",
PMM2,"AR (Congenital disorder of glycosylation, type Ia); AD (Menke-Hennekam syndrome 1); AD (Rubinstein-Taybi syndrome 1)",
PMP2,"AD (Charcot-Marie-Tooth disease, demyelinating, type 1G); AD (?Neuropathy, inflammatory demyelinating); AD (Charcot-Marie-Tooth disease, type 1A); AD (Charcot-Marie-Tooth disease, type 1E); AR (Dejerine-Sottas disease); AD (Neuropathy, recurrent, with pressure palsies); AD (Roussy-Levy syndrome)",
PMP22,"AD (?Neuropathy, inflammatory demyelinating); AD (Charcot-Marie-Tooth disease, type 1A); AD (Charcot-Marie-Tooth disease, type 1E); AR (Dejerine-Sottas disease); AD (Neuropathy, recurrent, with pressure palsies); AD (Roussy-Levy syndrome); AR (Erythrokeratodermia variabilis et progressiva 7); AD (Olmsted syndrome 2); AR (Basel-Vanagait-Smirin-Yosef syndrome)",
PMPCA,"AR (Spinocerebellar ataxia, autosomal recessive 2); AR (CODAS syndrome); AR (Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis syndrome); AR (Joubert syndrome 1)",
PMPCB,"AR (Multiple mitochondrial dysfunctions syndrome 6); AR (CODAS syndrome); AR (Spinocerebellar ataxia, autosomal recessive 2)",
PMS1,"Lynch syndrome 4; AR (Mismatch repair cancer syndrome 4); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome); AD ({Endometrial cancer, susceptibility to}); Colorectal cancer, hereditary nonpolyposis, type 7; Colorectal cancer, somatic; AR (Interstitial nephritis, karyomegalic); AD ({Endometrial cancer, familial}); AD (Lynch syndrome 5); AR (Mismatch repair cancer syndrome 3)",
PMS2,"Lynch syndrome 4; AR (Mismatch repair cancer syndrome 4); Lynch syndrome 2; AR (Mismatch repair cancer syndrome 1); AD (Muir-Torre syndrome); AD ({Endometrial cancer, familial}); AD (Lynch syndrome 5); AR (Mismatch repair cancer syndrome 3); AR (Leukodystrophy, hypomyelinating, 17)",
PMVK,"AD (Porokeratosis 1, multiple types)",
PNISR,"AD (Intellectual developmental disorder, autosomal dominant 72)",
PNKD,"AD (Paroxysmal nonkinesigenic dyskinesia 1); AD ({Epilepsy, idiopathic generalized, susceptibility to, 16}); AR (Cerebellar atrophy, developmental delay, and seizures); AD (Liang-Wang syndrome); AD (Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy); AD (Paroxysmal nonkinesigenic dyskinesia 2)",
PNKP,"AR (?Charcot-Marie-Tooth disease, type 2B2); AR (Ataxia-oculomotor apraxia 4); AR (Microcephaly, seizures, and developmental delay); AR (Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia); AR (Basel-Vanagait-Smirin-Yosef syndrome); AR (?Spinocerebellar ataxia, autosomal recessive 26)",
PNLDC1,AR (Spermatogenic failure 57),
PNLIP,AR (?Pancreatic lipase deficiency),
PNMT,"AR (Orthostatic hypotension 1, due to DBH deficiency); AD (Cardiomyopathy, hypertrophic, 25); AR (Muscular dystrophy, limb-girdle, autosomal recessive 7)",
PNN,"AD (Intellectual developmental disorder, autosomal dominant 72)",
PNO1,AR (Inflammatory poikiloderma with hair abnormalities and acral keratoses),
PNOC,AD ({Schizophrenia}),
PNP,"AR (Immunodeficiency due to purine nucleoside phosphorylase deficiency); AR (Blistering, acantholytic, of oral and laryngeal mucosa); AR (Dystonia, DOPA-responsive); AR (Hyperphenylalaninemia, BH4-deficient, B); AD (NESCAV syndrome); AR (Neuropathy, hereditary sensory, type IIC); AD (Spastic paraplegia 30, autosomal dominant); AR (Spastic paraplegia 30, autosomal recessive); AR (Pyridoxamine 5'-phosphate oxidase deficiency); AR (Immunodeficiency 7, TCR-alpha/beta deficient)",
PNPLA1,"AR (Ichthyosis, congenital, autosomal recessive 10)",
PNPLA2,"AR (Neutral lipid storage disease with myopathy); AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AR (Chanarin-Dorfman syndrome); AD (Lipodystrophy, familial partial, type 4)",
PNPLA3,"{Fatty liver disease, susceptibility to, 1}; AD ({Fatty liver disease, protection from}); AR (Neutral lipid storage disease with myopathy)",
PNPLA4,AR (Neutral lipid storage disease with myopathy),
PNPLA6,"AR (?Laurence-Moon syndrome); AR (Boucher-Neuhauser syndrome); AR (Oliver-McFarlane syndrome); AR (Spastic paraplegia 39, autosomal recessive)",
PNPLA8,AR (?Mitochondrial myopathy with lactic acidosis),
PNPO,AR (Pyridoxamine 5'-phosphate oxidase deficiency),
PNPT1,"AR (Combined oxidative phosphorylation deficiency 13); AR (Deafness, autosomal recessive 70, with or without adult-onset neurodegeneration); AD (Spinocerebellar ataxia 25)",
POC1A,"AR (Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis); AR (Cone-rod dystrophy 20)",
POC1B,"AR (Cone-rod dystrophy 20); AR (Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis); AR (Seckel syndrome 11)",
POC5,"AD (Scoliosis, idiopathic 1); AR (Seckel syndrome 11)",
PODXL2,"AD (Facial paresis, hereditary congenital, 1)",
POF1B,?Premature ovarian failure 2B,
POFUT1,AD (Dowling-Degos disease 2); AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1),
POFUT2,AR (Peters-plus syndrome),
POGLUT1,"AD (Dowling-Degos disease 4); AR (Muscular dystrophy, limb-girdle, autosomal recessive 21)",
POGZ,"AD (White-Sutton syndrome); AD (Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features)",
POLA1,"Pigmentary disorder, reticulate, with systemic manifestations, X-linked; Van Esch-O'Driscoll syndrome; AR (?Fanconi anemia, complementation group V)",
POLA2,AR (Cerebroretinal microangiopathy with calcifications and cysts 2); AR (Primordial dwarfism-immunodeficiency-lipodystrophy syndrome),
POLB,"AR (?Spinocerebellar ataxia, autosomal recessive 26); AD (Spinocerebellar ataxia 48); AR (Spinocerebellar ataxia, autosomal recessive 16); AD (Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities); AR (Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia); AR (Baller-Gerold syndrome); AR (RAPADILINO syndrome); AR (Rothmund-Thomson syndrome, type 2)",
POLD1,"AD ({Colorectal cancer, susceptibility to, 10}); AR (Immunodeficiency 120); AD (Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome); AD ({Colorectal cancer, susceptibility to, 12}); AR (FILS syndrome); AR (IMAGE-I syndrome); AR (Immunodeficiency 122); AR (Multiple mitochondrial dysfunctions syndrome 10)",
POLD2,"AR (Immunodeficiency 122); AD ({Colorectal cancer, susceptibility to, 10}); AR (Immunodeficiency 120); AD (Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome); AR (Werner syndrome)",
POLD3,"AR (Immunodeficiency 122); AR (Ruijs-Aalfs syndrome); AR (Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome); AD ({Colorectal cancer, susceptibility to, 10}); AR (Immunodeficiency 120); AD (Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome); AR (?Ataxia-telangiectasia-like disorder 2)",
POLD4,"AR (Immunodeficiency 122); AD ({Colorectal cancer, susceptibility to, 10}); AR (Immunodeficiency 120); AD (Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome)",
POLE,"AD ({Colorectal cancer, susceptibility to, 12}); AR (FILS syndrome); AR (IMAGE-I syndrome); AR (Joubert syndrome 21); AD ({Colorectal cancer, susceptibility to, 10}); AR (Immunodeficiency 120); AD (Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome); AR (Microcephaly 2, primary, autosomal recessive, with or without cortical malformations)",
POLE2,"AR (?Seckel syndrome 7); AD ({Colorectal cancer, susceptibility to, 12}); AR (FILS syndrome); AR (IMAGE-I syndrome)",
POLE3,"AD (?Epilepsy, myoclonic, familial adult, 4)",
POLE4,"AD (?Epilepsy, myoclonic, familial adult, 4)",
POLG,"AR (Mitochondrial DNA depletion syndrome 4A (Alpers type)); AR (Mitochondrial DNA depletion syndrome 4B (MNGIE type)); AR (Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)); AD (Progressive external ophthalmoplegia, autosomal dominant 1); AR (Progressive external ophthalmoplegia, autosomal recessive 1); AR (?Mitochondrial DNA depletion syndrome 16 (hepatic type)); AR (?Mitochondrial DNA depletion syndrome 16B (neuroophthalmic type)); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4); AR (Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)); AR (Perrault syndrome 5); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3)",
POLG2,"AR (?Mitochondrial DNA depletion syndrome 16 (hepatic type)); AR (?Mitochondrial DNA depletion syndrome 16B (neuroophthalmic type)); AD (Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4); AR (?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)); {Glaucoma, normal tension, susceptibility to}; AR (Behr syndrome); AD (Optic atrophy 1); AD (Optic atrophy plus syndrome); AR (Mitochondrial DNA depletion syndrome 4A (Alpers type)); AR (Mitochondrial DNA depletion syndrome 4B (MNGIE type)); AR (Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)); AD (Progressive external ophthalmoplegia, autosomal dominant 1); AR (Progressive external ophthalmoplegia, autosomal recessive 1)",
POLGARF,"AR (Mitochondrial DNA depletion syndrome 4A (Alpers type)); AR (Mitochondrial DNA depletion syndrome 4B (MNGIE type)); AR (Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)); AD (Progressive external ophthalmoplegia, autosomal dominant 1); AR (Progressive external ophthalmoplegia, autosomal recessive 1)",
POLH,"AR (Xeroderma pigmentosum, variant type); AR (Ruijs-Aalfs syndrome); AR (Werner syndrome)",
POLI,"AR (Keratosis linearis with ichthyosis congenita and sclerosing keratoderma); AD (Proteasome-associated autoinflammatory syndrome 2); {Crohn disease-associated growth failure}; {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}; AD ({Kaposi sarcoma in HIV+, susceptibility to}); {Rheumatoid arthritis, systemic juvenile}; AR ({Type 1 diabetes mellitus}); AD ({Type 2 diabetes mellitus}); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AD (Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant); AD (Neuropathy, hereditary sensory, type IE); AR (Immunodeficiency 72 with autoinflammation)",
POLK,"AR (Surfactant metabolism dysfunction, pulmonary, 1); AR (Werner syndrome); AD (46XY sex reversal 9); Diaphragmatic hernia 3; AD (Tetralogy of Fallot)",
POLL,"Intellectual developmental disorder, X-linked syndromic, Turner type; AD (Split-hand/foot malformation 3, gene duplication syndrome); AD (Mitchell syndrome); AR (Peroxisomal acyl-CoA oxidase deficiency); HSD10 mitochondrial disease",
POLQ,"AD ({Breast cancer, susceptibility to}); AD (Fanconi anemia, complementation group R); AD (Mirror movements 2)",
POLR1A,"AD (Acrofacial dysostosis, Cincinnati type); AR (Leukodystrophy, hypomyelinating, 27); AR (Warsaw breakage syndrome)",
POLR1B,"AD (Treacher-Collins syndrome 4); AD (Neurodegeneration, childhood-onset, with brain atrophy); AD (Acrofacial dysostosis, Cincinnati type); AR (Leukodystrophy, hypomyelinating, 27)",
POLR1C,"AR (Leukodystrophy, hypomyelinating, 11); AR (Treacher Collins syndrome 3); AD (Acrofacial dysostosis, Cincinnati type); AR (Leukodystrophy, hypomyelinating, 27); AR (Treacher Collins syndrome 2)",
POLR1D,AR (Treacher Collins syndrome 2),
POLR1E,"AD (Neurodegeneration, childhood-onset, with brain atrophy)",
POLR2A,"AD (Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities); AR (Congenital cataracts, facial dysmorphism, and neuropathy)",
POLR2B,"{Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1; AD (Charcot-Marie-Tooth disease, demyelinating, type 1I); AR (Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism)",
POLR2K,"AR (Ciliary dyskinesia, primary, 28)",
POLR2M,"AR (Cardiomyopathy, dilated, 2K)",
POLR3A,"AR (Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism); AR (Wiedemann-Rautenstrauch syndrome); AD (Charcot-Marie-Tooth disease, demyelinating, type 1I); AR (Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism); AD (Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities); AR (Leukodystrophy, hypomyelinating, 11); AR (Treacher Collins syndrome 3)",
POLR3B,"AD (Charcot-Marie-Tooth disease, demyelinating, type 1I); AR (Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism); AR (Leukodystrophy, hypomyelinating, 11); AR (Treacher Collins syndrome 3); AR (Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism); AR (Wiedemann-Rautenstrauch syndrome)",
POLR3C,"AR (Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism); AR (Wiedemann-Rautenstrauch syndrome)",
POLR3D,"AR (Short stature, oligodontia, dysmorphic facies, and motor delay)",
POLR3F,AD (?Immunodeficiency 101 (varicella zoster virus-specific)),
POLR3G,"AR (Short stature, oligodontia, dysmorphic facies, and motor delay)",
POLR3GL,"AR (Short stature, oligodontia, dysmorphic facies, and motor delay)",
POLR3K,"AR (Leukodystrophy, hypomyelinating, 21)",
POLRMT,AR (Combined oxidative phosphorylation deficiency 55); AR (Combined oxidative phosphorylation deficiency 58); AR (Combined oxidative phosphorylation deficiency 51); AD (Neurodevelopmental disorder with variable motor and speech impairment),
POM121,"AR (?Atrial fibrillation 15); AR (?Nephrotic syndrome, type 19); AD (Oocyte/zygote/embryo maturation arrest 3)",
POMC,"AR ({Obesity, early-onset, susceptibility to}); AR (Obesity, adrenal insufficiency, and red hair due to POMC deficiency); AR (Adrenocorticotropic hormone deficiency); Rhabdomyosarcoma, alveolar; AR (Obesity, morbid, due to leptin deficiency); AR (BDV syndrome); AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20))",
POMGNT1,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3); AR (Retinitis pigmentosa 76); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9); AR (Cardiomyopathy, dilated, 1X); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4); AR (Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4)",
POMGNT2,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 8); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8)",
POMK,"AR (?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12)",
POMP,"AR (Keratosis linearis with ichthyosis congenita and sclerosing keratoderma); AD (Proteasome-associated autoinflammatory syndrome 2); AR (Proteasome-associated autoinflammatory syndrome 1 and digenic forms); AR (Leukodystrophy, hypomyelinating, 10); AR (Lissencephaly 6, with microcephaly); AR (?Anencephaly 2)",
POMT1,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3); AR (Retinitis pigmentosa 76)",
POMT2,"AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1); AR (Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3); AR (Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3); AR (Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3); AR (Retinitis pigmentosa 76)",
POMZP3,AD (Oocyte/zygote/embryo maturation arrest 3),
PON1,"{Coronary artery disease, susceptibility to}; {Coronary artery spasm 2, susceptibility to}; {Microvascular complications of diabetes 5}; {Organophosphate poisoning, sensitivity to}; {Coronary artery disease, susceptibility to}; [Longevity 1]; AR (Homocystinuria, B6-responsive and nonresponsive types); AR (Thrombosis, hyperhomocysteinemic)",
PON2,"{Coronary artery disease, susceptibility to}; {Coronary artery disease, susceptibility to}; {Coronary artery spasm 2, susceptibility to}; {Microvascular complications of diabetes 5}; {Organophosphate poisoning, sensitivity to}",
PON3,"{Coronary artery disease, susceptibility to}; {Coronary artery disease, susceptibility to}; {Coronary artery spasm 2, susceptibility to}; {Microvascular complications of diabetes 5}; {Organophosphate poisoning, sensitivity to}",
POP1,"AR (Anauxetic dysplasia 2); AR (Muscular dystrophy, limb-girdle, autosomal recessive 25); AR (Muscular dystrophy, limb-girdle, autosomal recessive 26)",
POPDC1,"AR (Muscular dystrophy, limb-girdle, autosomal recessive 25); AR (Muscular dystrophy, limb-girdle, autosomal recessive 26)",
POPDC2,"AR (Muscular dystrophy, limb-girdle, autosomal recessive 25); AR (Muscular dystrophy, limb-girdle, autosomal recessive 26)",
POPDC3,"AR (Muscular dystrophy, limb-girdle, autosomal recessive 26); AR (Muscular dystrophy, limb-girdle, autosomal recessive 25)",
POR,"AR (Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis); Disordered steroidogenesis due to cytochrome P450 oxidoreductase; Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1)",
PORCN,Focal dermal hypoplasia; Angio serpiginosum,
POSTN,"AD (Cleidocranial dysplasia); AD (Cleidocranial dysplasia, forme fruste, dental anomalies only); AD (Cleidocranial dysplasia, forme fruste, with brachydactyly); AD (Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly); {Major depressive disorder and accelerated response to antidepressant drug treatment}; AR (Intellectual developmental disorder, autosomal recessive 43); AD (Craniosynostosis 1); AD (Robinow-Sorauf syndrome); AD (Saethre-Chotzen syndrome with or without eyelid anomalies); AD (Sweeney-Cox syndrome)",
POT1,"AR (?Cerebroretinal microangiopathy with calcifications and cysts 3); AD (?Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8); AD (Tumor predisposition syndrome 3); AR (?Dyskeratosis congenita, autosomal dominant 6); AR (?Dyskeratosis congenita, autosomal recessive 7); AD (Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6); AD (?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3); AD (?Myopathy, distal, 3); AD (Amyotrophic lateral sclerosis 20); AR (Cerebroretinal microangiopathy with calcifications and cysts 2); AR (Cerebroretinal microangiopathy with calcifications and cysts)",
POTEE,AD (Chromosome 6q25-q25 deletion syndrome),
POU1F1,"AR (Pituitary hormone deficiency, combined or isolated, 1); AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); AR (Pituitary hormone deficiency, combined, 2); AD ({Atrial fibrillation 8, susceptibility to}); Prostate cancer, somatic; AD (Spinocerebellar ataxia 4); AD ({Parkinson disease, susceptibility to}); AD (Spinocerebellar ataxia 17); AD (Pituitary hormone deficiency, combined, 4)",
POU2AF1,AD (Immunodeficiency 82 with systemic inflammation); AD (?Immunodeficiency 84),
POU2F1,"AD ({Breast-ovarian cancer, familial, 1}); {Pancreatic cancer, susceptibility to, 4}; AR (Fanconi anemia, complementation group S); AR (Cutis laxa, autosomal recessive, type IIE); AD ({Dyslexia, susceptibility to, 2}); AD (Lactase persistence/nonpersistence)",
POU2F3,AR (Congenital disorder of deglycosylation 1),
POU3F1,"AD (Snijders Blok-Fisher syndrome); AD (Charcot-Marie-Tooth disease, type 1D); AR (Dejerine-Sottas disease); AR (Hypomyelinating neuropathy, congenital, 1); AD (Autoinflammatory disease, familial, Behcet-like-3)",
POU3F2,"AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 5); AD ({Type 2 diabetes mellitus, susceptibility to}); Maturity-onset diabetes of the young 6; {Alzheimer disease 18, susceptibility to}; AD (Reticulate acropigmentation of Kitamura); AD (Snijders Blok-Fisher syndrome); AD (Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures); Renpenning syndrome; AD (Intellectual developmental disorder, autosomal dominant 39)",
POU3F3,AD (Snijders Blok-Fisher syndrome); AD (Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures),
POU3F4,"Deafness, X-linked 2; Xq21 deletion syndrome; AR (Deafness, autosomal recessive 116)",
POU4F1,"AD (Ataxia, intention tremor, and hypotonia syndrome, childhood-onset); AD (?Deafness, autosomal dominant 89); AR (Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay); AR (?Deafness, autosomal recessive 110); AD (Deafness, autosomal dominant 9)",
POU4F2,"AD (Denys-Drash syndrome); AD (Frasier syndrome); AD (Meacham syndrome); Mesothelioma, somatic; AD (Nephrotic syndrome, type 4); AD (Wilms tumor, type 1); AD (Ataxia, intention tremor, and hypotonia syndrome, childhood-onset)",
POU4F3,"AD (Deafness, autosomal dominant 15/52); AD (?Neutropenia, nonimmune chronic idiopathic, of adults); AD (Neutropenia, severe congenital 2, autosomal dominant); AD (Deafness, autosomal dominant 54)",
POU5F1,"Ewing sarcoma; Neuroepithelioma; {Prostate cancer, hereditary, 10}; AR (Otofacial neurodevelopmental syndrome); Rhabdomyosarcoma, alveolar",
POU5F1B,"{Prostate cancer, hereditary, 10}",
POU6F2,AD ({Wilms tumor susceptibility-5}),
PPA1,"AR (?Sudden cardiac failure, alcohol-induced); AR (Sudden cardiac failure, infantile); AR (Aphasia, primary progressive); AR (Ceroid lipofuscinosis, neuronal, 11); AR (Frontotemporal dementia 2)",
PPA2,"AR (?Sudden cardiac failure, alcohol-induced); AR (Sudden cardiac failure, infantile)",
PPARA,"AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AR (Cholestasis, progressive familial intrahepatic, 5); AR (?Bile acid malabsorption, primary, 1)",
PPARD,"AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); ?Charcot-Marie-Tooth disease, X-linked dominant, 6; Becker muscular dystrophy; Cardiomyopathy, dilated, 3B; Duchenne muscular dystrophy",
PPARG,"AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AD (Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia); AD (Plasma triglyceride level QTL, low); AR (?Lissencephaly 7 with cerebellar hypoplasia)",
PPARGC1A,"Rhabdomyosarcoma, alveolar; AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AD (Craniosynostosis 1); AD (Robinow-Sorauf syndrome); AD (Saethre-Chotzen syndrome with or without eyelid anomalies); AD (Sweeney-Cox syndrome)",
PPARGC1B,"AR (Immunodeficiency 46); AD (Ichthyosis, follicular, with atrichia and photophobia syndrome 2); AD (Mucoepithelial dysplasia, hereditary); AR (Neutral lipid storage disease with myopathy)",
PPAT,"AR (Neurodegeneration with brain iron accumulation 6); AR (Pontocerebellar hypoplasia, type 12); AR (AICA-ribosiduria due to ATIC deficiency); AR (?Phosphoribosylaminoimidazole carboxylase deficiency); AD (Prostate cancer 1); AD (Achondroplasia); Bladder cancer, somatic; AR (CATSHL syndrome); Cervical cancer, somatic; Colorectal cancer, somatic; AD (Crouzon syndrome with acanthosis nigricans); AD (Hypochondroplasia); AD (LADD syndrome 2); AD (Muenke syndrome); Nevus, epidermal, somatic; AD (SADDAN); Spermatocytic seminoma, somatic; AD (Thanatophoric dysplasia, type I); AD (Thanatophoric dysplasia, type II)",
PPBP,"AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}",
PPCDC,"AR (Cardiomyopathy, dilated, 2C); AR (Neurodegeneration with brain iron accumulation 6); AR (Pontocerebellar hypoplasia, type 12)",
PPCS,"AR (Cardiomyopathy, dilated, 2C); AR (Neurodegeneration with brain iron accumulation 6); AR (Pontocerebellar hypoplasia, type 12)",
PPFIA1,"AD (Houge-Janssens syndrome 4); AR (Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities); AD (Paul-Chao neurodevelopmental syndrome)",
PPFIA2,"AD (NESCAV syndrome); AR (Neuropathy, hereditary sensory, type IIC); AD (Spastic paraplegia 30, autosomal dominant); AR (Spastic paraplegia 30, autosomal recessive); AD (Intellectual developmental disorder with autistic features and language delay, with or without seizures)",
PPFIA3,AD (Paul-Chao neurodevelopmental syndrome),
PPFIBP1,"AR (Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities)",
PPHLN1,"AR (Ichthyosis, congenital, autosomal recessive 7); AD (Charcot-Marie-Tooth disease, axonal, type 2Z); AD (Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy)",
PPIA,"AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AR (Retinitis pigmentosa with or without skeletal anomalies)",
PPIB,"AR (Osteogenesis imperfecta, type IX); AR (Bruck syndrome 1); AR (Osteogenesis imperfecta, type XI); AR (Dyggve-Melchior-Clausen disease); AR (Smith-McCort dysplasia); AR (Osteogenesis imperfecta, type VIII)",
PPID,"AD (Bethlem myopathy 1A); AR (Ullrich congenital muscular dystrophy 1A); AR (Mitochondrial complex IV deficiency, nuclear type 17)",
PPIF,"AR (Muscular dystrophy, congenital, merosin deficient or partially deficient); AR (Muscular dystrophy, limb-girdle, autosomal recessive 23); Cardiomyopathy, dilated, 1L; AR (Muscular dystrophy, limb-girdle, autosomal recessive 6); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants)",
PPIG,AD (Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities),
PPIL1,"AR (Pontocerebellar hypoplasia, type 14); AR (?Pontocerebellar hypoplasia, type 15)",
PPIL4,"AD (Congenital heart defects, nonsyndromic, 2)",
PPIP5K1,"AR (Deafness, autosomal recessive 100)",
PPIP5K2,"AR (Deafness, autosomal recessive 100)",
PPL,"Specific language impairment QTL, 3; AD (Panic disorder syndrome 1); {Autism susceptibility 11}",
PPM1A,"AD (Intellectual developmental disorder, autosomal dominant 43)",
PPM1B,"AR (Hypotonia-cystinuria syndrome); AR (Myasthenic syndrome, congenital, 22)",
PPM1D,"Breast cancer, somatic; AD (Jansen-de Vries syndrome); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1)",
PPM1F,"AR (Neurodevelopmental disorder with variable familial hypercholanemia); AR (Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss); AR (Cholestasis, progressive familial intrahepatic, 8)",
PPM1H,"AD (Multiple endocrine neoplasia, type IV)",
PPM1K,"AR (Maple syrup urine disease, mild variant)",
PPM1L,"AD (Cardiospondylocarpofacial syndrome); AD (Frontometaphyseal dysplasia 2); AR ([High density lipoprotein cholesterol level QTL 11]); AD (Combined hyperlipidemia, familial); AR (Lipoprotein lipase deficiency)",
PPOX,"AD (Variegate porphyria); AR (Variegate porphyria, childhood-onset); AR (Encephalopathy, porphyria-related); AR (Leukoencephalopathy, porphyria-related); AD (Porphyria, acute intermittent); AD (Porphyria, acute intermittent, nonerythroid variant); AR (Hemochromatosis, type 1)",
PPP1CA,"Myelofibrosis, somatic; Thrombocythemia, somatic; AD ({Rhabdoid tumor predisposition syndrome 1}); AD ({Schwannomatosis-1, susceptibility to}); AD (Coffin-Siris syndrome 3); Rhabdoid tumors, somatic",
PPP1CB,"AD (Noonan syndrome-like disorder with loose anagen hair 2); AD (Noonan syndrome-like with loose anagen hair 1); AD (Cardiomyopathy, dilated, 1NN); AD (LEOPARD syndrome 2); AD (Noonan syndrome 5); AD ({Schwannomatosis-2, susceptibility to}); AD (Noonan syndrome 10); AR (Noonan syndrome 2); AD (Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant); AD (Neuropathy, hereditary sensory, type IE)",
PPP1CC,"AD (ZTTK syndrome); DNA topoisomerase I, camptothecin-resistant; AR (Congenital disorder of glycosylation, type Ir)",
PPP1R12A,"AD (Genitourinary and/or/brain malformation syndrome); Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic",
PPP1R13L,AR (Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities),
PPP1R15A,"Myelofibrosis, somatic; Thrombocythemia, somatic; AD ({Rhabdoid tumor predisposition syndrome 1}); AD ({Schwannomatosis-1, susceptibility to}); AD (Coffin-Siris syndrome 3); Rhabdoid tumors, somatic; AR (Wolcott-Rallison syndrome)",
PPP1R15B,"AR (Microcephaly, short stature, and impaired glucose metabolism 2)",
PPP1R17,"AR ({Hypercholesterolemia, susceptibility to})",
PPP1R1B,"AR (?Chorea, childhood-onset, with psychomotor retardation); AR (Hyperphosphatasia with impaired intellectual development syndrome 4)",
PPP1R21,"AR (Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities)",
PPP1R3A,"AD (Insulin resistance, severe, digenic); AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe); AD (Speech-language disorder-1)",
PPP1R3C,AR (Myoclonic epilepsy of Lafora 1),
PPP1R9B,"AD ({Melanoma and neural system tumor syndrome}); AD ({Melanoma-pancreatic cancer syndrome}); AD ({Melanoma, cutaneous malignant, 2}); AR (Intellectual developmental disorder, autosomal recessive 35)",
PPP2CA,"AD (Houge-Janssens syndrome 3); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2); AR (Nestor-Guillermo progeria syndrome); Fragile X syndrome; Fragile X tremor/ataxia syndrome; Premature ovarian failure 1; AR (Microcephaly 16, primary, autosomal recessive)",
PPP2R1A,"AD (Houge-Janssens syndrome 2); AD (Coffin-Siris syndrome 2); AD (Houge-Janssens syndrome 3); AR (Nestor-Guillermo progeria syndrome); AR (Microcephaly 16, primary, autosomal recessive); AR (Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development)",
PPP2R1B,"Lung cancer, somatic; AD (Houge-Janssens syndrome 2); AD (Hiatt-Neu-Cooper neurodevelopmental syndrome); Myelodysplastic syndrome, somatic",
PPP2R2A,"AD (Spinocerebellar ataxia 12); AR (Nestor-Guillermo progeria syndrome); AR (Microcephaly 16, primary, autosomal recessive)",
PPP2R2B,AD (Spinocerebellar ataxia 12); AD (Houge-Janssens syndrome 3),
PPP2R2D,AD (Houge-Janssens syndrome 3),
PPP2R3C,"AR (Myoectodermal gonadal dysgenesis syndrome); AD (Spermatogenic failure 36); {Colchicine resistance}; {Inflammatory bowel disease 13}; AR (Encephalopathy, acute transient); AD (Houge-Janssens syndrome 3); AR (Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development)",
PPP2R5A,"AD (Houge-Janssens syndrome 4); AD (Progressive familial heart block, type II); AD (Houge-Janssens syndrome 1)",
PPP2R5B,"AD (Houge-Janssens syndrome 4); AD (Houge-Janssens syndrome 1); AD ({Schizophrenia 15}); AD (Phelan-McDermid syndrome); Intellectual developmental disorder, X-linked 103",
PPP2R5C,AD (Houge-Janssens syndrome 4); AD (Houge-Janssens syndrome 1),
PPP2R5D,"AD (Houge-Janssens syndrome 1); AD (Houge-Janssens syndrome 3); AD (Houge-Janssens syndrome 4); AD (?Episodic ataxia, type 5); AD ({Epilepsy, idiopathic generalized, susceptibility to, 9}); AD ({Epilepsy, juvenile myoclonic, susceptibility to, 6})",
PPP2R5E,AD (Houge-Janssens syndrome 4); AD (Houge-Janssens syndrome 1),
PPP3CA,"AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91); AR (Lichtenstein-Knorr syndrome); AR (Gillespie syndrome); AD (Spinocerebellar ataxia 15); AD (Spinocerebellar ataxia 29, congenital nonprogressive); AR ({Diabetes, type 1, susceptibility to}); AD (Charcot-Marie-Tooth disease, demyelinating, type 1J); AR (Congenital myopathy 6 with ophthalmoplegia); AR (?Anhidrosis, isolated, with normal sweat glands); AD ({Coronary artery disease, autosomal dominant, 1})",
PPP3CB,"AR (Lichtenstein-Knorr syndrome); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91); AR (?Joint contracture, osteochondromas, and B-cell lymphoma); AR ({Epidermodysplasia verruciformis, susceptibility to, 3}); AR (Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1); AD (Optic atrophy 5)",
PPP3CC,AD ({Schizophrenia}),
PPP3R1,"AD (Deafness, autosomal dominant 58); AD (Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development); AD (Developmental and epileptic encephalopathy 91); Hyperparathyroidism 3",
PPP5C,"AD (Houge-Janssens syndrome 3); AR (Myoectodermal gonadal dysgenesis syndrome); AD (Spermatogenic failure 36); AR (Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development); {Colchicine resistance}; {Inflammatory bowel disease 13}; AR (Encephalopathy, acute transient)",
PPP6C,AD (Lessel-Kreienkamp syndrome),
PPT1,"AR (Ceroid lipofuscinosis, neuronal, 1); AR (Short-rib thoracic dysplasia 19 with or without polydactyly); AR (Ceroid lipofuscinosis, neuronal, 6A); AR (Ceroid lipofuscinosis, neuronal, 6B (Kufs type))",
PPT2,"AR (Ceroid lipofuscinosis, neuronal, 1)",
PPY,"AD (?Epilepsy, familial temporal lobe, 8)",
PQBP1,"Renpenning syndrome; AD (Vertebral, cardiac, tracheoesophageal, renal, and limb defects); AD (Spinocerebellar ataxia 1); Intellectual developmental disorder, X-linked 9",
PRAG1,AD (Adams-Oliver syndrome 5); AD (Aortic valve disease 1),
PRAME,"Leukemia, acute promyelocytic; AD ({Melanoma, cutaneous malignant, 1}); AR (Pontocerebellar hypoplasia, type 1C); AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal)",
PRB1,"AD (Brugada syndrome 3); AD (Long QT syndrome 8); AD (Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures); AD (Timothy syndrome)",
PRB2,AR (Brunet-Wagner neurodevelopmental syndrome),
PRC1,"Intellectual developmental disorder, X-linked 100; Taurodontism, microdontia, and dens invaginatus; AD (Luo-Schoch-Yamamoto syndrome); AD (Intellectual developmental disorder, autosomal dominant 26); Colorectal cancer, somatic; AD (Menke-Hennekam syndrome 2); AD (Rubinstein-Taybi syndrome 2); AR (?Meckel syndrome 12); AR (Microcephaly 20, primary, autosomal recessive)",
PRCC,"Renal cell carcinoma, papillary; Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies; Renal cell carcinoma, papillary, 1",
PRCD,Retinitis pigmentosa 36,
PRCP,AD (Abdominal obesity-metabolic syndrome 1),
PRDM1,"{Leukemia, acute lymphoblastic, susceptibility to, 3}; [Skin/hair/eye pigmentation, variation in, 8]; AR (Immunodeficiency 131); AD (Immunodeficiency 60 and autoimmunity); AR (Immunodeficiency with hyper-IgM, type 3)",
PRDM10,AD (?Birt-Hogg-Dube syndrome 2),
PRDM12,"AR (Neuropathy, hereditary sensory and autonomic, type VIII)",
PRDM13,"AR (Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism); AR (Pontocerebellar hypoplasia, type 17); AD (Chorioretinal atrophy, progressive bifocal); AD (Macular dystrophy 1); AD (Macular dystrophy, retinal, 3)",
PRDM16,"AD (Cardiomyopathy, dilated, 1LL); AD (Left ventricular noncompaction 8); Chromosome 1p36 deletion syndrome, distal; AD (Kleefstra syndrome 1)",
PRDM2,AR (Brittle cornea syndrome 2); AD (?Birt-Hogg-Dube syndrome 2),
PRDM5,AR (Brittle cornea syndrome 2); AR (Brittle cornea syndrome 1); AD (Ulnar-mammary syndrome),
PRDM6,"AD (Patent ductus arteriosus 3); AR ({Patent ductus arteriosus, susceptibility to})",
PRDM8,"AR (?Epilepsy, progressive myoclonic, 10)",
PRDX1,"AR (Methylmalonic aciduria and homocystinuria, cblC type, digenic); AR (Methylmalonic aciduria and homocystinuria, cblC type)",
PRDX2,"AD (?Advance sleep phase syndrome, familial, 4); AR (Methylmalonic aciduria and homocystinuria, cblC type, digenic); AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic",
PRDX3,"AD (Corneal dystrophy, punctiform and polychromatic pre-Descemet); AR (Spinocerebellar ataxia, autosomal recessive 32); AD ({Parkinson disease 8}); AR (?Combined oxidative phosphorylation deficiency 29); AR (?Glucocorticoid deficiency 5)",
PRDX5,"Alopecia areata 1; AD (Corneal dystrophy, punctiform and polychromatic pre-Descemet); AR (Spinocerebellar ataxia, autosomal recessive 32)",
PREB,"{AIDS, resistance to}; AR (?Agammaglobulinemia 4); AD (Immunodeficiency, common variable, 13); {Leukemia, acute lymphoblastic, susceptibility to, 3}; AR (Agammaglobulinemia 2)",
PRELID1,AR (?Optic atrophy 11),
PREP,"AR (Spinocerebellar ataxia, autosomal recessive 30); AD (Sotos syndrome); AR (Myasthenic syndrome, congenital, 22); Chromosome Xp11.23-p11.22 duplication syndrome",
PREPL,"AR (Myasthenic syndrome, congenital, 22); AR (Hypotonia-cystinuria syndrome)",
PREX2,"AD ({Melanoma, cutaneous malignant, 1})",
PRF1,"Aplastic anemia; AR (Hemophagocytic lymphohistiocytosis, familial, 2); Lymphoma, non-Hodgkin; AR (Hemophagocytic lymphohistiocytosis, familial, 1); AR (Hemophagocytic lymphohistiocytosis, familial, 3); AD ({Autoimmune lymphoproliferative syndrome}); AD (Autoimmune lymphoproliferative syndrome, type IA); Squamous cell carcinoma, burn scar-related, somatic; AR (?Immunodeficiency 69, mycobacteriosis); {AIDS, rapid progression to}; {Aplastic anemia}; {Hepatitis C virus, response to therapy of}; AD ({TSC2 angiomyolipomas, renal, modifier of}); {Tuberculosis, protection against}; AR ([Uridine-cytidineuria]); AR (Hemophagocytic lymphohistiocytosis, familial, 4)",
PRG2,"AR (Anterior segment dysgenesis 7, with sclerocornea)",
PRG4,AR (Camptodactyly-arthropathy-coxa vara-pericarditis syndrome),
PRICKLE1,"AR (Epilepsy, progressive myoclonic 1B); AD ({Wilms tumor 6, susceptibility to}); AD (Deafness, autosomal dominant 27); AD (Fibromatosis, gingival, 5); AR ({Amyotrophic lateral sclerosis, susceptibility to}); AD (Neuronopathy, distal hereditary motor, autosomal dominant 14); AD (Perry syndrome); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome)",
PRICKLE2,"AR (Mitochondrial DNA depletion syndrome 4A (Alpers type)); AR (Mitochondrial DNA depletion syndrome 4B (MNGIE type)); AR (Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)); AD (Progressive external ophthalmoplegia, autosomal dominant 1); AR (Progressive external ophthalmoplegia, autosomal recessive 1); AR (Epilepsy, progressive myoclonic 1B); AR (Bardet-Biedl syndrome 7); {Autism susceptibility 1}",
PRICKLE3,"{Leber hereditary optic neuropathy, modifier of}",
PRICKLE4,"AD (Amyotrophic lateral sclerosis 10, with or without FTD); AD (Frontotemporal lobar degeneration, TARDBP-related)",
PRIM1,AR (Primordial dwarfism-immunodeficiency-lipodystrophy syndrome),
PRIM2,AR (Primordial dwarfism-immunodeficiency-lipodystrophy syndrome),
PRIMA1,"[Blood group, Yt system]",
PRIMPOL,"AD (Myopia 22, autosomal dominant)",
PRKAA1,"AD (?Juvenile myelomonocytic leukemia); AD (Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia); AD (HDL deficiency, familial, 1); AR (Tangier disease); Melanoma, malignant, somatic; Pancreatic cancer, somatic; AD (Peutz-Jeghers syndrome); Testicular tumor, somatic",
PRKAA2,"Leukemia/lymphoma, B-cell, 2; Focal cortical dysplasia, type II, somatic; AD (Smith-Kingsmore syndrome)",
PRKAB1,"AR ([Skeletal muscle glycogen content and metabolism QTL]); AD (Cardiomyopathy, hypertrophic 6); AD (Glycogen storage disease of heart, lethal congenital); AD (Wolff-Parkinson-White syndrome); AR (Immunodeficiency 93 and hypertrophic cardiomyopathy)",
PRKACA,"AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic; AD (Pigmented nodular adrenocortical disease, primary, 4); AD (Cardioacrofacial dysplasia 2); AR (?Bleeding disorder, platelet-type, 19)",
PRKACB,"AD (Cardioacrofacial dysplasia 2); AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic; AR (?Bleeding disorder, platelet-type, 19)",
PRKACG,"AR (?Bleeding disorder, platelet-type, 19); AD (Cardioacrofacial dysplasia 2); Pituitary tumor, invasive; AD (Developmental and epileptic encephalopathy 27); AD (Intellectual developmental disorder, autosomal dominant 6, with or without seizures); AD (Epilepsy, focal, with speech disorder and with or without impaired intellectual development); AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic",
PRKAG1,"AR ([Skeletal muscle glycogen content and metabolism QTL]); AD (Cardiomyopathy, hypertrophic 6); AD (Glycogen storage disease of heart, lethal congenital); AD (Wolff-Parkinson-White syndrome); AR (Immunodeficiency 93 and hypertrophic cardiomyopathy)",
PRKAG2,"AD (Cardiomyopathy, hypertrophic 6); AD (Glycogen storage disease of heart, lethal congenital); AD (Wolff-Parkinson-White syndrome); AD (Cardiomyopathy, hypertrophic, 21); AR ([Skeletal muscle glycogen content and metabolism QTL]); Danon disease; AR (Immunodeficiency 93 and hypertrophic cardiomyopathy); AR (Homocystinuria, B6-responsive and nonresponsive types); AR (Thrombosis, hyperhomocysteinemic)",
PRKAG3,"AR ([Skeletal muscle glycogen content and metabolism QTL]); AD (Cardiomyopathy, hypertrophic 6); AD (Glycogen storage disease of heart, lethal congenital); AD (Wolff-Parkinson-White syndrome)",
PRKAR1A,"AD (Acrodysostosis 1, with or without hormone resistance); Adrenocortical tumor, somatic; AD (Carney complex, type 1); AD (Myxoma, intracardiac); AD (Pigmented nodular adrenocortical disease, primary, 1); Leukemia, acute promyelocytic; AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic",
PRKAR1B,"AD (Marbach-Schaaf neurodevelopmental syndrome); AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic",
PRKAR2A,"AR (Ciliary dyskinesia, primary, 32); AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic; AD ({Parkinson disease 26, autosomal dominant, susceptibility to})",
PRKAR2B,"AD (Cardioacrofacial dysplasia 1); Cushing syndrome, ACTH-independent adrenal, somatic; AR (Ciliary dyskinesia, primary, 32); AR (Muscular dystrophy, limb-girdle, autosomal recessive 25)",
PRKCA,"Pituitary tumor, invasive; [Body mass index QTL 15]; AD (Developmental and epileptic encephalopathy 14); AD (Epilepsy nocturnal frontal lobe, 5); AD (Spinocerebellar ataxia 14); {Cerebral infarction, susceptibility to}; AD (van der Woude syndrome 2)",
PRKCB,"AR (Autoimmune lymphoproliferative syndrome, type III)",
PRKCD,"AR (Autoimmune lymphoproliferative syndrome, type III); AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis); AR (CHAND syndrome); AR (Popliteal pterygium syndrome, Bartsocas-Papas type 1); AD (Spinocerebellar ataxia 14)",
PRKCE,"AR (?Microcephaly 19, primary, autosomal recessive); AD (Osteoporosis, childhood- or juvenile-onset, with developmental delay); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (?Hirschsprung disease, cardiac defects, and autonomic dysfunction); {Hypertension, essential, susceptibility to}; AD (Spinocerebellar ataxia 14); AR (Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements)",
PRKCG,"AD (Spinocerebellar ataxia 14); AD (Spinocerebellar ataxia 48); AR (Spinocerebellar ataxia, autosomal recessive 16); Pituitary tumor, invasive",
PRKCH,"{Cerebral infarction, susceptibility to}; AR (Polyglucosan body myopathy 1 with or without immunodeficiency)",
PRKCI,AD (Takenouchi-Kosaki syndrome),
PRKCQ,"AR (Immunodeficiency 92); AD (B-cell expansion with NFKB and T-cell anergy); AR (Immunodeficiency 11A); AD (Immunodeficiency 11B with atopic dermatitis); AR ({Diabetes mellitus, insulin-dependent-1}); AR (Immunodeficiency 67); AR (Immunodeficiency 12); AD (Immunodeficiency 15A); AR (Immunodeficiency 15B); AR (?Immunodeficiency 37); {Lymphoma, follicular, somatic}; {Male germ cell tumor, somatic}; {Mesothelioma, somatic}; {Sezary syndrome, somatic}; Lymphoma, MALT, somatic",
PRKCSH,"AD (Polycystic liver disease 1); AD (Polycystic kidney disease 2); AD (Polycystic liver disease 2); AR (Polycystic kidney disease 4, with or without hepatic disease); AD (Polycystic kidney disease 1); AD (Polycystic kidney disease 3)",
PRKCZ,"[Memory, enhanced, QTL]; Chromosome 1p36 deletion syndrome, distal; AD (Houge-Janssens syndrome 3); AD (Spinocerebellar ataxia 14); AR (Immunodeficiency 116); AD ({?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to})",
PRKD1,"AD (Congenital heart defects and ectodermal dysplasia); AD (Rett syndrome, congenital variant); AR ([High density lipoprotein cholesterol level QTL 11]); AD (Combined hyperlipidemia, familial); AR (Lipoprotein lipase deficiency)",
PRKDC,"AR (Immunodeficiency 26, with or without neurologic abnormalities); AR (Omenn syndrome); AR (Severe combined immunodeficiency, Athabascan type); AR (Immunodeficiency 54); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity; AR (Combined cellular and humoral immune defects with granulomas); AR (Omenn syndrome); AR (Severe combined immunodeficiency, B cell-negative); AD (Cardiomyopathy, dilated, 1A); AR (Charcot-Marie-Tooth disease, type 2B1); AD (Emery-Dreifuss muscular dystrophy 2, autosomal dominant); AR (Emery-Dreifuss muscular dystrophy 3, autosomal recessive); AD (Heart-hand syndrome, Slovenian type); AD (Hutchinson-Gilford progeria); AD (Lipodystrophy, familial partial, type 2); AD (Malouf syndrome); AR (Mandibuloacral dysplasia); AD (Muscular dystrophy, congenital); AD (Restrictive dermopathy 2)",
PRKG1,"AD (Aortic aneurysm, familial thoracic 8); AR (Lipodystrophy, congenital generalized, type 3); AD (Lipodystrophy, familial partial, type 7); AD (Pulmonary hypertension, primary, 3); Aortic aneurysm, familial thoracic 1; AR ([ER blood group system]); AD (Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema); AR (Lymphatic malformation 6)",
PRKG2,"AR (Acromesomelic dysplasia 4); AR (Spondylometaphyseal dysplasia, Pagnamenta type); AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal); Chromosome 4q21 deletion syndrome",
PRKN,"Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AR (Parkinson disease 6, early onset); AD (STING-associated vasculopathy, infantile-onset)",
PRKRA,"AR (Dystonia 16); {Bacteremia, protection against}; {Malaria, protection against}; {Tuberculosis, protection against}; AD (Singleton-Merten syndrome 2)",
PRKRIP1,"AR (Dystonia 33); AD (Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome)",
PRKX,FG syndrome 3,
PRL,"AR (Pituitary hormone deficiency, combined or isolated, 1); AR (Hyperprolactinemia); AD (Multiple fibroadenomas of the breast); AD (Agammaglobulinemia 8A, autosomal dominant); AR (Agammaglobulinemia 8B, autosomal recessive); AD (?Epilepsy, familial temporal lobe, 8); AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome)",
PRLR,"AR (Hyperprolactinemia); AD (Multiple fibroadenomas of the breast); AD (?Epilepsy, familial temporal lobe, 8); AD (Silver-Russell syndrome 3); {Budd-Chiari syndrome, somatic}; Erythrocytosis, somatic; Leukemia, acute myeloid, somatic; Myelofibrosis, somatic; Polycythemia vera, somatic; AD (Thrombocythemia 3); AR (Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome); AR (Amegakaryocytic thrombocytopenia, congenital, 1); Myelofibrosis with myeloid metaplasia, somatic; AD (Thrombocythemia 2)",
PRM1,"AD (Autoinflammatory syndrome, familial, with or without immunodeficiency)",
PRM2,"AR (Immunodeficiency 26, with or without neurologic abnormalities); AD (Autoinflammatory syndrome, familial, with or without immunodeficiency); AD (Spermatogenic failure 11)",
PRMT1,"Colorectal cancer, somatic; AD (Menke-Hennekam syndrome 2); AD (Rubinstein-Taybi syndrome 2); AR (Ataxia-telangiectasia-like disorder 1)",
PRMT5,"AD (Diaphyseal medullary stenosis with malignant fibrous histiocytoma); Burkitt lymphoma, somatic; AD (Imagawa-Matsumoto syndrome)",
PRMT7,"AR (Short stature, brachydactyly, intellectual developmental disability, and seizures)",
PRMT9,AD (Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities),
PRND,"{Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features); AD (Developmental delay with or without intellectual impairment or behavioral abnormalities)",
PRNP,"{Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features)",
PROC,"AD (Thrombophilia 3 due to protein C deficiency, autosomal dominant); AR (Thrombophilia 3 due to protein C deficiency, autosomal recessive); {Malaria, resistance to}; AD (Delta-beta thalassemia); AD (Erythrocytosis, familial, 6); AD (Heinz body anemia); AD (Hereditary persistence of fetal hemoglobin); AD (Methemoglobinemia, beta type); AR (Sickle cell disease); AD (Thalassemia-beta, dominant inclusion-body); Thalassemia, beta; AR (Amyotrophic lateral sclerosis 1); AR (Spastic tetraplegia and axial hypotonia, progressive); AD ({Adrenocortical carcinoma, pediatric}); AD ({Basal cell carcinoma 7}); AD ({Choroid plexus papilloma}); AD ({Colorectal cancer}); AD ({Glioma susceptibility 1}); {Osteosarcoma}; AD (Bone marrow failure syndrome 5); Breast cancer, somatic; Hepatocellular carcinoma, somatic; AD (Li-Fraumeni syndrome); Nasopharyngeal carcinoma, somatic; Pancreatic cancer, somatic; AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); Burkitt lymphoma, somatic",
PROCR,"AD (Ayme-Gripp syndrome); AD (Cataract 21, multiple types); AD (Thrombophilia 3 due to protein C deficiency, autosomal dominant); AR (Thrombophilia 3 due to protein C deficiency, autosomal recessive)",
PRODH,"AD ({Schizophrenia, susceptibility to, 4}); AR (Hyperprolinemia, type I)",
PRODH2,"AD ({Schizophrenia, susceptibility to, 4}); AR (Hyperprolinemia, type I)",
PROK1,AD (Hypogonadotropic hypogonadism 3 with or without anosmia); AD (Hypogonadotropic hypogonadism 4 with or without anosmia),
PROK2,AD (Hypogonadotropic hypogonadism 4 with or without anosmia); AD (Hypogonadotropic hypogonadism 3 with or without anosmia); AD ({Hypogonadotropic hypogonadism 16 with or without anosmia}),
PROKR1,AD (Hypogonadotropic hypogonadism 4 with or without anosmia); AD (Hypogonadotropic hypogonadism 3 with or without anosmia),
PROKR2,AD (Hypogonadotropic hypogonadism 3 with or without anosmia); AD (Hypogonadotropic hypogonadism 4 with or without anosmia); AD ({Hypogonadotropic hypogonadism 16 with or without anosmia}); AR (?Hypogonadotropic hypogonadism 12 with or without anosmia); Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1),
PROM1,"AR (Cone-rod dystrophy 12); AD (Macular dystrophy, retinal, 2); AR (Retinitis pigmentosa 41); AD (Stargardt disease 4); AD ({Macular degeneration, age-related, 2}); AR (Cone-rod dystrophy 3); AR (Fundus flavimaculatus); AR (Retinal dystrophy, early-onset severe); AR (Retinitis pigmentosa 19); AR (Stargardt disease 1); AR (Retinitis pigmentosa 39); AR (Usher syndrome, type 2A)",
PROP1,"AR (Pituitary hormone deficiency, combined, 2); AR (Growth hormone deficiency, isolated, type IV); AD (Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly); AR (Pituitary hormone deficiency, combined or isolated, 1); AR (Growth hormone deficiency, isolated, type IA); Growth hormone deficiency, isolated, type IB; AD (Growth hormone deficiency, isolated, type II); AR (Kowarski syndrome); AR (Pituitary hormone deficiency, combined, 3); AR (Growth hormone deficiency with pituitary anomalies); AR (Pituitary hormone deficiency, combined, 5); AR (Septooptic dysplasia)",
PRORP,AR (Combined oxidative phosphorylation deficiency 54),
PROS1,"AD (Thrombophilia 5 due to protein S deficiency, autosomal dominant); AR (Thrombophilia 5 due to protein S deficiency, autosomal recessive); AR (Retinitis pigmentosa 38)",
PROX1,"AR (CPT deficiency, hepatic, type IA); AR (Hypotrichosis-lymphedema-telangiectasia syndrome); AD (Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome); AD (Microphthalmia, syndromic 6); AD (Orofacial cleft 11); AR ({Cystic fibrosis lung disease, modifier of}); AD (Camurati-Engelmann disease); AR (Inflammatory bowel disease, immunodeficiency, and encephalopathy); AD ({Leukemia, acute myeloid, susceptibility to}); {Myelodysplastic syndrome, susceptibility to}; AD (Emberger syndrome); AD (Immunodeficiency 21); AD (Lymphatic malformation 14)",
PROZ,"[Protein Z deficiency]; AR ({Budd-Chiari syndrome}); AD ({Pregnancy loss, recurrent, susceptibility to, 1}); {Stroke, ischemic, susceptibility to}; AD ({Thrombophilia, susceptibility to, due to factor V Leiden}); AR (Factor V deficiency); AD (Thrombophilia 2 due to activated protein C resistance)",
PRPF19,"AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); ?Intellectual developmental disorder, X-linked syndromic, Gustavson type; ?Intellectual developmental disorder, X-linked syndromic, Shashi type; Trichothiodystrophy 5, nonphotosensitive; AR (?Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias)",
PRPF3,AD (Retinitis pigmentosa 18); AD (Retinitis pigmentosa 11); AD (Retinitis pigmentosa 13); AD (?Retinitis pigmentosa 9); AR (Cone-rod dystrophy 8); AD (Retinitis pigmentosa 70),
PRPF31,AD (Retinitis pigmentosa 11); AD (Retinitis pigmentosa 18); AD (Retinitis pigmentosa 13); AD (Retinitis pigmentosa 70),
PRPF4,AD (Retinitis pigmentosa 70); AD (Retinitis pigmentosa 18),
PRPF40A,"AR (Neurodevelopemental disorder with hypotonia, feeding difficulties, facial dysmorphism, and brain abnormalities)",
PRPF6,"AD (Retinitis pigmentosa 60); AD (Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant); AD (Retinitis pigmentosa 11); AD (Retinitis pigmentosa 70)",
PRPF8,"AD (Retinitis pigmentosa 13); AD (Retinitis pigmentosa 33); AD (Retinitis pigmentosa 11); AD (Retinitis pigmentosa 18); AD (Mandibulofacial dysostosis, Guion-Almeida type); AD (Retinitis pigmentosa 70)",
PRPH,"AR ({Amyotrophic lateral sclerosis, susceptibility to}); AD (Choroidal dystrophy, central areolar 2); AR (Leber congenital amaurosis 18); AD (Macular dystrophy, patterned, 1); AD (Macular dystrophy, vitelliform, 3); AR (Retinitis pigmentosa 7 and digenic form); AR (Retinitis punctata albescens)",
PRPH2,"AD (Choroidal dystrophy, central areolar 2); AR (Leber congenital amaurosis 18); AD (Macular dystrophy, patterned, 1); AD (Macular dystrophy, vitelliform, 3); AR (Retinitis pigmentosa 7 and digenic form); AR (Retinitis punctata albescens); AD (?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2); Bestrophinopathy, autosomal recessive; AD (Macular dystrophy, vitelliform, 2); Retinitis pigmentosa-50; Retinitis pigmentosa, concentric; AD (Vitreoretinochoroidopathy)",
PRPS1,"Arts syndrome; Charcot-Marie-Tooth disease, X-linked recessive, 5; Deafness, X-linked 1; Gout, PRPS-related; Phosphoribosylpyrophosphate synthetase superactivity; ?Intellectual developmental disorder, X-linked 101",
PRPS1L1,"Arts syndrome; Charcot-Marie-Tooth disease, X-linked recessive, 5; Deafness, X-linked 1; Gout, PRPS-related; Phosphoribosylpyrophosphate synthetase superactivity",
PRPS2,"Arts syndrome; Charcot-Marie-Tooth disease, X-linked recessive, 5; Deafness, X-linked 1; Gout, PRPS-related; Phosphoribosylpyrophosphate synthetase superactivity; ?Intellectual developmental disorder, X-linked 101",
PRR12,AD (Neuroocular syndrome),
PRR4,AR (Ectodermal dysplasia-syndactyly syndrome 1),
PRRG2,"AD (Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development)",
PRRT2,"AD (Convulsions, familial infantile, with paroxysmal choreoathetosis); AD (Episodic kinesigenic dyskinesia 1); AD (Seizures, benign familial infantile, 2); AD (Episodic kinesigenic dyskinesia 3); AD (Alternating hemiplegia of childhood 1); AD (Developmental and epileptic encephalopathy 98); AR (Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies); AD (Migraine, familial basilar); AD (Migraine, familial hemiplegic, 2); AR ([Uridine-cytidineuria]); AD (Seizures, benign familial infantile, 1)",
PRRX1,"AR (Agnathia-otocephaly complex); AD (Deafness, autosomal dominant 56); AD (Microphthalmia, syndromic 5); AD (Pituitary hormone deficiency, combined, 6); AD (Retinal dystrophy, early-onset, with or without pituitary dysfunction); AD (Pulmonary hypertension, primary, 2)",
PRRX2,AR (Agnathia-otocephaly complex),
PRSS1,"AD (Pancreatitis, hereditary); AD ({Pancreatitis, chronic, protection against}); AR ({Fibrocalculous pancreatic diabetes, susceptibility to}); AD (Pancreatitis, hereditary); AR (Tropical calcific pancreatitis)",
PRSS12,"AR (Intellectual developmental disorder, autosomal recessive 1)",
PRSS2,"AD ({Pancreatitis, chronic, protection against}); AD (Pancreatitis, hereditary)",
PRSS3,"AD (Pancreatitis, hereditary)",
PRSS56,"AR (Microphthalmia, isolated 6); AR (Microphthalmia, isolated 1)",
PRSS8,"AD (?Liddle syndrome 3); AD (Bronchiectasis with or without elevated sweat chloride 2); AR (Pseudohypoaldosteronism, type IB1, autosomal recessive); AD (Li-Ghorgani-Weisz-Hubshman syndrome)",
PRTFDC1,"Hyperuricemia, HRPT-related; Lesch-Nyhan syndrome",
PRTN3,"AD (Neutropenia, cyclic); AD (Neutropenia, severe congenital 1, autosomal dominant); AD (?Neutropenia, nonimmune chronic idiopathic, of adults); AD (Neutropenia, severe congenital 2, autosomal dominant); AR (Emphysema due to AAT deficiency); AR (Emphysema-cirrhosis, due to AAT deficiency); AR (Hemorrhagic diathesis due to antithrombin Pittsburgh)",
PRUNE1,"AR (Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies)",
PRX,"AR (Charcot-Marie-Tooth disease, type 4F); AR (Dejerine-Sottas disease); AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related); AD (Corneal dystrophy, punctiform and polychromatic pre-Descemet); AR (Spinocerebellar ataxia, autosomal recessive 32); AR (Methylmalonic aciduria and homocystinuria, cblC type, digenic)",
PSAP,"AD ({Parkinson disease 24, autosomal dominant, susceptibility to}); AR (Combined SAP deficiency); Gaucher disease, atypical; AR (Krabbe disease, atypical); AR (Metachromatic leukodystrophy due to SAP-b deficiency); AR (Interstitial lung disease 1); AD (Congenital disorder of glycosylation, type Iw, autosomal dominant); AR (Congenital disorder of glycosylation, type Iw, autosomal recessive)",
PSAT1,"AR (Neu-Laxova syndrome 2); AR (Phosphoserine aminotransferase deficiency); AD (Immunodeficiency, developmental delay, and hypohomocysteinemia)",
PSD,"AR (Liberfarb syndrome); AD (Intellectual developmental disorder, autosomal dominant 62); AR (?Intellectual developmental disorder, autosomal recessive 63); AD (Intellectual developmental disorder, autosomal dominant 53); AR (Developmental and epileptic encephalopathy 61)",
PSEN1,"AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V); AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AD (Acne inversa, familial, 2, with or without Dowling-Degos disease)",
PSEN2,"AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); AD ({?Alzheimer disease, protection against, due to APOE3-Christchurch}); AD ({?Macular degeneration, age-related}); {Coronary artery disease, severe, susceptibility to}; AD (Alzheimer disease 2); Hyperlipoproteinemia, type III; Lipoprotein glomerulopathy; AR (Sea-blue histiocyte disease); AD (?Spinocerebellar ataxia 43); AR (Charcot-Marie-Tooth disease, axonal, type 2T)",
PSENEN,"AD (Acne inversa, familial, 2, with or without Dowling-Degos disease); AD (?Acne inversa, familial, 3); AD (?Cardiomyopathy, dilated, 1U); AD (Alzheimer disease, type 3, with or without spastic paraparesis); AD (Dementia, frontotemporal); AD (Pick disease); AD (Acne inversa, familial, 1); AD (Alzheimer disease-4); AD (Cardiomyopathy, dilated, 1V)",
PSG5,"Gastric cancer, somatic; Prostate cancer, somatic",
PSKH1,"AR (Cholestasis, progressive familial intrahepatic, 13)",
PSMA1,AR (Keratosis linearis with ichthyosis congenita and sclerosing keratoderma); AD (Proteasome-associated autoinflammatory syndrome 2),
PSMA2,"AR (?Neurodevelopmental disorder with microcephaly, hypotonia, and absent language)",
PSMA3,"AR (Proteasome-associated autoinflammatory syndrome 1 and digenic forms); AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to}); AR (Keratosis linearis with ichthyosis congenita and sclerosing keratoderma); AD (Proteasome-associated autoinflammatory syndrome 2)",
PSMA4,"{Lung cancer susceptibility 2}; AR (Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT); {Lung cancer susceptibility 2}; {Nicotine dependence, susceptibility to}; AR (Keratosis linearis with ichthyosis congenita and sclerosing keratoderma); AD (Proteasome-associated autoinflammatory syndrome 2)",
PSMA5,AR (Proteasome-associated autoinflammatory syndrome 1 and digenic forms),
PSMA6,"{Myocardial infarction, susceptibility to}",
PSMA7,"Adenocarcinoma of lung, somatic; Ovarian cancer, somatic; AR (Parkinson disease, juvenile, type 2); AR (Keratosis linearis with ichthyosis congenita and sclerosing keratoderma); AD (Proteasome-associated autoinflammatory syndrome 2)",
PSMB1,"AR (?Neurodevelopmental disorder with microcephaly, hypotonia, and absent language); AR (Keratosis linearis with ichthyosis congenita and sclerosing keratoderma); AD (Proteasome-associated autoinflammatory syndrome 2)",
PSMB10,AD (Immunodeficiency 121 with autoinflammation); AR (Proteasome-associated autoinflammatory syndrome 5),
PSMB11,"AR (T-cell immunodeficiency, congenital alopecia, and nail dystrophy); AD (T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant)",
PSMB2,"AR (?Neurodevelopmental disorder with microcephaly, hypotonia, and absent language)",
PSMB3,AR (Proteasome-associated autoinflammatory syndrome 1 and digenic forms); AR (?Proteasome-associated autoinflammatory syndrome 3 and digenic forms),
PSMB4,AR (?Proteasome-associated autoinflammatory syndrome 3 and digenic forms); AD (Proteasome-associated autoinflammatory syndrome 6); AR (Proteasome-associated autoinflammatory syndrome 1 and digenic forms),
PSMB6,"AR (?Lessel-Kubisch syndrome); AD ({Accelerated tumor formation, susceptibility to})",
PSMB8,AR (Proteasome-associated autoinflammatory syndrome 1 and digenic forms); AR (?Proteasome-associated autoinflammatory syndrome 3 and digenic forms); AD (Immunodeficiency 121 with autoinflammation); AR (Proteasome-associated autoinflammatory syndrome 5); AD (Familial cold autoinflammatory syndrome 2),
PSMB9,AD (Proteasome-associated autoinflammatory syndrome 6); AR (?Proteasome-associated autoinflammatory syndrome 3 and digenic forms); AD (Immunodeficiency 121 with autoinflammation); AR (Proteasome-associated autoinflammatory syndrome 5); AR (Proteasome-associated autoinflammatory syndrome 1 and digenic forms),
PSMC1,"AR (?Birk-Aharoni syndrome); AR (?Deafness, cataract, impaired intellectual development, and polyneuropathy)",
PSMC2,AR (?Birk-Aharoni syndrome),
PSMC3,"AR (?Deafness, cataract, impaired intellectual development, and polyneuropathy); AR (Ovarian dysgenesis 3); AR (?Birk-Aharoni syndrome)",
PSMC3IP,AR (Ovarian dysgenesis 3),
PSMC4,"AR (?Birk-Aharoni syndrome); AR (?Deafness, cataract, impaired intellectual development, and polyneuropathy)",
PSMC5,"AR (Proteasome-associated autoinflammatory syndrome 1 and digenic forms); AR (?Deafness, cataract, impaired intellectual development, and polyneuropathy); AR (?Birk-Aharoni syndrome)",
PSMC6,"AR (?Deafness, cataract, impaired intellectual development, and polyneuropathy); AR (?Birk-Aharoni syndrome)",
PSMD12,AD (Stankiewicz-Isidor syndrome),
PSMD13,AR (Leber congenital amaurosis 2); AR (Retinitis pigmentosa 20); AD (Retinitis pigmentosa 87 with choroidal involvement),
PSMD2,AD (Angelman syndrome); AR (Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities),
PSMD3,"Intellectual developmental disorder, X-linked syndromic, Nascimento type",
PSMD5,AR (Lissencephaly 8); AR (CODAS syndrome),
PSMD9,"AD ({Diabetes mellitus, type II, susceptibility to}); MODY, type IV; AR (Pancreatic agenesis 1)",
PSME1,"AR (Immunodeficiency 65, susceptibility to viral infections); AR (Neurodevelopmental disorder with hypotonia and seizures)",
PSME2,"AR (Immunodeficiency 65, susceptibility to viral infections); AR (Neurodevelopmental disorder with hypotonia and seizures)",
PSMF1,"Intellectual developmental disorder, X-linked syndromic, Nascimento type",
PSMG1,AR (?Proteasome-associated autoinflammatory syndrome 4); AR (Keratosis linearis with ichthyosis congenita and sclerosing keratoderma); AD (Proteasome-associated autoinflammatory syndrome 2),
PSMG2,AR (?Proteasome-associated autoinflammatory syndrome 4),
PSPC1,"AR (Immunodeficiency 75); Myelodysplastic syndrome, somatic; Intellectual developmental disorder, X-linked syndromic 34; {Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1",
PSPH,AR (Phosphoserine phosphatase deficiency),
PSRC1,AD ([Low density lipoprotein cholesterol level QTL6]),
PSTK,AR (Pontocerebellar hypoplasia type 2D),
PSTPIP1,"AD (Autoinflammatory syndrome with cytopenia, hyperzincemia, and hypercalprotectinemia); AD (Pyogenic sterile arthritis, pyoderma gangrenosum, and acne); AD (Familial Mediterranean fever, AD); AR (Familial Mediterranean fever, AR); AD (Neutrophilic dermatosis, acute febrile); AD (Congenital heart defects and skeletal malformations syndrome); Leukemia, Philadelphia chromosome-positive, resistant to imatinib; Colon cancer, somatic; AD (Acne inversa, familial, 1)",
PSTPIP2,"Anemia, congenital, nonspherocytic hemolytic, 9; Anemia, X-linked, with/without neutropenia and/or platelet abnormalities; Leukemia, megakaryoblastic, with or without Down syndrome, somatic; Thrombocytopenia with beta-thalassemia, X-linked; Thrombocytopenia, X-linked, with or without dyserythropoietic anemia",
PTAFR,AR (Immunodeficiency 35),
PTBP1,"AR (Myopathy with lactic acidosis, hereditary)",
PTBP2,"Developmental and epileptic encephalopathy 90; Intellectual developmental disorder, X-linked 110; AD (Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities)",
PTCD3,AR (Combined oxidative phosphorylation deficiency 51); AR (Combined oxidative phosphorylation deficiency 55); AR (Combined oxidative phosphorylation deficiency 58); AD (Neurodevelopmental disorder with variable motor and speech impairment),
PTCH1,"Basal cell carcinoma, somatic; AD (Basal cell nevus syndrome 1); AD (Holoprosencephaly 7); AD (Holoprosencephaly 3); AD (Microphthalmia/coloboma 5); AD (Single median maxillary central incisor); Basal cell carcinoma, somatic; Curry-Jones syndrome, somatic mosaic; AR (Pallister-Hall-like syndrome); AD (Holoprosencephaly 11); AR (Acrocapitofemoral dysplasia); AD (Brachydactyly, type A1); {Basal cell carcinoma, susceptibility to, 1}; AD (Microphthalmia, syndromic 3); AD (Optic nerve hypoplasia and abnormalities of the central nervous system)",
PTCH2,"Basal cell carcinoma, somatic; Medulloblastoma, somatic; Macrostomia; {Basal cell carcinoma, susceptibility to, 1}",
PTCHD1,"{Autism, susceptibility to, X-linked 4}; {Autism susceptibility 1}",
PTCRA,AR (Immunodeficiency 126),
PTDSS1,AD (Lenz-Majewski hyperostotic dwarfism),
PTDSS2,AD (Lenz-Majewski hyperostotic dwarfism),
PTEN,"AD ({Glioma susceptibility 2}); AD ({Meningioma}); AD (Cowden syndrome 1); AD (Lhermitte-Duclos disease); AD (Macrocephaly/autism syndrome); Prostate cancer, somatic; AR (Parkinson disease 6, early onset); AR (Neurodevelopmental disorder with ataxia and brain abnormalities)",
PTER,"{Kuru, susceptibility to}; AD (Cerebral amyloid angiopathy, PRNP-related); AD (Creutzfeldt-Jakob disease); AD (Gerstmann-Straussler disease); AD (Huntington disease-like 1); AD (Insomnia, fatal familial); AD (Spongiform encephalopathy with neuropsychiatric features); AD (Brugada syndrome 3); AD (Long QT syndrome 8); AD (Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures); AD (Timothy syndrome); AD (Erythrocytosis, familial, 7); AD (Heinz body anemias, alpha-); Hemoglobin H disease, nondeletional; AD (Methemoglobinemia, alpha type); Thalassemias, alpha-; AR (Otofaciocervical syndrome 2 with T-cell deficiency); AD (3p- syndrome); AR (Mucopolysaccharidosis VII); AR ([AMP deaminase deficiency, erythrocytic]); AD (Cat eye syndrome); [Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]; AR (Albinism, oculocutaneous, type III)",
PTF1A,"AR (Pancreatic agenesis 2); AR (Pancreatic and cerebellar agenesis); AR (Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism); AR (Pontocerebellar hypoplasia, type 17); AD (Adams-Oliver syndrome 3); AD (Atrial septal defect 9); AD (Atrioventricular septal defect 5); AD (Pancreatic agenesis and congenital heart defects); Persistent truncus arteriosus; AD (Tetralogy of Fallot)",
PTGDR,"{Asthma, susceptibility to, 1}; AD ({Diabetes, type 2}); AD (Insulin resistance, severe, digenic); AD (Lipodystrophy, familial partial, type 3); AR (Obesity, severe)",
PTGDS,"AD (Alzheimer disease 1, familial); AD (Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants); {Asthma, susceptibility to, 1}",
PTGER1,"AR ({Asthma, aspirin-induced, susceptibility to})",
PTGER2,"AR ({Asthma, aspirin-induced, susceptibility to}); {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AD (Polycystic kidney disease 1)",
PTGER3,"AR ({Asthma, aspirin-induced, susceptibility to})",
PTGER4,"{Inflammatory bowel disease 18}; {Graft-versus-host disease, protection against}; {HIV-1, susceptibility to}; {Rheumatoid arthritis, progression of}; AR (?Cocoon syndrome); AR (?Popliteal pterygium syndrome, Bartsocas-Papas type 2)",
PTGES3,"AD ([Hemoglobin, high altitude adaptation]); AD (Erythrocytosis, familial, 3)",
PTGIR,AD (?Marsili syndrome),
PTGIS,"Hypertension, essential",
PTGS1,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AD (?Familial cold autoinflammatory syndrome 4); AD (Autoinflammation with infantile enterocolitis)",
PTGS2,"AR (Immunodeficiency 68); Macroglobulinemia, Waldenstrom, somatic; AR (Gastrointestinal ulceration, recurrent, with dysfunctional platelets); {Transcription of plasminogen activator inhibitor, modulator of}; AR (Plasminogen activator inhibitor-1 deficiency)",
PTH,"AR (Hypoparathyroidism, familial isolated 1); AR (Chondrodysplasia, Blomstrand type); AR (Eiken syndrome); AD (Failure of tooth eruption, primary); AD (Metaphyseal chondrodysplasia, Murk Jansen type); AD ({Colorectal cancer, susceptibility to}); {Multiple myeloma, susceptibility to}; AD ({von Hippel-Lindau syndrome, modifier of}); AD (Brachydactyly, type E2); AR (Bardet-Biedl syndrome 9); AD ({?Epilepsy idiopathic generalized, susceptibility to, 8}); AR (Hyperparathyroidism, neonatal); AD (Hypocalcemia, autosomal dominant); AD (Hypocalcemia, autosomal dominant, with Bartter syndrome); AD (Hypocalciuric hypercalcemia, type I)",
PTH1R,"AR (Chondrodysplasia, Blomstrand type); AR (Eiken syndrome); AD (Failure of tooth eruption, primary); AD (Metaphyseal chondrodysplasia, Murk Jansen type); AD (Nephrolithiasis/osteoporosis, hypophosphatemic, 2); AR (?Spondyloepimetaphyseal dysplasia, Krakow type); AD ({Coronary artery disease, autosomal dominant, 2}); AD (Tooth agenesis, selective, 7)",
PTH2,AR (Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities),
PTHLH,"AD (Brachydactyly, type E2); AR (Hypoparathyroidism, familial isolated 1); AR (Chondrodysplasia, Blomstrand type); AR (Eiken syndrome); AD (Failure of tooth eruption, primary); AD (Metaphyseal chondrodysplasia, Murk Jansen type); AD (Hypertension and brachydactyly syndrome); Rhabdomyosarcoma, alveolar",
PTK2,"AD (Dermatopathia pigmentosa reticularis); AD (Epidermolysis bullosa simplex 1A, generalized severe); AD (Epidermolysis bullosa simplex 1B, generalized intermediate); AD (Epidermolysis bullosa simplex 1C, localized); AR (Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive); AD (Naegeli-Franceschetti-Jadassohn syndrome); AD (Pachyonychia congenita 1); AD (Palmoplantar keratoderma, nonepidermolytic, focal); AR (Renal tubular dysgenesis); AD (?Spondyloepimetaphyseal dysplasia, Li-Shao-Li type); AR (Kyphomelic dysplasia)",
PTK2B,"AR (Joubert syndrome 4); AR (Nephronophthisis 1, juvenile); AR (Senior-Loken syndrome-1); AD ({Melanoma, cutaneous malignant, 1}); AD (Amyotrophic lateral sclerosis 19); AR (?Bent bone dysplasia syndrome 2); AR (Nephrotic syndrome, type 26); AR (Nephronophthisis 4); AR (Senior-Loken syndrome 4); AR (Immunodeficiency, common variable, 2); Immunoglobulin A deficiency 2",
PTK7,AD (Neural tube defects),
PTMS,AD (Bryant-Li-Bhoj neurodevelopmental syndrome 2); AD (Bryant-Li-Bhoj neurodevelopmental syndrome 1),
PTN,"Encephalocraniocutaneous lipomatosis, somatic mosaic; AD (Hartsfield syndrome); AD (Hypogonadotropic hypogonadism 2 with or without anosmia); AD (Jackson-Weiss syndrome); AD (Osteoglophonic dysplasia); AD (Pfeiffer syndrome); AD (Trigonocephaly 1); AD (Hypospadias 3, autosomal)",
PTOV1,AR (Basel-Vanagait-Smirin-Yosef syndrome),
PTPA,"AR (Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development)",
PTPMT1,AR (Neurodevelopmental disorder with ataxia and brain abnormalities),
PTPN1,"AD ({Insulin resistance, susceptibility to}); Colon cancer, somatic; AR ({Diabetes, type 1, susceptibility to}); {Rheumatoid arthritis, susceptibility to}; AD ({Systemic lupus erythematosus susceptibility to}); AD (Immunodeficiency 132A); AD (Immunodeficiency 132B); AD (Abdominal obesity-metabolic syndrome 1)",
PTPN11,"AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); AD (Leukemia, juvenile myelomonocytic); AD (Neurofibromatosis-Noonan syndrome); AD (Neurofibromatosis, familial spinal); AD (Neurofibromatosis, type 1); AD (Watson syndrome); AR (Pycnodysostosis)",
PTPN12,"Colon cancer, somatic; AD (Autoinflammatory syndrome with cytopenia, hyperzincemia, and hypercalprotectinemia); AD (Pyogenic sterile arthritis, pyoderma gangrenosum, and acne)",
PTPN13,"AD (Immunodeficiency 32A, mycobacteriosis, autosomal dominant); AR (Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive); AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2)",
PTPN14,"AR (Choanal atresia and lymphedema); AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2)",
PTPN2,"AD (Aicardi-Goutieres syndrome 7); AR (Immunodeficiency 95); AD (Singleton-Merten syndrome 1); AD ({Inflammatory bowel disease 21}); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR ({Diabetes mellitus, insulin-dependent-1})",
PTPN21,AD (Developmental and epileptic encephalopathy 109),
PTPN22,"AR ({Diabetes, type 1, susceptibility to}); {Rheumatoid arthritis, susceptibility to}; AD ({Systemic lupus erythematosus susceptibility to}); {Multiple sclerosis, susceptibility to, 1}; AD ({Sarcoidosis, susceptibility to, 1}); AR ({Diabetes mellitus, insulin-dependent-1}); AD (Hashimoto thyroiditis)",
PTPN23,"AR (Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity); AD (Spastic paraplegia 80, autosomal dominant)",
PTPN3,"AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2); AR (Choanal atresia and lymphedema)",
PTPN4,AR (Choanal atresia and lymphedema),
PTPN6,"AD (LEOPARD syndrome 1); Leukemia, juvenile myelomonocytic, somatic; AD (Metachondromatosis); AD (Noonan syndrome 1); AD (Autoimmune disease, multisystem, infantile-onset, 1); AD (Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections); AR (Autoimmune lymphoproliferative syndrome, type III); AD (Basal ganglia calcification, idiopathic, 5); AD (Meningioma, SIS-related); AD (Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant); AD (Neuropathy, hereditary sensory, type IE); AD (Immunodeficiency, common variable, 12)",
PTPRA,"AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2)",
PTPRC,"AR (Immunodeficiency 105, severe combined); Immunodeficiency 74, COVID19-related, X-linked; Systemic lupus erythematosus 17; AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity; AR (Combined cellular and humoral immune defects with granulomas); AR (Omenn syndrome); AR (Severe combined immunodeficiency, B cell-negative); [Longevity 1]",
PTPRD,{Restless legs syndrome 3},
PTPRE,"Colon cancer, somatic; AR (Thrombocytopenia 10)",
PTPRF,"AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2); AR (Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities); AD (Paul-Chao neurodevelopmental syndrome)",
PTPRG,"AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2); AR (Choanal atresia and lymphedema)",
PTPRJ,"Colon cancer, somatic; AR (Thrombocytopenia 10); {Aspergillosis, susceptibility to}; AR (Candidiasis, familial, 4, autosomal recessive)",
PTPRN,"AR (Neurodevelopmental disorder with hypotonia, neuropathy, and deafness); AR ({Obesity, susceptibility to}); AD ({Diabetes mellitus, noninsulin-dependent, susceptibility to})",
PTPRN2,"AR ({Obesity, susceptibility to})",
PTPRO,"AR (Nephrotic syndrome, type 6); AR (Nephrotic syndrome, type 2)",
PTPRQ,"AD (Deafness, autosomal dominant 73); AR (Deafness, autosomal recessive 84A); AR (Deafness, autosomal recessive 84B); AD (Deafness, autosomal dominant 50)",
PTPRS,"AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2); AD (?Spondyloepiphyseal dysplasia, Kimberley type); AD (Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans); AR (Spondyloepimetaphyseal dysplasia, aggrecan type)",
PTPRT,"AR (?Breasts and/or nipples, aplasia or hypoplasia of, 2); AR (Choanal atresia and lymphedema)",
PTPRZ1,"AR (Hypomyelinating neuropathy, congenital, 3); AR (Lethal congenital contracture syndrome 7)",
PTRH2,"AR (Infantile-onset multisystem neurologic, endocrine, and pancreatic disease)",
PTRHD1,AR (Neurodevelopmental disorder with early-onset parkinsonism and behavioral abnormalities),
PTS,"AR (Hyperphenylalaninemia, BH4-deficient, A); AR (Peroxisome biogenesis disorder 9B); AR (Rhizomelic chondrodysplasia punctata, type 1); AR (Peroxisome biogenesis disorder 13A (Zellweger))",
PTTG1,"AD (Thyroid hormone resistance); AR (Thyroid hormone resistance, autosomal recessive); AD (Thyroid hormone resistance, selective pituitary); AD (46XX sex reversal 2); AD (46XY sex reversal 10); AD (Acampomelic campomelic dysplasia); AD (Campomelic dysplasia); AD (Campomelic dysplasia with autosomal sex reversal); AD (Houge-Janssens syndrome 3); AR (Ceroid lipofuscinosis, neuronal, 1); AR (?Mungan syndrome); AD (Cornelia de Lange syndrome 4); AR (Ceroid lipofuscinosis, neuronal, 6A); AR (Ceroid lipofuscinosis, neuronal, 6B (Kufs type))",
PTTG1IP,Down syndrome,
PTX3,"AD (Anterior segment dysgenesis 1, multiple subtypes); AR (Cataract 11, multiple types); AR (Cataract 11, syndromic, autosomal recessive); AD (Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly)",
PUF60,AD (Verheij syndrome),
PUM1,"AD (Neurodevelopmental disorder with motor abnormalities, and facial dysmorphism); AD (Spinocerebellar ataxia 27A); AD (Spinocerebellar ataxia 27B, late-onset); AD (Chromosome 1p35 deletion syndrome)",
PUM2,"AD (Neurodevelopmental disorder with motor abnormalities, and facial dysmorphism); AD (Spermatogenic failure 12)",
PURA,"AD (Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties); AR (?Premature ovarian failure 10); AR (Combined oxidative phosphorylation deficiency 57)",
PURB,"AD (Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties)",
PURG,AR (Werner syndrome),
PUS1,"AR (Myopathy, lactic acidosis, and sideroblastic anemia 1)",
PUS3,AR (Neurodevelopmental disorder with microcephaly and gray sclerae),
PUS7,"AR (Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature)",
PVALB,"AD (Tolchin-Le Caignec syndrome); {Schizophrenia 9, susceptibility to}; AD (Cataract 3, multiple types); {Autism susceptibility, X-linked 1}",
PVR,"Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial; Hypereosinophilic syndrome, idiopathic, resistant to imatinib; AR (Cleft lip/palate-ectodermal dysplasia syndrome); AR (Orofacial cleft 7); AD (Orofacial cleft 3); AD (C syndrome)",
PXDN,"AR (Anterior segment dysgenesis 7, with sclerocornea)",
PXDNL,"AR (Anterior segment dysgenesis 7, with sclerocornea)",
PXK,"{Systemic lupus erythematosus, susceptibility to, 6}",
PXN,"AR (Anterior segment dysgenesis 7, with sclerocornea); AR (Renal tubular dysgenesis); AD (Deafness, autosomal dominant 1, with or without thrombocytopenia); AR (Seizures, cortical blindness, microcephaly syndrome)",
PYCARD,"AD (CINCA syndrome); AD (Deafness, autosomal dominant 34, with or without inflammation); AD (Familial cold inflammatory syndrome 1); AD (Keratoendothelitis fugax hereditaria); AD (Muckle-Wells syndrome); AR (Hatipoglu immunodeficiency syndrome); {Gastric cancer risk after H. pylori infection}; AR (Dystonia 33); AD (Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome); AD ({Schistosoma mansoni infection, susceptibility/resistance to}); AD (Intellectual developmental disorder, autosomal dominant 42); Leukemia, acute lymphoblastic, somatic; Myelodysplastic syndrome, somatic; AD (Immunodeficiency 82 with systemic inflammation)",
PYCR1,"AR (Cutis laxa, autosomal recessive, type IIB); AR (Cutis laxa, autosomal recessive, type IIIB); AR (Leukodystrophy, hypomyelinating, 10); AD (Cutis laxa, autosomal dominant 3); AR (Cutis laxa, autosomal recessive, type IIIA); AD (Spastic paraplegia 9A, autosomal dominant); AR (Spastic paraplegia 9B, autosomal recessive)",
PYCR2,"AR (Leukodystrophy, hypomyelinating, 10); AR (Cutis laxa, autosomal recessive, type IIB); AR (Cutis laxa, autosomal recessive, type IIIB)",
PYGB,AR (McArdle disease),
PYGL,"AR (Glycogen storage disease VI); AR (McArdle disease); Colon cancer, somatic; AR (Glycine N-methyltransferase deficiency)",
PYGM,"AR (McArdle disease); AR (Retinitis pigmentosa 7, digenic form); Adrenal adenoma, somatic; Angiofibroma, somatic; Carcinoid tumor of lung; Lipoma, somatic; AD (Multiple endocrine neoplasia 1); Parathyroid adenoma, somatic; AR (?Bleeding disorder, platelet-type, 18)",
PYGO2,"{Prostate cancer, susceptibility to}; Androgen insensitivity; Androgen insensitivity, partial, with or without breast cancer; Hypospadias 1, X-linked; Spinal and bulbar muscular atrophy, X-linked 1",
PYROXD1,"AR (Myopathy, myofibrillar, 8)",
PYURF,AR (Hyperphosphatasia with impaired intellectual development syndrome 6),
PYY,"AR ({Obesity, resistance to (BMIQ20)}); AR (Obesity (BMIQ20))",
PZP,"AR (Anterior segment dysgenesis 8); AD ({Otitis media, susceptibility to})",
QARS1,"AR (Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy)",
QDPR,"AR (Hyperphenylalaninemia, BH4-deficient, C); AD ({Malignant hyperthermia susceptibility 1}); AD (Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia); AR (Congenital myopathy 1B, autosomal recessive); AD (King-Denborough syndrome); AD (Huntington disease); AR (Lopes-Maciel-Rodan syndrome)",
QKI,"AR (Spastic paraplegia 75, autosomal recessive); Pelizaeus-Merzbacher disease; Spastic paraplegia 2, X-linked; AD (Alexander disease)",
QRICH1,AD (Ververi-Brady syndrome),
QRICH2,AR (Spermatogenic failure 35),
QRSL1,AR (Combined oxidative phosphorylation deficiency 40); AR (Combined oxidative phosphorylation deficiency 42); AR (?Combined oxidative phosphorylation deficiency 41); AR (Combined oxidative phosphorylation deficiency 12),
QSOX2,{Stature QTL 1},
RAB10,"AD ({Parkinson disease 8}); {Diabetes mellitus, noninsulin-dependent, 5}",
RAB11A,"AR (Cholestasis, progressive familial intrahepatic, 10); AR (Diarrhea 2, with microvillus atrophy, with or without cholestasis)",
RAB11B,"AD (Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter); Nephrotic syndrome, type 20",
RAB11FIP2,AR (?Neurodegeneration with brain iron accumulation 7),
RAB11FIP5,"AR (Cholestasis, progressive familial intrahepatic, 10); AR (Diarrhea 2, with microvillus atrophy, with or without cholestasis)",
RAB13,AR (Cone-rod dystrophy 18),
RAB14,"{Diabetes mellitus, noninsulin-dependent, 5}; Breast cancer, somatic; Colorectal cancer, somatic; AD (Cowden syndrome 6); Ovarian cancer, somatic; Proteus syndrome, somatic mosaic",
RAB15,"AR (Griscelli syndrome, type 2)",
RAB17,AR (Warburg micro syndrome 3),
RAB18,"AR (Warburg micro syndrome 3); AR (Martsolf syndrome 2); AR (Warburg micro syndrome 1); Chromosome 1p36 deletion syndrome, distal",
RAB1A,Choroideremia,
RAB1B,"AR (Intellectual developmental disorder, autosomal recessive 61)",
RAB22A,"AR (Neurodevelopmental disorder with seizures and gingival overgrowth); AD (Corneal dystrophy, Fuchs endothelial, 6); AD (Corneal dystrophy, posterior polymorphous, 3)",
RAB23,AR (Carpenter syndrome); AR (Hepatorenocardiac degenerative fibrosis); AR (Joubert syndrome 13),
RAB2A,"{Diabetes mellitus, noninsulin-dependent, 5}",
RAB3A,"AR (Cone-rod synaptic disorder syndrome, congenital nonprogressive); Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders; Intellectual developmental disorder, X-linked 50; AR (Martsolf syndrome 2); AR (Warburg micro syndrome 1)",
RAB3C,"AR (Cone-rod synaptic disorder syndrome, congenital nonprogressive)",
RAB3D,"AD (Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter)",
RAB3GAP1,"AR (Martsolf syndrome 2); AR (Warburg micro syndrome 1); AR (Martsolf syndrome 1); AR (Warburg micro syndrome 2); AR (Warburg micro syndrome 3); Chromosome 1p36 deletion syndrome, distal",
RAB3GAP2,"AR (Martsolf syndrome 1); AR (Warburg micro syndrome 2); AR (Martsolf syndrome 2); AR (Warburg micro syndrome 1); AR (Warburg micro syndrome 3); Chromosome 1p36 deletion syndrome, distal",
RAB3IP,AR (Bardet-Biedl syndrome 4); AR (Bardet-Biedl syndrome 1); AR (Bardet-Biedl syndrome 2); AR (Retinitis pigmentosa 74); AR (Bardet-Biedl syndrome 5); AR (Bardet-Biedl syndrome 9); AR (?Retinitis pigmentosa 51); AR (Bardet-Biedl syndrome 8); AR (Bardet-Biedl syndrome 7),
RAB4A,"AR (Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis); AR (Pontocerebellar hypoplasia, type 13); AR (Pontocerebellar hypoplasia, type 2E)",
RAB5A,"AD (MIRAGE syndrome); AD (Monosomy 7 myelodysplasia and leukemia syndrome 2); AR (Tumoral calcinosis, familial, normophosphatemic)",
RAB5B,"AR (Macrocephaly, alopecia, cutis laxa, and scoliosis)",
RAB5IF,"AR (?Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 2)",
RAB6A,"AR (CATIFA syndrome); AD (Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant); AD (Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant); AR (Pontocerebellar hypoplasia, type 2E); AR (Developmental and epileptic encephalopathy 49)",
RAB6B,"AR (Pontocerebellar hypoplasia, type 2E)",
RAB7A,"AD (Charcot-Marie-Tooth disease, type 2B); AD (MIRAGE syndrome); AD (Monosomy 7 myelodysplasia and leukemia syndrome 2); AR (Tumoral calcinosis, familial, normophosphatemic)",
RAB7B,AR (Cone-rod dystrophy 18),
RAB8A,"Cone-rod dystrophy, X-linked, 1; Macular degeneration, X-linked atrophic; Retinitis pigmentosa 3; Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness; AR (Cholestasis, progressive familial intrahepatic, 10); AR (Diarrhea 2, with microvillus atrophy, with or without cholestasis); AR (Joubert syndrome 3); AR (?Bardet-Biedl syndrome 14); AR (Joubert syndrome 5); Leber congenital amaurosis 10; AR (Meckel syndrome 4); AR (Senior-Loken syndrome 6); AR (Osteopetrosis, autosomal recessive 8)",
RAB8B,"AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 3); AD (Myopathy, distal, with rimmed vacuoles); AR (Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset); AD (Paget disease of bone 3); AD ({Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}); AR (Autoinflammation with arthritis and vasculitis); AD (Frontotemporal dementia and/or amyotrophic lateral sclerosis 4)",
